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ADC Activated diffusion coefficients
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BDNF Brain-derived neurotrophic factor
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CNS Central nervous system
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MOTOR SYSTEM AND MOTOR DISORDERS
The spinal cord anterior horn cells are influenced by descending pathways 
from the cerebral cortex and from brainstem centres. These motor cortical and 
brainstem outflow areas are regulated by other cortical areas, the basal ganglia 
and cerebellum. The basal ganglia and the cerebellum are both characterized by 
parallel processing of inputs from cortical areas and subsequent projection back 
to cortex via thalamic relay nuclei.
MOTOR CORTEX
There are several motor cortical areas in the human; these are classified 
simply as the primary motor cortex, lateral pre-motor cortex, supplementary mo­
tor area (SMA), and motor regions of the cingulate cortex.
The primary motor cortex (Brodmann's area 4) pyramidal cells are the 
principal source of the pyramidal tract but also project to other motor cortical 
areas and to sensory cortex, the thalamus, the basal ganglia (corpus striatum), 
the red nucleus, brainstem reticular nuclei, and the cerebellum (via the cortico­
pontine fibres and pontine nuclei). The primary motor cortex shows a soma- 
totopic organization but pyramidal cells may activate more than one muscle and 
a muscle may be affected by pyramidal cells spread over a wide cortical area. 
Primary motor cortex cells are activated prior to and during voluntary contralat­
eral movement, as shown by functional imaging and neurophysiological event- 
related recordings. Lesions of the primary motor cortex are associated princi­
pally with deficits of small accurate finger and hand movements. Such move­
ments require motor cortex outputs not only to agonist muscle spinal motor neu­
rons but also those needed to regulate the activity of antagonists and muscles 
needed to stabilize proximal joints.
The lateral pre-motor cortex (the lateral part of Brodmann's area 6) is lo­
cated on the lateral aspect of the frontal lobe, anterior to the primary motor cor­
tex. There are two discreet motor areas (superior and inferior) within the lateral 
premotor cortex with separate motor cortical maps and corticospinal projections. 
There is a considerable output from the lateral pre-motor cortex to the medial 
brainstem tegmentum which projects to the spinal cord in the ventromedial de­
scending system (see below). The pre-motor cortex is important for the control 
of axial and proximal limb movements and also for the control of movements in 
response to external cues or instructions. The activation of the lateral pre-motor 
cortex begins prior to the execution of movement, suggesting an important role 
in preparation for movement, and may be bilateral. Lesions of the lateral pre­
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motor area produce proximal limb weakness and impairment of movements re­
quiring use of the whole arm and hand. There is also impaired learning of motor 
responses to external cues.
The SMA (medial part of Brodmann's area 6) is on the inner aspect of the 
frontal lobe, anterior to area 4 and continuous with the lateral pre-motor cortex. 
The SMA receives considerable basal ganglia inputs and has outputs to the pri­
mary motor cortex, corticospinal tract, basal ganglia, cerebellum, red nucleus, 
and reticular formation. Like the lateral pre-motor cortex, the SMA seems to be 
important for the preparation of movements, particularly internally generated, 
learned, sequential, or bimanual movements. SMA lesions lead to difficulty ini­
tiating speech and movement, impaired bimanual co-ordination, and the 'alien 
limb' phenomenon where the arm moves spontaneously in response to external 
stimuli, grasping at objects spontaneously. This may represent a dissociation of 
externally (lateral pre-motor cortex) and internally (SMA) cued movement.
Cingulate motor areas have been identified in humans and non-human 
primates. They have outputs to spinal cord and the basal ganglia and receive in­
puts from frontal pre-motor cortex. Cingulate motor neurons are active in inter­
nally generated movements and cingulate activation is seen mainly with com­
plex motor tasks. Stimulation of cingulate cortex produces complex motor activ­
ity.
The descending pathways
The descending pathways are grouped into two divisions within the spinal 
cord. A dorso-lateral group contains the lateral corticospinal tract along with the 
rubrospinal tract and the crossed reticulospinal tract (from the lateral pontine 
tegmentum). These dorso-lateral pathways are concerned with distal move­
ments. The ventro-lateral group is made up of the ventral corticospinal tract with 
the interstitiospinal, vestibulospinal, and reticulospinal (from medial pontine and 
medullary tegmentum) tracts and is involved in the control of proximal move­
ments.
The pyramidal tract comprises the corticobulbar and corticospinal tracts 
and in the human, the latter component contains about one million fibres on each 
side. About 60 per cent of the fibres in the corticospinal tract originate in the 
frontal motor areas. The remainders are from parietal and somatosensory cortex. 
The corticospinal tract influences spinal afferent pathways, inhibitory interneu­
rons, and gamma efferent cells as well as the alpha motor neurons. There is con­
siderable convergence and divergence within the corticospinal tract; cortical py­
ramidal cells project to several muscles and each muscle can be activated by 
cells from a large cortical motor field. Direct synapses with alpha motor neurons 
are particularly dense on cells concerned with finger movements and there is a 
close association between the corticospinal tract and the execution of fine finger 
movements. Lesions of'the pyramidal tract tend to produce impaired manual 
dexterity with variable degrees of weakness.
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Other descending pathways are poorly understood in man. The reticu­
lospinal pathway appears to be important in the startle reflex. Vestibulospinal 
pathways are concerned in part with postural control.
THE CEREBELLUM AND BASAL GANGLIA
Neither the cerebellum nor the basal ganglia have direct efferent connec­
tions to the spinal motor apparatus and yet both are clearly involved in the cor­
rect execution and control of movement. Profound disturbances of movement as 
their primary symptoms we can find in patients with lesions of these structures. 
Anatomically, both structures are characterized by extensive inputs from the 
cerebral cortex, parallel internal circuitry, and projections back to the cortex via 
thalamic relay nuclei. Despite much information about the anatomy and cellular 
neurophysiology of the cerebellum and basal ganglia, their precise functions are 
not clear.
The cerebellum
The cerebellum is made up of two hemispheres separated by a midline 
vermis. There are three lobes, the anterior, posterior, and the flocculonodular 
lobe. There are three deeply situated outflow nuclei in each hemisphere, the fas- 
tigial nucleus medially, the interposed (made up of globose and emboliform), 
and the dentate nucleus laterally. The majority of cerebellar efferents leave via 
the superior peduncle. The inferior and middle peduncles are largely composed 
of afferent fibres from the spinal cord and brainstem nuclei. Within the cerebel­
lum there are three phylogenetic regions:
1. The neocerebellum (pontocerebellum) includes the bulk of the cerebel­
lar hemispheres and the central portion of the vermis. It receives the bulk of the 
pontine inputs via the middle peduncle. The neocerebellum is principally con­
cerned with the co-ordination of the ipsilateral limbs.
2. The paleocerebellum (spinocerebellum) consists of the parafloccular 
lobes and the remainder of the vermis of the anterior and posterior lobes. It re­
ceives direct inputs from the spinal cord via the inferior peduncle and is proba­
bly concerned with the regulation of muscle tone.
3. The archicerebellum (vestibulocerebellum) is composed of the floccu­
lonodular lobe only and receives direct vestibular inputs via the inferior pedun­
cle.
In fact, there is considerable overlap in the connections of these three re­
gions and their separation on the basis of their inputs is only approximate. The 
cerebellum may also be subdivided on the basis of outflow projections. The lat­
eral mass of each hemisphere projects to the dentate nucleus, the vermis projects 
mainly to the fastigial nucleus and an intermediate zone sends fibres to the in­
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terposed nucleus. The flocculonodular lobe, vermis, and certain hemisphere ar­
eas also project to the vestibular nuclei. Another interesting feature of cerebellar 
organization concerns sagittal strips of cortex which share inputs from the same 
regions of the olivary nuclei.
Afferents
All cerebellar afferents terminate in both the cortex and the cerebellar nu­
clei. The cerebellar afferent systems are as follows.
The vast majority of cerebellar afferents are from the pontine nuclei, 
through the middle peduncle. These nuclei relay cortical inputs to the cerebel­
lum from the ipsilateral frontal and parietal lobes. These are not collaterals of 
motor corticospinal fibres. The pontocerebellar projection is to most areas of the 
contralateral cerebellum and the interposed and dentate nuclei. Pontocerebellar 
afferents form mossy fibres within the cerebellum, synapsing in the granule cell 
layer of the cerebellar cortex and in the cerebellar nuclei.
Direct spinocerebellar input is via the inferior peduncle along with affer­
ents from the vestibular and brainstem reticular nuclei. These also enter the 
cerebellum as mossy fibres.
The inferior olivary nucleus receives inputs from the spinal cord, cerebral 
motor cortex, and brainstem. It sends climbing fibres directly to cerebellar Pur- 
kinje cells and the cerebellar nuclei.
Direct aminergic inputs arise from the locus coeruleus (noradrenergic), 
raphe nuclei (SHT), and midbrain ventral tegmentum (dopaminergic). These 
project directly to Purkinje cells.
Cerebellar cortex
There is a complex somatotopic representation in the cerebellar cortex 
which can only be detected in anaesthetized animals. There appear to be two 
maps, one in the anterior lobe and one in the posterior lobe. Midline structures 
are represented in the vermis and limbs laterally in the hemispheres.
The circuitry of the cerebellar cortex is located in three cortical layers; the 
superficial molecular layer, the Purkinje cell layer, and a deep granule cell layer. 
Afferents arrive as either mossy or climbing fibres (except for the smalt number 
of aminergic afferents) and all efferents are Purkinje cell axons which terminate 
in the cerebellar or vestibular nuclei. There is some evidence that the firing 
characteristics of the Purkinje cells are altered by the pattern of climbing and 
parallel fibre activation, and that this may form the basis of cerebellar learning.
Efferents
The Purkinje cells are the only efferent cells of the cerebellum and they 
project to the cerebellar and vestibular nuclei; they are inhibitory. The fastigial 
nucleus, the main outflow of the medial cerebellar structures, projects mainly to 
the vestibular nuclei, brainstem reticular formation, and the spinal cord. The in­
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terposed and dentate nuclei relay efferents from more lateral cerebellar struc­
tures to the contralateral red nucleus and thalamus via the superior peduncle. 
These axons also have descending branches to the lower brainstem reticular 
formation. In the thalamus, cerebellar efferents reach the VL and VPL nuclei 
which then project to the primary motor cortex (area 4). Thalamic nucleus X 
also receives cerebellar efferents and projects to the lateral pre-motor cortex 
(area 6). Although cerebellar projections via the thalamus reach a wide area of 
cerebral cortex, the bulk of the output is to frontal motor cortex.
Cerebellar function
The cerebellum receives inputs from the cerebral cortex and also from the 
spinal cord and vestibular system via the mossy and climbing systems, respec­
tively. This may enable a comparison of the motor command and the actual 
movement of the body, allowing correction and adjustment of the movement. 
The cerebellum is also involved in the correct planning of movement. Activation 
of lateral cerebellar cortical neurons occurs before movement, suggesting that 
cerebellar input to the frontal motor cortex is an important part of preparation 
for movement. There is evidence that the cerebellum is involved in the correct 
timing and force of the agonist and antagonist activation during movement; 
cerebellar dysfunction leads to delayed and prolonged agonist bursts and de­
layed antagonist activation, leading to dysmetria and dysdiadochokinesis. The 
cerebellum is also thought to be involved in the learning of motor tasks. There 
are three main theories of cerebellar function in relation to movement.
A. A feedback control of the ongoing movement. This assumes continu­
ous monitoring of afferent signals from the periphery by the cerebellum. This 
allows a continuous correction of the motor cortex activity by the cerebellar out­
flow (feedback mechanism).
B. A centre for the generation of precise motor plans concerning the tim­
ing and amplitude of movements which are then sent to the frontal motor cortex 
for execution (feedforward mechanism).
C. The efference copy theory integrates feedback and feedforward models 
and assumes that the cerebellum receives a copy of the movement command 
from the cerebral cortex and compares it to current and ongoing afferent signals 
from the periphery. The motor command is then adjusted and refined by the 
cerebellum to allow for the position and motion of the body prior to movement 
onset and during the execution of the movement itself.
The basal ganglia
The basal ganglia are thought to be important for motor control because of 
their anatomical connections, the neurophysiological properties of their neurons, 
and the effects of anatomical lesions and alterations in basal ganglia neurotrans­
mitter function on movement. The basal ganglia are made up of the putamen and
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caudate nucleus (neostriatum), the globus pallidus (paleostriatum), the substantia 
nigra, and the subthalamic nucleus (STN). The inclusion of other nuclear struc­
tures such as the nucleus accumbens and parts of the olfactory tubercle (the ven­
tral striatum) has been emphasized recently.
Anatomy and physiology
The putamen, globus pallidus, and caudate nucleus are large masses of 
grey matter lateral to the thalamus and separated from it by the internal capsule; 
anteriorly the internal capsule also separates the putamen from the head of the 
caudate nucleus. The putamen lies lateral to the globus pallidus and these to­
gether form the lentiform nucleus with the head of the caudate nucleus lying an­
teriorly and the body curving over superiorly and then posteriorly in the floor of 
the lateral ventricle. The subthalamic nucleus and substantia nigra lie inferiorly 
and caudally in the diencephalon and rostral midbrain, respectively.
The striatum takes its name from the histological appearance caused by 
efferent myelinated fibres traversing the putamen and caudate. The globus pal­
lidus is subdivided into external (GPe) and internal (GPi) regions which have 
different connections. The substantia nigra is also divided into a dorsal pars 
compacta (SNpc) and a ventral pars reticulata (SNpr); the latter is homologous 
to the GPi.
Connections and functional loops
The striatum is the input region of the basal ganglia and receives excita­
tory corticostriatal fibres from all areas of the cerebral cortex but mainly the mo­
tor and somatosensory areas, prefrontal, and limbic cortex; it also receives the 
dopaminergic nigrostratal projection. There are two pathways from the striatum 
to the GPi, the source of the basal ganglia output; a direct pathway and an indi­
rect circuit via Gpe and the STN. The basal ganglia output from GPi (and also 
SNpr) is inhibitory and is mainly to the thalamus; there is a smaller output to the 
superior colliculus and the pedunculopontine nucleus. The thalamic output is 
excitatory and is thought to 'drive' the motor cortical outflow. The input-output 
connections of the basal ganglia therefore form a loop from cortex to basal gan­
glia and back to cortex. Several separate and parallel loops through the basal 
ganglia have been identified (motor, oculomotor, limbic, and prefrontal) depend­
ing on the cortical component of the circuit. Different areas of the striatum are 
involved with different loops; for the motor loop the putamen is the striatal 
component. Within the striatum there are groups of cells which are more densely 
packed and contain more substance P, met-enkephalin and opiate receptors but 
less acetylcholinesterase. These areas 'striosomes' appear to be involved in the 
processing of the limbic and prefrontal inputs and are seen mainly in the caudate 
rather than the putamen. The patches also receive most of the dopaminergic af- 
ferents from the SNc.
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Within the motor loop there are smaller but still separate loops related to 
different body regions. There is therefore considerable somatotopy within the 
putamen corresponding to the routes of the various parts of the motor loop. Neu­
rophysiological studies indicate that the various loops remain separate during 
their course through the basal ganglia although the anatomical studies suggest 
otherwise.
With regard to the functions of the direct and indirect pathways from pu­
tamen to GPi within the motor loop, increased activity in the direct pathway will 
inhibit basal ganglia outflow and therefore increase motor cortex activation 
whereas indirect pathway activity increases STN activity and therefore GPi out­
flow with an opposite effect on motor cortex activity.
The corticostriatal projection is excitatory and glutamatergic and these fi­
bres synapse on the GABA containing medium spiny neurons (MSNs) which are 
the major cell type in the striatum; the remainder are mainly the large aspiny 
neurons which are cholinergic and inhibitory to the MSNs. The projection from 
the putamen to the globus pallidus via the direct or indirect pathways is from the 
inhibitory MSNs which all utilize GABA; the direct pathway MSNs also contain 
dynorphin and substance P while the indirect MSNs which project initially to the 
GPe utilize enkephalin as a co-transmitter. All other circuits within the basal 
ganglia are inhibitory (utilizing GABA) with the exception of the glutamatergic 
subthalamic input to the Gpi which is excitatory.
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MOTOR DEFICITS
Motor function can be impaired by a lesion that involves the nervous sys­
tem either centrally or peripherally. Several parts of the central nervous system 
are involved in the regulation of motor activity; these include the pyramidal and 
extrapyramidal pathways, the cerebellum, and the lower motor neurons of the 
brains tern and spinal cord.
The pyramidal system consists of fibers that descend from the cerebral 
cortex through the internal capsule, traverse the medullary pyramid, and then 
mostly decussate, to descend in the lateral corticospinal tract on the side oppo­
site that of their origin, where they synapse on lower motor neurons in the spinal 
cord. All other descending influences on lower motor neurons belong to the ex­
trapyramidal system and originate primarily in the basal ganglia and cerebellum. 
Disorders of the basal ganglia and cerebellum are considered separately.
The motor fibers that make up the cranial and peripheral nerves have their 
origin in the lower motor neurons. A disturbance of function at any point in the 
peripheral nervous system (anterior horn cell, nerve root, limb plexus, peripheral 
nerve, or neuromuscular junction) can disturb motor function, as can disease that 
primarily affects the muscles themselves.
Patients with motor deficits generally complain of weakness, heaviness, 
stiffness, clumsiness, impaired muscular control, or difficulty in executing 
movements. The term weakness is sometimes used in a nonspecific way to de­
note loss of energy, drive, or enthusiasm, and care must be taken to clarify what 
the patient means. The word is properly used to mean loss of muscle power, and 
it is in this sense that it is employed here.
EXAMINATION OF THE MOTOR SYSTEM
In examining the motor system, a systematic approach will help to avoid 
overlooking important abnormalities. A sequential routine for the examination 
should be developed.
A. Muscle Appearance. Wasting, or muscle atrophy, suggests that weak­
ness is due to a lesion of the lower motor neurons or of the muscle itself. The 
distribution of wasting may help to localize the underlying disorder. Upper mo­
tor neuron disorders are not usually accompanied by muscle wasting, though 
muscle atrophy may occasionally occur with prolonged disuse. Pseudohypertro­
phy of muscles occurs in certain forms of myopathy, but the apparently enlarged 
muscles are weak and flabby.
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Upper motor neurones
Fig. 1. Schematic representation showing the course of the pyramidal tract, the 
homuncular organization of the motor cortex in the precentral gyrus, the concen­
tration of the motor output within the internal capsule, and the decussation of the 
pyramidal tract in the medulla oblongata (from M. Donaghy 1997)
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The presence of fasciculations -  visible irregular flickerings over the sur­
face of the affected muscle caused by spontaneous contractions of individual 
motor units -  suggests that weakness is due to a lower motor neuron lesion. Fas­
ciculations are most apt to be seen in anterior horn cell disorders. While such ac­
tivity does not occur with upper motor neuron disorders, flexor or extensor 
spasms of the limbs are sometimes seen in these latter conditions as a result of 
impaired supraspinal control of reflex activity.
B. Muscle Tone. For clinical purposes, tone can be defined as the resis­
tance of muscle to passive movement of a joint. Tone depends on the degree of 
muscle contraction and on the mechanical properties of muscle and connective 
tissue. The degree of muscle contraction depends, in turn, on the activity of an­
terior horn cells, which is governed by spinal and supraspinal mechanisms. Tone 
is assessed by observing the position of the extremities at rest, by palpating the 
muscle belly, and particularly by determining the resistance to passive stretch 
and movement. Postural abnormalities may result from the increased activity of 
certain muscle groups caused by disturbances of reflex function, as exemplified 
by the typical hemiplegic posture-flexion of the upper limb and extension of the 
ipsilateral lower limb-of many patients who have had a stroke. To assess re­
sistance to passive movement, the patient is asked to relax while each limb is 
examined in turn by passively taking the major joints through their full range of 
movement at different speeds and estimating whether the force required is more 
or less than normal.
1. Hypertonia. Two types of increased tone can be distinguished.
a. Spasticity. Consists of an increase in tone that affects different muscle 
groups to different extents. In the arms, tone is increased to a greater extent in 
the flexor muscles than in the extensors; in the legs, tone is increased to a greater 
extent in the extensor muscles than in the flexors. Moreover, the resistance of 
affected muscle is not the same throughout the range of movement but tends to 
be most marked when passive movement is initiated and then diminishes as the 
movement continues (the clasp-knife phenomenon). The increase in tone is ve­
locity-dependent, so that passive movement at a high velocity -  but not at lower 
velocities -  may be met with increased resistance. Spasticity is caused by an up­
per motor neuron lesion, such as a stroke that involves the supplementary motor 
cortex or corticospinal tract. Spasticity may not become apparent for several 
days following the onset of an acute lesion, however.
b. Rigidity, consists of increased resistance to passive movement that is 
independent of the direction of the movement -  ie, it affects agonist and an­
tagonist muscle groups equally. The term lead-pipe rigidity is sometimes used 
for descriptive purposes, while cogwheel rigidity is used when there are su­
perimposed ratchetlike interruptions in the passive movement, which probably 
relate to underlying tremor. In general, rigidity indicates extrapyramidal dys­
function and is due to a lesion of the basal ganglia (eg, Parkinson's disease).
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2. Hypotonia (flaccidity). This is characterized by excessive floppiness -  
a reduced resistance to passive movement -  so that the distal portion of the limb 
is easily waved to and fro when the extremity is passively shaken. In hypotonic 
limbs it is often possible to hyperextend the joints, and the muscle belly may 
look flattened and feel less firm than usual. While hypotonia usually relates to 
pathologic involvement of the lower motor neuron supply to the affected mus­
cles, it can also occur with primary muscle disorders, disruption of the sensory 
(afferent) limb of the reflex arc, cerebellar disease, and certain extrapyramidal 
disorders such as Huntington's disease as well as in the acute stage of a pyrami­
dal lesion.
3. Paratonia. Some patients give the impression of being unable to relax 
and will move the limb being examined as the physician moves it, despite in­
structions to the contrary. In more advanced cases, there seems to be rigidity 
when the examiner moves the limb rapidly but normal tone when the limb is 
moved slowly. This phenomenon -  paratonia -  is particularly apt to occur in pa­
tients with frontal lobe or diffuse cerebral disease.
C. Muscle Power. When muscle power is to be tested, the patient is asked 
to resist pressure exerted by the examiner. Selected individual muscles are tested 
in turn, and strength on the two sides is compared so that minor degrees of 
weakness can be recognized. Weakness can result from a disturbance in function 
of the upper or the lower motor neurons; the distribution of weakness is of 
paramount importance in distinguishing between these two possibilities. Upper 
motor neuron lesions (eg, stroke) lead to weakness that characteristically in­
volves the extensors and abductors more than the flexors and adductors of the 
arms -  and the flexors more than the extensors of the legs. Lower motor neuron 
lesions produce weakness of the muscles supplied by the affected neurons; the 
particular distribution of the weakness may point to lower motor neuron in­
volvement at the spinal cord, nerve root, plexus, or peripheral nerve level.
On the basis of the history and other findings, muscles that are particularly 
likely to be affected are selected for initial evaluation, and other muscles are 
subsequently examined to determine the distribution of the weakness more fully 
and to shorten the list of diagnostic possibilities. For instance, if an upper motor 
neuron (pyramidal) lesion is suspected, the extensors and abductors of the upper 
extremity and the flexors of the lower extremity are tested in the most detail, 
since these muscles will be the most affected.
Weakness may also result from a primary muscle disorder (myopathy) or 
from a disorder of neuromuscular transmission. In patients with a motor deficit 
in all limbs that is not due to an upper motor neuron lesion, proximal distribu­
tion of weakness suggests a myopathic disorder, whereas predominantly distal 
involvement suggests a lower motor neuron disturbance. Marked variability in 
the severity and distribution of weakness over short periods of time suggests 
myasthenia gravis, a disorder of neuromuscular transmission. Apparent weak­
ness that is not organic in nature also shows a characteristic variability; it is of­
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ten more severe on formal testing than is consistent with the patient's daily ac­
tivities. Moreover, palpation of antagonist muscles commonly reveals that they 
contract each time the patient is asked to activate the agonist.
For practical and comparative purposes, power is best graded in the fol­
lowing manner: 5 -  Normal power; 4 -  Active movement against resistance and 
gravity; 3 -  Active movement against gravity but not resistance; 2 -  Active 
movement possible only with gravity eliminated; 1 -  Flicker or trace of contrac­
tion; 0 -  No contraction.
Monoplegia denotes paralysis or severe weakness of the muscles in one 
limb, and monoparesis denotes less severe weakness in one limb, although the 
two words are often used interchangeably. Hemiplegia or hemiparesis is weak­
ness in both limbs (and sometimes the face) on one side of the body; paraplegia 
or paraparesis is weakness of both legs; and quadriplegia or quadriparesis (also 
tetraplegia, tetraparesis) is weakness of all four limbs.
D. Coordination. The coordination of motor activity can be impaired by 
weakness, sensory disturbances, or cerebellar disease and requires careful 
evaluation.
Voluntary activity is observed with regard to its accuracy, velocity, range, 
and regularity, and the manner in which individual actions are integrated to pro­
duce a smooth complex movement. In the fingernose test, the patient moves the 
index finger to touch the tip of his or her nose and then the tip of the examiner's 
index finger; the examiner can move his or her own finger about during the test 
to change the location of the target and should position it so that the patient's 
arm must extend fully to reach it. In the heel-knee-shin test, the recumbent pa­
tient lifts one leg off the bed, flexes it at the knee, places the heel on the other 
knee, and runs the heel down the shin as smoothly as possible.
The patient should also be asked to tap repetitively with one hand on the 
back of the other; to tap alternately with the palm and back of one hand on the 
back of the other hand or on the knee; to screw an imaginary light bulb into the 
ceiling with each arm in turn; and to rub the fingers of one hand in a circular 
polishing movement on the back of the other hand. Other tests of rapid alternat­
ing movement include tapping on the ball of the thumb with the tip of the index 
finger or tapping the floor as rapidly as possible with the sole while keeping the 
heel of the foot in place. During all these tests, the examiner looks for irregulari­
ties of rate, amplitude, and rhythm and for precision of movements. With py­
ramidal lesions, fine voluntary movements are performed slowly. With cerebel­
lar lesions, the rate, rhythm, and amplitude of such movements are irregular.
If loss of sensation may be responsible for impaired coordination, the ma­
neuver should be repeated both with eyes closed and with visual attention di­
rected to the limb; with visual feedback the apparent weakness or incoordination 
will improve. In patients with cerebellar disease, the main complaint and physi­
cal finding are often of incoordination, and examination may reveal little else.
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E. Tendon Reflexes. Changes in the tendon reflexes may accompany dis­
turbances in motor (or sensory) function and provide a guide to the cause of the 
motor deficit. The tendon is tapped with a reflex hammer to produce a sudden 
brisk stretch of the muscle and its contained spindles. When the reflexes are 
tested, the limbs on each side should be placed in identical positions and the re­
flexes elicited in the same manner.
1. Areflexia. Apparent loss of the tendon reflexes in a patient may merely 
reflect a lack of clinical expertise on the part of the examiner. Performance of 
Jendrassik's maneuver (an attempt by the patient to pull apart the fingers of the 
two hands when they are hooked together) or some similar action (such as mak­
ing a fist with the hand that is not being tested) may elicit the reflex response 
when it is otherwise unobtainable. A reflex may be lost or depressed by any le­
sion that interrupts the structural or functional continuity of its reflex arc, as in a 
root lesion or peripheral neuropathy. In addition, reflexes are often depressed 
during the acute stage of an upper motor neuron lesion, in patients who are 
deeply comatose, and in patients with cerebellar disease.
2. Hyperreflexia. Increased reflexes occur with upper motor neuron le­
sions, but they may also occur with symmetric distribution in certain healthy 
subjects and in patients under emotional tension. The presence of reflex asym­
metry is therefore of particular clinical significance. Clonus consists of a series 
of rhythmic reflex contractions of a muscle that is suddenly subjected to sus­
tained stretch, with each beat caused by renewed stretch of the muscle during 
relaxation from its previous contracted state. Sustained clonus -  more than three 
or four beats in response to sudden sustained stretch -  is always pathologic and 
is associated with an abnormally brisk reflex. In hyperreflexic states, there may 
be spread of the region from which a particular reflex response can be elicited. 
For example, elicitation of the biceps reflex may be accompanied by reflex fin­
ger flexion, or eliciting the finger flex ion reflex may cause flexion of the thumb 
(Hoffmann's sign).
3. Reflex asymmetry. Although the intensity of reflex responses varies 
considerably among subjects, reflexes should be symmetric in any individual. 
Several general points can be made regarding reflex asymmetries.
a. Lateralized asymmetries of response -  ie, reflexes that are brisker on 
one side of the body than on the other -  usually indicate an upper motor neuron 
disturbance.
b. Focal reflex deficits often relate to root, plexus, or peripheral nerve le­
sions. For example, unilateral depression of the ankle jerk commonly reflects an 
SI radiculopathy resulting from a lumbosacral disk lesion.
c. Loss of distal tendon reflexes (especially ankle jerks), with preservation 
of more proximal ones, is common in polyneuropathies.
F. Superficial Reflexes
1. The polysynaptic superficial abdominal reflexes, which depend on 
the integrity of the T8-12 spinal cord segments, are elicited by gently stroking
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each quadrant of the abdominal wall with a blunt object such as a wooden stick.
A normal response consists of contraction of the muscle in the quadrant stimu­
lated, with a brief movement of the umbilicus toward the stimulus. Asymmetric 
loss of the response may be of diagnostic significance.
a. The response may be depressed or lost on one side in patients with an 
upper motor neuron disturbance from a lesion of the contralateral motor cortex 
or its descending pathways.
b. Segmental loss of the response may relate to local disease of the ab­
dominal wall or its innervation, as in a radiculopathy.
c. The cutaneous abdominal reflexes are frequently absent bilaterally in 
the elderly, in the obese, in multiparous women, and in patients who have had 
abdominal surgery.
2. The cremasteric reflex, mediated through the LI and L2 reflex arcs, 
consists of retraction of the ipsilateral testis when the inner aspect of the thigh is 
lightly stroked; it is lost in patients with a lesion involving these nerve roots. It is 
also lost in patients with contralateral upper motor neuron disturbances.
3. Stimulation of the lateral border of the foot in a normal adult leads to 
plantar flexion of the toes and dorsiflexion of the ankle. The Babiński response 
consists of dorsiflexion of the big toe and fanning of the other toes in response 
to stroking the lateral border of the foot, which is part of the SI dermatome; flex­
ion at the hip and knee may also occur. Such an extensor plantar response indi­
cates an upper motor neuron lesion involving the contralateral motor cortex or 
the corticospinal tract. It can also be found in anesthetized or comatose subjects, 
in patients who have had a seizure, and in normal infants. An extensor plantar 
response can also be elicited, though less reliably, by such maneuvers as prick­
ing the dorsal surface of the big toe with a pin (Bing's sign), firmly stroking 
down the anterior border of the tibia from knee to ankle (Oppenheim's maneu­
ver), squeezing the calf muscle (Gordon's maneuver) or Achilles tendon 
(Schafer's maneuver), flicking the little toe (Gonda's maneuver), or stroking the 
back of the foot just below the lateral malleolus (Chaddock's maneuver). In in­
terpreting responses, attention must be focused only on the direction in which 
the big toe first moves.
G. Gait. In evaluating gait, the examiner first observes the patient walk­
ing at a comfortable pace. Attention is directed at the stance and posture; the fa­
cility with which the patient starts and stops walking and turns to either side; the 
length of the stride; the rhythm of walking; the presence of normally associated 
movements, such as swinging of the arms; and any involuntary movements. 
Subtle gait disorders become apparent only when the patient is asked to run, 
walk on the balls of the feet or the heels, hop on either foot, or walk heel-to-toe 
along a straight line. Gait disorders occur in many neurologic disturbances and 
in other contexts that are beyond the scope of this chapter. A motor or sensory 
disturbance may lead to an abnormal gait whose nature depends upon the site of
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pathologic involvement. Accordingly, the causes and clinical types of gait dis­
turbance are best considered together.
1. Apraxic gait. Apraxic gait occurs in some patients with disturbances, 
usually bilateral, of frontal lobe function, such as may occur in hydrocephalus or 
progressive dementing disorders. There is no weakness or incoordination of the 
limbs, but the patient is unable to stand unsupported or to walk properly -  the 
feet seem glued to the ground. If walking is possible at all, the gait is unsteady, 
uncertain, and short-stepped, with marked hesitation ("freezing"), and the legs 
are moved in a direction inappropriate to the center of gravity.
2. Corticospinal lesions. A corticospinal lesion, irrespective of its cause, 
can lead to a gait disturbance that varies in character depending on whether there 
is unilateral or bilateral involvement. In patients with hemiparesis, the selective 
weakness and spasticity lead to a gait in which the affected leg must be circum­
ducted to be advanced. The patient tilts at the waist toward the normal side and 
swings the affected leg outward as well as forward, thus compensating for any 
tendency to drag or catch the foot on the ground because of weakness in the hip 
and knee flexors or the ankle dorsiflexors. The arm on the affected side is usu­
ally held flexed and adducted. In mild cases, there may be no more than a ten­
dency to drag the affected leg, so that the sole of that shoe tends to be exces­
sively worn.
With severe bilateral spasticity, the legs are brought stiffly forward and 
adducted, often with compensatory movements of the trunk. Such a gait is 
commonly described as scissorslike. This gait is seen in its most extreme form in 
children with spastic diplegia from perinatally acquired static encephalopathy. In 
patients with mild spastic paraparesis, the gait is shuffling, slow, stiff, and awk­
ward, with the feet tending to drag.
3. Frontal disorders. Some patients with frontal lobe or white matter le­
sions have a gait characterized by short, shuffling steps; hesitation in starting or 
turning; unsteadiness; and a wide or narrow base. Sometimes referred to as 
marche a petit pas, this abnormality may be mistaken for a parkinsonian gait, 
but the wide base, preserved arm swing, absence of other signs of parkinsonism, 
and accompanying findings of cognitive impairment, frontal release signs, pseu­
dobulbar palsy, pyramidal deficits, and sphincter disturbances are helpful in in­
dicating the correct diagnosis.
4. Extrapyramidal disorders. Extrapyramidal disorders can produce 
characteristic gait disturbances.
a. In advanced parkinsonism, the patient is often stooped and has diffi­
culty in beginning to walk. Indeed, the patient may need to lean farther and far­
ther forward while walking in place in order to advance; once in motion, there 
may be unsteadiness in turning and difficulty in stopping. The gait itself is char­
acterized by small strides, often taken at an increasing rate until the patient is 
almost running (festination), and by loss of the arm swinging that normally ac­
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companies locomotion. In mild parkinsonism, a mildly slowed or unsteady gait, 
flexed posture, or reduced arm swinging may be the only abnormality found.
b. Abnormal posturing of the limbs or trunk is a feature of dystonia; it can 
interfere with locomotion or lead to a distorted and bizarre gait.
c. Chorea can cause an irregular, unpredictable, and unsteady gait, as the 
patient dips or lurches from side to side. Choreiform movements of the face and 
extremities are usually well in evidence.
d. Tremor that occurs primarily on standing (orthostatic tremor) may lead 
to an unsteady, uncertain gait, with hesitancy in commencing to walk.
5. Cerebellar disorders. In cerebellar disorders the gait may be disturbed 
in several ways.
a. Truncal ataxia results from involvement of midline cerebellar struc­
tures, especially the vermis. The gait is irregular, clumsy, unsteady, uncertain, 
and broad-based, with the patient walking with the feet wide apart for additional 
support. Turning and heel-to-toe walking are especially difficult. There are often 
few accompanying signs of a cerebellar disturbance in the limbs. Causes include 
midline cerebellar tumors and the cerebellar degeneration that can occur with 
alcoholism or hypothyroidism, as a nonmetastatic complication of cancer, and 
with certain hereditary disorders.
b. In extreme cases, with gross involvement of midline cerebellar struc­
tures (especially the vermis), the patient cannot stand without falling.
c. A lesion of one cerebellar hemisphere leads to an unsteady gait in 
which the patient consistently falls or lurches toward the affected side.
6. Impaired sensation. Impaired sensation, especially disturbed proprio­
ception, also leads to an unsteady gait, which is aggravated by walking in the 
dark or with the eyes closed, since visual input can not then compensate for the 
sensory loss. Because of their defective position sense, many patients lift their 
feet higher than necessary when walking, producing a steppage gait. Causes in­
clude tabes dorsalis, sensory neuropathies, vitamin B12 deficiency, and certain 
hereditary disorders.
7. Anterior horn cell, peripheral motor nerve, or voluntary muscle 
disorders. These disorders lead to gait disturbances if the muscles involved in 
locomotion are affected. Weakness of the anterior tibial muscles leads to foot 
drop; to avoid catching or scuffing the foot on the ground, the patient must lift 
the affected leg higher than the other, in a characteristic steppage gait. Weakness 
of the calf muscles leads to an inability to walk on the balls of the feet. Weak­
ness of the trunk and girdle muscles, such as occurs in muscular dystrophy, 
other myopathic disorders, and Kugelberg-Welander syndrome, leads to a wad­
dling gait because the pelvis tends to slump toward the non-weight-bearing side.
8. Unsteady gait in the elderly. Many elderly persons complain of un­
steadiness when walking and a fear of falling, but neurologic examination re­
veals no abnormality. Their symptoms have been attributed to reduced sensory
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input from several different afferent systems and impaired central processing of 
sensory input; an impairment of vestibular function may also be important.
CLINICAL LOCALIZATION OF THE LESION
The findings on examination should indicate whether the weakness or 
other motor deficit is due to an upper or lower motor neuron disturbance, a dis­
order of neuromuscular transmission, or a primary muscle disorder. In the case 
of an upper or lower motor neuron disturbance, the clinical findings may also 
help to localize the lesion more precisely to a single level of the nervous system. 
Such localization helps to reduce the number of diagnostic possibilities.
Upper Motor Neuron Lesions
A. Signs:
■ Weakness or paralysis
■ Spasticity
■ Increased tendon reflexes
■ An extensor plantar (Babiński) response
■ Loss of superficial abdominal reflexes
■ Little, if any, muscle atrophy
Such signs occur with involvement of the upper motor neuron at any point, 
but further clinical findings depend upon the actual site of the lesion. Note that it 
may not be possible to localize a lesion by its motor signs alone.
B. Localization of Underlying Lesion:
1. A parasagittal intracranial lesion produces an upper motor neuron defi­
cit that characteristically affects both legs and may later involve the arms.
2. A discrete lesion of the cerebral cortex or its projections may produce a 
focal motor deficit involving, for example, the contralateral hand. Weakness 
may be restricted to the contralateral leg in patients with anterior cerebral artery 
occlusion or to the contralateral face and arm if the middle cerebral artery is in­
volved. A more extensive cortical or subcortical lesion will produce weakness or 
paralysis of the contralateral face, arm, and leg and may be accompanied by 
aphasia, a visual field defect, or a sensory disturbance of cortical type.
3. A lesion at the level of the internal capsule, where the descending fibers 
from the cerebral cortex are closely packed, commonly results in a severe hemi- 
paresis that involves the contralateral limbs and face.
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4. A brainstem lesion commonly -  but not invariably -  leads to bilateral 
motor deficits, often with accompanying sensory and cranial nerve disturbances, 
and disequilibrium. A more limited lesion involving the brainstem characteristi­
cally leads to a cranial nerve disturbance on the ipsilateral side and a contralat­
eral hemiparesis; the cranial nerves affected depend on the level at which the 
brainstem is involved.
5. A unilateral spinal cord lesion above the fifth cervical segment (C5) 
causes an ipsilateral hemiparesis that spares the face and cranial nerves. Lesions 
between C5 and the first thoracic segment (Tl) affect the ipsilateral arm to a 
variable extent as well as the ipsilateral leg; a lesion below Tl will affect only 
the ipsilateral leg. Because, in practice, both sides of the cord are commonly in­
volved, quadriparesis or paraparesis usually results. If there is an extensive but 
unilateral cord lesion, the motor deficit is accompanied by ipsilateral impairment 
of vibration and position sense and by contralateral loss of pain and temperature 
appreciation (Brown-Sequard syndrome). With compressive and other focal le­
sions that involve the anterior horn cells in addition to the fiber tracts traversing 
the cord, the muscles innervated by the affected cord segment weaken and atro­
phy. Therefore, a focal lower motor neuron deficit exists at the level of the le­
sion and an upper motor neuron deficit exists below it -  in addition to any asso­
ciated sensory disturbance.
Lower Motor Neuron Lesions
A. Signs:
■ Weakness or paralysis
■ Wasting and fasciculations of involved muscles
■ Hypotonia (flaccidity)
■ Loss of tendon reflexes when neurons subserving them are affected
■ Normal abdominal and plantar reflexes -  unless the neurons subserving
them are directly involved, in which case reflex responses are lost
B. Localization of the Underlying Lesion. In distinguishing weakness 
from a root, plexus, or peripheral nerve lesion, the distribution of the motor defi­
cit is of particular importance. Only those muscles supplied wholly or partly by 
the involved structure are weak. The distribution of any accompanying sensory 
deficit similarly reflects the location of the underlying lesion. It may be impos­
sible to distinguish a radicular (root) lesion from discrete focal involvement of 
the spinal cord. In the latter situation, however, there is more often a bilateral 
motor deficit at the level of the lesion, a corticospinal or sensory deficit below it, 
or a disturbance of bladder, bowel, or sexual function. Certain disorders selec­
tively affect the anterior horn cells of the spinal cord diffusely or the motor
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nerves; the extensive lower motor neuron deficit without sensory changes helps 
to indicate the site and nature of the pathologic involvement.
Cerebellar Dysfunction
A. Signs:
■ Hypotonia
■ Depressed or pendular tendon reflexes
■ Ataxia
■ Gait disorder
■ Imbalance of station
■ Disturbances of eye movement
■ Dysarthria
Ataxia is a complex movement disorder caused, at least in part, by im­
paired coordination. It occurs in the limbs on the same side as a lesion affecting 
the cerebellar hemisphere. With midline lesions, incoordination may not be evi­
dent in the limbs at all, but there is marked truncal ataxia that becomes evident 
on walking. The term dysmetria is used when movements are not adjusted accu­
rately for range, so that for example -  a moving finger overshoots a target at 
which it is aimed. Dysdiadochokinesia denotes rapid alternating movements that 
are clumsy and irregular in terms of rhythm and amplitude. Asynergia or 
dyssynergia denotes the breakdown of complex actions into the individual 
movements composing them; when asked to touch the tip of the nose with a fin­
ger, for example, the patient may first flex the elbow and then bring the hand up 
to the nose instead of combining the maneuvers into one action. Intention tremor 
occurs during activity and is often most marked as the target is neared. The re­
bound phenomenon is the overshooting of the limb when resistance to a move­
ment or posture is suddenly withdrawn.
The gait becomes unsteady in patients with disturbances of either the cere­
bellar hemispheres or midline structures.
Jerk nystagmus, which is commonly seen in patients with a unilateral le­
sion of the cerebellar hemisphere, is slowest and of greatest amplitude when the 
eyes are turned to the side of the lesion. Nystagmus is not present in patients 
with lesions of the anterior cerebellar vermis.
Speech becomes dysarthric and takes on an irregular and explosive quality 
in patients with lesions that involve the cerebellar hemispheres. Speech is usu­
ally unremarkable when only the midline structures are involved.
B. Localization of the Underlying Lesion. The relationship of symptoms 
and signs to lesions of different parts of the cerebellum is considered later.
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Neuromuscular-Transmission Disorders
A. Signs:
■ Normal or reduced muscle tone
■ Normal or depressed tendon and superficial reflexes
■ No sensory changes
■ Weakness, often patchy in distribution, not conforming to the distribution 
of any single anatomic structure; frequently involves the cranial muscles 
and may fluctuate in severity over short periods, particularly in relation to 
activity
B. Localization of the Underlying Lesion. Pathologic involvement of ei­
ther the pre- or postsynaptic portion of the neuromuscular junction may impair 
neuromuscular transmission. Disorders affecting neuromuscular transmission 
are discussed below.
Myopathic Disorders
A. Signs:
■ Weakness, usually most marked proximally rather than distally
■ No muscle wasting or depression of tendon reflexes until at least an ad­
vanced stage of the disorder
■ Normal abdominal and plantar reflexes
■ No sensory loss or sphincter disturbances
B. Differentiation. In distinguishing the various myopathic disorders, it is 
important to determine whether the weakness is congenital or acquired, whether 
there is a family history of a similar disorder, and whether there is any clinical 
evidence that a systemic disease may be responsible. The distribution of affected 
muscles is often especially important in distinguishing the various hereditary 
myopathies.
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MOVEMENT (EXTRAPYRAMIDAL) DISORDERS
Movement disorders (sometimes called extrapyramidal disorders) impair 
the regulation of voluntary motor activity without directly affecting strength, 
sensation, or cerebellar function. They include hyperkinetic disorders associated 
with abnormal, involuntary movements and hypokinetic disorders characterized 
by poverty of movement. Movement disorders result from dysfunction of deep 
subcortical gray matter structures termed the basal ganglia. While there is no 
universally accepted anatomic definition of the basal ganglia, for clinical pur­
poses they may be considered to comprise the caudate nucleus, putamen, globus 
pallidus, subthalamic nucleus, and substantia nigra. The putamen and globus 
pallidus are collectively termed the lentiform nucleus; the combination of lenti- 
form nucleus and caudate nucleus is designated the corpus striatum.
The basic circuitry of the basal ganglia consists of three interacting neu­
ronal loops. The first is a corticocortical loop that passes from the cerebral cor­
tex, through the caudate and putamen, the internal segment of globus pallidus, 
and the thalamus, and then back to the cerebral cortex. The second is a nigrostri- 
atal loop connecting the substantia nigra with the caudate and putamen. The 
third, a striatopallidal loop, projects from the caudate and putamen to the exter­
nal segment of globus pallidus, then to the subthalamic nucleus, and finally to 
the internal segment of globus pallidus. In some movement disorders (eg, Park­
inson's disease), a discrete site of pathology within these pathways can be identi­
fied; in other cases (eg, essential tremor), the precise anatomic abnormality is 
unknown.
TYPES OF ABNORMAL MOVEMENTS
Categorizing an abnormal movement is generally the first step toward ar­
riving at the neurologic diagnosis. Abnormal movements can be classified as 
tremor, chorea, athetosis or dystonia, ballismus, myoclonus, or tics. Such 
movements can arise for a variety of reasons. In many disorders, abnormal 
movements are the sole clinical features.
TREMOR
A tremor is a rhythmic oscillatory movement best characterized by its re­
lationship to voluntary motor activity -  ie, according to whether it occurs at rest, 
during maintenance of a particular posture, or during movement. The major 
causes of tremor are listed below. Tremor is enhanced by emotional stress and
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Fig. 2. Basic neuronal circuity of the basal ganglia (From R. Simon, M. 
Aminoff, D. Greenberg, 1999)
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disappears during sleep. Tremor that occurs when the limb is at rest is generally 
referred to as static tremor or rest tremor. If present during sustained posture, it 
is called a postural tremor; while this tremor may continue during movement, 
movement does not increase its severity. When present during movement but not 
at rest, it is generally called an intention tremor. Both postural and intention 
tremors are also called action tremors.
Postural Tremor
A. Physiologic Tremor. An 8- to 12-Hz tremor of the outstretched hands 
is a normal finding. Its physiologic basis is uncertain.
B. Enhanced Physiologic Tremor. Physiologic tremor may be enhanced 
by fear or anxiety. A more conspicuous postural tremor may also be found fol­
lowing excessive physical activity or sleep deprivation. It can complicate treat­
ment with certain drugs (notably lithium, tricyclic antidepressants, sodium val­
proate, and bronchodilators) and is often conspicuous in patients with alcohol­
ism or in alcohol or drug withdrawal states. It is common in thyrotoxicosis, and 
it can also result from poisoning with a number of substances, including mer­
cury, lead, arsenic, and carbon monoxide. There is no specific medical therapy.
C. Other Causes. The most common type of abnormal postural tremor is 
benign essential trem or, which often has a familial basis. Postural tremor may 
also be conspicuous in patients with Wilson's disease or cerebellar disorders.
Causes of tremor
Postural tremor
Physiologic tremor 
Enhanced physiologic tremor
Anxiety or fear
Excessive physical activity or sleep deprivation Sedative drug or al­
cohol withdrawal
Drug toxicity (eg, lithium, bronchodilators, sodium valproate, tri­
cyclic antidepressants)
Heavy metal poisoning (eg, mercury, lead, arsenic) Carbon monox­
ide poisoning
Thyrotoxicosis
Familial (autosomal dominant) or idiopathic (benign essential) tremor 
Cerebellar disorders 
Wilson's disease 
Intention tremor
Brainstem or cerebellar disease
Drug toxicity (eg, alcohol, anticonvulsants, sedatives)
Wilson’s disease 
Rest tremor
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Parkinsonism
Wilson's disease
Heavy metal poisoning (eg, mercury)
Asterixis
Asterixis may be associated with postural tremor, but is itself more prop­
erly considered a form of myoclonus (see below) than of tremor. It is seen most 
commonly in patients with metabolic encephalopathy such as occurs with he­
patic or renal failure.
To detect asterixis, the examiner asks the patient to hold the arms out­
stretched with fingers and wrists extended. Episodic cessation of muscular activ­
ity causes sudden flex ion at the wrists followed by a return to extension, so that 
the hands flap in a regular or, more often, an irregular rhythm. The asterixis re­
solves with clearing of the metabolic encephalopathy.
Intention Tremor
Intention tremor occurs during activity. If the patient is asked to touch his 
or her nose with a finger, for example, the arm exhibits tremor during move­
ment, often more marked as the target is reached. This form of tremor is some­
times mistaken for limb ataxia, but the latter has no rhythmic oscillatory com­
ponent.
Intention tremor results from a lesion affecting the superior cerebellar pe­
duncle. Because it is often very coarse, it can lead to severe functional disability. 
No satisfactory medical treatment exists, but stereotactic surgery of the ventro­
lateral nucleus of the thalamus is sometimes helpful when patients are severely 
incapacitated.
Intention tremor can also occur-together with other signs of cerebellar in- 
volvement-as a manifestation of toxicity of certain sedative or anticonvulsant 
drugs (such as phenytoin) or alcohol; it is seen in patients with Wilson's disease.
Rest Tremor
A. Parkinsonism. Rest tremor usually has a frequency of 4-6 Hz and is 
characteristic of parkinsonism whether the disorder is idiopathic or secondary 
(ie, postencephalitic, toxic, or drug-induced in origin). The rate of the tremor, its 
relationship to activity, and the presence of rigidity or hypokinesia usually dis­
tinguish the tremor of parkinsonism from other forms. Tremor in the hands may 
appear as a "pill-rolling" maneuver-rhythmic, opposing circular movements of 
the thumb and index finger. There may be alternating flexion and extension of 
the fingers or hand, or alternating pronation and supination of the forearm; in the 
feet, rhythmic alternating flexion and extension are common. Parkinsonism is 
discussed in more detail later.
B. Other Causes! Less common causes of rest tremor include Wilson's 
disease and poisoning with heavy metals such as mercury.
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CHOREA
The word chorea denotes rapid irregular muscle jerks that occur involun­
tarily and unpredictably in different parts of the body. In florid cases, the often 
forceful involuntary movements of the limbs and head and the accompanying 
facial grimacing and tongue movements are unmistakable. Voluntary move­
ments may be distorted by the superimposed involuntary ones. In mild cases, 
however, patients may exhibit no more than a persistent restlessness and clumsi­
ness. Power is generally full, but there may be difficulty in maintaining muscu­
lar contraction such that, for example, hand grip is relaxed intermittently (milk­
maid grasp). The gait becomes irregular and unsteady, with the patient suddenly 
dipping or lurching to one side or the other (dancing gait). Speech often be­
comes irregular in volume and tempo and may be explosive in character. In 
some patients, athetotic movements or dystonic posturing may also be promi­
nent. Chorea disappears during sleep.
Classification & Pathology
The pathologic basis of chorea is unclear, but in some cases it is associ­
ated with cell loss in the caudate nucleus and putamen, and it can be provoked 
by dopaminergic agonist drugs. The important causes of chorea are shown in 
Table 8-2 and are discussed later in this chapter. When chorea is due to a treat­
able medical disorder, such as polycythemia vera or thyrotoxicosis, adequate 
treatment of the primary disorder abolishes the dyskinesia.
Causes of chorea
Hereditary
Huntington’s disease 
Benign hereditary chorea 
Wilson's disease 
Paroxysmal choreoathetosis 
Familial chorea with associated acanthocytosis 
Static encephalopathy (cerebral palsy) acquired antenatally or perinatally (eg, 
from anoxia, hemorrhage, trauma, kernicterus)
Sydenham's chorea 
Chorea gravidarum 
Drug toxicity
Levodopa and other dopaminergic drugs Antipsychotic drugs 
Lithium 
Phenytoin 
Oral contraceptives 
Miscellaneous medical disorders
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Thyrotoxicosis, hypoparathyroidism, or Addison's disease
Hypocalcemia, hypomagnesemia, or hypernatremia Polycythemia vera
Hepatic cirrhosis
Systemic lupus erythematosus
Encephalitis lethargica
Cerebrovascular disorders
Vasculitis
Ischemic or hemorrhagic stroke 
Subdural hematoma
Structural lesions of the subthalamic nucleus 
HEMIBALLISMUS
Hemiballismus is unilateral chorea that is especially violent because the 
proximal muscles of the limbs are involved. It is due most often to vascular dis­
ease in the contralateral subthalamic nucleus and commonly resolves spontane­
ously in the weeks following its onset. It is sometimes due to other types of 
structural disease; in the past, it was an occasional complication of thalamo­
tomy. Pharmacologic treatment is similar to that for chorea.
DYSTONIA & ATHETOSIS
The term athetosis generally denotes abnormal movements that are slow, 
sinuous, and writhing in character. When the movements are so sustained that 
they are better regarded as abnormal postures, the term dystonia is used, and 
many now use the terms interchangeably. The abnormal movements and pos­
tures may be generalized or restricted in distribution. In the latter circumstance, 
one or more of the limbs may be affected (segmental dystonia) or the distur­
bance may be restricted to localized muscle groups (focal dystonia).
The abnormal movements are not present during sleep. They are generally 
enhanced by emotional stress and by voluntary activity. In some cases, abnonnal 
movements or postures occur only during voluntary activity and sometimes only 
during specific activities such as writing, speaking, or chewing.
Etiology
Perinatal anoxia, birth trauma, and kernicterus are the most common 
causes. In these circumstances, abnonnal movements usually develop before age 
5 years. Careful questioning usually discloses a history of abnonnal early devel­
opment and often of seizures. Examination may reveal signs of mental retarda­
tion or a pyramidal deficit in addition to the movement disorder.
Torsion dystonia may occur as a manifestation of Wilson's disease or 
Huntington's disease or as a sequela of previous encephalitis lethargica. 
Dystonic movements and postures are the cardinal features of the disorder
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known as idiopathic torsion dystonia. Acute dystonic posturing may result from 
treatment with dopamine receptor antagonist drugs. Lateralized dystonia may 
occasionally relate to focal intracranial disease, but the clinical context in which 
it occurs usually identifies the underlying cause.
Causes of dystonia and athetosis
Static perinatal encephalopathy (cerebral palsy)
Pelizaeus-Merzbacher disease 
Neuroacanthocytosis 
Wilson's disease 
Huntington's disease 
Parkinson's disease 
Drugs
Levodopa
Antipsychotic drugs 
Others (see text)
Toxins (eg, methanol, manganese) Encephalitis lethargica 
Ischemic anoxia 
Focal intracranial disease 
Progressive supranuclear palsy 
Idiopathic torsion dystonia 
Hereditary 
Sporadic
Formes frustes of idiopathic torsion dystonia 
Dopa-responsive dystonia 
Myoclonic dystonia 
Psychogenic
MYOCLONUS
Myoclonic jerks are sudden, rapid, twitchlike muscle contractions. They 
can be classified according to their distribution, relationship to precipitating 
stimuli, or etiology. Generalized myoclonus has a widespread distribution, while 
focal or segmental myoclonus is restricted to a particular part of the body. Myo­
clonus can be spontaneous, or it can be brought on by sensory stimulation, 
arousal, or the initiation of movement (action myoclonus). Myoclonus may oc­
cur as a normal phenomenon (physiologic myoclonus) in healthy persons, as an 
isolated abnonnality (essential myoclonus), or as a manifestation of epilepsy 
(epileptic myoclonus). It can also occur as a feature of a variety of degenerative, 
infectious, and metabolic disorders (symptomatic myoclonus).
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Generalized Myoclonus
Physiologic myoclonus includes the myoclonus that occurs upon falling 
asleep or awakening (nocturnal myoclonus), as well as hiccup. Essential myo­
clonus is a benign condition that occurs in the absence of other neurologic ab- 
nonnalities and is sometimes inherited. Epileptic myoclonus may be impossible 
to differentiate clinically from nonepileptic fonns. It may be possible to distin­
guish the two types electrophysiologically, however, by the duration of the elec­
tromyographic burst associated with the jerking, by demonstrating an EEG cor­
relate with a consistent temporal relationship to the jerks, or by determining 
whether muscles involved in the same jerk are activated synchronously.
Causes of generalized myoclonus
Physiologic myoclonus
Nocturnal myoclonus
Hiccup
Essential myoclonus 
Epileptic myoclonus 
Symptomatic myoclonus
Degenerative disorders
Dentatorubrothalamic atrophy (Ramsay Hunt syndrome) Storage 
diseases (eg, Lafora body disease)
Wilson's disease 
Huntington's disease 
Myoclonic dystonia 
Alzheimer's disease 
Infectious disorders
Creutzfeldt-Jakob disease 
AIDS dementia complex 
Subacute sclerosing panencephalitis 
Encephalitis lethargica 
Viral encephalitis 
Metabolic disorders
Drug intoxications (eg, penicillin, antidepressants, bismuth, levodopa, an­
ticonvulsants)
Drug withdrawal (ethanol, sedatives)
Hypoglycemia
Hyperosmolar nonketotic hyperglycemia
Hyponatremia
Hepatic encephalopathy
Uremia
Hypoxia
Focal brain damage
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Head injury
Stroke
Tumors
Segmental Myoclonus
Segmental myoclonus can arise from lesions affecting the cerebral cortex, 
brainstem, or spinal cord. For example, involvement of the dentatorubro-olivary 
pathway by stroke, multiple sclerosis, tumors, or other disorders can produce 
palatal myoclonus, which may be associated with an audible click or synchro­
nous movements of ocular, facial, or other bulbar muscles. Segmental myo­
clonus can result from many of the same disturbances that produce symptomatic 
generalized myoclonus. Metabolic disorders such as hyperosmolar nonketotic 
hyperglycemia can cause epilepsia partialis continua, in which a repetitive focal 
epileptic discharge occurs from the contralateral sensorimotor cortex and leads 
to segmental myoclonus. Segmental myoclonus is usually unaffected by external 
stimuli and persists during sleep.
Treatment
Although myoclonus can be difficult to treat, it sometimes responds to an­
ticonvulsant drugs such as valproic acid, 250-500 mg orally three times daily, or 
to benzodiazepines such as clonazepam, 0.5 mg orally three times daily, gradu­
ally increased to as much as 12 mg/d. Postanoxic action myoclonus has been 
found to be remarkably responsive to 5-hydroxytryptophan, the metabolic pre­
cursor of the neurotransmitter 5-hydroxytryptamine (serotonin). The dosage of 
5-hydroxytryptophan is increased gradually to a maximum of 1-1.5 mg/d orally 
and may be combined with carbidopa (maximum, 400 mg/d orally) to inhibit 
metabolism in peripheral tissues.
TICS
Tics are sudden, recurrent, quick, coordinated abnormal movements that 
can usually be imitated without difficulty. The same movement occurs again and 
again and can be suppressed voluntarily for short periods, although doing so 
may cause anxiety. Tics tend to worsen with stress, diminish during voluntary 
activity or mental concentration, and disappear during sleep.
Tics can be classified into four groups depending upon whether they are 
simple or multiple and transient or chronic. Transient simple tics are very com­
mon in children, usually terminate spontaneously within 1 year (often within a 
few weeks), and generally require no treatment. Chronic simple tics can develop 
at any age but often begin in childhood, and treatment is unnecessary in most 
cases. The benign nature of the disorder must be explained to the patient.
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Persistent simple or multiple tics of childhood or adolescence generally 
begin before age 15 years. There may be single or multiple motor tics-and often 
vocal tics-but complete remission occurs by the end of adolescence.
The syndrome of chronic multiple motor and vocal tics is generally re­
ferred to as Gilles de la Tourette's syndrome, after the French physician who was 
one of the first to describe its clinical features. It is discussed in detail later.
EXAMINATION
Clinical examination will indicate the nature of the abnormal movements, 
the extent of neurologic involvement, and the presence of coexisting disease; 
these in turn may suggest the diagnosis.
The mental status examination may suggest psychiatric disease, raising 
the possibility that the abnormal movements are related to the psychiatric disor­
der or to its treatment with psychoactive drugs-or that the patient has a disorder 
characterized by both abnormal movements and behavioral disturbances, such as 
Huntington's disease or Wilson's disease.
Focal motor or sensory deficits raise the possibility of a structural space- 
occupying lesion, as does papilledema. Kayser-Fleischer rings suggest Wilson's 
disease. Signs of vascular, hepatic, or metabolic disease may suggest other 
causes for a movement disorder, such as acquired hepatocerebral degeneration 
or vasculitis.
Serum and urine copper and serum ceruloplasmin levels are important in 
diagnosing Wilson's disease. Complete blood count and sedimentation rate are 
helpful in excluding polycythemia, vasculitis, or systemic lupus erythematosus, 
any of which can occasionally lead to a movement disorder. Blood chemistries 
may reveal hepatic dysfunction related to Wilson's disease or acquired hepato­
cerebral degeneration; hyperthyroidism or hypocalcemia as a cause of chorea; or 
a variety of metabolic disorders associated with myoclonus.
Serologic tests are helpful for diagnosing movement disorders caused by 
systemic lupus erythematosus. Neurosyphilis can be manifested clinically in a 
variety of ways and should always be excluded by appropriate serologic tests in 
patients with neurologic disease of uncertain etiology.
An EEG is sometimes helpful in diagnosing patients with myoclonus; 
otherwise, it is of limited usefulness.
Radiologic studies are occasionally helpful in evaluating patients with 
movement disorders. In some patients, intracranial calcification may be found 
by skull x-rays or er scans; the significance of this finding, however, is not clear. 
CT scans or MR1 may also reveal a tumor associated with focal dyskinesia or 
dystonia, caudate atrophy due to Huntington’s disease, or basal ganglia abnor­
malities associated with Wilson's disease.
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Recombinant DNA technology has been used to generate probes for genes 
that determine certain inheritable movement disorders. In this manner, the gene 
responsible for Huntington's disease has been localized to the terminal band of 
the short arm of chromosome 4, and the gene for Wilson's disease to the long 
arm of chromosome 13. Genetic markers are therefore of diagnostic value in 
such disorders. Their use may be limited, however, by the genetic heterogeneity 
of some diseases, imprecise gene localization by certain probes, ethical concerns 
about adverse psychological reactions to the presymptomatic diagnosis of fatal 
disorders, and the potential for misuse of such information by prospective em­
ployers, insurance companies, and government agencies.
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ATAXIA
Ataxia is incoordination or clumsiness of movement that is not the result 
of muscular weakness. It is caused by vestibular, cerebellar, or sensory (proprio­
ceptive) disorders. Ataxia can affect eye movement, speech (producing dy­
sarthria), individual limbs, the trunk, stance, or gait.
Cerebellar Ataxia
Cerebellar ataxia is produced by lesions of the cerebellum itself or its af­
ferent or efferent connections in the cerebellar peduncles, red nucleus, pons, or 
spinal cord. Because of the crossed connection between the frontal cerebral cor­
tex and the cerebellum, unilateral frontal disease can also occasionally mimic a 
disorder of the contralateral cerebellar hemisphere. The clinical manifestations 
of cerebellar ataxia consist of irregularities in the rate, rhythm, amplitude, and 
force of voluntary movements.
A. Hypotonia. Cerebellar ataxia is commonly associated with hypotonia, 
which results in defective posture maintenance. Limbs are easily displaced by a 
relatively small force and, when shaken by the examiner, exhibit an increased 
range of excursion. The range of arm swing during walking may be similarly in­
creased. Tendon reflexes take on a pendular quality, so that several oscillations 
of the limb may occur after the reflex is elicited, although neither the force nor 
the rate of the reflex is increased. When muscles are contracted against resis­
tance that is then removed, the antagonist muscle fails to check the movement 
and compensatory muscular relaxation does not ensue promptly. This results in 
rebound movement of the limb.
B. Incoordination. In addition to hypotonia, cerebellar ataxia is associ­
ated with incoordination of voluntary movements. Simple movements are de­
layed in onset, and their rates of acceleration and deceleration are decreased. 
The rate, rhythm, amplitude, and force of movements fluctuate, producing a 
jerky appearance. Because these irregularities are most pronounced during ini­
tiation and termination of movement, their most obvious clinical manifestations 
include terminal dysmetria, or "overshoot," when the limb is directed at a tar­
get, and terminal intention tremor as the limb approaches the target. More 
complex movements tend to become decomposed into a succession of individual 
movements rather than a single smooth motor act (asynergia). Movements that 
involve rapid changes in direction or greater physiologic complexity, such as 
walking, are most severely affected.
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Fig. 3. Peripheral and central vestibular pathways. The vestibular nerve 
terminates in the vestibular nucleus of the brainstem and in midline cerebellar 
structures that also project to the vestibular nucleus. From here, bilateral 
pathways in the medial longitudinal fasciculus ascend to the abducens and 
oculomotor nuclei and descend to the spinal cord. (From R. Simon, M. Aminoff,
D. Greenberg, 1999)
37
C. Associated Ocular Abnormalities. Because of the cerebellum's 
prominent role in the control of eye movements, ocular abnormalities are a fre­
quent consequence of cerebellar disease. These include nystagmus and related 
ocular oscillations, gaze pareses, and defective saccadic and pursuit movements.
D. Anatomic Basis of Distribution of Clinical Signs. Various anatomic 
regions of the cerebellum are functionally distinct, corresponding to the soma- 
totopic organization of their motor, sensory, visual, and auditory connections.
1. Midline lesions. The middle zone of the cerebellum -  the vermis and 
flocculonodular lobe and their associated subcortical (fastigial) nuclei -  is 
involved in the control of axial functions, including eye movements, head and 
trunk posture, stance, and gait. Midline cerebellar disease therefore results in a 
clinical syndrome characterized by nystagmus and other disorders of ocular mo­
tility, oscillation of the head and trunk (titubation), instability of stance, and gait 
ataxia. Selective involvement of the superior cerebellar vermis, as commonly 
occurs in alcoholic cerebellar degeneration, produces exclusively or primarily 
ataxia of gait, as would be predicted from the somatotopic map of the cerebel­
lum.
2. Hemispheric lesions. The lateral zones of the cerebellum (cerebellar 
hemispheres) help to coordinate movements and maintain tone in the ipsilateral 
limbs. The hemispheres also have a role in regulating ipsilateral gaze. Disorders 
affecting one cerebellar hemisphere cause ipsilateral hemiataxia and hypotonia 
of the limbs as well as nystagmus and transient ipsilateral gaze paresis (an in­
ability to look voluntarily toward the affected side). Cerebellar dysarthria may 
also occur with paramedian lesions in the left cerebellar hemisphere.
3. Diffuse lesions. Many cerebellar disorders -  typically toxic, metabolic, 
and degenerative conditions -  affect the cerebellum diffusely. The clinical pic­
ture in such states combines the features of midline and bilateral hemisphere 
disease.
Causes of cerebellar ataxia
Acute
Drug intoxications: ethanol, sedative-hypnotics, anticonvulsants, hallu­
cinogens
Wernicke's encephalopathy 
Vertebrobasilar ischemia or infarction 
Cerebellar hemorrhage 
Inflammatory disorders 
Chronic
Multiple sclerosis
Alcoholic cerebellar degeneration
Phenytoin-induced cerebellar degeneration
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Hypothyroidism
Paraneoplastic cerebellar degeneration 
Hereditary spinocerebellar ataxias 
Friedreich's ataxia 
Ataxia-telangiectasia 
Wilson's disease
Acquired hepatolenticular degeneration 
Creutzfeldt-Jakob disease 
Posterior fossa tumor 
Posterior fossa malformations
Sensory Ataxia
Sensory ataxia results from disorders that affect the proprioceptive path­
ways in peripheral sensory nerves, sensory roots, posterior columns of the spinal 
cord, or medial lemnisci. Thalamic and parietal lobe lesions are rare causes of 
contralateral sensory hemiataxia. Sensations of joint position and movement 
(kinesthesis) originate in pacinian corpuscles and unencapsulated nerve endings 
in joint capsules, ligaments, muscle, and periosteum. Such sensations are trans­
mitted via heavily myelinated А-fibers of primary afferent neurons, which enter 
the dorsal horn of the spinal cord and ascend uncrossed in the posterior columns. 
Proprioceptive information from the legs is conveyed in the medially located 
fasciculus gracilis, and that from the arms is conveyed in the more laterally situ­
ated fasciculus cuneatus. These tracts synapse on second-order sensory neurons 
in the nucleus gracilis and nucleus cuneatus in the lower medulla. The second- 
order neurons decussate as internal arcuate fibers and ascend in the contralateral 
medial lemniscus. They terminate in the ventral posterior nucleus of the thala­
mus, from which third-order sensory neurons project to the parietal cortex.
Numbness or tingling in the legs is common in patients with sensory 
ataxia. Clinical findings include defective joint position and vibration sense in 
the legs and sometimes the arms, unstable stance with Romberg's sign, and a 
gait of slapping or steppage quality. Because proprioceptive deficits may, to 
some extent, be compensated for by other sensory cues, patients with sensory 
ataxia may report that their balance is improved by watching their feet when 
they walk or by using a cane or the arm of a companion for support. They thus 
find that they are much more unsteady in the dark and may experience particular 
difficulty in descending stairs. Sensory ataxia from polyneuropathy or posterior 
column lesions typically affects the gait and legs in symmetric fashion; the arms 
are involved to a lesser extent or spared entirely. Vertigo, nystagmus, and dy­
sarthria are characteristically absent.
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Fig. 4. Pathway mediating proprioceptive sensation. (From R. Simon, M. 
Aminoff, D. Greenberg, 1999)
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Causes of sensory ataxia 
Polyneuropathy'
Autosomal dominant sensory ataxic neuropathy 
Cisplatin (cis-platinum)
Dejerine-Sottas disease 
Diabetes 
Diphtheria 
Hypothyroidism
Immune-mediated neuropathies (GALOP syndrome, anti-MAG antibody 
syndrome, Miller Fisher syndrome, anti-GDlb antibody syndrome) 
Isoniazid
Paraneoplastic sensory neuronopathy (anti-Hu antibodies)
Pyridoxine 
Refsum's disease 
Taxol 
Myelopathy
Acute transverse myelitis 
AIDS (vacuolar myelopathy)
Multiple sclerosis 
Tumor or cord compression 
Vascular malformations 
Polyneuropathy or myelopathy 
Friedreich's ataxia 
Neurosyphilis (tabes dorsalis)
Nitrous oxide 
Vitamin B]2 deficiency 
Vitamin E deficiency
Vestibular Ataxia
Ataxia associated with vertigo suggests a vestibular disorder, whereas 
numbness or tingling in the legs is common in patients with sensory ataxia. Ves­
tibular ataxia can be produced by the same central and peripheral lesions that 
cause vertigo. Nystagmus is frequently present and is typically unilateral and 
most pronounced on gaze away from the side of vestibular involvement. Dy­
sarthria does not occur. Vestibular ataxia is gravity-dependent: incoordination of 
limb movements cannot be demonstrated when the patient is examined lying 
down but becomes apparent when the patient attempts to stand or walk.
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NEUROLOGIC EXAMINATION
Stance & Gait
Observation of stance and gait is helpful in distinguishing between cere­
bellar, vestibular, and sensory ataxias. In any ataxic patient, the stance and gait 
are wide-based and unsteady, often associated with reeling or lurching move­
ments.
A. Stance. The ataxic patient asked to stand with the feet together may 
show great reluctance or an inability to do so. With persistent urging, the patient 
may gradually move the feet closer together but will leave some space between 
them. Patients with sensory ataxia and some with vestibular ataxia are, neverthe­
less, ultimately able to stand with the feet together, compensating for the loss of 
one source of sensory input (proprioceptive or labyrinthine) with another (vis­
ual). This compensation is demonstrated when the patient closes the eyes, elimi­
nating visual cues. With sensory or vestibular disorders, unsteadiness increases 
and may result in falling (Romberg's sign). With a vestibular lesion, the ten­
dency is to fall toward the side of the lesion. Patients with cerebellar ataxia are 
unable to compensate for their deficit by using visual input and unstable on their 
feet whether the eyes are open or closed.
B. Gait.
1. The gait seen in cerebellar ataxia is wide based, often with a staggering 
quality that might suggest drunkenness. Oscillation of the head or trunk (tituba- 
tion) may be present. If a unilateral cerebellar hemisphere lesion is responsible, 
there is a tendency to deviate toward the side of the lesion when the patient at­
tempts to walk in a straight line or circle or marches in place with eyes closed. 
Tandem (heel-to-toe) gait, which requires walking with an exaggeratedly narrow 
base, is always impaired.
2. In sensory ataxia, the gait is also wide-based and tandem gait is poor. In 
addition, walking is typically characterized by lifting the feet high off the 
ground and slapping them down heavily (steppage gait) because of impaired 
proprioception. Stability may be dramatically improved by letting the patient use 
a cane or lightly rest a hand on the examiner's arm for support. If the patient is 
made to walk in the dark or with eyes closed, gait is much more impaired.
3. Gait ataxia may also be a manifestation of conversion disorder (conver­
sion disorder with motor symptom or deficit) or malingering. Determining this 
can be particularly difficult, since isolated gait ataxia without ataxia of individ­
ual limbs can also be produced by diseases that affect the superior cerebellar 
vermis. The most helpful observation in identifying factitious gait ataxia is that 
such patients often exhibit wildly reeling or lurching movements from which 
they are able to recover without falling. In fact, recovery of balance from such 
awkward positions requires excellent equilibratory function.
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Oculomotor (III), Trochlear (IV), Abducens (VI), & Acoustic (VIII)
Nerves
Abnormalities of ocular and vestibular nerve function are typically present 
with vestibular disease and often present with lesions of the cerebellum.
A. Ocular Alignment. The eyes are examined in the primary position of 
gaze (looking directly forward) to detect mal alignment in the horizontal or ver­
tical plane.
B. Nystagmus and Voluntary Eye Movements. The patient is asked to 
turn the eyes in each of the cardinal directions of gaze (left, up and left, down 
and left, right, up and right, down and right) to determine whether gaze paresis 
(impaired ability to move the two eyes coordinately in any of the cardinal direc­
tions of gaze) or gazeevoked nystagmus is present. Nystagmus -  an abnormal 
involuntary oscillation of the eyes -  is characterized in terms of the positions of 
gaze in which it occurs, its amplitude, and the direction of its fast phase. Pendu­
lar nystagmus has the same velocity in both directions of eye movement; jerk 
nystagmus is characterized by both fast (vestibular-induced) and slow (cortical) 
phases. The direction of jerk nystagmus is defined by the direction of the fast 
component. Fast voluntary eye movements (saccades) are elicited by having the 
patient rapidly shift gaze from one target to another placed in a different part of 
the visual field. Slow voluntary eye movements (pursuits) are assessed by hav­
ing the patient track a slowly moving target such as the examiner's finger.
1. Peripheral vestibular disorders produce unidirectional horizontal jerk 
nystagmus that is maximal on gaze away from the involved side. Central vesti­
bular disorders can cause unidirectional or bidirectional horizontal nystagmus, 
vertical nystagmus, or gaze paresis. Cerebellar lesions are associated with a 
wide range of ocular abnormalities, including gaze pareses, defective saccades 
or pursuits, nystagmus in any or all directions, and ocular dysmetria (overshoot 
of visual targets during saccadic eye movements).
2. Pendular nystagmus is usually the result of visual impairment that be­
gins in infancy.
Motor System and Motor Co-ordination
Examination of motor function in the patient with a disorder of equilib­
rium should determine the pattern and severity of ataxia and disclose any associ­
ated pyramidal, extrapyramidal, or peripheral nerve involvement that might sug­
gest a cause.
A. Ataxia and Disorders of Muscle Tone. Muscle tone is assessed as 
discussed in this chapter earlier. Truncal stability is assessed with the patient in 
the sitting position, and the limbs are examined individually.
1. Movement of the patient's arm is observed as his or her finger tracks 
back and forth between his or her own nose or chin and the examiner's finger. 
With mild cerebellar ataxia, an intention tremor characteristically appears near
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the beginning and end of each such movement, and the patient may overshoot 
the target.
2. When the patient is asked to raise the arms rapidly to a given height -  
or when the arms, extended and outstretched in front of the patient, are displaced 
by a sudden force -  there may be overshoot (rebound). Impaired ability to check 
the force of muscular contractions can also be demonstrated by having the pa­
tient forcefully flex the arm at the elbow against resistance-and then suddenly 
removing the resistance. If the limb is ataxic, continued contraction without re­
sistance may cause the hand to strike the patient at the shoulder or in the face.
3. Ataxia of the legs is demonstrated by the supine patient's inability to 
run the heel of the foot smoothly up and down the opposite shin.
4. Ataxia of any limb is reflected by irregularity in the rate, rhythm, am­
plitude, and force of rapid successive tapping movements.
5. Hypotonia is characteristic of cerebellar disorders; with unilateral cere­
bellar hemispheric lesions, the ipsilateral limbs are hypotonic.
6. Extrapyramidal hypertonia (rigidity) occurs with cerebellar ataxia in 
Wilson's disease, acquired hepatocerebral degeneration, Creutzfeldt-Jakob dis­
ease, and certain types of olivopontocerebellar degeneration.
7. Ataxia with spasticity may be seen in multiple sclerosis, posterior fossa 
tumors or congenital anomalies, vertebrobasilar ischemia or infarction, olivo­
pontocerebellar degeneration, Friedreich's and other hereditary ataxias, neuro­
syphilis, Creutzfeldt-Jakob disease, and vitamin B12 deficiency.
B. Weakness. The pattern of any weakness should be determined. Distal 
neuropathic weakness can be caused by disorders that produce sensory ataxia, 
such as polyneuropathies and Friedreich's ataxia. Paraparesis may be superim­
posed on ataxia in vitamin Bi2 deficiency, multiple sclerosis, foramen magnum 
lesions, or spinal cord tumors. Ataxic quadriparesis, hemiataxia with contralat­
eral hemiparesis, or ataxic hemiparesis suggests a brainstem lesion.
C. Abnormal Involuntary Movements. Asterixis may occur in hepatic 
encephalopathy, acquired hepatocerebral degeneration, or other metabolic en­
cephalopathies. Myoclonus occurs in the same conditions as asterixis and is a 
prominent manifestation of Creutzfeldt-Jakob disease. Chorea may be associated 
with cerebellar signs in Wilson's disease, acquired hepatocerebral degeneration, 
or ataxia-telangiectasia.
Sensory System
A. Joint Position Sense. In patients with sensory ataxia, joint position 
sense is always impaired in the legs and may be defective in the arms as well. 
Testing is accomplished by asking the patient to detect passive movement of the 
joints, beginning distally and moving proximally, to establish the upper level of 
deficit in each limb. Abnormalities of position sense can also be demonstrated 
by positioning one limb and having the patient, with eyes closed, place the op­
posite limb in the same position.
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В. Vibratory Sense. Perception of vibratory sensation is frequently im­
paired in patients with sensory ataxia. The patient is asked to detect the vibration 
of a 128-Hz tuning fork placed over a bony prominence. Again, successively 
more proximal sites are tested to determine the upper level of the deficit in each 
limb or over the trunk. The patient's threshold for appreciating the vibration is 
compared with the examiner's own ability to detect it in the hand that holds the 
tuning fork.
Reflexes
Tendon reflexes are typically hypoactive, with a pendular quality, in cere­
bellar disorders; unilateral cerebellar lesions produce ipsilateral hyporeflexia. 
Hyporeflexia of the legs is a prominent manifestation of Friedreich's ataxia, ta­
bes dorsalis, and polyneuropathies that cause sensory ataxia. Hyperactive re­
flexes and extensor plantar responses may accompany ataxia caused by multiple 
sclerosis, vitamin BI2 deficiency, focal brainstem lesions, and certain olivopon­
tocerebellar or spinocerebellar degenerations.
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SENSORY SYSTEM AND SENSORY DISORDERS
An appreciation of the functional anatomy of the sensory components of 
the nervous system is essential for properly interpreting the history and clinical 
signs of patients with disorders of somatic sensation. As used here, the term in­
cludes sensations of touch or pressure, vibration, joint position, pain, tempera­
ture, and more complex functions that rely on these primary sensory modalities 
(eg, two-point discrimination, stereognosis, graphesthesia); it excludes special 
senses such as smell, vision, taste, and hearing.
FUNCTIONAL ANATOMY OF THE SENSORY PATHWAYS
The sensory pathway between the skin and deeper structures and the cere­
bral cortex involves three neurons, with two synapses occurring centrally. The 
cell body of the first sensory neuron of the spinal nerve is in the dorsal root gan­
glion. Each cell located there sends a peripheral process that terminates in a free 
nerve ending or encapsulated sensory receptor and a central process that enters 
the spinal cord. Sensory receptors are relatively specialized for particular sensa­
tions and, in addition to free nerve endings (pain), include Meissner's corpus­
cles, Merkel's corpuscles, and hair cells (touch); Krause's end-bulbs (cold); and 
Ruffini's corpuscles (heat). The location of the first central synapse depends 
upon the type of sensation but is either in the posterior gray column of the spinal 
cord or in the upward extension of this column in the lower brainstem.
The second synapse is located in the anterior part of the anterolateral nu­
cleus of the thalamus, from which there is sensory radiation to the cerebral cor­
tex. In the spinal cord, fibers mediating touch, pressure, and postural sensation 
ascend in the posterior white columns to the medulla, where they synapse in the 
gracile and cuneate nuclei. From these nuclei, fibers cross the midline and as­
cend in the medial lemniscus to the thalamus. Other fibers that mediate touch 
and those subserving pain and temperature appreciation synapse on neurons in 
the posterior horns of the spinal cord, particularly in the substantia gelatinosa. 
The fibers from these neurons then cross the midline and ascend in the anter­
olateral part of the cord; fibers mediating touch pass upward in the anterior spi­
nothalamic tract, whereas pain and temperature fibers generally travel in the lat­
eral spinothalamic tract. Fibers from this anterolateral system pass to the tha­
lamic relay nuclei and to nonspecific thalamic projection nuclei and the mesen­
cephalic reticular formation. Fibers from the lemniscal and anterolateral systems 
are joined in the brainstem by fibers subserving sensation from the head.
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Fig. 5. Sensory pathways conveying touch, pressure, vibration, joint position, 
pain, and temperature sensation. (From R. Simon, M. Aminoff, D. Greenberg, 
1999)
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Fig. 6. Location and lamination of sensory pathways in the spinal cord. C 
(cervical), T (thoracic), L (lumbar), and S (sacral) indicate the level of origin of 
fibers within each tract. (From R. Simon, M. Aminoff, D. Greenberg, 1999)
48
Cephalic pain and temperature sensation are dependent upon the spinal 
nucleus of the trigeminal (V) nerve; touch, pressure, and postural sensation are 
conveyed mostly by the main sensory and mesencephalic nuclei of this nerve.
HISTORY
Sensory disturbances may consist of loss of sensation, the occurrence of 
abnormal sensations, or pain. The term paresthesia is used to denote abnormal 
spontaneous sensations, such as burning, tingling, or pins and needles. The term 
dysesthesia denotes any unpleasant sensation produced by a stimulus that is usu­
ally painless. The term numbness is often used by patients to describe a sense of 
heaviness, weakness, or deadness in the affected part of the body -  and some­
times to signify any sensory impairment; its meaning must be clarified whenever 
the word is used.
In obtaining a history of sensory complaints, it is important to determine 
the location of the symptoms; the mode of onset and progression of the symp­
toms; whether the symptoms are constant or episodic in nature; whether any fac­
tors specifically produce, enhance, or relieve symptoms; and whether there are 
any accompanying symptoms.
The location of symptoms may provide a clue to their origin. For exam­
ple, sensory disturbances involving all the limbs suggest peripheral neuropathy, 
a cervical cord or brainstem lesion, or a metabolic disturbance such as hyperven­
tilation syndrome. Involvement of one entire limb -  or of one side of the body -  
suggests a central (brain or spinal cord) lesion. A hemispheric or brainstem le­
sion may lead to lateralized sensory symptoms, but the face is also commonly 
affected. In addition, there may be other symptoms and signs, such as aphasia, 
apraxia, and visual field defects with hemispheric disease, or dysarthria, weak­
ness, vertigo, diplopia, disequilibrium, and ataxia with brainstem disorders. In­
volvement of part of a limb or a discrete region of the trunk raises the possibility 
of a nerve or root lesion, depending upon the precise distribution. With a root 
lesion, symptoms may show some relationship to neck or back movements, and 
pain is often conspicuous.
The course of sensory complaints provides a guide to their cause. Inter­
mittent or repetitive transient symptoms may represent sensory seizures, is­
chemic phenomena, or metabolic disturbances such as those accompanying hy­
perventilation. Intermittent localized symptoms that occur at a consistent time 
may suggest the diagnosis or an exogenous precipitating factor. For example, 
the pain and paresthesias of carpal tunnel syndrome (of median nerve com­
pression) characteristically occur at night and awaken the patient from sleep.
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EXAMINATION
In the investigation of sensory complaints, various modalities are tested in 
turn, and the distribution of any abnormality is plotted with particular reference 
to the normal root and peripheral nerve territories. Complete loss of touch ap­
preciation is anesthesia, partial loss is hypesthesia, and increased sensitivity is 
hyperesthesia. The corresponding terms for pain appreciation are analgesia, hy- 
palgesia, and hyperalgesia or hyperpathia; allodynia refers to the misperception 
of a trivial tactile sensation as pain.
1. PRIMARY SENSORY MODALITIES
Light Touch
The appreciation of light touch is evaluated with a wisp of cotton wool, 
which is brought down carefully on a small region of skin. The patient lies qui­
etly, with the eyes closed, and makes a signal each time the stimulus is felt. The 
appreciation of light touch depends on fibers that traverse the posterior column 
of the spinal cord in the gracile (leg) and cuneate (arm) fasciculi ipsilaterally, 
passing to the medial lemniscus of the brainstem, and on fibers in the contralat­
eral anterior spinothalamic tract.
Pinprick & Temperature
Pinprick appreciation is tested by asking the patient to indicate whether 
the point of a pin (not a hypodermic needle, which is likely to puncture the skin 
and draw blood) feels sharp or blunt. Appreciation of pressure or touch by the 
pinpoint must not be confused with the appreciation of sharpness. Temperature 
appreciation is evaluated by application to the skin of containers of hot or cold 
water. Pinprick and temperature appreciation depend upon the integrity of the 
lateral spinothalamic tracts. The afferent fibers cross in front of the central canal 
after ascending for two or three segments from their level of entry into the cord.
Deep Pressure
Deep pressure sensibility is evaluated by pressure on the tendons, such as 
the Achilles tendon at the ankle.
Vibration
Vibration appreciation is evaluated with a tuning fork (128 Hz) that is set 
in motion and then placed over a bony prominence; the patient is asked to indi­
cate whether vibration, rather than simple pressure, is felt. Many elderly patients 
have impaired appreciation of vibration below the knees.
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Joint Position
Joint position sense is tested by asking the patient to indicate the direction 
of small passive movements of the terminal interphalangeal joints of the fingers 
and toes. Patients with severe impairment of joint position sense may exhibit 
slow, continuous movement of the fingers (pseudoathetoid movement) when at­
tempting to hold the hands outstretched with the eyes closed. For clinical pur­
poses, both joint position sense and the ability to appreciate vibration are con­
sidered to depend on fibers carried in the posterior columns of the cord, although 
there is evidence that this is not true for vibration.
2. COMPLEX SENSORY FUNCTIONS
Romberg's Test
The patient is asked to assume a steady stance with feet together, arms 
outstretched, and eyes closed and is observed for any tendency to sway or fall. 
The test is positive (abnormal) if unsteadiness is markedly increased by eye clo- 
sure-as occurs, for example, in tabes dorsalis. A positive test is indicative of 
grossly impaired joint position sense in the legs.
Two-Point Discrimination
The ability to distinguish simultaneous touch at two neighboring points 
depends upon the integrity of the central and peripheral nervous system, the de­
gree of separation of the two points, and the part of the body that is stimulated. 
The patient is required to indicate whether he or she is touched by one or two 
compass points, while the distance between the points is varied in order to de­
termine the shortest distance at which they are recognized as different points. 
The threshold for two-point discrimination approximates 4 mm at the fingertips 
and may be several centimeters on the back. When peripheral sensory function 
is intact, impaired two-point discrimination suggests a disorder affecting the 
sensory cortex.
Graphesthesia, Stereognosis, & Barognosis
Agraphesthesia, the inability to identify a number traced on the skin of the 
palm of the hand despite normal cutaneous sensation, implies a lesion involving 
the contralateral parietal lobe. The same is true of inability to distinguish be­
tween various shapes or textures by touch (astereognosis) or impaired ability to 
distinguish between different weights (abarognosis).
Bilateral Sensory Discrimination
In some patients with apparently normal sensation, simultaneous stimula­
tion of the two sides of the body reveals an apparent neglect of (or inattention
51
to) sensation from one side, usually because of some underlying contralateral 
cerebral lesion.
SENSORY CHANGES, CLINICAL INTERPRETATION
It is important to determine the nature and distribution of any sensory 
change. Failure to find clinical evidence of sensory loss in patients with sensory 
symptoms must never be taken to imply that the symptoms have a psychogenic 
basis. Sensory symptoms often develop well before the onset of sensory signs.
Peripheral Nerve Lesions
A. Mononeuropathy. In patients with a lesion of a single peripheral 
nerve, sensory loss is usually less than would have been predicted on anatomic 
grounds because of overlap from adjacent nerves. Moreover, depending upon 
the type of lesion, the fibers in a sensory nerve may be affected differently. 
Compressive lesions, for example, tend to affect preferentially the large fibers 
that subserve touch.
B. Polyneuropathy. In patients with polyneuropathies, sensory loss is 
generally symmetric and is greater distally than proximally -  as suggested by the 
term stocking-and-glove sensory loss. As a general rule the loss will have pro­
gressed almost to the knees before the hands are affected. Certain metabolic dis­
orders (such as Tangier disease, a recessive trait characterized by the near ab­
sence of high-density lipoproteins) preferentially involve small nerve fibers that 
subserve pain and temperature appreciation. Sensory loss may be accompanied 
by a motor deficit and reflex changes.
Root Lesions
Nerve root involvement produces impairment of cutaneous sensation in a 
segmental pattern, but because of overlap there is generally no loss of sensation 
unless two or more adjacent roots are affected. Pain is often a conspicuous fea­
ture in patients with compressive root lesions. Depending on the level affected, 
there may be loss of tendon reflexes (C5-6, biceps and brachioradialis; C7-8, tri­
ceps; L3-4, knee; SI, ankle), and if the anterior roots are also involved, there 
may be weakness and muscle atrophy.
Spinal Cord Lesion
In patients with a spinal cord lesion, there may be a transverse sensory 
level. Physiologic areas of increased sensitivity do occur, however, at the costal 
margin, over the breasts, and in the groin, and these must not be taken as abnor­
mal. Therefore, the level of a sensory deficit affecting the trunk is best deter­
mined by careful sensoiy testing over the back rather than the chest and abdo­
men.
52
Pe riphe ra l ne rve N e rve  root
Fig. 7. Cutaneous innervation (anterior view). The segmental or radicular (nerve 
root) distribution is shown on the left side of the body, and the peripheral nerve 
distribution on the right side of the body. (From R. Simon, M. Aminoff, D. 
Greenberg, 1999)
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N e rve  roo t P e rip h e ra l n e rve
Fig. 8. Cutaneous innervation (posterior view). The segmental or radicular 
(nerve root) distribution is shown on the left side of the body, and the peripheral 
nerve distribution on the right side of the body. (From R. Simon, M. Aminoff, 
D. Greenberg, 1999)
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A. Central Spinal Cord Lesion. With a central spinal cord lesion -  such 
as occurs in syringomyelia, following trauma, and with certain cord tumors -  
there is characteristically a loss of pain and temperature appreciation with spar­
ing of other modalities. This loss is due to the interruption of fibers conveying 
pain and temperature that cross from one side of the spinal cord to the spinotha­
lamic tract on the other. Such a loss is usually bilateral, may be asymmetric, and 
involves only the fibers of the involved segments. It may be accompanied by 
lower motor neuron weakness in the muscles supplied by the affected segments 
and sometimes by a pyramidal and posterior column deficit below the lesion.
B. Anterolateral Spinal Cord Lesion. Lesions involving the anter­
olateral portion of the spinal cord (lateral spinothalamic tract) can cause contra­
lateral impairment of pain and temperature appreciation in segments below the 
level of the lesion. The spinothalamic tract is laminated, with fibers from the 
sacral segments the outermost. Intrinsic spinal cord (intramedullary) lesions of­
ten spare the sacral fibers, while extramedullary lesions, which compress the 
spinal cord, tend to involve these fibers as well as those arising from more ros­
tral levels.
C. Anterior Spinal Cord Lesion. With destructive lesions involving pre­
dominantly the anterior portion of the spinal cord, pain and temperature appre­
ciation are impaired below the level of the lesion from lateral spinothalamic tract 
involvement. In addition, weakness or paralysis of muscles supplied by the in­
volved segments of the spinal cord results from damage to motor neurons in the 
anterior horn. With more extensive disease, involvement of the corticospinal 
tracts in the lateral funiculi may cause a pyramidal deficit below the lesion. 
There is relative preservation of posterior column function. Ischemic myelo­
pathies caused by occlusion of the anterior spinal artery take the form of anterior 
spinal cord lesions.
D. Posterior Spinal Column Lesion. A patient with a posterior column 
lesion may complain of a tight or bandlike sensation in the regions correspond­
ing to the level of spinal involvement and sometimes also of paresthesias (like 
electric shocks) radiating down the extremities on neck flexion (Lhermitte's 
sign). There is loss of vibration and joint position sense below the level of the 
lesion, with preservation of other sensory modalities. The deficit may resemble 
that resulting from involvement of large fibers in the posterior roots.
E. Spinal Cord Hemisection. Lateral hemisection of the spinal cord leads 
to Brown-Sequard's syndrome. Below the lesion, there is an ipsilateral pyrami­
dal deficit and disturbed appreciation of vibration and joint position sense, with 
contralateral loss of pain and temperature appreciation that begins two or three 
segments below the lesion.
Brainstem lesion
Sensory disturbances may be accompanied by a motor deficit, cerebellar 
signs, and cranial nerve palsies when the lesion is in the brainstem. In patients
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with lesions involving the spinothalamic tract in the dorsolateral medulla and 
pons, pain and temperature appreciation are lost in the limbs and trunk on the 
opposite side of the body. When such a lesion is located in the medulla, it also 
typically involves the spinal trigeminal nucleus, impairing pain and temperature 
sensation on the same side of the face as the lesion. The result is a crossed sen­
sory deficit that affects the ipsilateral face and contralateral limbs. In contrast, 
spinothalamic lesions above the spinal trigeminal nucleus affect the face, limbs, 
and trunk contralateral to the lesion. With lesions affecting the medial lemnis­
cus, there is loss of touch and proprioception on the opposite side of the body. In 
the upper brainstem, the spinothalamic tract and medial lemniscus run together 
so that a single lesion may cause loss of all superficial and deep sensation over 
the contralateral side of the body.
Thalamic lesions
Thalamic lesions may lead to loss or impairment of all forms of sensation 
on the contralateral side of the body. Spontaneous pain, sometimes with a partic­
ularly unpleasant quality, may occur on the affected side. Patients may describe 
it as burning, tearing, knifelike, or stabbing, but often have difficulty char­
acterizing it. Any form of cutaneous stimulation can lead to painful or unpleas­
ant sensations. Such a thalamic syndrome (Dejerine-Roussy syndrome) can also 
occasionally result from lesions of the white matter of the parietal lobe or from 
cord lesions.
Sensory Cortex lesions
Disease limited to the sensory cortex impairs discriminative sensory func­
tion on the opposite side of the body. Thus, patients may be unable to localize 
stimuli on the affected side or to recognize the position of different parts of the 
body. They may not be able to recognize objects by touch or to estimate their 
size, weight, consistency, or texture. Cortical sensory disturbances are usually 
more conspicuous in the hands than in the trunk or proximal portions of the 
limbs.
PAIN SYNDROMES
Pain from infective, inflammatory, or neoplastic processes is a feature of 
many visceral diseases and may be a conspicuous component of certain neuro­
logic or psychiatric diseases. It can also occur with no obvious cause.
In evaluating patients with pain, it is important to determine the level of 
the nervous system at which the pain arises and whether it has a primary neuro­
logic basis. In taking the history, attention should be focused on the mode of on­
set, duration, nature, severity, and location of the pain; any associated symp­
toms; and factors that precipitate or relieve the pain.
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Treatment depends on the underlying cause and clinical context of the 
pain and is discussed below. A brief comment is necessary, however, about 
stimulation-produced analgesia and, in particular, about spinal cord stimulation 
(previously known as dorsal column stimulation) and peripheral nerve stimula­
tion. These approaches were based on principles encapsulated by the Gate Con­
trol theory, in which activation of large myelinated fibers was held to interrupt 
nociceptive transmission in the spinal cord, but their precise mechanism of ac­
tion is uncertain. Spinal cord stimulation is known to affect certain neurotrans­
mitter systems, particularly substance P and y-aminobutyric acid (GABAergic) 
sytems.
Peripheral nerve pain
Pain arising from peripheral nerve lesions is usually localized to the re­
gion that is affected pathologically or confined to the territory of the affected 
nerve. It may have a burning quality, and when mixed (motor and sensory) 
nerves are involved, there may be an accompanying motor deficit. Painful pe­
ripheral neuropathies include those caused by diabetes, polyarteritis, alcoholic- 
nutritional deficiency states, and the various entrapment neuropathies. Treatment 
of pain associated with peripheral neuropathies is discussed in the section on 
diabetic neuropathy earlier.
The term causalgia correctly is used for the severe persistent pain, often 
burning in quality, that results from nerve trauma. Such pain often radiates to a 
more extensive territory than is supplied by the affected nerve and is associated 
with exquisite tenderness. Onset of pain may be at any time within the first 6 
weeks or so after nerve injury. The cause is uncertain, but it has been attributed 
to ephaptic transmission between efferent sympathetic and afferent somatic fi­
bers at the site of injury. Pain may be accompanied by increased sweating and 
vasoconstriction of the affected extremity, which is commonly kept covered up 
and still by the patient.
Reflex sympathetic dystrophy is a more general term that denotes sympa­
thetically mediated pain syndromes precipitated by a wide variety of tissue inju­
ries, including soft tissue trauma, bone fractures, and myocardial infarction.
Medical approaches to treatment include sympathetic blockade by injec­
tion of local anesthetics into the sympathetic chain or by regional infusion of re- 
serpine or guanethidine. One such procedure may produce permanent cessation 
of pain-or repeated sympathetic blocks may be required. Surgical sym­
pathectomy is beneficial in up to 75% of cases. Spinal cord stimulation has also 
been successful in some instances for the treatment of reflex sympathetic dys­
trophy or causalgia.
Radicular pain
Radicular pain is localized to the distribution of one or more nerve roots 
and is often exacerbated by coughing, sneezing, and other maneuvers that in­
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crease intraspinal pressure. It is also exacerbated by maneuvers that stretch the 
affected roots. Passive straight leg raising leads to stretching of the sacral and 
lower lumbar roots, as does passive flexion of the neck. Spinal movements that 
narrow the intervertebral foramina can aggravate root pain. Extension and lateral 
flex ion of the head to the affected side may thus exacerbate cervical root symp­
toms. In addition to pain, root lesions can cause paresthesias and numbness in a 
dermatomal distribution; they can also cause segmental weakness and reflex 
changes, depending upon the level affected. Useful modes of treatment include 
immobilization, nonsteroidal anti-inflammatory drugs or other analgesics, and 
surgical decompression.
Thalamic pain
Depending upon their extent and precise location, thalamic lesions may 
lead to pain in all or part of the contralateral half of the body. The pain is of a 
burning nature with a particularly unpleasant quality that patients have difficulty 
describing. It is aggravated by emotional stress and tends to develop during par­
tial recovery from a sensory deficit caused by the underlying thalamic lesion. 
Mild cutaneous stimulation may produce very unpleasant and painful sensations. 
This combination of sensory loss, spontaneous pain, and perverted cutaneous 
sensation has come to be called Dejerine-Roussy syndrome. Similar pain can be 
produced by a lesion that involves the parietal lobe or the sensory pathways at 
any point in the cord (posterior columns or spinothalamic tract) or in the brain­
stem. Treatment with analgesics, anticonvulsants (carbamazepine or phenytoin), 
or antidepressants and phenothiazines in combination is occasionally helpful.
Back and Neck pain
Spinal disease occurs most commonly in the neck or low back and can 
cause local or root pain or both. It can also lead to pain that is referred to other 
parts of the involved dermatomes. Pain from the lower lumbar spine, for exam­
ple, is often referred to the buttocks. Conversely, pain may be referred to the 
back from the viscera, especially the pelvic organs. Local pain may lead to pro­
tective reflex muscle spasm, which in turn causes further pain and may result in 
abnormal posture, limitation of movement, and local spinal tenderness. The his­
tory may provide clues to the underlying cause, and physical examination will 
define any neurologic involvement.
DISTINCTION OF ORGANIC & PSYCHOGENIC SENSORY 
DISTURBANCES
Psychogenic disturbances of sensation may be associated with such psy­
chiatric disturbances as conversion disorder. They may take any form but most
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often are restricted to loss of cutaneous sensation. There may be several charac­
teristic features.
Nonorganic sensory loss does not conform in its distribution to any spe­
cific neuroanatomic pattern. It may surround a bony landmark or involve an area 
defined by surface landmarks rather than innervation. Indeed, it is not uncom­
mon for there to be an apparent loss of sensation in one or more extremities, 
with the margin occurring circumferentially in the axilla or groin; organic sen­
sory loss with such a margin is unusual. Organic peripheral sensory loss over the 
trunk or face does not usually extend to the midline but stops 3-5 cm before it, 
because of overlap in the innervation on the two sides; with nonorganic distur­
bances, apparent sensory loss commonly stops precisely at the midline.
There is often a sudden transition between areas of nonorganic sensory 
loss and areas with normal sensation. By contrast, with organic disturbances, 
there is usually an area of altered sensation between insensitive areas and adja­
cent areas with normal sensibility.
In nonorganic disturbances, there may be a dissociated loss that is difficult 
to interpret on an anatomic basis. For example, there may be a total loss of pin­
prick appreciation but preserved temperature sensation. Moreover, despite the 
apparent loss of posterior column function, the patient may be able to walk nor­
mally or maintain the arms outstretched without difficulty or pseudo athetoid 
movements.
In nonorganic sensory disturbances, appreciation of vibration may be im­
paired on one side but not the other side of a bony midline structure, such as the 
skull or sternum. The vibrations are in fact conducted to both sides by the bone, 
so that even if there is a hemisensory disturbance, the vibrations are appreciated 
on either side in patients with organic sensory disorders.
Finally, it should be noted that sensory disturbances are often suggested to 
the patient by the examiner's own expectations. Such findings can be particularly 
misleading because they may be neuroanatomically correct. One helpful ap­
proach is to have the patient outline on the body the extent of any perceived sen­
sory disturbance before formal sensory testing is undertaken.
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DISORDERS OF CRANIAL NERVES FUNCTIONS
OLFACTORY NERVE (I) AND OLFACTION
Anatomy and physiology of olfaction
Odours, which must be volatile and soluble in water, are detected by spe­
cialized olfactory receptor cells in the olfactory epithelium, located in the mu­
cous membrane of the upper and posterior parts of the nasal cavity (superior tur­
binates and nasal septum), and by the free nerve endings of the trigeminal nerve. 
The olfactory epithelium contains three cell types.
The olfactory receptor cell is a bipolar sensory neuron with a thin, single, 
dendritic knob which extends into the mucus layer of the nasal cavity. The mu­
cus layer contains immunoglobulins A and M, lactoferrin, lysoenzyme, and 
odorant-binding proteins. These molecules are thought to prevent the passage of 
noxious pathogens into the intracranial cavity via the olfactory nerve. From the 
knob protrude 10-30 non-motile cilia which bear the specific membrane receptor 
proteins, and where signal transduction is initiated. When an odour binds to a 
receptor there is activation of a membrane-bound GTP-dependent adenylcyclase 
(G protein), which then activates a second messenger, leading to conformational 
changes in the transmembrane receptor and a series of intracellular events lead­
ing to the generation of axon potentials. Since the odour receptor cells respond 
to wide range of odorants, odour quality is presumably coded by some form of 
cross-fibre pattern. Very thin unmyelinated nerve axons leave the receptor cells 
and converge into small fascicles, enwrapped by Schwann cells, which pass 
through the cribriform plate of the ethmoid bone to the olfactoiy bulb. These ax­
ons collectively constitute the olfactory or first cranial nerve, and terminate 
within the olfactory glomeruli of the olfactory bulb. Here they form synaptic 
contacts with interneurons that have processes restricted to the bulb and with 
output neurons (mitral and internal tufted cells) that contribute axons to the lat­
eral olfactory tract. From the olfactory tract axons project to terminate in primi­
tive cortical areas, known as the primary olfactory cortex. In the human this 
probably includes small portions of the uncus, hippocampal gyrus, amygdaloid 
complex, and entorhinal cortex.
Olfactory disorders
Disturbances of olfaction can be grouped into four main subtypes:
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1. Quantitative abnormalities: a total (general anosmia) or partial (partial 
anosmia) ability to detect olfactory sensations. There may also be a complete 
(general hyposmia) or incomplete (partial hyposmia) insensitivity to odorants, or 
heightened sensitivity (partial or total hyperosmia).
2. Qualitative abnormalities: distortions or illusions of smell (dysosmia or 
parosmia).
3. Olfactory delusions or hallucinations associated with disorders of the 
temporal lobe and psychiatric disease.
4. Olfactory agnosia in which there is an inability to recognize an odour 
sensation despite intact olfactory sensory processing, language, and general in­
tellectual function.
Evaluation of olfactory function
In the clinical examination of olfactory function it is necessary to dis­
criminate between deficits due to nasal obstruction, which prevent volatile sub­
stances from reaching the olfactory epithelium (transport olfactory loss), and 
neurogenic loss, which may be due to abnormalities of the receptors or their ax­
ons (sensory olfactory loss) or due to pathological processes affecting the central 
pathways. Transport olfactory loss can result from a variety of causes, including 
rhinitis, upper respiratory infection, polyps, sinusitis, and neoplasms. The symp­
toms of impaired olfactory detection, discrimination, or distortion of normal 
smells are no different to those accompanying sensory olfactory loss, which may 
be due to impaired receptor cell turnover resulting from radiation or chemo­
therapeutic drugs, or damage to the olfactory axons due to closed head injury, 
toxic substances, and viral infection.
It is therefore essential that, in addition to taking a full history and testing 
smell and taste, careful examination of the nose, mouth, and nasopharynx is un­
dertaken. Examination of smell is usually carried out using a variety of familiar 
odiferous substances such as coffee, oil of peppermint, tobacco, oil of cloves, 
and vanilla. A bottle of each is held under one nostril with the other being oc­
cluded by a finger. The patient is asked whether or not he can detect an odour 
and, if so, whether or not he can identify it. If the odour can be detected even if 
it cannot be described, it may be assumed that the olfactory nerves are relatively 
intact. Malingering can be detected by using ammonia, which stimulates the 
trigeminal nerve. If the patient denies noticing the stimulus, the anosmia is likely 
to be bogus. A more refined assessment of olfaction can be performed using spe­
cial standardized tests.
Disorders of olfaction and their interpretation
The most common causes of loss of smell are nasal and paranasal sinus 
disease, viral infection of the upper respiratory tract, and closed head injury.
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Hypertrophy and hyperaemia of the nasal passages, from whatever cause, leads 
to hyposmia or anosmia, due to odours being unable to reach the olfactory epi­
thelium. Chronic rhinitis and sinusitis of allergic, infective, or vasomotor origin 
are frequent causes. Nutritional and endocrinological disorders, such as thiamine 
deficiency, adrenal insufficiency, vitamin A deficiency, cirrhosis, renal failure, 
hypothyroidism, Cushing syndrome, may also have similar effects, due to sen­
sorineural dysfunction. A frequent cause of hyposmia is heavy smoking. Infec­
tions due to influenza, herpes simplex, and hepatitis viruses can lead to hypos­
mia or anosmia due to destruction of the receptor cells, and recovery may not 
occur if the basal cells are also destroyed. There are several congenital diseases 
in which the receptor cells are absent or hypoplastic (Kallmann's syndrome, 
Turner's syndrome, and albinism).
Loss of smell in head trauma is usually due to the severing of the delicate 
axons of the receptor cells, as they pass through the cribriform plate, but may 
also occur due to damage of the olfactory bulb and possibly cerebral cortical in­
jury. The incidence of smell dysfunction following head trauma is 5-10 per cent 
and is proportional to the severity of the injury. Anosmia or hyposmia may be 
unilateral or bilateral. Recovery of smell occurs in about a third of cases, but is 
unlikely to occur if the loss of smell has been present for more than 1 year after 
injury. The olfactory epithelium can be damaged by a variety of toxic agents, 
including organic solvents such as benzene, and drugs such as antimicrobial 
agents (ampicillin, griseofulvin, streptomycin, tetracyclines), anti-inflammatory 
agents (allopurinol, colchicine, gold, D-penicillamine, phenylbutazone), antipro­
liferative agents (methotrexate, vincristine, doxorubicin), and other drugs, in­
cluding phenindione, amphetamines, cocaine, corticosteroids.
Impaired odour detection or discrimination has been described in Parkin­
son's disease and Alzheimer's disease. Alcoholics with Korsakoff's psychosis 
have a defect of odour discrimination, as have some patients with temporal lobe 
epilepsy. A similar deficit is found in patients in whom anterior temporal lobe or 
orbitofrontal cortical excision has been performed. Anosmia may be the first 
symptom of an olfactory groove meningioma, which may involve the olfactory 
bulb and tract, and extend posteriorly to involve the optic nerve, leading to atro­
phy (Foster Kennedy syndrome).
There is no specific treatment for patients with hyposmia or anosmia, 
unless there is a local, remediable cause. However, these patients are at potential 
risk from inhaling noxious fumes and failing to detect burning, so it is important 
to advise them of the necessary precautions. These should include the use of 
domestic smoke and gas detectors, and the provision of adequate ventilation in 
enclosed areas in which toxic solvents are being used.
The most common cause of parosmia, the distortion of normal smell, is a 
local nasopharyngeal condition such as sinusitis. Other causes include temporal 
lobe seizure, partial injuries of the olfactory bulb, and depression. The majority 
of patients have associated hyposmia or anosmia.
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Olfactory hallucinations are always of central origin, and are most often 
due to temporal lobe seizures (uncinate seizures). Other causes include Alz­
heimer's disease, endogenous depression, schizophrenia, and alcohol with­
drawal.
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VISUAL & OCULAR MOTOR SYSTEMS (II, III, IV, VI)
Disorders that affect the ocular muscles, cranial nerves, or visual or ocular 
motor pathways in the brain produce a wide variety of neuro-ophthalmologic 
disturbances. Because the anatomic pathways of the visual and ocular motor sys­
tems traverse major portions of the brainstem and cerebral hemispheres, neuro- 
ophthalmologic signs are often of great value in the anatomic localization of 
neurologic disease, which in turn suggests possible etiologies. Symptoms most 
commonly involve vision (disorders of visual pathways) or eye movements (dis­
orders of ocular motility) or both.
FUNCTIONAL ANATOMY OF THE VISUAL SYSTEM
Reception of Visual Information
Visual information enters the nervous system when light, refracted and 
focused by the lens, creates a visual image on the retina at the posterior pole of 
the eye. The action of the lens causes this image to be reversed in the horizontal 
and vertical planes. Thus, the superior portion of the visual image falls on the 
inferior retina and vice versa, and the temporal (lateral) and nasal (medial) fields 
are likewise reversed. The center of the visual field is focused at the fovea, 
where the retina's perceptual sensitivity is greatest. Within the retina, photore­
ceptor cells (rods and cones) transduce incident light into neuronal impulses, 
which are transmitted by retinal neurons to the optic (II) nerve. At this and all 
other levels of the visual system, the topographic relations of the visual field are 
preserved.
Peripheral Visual Pathways
Each optic nerve contains fibers from one eye, but the nasal (medial) fi­
bers, conveying information from the temporal (lateral) visual fields, cross in the 
optic chiasm. As a result, each optic tract contains fibers not from one eye but 
from one half of the visual field. Because of this arrangement, prechiasmal le­
sions affect vision in the ipsilateral eye and retrochiasmal lesions produce de­
fects in the contralateral half of the visual field of both eyes.
Central Visual Pathways
The optic tracts terminate in the lateral geniculate nuclei, where their neu­
rons synapse on neurons that project through the optic radiations to the primary 
visual or calcarine cortex (area 17), located near the posterior poles of the oc­
cipital lobes, and visual association areas (areas 18 and 19). Here, too, the visual 
image is represented in such a way that its topographic organization is pre­
served. The central region of the visual field (macula) projects to the most poste­
64
rior portion of the visual cortex, while the inferior and superior parts of the field 
are represented above and below the calcarine fissure, respectively.
Vascular Supply
The vascular supply of the visual system is derived from the ophthalmic, 
middle cerebral, and posterior cerebral arteries; thus, ischemia or infarction in 
the territory of any of these vessels can produce visual field defects.
A. Retina. The retina is supplied by the central retinal artery, a branch of 
the ophthalmic artery that, in turn, branches from the internal carotid artery. Be­
cause the central retinal artery subsequently divides into superior and inferior 
retinal branches, vascular disease of the retina tends to produce altitudinal (ie, 
superior or inferior) visual field deficits.
B. Optic Nerve. The optic nerve receives arterial blood primarily from 
the ophthalmic artery and its branches.
C. Optic Radiations. As the optic radiations course backward toward the 
visual cortex, they are supplied by branches of the middle cerebral artery.
Ischemia or infarction in the distribution of the middle cerebral artery may 
thus cause loss of vision in the contralateral visual field.
D. Primary Visual Cortex. The principal source of arterial blood for the 
primary visual cortex is the posterior cerebral artery. Occlusion of one posterior 
cerebral artery produces blindness in the contralateral visual field, although the 
dual (middle and posterior cerebral) arterial supply to the macular region of the 
visual cortex may spare central (macular) vision. Because the posterior cerebral 
arteries arise together from the basilar artery, occlusion at the tip of the basilar 
artery can cause bilateral occipital infarction and complete cortical blindness- 
although, in some cases, macular vision is spared.
FUNCTIONAL ANATOMY OF THE OCULAR MOTOR SYSTEM 
Extraocular Muscles
Movement of the eyes is accomplished by the action of six muscles at­
tached to each globe. These muscles act to move the eye into each of six cardi­
nal positions of gaze. Equal and opposed actions of these six muscles in the rest­
ing state place the eye in mid or primary position, ie, looking directly forward. 
When the function of one extraocular muscle is disrupted, the eye is unable to 
move in the direction of action of the affected muscle (ophthalmoplegia) and 
may deviate in the opposite direction because of the unopposed action of other 
extraocular muscles. When the eyes are thus misaligned, visual images of per­
ceived objects fall on a different region of each retina, creating the illusion of 
double vision, or diplopia.
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Cranial Nerves
The extraocular muscles are innervated by the oculomotor (III), trochlear 
(IV), and abducens (VI) nerves. Because of this differential innervation of the 
ocular muscles, the pattern of their involvement in pathologic conditions can 
help to distinguish a disorder of the ocular muscles per se from a disorder that is 
affecting a cranial nerve. Cranial nerves that control eye movement traverse long 
distances to pass from the brainstem to the eye; they are thereby rendered vul­
nerable to injury by a variety of pathologic processes.
A. Nerve III. The oculomotor nerve supplies the medial rectus, superior 
and inferior rectus, and inferior oblique muscles and carries fibers to the levator 
palpebrae (which raises the eyelid). It also supplies the parasympathetic fibers 
responsible for pupillary constriction. With a complete nerve III lesion, the eye 
is therefore partially abducted and there is an inability to adduct, elevate, and 
depress the eye; the eyelid droops (ptosis), and the pupil is nonreactive.
B. Nerve IV. The trochlear nerve innervates the superior oblique muscle. 
Lesions of this nerve result in defective depression of the adducted eye.
C. Nerve VI. Lesions of the abducens nerve cause lateral rectus palsy, 
with impaired abduction of the affected eye.
Cranial Nerve Nuclei
The nuclei of the oculomotor and trochlear nerves are located in the dorsal 
midbrain, ventral to the cerebral aqueduct (of Sylvius), while the abducens nerve 
nucleus occupies a similarly dorsal and periventricular position in the pons.
Lesions involving these nuclei give rise to clinical abnormalities similar to 
those produced by involvement of their respective cranial nerves; in some cases, 
nuclear and nerve lesions can be distinguished.
A. Nerve III Nucleus. Familiarity with the organization of the oculomo­
tor nerve nucleus sometimes makes it possible to distinguish nuclear from nerve 
lesions. While each oculomotor nerve supplies muscles of the ipsilateral eye 
only, fibers to the superior rectus originate in the contralateral oculomotor nerve 
nucleus, and the levator palpebrae receives bilateral nuclear innervation. Thus, 
ophthalmoplegia affecting only one eye with ipsilateral ptosis or superior rectus 
palsy suggests oculomotor nerve disease, whereas ophthalmoplegia accompa­
nied by bilateral ptosis or a contralateral superior rectus palsy is probably due to 
a nuclear lesion.
B. Nerve IV Nucleus. It is not possible to distinguish clinically between 
lesions of the trochlear nerve and those of its nucleus.
C. Nerve VI Nucleus. In disorders affecting the abducens nerve nucleus 
rather than the nerve itself, lateral rectus paresis is often associated with facial 
weakness, paresis of ipsilateral conjugate gaze, or a depressed level of con­
sciousness. This is because of the proximity of the abducens nerve nucleus to the 
facial (VII) nerve fasciculus, pontine lateral gaze center, and ascending reticular 
activating system, respectively.
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Supranuclear Control of Eye Movements
Supranuclear control of eye movements enables the two eyes to act in 
concert to produce version (conjugate gaze) or vergence (convergence and di­
vergence) movements.
A. Brainstem Gaze Centers. Centers that control horizontal and vertical 
gaze are located in the pons and in the pretectal region of the midbrain, respec­
tively, and receive descending inputs from the cerebral cortex that allow volun­
tary control of gaze. Each lateral gaze center, located in the paramedian pontine 
reticular formation (PPRF) adjacent to the abducens nerve nucleus, mediates ip- 
silateral conjugate horizontal gaze via its connections to the ipsilateral abducens 
and contralateral oculomotor nerve nucleus. A lesion in the pons affecting the 
PPRF therefore produces a gaze preference away from the side of the lesion-and 
toward the side of an associated hemiparesis, if present.
B. Cortical Input. The PPRF receives cortical input from the contralat­
eral frontal lobe, which regulates rapid eye movements (saccades), and from the 
ipsilateral parieto-occipital lobe, which regulates slow eye movements (pur­
suits). Therefore, a destructive lesion affecting the frontal cortex interferes with 
the mechanism for contralateral horizontal gaze and may result in a gaze prefer­
ence toward the side of the lesion (and away from the side of associated hemi­
paresis). By contrast, an irritative (seizure) focus in the frontal lobe may cause 
gaze away from the side of the focus.
NEURO-OPHTHALMOLOGIC EXAMINATION
Visual Acuity
A. Assessment. To assess visual acuity from a neurologic standpoint, vi­
sion is tested under conditions that eliminate refractive errors. Therefore, pa­
tients who wear glasses should be examined while wearing them (a pinhole can 
be substituted if the corrective lenses usually worn are not available at the time 
of testing). Visual acuity must be assessed for each eye separately. Distant vi­
sion is tested using a Snellen eye chart, with the patient 6 m (20 ft) away. Near 
vision is tested with the Rosenbaum pocket eye chart held about 36 cm (14 in) 
from the patient. In each case, the smallest line of print that can be read is noted.
B. Recording. Visual acuity is expressed as a fraction (eg, 20/20, 20/40, 
20/200). The numerator is the distance (in feet) from the test figures at which the 
examination is performed, and the denominator is the distance (in feet) at which 
figures of a given size can be correctly identified by persons with normal vision. 
For example, if a patient standing 20 ft away from the eye chart is unable to 
identify figures that can normally be seen from that distance but can identify the 
larger figures that would be visible 40 ft away with normal acuity, the visual 
acuity is recorded as 20/40. If the patient can read most of a given line but
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makes some errors, acuity may be recorded as 20/40-1, for example, indicating 
that all but one letter on the 20/40 line were correctly identified. When visual 
acuity is markedly reduced, it can still be quantified, though less precisely, in 
terms of the distance at which the patient can count fingers (CF), discern hand 
movement (HM), or perceive light. If an eye is totally blind, the examination 
will reveal no light perception (NLP).
C. Red-Green Color Vision. Red-green color vision is often dispropor­
tionately impaired in optic nerve lesions and can be tested with colored objects 
such as pens or hatpins or with color vision plates.
Visual Fields
Evaluating the visual fields can be a lengthy and tedious procedure if con­
ducted in an undirected fashion. Familiarity with the common types of visual 
field defects is important if testing is to be reasonably rapid and yield useful in­
formation. The most common visual field abnormalities are illustrated in Figure.
A. Extent of Visual Fields. The normal monocular visual field subtends 
an angle of about 160 degrees in the horizontal plane and about 135 degrees in 
the vertical plane. With binocular vision, the horizontal range of vision exceeds 
180 degrees.
B. Physiologic Blind Spot. Within the normal field of each eye is a 5- 
degree blind spot, corresponding to the optic disk, which lacks receptor cells.
C. Measurement Techniques. Numerous techniques exist for measuring 
the visual field -  which, like visual acuity, must be examined separately for each 
eye.
1. The simplest method for visual field testing is the confrontation tech­
nique. The examiner stands at about arm's length from the patient, with the eyes 
of both patient and examiner aligned in the horizontal plane. The eye not being 
tested is covered by the patient's hand or an eye patch. The examiner closes the 
eye opposite the patient's covered eye, and the patient is instructed to fix on the 
examiner's open eye. Now the monocular fields of patient and examiner are su­
perimposed, which allows comparison of the patient's field with the examiner's 
presumably normal field. The examiner uses the index fingers of both hands to 
locate the boundaries of the patient's field, moving them slowly inward from the 
periphery in all directions until the patient detects them. The boundaries are then 
defined more carefully by determining the farthest peripheral sites at which the 
patient can detect slight movements of the fingertips or the white head of a pin. 
The patient's blind spot can be located in the region of the examiner's own blind 
spot, and the sizes of these spots can be compared using a pin with a white head 
as the target. The procedure is then repeated for the other eye.
2. Subtle field defects may be detected by asking the patient to compare 
the brightness of colored objects presented at different sites in the field or by 
measuring the fields using a pin with a red head as the target.
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3. In young children, the fields may be assessed by standing behind the 
child and bringing an attention-getting object, such as a toy, forward around the 
child's head in various directions until it is first noticed.
4. A gross indication of visual field abnormalities may be obtained in ob- 
tunded patients by determining whether they blink in response to a visual threat 
-  typically the examiner's finger -  brought toward the patient's eye in various 
regions of the field.
5. While many visual field deficits are detectable by these screening pro­
cedures, more precise mapping of the fields requires the use of one of many pe­
rimetry techniques. In tangent screen testing, the patient typically sits I m from 
the screen with one eye covered, and the examiner places pins of various sizes 
and colors on the surface of the screen. The field is plotted for each eye, indicat­
ing the sizes of the test objects and the distance of the patient from the screen.
Ophthalmoscopy
A. Preparation of the Patient. Ophthalmoscopic examination of the op­
tic fundus is particularly important in evaluating neuro-ophthalmologic disorders 
that affect the retina or optic disk and in the evaluation of patients with a sus­
pected increase in intracranial pressure. The examination should be conducted in 
a dark room so that the pupils are dilated; in some patients, the use of mydriatic 
(sympathomimetic or anticholinergic) eye drops is necessary. In the latter case, 
visual acuity and pupillary reflexes should always be assessed before instilling 
the drops. Mydriatic agents should be avoided in patients with glaucoma and in 
situations-such as impending or ongoing transtentorial herniation-in which the 
state of pupillary reactivity is an important guide to management.
B. Examination of the Fundus. Familiarity with the normal appearance 
of the optic fundus is necessary if abnormalities are to be appreciated.
1. Optic disk
a. Normal appearance. The optic disk is usually easily recognizable as a 
yellowish, slightly oval structure situated nasally at the posterior pole of the eye. 
The temporal side of the disk is often paler than the nasal side. The disk margins 
should be sharply demarcated, though the nasal edge is commonly somewhat 
less distinct than the temporal edge. The disk is normally in the same plane as 
the surrounding retina.
b. Optic disk swelling. Among the many ophthalmoscopic findings that 
provide useful diagnostic information, the abnormality that most often requires 
prompt interpretation and attention is optic nerve swelling (papilledema). While 
this condition implies increased intracranial pressure, it must be differentiated 
from swelling that is due to other causes, such as local inflammation (papillitis) 
and ischemic optic neuropathy. In making this distinction, it is most helpful to 
bear in mind that papilledema is almost always bilateral; it does not typically 
impair vision, except for enlargement of the blind spot; and it is not associated
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with eye pain. Papilledema can also be simulated by disk abnormalities such as 
drusen (colloid or hyaline bodies).
Increased intracranial pressure is thought to cause papilledema by 
transmitting the increased pressure through the intravaginal space surrounding 
the optic nerve. Because this compartment communicates with the subarachnoid 
space, disorders associated with increased intracranial pressure that also obstruct 
the subarachnoid space, such as meningitis, are less likely to cause papilledema. 
The ophthalmoscopic changes in papilledema typically develop over days or 
weeks but may become apparent within hours following a sudden increase in in­
tracranial pressure-as, for example, following intracranial hemorrhage. In early 
papilledema, the retinal veins appear engorged and spontaneous venous pulsa­
tions are absent. The disk may be hyperemic, and linear hemorrhages may be 
seen at its borders. The disk margins become blurred, with the temporal edge 
last to be affected. In fully developed papilledema, the optic disk is elevated 
above the plane of the retina.
c. Optic disk pallor. Optic disk pallor with impaired visual acuity, visual 
fields, or pupillary reactivity is associated with a wide variety of disorders that 
affect the optic nerve, including inflammatory conditions, nutritional deficien­
cies, and heredodegenerative diseases. Note that a pale optic disk with normal 
visual function can occur as a congenital variant.
2. Arteries and veins. To determine the caliber of the retinal arteries and 
veins, they are observed at the point where they arise from the disk and pass 
over its edges onto the retina. Observations include whether they are easily visi­
ble throughout their course, whether they appear engorged, and whether sponta­
neous venous pulsations are present. The remainder of the visible retina is in­
spected, noting the presence of hemorrhages, exudates, or other abnormalities.
3. Macula. The macula, a somewhat paler area than the rest of the retina, 
is located about two disk diameters temporal to the temporal margin of the optic 
disk. It can be visualized quickly by having the patient look at the light from the 
ophthalmoscope. Ophthalmoscopic examination of the macula can reveal ab­
normalities related to visual loss from age-related macular degeneration, from 
macular holes, or from hereditary cerebromacular degenerations.
Pupils
A. Size. Assessing the size and reactivity of the pupils provides an evalua­
tion of nervous system pathways from the optic nerve to the midbrain. The nor­
mal pupil is round, regular, and centered within the iris; its size varies with age 
and with the intensity of ambient light. In a brightly illuminated examining 
room, normal pupils are about 3 mm in diameter in adults. They are often 
smaller in the elderly and commonly 5 mm or more in diameter in children. Pu­
pillary size may be asymmetric in as much as 20% of the population (physiol­
ogic anisocoria), but the difference in size is not more than I mm. Symmetrically
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rapid constriction in response to a bright light indicates that the size difference is 
not due to oculomotor nerve compression.
B. Reaction to Light. Direct (ipsilateral) and consensual (contralateral) 
pupillary constriction in response to a bright light shined in one eye demon­
strates the integrity of the pathways. Normally, the direct response to light is 
slightly brisker and more pronounced than the consensual response.
C. Reaction to Accommodation. When the eyes converge to focus on a 
nearer object, the pupils normally constrict. The reaction to accommodation is 
tested by having the patient focus alternately on a distant object and a finger 
held just in front of his or her nose.
D. Pupillary Abnormalities:
1. Nonreactive pupils. Unilateral disorders of pupillary constriction are 
seen with local disease of the iris (trauma, iritis, glaucoma), oculomotor nerve 
compression (tumor, aneurysm), and optic nerve disorders (optic neuritis, multi­
ple sclerosis).
2. Light-near dissociation. Impaired pupillary reactivity to light with 
preserved constriction during accommodation (light-near dissociation) is usually 
bilateral and may result from neurosyphilis, diabetes, optic nerve disorders, and 
tumors compressing the midbrain tectum.
3. Argyll Robertson pupils. These pupils are small, poorly reactive to 
light, often irregular in shape, and frequently unequal in size; they show light- 
near dissociation. Neurosyphilis is the usual cause.
4. Tonic pupil. The tonic (Adie's) pupil is larger than the contralateral un­
affected pupil and reacts sluggishly to changes in illumination or accommoda­
tion. Since the tonic pupil does eventually react, anisocoria becomes less marked 
during the time of the examination. This abnormality is most commonly a mani­
festation of a benign, often familial disorder that frequently affects young 
women (Holmes-Adie syndrome) and may be associated with depressed deep 
tendon reflexes (especially in the legs), segmental anhidrosis (localized lack of 
sweating), orthostatic hypotension, or cardiovascular autonomic instability. The 
condition may be bilateral. The pupillary abnormality may be caused by de­
generation of the ciliary ganglion, followed by aberrant reinnervation of the pu- 
pilloconstrictor muscles.
5. Horner's syndrome. Horner's syndrome results from a lesion of the 
central or peripheral sympathetic nervous system and consists of a small (mi­
otic) pupil associated with mild ptosis and sometimes loss of sweating (anhidro­
sis).
a. Oculosympathetic pathways. The sympathetic pathway controlling 
pupillary dilation consists of an uncrossed three-neuron arc: hypothalamic neu­
rons, the axons of which descend through the brainstem to the internediolateral 
column of the spinal cord at the Tllevel; preganglionic sympathetic neurons pro­
jecting from the spinal cord to the superior cervical ganglion; and postganglionic 
sympathetic neurons that originate in the superior cervical ganglion, ascend in
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the neck along the internal carotid artery, and enter the orbit with the first (oph­
thalmic) division of the trigeminal (V) nerve. Homer's syndrome is caused by 
interruption of these pathways at any site.
b. Clinical features. The lesions-and the pupillary abnormality produced- 
are usually unilateral. The pupillary diameter on the involved side is typically 
reduced by 0.5-1 mm compared with the normal side. This inequality is most 
marked in dim illumination and in other situations in which the pupils are nor­
mally dilated, such as during a painful stimulus or startle. The pupillary abnor­
mality is accompanied by mild to moderate ptosis (see below) of the upper lid 
(as opposed to the pronounced ptosis with oculomotor nerve lesions), often as­
sociated with elevation of the lower lid. When Homer's syndrome has been pre­
sent since infancy, the ipsilateral iris is lighter and blue (heterochromia iridis).
Deficits in the pattern of sweating, which are most prominent in acute- 
onset Homer's syndrome, can help localize the lesion. If sweating is decreased 
on an entire half of the body and face, the lesion is in the central nervous system. 
Cervical lesions produce anhidrosis of the face, neck, and arm only. Sweating is 
unimpaired if the lesion is above the bifurcation of the carotid artery.
6. Relative afferent pupillary defect (Marcus Gunn pupil). In this con­
dition, one pupil constricts less markedly in response to direct illumination than 
to illumination of the contralateral pupil, whereas normally the direct response is 
greater than the consensual response. The abnormality is detected by rapidly 
moving a bright flashlight back and forth between the eyes while continuously 
observing the suspect pupil (Gunn's pupillary test). Relative afferent pupillary 
defect is commonly associated with disorders of the ipsilateral optic nerve, 
which interrupt the afferent limb and affect the pupillary light reflex. Such dis­
orders also commonly impair vision (especially color vision) in the involved 
eye.
Optokinetic Response
Optokinetic nystagmus consists of eye movements elicited by sequential 
fixation on a series of targets passing in front of a patient's eyes, such as tele­
phone poles seen from a moving train. For clinical testing, a revolving drum 
with vertical stripes or a vertically striped strip of cloth moved across the visual 
field is used to generate these movements. Testing produces a slow following 
phase in the direction of the target's movement, followed by a rapid return jerk 
in the opposite direction. The slow (pursuit) phase tests ipsilateral parieto­
occipital pathways; the rapid (saccadic) movement tests pathways originating in 
the contralateral frontal lobe. The presence of an optokinetic response reflects 
the ability to perceive movement or contour and is sometimes useful for docu­
menting visual perception in newborns or in psychogenic blindness. Visual acu­
ity required to produce the optokinetic response is minimal, however (20/400, or 
finger counting at 3-5 ft). Unilateral impairment of the optokinetic response may 
be found when targets are moved toward the side of a parietal lobe lesion.
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Fig. 9. Common visual field defects and their anatomical bases. 1. Central 
scotoma caused by inflammation of the optic disk (optic neuritis) or optic nerve 
(retrobulbar neuritis). 2. Total blindness of the right eye from a complete 
lesion of the right optic nerve. 3. Bitemporal hemianopia caused by pressure 
exerted on the optic chiasm by a pituitary tumor. 4. Right nasal hemianopia 
caused by a perichiasmal lesion (eg, calcified internal carotid artery). 5. Right 
homonymous hemianopia from a lesion of the left optic tract. 6. Right 
homonymous superior quadrantanopia caused by partial involvement of the 
optic radiation by a lesion in the left temporal lobe (Meyer's loop). 7. Right 
homonymous inferior quadrantanopia caused by partial involvement of the 
optic radiation by a lesion in the left parietal lobe. 8. Right homonymous 
hemianopia from a complete lesion of the left optic radiation. (A similar defect 
may also result from lesion 9.) 9. Right homonymous hemianopia (with 
macular sparing) resulting from posterior cerebral artery occlusion. (From R. 
Simon, M. Aminoff, D. Greenberg, 1999)
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Pupillary constrictor muscle
Light
О
Fig. 10. Anatomic basis of the pupillary light reflex. The afferent visual 
pathways from the retina to the pretectal nuclei of the midbrain are represented 
by dashed lines and the efferent pupilloconstrictor pathways from the midbrain 
to the retinas by solid lines. Note that illumination of one eye results in bilateral 
pupillary constriction. (From R. Simon, M. Aminoff, D. Greenberg, 1999)
74
Eyelids
The eyelids (palpebrae) should be examined with the patient's eyes open. 
The distance between the upper and lower lids (interpalpebral fissure) is usually 
about 10 mm and equal in both eyes, though physiological asymmetries do oc­
cur. The position of the inferior margin of the upper lid relative to the superior 
border of the iris should be noted in order to detect drooping (ptosis) or abnor­
mal elevation of the eyelid (lid retraction). The upper lid normally covers 1-2 
mm of the iris.
Unilateral ptosis is seen with paralysis of the levator palpebrae muscle it­
self, lesions of the oculomotor nerve or its superior branch, and Homer's syn­
drome. In the last condition, ptosis is customarily associated with miosis and 
may be momentarily overcome by effortful eye opening.
Bilateral ptosis suggests disease affecting the oculomotor nerve nucleus; a 
disorder of the neuromuscular junction, such as myasthenia gravis; or a disorder 
of muscle, such as myotonic, ocular, or oculopharyngeal dystrophy.
Lid retraction (abnormal elevation of the upper lid) is seen in hyperthy­
roidism; in Parinaud's syndrome, it is caused by tumors in the pineal region.
Exophthalmos
Abnormal protrusion of the eye from the orbit (exophthalmos or prop­
tosis) is best detected by standing behind the seated patient and looking down at 
his or her eyes. The causes include hyperthyroidism, orbital tumor or pseudotu­
mor, and carotid artery-cavernous sinus fistula. A bruit may be audible on aus­
cultation over the proptotic eye in patients with carotid artery-cavernous sinus 
fistula or other vascular anomalies.
Eye Movements
A. Ocular Excursion and Gaze. Ocular palsies and gaze palsies are de­
tected by having the patient gaze in each of the six cardinal positions. If volun­
tary eye movement is impaired or the patient is unable to cooperate with the ex­
amination (eg, is comatose), reflex eye movements can be induced by one of 
two maneuvers. The doll's head (oculocephalic) maneuver is performed by rotat­
ing the head horizontally, to elicit horizontal eye movements, and vertically, to 
elicit vertical movements. The eyes should move in the direction opposite to that 
of head rotation. This may be an inadequate stimulus for inducing eye move­
ments, however, and the reflex may be overridden in conscious patients. Caloric 
(oculovestibular) stimulation is a more potent stimulus and is performed by irri­
gating the tympanic membrane with cold (30°C) or warm (44°C) water. Oto- 
scopic examination should always be undertaken before this maneuver is at­
tempted: it is contraindicated if the tympanic membrane is perforated. In con­
scious patients, unilateral cold water irrigation produces nystagmus with the fast 
phase directed away from the irrigated side. Because this procedure may pro-
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duce discomfort and nausea or vomiting, only small volumes (eg, 1 mL) of wa­
ter should be used in conscious patients. In comatose patients with intact brain­
stem function, unilateral cold water irrigation results in tonic deviation of the 
eyes toward the irrigated side. Bilateral irrigation with cold water causes tonic 
downward deviation, whereas bilateral stimulation with warm water induces 
tonic upward deviation. An absent or impaired response to caloric stimulation 
with large volumes (eg, 50 mL) of cold water is indicative of peripheral vestibu­
lar disease, a structural lesion in the posterior fossa (cerebellum or brainstem), or 
intoxication with sedative drugs. If limitations in movement are observed, the 
muscles involved are noted and the nature of the abnormality is determined ac­
cording to the following scheme.
1. Ocular palsy. This weakness of one or more eye muscles results from 
nuclear or infranuclear (nerve, neuromuscular junction, or muscle) lesions. An 
ocular palsy cannot be overcome by caloric stimulation of reflex eye movement. 
Nerve lesions produce distinctive patterns of ocular muscle involvement.
a. Oculomotor (III) nerve palsy. A complete lesion of the oculomotor 
nerve produces closure of the affected eye because of impaired levator function. 
Passively elevating the paralyzed lid shows the involved eye to be laterally devi­
ated because of the unopposed action of the lateral rectus muscle, which is not 
innervated by the oculomotor nerve. Diplopia is present in all directions of gaze 
except for lateral gaze toward the side of involvement. The pupil's function may 
be normal (pupillary sparing) or impaired.
b. Trochlear (IV) nerve palsy. With trochlear nerve lesions, which para­
lyze the superior oblique muscle, the involved eye is elevated during primary 
(forward) gaze; the extent of elevation increases during adduction and decreases 
during abduction. Elevation is greatest when the head is tilted toward the side of 
the involved eye and abolished by tilt in the opposite direction (Bielschowsky's 
head-tilt test). Diplopia is most pronounced when the patient looks downward 
with the affected eye adducted (as in looking at the end of one's nose). Sponta­
neous head tilting, intended to decrease or correct the diplopia, is present in 
about half the patients with unilateral palsies and in an even greater number with 
bilateral palsies.
c. Abducens (VI) nerve palsy. An abducens nerve lesion causes paralysis 
of the lateral rectus muscle, resulting in adduction of the involved eye at rest and 
failure of attempted abduction. Diplopia occurs on lateral gaze to the side of the 
affected eye.
2. Gaze palsy. Gaze palsy is the diminished ability of a pair of yoked 
muscles (muscles that operate in concert to move the two eyes in a given direc­
tion) to move the eyes in voluntary gaze; it is caused by supranuclear lesions in 
the brainstem or cerebral hemisphere. Gaze palsy, unlike ocular palsies, affects 
both eyes and can usually be overcome by caloric stimulation. Its pathophysiol­
ogy and causes are discussed more fully in the section on gaze palsy. Mild im­
pairment of upgaze is not uncommon in asymptomatic elderly subjects.
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3. Internuclear ophthalmoplegia. This disorder results from a lesion of 
the medial longitudinal fasciculus, an ascending pathway in the brainstem that 
projects from the abducens to the contralateral oculomotor nerve nucleus. As a 
consequence, the actions of the abducens and oculomotor nerves during volun­
tary gaze or caloric-induced movement are uncoupled. Excursion of the abduct­
ing eye is full, but adduction of the contralateral eye is impaired. Internuclear 
ophthalmoplegia cannot be overcome by caloric stimulation; it can be distin­
guished from oculomotor nerve palsy by noting preservation of adduction with 
convergence.
4. One-and-a-half syndrome. A pontine lesion affecting both the medial 
longitudinal fasciculus and the ipsilateral paramedian pontine reticular formation 
(lateral gaze center) produces a syndrome that combines internuclear ophthal­
moplegia with an inability to gaze toward the side of the lesion. The ipsilateral 
eye is immobile in the horizontal plane and movement of the contralateral eye is 
restricted to abduction, which may be associated with nystagmus. The causes 
include pontine infarct, multiple sclerosis, and pontine hemorrhage.
B. Diplopia Testing. When the patient complains of diplopia, maneuvers 
to test eye movement should be used to determine its anatomic basis. The patient 
is asked to fix his or her vision on an object, such as a flashlight, in each of the 
six cardinal positions of gaze. With normal conjugate gaze, light from the flash­
light falls at the same spot on both corneas; a lack of such congruency confirms 
that gaze is disconjugate. When the patient notes diplopia in a given direction of 
gaze, each eye should be covered in turn and the patient asked to report which of 
the two images disappears. The image displaced farther in the direction of gaze 
is always referable to the weak eye, because that image will not fall on the fo­
vea. A variation of this procedure is the red glass test, in which one eye is cov­
ered with translucent red glass, plastic, or cellophane; this allows the eye re­
sponsible for each image to be identified.
C. Nystagmus. Nystagmus is rhythmic oscillation of the eyes. Pendular 
nystagmus, which usually has its onset in infancy, occurs with equal velocity in 
both directions. Jerk nystagmus is characterized by a slow phase of movement 
followed by a fast phase in the opposite direction; the direction of jerk nystag­
mus is specified by stating the direction of the fast phase (eg, leftward-beating 
nystagmus). Jerk nystagmus usually increases in amplitude with gaze in the di­
rection of the fast phase.
Nystagmus, a normal component of both the optokinetic response and. the 
response to caloric stimulation of reflex eye movements, can also occur at the 
extremes of voluntary gaze in normal subjects. In other settings, however, it is 
commonly due to anticonvulsant or sedative drugs or is a sign of disease in the 
peripheral vestibular apparatus, central vestibular pathways, or cerebellum.
To detect nystagmus, the eyes are observed in the primary position and in 
each of the cardinal positions of gaze. Nystagmus is described in terms of the
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position of gaze in which it occurs, its direction and amplitude, precipitating fac­
tors such as changes in head position, and associated symptoms, such as vertigo.
Many forms of nystagmus and related ocular oscillations have been de­
scribed, but two syndromes of acquired pathologic jerk nystagmus are by far the 
most common.
1. Gaze-evoked nystagmus. As its name implies, gaze-evoked nystagmus 
occurs when the patient attempts to gaze in one or more directions away from 
the primary position. The fast phase is in the direction of gaze. Nystagmus 
evoked by gaze in a single direction is a common sign of early or mild residual 
ocular palsy. Multidirectional gaze-evoked nystagmus is most often an adverse 
effect of anticonvulsant or sedative drugs, but it can also result from cerebellar 
or central vestibular dysfunction.
2. Vestibular nystagmus. Vestibular nystagmus increases with gaze to­
ward the fast phase and is usually accompanied by vertigo when caused by a le­
sion of the peripheral vestibular apparatus. Vestibular nystagmus is characteris­
tically unidirectional, horizontal, or horizontal and rotatory and associated with 
severe vertigo. In contrast, central vestibular nystagmus may be bidirectional 
and purely horizontal, vertical, or rotatory, and the accompanying vertigo is 
typically mild. Positional nystagmus -  elicited by changes in head position -  can 
occur with either peripheral or central vestibular lesions. The most helpful dis­
tinguishing features are the presence of hearing loss or tinnitus with peripheral 
lesions and of corticospinal tract or additional cranial nerve abnormalities with 
central lesions.
DISORDERS OF THE VISUAL SYSTEM
Common syndromes of monocular visual loss include two reversible and 
two irreversible disorders. Transient monocular blindness caused by optic nerve 
ischemia is sudden in onset and resolves rapidly. Subacute, painful, unilateral 
visual loss with partial resolution is associated with optic neuritis. Irreversible 
visual loss of sudden onset occurs in idiopathic ischemic optic neuropathy and in 
giant cell (temporal) arteritis.
1. TRANSIENT MONOCULAR BLINDNESS
This condition, sometimes called amaurosis fugax, is characterized by 
unilateral transient diminution or loss of vision that develops over seconds, re­
mains maximal for 1-5 minutes, and resolves over 10-20 minutes. Although the 
cause of these episodes often remains uncertain, the presence of what appears to 
be embolic material in retinal arteries during episodes suggests that emboli are
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the cause. The major site of origin of such emboli appears to be atherosclerotic 
lesions at the carotid bifurcation. Mitral valve prolapse and other cardiac sources 
of emboli can produce a similar syndrome. The risk for subsequent hemispheric 
infarction is increased (14% within 7 years) in patients with a history of tran­
sient monocular blindness but is only about one-half that in patients with hemi­
spheric transient ischemic attacks (TIAs).
Diagnostic evaluation and treatment of patients with transient monocular 
blindness resemble that recommended for patients with hemispheric TIAs. Re­
cent studies have shown that in patients with transient monocular blindness or 
TIAs and high-grade (>70%) stenosis of the carotid artery at angiography, the 
combination of aspirin plus surgical removal of thrombus (endarterectomy) is 
superior to aspirin alone.
2. OPTIC NEURITIS
Inflammation of the optic nerve produces the syndrome of optic neuritis, 
which can be idiopathic; it is caused by demyelination or (rarely) paramen- 
ingeal, meningeal, or intraocular inflammation or is associated with viral infec­
tions or post-viral-infection syndromes. Unilateral impairment of visual acuity 
occurs over hours to days, becoming maximal within 1 week. The visual loss is 
associated with headache, globe tenderness, or eye pain; the last is typically ex­
acerbated by eye movement.
On visual field testing, there is usually a central scotoma (blind spot) as­
sociated with decreased visual acuity. Examination of the fundus is normal in 
two-thirds of patients, since the inflammatory process is usually posterior to the 
optic disk (retrobulbar neuritis), but unilateral disk swelling may be seen. The 
pupils are equal in size but show a diminished reaction to illumination of the af­
fected eye (relative afferent pupillary defect; discussed above). Visual acuity 
usually but not invariably improves over 2-3 weeks to normal. Intravenous 
methylprednisolone, 1 g/d for 3 days, followed by oral prednisone, 1 mg/kg/d 
for 11 days, has been shown to hasten recovery but does not alter the final out­
come. Oral prednisone alone in lower doses was associated with a higher recur­
rence rate than occurred in patients treated with placebo. The frequency with 
which optic neuritis is the first sign of more widespread central nervous system 
demyelination (multiple sclerosis) remains uncertain and varies with the length 
of follow-up studies. Most prospective and retrospective series, however, report 
progression to definite multiple sclerosis in many of these patients (74% of 
women and 34% of men) over the subsequent 15 years. Rare causes of optic 
neuropathy include toxins (eg, methanol, ethambutol), neurosyphilis, and vita­
min В |2 deficiency.
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3. ANTERIOR ISCHEMIC OPTIC NEUROPATHY (AION)
Idiopathic infarction of the anterior portion of the optic nerve is termed 
anterior ischemic optic neuropathy. Such visual loss is sudden in onset, usually 
painless, always monocular, and without premonitory ocular symptoms. Visual 
loss is usually maximal at onset and frequently subtotal, producing a field defect 
that is typically altitudinal (superior or inferior) in configuration; in one-third of 
cases the course is stuttering or progressive. Examination reveals ipsilateral disk 
swelling. In the absence of this finding, the diagnosis is tenuous, and other 
causes, such as a rapidly expanding intracranial mass or neoplastic meningitis, 
should be sought. Although ischemic optic neuropathy is often assumed to be 
atherosclerotic in origin, there is no consistent association with other risk factors 
for cerebrovascular disease, such as hypertension, diabetes, or atherosclerotic 
carotid artery disease. Patients with AION have a structurally smaller disc than 
nomal; 40% will go on to have the other eye affected within 2-4 years. Attempts 
at treatment have been uniformly unsuccessful. As disk swelling resolves, oph­
thalmoscopic evaluation shows optic atrophy.
4. GIANT CELL (TEMPORAL) ARTERITIS
Arteritic infarction of the anterior portion of the optic nerve is the most 
devastating complication of giant cell, or temporal, arteritis. This disorder is 
usually accompanied by systemic symptoms such as fever, malaise, night 
sweats, weight loss, and headache and often by polymyalgia rheumatica. Tran­
sient retinal ischemia, mimicking embolic events, may precede optic nerve in­
farction. The visual loss is sudden and often total. On examination, the optic 
disk appears swollen and pale. Immediate treatment with corticosteroids 
(methylprednisolone, 1000 mg/d intravenously, then prednisone, 60-80 mg/d 
orally) is urgently required to protect what vision remains. The prednisone may 
be gradually reduced over many months while monitoring the erythrocyte sedi­
mentation rate.
Because giant cell arteritis is treatable, it is most important to distinguish 
it from anterior ischemic optic neuropathy as the cause of monocular visual loss. 
Patients with giant cell arteritis tend to be older (aged 70-80 years), and they 
may have premonitory symptoms. The most helpful differential features are the 
erythrocyte sedimentation rate, which is greater than 50 mm/h (Westergren) in 
most patients with giant cell arteritis, and the C-reactive protein.
5. PAPILLEDEMA
Papilledema is the passive bilateral disk swelling that is associated with 
increased intracranial pressure. Less common causes include congenital cyanotic 
heart disease and disorders associated with increased CSF protein content, in­
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eluding spinal cord tumor and idiopathic inflammatory polyneuropathy (Guil- 
lain-Barre syndrome).
The speed with which papilledema develops is dictated by the underlying 
cause. When intracranial pressure increases suddenly, as in subarachnoid or in­
tracerebral hemorrhage, disk swelling may be seen within hours, but it most of­
ten evolves over days. Papilledema may require 2-3 months to resolve following 
restoration of normal intracranial pressure. Associated nonspecific symptoms of 
raised intracranial pressure include headache, nausea, vomiting, and diplopia 
from abducens nerve palsy. Funduscopic examination reveals (in order of onset) 
blurring of the nerve fiber layer, absence of venous pulsations (signifying intrac­
ranial pressure greater than approximately 200 mm Hg), hemorrhages in the 
nerve fiber layer, elevation of the disk surface with blurring of the margins, and 
disk hyperemia.
Papilledema requires urgent evaluation to search for an intracranial mass 
and to exclude papillitis from syphilis, carcinoma, or sarcoidosis, which may 
produce a similar ophthalmoscopic appearance. In the history and examination, 
attention should be directed at symptoms and signs of intracranial masses, such 
as hemiparesis, hemianopia or seizures, and signs of meningeal irritation.
If an intracranial mass lesion and some other disorders are ruled out by the 
history, examination, and CT scanning or MR1; if inflammatory meningeal 
processes are excluded by CSF examination; and if CSF pressure is elevated, a 
diagnosis of pseudotumor cerebri is established by exclusion. The idiopathic 
form, which is the most common, occurs most often in obese women during the 
childbearing years. Although this disorder is usually self-limited, prolonged ele­
vation of intracranial pressure can lead to permanent visual loss.
6. CHIASMAL LESIONS
The major lesions that produce visual impairment at the level of the optic 
chiasm are tumors, especially those of pituitary origin. Other causes include 
trauma, demyelinating disease, and expanding berry aneurysms. The classic pat­
tern of visual deficit caused by lesions of the optic chiasm is bitemporal he­
mianopia. Chiasmal visual loss is gradual in onset, and the resulting impairment 
in depth perception or in the lateral visual fields may not be noted for some time. 
Associated involvement of the oculomotor, trochlear, trigeminal, or abducens 
nerve suggests tumor expansion laterally into the cavernous sinus. Nonophthal- 
mologic manifestations of pituitary tumors include headache, acromegaly, 
amenorrhea, galactorrhea, and Cushing's syndrome.
Headache, endocrine abnormalities, and occasionally blurred or double 
vision may occur in patients with an enlarged sella turcica (shown on radio- 
graphic examination) but in whom neither tumor nor increased intracranial pres­
sure is found. This empty sella syndrome is most common in women and occurs
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mainly between the fourth and seventh decades of life. Treatment is sympto­
matic.
7. RETROCHIASMAL LESIONS
Optic Tract & Lateral Geniculate Body
Lesions of the optic tract and lateral geniculate body are usually due to in­
farction. The resulting visual field abnormality is typically a noncongruous ho­
monymous hemianopia; ie, the field defect is not the same in the two eyes. As­
sociated hemisensory loss may occur with thalamic lesions.
Optic Radiations
Lesions of the optic radiations produce field deficits that are congruous 
and homonymous (bilaterally symmetric). Visual acuity is normal in the unaf­
fected portion of the field. With lesions in the temporal lobe, where tumors are 
the most common cause, the field deficit is denser superiorly than inferiorly, re­
sulting in a superior quadrantanopia (pie in the sky deficit).
Lesions affecting the optic radiations in the parietal lobe may be due to 
tumor or vascular disease and are usually associated with contralateral weakness 
and sensory loss. A gaze preference is common, with the eyes conjugately devi­
ated to the side of the parietal lesion. The visual field abnormality is either com­
plete homonymous hemianopia or inferior quadrantanopia. The optokinetic re­
sponse to a visual stimulus moved toward the side of the lesion is impaired, 
which is not the case with pure temporal or occipital lobe lesions.
Occipital Cortex
Lesions in the occipital cortex usually produce homonymous hemianopias 
affecting the contralateral visual field. The patient may be unaware of the visual 
deficit. Since the region of the occipital cortex in which the macula is repre­
sented is often supplied by branches of both the posterior and middle cerebral 
arteries, visual field abnormalities caused by vascular lesions in the occipital 
lobe may show sparing of macular vision. It has also been suggested that in 
some cases, macular sparing may result from bilateral cortical representation of 
the macular region of the visual field.
The most common cause of visual impairment in the occipital lobe is in­
farction in the posterior cerebral artery territory (90% of cases). Occipital lobe 
arteriovenous malformations (AVMs), vertebral angiography, and watershed in­
farction following cardiac arrest are less common causes. Additional symptoms 
and signs of basilar artery ischemia may occur. Tumors and occipital lobe 
AVMs are often associated with unformed visual hallucinations that are typi­
cally unilateral, stationary or moving, and often brief or flickering; they can be 
colored or not colored.
Bilateral occipital lobe involvement produces cortical blindness. Pupillary 
reactions are normal, and bilateral macular sparing may preserve central (tunnel)
8 2
vision. With more extensive lesions, denial of blindness may occur (Anton's 
syndrome).
DISORDERS OF OCULAR MOTILITY
GAZE PALSY
Lesions in the cortex or brainstem above the level of the oculomotor nu­
clei may impair conjugate (yoked) movement of the eyes, producing gaze disor­
ders.
Hemispheric Lesions
Acutely, hemispheric lesions produce tonic deviation of both eyes toward 
the side of the lesion and away from the side of the hemiparesis. This gaze de­
viation lasts for up to several days in alert patients-somewhat longer in comatose 
patients. Seizure discharges involving the frontal gaze centers can also produce 
gaze deviation by driving the eyes away from the discharging focus. When the 
ipsilateral motor cortex is also involved, producing focal motor seizures, the pa­
tient gazes toward the side of the motor activity.
Midbrain Lesions
Lesions of the dorsal midbrain affect the center responsible for voluntary 
upward gaze and may therefore produce upgaze paralysis. In addition, all or 
some of the features of Parinaud's syndrome may occur. These include preserved 
reflex vertical eye movements with the doll's head maneuver or Bell's phe­
nomenon (elevation of the eye with eyelid closure), nystagmus (especially on 
downward gaze and typically associated with retraction of the eyes), paralysis of 
accommodation, midposition pupils, and light-near dissociation.
Pontine Lesions
Brainstem lesions at the level of the pontine gaze centers produce disor­
ders of conjugate horizontal gaze. Gaze palsies from pontine involvement 
(unlike those from hemispheric lesions) cause eye deviation toward-rather than 
away from-the side of the hemiparesis. This occurs because, at this level of the 
brainstem, the corticobulbar pathways that regulate gaze have decussated but the 
descending motor pathways have not. Brainstem gaze pareses are characteristi­
cally far more resistant to attempts to move the eyes (via the doll's eye maneuver 
or caloric stimulation) than are supratentorial gaze pareses and are commonly 
associated with abducens nerve dysfunction because of the involvement of the 
abducens nerve nucleus.
INTERNUCLEAR OPHTHALMOPLEGIA
Intemuclear ophthalmoplegia results from lesions of the medial longitudi­
nal fasciculus between the midpons and the oculomotor nerve nucleus that dis­
connect the abducens nerve nucleus from the contralateral oculomotor nucleus.
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The site of the internuclear ophthalmoplegia is named according to the side on 
which oculomotor nerve function is impaired. There is a characteristic abnor­
mality consisting of disconjugate gaze with impaired adduction and nystagmus 
of the abducting eye. Such a finding strongly supports a diagnosis of intrinsic 
brainstem disease. The most common cause, especially in young adults or in pa­
tients with bilateral involvement, is multiple sclerosis. In older patients and 
those with unilateral involvement, vascular disease is likely. These two diagno­
ses encompass 80% or more of all cases in reported series. Rarer causes include 
brainstem encephalitis, intrinsic brainstem tumors, syringobulbia, sedative drug 
intoxication, and Wernicke's encephalopathy. Because the oculomotor abnor­
malities of myasthenia gravis can closely mimic a lesion of the medial longitu­
dinal fasciculus, myasthenia must be ruled out in patients with isolated intemu- 
clear ophthalmoplegia.
OCULOMOTOR (111) NERVE LESIONS
Brainstem
Within the brainstem, associated neurologic signs permit localization of 
the lesion; associated contralateral hemiplegia (Weber's syndrome) and contra­
lateral ataxia (Benedikt's syndrome) are the most common vascular syndromes.
Subarachnoid Space
As the oculomotor nerve exits the brainstem in the interpeduncular space, 
it is susceptible to injury from trauma and from aneurysms of the posterior 
communicating artery. The latter often cause acute oculomotor palsy from aneu­
rysmal expansion with a characteristic impairment of the pupillary light reflex.
Cavernous Sinus
In the cavernous sinus the oculomotor nerve is usually involved along 
with the trochlear and abducens nerves and the first and sometimes the second 
division of the trigeminal nerve. Homer's syndrome may occur. Oculomotor 
nerve lesions in the cavernous sinus tend to produce partial deficits that mayor 
may not spare the pupil.
Orbit
Unlike cavernous sinus lesions, orbital lesions that affect the oculomotor 
nerve are often associated with optic nerve involvement and exophthalmos; 
however, disorders of the orbit and cavernous sinus may be clinically indistin­
guishable except by CT scanning or MRI.
TROCHLEAR (IV) NERVE LESIONS
Head trauma, often minor, is the most common cause of an isolated 
trochlear nerve palsy. While trochlear palsies in middle-aged and elderly pa­
tients are also frequently' attributed to vascular disease or diabetes, they often 
occur without obvious cause. For patients with isolated trochlear nerve palsies
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without a history of trauma, in whom diabetes, myasthenia, thyroid disease, and 
orbital mass lesions have been excluded, observation is the appropriate clinical 
approach.
ABDUCENS (VI) NERVE LESIONS
Patients with abducens nerve lesions complain of horizontal diplopia due 
to weakness of the lateral rectus muscle. Lateral rectus palsies can occur as a re­
sult of disorders of either the muscle itself or the abducens nerve, and each of 
these possibilities should be investigated in turn. In elderly patients, abducens 
nerve involvement is most often idiopathic or caused by vascular disease or dia­
betes, but the erythrocyte sedimentation rate should be determined to exclude a 
rare presentation of giant cell arteritis. Radiographic investigation of the base of 
the skull is indicated to exclude nasopharyngeal carcinoma or other tumors. In 
painless abducens palsy-when the above studies are normal, other systemic and 
neurologic symptoms are absent, and intracranial pressure is not elevated- 
patients can be followed conservatively. A trial of prednisone (60 mg/d orally 
for 5 days) may produce dramatic relief in painful abducens nerve palsy, giving 
support to a tentative diagnosis of idiopathic inflammation of the superior orbital 
fissure (superior orbital fissure syndrome) or cavernous sinus (Tolosa-Hunt syn­
drome). Persistent pain despite treatment with steroids should prompt investiga­
tion of the cavernous sinus by CT scanning or MR1, followed, in some cases, by 
angiography.
DIABETIC OPHTHALMOPLEGIAS
An isolated oculomotor, trochlear, or abducens nerve lesion may occur in 
patients with diabetes mellitus, and noninvasive imaging procedures (CT scan­
ning or MRI) reveal no abnormality. Such oculomotor nerve lesions are charac­
terized by pupillary sparing with or without pain. Pain, when present, may be 
severe enough to suggest aneurysmal expansion as a likely diagnosis. The lack 
of pupillary involvement is commonly attributed to infarction of the central por­
tion of the nerve with sparing of the more peripherally situated fibers that medi­
ate pupillary constriction. Pupil-sparing oculomotor palsies can also be seen oc­
casionally, however, with compressive, infiltrative, or inflammatory lesions of 
the oculomotor nerve or with infarcts, hemorrhages, or tumors that affect the 
oculomotor nucleus or fascicle within the midbrain.
In known diabetics, painful ophthalmoplegia with exophthalmos and 
metabolic acidosis requires urgent attention to determine the possibility of fun­
gal infection in the paranasal sinus, orbit, or cavernous sinus by mucormycosis. 
The diagnosis is usually made by biopsy of the nasal mucosa. Failure to make a 
prompt diagnosis and to institute treatment at once with amphotericin В and sur­
gical debridement of necrotic tissue may lead to a fatal outcome.
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PAINFUL OPHTHALMOPLEGIAS
Dysfunction of one or more of the ocular motor nerves with accompany­
ing pain may be produced by lesions located anywhere from the posterior fossa 
to the orbit. The evaluation should consist of careful documentation of the clini­
cal course, inspection and palpation of the globe for proptosis (localizing the 
process to the orbit or anterior cavernous sinus), auscultation over the globe to 
detect a bruit (which would strongly support a diagnosis of carotid artery- 
cavernous sinus fistula or another vascular anomaly), and evaluation for diabe­
tes. Useful laboratory studies include an orbital CT scan or MRi, carotid arte­
riography, and orbital venography.
Therapy for these disorders is dictated by the specific diagnosis. Idio­
pathic inflammation of the orbit (orbital pseudotumor) or cavernous sinus 
(Tolosa Hunt syndrome) responds dramatically to corticosteroids (prednisone, 
60-100 mg/d orally). However, the pain and ocular signs of some neoplasms 
may also improve transiently during corticosteroid therapy so that a specific 
etiologie diagnosis may depend on biopsy.
MYASTHENIA GRAVIS
Myasthenia eventually involves the ocular muscles in approximately 90% 
of patients; more than 60% present with ocular involvement. The syndrome is 
painless; pupillary responses are always normal, and there are no sensory ab­
normalities. The diagnosis is confirmed by a positive response to intravenous 
edrophonium (Tensilon).
OCULAR MYOPATHIES
Ocular myopathies are painless syndromes that spare pupillary function 
and are usually bilateral. The most common is the myopathy of hyperthyroid­
ism, a common cause of double vision beginning in midlife or later. Note that 
many patients are otherwise clinically euthyroid at the time of diagnosis. Double 
vision on attempted elevation of the globe is the most common symptom, but in 
mild cases there is lid retraction during staring or lid lag during rapid up-and- 
down movements of the eye. Exophthalmos is a characteristic finding, especially 
in advanced cases. The diagnosis can be confirmed by the forced duction test, 
which detects mechanical resistance to forced movement of the anesthetized 
globe in the orbit. This restrictive ocular myopathy is usually self-limited. The 
patient should be referred for testing of thyroid function and treated for hyper­
thyroidism as appropriate.
The progressive external ophthalmoplegias are a group of syndromes 
characterized by slowly progressive, symmetric impairment of ocular movement
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that cannot be overcome by caloric stimulation. Pupillary function is spared, and 
there is no pain; ptosis may be prominent. This clinical picture can be produced 
by ocular or oculopharyngeal muscular dystrophy. Progressive external oph­
thalmoplegia associated with myotonic contraction on percussion of muscle 
groups (classically, the thenar group in the palm) suggests the diagnosis of 
myotonic dystrophy. In Kearns-Sayre-Daroff syndrome, which has been associ­
ated with deletions in muscle mitochondrial DNA, progressive external oph­
thalmoplegia is accompanied by pigmentary degeneration of the retina, cardiac 
conduction defects, cerebellar ataxia, and elevated CSF protein. The muscle bi­
opsy shows ragged red fibers that reflect the presence of abnormal mitochondria. 
Disorders that simulate progressive external ophthalmoplegia include progres­
sive supranuclear palsy and Parkinson's disease, but in these conditions the im­
pairment of (usually vertical) eye movements can be overcome by oculocephalic 
or caloric stimulation.
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TRIGEMINAL NERVE (V)
FUNCTIONAL ANATOMY
The trigeminal nerve contains both sensory (afferent) and motor (efferent) 
fibres. Sensory information is conveyed from the skin of the face and forehead, 
from the mucous membranes of the nasal sinuses and oral cavities, from the 
teeth, and from the dura of the anterior and middle cranial fossae. Efferent fibres 
innervate the masseter, temporalis, and pterygoid muscles (the muscles of masti­
cation). Whereas the organization of the motor pathways is relatively straigh- 
forward, the sensory system is complex, with three major peripheral branches 
(each with several smaller branches), and two central pathways each subserving 
different sensory modalities. The peripheral distribution will be discussed first 
followed by a description of the central connections.
Peripheral sensory pathways
The cell bodies of the afferent fibres lie in the trigeminal ganglion (also 
known as the Gasserian or semilunar ganglion) which sits in a dural cavity 
(Meckel's cave) near the tip of the petrous apex bone. The peripheral processes 
of these unipolar ganglion cells give rise to the three main divisions of the 
trigeminal nerve: the ophthalmic, maxillary, and mandibular branches, often 
conveniently referred to as VI, V2 and V3. The central processes form the sen­
sory root which enters the pons on its lateral aspect.
The ophthalmic nerve passes forwards in the lateral wall of the cavernous 
sinus, where it lies close to the third, fourth, and sixth cranial nerves, and enters 
the orbit through the superior orbital fissure. Branches of the nerve supply sen­
sation to the scalp, forehead and nose, to the mucous membrane of the frontal 
sinus and upper part of the nasal cavity, and to the eye (conjunctiva and cornea), 
the latter providing the afferent limb of the corneal reflex. The area of cutaneous 
distribution is clearly defined but often misunderstood. Posteriorly, the nerve 
supplies the scalp as far back as the lambdoidal suture. Non-organic sensory loss 
over the face and forehead often extends only to the hairline, but care must be 
taken in interpretation because such apparently non-anatomical distribution of 
sensory loss may be seen in organic disease. The lateral extent of the cutaneous 
distribution and the boundaries with the areas of supply of the maxillary and 
mandibular divisions.
The maxillary nerve passes through the inferior part of the cavernous si­
nus and leaves the skull through the foramen rotundum. A major branch, the in­
fraorbital nerve, enters the orbit through the inferior orbital fissure and exits 
through the infraorbital foramen. The nerve also supplies the mucous membrane
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of the upper lip, hard palate, and anterior part of the soft palate, the mucous 
membrane of the maxillary sinus and of the lower nasal cavity, and the teeth of 
the upper jaw.
The mandibular nerve fuses with the motor root and leaves the skull 
through the foramen ovale. The angle of the jaw is not supplied by the mandibu­
lar nerve, but in non-organic facial sensory loss this area is often affected. As 
noted for ophthalmic sensory loss, caution must be taken in interpreting this 
sign. The area of sensory supply includes part of the pinna, external auditory 
meat us, and tympanic membrane. The nerve also supplies the mucous mem­
brane of the cheek, floor of the mouth and anterior two-thirds of the tongue, and 
the teeth of the lower jaw. The lingual branch carries taste fibres from the ante­
rior two-thirds of the tongue, which then join the facial nerve via the chorda 
tympani.
Peripheral motor pathways
The motor fibres emerging from the pons pass under the trigeminal gan­
glion and fuse with sensory fibres to form the mandibular nerve, which leaves 
the skull through the foramen ovale. They innervate the temporalis, masseter, 
and medial and lateral pterygoid muscles. Other muscles are supplied by the 
mandibular nerve, but they cannot be tested at the bedside and their involvement 
in isolation is not associated with specific clinical features.
Central connections
The sensory root, formed by the central processes of the trigeminal gan­
glion cells, enters the lateral pons and divides into short ascending and long de­
scending branches. The short ascending fibres terminate in the principal sensory 
nucleus of the trigeminal nerve, which lies in the substantia gelatinosa of the lat­
eral tegmentum of the upper pons. These fibres subserve tactile and pressure 
sensation (in clinical practice, lesions impair light-touch sensation and the cor­
neal reflex). The long descending fibres form the spinal trigeminal tract, which 
reaches down as far as the upper cervical spinal cord (C2 level). As the tract de­
scends, the fibres gradually terminate in the medially placed substantia gelati­
nosa, forming the spinal trigeminal nucleus which therefore can also be seen to 
extend from the pons down to the upper cervical cord. This pathway subserves 
pain and thermal sensation (in clinical practice, lesions impair pinprick and tem­
perature sensation). There is a specific but complex topographical arrangement 
of fibres within the trigeminal tract; fibres from the ophthalmic division lie most 
ventrally, and those from the mandibular division most dorsally.
The secondary trigeminal pathways arise from the primary sensory nu­
cleus and from the spinal trigeminal nucleus. Crossed and uncrossed fibres are 
important in various reflex pathways, discussed below, but the major sensory 
pathways involve crossed fibres. The secondary fibres arising from the principal 
sensory nucleus cross the midline in the pons and ascend as the quintothalamic 
tract, in close association with the medial lemniscus. Secondary fibres arising 
from the long spinal trigeminal nucleus cross the midline raphe and ascend in
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association with the medial lemniscus. Secondary trigeminal pathways, from 
both the principal sensory nucleus and the spinal trigeminal nucleus, terminate 
in the thalamus.
Trigeminal reflexes
Secondary crossed and uncrossed fibres from the two trigeminal nuclei 
are involved in several reflex pathways, including, lacrimation, sneezing, and 
vomiting. In clinical practice the most important are the comeal reflex and the 
jaw jerk.
Stimulation of the cornea sends afferent impulses via the ophthalmic divi­
sion to the trigeminal nucleus. Secondary fibres project bilaterally to the facial 
nuclei which, with the facial nerves, complete the reflex arc. Unilateral corneal 
sensation evokes bilateral blinking. In the presence of a facial-nerve palsy, ipsi- 
lateral comeal stimulation will cause contralateral blinking. Corneal stimulation 
on the side of an ophthalmic nerve lesion will produce no response, but contra­
lateral comeal stimulation will produce bilateral blinking.
The jaw jerk is a monosynaptic reflex. Jaw tapping invokes bilateral con­
traction of the masseter and temporalis muscles. The reflex is not noticeably af­
fected by a unilateral upper or lower motor neuron lesion of the trigeminal 
nerve, but is exaggerated in the presence of bilateral upper motor neuron lesions.
LESIONS OF THE TRIGEMINAL NERVE
Trigeminal nerve function may be affected by supranuclear (upper motor 
neuron), nuclear, or peripheral lesions.
Supranuclear lesions
The motor nuclei receive bilateral supranuclear (corticobulbar) innerva­
tion. A unilateral upper motor neuron lesion (e.g. a hemispheric stroke) causes 
no clinically discernible weakness of the trigeminal nerve-innervated muscles. 
Bilateral upper motor neuron lesions (e.g. bilateral hemispheric strokes, occur­
ring simultaneously or consecutively, or an upper brainstem lesion affecting 
both corticobulbar pathways) result in a pseudobulbar palsy with dysarthria, 
dysphagia, and a brisk jaw jerk.
Nuclear lesions
Lesions involving the motor nucleus in the pons will cause ipsilateral 
weakness and wasting of the muscles of mastication. Masseter and temporalis 
can be seen and felt to be wasted, on jaw closure, and on jaw opening the jaw 
will deviate to the affected side because of weakness of the pterygoid muscles.
Isolated involvement of the pontine primary sensory nucleus would be 
expected to produce ipsilateral loss of facial lighttouch sensation, with preserva­
tion of pinprick sensation, but in practice lesions invariably also involve de­
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scending fibres and both sensory modalities are impaired. Lesions in this area 
affecting trigeminal motor and sensory function also frequently cause contralat­
eral hemiplegia and spinothalamic sensory loss. Common pathologies include 
vascular disease, demyelination, and tumour. Rarer causes are a variety of vas­
cular malformations and (very rare) syringobulbia.
Lesions in the medulla and upper cervical cord may affect the spinal 
trigeminal tract and nucleus, causing ipsilateral loss of facial pain (pinprick) and 
temperature sensation, with preservation of light-touch and the corneal reflex. 
By far the most common cause is infarction of the lateral medulla secondary to 
occlusion of the vertebral artery or the posterior inferior cerebellar artery (the 
lateral medullary syndrome of Wall enberg). Further symptoms include hic­
coughs, dizziness, dysarthria, and dysphagia. Ipsilateral signs, in addition to the 
facial sensory loss, include Homer's syndrome, palatal and vocal cord paresis, 
and cerebellar ataxia. Contralaterally there is limb and trunk spinothalamic (pin­
prick and temperature) sensory loss.
In syringomyelia a central cord lesion (a syrinx or cavity) gradually ex­
tends upwards from the cervical spinal cord into the medulla (when it is referred 
to as syringobulbia) and possibly as far as the pons. Spinal cord tumours may 
behave in the same fashion. In these situations there is bilateral involvement of 
the trigeminal tract and nuclei and, due to the topographic organization of nerve 
fibres, a particular pattern of facial sensory loss (to pinprick and temperature) 
evolves, which has been likened to an onion-skin or the wearing of a balaclava 
helmet. Thus, the sensory loss gradually progresses forwards and medially to­
wards the nose.
Peripheral lesions
Numerous pathologies can affect the intracranial parts of the trigeminal 
nerve complex (the motor and sensory roots, trigeminal ganglion, and the three 
major nerve divisions). These include tumours (metastases, carcinomatous men­
ingitis, acoustic neuromas, trigeminal neuromas, meningiomas, nasopharyngeal 
carcinoma), infections (viral, acute and chronic meningitis, abscesses, osteitis), 
Paget's disease, trauma, aneurysms, and granulomatous processes. Depending 
upon the site of the lesion, other cranial nerves may be involved and particular 
syndromes can be identified.
A lesion affecting both the sympathetic nerve fibres around the internal 
carotid artery and the trigeminal ganglion may produce a Horner's syndrome 
(without anhydrosis as sudomotor fibres travel along the external carotid artery) 
and trigeminal nerve involvement (either with pain alone or with a demonstrable 
sensorimotor neuropathy). This combination is referred to as Raeder's para- 
trigeminal syndrome, and causes include carotid aneurysm, infection, tumours, 
and trauma. Such lesions may involve the optic nerve and cranial nerves III, IV, 
and VI in the parasellar region.
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Peripheral branches of the three main nerves may be damaged by blunt or 
penetrating, or surgical, trauma, resulting in areas of sensory disturbance, some­
times accompanied by continuous or neuralgic pain. Those most commonly af­
fected are the supraorbital, infraorbital, and inferior alveolar nerves. The rather 
specific numb cheek and chin syndromes are discussed below.
Trigeminal neuralgia is the most frequently encountered disorder of the 
trigeminal nerve. It may be symptomatic of an underlying structural disorder af­
fecting the nerve, but in the majority of patients no specific cause is identified. It 
is more common in the second half of life, cases in younger people more often 
being symptomatic, is slightly more frequent in women.
EXAMINATION
Facial Sensation
Simultaneously touch both sides of the forehead, then the cheek, and then 
the jaw and ask if they feel the same. Check for temperature perception in the 
same sequence, using the cool surface of a tuning fork or other appropriate 
stimulus. The stimulus will be perceived as warmer on the side of impaired sen­
sation.
Corneal Reflex
Sweep a wisp of cotton lightly across the lateral surface of the eye (out of 
the direct visual field) from sclera to cornea. As soon as the stimulus reaches the 
sensitive cornea, the patient will wince and blink vigorously if nerves V and VII 
are both intact. Compare the sides for symmetry.
Motor V Testing
Observe the symmetry of opening and closing of the mouth; the jaw will 
fall faster and farther on the side of the lesion, so that the face looks askew. For 
more subtle weakness, ask the patient to clench the teeth and then attempt to 
force jaw opening or lateral jaw displacement. Normal strength cannot be over­
come.
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FACIAL NERVE (VII)
FUNCTIONAL ANATOMY
The facial nerve has two roots. The larger contains the motor nerve fibres 
which supply the ipsilateral facial muscles. The smaller root, the intermediate 
nerve, contains fibres conveying taste sensation from the anterior two-thirds of 
the tongue, cutaneous sensory fibres from the posterior part of the ear, and pre­
ganglionic parasympathetic fibres that innervate the lacrimal and submandibular 
glands.
Motor pathways
The facial-nerve motor nucleus lies in the ventrolateral tegmentum of the 
pons. The efferent fibres arising from the nucleus sweep dorsomedially, to the 
floor of the fourth ventricle, loop sharply around the sixth nerve nucleus, and 
then pass ventrolaterally to emerge from the lateral border of the caudal pons, at 
the cerebellopontine angle. The facial nerve is medial to the eighth nerve and be­
tween the two lies the intermediate nerve. These three nerves pass through the 
internal acoustic meatus and then the facial nerve and intermediate nerve enter 
the facial canal. In the facial canal, on the medial side of the middle ear, the fa­
cial nerve turns sharply (the genu of the facial nerve), moving posteriorly and 
inferiorly, gives off a branch to the stapedius muscle, and exits from the skull 
through the stylomastoid foramen.
After leaving the stylomastoid foramen the facial nerve sends branches to 
the stylohyoid muscle and to the posterior belly of the digastric, and then passes 
through the parotid gland, dividing into several branches which supply platysma 
and all of the muscles of facial expression, excluding levator palpebrae superi- 
oris (which is supplied by the oculomotor nerve-thus, facial-nerve lesions do not 
cause ptosis).
Corticobuibar pathways
The facial nucleus is composed of a number of distinct cell groups, each 
innervating specific facial muscles. Those supplying the upper facial muscles 
receive bilateral supranuclear (corticobuibar) innervation, whereas those supply­
ing the lower facial muscles receive mainly crossed fibres from the contralateral 
hemisphere. In addition to direct corticobuibar fibres, there are several indirect 
pathways between the cortex and facial nuclei, involving the thalamus and re­
ticular formation.
Sensory pathways
In the facial canal there is an expansion of the facial nerve as it makes its 
sharp backwards tum, at the genu. This expansion is the geniculate ganglion and
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is formed by the cell bodies of the nerves that give rise to the two sensory com­
ponents of the facial nerve.
Special visceral afferent fibres convey taste sensation from the anterior 
two-thirds of the tongue. From the tongue these fibres travel first in the lingual 
nerve, and then in the chorda tympani which enters the skull, crosses the tym­
panic cavity, and joins the facial nerve in the facial canal. From the geniculate 
ganglion, the central connections pass via the intermediate nerve and terminate 
in the nucleus solitarius in the medulla.
Cutaneous nerve fibres arise from a small area, which includes the poste­
rior part of the external auditory meatus and the skin behind the ear and in front 
of the mastoid. They enter the facial canal just proximal to the stylomastoid fo­
ramen. From the cell bodies in the geniculate ganglion the fibres pass centrally 
in the intermediate nerve and terminate in the spinal trigeminal tract. Sensory 
loss is not a clinically detectable feature of facial-nerve lesions, presumably be­
cause of overlap from adjacent cutaneous nerve territories, but the presence of 
this sensory pathway probably explains the symptom of pain in the mastoid re­
gion which is so common in patients with Bell's palsy.
Autonomic pathways
Preganglionic parasympathetic fibres arise from the superior salivary nu­
cleus, in the dorsolateral reticular formation. They travel in the intermediate 
nerve and at the genu of the facial nerve divide into two groups. One group 
passes with the greater superficial petrosal nerve to the pterygopalatine gan­
glion. Postganglionic fibres innervate the lacrimal gland and mucous membrane 
of the nose and mouth. The other group of fibres travels in the chorda tympani 
and terminates in the submandibular ganglion. Postganglionic fibres innervate 
the submandibular and sublingual salivary glands.
Facial-nerve reflexes
In clinical practice the corneal reflex and, to a lesser extent, the glabellar 
tap reflex, are of value. The glabellar tap reflex is polysynaptic and comprises 
tapping the forehead over the bridge of the nose and observing contraction of or­
bicularis oculi (i.e. blinking) bilaterally. After several taps there is habituation 
and blinking stops. In early childhood and in Parkinsonian syndromes there is 
failure of habituation and blinking continues in time with the tapping.
Other reflexes include the naso-lacrimal reflex (lacrimation in response to 
stimulation of the nasal mucosa), naso-mental reflex (tapping the side of the 
nose causes elevation of the upper lip), and the stapedius reflex (contraction of 
stapedius in response to a loud noise). These and other similar reflexes are of lit­
tle importance at the bedside but some, such as the stapedial reflex, may be stud­
ied in the laboratory and can help with localization of facial-nerve lesions.
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Fig 11. The facial nerve, lesions involving the facial-nerve trunk above the geni­
culate ganglion will cause loss of lacrimation (greater petrosal nerve) and loss of 
taste in the anterior two-thirds of the tongue (chorda tympani nerve), as well as 
paralysis of both upper and lower facial muscles, lesions between the geniculate 
ganglion and the point where the chorda tympani nerve leaves the facial nerve (6 
mm above the stylomastoid foramen), will cause loss of taste sensation in the 
anterior two-thirds of the tongue, as well as paralysis of the facial muscles, but 
lacrimation will still be present, lesions below the point where the chorda tym­
pani nerve leaves the facial nerve will cause paralysis of the facial muscles, but 
both taste and lacrimation will be present. (From Brain’s Diseases of the Nerv­
ous System, 2001)
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LESIONS OF THE FACIAL NERVE
Lesions of the facial nerve, its nucleus or supranuclear pathways, may 
produce facial muscle weakness; but only peripheral lesions, affecting the facial 
nerve itself, affect taste sensation and autonomic function. As noted above, 
numbness is not an expected finding in facial-nerve lesions, although sympto­
matic complaints of sensory disturbance are common in Bell's palsy.
Supranuclear lesions
The upper facial muscles have almost equal bilateral cortical representa­
tion, whereas the lower facial muscles receive mainly crossed fibres from the 
contralateral hemisphere. Thus, a unilateral upper motor neuron lesion causes 
contralateral facial weakness, with the lower part of the face being more affected 
than the upper (NB it is relative rather than absolute sparing of the upper facial 
muscles). As noted above, there is more than one pathway of supranuclear in­
nervation and, depending upon the site of the lesion, spontaneous emotional 
movements may be more affected than voluntary movements, and vice versa.
Nuclear and peripheral lesions
A lesion of the nucleus or facial nerve generally causes equal weakness of 
all ipsilateral facial muscles and the clinical features are exemplified by Bell's 
palsy. Occasionally, partial lesions of the nucleus or nerve may selectively affect 
the lower facial muscles, thus mimicking the appearance seen with an upper mo­
tor neuron lesion.
Considering the origins and sites of union with the facial nerve of the 
greater superficial petrosal nerve, the nerve to stapedius and the chorda tympani, 
the presence of impaired lacrimation, hyperacusis or an impaired stapedial re­
flex, or altered taste sensation can help in localizing the site of a facial-nerve le­
sion. The absence of such features is not of localizing value.
The facial nucleus may be affected by pontine lesions, and the nerve by 
lesions in the cerebellopontine angle, within the petrous temporal bone and out­
side the skull.
Pontine lesions
These rarely affect the facial nucleus or nerve fibres in isolation, and as­
sociated features include ipsilateral lateral rectus or conjugate gaze palsy, 
trigeminal motor and sensory involvement, and contralateral hemiparesis and 
hemisensory loss. Common pathologies include vascular lesions, multiple scle­
rosis, and tumours, less common disorders being brainstem encephalitis, syrin­
gobulbia, and poliomyelitis. Bilateral facial paralysis due to agenesis of the fa­
cial nuclei (Mobius' syndrome) is a rare disorder that may be associated with 
other cranial nerve lesions and dysmorphic features.
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Cerebellopontine angle lesion
The most common lesions at this site, which affect the facial nerve, inter­
mediate nerve, and eighth nerve, are acoustic neuromas and meningiomas. Less 
common lesions include secondary tumours, nasopharyngeal carcinoma, devel­
opmental tumours, cholesteatomas, and any basal meningitic process (e.g. sar­
coid).
Petrous temporal bone lesions
In the facial canal the nerve may be affected by infection spreading from 
the middle ear or mastoid, or by surgical procedures in that area. Inflammation 
and swelling of the facial nerve in the facial canal and at the stylomastoid fora­
men is presumed to be present in Bell’s palsy. In the Ramsay Hunt syndrome 
swelling of the geniculate ganglion due to reactivation of latent herpes zoster in­
fection may compress the motor fibres, or there may be direct infection of the 
motor nerve. The resultant facial palsy is accompanied by a rash, typically seen 
in the external auditory meatus, although it is often more extensive than this and 
involves the trigeminal distribution (e.g. the anterior pillar of the fauces) and 
cervical dermatomes. There is often pain around the ear.
Lesions outside the skull
Benign and malignant lesions of the parotid gland may involve some or 
all of the branches of the facial nerve.
Bilateral facial palsy
Bilateral, as well as unilateral, lower motor neuron facial weakness may 
be seen in Guillain-Barre syndrome, sarcoidosis (due to basal meningeal or pa­
rotid involvement), Lyme disease (often accompanied by facial rash and indura­
tion), HIV infection (at seroconversion), and Melkersson's syndrome. In the lat­
ter disorder, recurrent episodes of unilateral or bilateral facial swelling and facial 
palsy are associated with a deeply furrowed tongue.
EXAMINATION
A central "supranuclear" lesion, such as a hemispheric stroke, will pre­
serve forehead wrinkling and cause only mild weakness of eye closure, while 
the lower face is more severely involved. If there is a peripherallesion of the 
cranial nerve (or nucleus), the entire hemiface will be flaccid and the eyelids 
will gape open.
Some cranial neuropathies or neuromuscular diseases cause bilateral fa­
cial weakness, and in such cases the usual criterion of facial asymmetry as a 
marker of weakness will not apply.
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Facial Symmetry
Observe the patient's face for symmetry of the palpebral fissures and na­
solabial folds at rest. Ask the patient to wrinkle the forehead, then to squeeze the 
eyes tightly shut (looking for asymmetry in the extent to which the eyelashes 
protrude), then to smile or snarl, saying, "Show me your teeth."
Bilateral Facial Weakness
Ask the patient to squeeze the eyes tightly shut, then press the lips tightly 
together, then puff air into the checks. If strength is normal, one should not be 
able to pry the eyelids open, force the lips apart, or forcibly expel air from the 
mouth.
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V E S T IB U L O C O C H L E A R  N E R V E  (V III)
Disturbances of the eighth or vestibulocochlear cranial nerve and its cen­
tral connections lead to various combinations of deafness, vertigo, and imbal­
ance. The cochlear division of the nerve supplies the cochlea and is concerned 
with hearing, whereas the vestibular division supplies the semicircular canals, 
the utricle, and saccule, and is concerned in postural and equilibratory functions.
Equilibrium is the ability to maintain orientation of the body and its parts 
in relation to external space. It depends upon continuous visual, labyrinthine, 
and proprioceptive input and its integration in the brainstem and cerebellum.
Disorders of equilibrium result from diseases that affect central or periph­
eral vestibular pathways, the cerebellum, or the sensory pathways involved in 
proprioception. Such disorders usually present with vertigo and ataxia.
VERTIGO
Vertigo is the illusion of movement of the body or the environment. It is 
often associated with other symptoms, such as impulsion (a sensation that the 
body is being hurled or pulled in space), oscillopsia (a visual illusion of moving 
back and forth), nausea, vomiting, or gait ataxia.
Distinction between Vertigo & Other Symptoms
Vertigo must be distinguished from non vertiginous dizziness, which in­
cludes sensations of light-headedness, faintness, or giddiness not associated with 
an illusion of movement. In contrast to vertigo, these sensations are produced by 
conditions that impair the brain's supply of blood, oxygen, or glucose - eg, ex­
cessive vagal stimulation, orthostatic hypotension, cardiac arrhythmias, myocar­
dial ischemia, hypoxia, or hypoglycemia - and may culminate in loss of con­
sciousness. Vertigo is typically described as spinning, rotating, or moving, but 
when the description is vague, the patient should be asked specifically if the 
symptom is associated with a sense of movement. The circumstances under 
which symptoms occur may also be diagnostically helpful. Vertigo is often 
brought on by changes in head position. The occurrence of symptoms upon aris­
ing after prolonged recumbency is a common feature of orthostatic hypotension, 
and nonvertiginous dizziness related to pancerebral hypoperfusion may be im­
mediately relieved by sitting or lying down. Such hypoperfusion states can lead 
to loss of consciousness, which is rarely associated with true vertigo.
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Differential Diagnosis
A. Anatomic Origin. The first step in the differential diagnosis of vertigo 
is to localize the pathological process in the peripheral or central vestibular 
pathways. Peripheral vestibular lesions affect the labyrinth of the inner ear or the 
vestibular division of the acoustic (VIII) nerve. Central lesions affect the brain­
stem vestibular nuclei or their connections. Rarely, vertigo is of cortical origin, 
occurring as a symptom associated with complex partial seizures.
B. Symptomatology. Certain characteristics of vertigo, including the 
presence of any associated abnormalities, can help differentiate between periph­
eral and central causes.
1. Peripheral vertigo tends to occur intermittently, last for briefer periods, 
and produce more distress than does vertigo of central origin. Nystagmus 
(rhythmic oscillation of the eyeballs) is always associated with peripheral ver­
tigo; it is usually unidirectional and never vertical (see below). Peripheral le­
sions commonly produce additional symptoms of inner ear or acoustic nerve 
dysfunction, ie, hearing loss and tinnitus.
2. Central vertigo may occur with or without nystagmus; if nystagmus is 
present, it can be vertical, unidirectional, or multidirectional and may differ in 
character in the two eyes. (Vertical nystagmus is oscillation in a vertical plane; 
that produced by upgaze or downgaze is not necessarily in the vertical plane.) 
Central lesions may produce intrinsic brain stem or cerebellar signs, such as mo­
tor or sensory deficits, hyperreflexia, extensor plantar responses, dysarthria, or 
limb ataxia.
NEUROLOGIC EXAMINATION
A. Nystagmus and Voluntary Eye Movements. The patient is asked to 
turn the eyes in each of the cardinal directions of gaze (left, up and left, down 
and left, right, up and right, down and right) to determine whether gaze paresis 
(impaired ability to move the two eyes coordinately in any of the cardinal direc­
tions of gaze) or gazeevoked nystagmus is present. Nystagmus -  an abnormal 
involuntary oscillation of the eyes -  is characterized in terms of the positions of 
gaze in which it occurs, its amplitude, and the direction of its fast phase. Pendu­
lar nystagmus has the same velocity in both directions of eye movement; jerk 
nystagmus is characterized by both fast (vestibular-induced) and slow (cortical) 
phases. The direction of jerk nystagmus is defined by the direction of the fast 
component. Fast voluntary eye movements (saccades) are elicited by having the 
patient rapidly shift gaze from one target to another placed in a different part of 
the visual field. Slow voluntary eye movements (pursuits) are assessed by hav­
ing the patient track a slowly moving target such as the examiner's finger.
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1. Peripheral vestibular disorders produce unidirectional horizontal jerk 
nystagmus that is maximal on gaze away from the involved side. Central vesti­
bular disorders can cause unidirectional or bidirectional horizontal nystagmus, 
vertical nystagmus, or gaze paresis. Cerebellar lesions are associated with a 
wide range of ocular abnormalities, including gaze pareses, defective saccades 
or pursuits, nystagmus in any or all directions, and ocular dysmetria (overshoot 
of visual targets during saccadic eye movements).
2. Pendular nystagmus is usually the result of visual impairment that be­
gins in infancy.
B. Hearing. Preliminary examination of the acoustic (VIII) nerve should 
include otoscopic inspection of the auditory canals and tympanic membranes, 
assessment of auditory acuity in each ear, and Weber and Rinne tests performed 
with a 256-Hz tuning fork.
1. In the Weber test, unilateral sensorineural hearing loss (from lesions of 
the cochlea or cochlear nerve) causes the patient to perceive the sound produced 
by a vibrating tuning fork placed at the vertex of the skull as coming from the 
normal ear. With a conductive (external or middle ear) disorder, sound is local­
ized to the abnormal ear.
2. The Rinne test may also distinguish between sensorineural and conduc­
tive defects in the affected ear. Air conduction (tested by holding the vibrating 
tuning fork next to the external auditory canal) normally produces a louder 
sound than does bone conduction (tested by placing the base of the tuning fork 
over the mastoid bone). This pattern also occurs with acoustic nerve lesions but 
is reversed in the case of conductive hearing loss.
C. Positional Tests. When patients indicate that vertigo occurs with a 
change in position, the Nylen-Barany or Dix-Hallpike maneuver is used to try to 
reproduce the precipitating circumstance. The head, turned to the right, is rap­
idly lowered 30 degrees below horizontal while the gaze is maintained to the 
right. This process is repeated with the head and eyes turned first to the left and 
then straight ahead. The eyes are observed for nystagmus, and the patient is 
asked to note the onset, severity, and cessation of vertigo.
Positional nystagmus and vertigo are usually associated with peripheral 
vestibular lesions and are most often a feature of benign positional vertigo. This 
is typically characterized by severe distress, a latency of several seconds be­
tween assumption of the position and the onset of vertigo and nystagmus, a ten­
dency for the response to remit spontaneously (fatigue) as the position is main­
tained, and attenuation of the response (habituation) as the offending position is 
repeatedly assumed. Positional vertigo can also occur with central vestibular 
disease.
D. Caloric Testing. Disorders of the vestibuloocular pathways can be de­
tected by caloric testing. The patient is placed supine with the head elevated 30 
degrees to bring the superficially situated lateral semicircular canal into the up­
right position. Each ear canal is irrigated in turn with cold (33°C) or warm
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(44°C) water for 40 seconds, with at least 5 minutes between tests. Warm water 
tends to produce less discomfort than cold. Caution: Caloric testing should be 
preceded by careful otoscopic examination; it is precluded if the tympanic 
membrane is perforated.
1. In the normal awake patient, cold-water caloric stimulation produces 
nystagmus with the slow phase toward and the fast phase away from the irri­
gated ear. Warm water irrigation produces the opposite response.
2. In patients with unilateral labyrinthine, vestibular nerve, or vestibular 
nuclear dysfunction, irrigation of the affected side fails to cause nystagmus or 
elicits nystagmus that is later in onset or brief er in duration than on the normal 
side.
E. Stance & Gait. Observation of stance and gait is helpful in distin­
guishing between cerebellar, vestibular, and sensory ataxias.
DISORDERS OF HEARING, DEAFNESS. TINNITUS
Deafness is usually caused by primary diseases of the middle ear, such as 
otosclerosis, otitis media, or trauma, or of the inner ear, such as noise exposure, 
various genetic causes, congenital rubella, and age-related presbyacusis. Unilat­
eral deafness is often not noticed unless patients find they are unable to hear the 
telephone earpiece with that ear. The main neurological cause of deafness is a 
tumour affecting the eighth cranial (auditory) nerve in its course between the 
brainstem and the internal auditory meatus. Partial deafness is a common sequel 
to bacterial meningitis or other infiltrating processes in the meninges surround­
ing the nerve.
Tinnitus is a symptom in which the person hears noises in the ears or head 
in the absence of any sound stimulus. The subjective sensations can take many 
forms which include buzzing, humming, hissing, roaring, clicking, or some 
similar description. It is usually constant, but some patients describe it as inter­
mittent, pulsating, or fluctuating.
Subjective tinnitus is an auditory sensation which is only heard by the pa­
tient, whereas objective tinnitus, which is much rarer, may be perceived by the 
examiner as well. The latter includes vascular causes, such as fistulae or arterio­
venous malformations, or mechanical causes, as in palatal myoclonus.
Tinnitus is a symptom which, in addition to the common inner ear causes 
such as Meniere's disease, may herald a number of disorders, such as a glomus 
tumour, tumours of the internal auditory meatus or cerebellopontine angle, or a 
vascular abnormality in the temporal bone or skull.
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VESTIBULAR DISORDERS
BENIGN POSITIONAL VERTIGO
Positional vertigo is vertigo that occurs upon assuming a particular head 
position. It is usually associated with peripheral vestibular lesions but may also 
be due to central (brain stem or cerebellar) disease.
Benign positional vertigo is the most common cause of vertigo of periph­
eral origin, accounting for about 30% of cases. The most frequently identified 
cause is head trauma, but in most instances, no cause can be determined. The 
pathophysiologic basis of benign positional vertigo is thought to be canalolithia- 
sis-stimulation of the semicircular canal by debris floating in the endolymph.
The syndrome is characterized by brief (seconds to minutes) episodes of 
severe vertigo that may be accompanied by nausea and vomiting. Symptoms 
may occur with any change in head position but are usually most severe in the 
lateral decubitus position with the affected ear down. Episodic vertigo typically 
continues for several weeks and then resolves spontaneously; in some cases it is 
recurrent. Hearing loss is not a feature.
Peripheral and central causes of positional vertigo can usually be distin­
guished on physical examination by means of the Nylen-Baniny or Dix-Hallpike 
maneuver. Positional nystagmus always accompanies vertigo in the benign dis­
order and is typically unidirectional, rotatory, and delayed in onset by several 
seconds after assumption of the precipitating head position. If the position is 
maintained, nystagmus and vertigo resolve within seconds to minutes. If the 
maneuver is repeated successively, the response is attenuated. In contrast, po­
sitional vertigo of central origin tends to be less severe, and positional nystag­
mus may be absent. There is no latency, fatigue, or habituation in central posi­
tional vertigo.
The mainstay of treatment in most cases of benign positional vertigo of 
peripheral origin (canalolithiasis) is the use of repositioning maneuvers that em­
ploy the force of gravity to move endolymphatic debris out of the semicircular 
canal and into the vestibule, where it can be reabsorbed. In one such maneuver, 
the head is turned 45 degrees in the direction of the affected ear (determined 
clinically, as described above), and the patient reclines to a supine position, with 
the head (still turned 45 degrees) hanging down over the end of the examining 
table. The head, still hanging down, is then turned 90 degrees in the opposite di­
rection, to 45 degrees toward the opposite ear. Next, the patient rolls to a lateral 
decubitus position with the affected ear up, and the head still turned 45 degrees 
toward the unaffected ear and hanging down. Finally, the patient turns to a prone 
position and sits up. Vestibulosuppressant drugs may also be useful in the acute 
period, and vestibular rehabilitation, which promotes compensation for vestibu-
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lar dysfunction through the recruitment of other sensory modalities, may be 
helpful as well.
MENIERE’S DISEASE
Meniere's disease is characterized by repeated episodes of vertigo lasting 
from minutes to days, accompanied by tinnitus and progressive sensorineural 
hearing loss. Onset is between the ages of 20 and 50 years in about three-fourths 
of cases, and men are affected more often than women. The cause is thought to 
be an increase in the volume of labyrinthine endolymph (endolymphatic hy­
drops), but the pathogenetic mechanism is unknown.
At the time of the first acute attack, patients may already have noted the 
insidious onset of tinnitus, hearing loss, and a sensation of fullness in the ear. 
Acute attacks are characterized by vertigo, nausea, and vomiting and recur at in­
tervals ranging from weeks to years. Hearing deteriorates in a stepwise fashion, 
with bilateral involvement reported in 10-70% of patients. As hearing loss in­
creases, vertigo tends to become less severe.
Physical examination during an acute episode shows spontaneous hori­
zontal or rotatory nystagmus (or both) that may change direction. Although 
spontaneous nystagmus is characteristically absent between attacks, caloric test­
ing usually reveals impaired vestibular function. The hearing deficit is not al­
ways sufficiently advanced to be detectable at the bedside. Audiometry shows 
low-frequency pure-tone hearing loss, however, that fluctuates in severity as 
well as impaired speech discrimination and increased sensitivity to loud sounds.
As has been noted, episodes of vertigo tend to resolve as hearing loss pro­
gresses. Treatment is with diuretics, such as hydrochlorothiazide and triam- 
terenen, vestibulosuppressants may also be helpful during acute attacks. In per­
sistent, disabling, drug-resistant cases, surgical procedures such as en­
dolymphatic shunting, labyrinthectomy, or vestibular nerve section are helpful.
ACUTE PERIPHERAL VESTIBULOPATHY
This term is used to describe a spontaneous attack of vertigo of inapparent 
cause that resolves spontaneously and is not accompanied by hearing loss or 
evidence of central nervous system dysfunction. It includes disorders diagnosed 
as acute labyrinthitis or vestibular neuronitis, which are based on unverifiable 
inferences about the site of disease and the pathogenetic mechanism. A recent 
antecedent febrile illness can sometimes be identified, however.
The disorder is characterized by vertigo, nausea, and vomiting of acute 
onset, typically lasting up to 2 weeks. Symptoms may recur, and some degree of 
vestibular dysfunction may be permanent.
During an attack,'the patient -  who appears ill typically lies on one side 
with the affected ear upward and is reluctant to move his or her head. Nys­
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tagmus with the fast phase away from the affected ear is always present. The 
vestibular response to caloric testing is defective in one or both ears with about 
equal frequency. Auditory acuity is normal.
Acute peripheral vestibulopathy must be distinguished from central disor­
ders that produce acute vertigo, such as stroke in the posterior cerebral circu­
lation. Central disease is suggested by vertical nystagmus, altered consciousness, 
motor or sensory deficit, or dysarthria. Treatment is with a 10- to 14day course 
of prednisone, 20 mg orally twice daily, vestibulosuppressants.
OTOSCLEROSIS
Otosclerosis is caused by bony changes in the tympanic cavity that result 
in immobility of the stapes, the ear ossicle that normally transmits soundinduced 
vibration of the tympanic membrane to the inner ear. Its most distinctive clinical 
feature is conductive hearing loss, but sensorineural hearing loss and vertigo are 
also common; tinnitus occurs less frequently. Auditory symptoms usually begin 
before 30 years of age, and familial occurrence is common.
Vestibular dysfunction in otosclerosis is most often characterized by re­
current episodic vertigo-with or without positional vertigo-and a sense of posi­
tional imbalance. More continuous symptoms may also occur, and the frequency 
and severity of attacks may increase with time.
Vestibular abnormalities that can be seen on examination include sponta­
neous or positional nystagmus of the peripheral type and attenuated caloric re­
sponses. Abnormalities shown by caloric testing are usuall у unilateral.
Hearing loss is always demonstrable by audiometry. Usually of mixed 
conductive-sensorineural character, the loss is bilateral in about two-thirds of 
patients. In patients with episodic vertigo, progressive hearing loss, and tinnitus, 
otosclerosis must be distinguished from Meniere's disease. Otosclerosis (rather 
than Meniere's disease) is suggested by a positive family history, a tendency to­
ward onset at an earlier age, the presence of conductive hearing loss, or bilateral 
symmetric auditory impairment. The CT scan may also be diagnostically useful.
Medical treatment with a combination of sodium fluoride, calcium glu­
conate, and vitamin D may be effective. If not, surgical stapedectomy should be 
considered.
HEAD TRAUMA
Head trauma is the most common identifiable cause of benign positional 
vertigo. Injury to the labyrinth is usually responsible for posttraumatic vertigo; 
however, fractures of the petrosal bone may lacerate the acoustic nerve, produc­
ing vertigo and hearing loss. Hemo-tympanum or CSF otorrhea suggests such a 
fracture.
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CEREBELLOPONTINE ANGLE TUMOR
The cerebellopontine angle is a triangular region in the posterior fossa 
bordered by the cerebellum, the lateral pons, and the petrous ridge. By far the 
most common tumor in this area is the histologically benign acoustic neuroma 
(also termed neurilemoma, neurinoma, or schwannoma), which typically arises 
from the neurilemma! sheath of the vestibular portion of the acoustic nerve in 
the internal auditory canal. Less common tumors at this site include meningio­
mas and primary cholesteatomas (epidermoid cysts). Symptoms are produced by 
compression or displacement of the cranial nerves, brainstem, and cerebellum 
and by obstruction of CSF flow. Because of their anatomic relationship to the 
acoustic nerve, the trigeminal (V) and facial (VII) nerves are often affected.
Acoustic neuromas occur most often as isolated lesions in patients 30-60 
years old, but they may also be a manifestation of neurofibromatosis. Neurofi­
bromatosis I (von Recklinghausen's disease) is a common autosomal dominant 
disorder related to a gene defect on chromosome 17 (17ql 1.2). In addition to 
unilateral acoustic neuromas, neurofibromatosis I is associated with cafe-au-lait 
spots on the skin, cutaneous neurofibromas, axillary or inguinal freckles, optic 
gliomas, iris hamartomas, and dysplastic bony lesions. Neurofibromatosis 2 is a 
rare autosomal dominant disorder localized to chromosome 22 (22ql 1.1-13.1). 
Its hallmark is bilateral acoustic neuromas, which may be accompanied by other 
tumors of the central or peripheral nervous system, including neurofibromas, 
meningiomas, gliomas, and schwannomas.
Hearing loss of insidious onset is usually the initial symptom. Less often, 
patients present with headache, vertigo, gait ataxia, facial pain, tinnitus, a sensa­
tion of fullness in the ear, or facial weakness. Although vertigo ultimately de­
velops in 20-30% of patients, a nonspecific feeling of unsteadiness is encoun­
tered more commonly. In contrast to Meniere's disease, there is a greater ten­
dency for mild vestibular symptoms to persist between attacks. Symptoms may 
be stable or progress very slowly for months or years.
Unilateral hearing loss of the sensorineural type is the most common find­
ing on physical examination. Other frequently noted abnormalities are ipsilateral 
facial palsy, depression or loss of the corneal reflex, and sensory loss over the 
face. Ataxia, spontaneous nystagmus, other lower cranial nerve palsies, and 
signs of increased intracranial pressure are less common. Unilateral vestibular 
dysfunction can usually be demonstrated with caloric testing.
Audiometry shows a sensorineural pattern of deficit with high-frequency 
pure-tone hearing loss, poor speech discrimination, and marked tone decay. CSF 
protein is elevated in about 70% of patients, usually in the range of 50-200 
mg/dL. The most useful diagnostic radiologic study is MR1 of the cerebellopon­
tine angle. CT scanning is less sensitive. Acoustic neuromas sometimes cause 
abnormalities of the brainstem auditory evoked potentials at a time when ra­
diologic studies show no abnormalities.
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Treatment is complete surgical excision. In untreated cases, severe com­
plications may result from brainstem compression or hydrocephalus.
TOXIC VESTIBULOPATHIES (ALCOHOL)
Several drugs can produce vertigo by their effects on the peripheral vesti­
bular system. Alcohol causes an acute syndrome of positional vertigo because of 
its differential distribution between the cupula and endolymph of the inner ear. 
Alcohol initially diffuses into the cupula, reducing its density relative to the en­
dolymph. This difference in density makes the peripheral vestibular apparatus 
unusually sensitive to gravity and thus to position. With time, alcohol also dif­
fuses into the endolymph, and the densities of cupula and endolymph equalize, 
eliminating the gravitational sensitivity. As the blood alcohol level declines, al­
cohol leaves the cupula before it leaves the endolymph. This produces a second 
phase of gravitational sensitivity that persists until the alcohol diffuses out of the 
endolymph also.
Alcohol-induced positional vertigo typically occurs within 2 hours after 
ingesting ethanol in amounts sufficient to produce blood levels in excess of 40 
mg/dL. It is characterized clinically by vertigo and nystagmus in the lateral re­
cumbent position and is accentuated when the eyes are closed. The syndrome 
lasts up to about 12 hours and consists of two symptomatic phases separated by 
an asymptomatic interval of 1-2 hours. Other signs of alcohol intoxication, such 
as spontaneous nystagmus, dysarthria, and gait ataxia, are caused primarily by 
cerebellar dysfunction.
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G L O S S O P H A R Y N G E A L  N E R V E  (IX )
Although the glossopharyngeal nerve contains sensory, motor, and para­
sympathetic fibres, only its sensory function is testable at the bedside and for all 
practical purposes its other functions can be ignored. Functionally and anatomi­
cally it is closely related to the vagus nerve and, together with the accessory 
nerve, all three nerves may be affected by lesions in the jugular foramen. Iso­
lated glossopharyngeal nerve lesions are rare, but this nerve alone is affected in 
the rare syndrome of glossopharyngeal neuralgia.
FUNCTIONAL ANATOMY
Three components of the glossopharyngeal nerve are of little interest in 
everyday clinical neurology. Special visceral afferent fibres subserve taste sen­
sation from the posterior one-third of the tongue. Symptomatic loss of taste sen­
sation from lesions of the nerve is not seen and there are no practical tests of this 
function at the bedside. General visceral efferent fibres give rise to parasympa­
thetic fibres which stimulate secretion from the parotid gland. Special visceral 
efferent fibres innervate the stylopharyngeus, but this muscle cannot be assessed 
clinically.
Peripheral course
The glossopharyngeal nerve is formed by a series of radicles which enter 
and leave the medulla, in the posterior lateral sulcus, rostral to the vagus nerve. 
The nerve crosses the posterior fossa and leaves the skull, together with the 
vagus and accessory nerves, through the jugular foramen. It crosses in front of 
the internal carotid artery to reach the lateral wall of the pharynx. The nerve 
contains two peripheral ganglia, the superior ganglion which lies in the jugular 
foramen and the inferior (petrosal) ganglion which is extracranial. The ganglia 
contain the cell bodies of primary sensory neurons that subserve general somatic 
and general visceral sensation.
Sensory pathways
General visceral afferent fibres convey sensory impulses (tactile, thermal, 
and pain) from the posterior one-third of the tongue, tonsil, posterior wall of the 
upper pharynx and Eustachian tube, via the inferior ganglion, to the solitary fas­
ciculus and its nucleus. Clinically, this particular sensory pathway is the most 
important function of the nerve and the only function readily assessed at the 
bedside. General somatic afferent fibres carry sensation from the posterior part 
of the ear, via the superior ganglion, and terminate in the spinal trigeminal tract 
and nucleus.
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LESIONS OF THE GLOSSOPHARYNGEAL NERVE
As noted above, clinically the most important function of the glosso­
pharyngeal nerve is its provision of sensory input from the upper pharynx. It 
thus provides the afferent limb of the gag or palatal reflex, the efferent limb of 
which is provided by the vagus. This reflex is too gross a test of glossopharyn­
geal function. If a lesion is suspected, the sensation on each side of the posterior 
pharyngeal wall should be tested using an orange stick or a firmly secured pin. 
Most patients will gag, and the palate will be seen to move, but what is more 
important is for the patient to state whether the sensation is the same on both 
sides.
Supranuclear and nuclear lesions
Supranuclear lesions have no specific discernible effect on glos­
sopharyngeal nerve function, although involvement of stylopharyngeus may 
contribute to pseudobulbar palsy. Nuclear lesions in isolation are rarely, if ever, 
seen and other cranial nerve nuclei, particularly the vagus, are usually also in­
volved. The most common cause is a vascular lesion, with other causes includ­
ing primary and secondary neoplasia and syringobulbia.
Peripheral lesions
Between the medulla and jugular foramen the nerve may be affected by 
meningeal disease (e.g. inflammatory and neoplastic processes) and metastases. 
In the jugular foramen probably the most common lesion, which of course may 
also affect the vagus and accessory nerves, is a glomus tumour. Neuromas of 
any of these three nerves may arise in or near the jugular foramen and each 
nerve may be affected by basal skull fracture and basilar invagination. Metas­
tatic disease may affect the nerve anywhere along its course, intracranially or 
extracranially.
GLOSSOPHARYNGEAL NEURALGIA
Although much rarer, glossopharyngeal neuralgia shares many similarities 
with trigeminal neuralgia with respect to aetiology, treatment, and the character­
istics of the paroxysms of pain. Most cases are idiopathic but neuralgia may be 
symptomatic of lesions affecting the glossopharyngeal nerve, particularly neo­
plastic disorders, and there is evidence that new cases, like trigeminal neuralgia, 
may be caused by compression of the nerve by an aberrantly situated artery.
The paroxysms of pain may occur in clusters, with long periods of remis­
sion, or may be chronic. The pain is experienced in the back of the throat, below 
the angle of the jaw, and within the ear. The stabbing or lancinating quality is 
similar to that occurring in trigeminal neuralgia. Precipitants include eating, 
swallowing, talking, head turning, coughing, sneezing, and touching the outer 
ear. Syncope may occur in association with pain and is due to sinus bradycardia
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or asystole, reflecting the intimate associations between the glossopharyngeal 
and vagus nerves.
The treatment of choice is carbamazepine, but if this does not work, or 
can not be tolerated, then the same drugs as used in trigeminal neuralgia (e.g. 
phenytoin, sodium valproate, baclofen, and lamotrigine) may be tried before re­
sorting to surgical techniques, which include microvascular decompression, 
nerve section, and medullary tractotomy.
VAGUS NERVE (X)
FUNCTIONAL ANATOMY
The vagus nerve has the most extensive course of any of the cranial 
nerves and is anatomically complex, with different courses for the main nerve 
trunks and their branches on each side of the body. The nerve carries motor, sen­
sory, and autonomic fibres, but with respect to structural lesions only the motor 
pathways are of great clinical importance. Disturbances of autonomic function 
are discussed elsewhere.
Sensory and autonomic pathways
General somatic afferent fibres subserve sensation from the skin over the 
back of the ear and the posterior wall of the external auditory meatus. The cell 
bodies are situated in the superior ganglion, which sits in or just below the jugu­
lar foramen, and centrally the fibres enter the spinal trigeminal tract in the me­
dulla. General visceral afferent fibres, from the pharynx, larynx, trachea, oe­
sophagus, and thoracic and abdominal viscera have their cell bodies in the infe­
rior ganglion, and centrally the fibres enter the nucleus and tractus solitarius.
Preganglionic parasympathetic fibres (general visceral efferent) arise from 
the dorsal motor nucleus of the vagus nerve, situated in the floor of the fourth 
ventricle, and are destined to innervate the thoracic and abdominal viscera.
Motor pathways
Special visceral efferent fibres innervate the voluntary striated muscles of 
the pharynx and larynx. They originate in the nucleus ambiguus (which also 
gives rise to the special visceral efferent fibres of the glossopharyngeal nerve 
and cranial part of the spinal accessory nerve) which lies in the medullary reticu­
lar formation between the inferior olive and the spinal trigeminal nucleus.
Peripheral course
The trunk of the vagus nerve is formed by a series of rootlets which 
emerge from the medulla, anterior to the inferior cerebellar peduncle, in line
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with the radicles of the glossopharyngeal and accessory nerves. The nerve leaves 
the skull through the jugular foramen, intimately associated with the accessory 
nerve and separated from the glossopharyngeal nerve only by a fibrous septum. 
In the neck it lies in the carotid sheath, initially between the internal carotid ar­
tery and internal jugular vein, and then between the common carotid artery and 
internal jugular vein. Below the root of the neck the course of the nerve is dif­
ferent on the two sides of the body.
On the right, the nerve crosses the subclavian artery and descends through 
the superior mediastinum posterior to the brachiocephalic vein and to the right 
of the trachea, to reach the posterior aspect of the lung root. On the left, the 
nerve passes between the common carotid and subclavian arteries to enter the 
thorax. It descends through the superior mediastinum, behind the phrenic nerve 
and brachiocephalic vein and crosses the left side of the aortic arch, reaching the 
posterior surface of the lung root.
The nerves branch behind the lung roots, and these branches unite with fi­
bres from thoracic sympathetic ganglia to form the right and left posterior pul­
monary plexuses. Fibres from these form the posterior and anterior oesophageal 
plexuses, respectively. Trunks, containing fibres from both vagus nerves, are re­
formed from these plexuses and pass into the abdomen, through the oesophageal 
opening, where they undergo complex further branching before supplying the 
abdominal viscera.
On each side, the vagus nerve has important branches arising in the jugu­
lar foramen, neck, and thorax. From the superior ganglion arises a meningeal 
branch, which innervates the dura in the posterior fossa, and an auricular branch 
which subserves sensation from the posterior auricle and external auditory mea­
tus. The pharyngeal branch arises from the inferior ganglion and is the main mo­
tor nerve to the pharynx and soft palate. The superior laryngeal nerve also arises 
from the inferior ganglion. It has two branches: the internal, which is the main 
sensory nerve of the larynx, and the external, which is motor to the inferior pha­
ryngeal constrictor and cricothyroid muscles. The recurrent laryngeal nerves 
have a different origin and course on each side of the body. On the right, this 
nerve arises from the vagus at the root of the neck, in front of the subclavian ar­
tery. It winds below and behind that vessel and ascends beside the trachea and 
behind the common carotid artery.
At the level of the thyroid gland the nerve is closely related to the inferior 
thyroid artery. On the left, the nerve arises from the vagus at the level of the aor­
tic arch. It winds under the arch and then ascends along the side of the trachea. 
On both sides the recurrent laryngeal nerves ascend in a groove between the oe­
sophagus and trachea, pass closely next to the medial surface of the thyroid 
gland, and enter the larynx to supply all of the laryngeal muscles except the cri­
cothyroid.
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LESIONS OF THE VAGUS NERVE AND ITS BRANCHES
Supranuclear, nuclear, nerve trunk, and branch lesions may affect swal­
lowing and phonation, the exact pattern of symptoms depending upon the site 
and chronicity of the lesion.
Supranuclear lesions
Because the nuclei receive both crossed and uncrossed corticobulbar fi­
bres, unilateral supranuclear lesions do not usually cause persisting problems 
with phonation and swallowing, although dysphagia may be prominent follow­
ing an acute hemispheric stroke. Bilateral lesions are associated with the syn­
drome of pseudobulbar palsy, in which dysphagia and dysarthria are due to dis­
ordered movements of the pharyngeal and laryngeal (and tongue) muscles rather 
than frank paralysis. Common causes include upper brainstem or bilateral hemi­
spheric strokes, motor neuron disease, and demyelination.
Nuclear lesions
A unilateral nuclear lesion will cause ipsilateral palatal, pharyngeal, and 
laryngeal paralysis. On phonation the soft palate does not rise on the affected 
side and the uvula is drawn to the normal side. Dysphagia is variable but usually 
mild. Phonation is affected not only because of laryngeal muscle weakness but 
also by accumulation of frothy mucus which collects near the opening of the oe­
sophagus and overflows into the larynx as a result of impaired pharyngeal emp­
tying. The voice and cough are weak and there is difficulty clearing the voice. 
Bilateral lesions, in the syndrome of bulbar palsy, produce much more severe 
symptoms. The speech is nasal and on attempting to swallow fluids regurgitate 
through the nose due to palatal weakness. There may be snoring and inspiratory 
stridor. Coughing is paralysed, leading to a high risk of bronchial aspiration. 
Acute bulbar palsy is life threatening and tracheostomy is required.
Unilateral nuclear lesions rarely occur in isolation and are usually accom­
panied by involvement of other cranial nerve nuclei and long tracts. Causes in­
clude vascular lesions (e.g. lateral medullary syndrome) and tumour. Bilateral 
nuclear lesions, sometimes asymmetric, may be due to vascular lesions, motor 
neuron disease, tumour, syringobulbia, encephalitis, poliomyelitis, and rabies.
Nerve-trunk lesions
The clinical features of a lesion affecting the vagus nerve trunk between 
its origin and the jugular foramen are as described above for a unilateral nuclear 
lesion. Thus, there is unilateral paralysis of the soft palate, pharynx, and larynx. 
Causes include primary (glomus jugulare, meningioma) and secondary tumour, 
meningitic processes, and basal skull fracture. There is frequently involvement 
of other cranial nerves (IX, XI, and XII).
The inferior ganglion lies just below the jugular foramen and from it arise 
the pharyngeal and superior laryngeal nerves, which supply the muscles of the 
soft palate and pharynx, and the tensors of the cords (cricothyroids). A lesion of 
the vagus nerve trunk below the inferior ganglion thus spares these muscles and
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the pattern of laryngeal paralysis is the same as is seen with an isolated lesion of 
the recurrent laryngeal nerve.
Recurrent laryngeal nerve lesions
In practice, isolated vagus nerve trunk lesions are rare, but recurrent la­
ryngeal nerve palsies are common. A unilateral lesion causes paralysis of the ip- 
silateral larynx and lower sphincter of the pharynx. The vocal cord is immobile 
and lies near the midline. Dysphagia is not a major feature, because the pharyn­
geal nerve is unaffected, although following an acute lesion there may be tran­
sient difficulties swallowing fluids. In the acute phase there may also be dys- 
phonia but despite the paralysed vocal cord compensatory mechanisms are so 
efficient that the voice may remain or soon return to normal.
The left recurrent laryngeal nerve is more commonly involved than the 
right, as a result of mediastinal lesions, particularly neoplasia but less frequently 
aortic aneurysm and enlargement of the left atrium. In the neck the nerve may be 
affected unilaterally or bilaterally by trauma, surgery, cervical lymph gland 
enlargement (inflammatory or neoplastic), thyroid enlargement, and oesophag­
eal carcinoma. Up to one-third of cases of recurrent laryngeal nerve palsy are 
idiopathic. They may be persistent or show partial or complete recovery.
ACCESSORY NERVE (XI)
This is a purely motor nerve. It is formed from cranial and spinal roots 
which, as the accessory nerve, run together for only a very short distance. The 
cranial component is essentially part of the vagus nerve and is distributed mainly 
to the pharyngeal and recurrent laryngeal branches of that nerve, whereas the 
spinal component innervates sternomastoid and trapezius.
FUNCTIONAL ANATOMY
The spinal nucleus of the accessory nerve lies in the lateral part of the an­
terior horn grey matter and extends from the pyramidal decussation to the fifth 
cervical segment. The fibres arising from it emerge from the lateral aspect of the 
cord, between the dorsal and ventral roots, and unite to form a trunk which as­
cends posterior to the denticulate ligament and enters the skull through the fo­
ramen magnum, dorsal to the vertebral artery. The cranial root is formed by 
nerve fibres arising from the lower part of the nucleus ambiguus. Rootlets 
emerge from the lateral medulla, below the origin of the vagus.
Peripheral course
The cranial and spinal components unite for a short distance and leave the 
skull through the jugular foramen, in close relationship to the vagus nerve to 
which the cranial root fibres are distributed. The spinal part runs backwards and 
laterally between the internal jugular vein and internal carotid artery and crosses 
the transverse process of the atlas. It passes deep to the stemomastoid muscle, 
which it supplies, and emerges from its posterior border from where it crosses 
the posterior triangle, lying on levator scapulae. In this part of its course it is 
quite superficial, thus subject to trauma, and also related to cervical lymph 
nodes. The nerve then passes under the anterior border of the trapezius and 
unites with branches of the third and fourth cervical nerves (C3 and C4) to form 
a plexus which innervates the muscle. The pattern of innervation of the different 
parts of trapezius is probably quite variable but, in general, the accessory nerve 
appears to supply the upper part of the muscle, and fibres derived from C3 and 
C4 supply the lower part.
LESIONS OF THE ACCESSORY NERVE
Unilateral stemomastoid weakness is asymptomatic because it normally 
acts in concert with other cervical muscles which can compensate. Bilateral, but 
otherwise isolated, nerve lesions must be vanishingly rare. Bilateral sternomas- 
toid weakness, with symptomatic weakness of neck flexion, is seen in myotonic 
dystrophy, inflammatory myopathies, various muscular dystrophies, myasthenia 
gravis, and motor neuron disease, but in all of these cases other cervical muscles 
are also involved.
Trapezius weakness is symptomatic. The shoulder droops slightly and 
there is mild scapular winging at rest, with the scapular rotated outwards and 
downwards. The winging is exacerbated by abduction of the arm, whereas wing­
ing due to serratus anterior weakness is most evident on forward flexion of the 
arm. The patient notices difficulty in shrugging the shoulder, abducting the arm 
above 90° and carrying the extended arm backwards. Bilateral trapezius weak­
ness causes the head to fall forwards. This is rarely the result of bilateral nerve- 
trunk involvement but is seen in myasthenia gravis, motor neuron disease, and 
various myopathies.
Supranuclear lesions
The cortical representation is mainly ipsilateral for stemomastoid and con­
tralateral for trapezius. Thus, following a major hemisphere stroke, trapezius is 
weak on the paralysed side but stemomastoid is weak on the side of the hemi­
spheric event.
Nuclear and nerve-trunk lesions
The spinal cord nucleus is rarely involved in isolation. The anterior horn 
cells may be affected by motor neuron disease and poliomyelitis and the nuclei 
may be compressed by upper cervical cord tumours and syringomyelia.
114
In the posterior fossa, lesions affecting the accessory nerve often also in­
volve cranial nerves IX, X, and XII. Common pathologies include primary and 
secondary tumours, meningitic processes, and basal skull fracture through the 
jugular foramen.
Outside the skull the most common site of damage is in the posterior tri­
angle (giving rise to trapezius but not stemomastoid weakness). The nerve may 
be damaged by trauma or during surgical procedures (particularly removal of 
cervical lymph glands) including carotid endarterectomy. Up to one-third of ac­
cessory nerve palsies are idiopathic, probably often as a forme fruste of neural­
gic amyotrophy.
HYPOGLOSSAL NERVE (XII)
This motor nerve innervates all of the muscles of the tongue through gen­
eral somatic efferent fibres. Although it contains some afferent fibres, their func­
tion is unclear and they are of no importance in clinical practice.
FUNCTIONAL ANATOMY
The nucleus, which is nearly 2 cm long, lies in the central grey matter of 
the medial eminence and extends from the stria medullaris to the most caudal 
part of the medulla. The axons arising from it pass ventro-laterally and emerge 
as a series of rootlets on the ventral aspect of the medulla between the inferior 
olivary complex and the pyramid.
Peripheral course
The rootlets pass behind the vertebral artery and unite as they exit the 
skull through the hypoglossal canal, which lies about 1 cm anterior, inferior, and 
medial to the jugular foramen. Immediately outside the skull the nerve is in 
close proximity to cranial nerves IX, X, and XI, the internal jugular vein, and the 
internal carotid artery. At the level of the angle of the mandible it sweeps antero- 
laterally, looping below the occipital artery and crossing the external carotid ar­
tery and then the loop of the lingual artery just above the hyoid bone. It then 
passes deep to the digastric muscle and terminates through multiple branches in 
the intrinsic and extrinsic tongue muscles.
LESIONS OF THE HYPOGLOSSAL NERVE
A unilateral lesion of the nucleus or nerve trunk causes ipsilateral wasting 
and weakness of the tongue. Fasciculation may be prominent, especially in in­
fantile spinal muscular atrophy and classical motor neuron disease. The epithe­
lium is thrown into folds, which accumulate fur. In the acute stage, articulation 
and swallowing may be slightly impaired but chronic lesions are typically as­
ymptomatic. The tongue deviates to the affected side on protrusion. Bilateral 
lower motor neuron lesions cause weakness of both sides of the tongue with in­
ability to protrude the tongue, marked dysarthria, and mild swallowing difficul­
ties. Such bilaterallesions are rare in isolation and are usually part of the syn­
drome of bulbar palsy, in which other bulbar muscles are affected and in which 
there is significant dysphagia. In one large series of cases of hypoglossal nerve 
palsy, 49 of 100 cases were due to tumour.
Supranuclear lesions
The nuclei have bilateral cortical representation so that a unilateral upper 
motor neuron lesion may have no observable effect, although occasionally the 
tongue may deviate to the contralateral side. Bilateral upper motor neuron in­
volvement is seen as part of the syndrome of pseudobulbar palsy. The tongue is 
weak, clumsy, and contracted secondary to spasticity, but not wasted. Causes 
include bilateral hemispheric vascular disease, upper brain stem stroke and tu­
mours, multiple sclerosis, and motor neuron disease.
Nuclear lesions
Unilateral nuclear damage may be caused by tumours or vascular lesions, 
in both of which cases other structures are usually involved. Thus, a vascular 
event in the lower medulla might cause a unilateral hypoglossal nerve palsy and 
contralateral hemiplegia due to corticospinal tract involvement. Bilateral, but 
sometimes asymmetric, hypoglossal nuclear lesions may result from vascular 
lesions, tumours, syringobulbia, spinal muscular atrophy, motor neuron disease, 
and poliomyelitis.
Nerve-trunk lesions
In the posterior fossa the hypoglossal nerve rootlets may be affected, often 
together with cranial nerves IX, X, and XI, by primary (e.g. glomus jugulare, 
meningioma) and secondary neoplasms and basal meningitic processes. Unilat­
eral or bilateral palsies may arise as a result of congenital or acquired bony ab­
normalities around the foramen magnum (basilar impression, Paget's disease).
In the neck, the nerve may be damaged by external trauma, during surgery 
(including carotid endarterectomy), by tumours, and as a late consequence of ra­
diotherapy to the region. Vascular causes include aberrantly placed arteries, ca­
rotid artery dissection, and as a complication of central venous catheterization. 
As with cranial nerves X and XI, idiopathic cases occur.
DYSPHAGIA
Difficulty in swallowing (dysphagia) is a common neurological problem 
and the most important sequelae include aspiration and malnutrition. Often it is 
these complications, particularly aspiration, that first draw the clinician's atten­
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tion to the possibility of a swallowing disorder. Dysphagia may be due to me­
chanical factors, upper and lower motor neuron disorders, myasthenic syn­
dromes, and myopathy.
Swallowing mechanisms
A complex sequence of movements, some voluntary but most involuntary 
or reflex, ensure that food is safely transferred from the outside world to the 
stomach. Normal swallowing depends upon the integrity of sensory and motor 
pathways of several cranial nerves: V, VII, IX, X, and XII. These events can be 
broken down into separate stages. In the first stage food is contained within the 
mouth, chewed, formed into a bolus, positioned on the tongue, and pushed into 
the oropharynx. The swallowing reflex is initiated as the bolus passes between 
the pillars of the fauces. The individual elements of this reflex include elevation 
of the soft palate (thus preventing nasal regurgitation), elevation of the larynx 
and closure of the entry to the trachea, and peristaltic propulsion of the bolus 
through the cricopharyngeal sphincter into the oesophagus. Coordinated peri­
stalsis carries the bolus through the lower oesophageal sphincter, into the stom­
ach.
Causes of dysphagia
In neurological practice dysphagia is most often seen in association with 
other, obvious, neurological problems. Apart from in oculopharyngeal muscular 
dystrophy, it is relatively rare as a sole presenting symptom, although occasion­
ally this is seen in motor neuron disease, myasthenia gravis, and inclusion-body 
myositis. Conversely, in general medical practice, there are many mechanical or 
structural disorders which may have dysphagia as the presenting feature. In 
some of the disorders notably motor neuron disease, both upper and lower motor 
neuron dysfunction may contribute to the dysphagia.
Symptoms
The patient's description of their swallowing problem may give a clear in­
dication as to the level of the problem. Oropharyngeal disorders cause symptoms 
on swallowing or immediately after-there may be nasal regurgitation, coughing, 
and choking due to aspiration, a sensation of blockage in the neck, and some­
times pain. With oesophageal problems, symptoms come on a little later and pa­
tients locate the site of blockage and discomfort to the lower throat or retroster­
nal region. As a generalization, obstructive causes of dysphagia, such as oeso­
phageal carcinoma, initially give rise to greater problems with solids than fluids, 
whereas in neuromuscular disorders dysphagia for fluids may be a relatively 
early feature.
As noted above, when considering individual cranial nerves, unilateral 
upper or lower motor lesions generally do not cause major problems with dys­
phagia, particularly if of gradual onset. An important exception is the dysphagia, 
sometimes severe, seen transiently following hemispheric stroke. This is a major 
contributing factor to aspiration pneumonia.
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It can not be overemphasized that aspiration may be silent, without symp­
toms such as coughing and choking, and without abnormal physical signs on 
bedside examination. If a patient with a disorder that might cause swallowing 
problems develops a chest infection then, even in the absence of specific fea­
tures pointing towards such a problem, further investigation, such as vide- 
ofluoroscopy, should be performed.
EXAMINATION AND INVESTIGATION
More often than not, the history and findings on examination (particularly 
those related to the lower cranial nerves) will identify the neurological disorder 
causing the dysphagia, or will at least point to the likely nature of the problem 
(e.g. a myopathy, neurogenic problem, or upper motor neuron disorder) and thus 
the direction of further investigations. In patients with mechanical oesophageal 
problems, physical examination may, of course, be normal. Endoscopy is of lim­
ited value in neurological practice, but of course invaluable when investigating 
structural disorders of the oesophagus.
CEREBRAL CORTEX AND NEUROPSYCHOLOGICAL 
DISORDERS
The diseases that disrupt the cerebral cortex and its subcortical connec­
tions result in a wide variety of clinical features, which include the classical 
syndromes of higher cortical dysfunction, such as the dysphasias, dyspraxias, 
amnesias, and agnosias, together with a wide variety of behavioural and emo­
tional disturbances. Clinical investigation of such disorders frequently overlaps 
with the disciplines of clinical psychology and psychiatry. Historically there has 
been a broad split between those diseases that are seen by neurologists and those 
that are seen by psychiatrists. To some extent the distinction reflects the differ­
ent clinical approaches employed; neurologists concentrate on the generality of 
disease caused by lesions in defined areas, whereas psychiatrists often deal with 
diseases that show a greater interaction with the individual's own personal his­
tory and place in society. In this chapter, disturbances of higher cortical func­
tion, the dementias, and behavioural aspects of neurological lesions are dis­
cussed. Awareness of the occasional presentation of psychiatric disease to the 
neurologist is important, and further details are available in textbooks of psy­
chiatry. A review of clinical syndromes referable to identified areas of the cere­
bral cortex is followed by a functional approach, which discusses the main 
neuropsychological syndromes. The more generalized cognitive impairment 
seen with the dementias, such as Alzheimer's and Pick's diseases, are then re­
viewed, followed by areas of neuropsychiatric overlap.
Anatomy and physiology of the cerebral cortex
The human cerebral cortex consists of six laminae, comprising in total 
some 28 x 109 neurons and approximately the same number of glial cells: from 
the external surface, these are the molecular layer, the external granular, the ex­
ternal pyramidal, the internal granular, the internal pyramidal, and the multiform 
or fusiform layer. The interconnection of the neurons comprises a staggering 
1012 synapses. Despite this dramatic development, the basic structural organiza­
tion of the cerebral cortex in modular terms is the same across species. The basis 
of the modular organization is the minicolumn, representing some 80-100 neu­
rons connected vertically, and within each minicolumn are all of the major corti­
cal neuronal types. Two broad categories of neuronal cell types can be distin­
guished: the large pyramidal cells, which are the origin of the main outflow 
tracts and which utilize glutamate as the main neurotransmitter; and the smaller, 
non-pyramidal cells, which have predominantly local connections and primarily
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utilize the inhibitory amino acid y-aminobutyric acid, together with a variety of 
coexistent neuropeptides. There is an increasing sub categorization of the small 
non-pyramidal cells, and an increasing understanding of the intrinsic connec­
tivity of these cells within the minicolumns. Cortical columns are minicolumns 
bound together by horizontal connections over a short range, which share 
physiological features based in part upon shared input and output characteristics. 
Layers 2 and 3 project to other cortical areas and layers 5 and 6 are primarily 
subcortical projections. Columns vary only from 300 to 600 pm in diameter 
across a very wide range of species. The expansion of the human brain is due to 
the increase of the total number of modular units rather than a difference in their 
size.
The organization of the cerebral cortex, in terms of the functional charac­
teristics of the cortical columns, was established using single-cell recording for 
the somatic sensory cortex by Mountcastle, and the visual cortex by Hubei and 
Wiesel. The response characteristics of a somatic sensory column depend both 
upon modality and topography of the receptive fields. Similarly, in the visual 
cortex, columns can be defined by various properties of increasing complexity 
from ocularity and place through to orientation. This modular organization in 
anatomical and functional terms accords with the general view from cognitive 
psychology of modular processing. As the modular processing becomes more 
complex, the defining characteristics of the cortical column become the inputs 
from other columns, the outputs of which represent a further level of cortical 
processing. This achieves greatest complexity in the association cortices or 
homotypical cortical areas.
There is regional specialization within the cerebral cortex, which is re­
flected to some extent in architectonic differences, such as that originally identi­
fied by Brodmann (1909). However, particularly at the higher level of cortical 
processing, as represented by the association areas, cortical operations are also 
distributed. Evidence for distributed networks is provided both by functional 
brain imaging and by anatomical evidence of enormous convergent and recipro­
cal connections, for example those between the parietal and frontal cortex.
CLINICAL SYNDROMES ASSOCIATED WITH SPECIFIC 
AREAS OF THE CEREBRAL CORTEX
A number of clinical syndromes are recognized as characteristic of lesions 
in specific areas of the cerebral cortex. The syndromes largely, but not invaria­
bly, involve loss of function, although in some instances loss of inhibition may 
present as release phenomena. The descriptions of many of these clinical syn­
dromes were derived from patients with discrete lesions due to ischaemic in­
farcts or tumours, and formerly required follow-up to post-mortem to determine
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the location. Modern neuroimaging has considerably improved the power of 
such studies and there has been a spate of reports that locate specific syndromes 
to precise brain regions.
However, it should be emphasized that the observed associations are be­
tween clinical syndromes and brain areas and do not necessarily locate function 
to a specific brain region. Although a specific function may be lost following 
damage at a given site, the function itself is more likely to depend upon suc­
cessful integration of a neural network. The particular area would be part of such 
a network and assumed to be of central importance.
In addition to the location of clinical syndromes to specific cortical areas, 
some syndromes may be better interpreted as representing disconnections of one 
area from another. The concept of disconnection syndromes was originally pos­
tulated by Dejerine and other early neurologists, and re-explored in considerable 
detail by Geschwind (1965). Some of the clinical syndromes arising from dam­
age to the corpus callosum are most easily explained in terms of disconnection.
Functional imaging has contributed further to our knowledge of localiza­
tion of function. Baseline measures of blood flow or cerebral glucose metabo­
lism with positron emission tomography (PET scanning) can identify areas of 
reduced basal function when abnormalities on structural imaging may not be 
readily apparent. This has been most valuable in patients with frontal lobe de­
generation. Activation studies can provide information on changes in cerebral 
blood flow, or deoxygenation of haemoglobin, and thus regions which are acti­
vated during a specific cognitive task relative to another. Such functional imag­
ing studies have revealed that activation is often widely distributed, indicating 
that distributed networks are involved in such cognitive tasks. However, as with 
structure-function relationships, caution has to be exercised in their interpreta­
tion. Although lesion studies show areas which may be necessary for a particular 
function, they can only localize deficits and it cannot be inferred that the specific 
function occurs in that area. They will show areas and structures that are neces­
sary, but not sufficient, for that function. Similarly, activation may occur in ar­
eas that are not necessarily essential to a function. For example, activation stud­
ies of language may show areas of increased blood flow in the right hemisphere 
and yet lesion studies indicate that dysphasia does not occur with lesions in the 
same area.
The most widely used activation studies involve subtraction paradigms. A 
baseline task is compared with an activation task that engages the cognitive 
component of interest. When the baseline data are subtracted, then areas that are 
activated are believed to relate directly to the particular cognitive component 
under study. More sophisticated models have been used to deal, for example, 
with language function, where it may be difficult to identify an appropriate base­
line task. In these paradigms, referred to as cognitive conjunctions, areas of 
common activation rather than areas of different activation are sought. Func­
tional imaging has provided valuable insights into the distributive networks in­
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volved in many cognitive processes, such as language. It does, however, remain 
a research tool and as yet has had limited impact on routine neurological man­
agement.
The frontal lobes
The frontal lobes lie rostral to the central sulcus and superior to the Syl­
vian fissure. They show the greatest development in humans, compared with 
other primates. Within the frontal lobes are the primary motor cortices, located 
within the precentral area, together with the supplementary motor areas and the 
frontal eye fields. The dominant frontal lobe encompasses Broca's area and the 
adjacent area of the motor cortex is involved with the motor control of the oro­
pharynx, lesions of which result in impairment of articulation and phonation. 
However, the prefrontal cortex, Brodmann areas 9, 10, 11, 12 and 45, 46 and 47, 
is particularly developed in humans and yet has a less clearly defined function.
The frontal cortex has widespread connections with other areas of the 
brain. The pyramidal cells of the motor cortex form the major fronto-striatal out­
flow tract and, similarly, there are extensive projections from subcortical struc­
tures into the frontal cortex, notably the dopaminergic, noradrenergic, and cho­
linergic cortical projection systems.
Early studies with experimental frontal lobe lesions in nonhuman primates 
revealed impaired performance on a number of tasks which suggested persevera- 
tive responses and difficulty in switching between preferred modes of response. 
These difficulties with switching cognitive sets were explored further using the 
Wisconsin card-sorting test. Patients tend to perseverate on these tasks and yet 
on other tasks, such as cognitive estimates, patients may be quite impulsive and 
unable to monitor their performance.
The combination of perseverative responses, lack of initiative, and impul- 
sivity has been brought together in the hypothesis of a supervisory attentional 
system for the frontal lobes. In this model, the frontal lobes have an important 
role in both selecting appropriate behavioural responses and inhibiting inappro­
priate ones. This can explain the paradoxical combination of both aspontaneity 
and lethargy together with impulsivity, even within the same patient. Breakdown 
in such a system results in markedly impaired social behaviour and adaptability, 
and yet formal testing shows that intelligence may often be spared. One of the 
most distinctive features of the frontal lobe syndrome is a change in personality, 
most commonly towards disinhibition. The effect upon personality of massive 
bifrontal lesions was well demonstrated by the celebrated case of Phineas Gage 
who, in 1848, had a crowbar driven through the front of his skull. He was de­
scribed as 'fitful, irreverent, indulging at times in the greatest profanity ... mani­
festing but little deference for his fellows, impatient of restraint or advice when 
it conflicts with his desires, at times pertinaciously obstinate, yet capricious and
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vacillatory'. Thus a frontal lobe syndrome has come to be recognized: an af­
fected individual previously capable of judgement and sustained application and 
organization of his life, may become aimless and improvident, with loss of tact, 
sensitivity, and self-control, and with impulsiveness and a failure to appreciate 
the consequences of reckless behaviour. The disinhibited behaviour may result 
in childish excitement (moria) or joking and pathological punning (Witzelsucht); 
there may in addition be sexual indiscretions and exhibitionism. Alternatively, 
the syndrome may present with lack of initiative and profound psychomotor 
slowing (abulia). This may be accompanied, particularly with bifrontallesions, 
by urinary incontinence, which can occasionally be seen with unilateral lesions. 
This incontinence is commonly associated with lack of concern and social 
awareness, which is a useful clinical clue since this type of incontinence is rarely 
found with generalized dementing conditions such as Alzheimer’s disease.
The behavioural disturbance can be striking, and can precede changes on 
formal tests of frontal lobe function by many years. A distinction has been 
drawn between dorsolateral frontal lesions, which may be associated with cogni­
tive decline and apathy, and/or orbitomediallesions with prominent behavioural 
change. Often the changes in behaviour are most apparent to the spouse, who 
may feel that they are married to somebody entirely different.
Clinical examination may be less revealing than the history, and often pa­
tients perform relatively well on formal tests of intelligence. However, specific 
tasks, such as the Wisconsin card sorting test, the Weigl sorting test, cognitive 
estimates, verbal fluency, and bimanual motor tasks, will show impairment, but 
even this may be patchy and inconsistent. The patient's appearance may be 
clearly abnormal, appearing unkempt, unwashed, and lacking all spontaneity. 
Neurological examination may reveal primitive reflexes, such as the rooting re­
flexes, both tactile and oral, and sucking reflexes, if severe. Grasp reflexes are 
easily elicited by running the hand across the palm and may be elicited from the 
foot. The grasp reflex and instinctive grasp reaction can be seen as part of a 
more generalized magnetic behaviour, elicited as utilization. This is a striking 
example of environmental dependency, in which presentation of an object will 
elicit a behavioural response regardless of whether or not it is appropriate. Pa­
tients offered spectacles, for example, may place them on their nose,, followed 
by further pairs, until three or four are stacked upon one another, the inappropri­
ateness of this completely eluding the patient.
As lesions extend more posteriorly in the dominant frontal lobe, there may 
be an associated non-fluent anterior dysphasia and impairment of speech pro­
duction. Lesions in relation to the orbital surface may result in unilateral visual 
failure and anosmia. The latter will rarely be found unless specifically sought 
and is a characteristic feature of olfactory groove meningiomas. On examina­
tion, prominent changes in tone may be found which increase in response to the 
stimulus, so-called paratonia or Gegenhalten. More posteriorly placed lesions 
may result in mild pyramidal signs, but most striking are bifrontal medial lesions
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causing prominent gait impairment with truncal instability, often referred to as 
gait apraxia. With the availability of CT and MRI scanning, frontal lobe tumours 
are far more readily diagnosed.
However, with the gradual onset of personality changes, many cases are 
still missed until late. In general, frontal lobe syndromes are seen more com­
monly with tumours and degenerative disease than with vascular disease.
The temporal lobes
The Sylvian fissure separates the temporal lobe from the frontal lobe and 
rostral part of the parietal lobe. There is, however, no clear boundary between 
the posterior temporal lobe and the parietal and occipital lobes. The temporal 
lobes have easily discernible gyri -  the superior, middle, and inferior temporal 
gyri -  and also the parahippocampal and hippocampal convolutions. The hippo­
campus demonstrates a three-layered cortical structure, in contrast to the six­
layered neocortex. Heschl's gyrus in the Sylvian fissure represents the primary 
auditory receptive area, and fibres terminating here do so in a tonotopic ar­
rangement. Deep within the temporal lobe is the amygdala.
Discrete lesions of the anterior temporal poles may be clinically silent 
and, in general, lesions of the non-dominant temporallobe are less obvious clini­
cally; sometimes the only clue on neurological examination being a superior 
quadran tic visual field defect or behavioural change. However, bitemporal le­
sions and those of the dominant temporal lobe may result in profound functional 
impairments. The predominant lesion of the dominant temporal lobe is that of a 
language impairment, classically a Wernicke's aphasia or, rarely, a pure word 
deafness or auditory verbal agnosia.
Unilateral lesions of the dominant temporal lobe can be shown to result in 
impairment of memory for verbal material, by contrast to impaired visual mem­
ory with non-dominant lesions. Unilateral lesions of Heschl's gyrus rarely result 
in deafness, but careful binaural testing reveals subtle abnormalities in the area 
contralateral to the lesions. The inability to recognize faces, prosopagnosia, is 
usually seen with bilateral lesions but has also been described with unilateral 
non-dominant temporoparietal lesions. Patients with prosopagnosia may have a 
variety of deficits, ranging from an inability to recognize the face through to loss 
of familiarity and inability to match faces. This can sometimes be so severe that 
patients are incapable of recognizing members of their own family but can do so 
immediately on hearing their voices.
Very rarely, lesions of the temporal lobe can result in a true auditory ag­
nosia. Simple perception of sound and pure tone is intact but the interpretation 
of complex sounds is severely impaired. In pure auditory agnosia recognition of 
all noises, for example the sound of a bell, dogs barking, or running water, is 
lost. More common is the loss of appreciation of music, or amusia, seen with
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right temporal lobe lesions. The patient’s appreciation of melody, timbre, and 
rhythm all tend to be impaired and they may also have difficulty in musical rec­
ognition.
Bilateral temporal lobe lesions are far more devastating. These cases are 
rare and occur after herpes encephalitis or in the later stages of frontotemporal 
degeneration. They are normally associated with a dysphasia and, in addition, 
profound memory impairments. Bilateral removal of the temporal lobes in the 
monkey produces a striking behavioural state referred to as the Kluver-Bucy 
syndrome. The monkeys show increased exploratory behaviour, in which they 
will examine objects by oral and manual manipulation with apparent inability to 
recognize them visually. They are usually placid but with hypersexuality. Simi­
lar cases have been described with herpes encephalitis and with frontotemporal 
degenerations. The frontotemporal degenerations encompass a variety of disease 
processes, including Pick's disease. They are often associated with obsessional 
behaviour, change in eating habits, hypereligiosity, and both hypo- and hyper­
sexuality. Some of these features may reflect involvement of the amygdala.
A variety of episodic symptoms may be found with temporal lobe lesions, 
which are usually on an epileptic basis and range from auditory hallucinations to 
disruption of time perception and disturbances of sexual behaviour. In addition, 
however, chronic bilateral lesions, particularly those of the medial tem- 
porallobes, may cause profound disintegration of personality and behaviour. In 
its extreme form patients react to any stimulus by excessive rage with scream­
ing, biting, and spitting. This distressing clinical picture is seen most commonly 
in survivors of herpes encephalitis.
The parietal lobes
The parietal lobes lie behind the central sulcus and above the Sylvian fis­
sure, but the posterior boundaries with the occipital and temporal lobes are not 
clearly defined. Immediately behind the central sulcus is the primary sensory 
cortex, which is delineated posteriorly by the post central sulcus. The superior 
temporal sulcus curves upwards posteriorly into the inferior parietal lobule in 
relation to the angular gyrus. This is adjacent to the posterior extremity of the 
Sylvian fissure, which also curves up into the inferior parietal lobule in relation 
to the supramarginal gyrus. The supramarginal and angular gyri, together with 
the posterior third of the superior temporal gyrus, constitute the Wernicke 
speech area. The parietal lobes are well developed in humans and continue to 
develop until about the seventh year of life. There are extensive connections 
with other association areas.
Lesions within the parietal lobes can present with an enormous variety of 
disturbances of higher cortical function, some of which are quite dramatic in 
their presentation. Dominant parietal lobe lesions are often associated with dys­
125
phasia. This may be predominantly a motor or sensory dysphasia, depending 
upon the antero-posterior location. More posterior lesions are associated with 
dyslexia, dysgraphia, and dyscalculia, and ideational apraxia is a consistent fea­
ture of dominant parietal lobe lesions. Gerstmann's syndrome refers to the asso­
ciation of finger agnosia, dyscalculia, right-left disorientation, and agraphia. Al­
though this is commonly seen with lesions of the dominant angular gyrus, this 
particular clustering of deficits is no more common than other patterns. Lesions 
of either parietal lobe may result in visuospatial disturbance and topographical 
disorientation. Similarly, both parietal lobes are involved with selective atten­
tion. However, it is with lesions of the non-dominant parietal lobe that the most 
striking disturbances of visuospatial function and disturbances of body image 
are seen. Patients with non-dominant parietal lesions have marked impairment 
of selective attention which will affect both right- and left-sided space, but most 
commonly left-sided space. This may be so severe that they will ignore the left 
side of the body, resulting in problems in dressing, and in shaving only one half 
of their face. If this is associated with a left hemiplegia, they may be unaware of 
the deficit (anosognosia) and indeed deny that the paralysed limb has anything 
to do with them.
On examination, patients with parietal lobe lesions may show the obvious 
neglect of the left side, with an arm hung loosely at the side or out of the sleeve 
of their jacket, with the left face unshaven, and associated pyramidal signs. Field 
defects are most commonly inferior quadrantanopias. Gaze impersistence, an in­
ability to sustain lateral gaze on testing eye movements, is seen quite commonly 
and can be very frustrating for the examiner. Cortical sensory loss may be found 
in the contralateral limbs, which can be most readily picked up by testing two- 
point discrimination, which is impaired together with astereognosis (inability to 
recognize objects by their shape), or alternatively inability to recognize figures 
written on the hand (agraphesthesia). Neglect can be unmasked by simultaneous 
tactile or visual stimuli, when the patient may only recognize one of the two si­
multaneously presented stimuli, ignoring that contralateral to the lesion. The 
sensory testing may be difficult, with patients showing considerable variability 
and being easily fatigued. Simple bedside tests of visuospatial function that can 
be helpful include drawing a cube or clock face, when patients will often ignore 
features to the left-hand side. Dressing apraxia can be assessed by watching the 
patient put on clothing, and the task made more difficult by inverting one sleeve.
The occipital lobes
The occipital lobes are separated on the medial surface from the parietal 
lobes by the parieto-occipital fissure, but there are no clearly defined margins 
between the parietal and temporal lobes on the lateral surface. The occipital 
lobes subsume the termination of the visual pathways, and the primary visual
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cortex, Brodmann area 17, lies on either side of the calcarine fissure, which runs 
from the occipital pole to the splenium of the corpus callosum. It has the histo­
logical characteristic that its fourth layer is divided into two granular cell layers 
by a thickened band of heavily myelinated fibres, the external band of Bail- 
larger. This band is visible to the naked eye, hence the name of striate cortex. 
The classical findings with lesions of the occipital cortex are homonymous vis­
ual field defects; a homonymous hemianopia when confined to one occipital 
lobe. Bilateral lesions may cause altitudinal defects, since the termination of the 
optic radiation is topographically arranged, with lower retinal fibres terminating 
in the cortex below the calcarine fissure. Superior quadran tic defects are found 
with inferior lesions and vice versa.
With extensive bilateral lesions various abnormalities are found, ranging 
from complete cortical blindness, through to subtle visual disturbances. With 
complete cortical blindness, the pupillary responses are preserved, as is visual 
imagery in dreams, but cortical evoked responses and the alpha rhythm on the 
EEG are both lost. Strikingly, patients with complete cortical blindness may de­
velop a visual anosognosia (Anton's syndrome) with denial of their loss of sight. 
These patients may walk around as if they can see but will bump into objects 
and often explain their difficulties by complaining about the light or their loss of 
glasses. With partial recovery from cortical blindness, or with lesions involving 
the visual association areas, there may be a variety of disturbances of higher vis­
ual processing. These may fractionate into distinct syndromes such as visual 
disorientation, in which the ability to locate objects within the visual field is 
considerably impaired and patients may be effectively blind. This forms a major 
component of Balint's syndrome, in which patients have an inability to direct 
gaze into the peripheral field despite full eye movements, a visual inattention af­
fecting the periphery of the visual field, and prominent optic ataxia, in which 
there is failure to grasp or touch an object under visual guidance. Other syn­
dromes involve selective loss of colour, achromatopsia, and (very rarely) im­
pairment of movement perception. Rarely patients may develop genuine visual 
object agnosia if the lesion involves the occipitotemporal areas. These patients 
are unable to recognize objects by sight, but can do so on palpation or by sound. 
The lesions are usually bilateral but may be found with dominant lesions.
Patients may complain of a variety of visual hallucinations and illusions, 
more commonly with bilateral or non-dominant lesions. Many of these are asso­
ciated with epileptic phenomena, such as elementary unformed hallucinations 
and flashes of light, colours, or geometric forms. They may be seen within the 
setting of a hemianopic disturbance. Striking visual illusions may occur with 
metamorphopsias and marked changes in shape. In addition polyopia (multiple 
images) may be seen, or the striking disturbance of palinopsia, in which 
perserveration of visual images occurs and colour may spread outside the geo­
metric confines of the object.
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Subcortical syndromes
Although the cerebral cortex is viewed as the main seat of cognitive be­
haviour, it is becoming increasingly recognized that damage to subcortical struc­
tures can give rise to profound behavioural and cognitive disturbance. In many 
instances, these may mimic deficits arising from lesions within the cerebral cor­
tex, for example the dysphasia and dyspraxia which may be seen with dominant 
thalamic lesions. These may share characteristics with cortical lesions by virtue 
of the extensive neural interconnections; an interpretation supported by observed 
changes in metabolism within connected areas of the cerebral cortex demon­
strated on SPECT scanning subsequent to subcortical infarcts. Many of the be­
havioural disturbances are discussed elsewhere under the appropriate sections, 
but some structures are particularly notable. The importance of the amygdalae in 
behaviour has already been referred to, and rare instances of a Kluver-Bucy 
syndrome have been described. In addition, bilateral damage to the amygdalae 
can result in disturbance of memory as well as disturbed social behaviour and 
impaired recognition of emotional facial recognition; the latter may contribute to 
some of the social behavioural disturbances seen in frontotemporal degenera­
tion.
Disease of the basal ganglia can give rise to prominent cognitive and 
conative dysfunction, most commonly observed with massive destructions fol­
lowing haemorrhage, infarcts, or intoxications. Bilateral thalamic infarcts are 
dominated by disturbances of attention, but fluctuating aphasia is characteristic 
of left-sided lesions, whereas right thalamic infarcts can result in the 'left ne­
glect' syndromes which mimic non-dominant parietallesions. Thalamic haemor­
rhages tend to be more dramatic in their presentation and usually cause a rela­
tively fluent aphasia with marked fluctuation and superimposed hypophonia. 
Caudate lesions are more commonly associated with behavioural disturbances, 
usually abulia, than with motor syndromes. A syndrome of dysphasia with dy­
sarthria and orofacial dyspraxia can occur with dominant head of caudate in­
farcts, and dysphasic syndromes can also occur with lesions of the adjacent 
white matter or internal capsule. Apraxia is very rare with lesions confined to 
basal ganglia, but can be seen more commonly with lesions of the thalamus. Bi­
lateral lesions of the basal ganglia can result in profound behavioural distur­
bance. Marked apathy, similar to a frontal lobe syndrome, can occur with bilat­
eral lesions of the globus pallidus, so-called pure psychic akinesia. Bilateral in­
farction of the head of caudate has resulted in severely aggressive and criminal 
behaviour. Occlusions of the basilar artery at the bifurcation, the socalled 'top of 
the basilar' syndrome, result in complex disorders of eye movement, with con­
vergent spasm, retraction nystagmus, and skew deviation. It is commonly ac­
companied by memory disturbance and an agitated confusional state with 
prominent visual hallucinations, so-called peduncular hallucinosis.
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NEUROPSYCHOLOGICAL SYNDROMES
In the preceding section clusters of neuropsychological deficits which are 
characteristic of damage to particular areas of cerebral cortex were described. 
Often relatively pure deficits may present to neurologists, and more detailed un­
derstanding of the precise nature of the functional impairment, over and above 
the localizing significance, can be helpful in diagnosis and management.
Disorders of perception and the agnosias
In 1890, Lissauer introduced the terms apperceptive and associative 'mind 
blindness' to distinguish between patients whose abilities to perceive and dis­
criminate an object are impaired, and those patients who are unable to recognize 
the object having correctly perceived it. The following year, Freud introduced 
the term agnosia, which subsequently replaced the term 'mind blindness'.
Visual agnosias have been most widely studied and Lissauer's original 
analysis has subsequently proved useful in the analysis of neurological patients. 
In order to perceive an object, a number of features must be analysed and proc­
essed, such as shape, colour, location within space, and movement; these may 
each be selectively damaged. Shape discrimination can be assessed by asking 
the patient to discriminate between rectangles and squares of increasing similar­
ity. Preservation of shape and location but with loss of colour (achromatopsia) is 
rare, and is usually seen with bilateral damage to the fusiform and lingual gyri. 
There is commonly an associated superior altitudinal field defect. Impairment of 
visual location, visual disorientation, can cause great impairment and render the 
patient functionally blind. Finally, patients have very rarely been described with 
inability to detect movement, indicating a further dimension of early visual 
processing.
These abnormalities of early visual processing are most commonly seen 
with bilateral occipital and occipitoparietal lesions, but can be seen with unilat­
eral lesions, in which case the deficit is found in the contralateral field of vision. 
In these instances the functional impairment may be less prominent and patients 
less likely to present with a specific history. These disorders of visual processing 
are usually due to ischaemic lesions, but visual disorientation can be found in 
degenerative lesions of the occipital and parietal cortex, sometimes referred to as 
posterior cortical atrophy, which can be a presenting feature of Alzheimer's dis­
ease.
In apperceptive agnosia there is impairment of the generation of a struc­
tured percept of an object despite adequate initial processing of shape, colour, 
and location. This impairment can be demonstrated in patients who have diffi-
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culty coping with perceptually difficult visual stimuli, such as incomplete line 
drawings, overlapping line drawings, fragmented letters, and unusual views. 
Unlike the retinotopic organization of early visual processing, the entire visual 
field is involved in patients with apperceptive agnosia, and the minimal lesion is 
usually found in the posterior non-dominant parietal lobe.
Associative visual agnosia is very rare. Patients can describe an object 
very well and copy drawings of it precisely but it has no meaning for them. They 
are, however, able to recognize the object immediately through other sensory 
channels. Patients with visual agnosia usually have bilateral lesions, but these 
can occur with unilateral left posterior parietal lesions. Classically, visual ag­
nosia has been interpreted as a disconnection of the percept from a central mean­
ing system, but an alternative interpretation is the existence of modality-specific 
meaning systems, and visual agnosia would thus be seen as a loss of the specific 
meaning system associated with the visual domain, i.e. a visual semantic mem­
ory impairment.
Within the overall category of visual agnosias, some defects have been 
singled out for particular consideration because they present as striking clinical 
deficits; examples include the inability to recognize colour (colour agnosia) and 
inability to recognize faces (prosopagnosia). Colour agnosia implies intact col­
our perception and semantic knowledge of colour, but the majority of cases ap­
pear to have an associated impairment of colour naming. Faces present a percep­
tually difficult visual task and, clearly, problems in visual processing and per­
ception will result in difficulty in face recognition. However, some patients pre­
sent with a relatively selective impairment of facial recognition. Such cases can 
present a striking clinical picture, in that patients may be unable to recognize 
those very close to them, but can immediately do so when they hear them speak, 
or by looking for other clues in their dress or mannerisms. Prosopagnosia is usu­
ally associated with right occipitotemporal lesions and is commonly associated 
with a left homonymous superior quadrantanopia Pro sop agnosia can be ana­
lysed in a similar way to object recognition-employing tests to assess perceptual 
analysis, such as matching pictures of faces and matching facial expressions. 
Some patients may have normal performance on face-matching tasks but be 
quite unable to recognize familiar faces. Others may show intact face matching 
but be unable to match facial expression. These theoretical aspects of pro sop 
agnosia have generated a number of information-processing models of face rec­
ognition.
Agnosias in other sensory domains have been far less well studied and 
have a less secure theoretical basis. Cortical deafness can occur with bilateral 
temporal lesions which result in deficits of discrimination, temporal sequencing, 
and spatial localization of sound. Pure word deafness as an isolated agnosia for 
speech sounds usually overlaps with Wernicke's aphasia. Auditory agnosia is ex­
tremely rare and refers to patients with intact hearing and intact language com­
prehension but who are unable to recognize meaningful nonverbal sounds. Fol­
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lowing Lissauer's original terminology, these have also been divided into apper­
ceptive and associative agnosias.
Tactile agnosia is even less secure as a distinct syndrome. Patients with 
parietal lesions will often have difficulty with the appreciation of size, texture, 
and shape of objects held in the hand, and astereognosis, which is more strictly 
referred to as stereoanasthesia or stereohypoasthesia. These patients will have 
impairment of two-point discrimination and sometimes subtle proprioceptive 
changes. Strictly speaking, astereognosis should exist when shape and discrimi­
nation is intact, as evidenced by the patient's description, but recognition im­
paired. Astereognosis, however, may occur as a disconnection syndrome in pa­
tients with callosal lesions. In such patients objects can be recognized in the 
right hand but not in the left; they can, however, be correctly identified from a 
visual array. This is interpreted as disconnection of the sensory information from 
the right parietal cortex reaching the left hemisphere language area.
Disorders of spatial awareness and the body image
We are aware of the existence of our bodies, their position in space, and 
the relation of their parts to one another because we receive data through nu­
merous sensory channels; these include vision, cutaneous sensibility, and pro­
prioceptive information from the muscles, joints, and labyrinths. The somatic 
impulses pass via the ventral nucleus of the thalamus to the supramarginal 
gyrus, which is thus concerned with awareness of the opposite side of the body. 
This concept of the body in consciousness is known as the body image or body 
schema.
Symptoms of disorders of the body image may be positive or negative. 
The chief positive symptom is the phantom-an illusion of the persistence of a 
part of the body lost by amputation, e.g. a phantom limb, or an illusory aware­
ness of a part from which sensation has been lost through interruption of afferent 
pathways. Phantom limbs after amputation may be painless or painful. The 
painless phantom soon becomes less obtrusive, and gradually shortens, eventu­
ally to disappear. Painful phantoms may persist indefinitely and cause much 
distress.
Impairment of spatial sense together with neglect is most commonly seen 
following right parietal lesions and can present a dramatic clinical picture. Such 
patients frequently manifest spatial disorientation both for external space and for 
the body image, and, within hospital, mislocate their bed. These patients often 
have an associated left hemiparesis, again indicating a relationship with the non­
dominant parietal lobe. Patients with right hemisphere lesions exhibit neglect 
that is most obvious to the left side of the body and left space, and these patients 
may not shave the left side of their face, may eat food only on the right side of 
the dinner plate, and may demonstrate neglect dyslexia. Most striking is inatten­
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tion to left-sided deficits, such as left hemiparesis, so called anosognosia. In a 
less severe degree of negelect, patients may recognize their left hemiparesis but 
are unconcerned, a complication which can make rehabilitation extremely diffi­
cult
There are two main theories of spatial neglect in association with lesions 
of the non-dominant parietal lobe. One proposes that there is a central represen­
tation of space, which is damaged; the other proposes that there is a defect of se­
lective attention, a function for which the right hemisphere is dominant.
Apraxia
Apraxia may be defined as the inability to carry out a purposive move­
ment, the nature of which the patient understands, in the absence of severe mo­
tor weakness or paralysis, sensory loss, or ataxia. For example, a patient who is 
asked to protrude his tongue is unable to do so on request, although he may 
carry out inappropriate movements such as opening his mouth. A moment later 
he spontaneously protrudes his tongue to lick his lips. Apraxia may involve any 
movement that is normally initiated voluntarily -  movements of the eyes, face, 
muscles of articulation, chewing and swallowing, manipulation of objects, ges­
tures with the upper limb, walking, or sitting down. Apraxia is seen most com­
monly with left hemisphere lesions, and is then found in association with dys­
phasia.
The terminology of apraxia is particularly confusing since it includes a 
number of conditions that are not genuinely apraxic and, additionally, employs 
terms that are derived from the theoretical framework developed by Liepmann at 
the turn of the century. He defined three types of apraxia, namely limbkinetic, 
ideomotor, and ideational. These were based upon a theoretical neuroanatomical 
model similar to those that have been developed for speech. Limb-kinetic 
apraxia is rarely used and probably reflects a mild pyramidal lesion. Ideomotor 
dyspraxia refers to the poor performance of a motor act in response to a verbal 
command. This is most commonly explored at the bedside by asking patients to 
mime. It has been interpreted in terms of disconnection, although the most se­
cure disconnection model for ideomotor dyspraxia is seen in patients with le­
sions of the anterior corpus callosum, who have difficulty with performing tasks 
to command using the left hand, i.e. the 'praxis centre' in the left hemisphere is 
disconnected from the right motor cortex which controls the left hand. This is 
sometimes referred to as callosal apraxia and is commonly seen with anterior 
cerebral artery infarcts.
Ideational apraxia was defined by Liepmann as an inability to perform a 
sequential motor act, even though each could be carried out separately. How­
ever, this is relatively non-specific and may be a feature of frontal lobe lesions, 
reflecting a difficulty of programming rather than of dyspraxia. De Renzi et al.
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(1968) have defined ideational apraxia as an impairment in manipulation of ac­
tual objects. Subsequently, De Renzi has postulated that these patients have an 
agnosia for tool usage which, in this context, is associated with lesions of the 
posterior dominant parietal lobe. Patients with clinically obvious apraxia are 
relatively rare but severely disabled. They have considerable difficulty using a 
knife and fork and with many other common tasks which require manual dexter­
ity, and they will often look at their hands in a bemused way. By contrast, pa­
tients who demonstrate ideomotor dyspraxia at the bedside may not be function­
ally disabled, representing merely a feature of a specific neurological examina­
tion.
In addition to the syndromes described above, which relate to manual dex­
terity, other body-part dyspraxias have been described. A dissociation between 
limb apraxia and an axial dyspraxia, demonstrated by difficulty with adopting 
truncal postures such as a boxer's stance, has been described. Patients with gait 
apraxia show severe impairment of walking and often of standing, with addi­
tional truncal instability. Orofacial dyspraxia is found with dominant frontal le­
sions and often associated with a cortical dysarthria; such patients show a char­
acteristic inability to make oral movements to command but with sparing of eye 
movements. When asked to cough they will frequently repeat the word 'cough'; 
however, they will be observed to carry out such motor acts spontaneously. This 
may be seen on a degenerative basis. Dressing apraxia is associated with non­
dominant parietal lobe lesions and is normally seen in a context of spatial im­
pairment and left-sided neglect.
Constructional apraxia refers to a disorder of the spatial disposition of an 
action and is illustrated at the bedside by inability to copy a cube or to make a 
simple arrangement of matches. This was originally identified as a disconnec­
tion syndrome between spatial analysis and voluntary action. This remains to be 
proven, and apparent constructional apraxia may be due to more than one defect. 
Patients with left hemisphere lesions may make dyspraxic errors and commonly 
they will retain the spatial organization but simplify a diagram, whereas those 
with right hemisphere lesions show impairment of the spatial organization and 
will often neglect the left side.
Dysphasias
Since so much of the complexity of human behaviour depends upon lan­
guage, impairment in this domain often presents early and with striking features. 
Historically the language disorders were also the first to be associated with pre­
cise focal brain lesions. The terms 'dysphasia' and 'aphasia' are often used inter­
changeably. American usage favours 'dysphasia' for developmental or congenital 
language disorders, reserving 'aphasia' for the acquired disorders of language. In 
Europe 'dysphasia' has been applied in the strict sense of a partial acquired lan­
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guage disorder, with 'aphasia' referring to complete absence of language. How­
ever, this is rarely adhered to strictly.
Aphasias are disturbances of language and not simply motor speech dys­
functions, thus a patient with aphasia will also have impairment of other aspects 
of language, such as writing. The term 'aphemia' is reserved for patients with 
impaired speech but with intact writing. 'Dysarthrias' refer to impaired speech 
sound production, and 'dysphonia' to local disturbances of the larynx and phar­
ynx. Different terms have been used to describe the clinical spectrum of lan­
guage disturbance. Many of these arose out of the early descriptions of neurolo­
gists, which were based on a variety of theoretical constructs, for example con­
duction, transcortical motor, and transcortical sensory aphasias were terms in­
troduced to describe syndromes based upon theoretical models of language de­
veloped by Wernicke and Lichtheim. These models implied precise localization 
of function with fibre tracts connecting them. These were assumed to have an 
anatomical basis. Subsequently considerable advances were made in analysing 
individual components of speech comprehension and production, using informa­
tion-processing models. The theoretical models and diagrams in these instances 
relate to individual components of the process without implying any anatomical 
correlates. However, in some instances the information-processing models can 
be correlated with the earlier theoretical and neurological models. With im­
proved techniques of neuro-imaging, and particularly the opportunities of func­
tional neuroimaging with activation paradigms on PET scanning, considerable 
advances in the anatomical correlates of the individual processes in language 
can be anticipated.
A broad distinction between fluent and non-fluent aphasias is followed 
here, as this can provide a useful starting point for the clinician, and within this 
framework the broad distinction between disturbances of production and com­
prehension are considered. Disturbances of reading, the dyslexias; of writing, 
the dysgraphias; and of calculation, the dyscalculias, are often associated but are 
considered separately.
Many of the clinical language syndromes can be identified by simple bed­
side testing, although detailed neuropsychological assessment is required both 
for quantitation and careful dissection of the individual components of language 
failure. Examination should include careful observation of the patient's sponta­
neous speech, which can be assisted by the use of picture description. The flu­
ency should be noted and the occurrence of paraphasias documented. These may 
be phonemic paraphasias, in which one or two of the syllables of the word are 
mistaken or substituted, for example 'stable' for 'table', a pattern more commonly 
found with anterior lesions. By contrast, semantic paraphasias, the substitution 
of semantically similar words, for example 'chair' for 'table', are found more 
commonly with posterior lesions. Comprehension can be tested at the single­
word and at the sentence level, and a variety of neuropsychological tests are 
available for this, such as the Peabody test. For bedside testing, word compre­
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hension can be assessed by giving the patient verbal instructions, but care has to 
be exercised both in patients in whom intellect may be impaired and in patients 
with dyspraxia, if the task is motor dependent. Individual word comprehension 
can be tested by verbal definition and confrontational naming, which can also 
assess word retrieval. Repetition can provide evidence of dissociations between 
errors in spontaneous speech and repetition, and serves to distinguish the clinical 
syndromes of conduction aphasias and the transcortical aphasias. Finally, both 
reading and writing should be assessed.
Aphasias are most commonly encountered in the setting of strokes and 
neoplasms, i.e. focal lesions, and patients will often have associated neurological 
signs such as hemiparesis or visual field defects. More difficult to assess are pa­
tients with aphasia as part of a more generalized cognitive impairment, such as 
occurs with degenerative dementias. In addition, patients with psychosis or with 
acute confusional states can create problems, although the language process it­
self is preserved if carefully observed. Thus paraphasic errors are rare in the 
psychoses, although the rare schizophrenic 'word salad' can create diagnostic 
difficulty. However, other evidence of disturbed behaviour is apparent, whereas 
the patient with jargon aphasia as part of a Wernicke's dysphasia is seen to be­
have normally in the realm of non-language behaviour. The mute patient pre­
sents a particular diagnostic challenge. Patients may be mute because of a severe 
dysphasia, but more commonly are anarthric, in which case writing will be pre­
served. Alternatively, mutism may be associated with disturbances in attention, 
such as occurs with frontal and subfrontal disease and may be seen in akinetic 
mutism.
Clearly, any assessment of a patient requires knowledge of handedness. 
The vast majority of people have language represented in the left hemisphere. 
Very rarely (less than 1 per cent) of right-handed individuals may develop apha­
sia with right hemisphere lesions (crossed aphasia in dextrals). In approximately 
half of patients who are left-handed language also resides in the left hemisphere.
Non-ftuent and Broca's aphasia'
In 1861 Broca described the case of Monsieur Leborgne, who had sus­
tained a stroke with damage to the left inferior frontal gyrus and underlying 
white matter. The patient was initially mute and was then left with a severe non­
fluent aphasia. Broca's original terminology for this, aphemia, has subsequently 
been confined to patients with impairment of speech but preservation of writing, 
usually with lesions of the dominant inferior motor cortex. The term aphasia, in­
troduced by Trousseau, supplanted the term aphemia. The striking feature of 
Broca's aphasia is that the speech is non-fluent, being both slow and reduced in 
output, and patients are often mute initially. The content of the speech may be 
impaired, with frequent phonemic errors, and is usually agrammatic, with the 
omission of prepositions, adjectives, and adverbs. Repetition and confrontation 
naming (see below) are normally impaired, although the patients are often
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helped by cueing. Writing is faulty, both in morphology and in terms of spelling 
and grammar.
One of the clinically distinguishing features of Broca's aphasia is that the 
impairment is largely confined to language expression, with relative preserva­
tion of comprehension. Indeed, auditory comprehension of individual words is 
very well preserved, although performance on tests used to explore sentence 
comprehension is usually impaired; similar subtle impairment of comprehension 
can be found in reading.
The traditional Broca's area, established in the original cases, is the poste­
rior part of the inferior frontal gyrus. An associated ideomotor apraxia of the 
non-dominant hand may be found, depending upon the extent of subcortical 
damage. Some patients will show quite striking dysarthria and associated oro­
facial dyspraxia.
Two distinct clinical patterns of Broca's aphasia have been described, de­
pending on the size of the lesion. Lesions confined to Broca's area and subcorti­
cal white matter are usually due to embolic strokes in the anterior branches of 
the left middle cerebral artery, and are associated with rapid recovery of expres­
sive speech. Patients with occlusions of the middle cerebral artery, sparing the 
territory of the inferior division which supplies the temporal lobe, or patients 
with occlusion of the internal carotid, have a more widespread lesion, which 
renders them globally aphasic initially, and often unable to comprehend, to­
gether with a dense hemiparesis. However, over the subsequent months of re­
covery, comprehension improves and a residual Broca's aphasia is left.
The majority of patients with Broca's aphasia have suffered strokes, but 
the syndrome may also be found with tumours, although in a less pure form. 
Some cases of selective left hemisphere degeneration may also present with a 
non-fluent speech, as in primary progressive aphasia, and some patients with 
degeneration of the frontal lobe, such as occurs in Pick's disease, may develop a 
striking orofacial dyspraxia with speech impairment.
Lichtheim had originally proposed a model of cortical concept centres for 
words, which were connected with the motor centre or word sound centre by 
transcortical pathways. Theoretical syndromes based on this model and involv­
ing disconnections between the centres were postulated for conduction (see be­
low), transcortical motor and transcortical sensory aphasias. In transcortical mo­
tor aphasia, patients make frequent errors of speech production with a very low 
output and frequent phonemic paraphasias. However, repetition is intact.
Transcortical motor aphasia is seen most commonly with anterior cerebral 
artery lesions, with an associated ideomotor apraxia of the left hand and a right 
hemiparesis affecting the leg more than the arm.
By contrast with transcortical motor aphasia, patients with conduction 
aphasia have a profound impairment of repetition with frequent phonemic 
paraphasias. This was explained as a disconnection between intact comprehen­
sion and intact motor centres which would allow for relatively normal spontane­
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ous speech. Anatomically, this was attributed to lesions of the arcuate fasciculus 
which, indeed, are often associated with conduction aphasias.
Speech production requires the correct selection and ordering of pho­
nemes, impairment of which gives rise to the characteristic phonemic errors seen 
with a conduction aphasia. A pattern of deficit has also been recognized due to 
impairment of the motor coordination required for phoneme production, so- 
called kinetic speech production impairment. This is often associated with le­
sions in the inferior precentral gyrus. These disturbances of phoneme selection 
and expression can be distinguished from dysarthrias, in which there are charac­
teristic impairments in swallowing and generation of meaningless sounds, which 
require the same motor apparatus.
Nominal dysphasia
Intact speech is dependent upon appropriate word retrieval. Patients with 
impaired word retrieval may be relatively fluent but their speech appears empty 
with frequent circumlocutions. Clinically this can be tested by confrontational 
naming, when abnormalities may be apparent, particularly for low-frequency 
words, that are less obvious in spontaneous speech. Wordfmding difficulties are 
found quite frequently in neurological practice, but can occur as a relatively iso­
lated finding in patients with left temporal lobe lesions. The study of word re­
trieval has proved to be a fertile area for theoretical modelling and a number of 
important clinical observations have been made. First, naming may be modality 
specific; for example, patients may be unable to name when presented with the 
object visually but are able to do so when presented to touch, so called optic 
aphasia. In addition, patients have been described in whom a tactile naming im­
pairment is confined to the left hand, and such cases are most easily interpreted 
as disconnection syndromes involving lesions of the corpus callosum. Another 
distinction has been drawn between patients whose failure at naming is consis­
tent, and patients in whom the failure varies between different testing sessions 
and appears to be sensitive to the precise timing of confrontation. Different 
names are failed on different occasions and an object may be correctly named, 
but not if immediately shown again. The latter has been interpreted as an im­
pairment of access to the word store, so called semantic access dysphasia. This 
syndrome of impaired access can be contrasted with patients in whom confron­
tational naming is impaired because they have lost their verbal semantic mem­
ory; in these instances the same words tend not to be named and patients can 
quite often verbalize their loss of comprehension.
One of the striking clinical features of word-finding difficulty is the phe­
nomenon of category specificity, namely that certain categories of words are 
more impaired than others. In some instances, the specificity is so striking as to 
have been recognized as a distinct syndrome, for example, colour anomia in pa­
tients who are unable to name but can adequately match colours; letter naming 
or letter anomia, and body part naming, or autotopagnosia. Many additional dis­
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sociations have been demonstrated, for example, between action naming and ob­
ject naming, living and inanimate objects, etc. These category-specific dyspha­
sias provide important theoretical insights into language organization and have 
been proposed to depend upon the association of the word with various attrib­
utes at the time meaning is acquired. Thus, for example, words which are asso­
ciated with a strong visual component, of which colour would be the most strik­
ing, can be contrasted with those, such as tools and manipulable objects, which 
would depend on a major proprioceptive input when the word acquires its mean­
ing. Such an account would accord well with current concepts of parallel dis­
tributed processing across neural networks.
Wernicke's aphasia
Shortly after Broca's description, Karl Wernicke outlined the features of a 
fluent aphasia which, in many respects, provided the clinical counterpart of a 
Broca's aphasia. The striking feature is that such patients speak fluently but the 
speech is often empty of meaning with frequent semantic paraphasias. At times 
the paraphasias may be profound with frequent neologisms, so called jargon 
aphasia. Comprehension is invariably impaired, as is reading. Writing reflects 
the language impairment, with frequent semantic paraphasias and spelling er­
rors. Repetition, as with Broca's aphasia, is impaired. Wernicke's aphasia is 
commonly due to a vascular lesion and the acute onset of a jargon aphasia is 
usually due to an embolus to the inferior division of the middle cerebral artery. 
The area involved is the posterior superior temporal gyrus, often extending into 
the inferior parietal area. By contrast to Broca's aphasia, Wernicke's aphasia is 
often unaccompanied by neurological deficit on examination, which to the un­
wary can lead to faulty diagnosis of a psychotic disturbance. A right superior 
quadrantanopia may be found if carefully sought.
Intact comprehension requires intact speech perception, and patients may 
be seen with so-called pure word deafness. A number of these patients, with bi­
lateral temporal lobe lesions, have been shown to have impairment of auditory 
temporal acuity. However, some patients have impairment of phoneme dis­
crimination which can be associated with left temporal lobe lesions.
As the counterpart to transcortical motor aphasia, Lichtheim proposed the 
syndrome of transcortical sensory aphasia, in which patients are able to repeat, 
and whose speech is fluent, but is associated with impaired comprehension and 
paraphasias. The model postulated that the word recognition centre was intact, 
as shown by an intact repetition, but dissociation from a central meaning system 
resulted in impaired comprehension. This syndrome is now interpreted as an im­
pairment of verbal semantic memory. It can be seen with posterior border zone 
infarcts but more commonly in frontotemporal degeneration, where it is the ma­
jor feature of the clinical syndrome of semantic dementia. Rarely, patients may 
be seen with isolation of the speech area who are neither able to speak nor to 
understand, but are able to repeat.
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Dysprosody
Patients with Broca’s aphasia often have impairment of the normal rhythm 
of speech, so-called dysprosody. Sometimes this may be so pronounced as to be 
referred to as the 'foreign accent syndrome'. Impairment of the emotional ex­
pression and comprehension of speech is often found with right hemisphere le­
sions, and attempts have been made to seek comparable dysphasia syndromes to 
those found with left hemisphere lesions.
Subcortical aphasias
Dysphasias are classically associated with cortical lesions, but subcortical 
damage is increasingly being recognized as a cause of dysphasia. To some ex­
tent these mimic the classical dysphasia syndromes, depending upon their loca­
tion, for example, anterior lesions resulting in a non-fluent aphasia. In many in­
stances reduced metabolism can be demonstrated on PET scanning in the appro­
priate cortical area, and is presumed to reflect impaired projection systems. 
Other syndromes have been described; for example, ischaemic lesions of the 
head of the caudate nucleus and associated internal capsule present with striking 
orofacial dyspraxia, dysarthria, and non-fluent dysphasia. Left thalamic haemor­
rhages frequently give rise to an aphasia, often with fluctuations in arousal with 
concomitant fluctuation in language function.
Disorders of speech production and dysarthria
Dysarthria as a disorder of articulation does not involve any disturbance in 
the proper construction and use of words. In the dysarthric patient, symbolic 
verbal formulation is normal: only the mechanism of verbal sound production is 
faulty. When so severely affected that the patient is totally unable to articulate, it 
is referred to as anarthria. Dysphonia is applied to local disturbance of the larynx 
and may also render the patient mute. As well as structural abnormalities of the 
larynx, impaired innervation of laryngeal muscles can lead to dysphonia. A 'bo­
vine cough' is a simple clinical sign of inability to close the larynx.
The articulatory muscles on each side appear to be innervated by both 
cerebral hemispheres. Hence a unilateral corticospinallesion, for example in the 
internal capsule, may cause temporary but not permanent dysarthria. However, 
an extensive unilateral lesion involving the motor cortex may cause persistent 
dysarthria, especially when the dominant hemisphere is involved; in this case the 
dysarthria is often associated with some degree of Broca's aphasia. However, 
dysarthria is consistently produced by bilateral corticospinal lesions, due, for ex­
ample, to congenital diplegia, vascular lesions of both internal capsules, degen­
eration of both corticospinal tracts (as in motor neuron disease), and lesions such 
as tumours involving both corticospinal tracts together in the midbrain. With 
such lesions, the articulatory muscles are weak and spastic and the tongue ap­
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pears smaller, firmer, and less mobile than normal. The jaw-jerk and the palatal 
and pharyngeal reflexes are exaggerated. Speech is slurred and often explosive, 
production of consonants, especially labials and dentals, being severely affected. 
Spastic dysarthria is usually associated with dysphagia and often with impair­
ment of voluntary control over emotional expression, the syndrome of 'pseu­
dobulbar palsy'.
With lesions of the corpus striatum, articulation is impaired, partly, at 
least, as a result of muscular rigidity. Thus in hepatolenticular degeneration and 
in parkinsonism, articulation is slow and slurred, owing to immobility of the lips 
and tongue, and the pitch of the voice is monotonous. In the dystonias and Hunt­
ington's disease, dysarthria is common; indeed in severe cases speech may be 
unintelligible. In these diseases irregular respiration may also contribute to the 
dysarthria.
The co-ordination of articulation suffers severely when the cerebellar 
vermis is damaged and also when lesions involve the cerebellar connections in 
the brainstem. Speech in such cases is often explosive, with slurring and undue 
separation of individual syllables-scanning or syllabic speech. Ataxic dysarthria 
of this character is seen after acute cerebellar lesions and in multiple sclerosis 
and the hereditary ataxias.
Lower motor neuron lesions cause wasting and weakness, and often fas- 
ciculation, of the muscles of articulation (true bulbar palsy). In the early stages, 
the pronunciation of labials suffers most. Later, progressive weakness of the 
tongue impairs the production of dentals and gutterals, and weakness of the soft 
palate gives the voice a nasal quality. There is often associated dysphonia and 
finally total anarthria. Motor neuron disease is the most common cause, but pa­
resis of the bulbar muscles may also be seen in syringobulbia, bulbar poliomye­
litis, cranial polyneuritis, and brainstem tumours.
Combinations of these varieties of dysarthria are common; for example, in 
multiple sclerosis the articulatory muscles may be both spastic and ataxic, and in 
motor neuron disease a combination of upper and lower motor neuron lesions 
may be present. Diseases of the muscles, such as myasthenia gravis, polymyosi­
tis, and muscular dystrophy involving facial muscles, lead to a dysarthria similar 
to that resulting from lesions of the lower motor neurons. In myasthenia, fatiga­
bility may cause increased slurring if the patient is asked to count aloud. In the 
myotonias, impaired muscular relaxation may add a spastic quality to the 
speech.
Palilalia
Palilalia is a rare disorder of speech which, as its name implies (from the 
Greek palin, again; lalein, to chatter), is characterized by repetition of a phrase 
which the patient reiterates with increasing rapidity. Palilalia most frequently 
occurs in postencephalitic parkinsonism, in general paresis, frontotemporal de­
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generations, and in pseudobulbar palsy due to vascular lesions. In echolalia the 
patient repeats or echoes words or brief phrases spoken by the examiner. It is 
usually seen in frontotemporal degenerations.
Agraphia, alexia, and acalculia
The majority of aphasic syndromes are associated with impairment of 
writing or dysgraphia. This is such a frequent association clinically that sparing 
of writing with impaired speech usually indicates that the speech impairment is 
due to a disruption of speech production rather than a pure dysphasic syndrome. 
Similarly, some patients may demonstrate dysgraphia with intact speech. 
Agraphias have been broadly divided into those that affect the processes of 
spelling and those that affect writing. The latter can be seen as a particular type 
of ideational dyspraxia, although patients are described in whom praxis is oth­
erwise preserved. Disorders of spelling as such have also been subdivided, and 
have allowed the generation of theoretical models similar to the informational 
processing models for reading. Dysgraphias are typically associated with poste­
rior dominant parietal lesions.
Acquired disorders of reading, or dyslexias, are commonly found with 
dysphasias but can present in isolation. These were originally classified by De- 
jerine into two broad groups: those with and those without dysgraphia. In clini­
cal terms this distinction has stood the test of time. Dyslexia with dysgraphia is 
commonly seen with lesions of the left angular gyrus. This type of dyslexia is 
often seen together with agraphia, acalculia, and anomia, and has been described 
as a distinct syndrome by Gerstmann, although this is only an observed cluster­
ing and each of these is not dependent on the others. In the syndrome of alexia 
without agraphia, patients are unable to read but are able to write, even though 
they cannot read their own writing. This is often found with colour anomia, and 
patients usually have a right hemianopia. It is most commonly seen with lesions 
of the left parieto-occipital area, often involving the splenium of the corpus cal­
losum. The classical interpretation of this syndrome has been that of a discon­
nection of visual information in the intact left field from the left angular gyrus. 
However, this does not explain readily a striking feature of these patients, which 
is the ability to read using a letter by letter strategy. Information-processing 
models have now largely replaced the neurological models of reading. Using 
these models, alexia without agraphia can be interpreted as a word-form dys­
lexia, supported by the fact that these patients are more impaired on reading 
script than print. It is argued that following initial word-form recognition, analy­
sis may proceed either by a phonological route or by a sight vocabulary route.
Impairment of arithmetic ability is relatively common and is seen fre­
quently with aphasia. However, it can be recognized as a selective lesion and is 
found most commonly with left parietal lesions. The dyscalculia commonly 
arises as a consequence of dyslexia or dysgraphia and so-called spatial acalculia
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due to visuospatial disorganization when written arithmetic calculations are per­
formed. Amusia, an inability to produce and appreciate music is seen most 
commonly with non-dominant hemisphere lesions, although the reading and 
writing of music notation may be seen with left hemisphere lesions.
DISORDERS OF MEMORY
Memory is the ability to store and subsequently retrieve past experience 
and is central to many cognitive functions, and the maintenance of an autobio­
graphical memory is central to personal identity.
It is clear that memory is not a unitary function and there is a profusion of 
different terms. However, it is usual to draw a distinction between short-term (or 
primary) and long-term (or secondary) memory. Short term, primary, or imme­
diate memory can be tested at the bedside as the digit span. A normal person can 
usually retain a maximum of seven or eight digits, with rapid forgetting over 
some 30 seconds unless rehearsed. Although less commonly tested at the bed­
side, patients may also have a selective impairment of short-term visual mem­
ory. The original simple model that memory involved entry into the short-term 
store before consolidation into a long-term store, secondary memory is no longer 
tenable, as patients with impaired digit span may have normal learning and sec­
ondary memory. Current theories of the role of primary memory range from a 
component of the working memory model of Baddeley (1986), to involvement 
in language fluency, or as a safety backup resource. From the neurologist's point 
of view, reduced digit span is commonly seen with impairment of attention, but 
as an isolated finding can be related to lesions of the inferior dominant parietal 
lobe, where it often occurs with dyscalculia.
Disabling memory impairments arise when individuals lose the ability to 
maintain an autobiographical memory. This can occur in a variety of clinical 
situations, such as dementia and confusional states, but it is the patients with 
otherwise intact cognition who have provided the main basis for study. Such pa­
tients typically have two components to their impairment: an anterograde amne­
sia (i.e. a deficit in acquiring new memories following the illness) and a retro­
grade amnesia (i.e. a loss of recall for events prior to the illness). The patient 
H.M., who had bilateral medial temporal lobe resections extending back some 8 
cm from the temporal poles, has been studied intensively and provided impor­
tant insights into amnesia. These studies demonstrate a profound impairment of 
both verbal and non-verbal learning with intact immediate recall, as evidenced 
by normal digit span (Scoville and Milner 1957; Milner et al. 1968). Subsequent 
similar cases of amnesia have followed this pattern. The status of remote memo­
ries has been less secure. Ribot's law states that there is a direct relationship be­
tween the strength of a memory and its recency, i.e. old memories being better
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preserved, and indeed this is often observed at the bedside. However, there are 
problems of interpretation since it is difficult to match the saliency of the re­
membered events. Despite the profound memory loss in H.M. and other similar 
cases, there is preservation of certain types of learning, for example improved 
performance on the recognition of fragmented letters can be demonstrated and, 
most strikingly, a retained ability to acquire new motor skills, often without rec­
ollection of having done so.
In the case of H.M., impaired learning of both verbal and visual material 
was found, but these can be selectively impaired. Group studies indicate that pa­
tients with left hemisphere damage have impaired verbal memory and the con­
verse for non-verbal or visual memory. Often these material-specific memory 
impairments do not present clinically, but rather are found on specific testing. 
On occasions, however, some do present to the neurologist, the most striking be­
ing a topographical memory impairment in patients who are unable to recall fa­
miliar routes or buildings.
Studies of amnesia had focused previously on failure at various putative 
stages of memory, in terms of input, storage, and retrieval. Impairments of input 
and consolidation suggested that the strength and endurance of a memory de­
pends on the extent of processing and thus consolidation. This interpretation of 
amnesia in terms of impaired storage had argued that consolidation and retrieval 
mechanisms were intact, but that there was an increased rate of forgetting. More 
recently, however, attention has focused on the dissociations between preserved 
and impaired memory functions, observations which cannot easily be accommo­
dated within a simple unitary model of memory with consolidation and retrieval 
models. Cohen and Squire (1982) contrasted procedural learning, i.e. 'knowing 
how', and declarative knowledge, 'knowing that', memory. This describes the 
situation of patients acquiring new motor skills often without explicit knowledge 
of having done so. One patient for example, was able to learn a new piano tune 
without any recollection of having done so, and replay if prompted with the ini­
tial bars. However, the dimension of declarative memory does not easily explain 
the deficits seen in patients such as H.M. in whom memory for words, part of 
declarative knowledge, is well preserved. There is difference between episodic, 
i.e. memory for day-to-day events, and semantic memory. Other approaches 
have looked at the dynamic processes involved rather than observed dichoto­
mies, for example the processes involved in implicit and explicit learning, i.e. 
those which are variably dependent upon the degree of conscious recall.
A large variety of diseases may be associated with amnesia. Most com­
monly, memory impairment is seen with confusional states or dementia, but in 
these instances the amnesia is part of a wider spectrum of cognitive impairment 
(see below). Diseases affecting the medial temporal lobes and other structures 
on the limbic circuit may cause amnesia. Thus midline tumours in the region of 
the third ventricle, such as craniopharyngiomas, colloid cysts, massive pituitary 
tumours, thalamic gliomas, and tumours of the splenium of the corpus callosum,
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believed to be due to involvement of the fornix, can all cause a severe amnesia. 
Inflammatory disorders, such as sarcoidosis and other granulomatous lesions in 
the same areas and limbic encephalitis as a paraneoplastic phenomenon, are also 
associated with amnesia. A profound memory impairment is also commonly 
seen with herpes encephalitis, due to the selective involvement of the medial 
temporal cortex. Vascular events of the posterior cerebral artery, which supplies 
the medial temporal lobe and hippocampus, can cause amnesia. This often oc­
curs with bilateral damage in association with basilar artery syndromes, but can 
occur with unilateral cerebral artery occlusions, particularly in the elderly, which 
may be due to pre-existing contralateral hippocampal damage.
The Korsakoff syndrome is a striking amnesia which usually follows a 
Wernicke's encephalopathy. Patients present with a profound amnesia and are 
quite unable to remember events even within the last half an hour, but may be 
shown to have implicit learning, of motor skills for example. Other tests of cog­
nitive function are well preserved in the pure form of Korsakoff s syndrome, but 
in clinical practice a spectrum may be seen, with the more generalized cognitive 
impairment of alcoholic dementia at one end and patients with a pure Korsakoff 
syndrome at the other. It is, however, the striking contrast between the profound 
amnesia and the relatively minor additional cognitive defects that characterizes 
Korsakoff s syndrome. There is often striking confabulation, when a patient may 
provide imaginary accounts of his actions to create what, at times, can be a plau­
sible autobiographical memory.
Transient loss of memory is also a common clinical problem with both an­
terograde and retrograde amnesia, the latter shrinking on recovery, leaving a gap 
in memory for the period of anterograde memory impairment subsequent to the 
onset. Temporary memory loss may occur with a variety of conditions which re­
sult in either generalized cerebral dysfunction or with selective disturbance of 
the medial temporal lobe and diencephalon. These include epilepsy, most com­
monly temporal lobe epilepsy, and in some patients there may be no obvious 
disturbance of consciousness. Cerebral tumours may cause episodic memory 
loss which may also be on an epileptic basis. Head injury, drugs, especially al­
cohol, and benzodiazepines are common causes. Transient memory impairment 
may also occur as a feature of transient ischaemic episodes in posterior cerebral 
territory. A picture resembling transient global amnesia may also occur with mi­
graine but this is usually with a clinical history of previous migraine attacks and 
the episodes are normally followed by headache. Psychogenic amnesia and hys­
terical fugue states, a not infrequent topic of newspaper stories, are discussed be­
low.
Transient global amnesia
This is a striking syndrome affecting the middle aged and the elderly. The 
history is obtained of sudden onset of impairment of episodic or autobiographi­
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cal memory. The attacks are frequently reported to have been triggered by sex­
ual intercourse or sudden cold, winter bathing in the elderly being a classic his­
tory. The attacks last from 1-24 hours and the patients may repeatedly ask ques­
tions and appear anxious, but otherwise able to drive home, and there have been 
reports of virtuoso musical performances during an attack. Investigations are 
usually normal and a full recovery can be anticipated, although some patients 
are left with mild memory impairment Recurrences are rare but do occur in a 
small proportion. A vascular cause may underlie the syndrome of transient 
global amnesia, although supportive evidence has been difficult to. establish and 
epidemiological studies have suggested a closer link to migraine.
Paramnesias
Confabulation, the production of memories without any basis in real 
events, can accompany amnesia and is most commonly observed in Korsakoffs 
syndrome. However, confabulation can be seen in patients with adequate per­
formance on routine memory testing and is therefore more appropriately consid­
ered as a paramnesia. Two classes of confabulation have been distinguished. 
Momentary or provoked confabulation occurs in response to questions and re­
quests for specific information that the patient might reasonably be expected to 
know. More florid is fantastic confabulation, in which the patient will spontane­
ously produce bizarre accounts, often far in excess of what might be required in 
response to the situation. Confabulation is found most commonly in association 
with frontal-lobe lesions, particularly in medial frontal-lobe lesions.
Reduplicative paramnesia describes a behavioural disturbance in which 
the patient transposes or reduplicates places. For example he might claim that 
his home is not his normal home but a very similar building in which he is stay­
ing, or alternatively that the hospital in which he has been admitted is in his 
home town. Such patients usually have bifrontal or right frontal lesions. A simi­
lar syndrome is the Capgras syndrome in which patients refuse to recognize 
people, often close relatives who are familiar to them, claiming them to be im­
postors. The Capgras syndrome is usually seen in association with right hemi­
sphere lesions.
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DEMENTIA & AMNESTIC SYNDROMES
DEMENTIA
Dementia refers to an acquired, generalized, and often progressive im­
pairment of cognitive function that affects the content, but not the level, of con­
sciousness. Although its incidence increases with advancing age (it has been es­
timated to affect 5-20% of individuals over age 65), dementia is not an invari­
able accompaniment of aging. It reflects instead an underlying pathology that 
affects the cerebral cortex, its subcortical connections, or both.
Minor changes in neurologic function, including alterations in memory 
and other cognitive spheres, are associated with normal aging. Enlargement of 
ventricles and cerebral cortical sulci seen on CT or MRI scans is also common 
with normal aging. These findings should not by themselves be considered in­
dicative of dementia.
Neurologic changes in normal aging
Cognitive
Memory loss (benign senescent forgetfulness) 
Neuro-ophthalmologic
Small, sluggishly reactive pupils 
Impaired upgaze 
Impaired convergence 
Motor
Muscular atrophy (intrinsic hand and foot muscles)
Increased muscle tone 
Flexion (stopped) posture
Gait disorders (small-stepped or broad-based gait)
Sensory
Impaired vision 
Impaired hearing 
Impaired taste 
Impaired olfaction 
Decreased vibration sense 
Reflexes
Primitive reflexes 
Absent abdominal reflexes 
Absent ankle jerks
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The first step in evaluating a patient with a disorder of cognitive function 
is to classify the disorder as either a disturbance of the level of consciousness 
(wakefulness or arousal), such as an acute confusional state or coma, or a distur­
bance of the content of consciousness, in which wakefulness is preserved. The 
latter category includes both global cognitive disorders (dementia) and more cir­
cumscribed deficits, such as aphasia and amnestic syndromes. This distinction is 
important because the initial classification of the disorder determines the subse­
quent diagnostic approach. The most common problem in this area is distin­
guishing dementia from an acute confusional state, such as that produced by 
drug intoxication. Another common problem is differentiating between dementia 
and so-called pseudodementia, such as that produced by depression.
An important goal in clinical evaluation of patients with suspected demen­
tia is to find the cause. Although only about 10% of dementias are reversible, the 
possibility of reversing or arresting the disorder through appropriate treatment 
and dramatically improving the qualify and duration of life justifies a thorough 
diagnostic investigation. A diagnosis is important in other cases for purposes of 
providing a prognosis, genetic counseling, or alerting family members and 
medical personnel to the risk of a transmissible disease. As better treatments are 
developed for dementing disorders that are unresponsive or poorly responsive to 
current therapy, the importance of arriving at an etiological diagnosis of demen­
tia will continue to increase.
Since dementia implies deterioration in cognitive ability, it is important to 
establish that the patient's previous level of functioning has declined. Data that 
can help to establish the cause of dementia include the time course of deteriora­
tion; associated symptoms such as headache, gait disturbance, or incontinence; 
family history of a similar condition; concurrent medical illnesses; and the use 
of alcohol and prescribed or unprescribed drugs.
The general physical examination can contribute to the etiologie diagnosis 
when it reveals signs of a systemic disease responsible for the dementia.
The mental status examination helps to determine whether it is the level or 
the content of consciousness that is impaired and whether the cognitive dysfunc­
tion is global or circumscribed. A disorder of the level of consciousness is sug­
gested by sleepiness, inattention, impairment of immediate recall, or disorienta­
tion as to place or time. Abnormalities in these areas are unusual in dementia un­
til the disorder is far advanced.
To determine the scope of the cognitive dysfunction (global or circum­
scribed), various spheres of cognition are tested in turn. These include memory, 
language, parietal lobe functions (pictorial construction, right-left discrimina­
tion, localization of objects in space), and frontal lobe or diffuse cerebral cortical 
functions (judgment, abstraction, thought content, the ability to perform previ­
ously learned acts). Multiple areas of cognitive function are impaired in de­
mentia. Certain disorders that produce dementia also affect vision, coordination,
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or motor or sensory function. Detecting such associated neurologic abnormali­
ties can help to establish an etiologie diagnosis.
DIFFERENTIAL DIAGNOSIS
Common Causes of Dementia
Although a wide variety of diseases can produce dementia, it is generally 
agreed that Alzheimer's disease is by far the most common cause. Dementia 
with Lewy bodies has been recognized in recent years as a distinct entity, rather 
than simply the concurrence of Alzheimer's disease and Parkinson's disease, and 
may be second in frequency to Alzheimer's disease as a cause of dementia. Vas­
cular dementia, sometimes referred to as multiinfarct dementia, is the next most 
common. Other causes of dementia, including reversible dementias, are com­
paratively rare.
Treatable Causes of Dementia
Treatable causes of dementia -  such as normal pressure hydrocephalus, 
intracranial mass lesions, vitamin BI2 deficiency, hypothyroidism, and neu­
rosyphilis -  are rare. They are important disorders to diagnose promptly, how­
ever, because treatment can arrest or reverse the intellectual decline.
Other Important Causes of Dementia
Recognizing that the dementia is caused by Huntington's disease allows 
patients with this disorder (and their families) to benefit from genetic counsel­
ing. If Creutzfeldt-Jakob disease or AIDS dementia complex is diagnosed, pre­
cautions can be instituted against transmission; the course of AIDS dementia 
complex may also be modified by antiviral treatment. Progressive multifocal en­
cephalopathy may indicate underlying immunosuppression that is due to human 
immunodeficiency virus (HIV) infection, lymphoma, leukemia, or another dis­
order.
Controversial Causes of Dementia
Some disorders to which dementia is often attributed may not directly 
cause the disorder. For example, the existence of a primary alcoholic dementia is 
questionable, since dementia in alcoholic patients may be the result of such re­
lated problems as head trauma or nutritional deficiency.
Pseudodementias
About 15% of patients referred for evaluation of possible dementia in­
stead have other disorders (pseudodementias), such as depression. Drug intoxi­
cation, commonly cited as a cause of dementia in the elderly, actually produces 
an acute confusional state, rather than dementia.
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ALZHEIMER'S DISEASE
General Considerations
Alzheimer's disease, by far the single most frequent cause of dementia, 
becomes increasingly common with advancing age and has an equal incidence 
in both sexes. A slowly progressive disorder of unknown cause that cannot be 
diagnosed with certainty on clinical grounds, it is characterized by typical histo­
pathologic features: neurofibrillary tangles, neuritic plaques, and granulovacuo- 
lar degeneration. Pick's disease, a closely related dementing process in which 
atrophy is most conspicuous in the frontal and temporal lobes, may be clinically 
indistinguishable from Alzheimer's disease. Although a distinction was formerly 
made between presenile Alzheimer's disease and senile dementia of the Alz­
heimer type, these conditions appear to be clinically and pathologicall у identi­
cal.
Pathogenesis
A. Genetic. Alzheimer's disease is usually sporadic, but a genetic basis 
can be identified in some cases. Patients with trisomy 21 (Down's syndrome), 
which is usually due to the presence of three free copies of chromosome 21 but 
can also result from translocation of the third copy to chromosome 14 or 21, 
have a high incidence of Alzheimer's disease beginning in the fourth decade. 
Familial Alzheimer's disease with autosomal dominant inheritance has also been 
documented and is genetically heterogeneous. In some families there are associ­
ated mutations in the gene for amyloid precursor protein on chromosome 21. 
These are missense mutations that result from single amino acid substitutions, 
producing a protein with altered function. In other kindreds, familial Alzheimer's 
disease has an especially early onset and more virulent course and is linked to 
mutations in the gene for presenilin 1, a membrane protein, on chromosome 14. 
Mutations in another transmembrane protein, presenilin 2, have been associated 
with familial Alzheimer's disease in a German kindred. Some cases of familial 
Alzheimer's disease are not caused by these defects, and mutations at other sites 
are presumed responsible. Genetic factors may also modify susceptibility to 
Alzheimer's disease without being directly causal: in late-onset familial (and to a 
lesser extent sporadic) Alzheimer's disease, the risk of being affected and the 
age at onset are related to the number of other apolipoprotein E (APOE4) alleles 
on chromosome 19. How the APOE4 allele (or the absence of APOE alleles) 
confers disease susceptibility is unclear. It has been speculated that apolipopro­
tein E produced by astrocytes may be taken up into neurons and interact abnor­
mally with microtubule-associated proteins, like tau, to produce paired helical 
filaments in neurofibrillary tangles.
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B. Role of p-amyloid. Amyloid р-protein (13amyloid or Ap) is deposited 
in neuritic plaques (as their principal constituent) and in cerebral and meningeal 
blood vessels of patients with Alzheimer’s disease. In addition, some cases of 
familial Alzheimer's disease are associated with mutations affecting the amyloid 
precursor protein. These findings suggest that alterations in the metabolism of 
amyloid precursor protein (APP) to p-amyloid may be involved in the patho­
genesis of Alzheimer's disease. In Down's syndrome, the extra copy of chromo­
some 21, which codes for APP, would be expected to cause increased produc­
tion of APP and its product, p-amyloid. Missense mutations in the APP gene al­
ter the enzymatic cleavage of APP, resulting in increased production of a long, 
42-amino-acid form of p-amyloid that may be especially likely to form amyloid 
fibrils. Missense mutations in the presenilin genes are also associated with ab­
normal processing of APP. Finally, apolipoprotein E may interact with p- 
amyloid. These observations are consistent with, but do not prove, a unifying 
role for p-amyloid in the genetic forms of Alzheimer's disease identified to date. 
P-Amyloid -  especially its aggregated form -  can also be toxic to neurons in vi­
tro under some circumstances. It has therefore been suggested that the abnormal 
accumulation of p-amyloid in Alzheimer's disease is responsible for the death of 
selectively vulnerable neurons. However, others have cited the lack of a clear 
correlation between the extent of amyloid deposition in the brain and the sever­
ity of dementia as evidence against the amyloid hypothesis.
C. Neurochemical. Changes in several neurotransmitter and neuromodu­
lator systems have been found in the brains of patients dying of Alzheimer's dis­
ease; whatever the underlying cause of the disorder, these changes may contrib­
ute to its clinical expression. The acetylcholine-synthesizing enzyme choline 
acetyltransferase is markedly depleted in the cerebral cortex and hippocampus of 
patients with Alzheimer's disease. Degeneration of the nucleus basalis of 
Meynert (the principal origin of cortical cholinergic innervation) and of the cho­
linergic septal-hippocampal tract may underlie this abnormality. Several neuro­
transmitters (acetylcholine, somatostatin, vasopressin, P-endorphin, corticotro­
pin, substance P) are depleted in the brains of patients with Alzheimer's disease, 
perhaps as a result of the selective loss of certain neuronal populations.
D. Toxic. A role has been proposed for aluminum toxicity in the patho­
genesis of Alzheimer's disease. This is based on findings that the concentration 
of aluminum in the brain increases with age, and aluminum is present in the neu­
rofibrillary tangles and neuritic plaques of brains from patients with Alzheimer's 
disease. In addition, aluminum-containing dialysates may be responsible for a 
dementia associated with chronic hemodialysis (see Dialysis Dementia, below). 
It is, however, unlikely that exposure to aluminum in antacids, drinking water, 
or cooking utensils increases the risk of developing Alzheimer's disease.
Endogenous excitotoxins, eg, the amino acid neurotransmitters glutamate 
and aspartate, may contribute to neuronal death in Alzheimer's disease, but this 
hypothesis is unproven.
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E. Infectious. No infectious agent has been identified in Alzheimer's dis­
ease.
Clinical Findings
A. Early Manifestations. Impairment of recent memory is typically the 
first sign of Alzheimer's disease -  often noticed only by family members. As the 
memory disorder progresses, the patient becomes disoriented to time and then to 
place. Aphasia, anomia, and acalculia may develop, forcing the patient to leave 
work or give up the management of family finances. The depression apparent in 
the earlier stages of the disorder may give way to an agitated, restless state. 
Apraxias and visuospatial disorientation ensue, causing the patient to become 
lost easily. Primitive reflexes are commonly found. A frontal lobe gait disorder 
may become apparent, with short, slow, shuffling steps, flexed posture, wide 
base, and difficulty in initiating walking.
B. Late Manifestations. In the late stages, previously preserved social 
graces are lost, and psychiatric symptoms, including psychosis with paranoia, 
hallucinations, or delusions, may be prominent. Seizures occur in some cases. 
Examination at this stage may show extrapyramidal rigidity and bradykinesia. 
Rare and usually late features of the disease include myoclonus, incontinence, 
spasticity, extensor plantar responses, and hemiparesis. Mutism, incontinence, 
and a bedridden state are terminal manifestations, and death typically occurs 
from 5 to 10 years after the onset of symptoms.
Investigative Studies
Laboratory investigations do not assist in the diagnosis -  except to ex­
clude other disorders. The CT scan or MRI often shows cortical atrophy and en­
larged ventricles, but such changes may also be seen in elderly nondemented pa­
tients.
Differential Diagnosis
A. Early Dementia. Alzheimer's disease must be distinguished from de­
pression and from such pure disorders of memory as the Korsakoff amnestic 
syndrome associated with chronic alcoholism.
B. More Advanced Dementia. Multi-infarct dementia and Creutzfeldt- 
Jakob disease must often be considered.
1. Multi-infarct dementia is suggested by a stepwise progression of defi­
cits, pseudobulbar palsy, or focal sensorimotor abnormalities.
2. Creutzfeldt-Jakob disease is characterized by a shorter course than Alz­
heimer's disease (often leading to death within 1 year), prominent myoclonus, 
cerebellar dysfunction, more frequent pyramidal and extrapyramidal signs, vis­
ual disturbances, and a characteristic electroencephalographic pattern of periodic 
complexes.
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Treatment
No currently available treatment has been shown unequivocally to revers 
existing deficits or arrest the disease's progression. Because cholinergic neuronal 
pathways degenerate and choline acetyltransferase is depleted in the brains of 
patients with Alzheimer's disease, cholinergic replacement therapy has been 
used in an effort at symptomatic treatment of cognitive dysfunction. The drugs 
tried have included acetylcholine precursors (choline, lecithin), drugs that stimu­
late acetylcholine release (piracetam, 4aminopyridine), acetylcholinesterase in­
hibitors (tacrine, donepezil), and muscarinic cholinergic receptor agonists (are- 
choline). Of these, tacrine and donepezil have been shown in some studies to 
improve cognitive function. Their effects are modest and their long-term effi­
cacy is unproven, however, and reversible hepatotoxicity is common with tac­
rine. Therefore, liver enzymes (especially alanine aminotransferase) must be 
monitored at frequent intervals. Several other pharmacologic treatments have 
been proposed for cognitive dysfunction in Alzheimer's disease, including cere­
bral vasodilators (papaverine, dihydroergotoxine), central nervous system stimu­
lants (amphetamines, pentylenetetrazol, procainamide), opioid antagonists 
(naloxone), and neuropeptides (vasopressin), but none has proved helpful. An­
tipsychotic drugs, antidepressants, and anxiolytics may be useful for controlling 
behavioral disturbances.
Prognosis
Early in the course of the disease, patients can usually remain at home and 
continue social, recreational, and limited professional activities. Early diagnosis 
can allow patients time to plan orderly retirement from work, to arrange for 
management of their finances, and to discuss with the physician and family 
members the management of future medical problems. Patients in advanced 
stages of the disease may require care in a nursing facility and the use of psy­
choactive medications. These patients must be protected and prevented from in­
juring themselves and their families by injudicious actions or decisions. Death 
from inanition or infection generally occurs 5-10 years after the first symptoms.
PICK'S DISEASE
Pick's disease is one of a group of idiopathic neurodegenerative disorders 
that produces a syndrome sometimes referred to as frontotemporal dementia. 
These disorders may be distinguished from Alzheimer's disease by their gener­
ally earlier onset, more prominent behavioral than cognitive dysfunction at pres­
entation, and preferential atrophy of the frontal and anterior temporal lobes on 
CT scan or MR1 of the brain. However, definitive diagnosis is usually not possi­
ble during life, and relies instead on histopathological features. These include 
the distinctively circumscribed pattern of lobar atrophy, the presence of Pick
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cells and Pick inclusion bodies, and the absence of amyloid plaque and neurofi­
brillary tangles characteristic of Alzheimer's disease. Familial occurrence of 
Pick's disease and of other frontotemporal dementias has been documented. In 
some kindreds with frontotemporal dementia, the gene defect has been mapped 
to chomosome 17 (17q21). There is no treatment.
CREUTZFELDT-JAKOB DISEASE
Creutzfeldt-Jakob disease is an invariably fatal transmissible disorder of 
the central nervous system and is characterized by rapidly progressive dementia 
and variable focal involvement of the cerebral cortex, basal ganglia, cerebellum, 
brain stem, and spinal cord. A proteinaceous infectious particle (prion) has been 
proposed as the etiologie agent, and prion proteins can be demonstrated by im- 
munohistologic methods in the brains of patients with Creutzfeldt-Jakob disease. 
Familial cases have been associated with mutations in a form of the prion pro­
tein (cellular isoform, or PrPc), which is expressed by normal neurons but whose 
function is unknown. In sporadic cases, an abnormal prion protein (scrapie iso­
form, or PrPsc), which differs from PrPc in its secondary (folding) structure, has 
been proposed as the infectious agent. In both circumstances, the result is accu­
mulation of abnormal PrPsc prions in brain tissue. To explain the ability of PrPsc 
prions to replicate in the brain (despite the fact that they contain no detectable 
nucleic acids), it has been suggested that infectious PrPsc prions induce a con­
formational change in normally expressed PrPsc prions that converts them to the 
PrPsc form. Prions have also been implicated in three other rare disorders -  kuru, 
a dementing disease of Fore-speaking tribes of New Guinea (apparently spread 
by cannibalism); Gerstmann-Straussler syndrome, a familial disorder character­
ized by dementia and ataxia; and fatal familial insomnia, which produces distur­
bances of sleep and of autonomic, motor, and endocrine function.
While transmission from humans to animals has been demonstrated ex­
perimentally, documented human-to-human transmission (by corneal transplan­
tation, cortical electrode implantation, or administration of human growth hor­
mone) is rare. The infectious agent is present in the brain, spinal cord, eyes, 
lungs, lymph nodes, kidneys, spleen, liver, and CSF, but not other body fluids. 
Conjugal cases are rare and do not necessarily imply spouse-to-spouse transmis­
sion. The annual incidence of Creutzfeldt-Jakob disease is about 1: 1,000,000 
population. The naturally acquired disease occurs in patients 16-82 years of age, 
with a peak incidence between 60 and 64 years and an equal sex incidence. 
More than one member of a family is affected in 5-10% of cases.
Clinical Findings
The clinical picture may be that of a diffuse central nervous system disor­
der or of a more localized dysfunction. Dementia is present in virtually all cases
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and may begin as a mild global cognitive impairment or a focal cortical disorder 
such as aphasia, apraxia, or agnosia. Progression to akinetic mutism or coma 
typically ensues over a period of months. Psychiatric symptoms including anxi­
ety, euphoria, depression, labile affect, delusions, hallucinations, and changes in 
personality or behavior may be prominent.
Aside from cognitive abnormalities, the most frequent clinical manifesta­
tions are myoclonus (often induced by a startle), extrapyramidal signs (rigidity, 
bradykinesia, tremor, dystonia, chorea, or athetosis), cerebellar signs, and ex­
trapyramidal signs. Visual field defects, cranial nerve palsies, and seizures occur 
less often.
A clinically and pathologically distinct new variant of Creutzfeldt-Jakob 
disease has been described and is thought to result from the transmission of bo­
vine spongiform encephalopathy to humans. This variant is characterized by an 
earlier onset (mean age, about 30 years), a more prolonged course (median dura­
tion over I year), and prominent early psychiatric abnormalities, including de­
pression and personality changes.
Investigative Studies
The EEG may show a typical but nonspecific pattern of periodic sharp 
waves or spikes. CSF protein may be mildly elevated (<100 mg/dL). Definitive 
diagnosis is by immunoblot detection of PrP*1 in brain tissue obtained at biopsy 
or, in familial cases, by detection of mutant forms of PrPc in DNA from lympho­
cytes.
Differential Diagnosis
A variety of other disorders must be distinguished from Creutzfeld-Jakob 
disease. Alzheimer's disease is often a consideration, especially in patients with 
a less fulminant course and a paucity of cerebellar and extrapyramidal signs. 
Where subcortical involvement is prominent, Parkinson's disease, cerebellar de­
generation, or progressive supranuclear palsy may be suspected. Striking focal 
signs raise the possibility of an intracerebral mass lesion. Acute metabolic disor­
ders that produce altered mentation and myoclonus (eg, sedative drug with­
drawal) can mimic Creutzfeldt-Jakob disease.
Prognosis
No treatment is currently available. The disease is usually relentlessly 
progressive and, although transient improvement may occur, invariably fatal. In 
most sporadic cases, death occurs within 1 year after the onset of symptoms: the 
mean duration of illness in these patients is 7 months. Depending on the specific 
mutation present, familial forms of the disease may have similar short or much 
longer courses.
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NORMAL-PRESSURE HYDROCEPHALUS
Normal-pressure hydrocephalus, a potentially reversible cause of demen­
tia, is characterized by the clinical triad of dementia, gait apraxia, and inconti­
nence. It may be idiopathic or secondary to conditions that interfere with cere­
brospinal fluid absorption, such as meningitis or subarachnoid hemorrhage. The 
dementia is often mild and insidious in onset, and is typically preceded by the 
gait disorder and incontinence. It is characterized initially by mental slowness 
and apathy and subsequently by global cognitive dysfunction. Deterioration of 
memory is common, but focal cognitive disorders such as aphasia and agnosia 
are rare.
Pathophysiology
Normal-pressure hydrocephalus is sometimes called communicating (be­
cause the lateral, third, and fourth ventricles remain in communication) or non­
obstructive hydrocephalus (because the flow of CSF between the ventricles is 
not obstructed). It is presumed to be due to impaired CSF absorption from 
arachnoid granulations in the subarachnoid space over the convexity of the 
hemispheres, eg, from meningeal fibrosis and adhesions following meningitis or 
subarachnoid hemorrhage. In contrast, noncommunicating or obstructive hydro­
cephalus is caused by a blockade of CSF circulation within the ventricular sys­
tem (eg, by an intraventricular cyst or tumor) and is associated with increased 
CSF pressure and often with headache and papilledema;
Clinical Findings
Normal-pressure hydrocephalus usually develops over a period of weeks 
to months; a gait disorder is often the initial manifestation. This typically takes 
the form of gait apraxia, characterized by unsteadiness on standing and difficulty 
in initiating walking even though there is no weakness or ataxia. The patient can 
perform the leg movements associated with walking, bicycling, or kicking a ball 
and can trace figures with the feet while lying or sitting but is unable to do so 
when the legs are bearing weight. The patient typically appears to be glued to 
the floor, and walking, once under way, is slow and shuffling.
Pyramidal signs, including spasticity, hyperreflexia, and extensor plantar 
responses, are sometimes present. Motor perseveration (the inappropriate repeti­
tion of motor activity) and grasp reflexes in the hands and feet may occur. Uri­
nary incontinence is a later development, and patients may be unaware of it; fe­
cal incontinence is uncommon.
Investigative Studies
Lumbar puncture reveals normal or low opening pressure. The CT scan or 
MRI typically shows enlarged lateral ventricles without increased prominence of
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cortical sulci. Radionuclide cisternography classically shows isotope accumula­
tion in the ventricles, delayed clearance, and failure of ascent over the cerebral 
convexities. This pattern is not necessarily present in patients who respond to 
shunting, however. Transient improvement in gait, cognitive testing, or sphinc- 
teric function following the removal of 30-50 mL of CSF by lumbar puncture is 
probably the best predictor of a favorable clinical response to shunting (see be­
low).
Differential Diagnosis
A variety of conditions that produce dementia must be considered in the 
differential diagnosis. Alzheimer's disease tends to follow a longer course, often 
with prominent focal cortical dysfunction and enlarged cortical sulci shown in a 
CT scan or MRI. Parkinsonism may be simulated by the gait disorder but can be 
distinguished by extrapyramidal rigidity, tremor, and response to anti parkinson­
ian medications. Multi-infarct dementia should be suspected if the disorder fol­
lows a stepwise course, or pseudobulbar palsy, focal sensorimotor signs, or a 
history of stroke are encountered.
Treatment
Some patients, especially those with hydrocephalus from meningitis or 
subarachnoid hemolThage, recover or improve following ventriculoatrial, ven­
triculoperitoneal, or lumboperitoneal shunting. In idiopathic normal-pressure 
hydrocephalus, about cne-half of patients have sustained improvement and 
about one-third have a good or excellent response (ie return to work) after shunt­
ing. As noted above, a favorable response to the removal of CSF by lumbar 
puncture may be the best predictor of successful surgery. Complications of 
shunting occur in about one-third of patients and include shunt infection, sub­
dural hematoma, and shunt malfunction that necessitates replacement.
DEMENTIA WITH LEWY BODIES
Up to one-fourth of elderly demented patients who come to autopsy have 
round, eosinophilic, intracytoplasmic neuronal inclusions (Lewy bodies) in the 
cerebral cortex and brainstem. Dementia with Lewy bodies is found in patients 
with (Lewy-body variant of Alzheimer's disease) and without (diffuse Lewy- 
body disease) histopathological features of Alzheimer's disease, and is probably 
a heterogeneous disorder. In contrast to Alzheimer's disease, it is characterized 
clinically by cognitive decline without prominent early memory impairment. 
Other distinctive features include fluctuating cognitive ability, well-formed vis­
ual hallucinations, and signs of parkinsonism, especially rigidity and bradykine- 
sia. These patients may respond well to anticholinesterase drugs such as tacrine 
or donepezil, but are especially sensitive to extrapyramidal side effects of antip­
sychotic drugs, which should therefore be avoided or used with caution.
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ALCOHOLISM
Several complications of alcoholism are known to cause dementia. These 
include acquired hepatocerebral degeneration as a result of alcoholic liver dis­
ease, chronic subdural hematoma from head trauma, and certain rare disorders 
resulting from nutritional deficiency.
Pellagra, caused by deficiency of nicotinic acid (niacin), affects neurons 
in the cerebral cortex, basal ganglia, brainstem, cerebellum, and anterior horns 
of the spinal cord. Systemic involvement is manifested by diarrhea, glossitis, 
anemia, and erythematous skin lesions. Neurologic involvement may produce 
dementia; psychosis; confusional states; pyramidal, extrapyramidal, and cerebel­
lar signs; polyneuropathy; and optic neuropathy. Treatment is with nicotin­
amide, but the neurologic deficits may persist despite treatment.
Marchiafava Bignami syndrome is characterized by necrosis of the cor­
pus callosum and subcortical white matter and occurs most often in malnour­
ished alcoholics. The course can be acute, subacute, or chronic. Clinical features 
include dementia, spasticity, dysarthria, gait disorder, and coma. The diagnosis 
can sometimes be made by CT scan or MRI. No specific treatment is available, 
but cessation of drinking and improvement of nutrition are advised. The out­
come is variable: patients may die, survive with dementia, or recover.
The Korsakoff amnestic syndrome is a common and well-recognized 
cause of cognitive dysfunction in malnourished alcoholic patients. Because this 
disorder produces selective impairment of memory rather than global cognitive 
dysfunction, it is discussed in the section on amnestic syndromes (below).
It has been proposed that dementia can occur as a direct result of the toxic 
effects of ethanol on the brain, but this is disputed, and no distinctive corre­
sponding abnormalities have been identified in the brains of demented alcohol­
ics. Therefore, alcoholism should not be considered an adequate explanation for 
dementia, at least until other causes -  especially those that are treatable -  have 
been investigated and excluded.
HYPOTHYROIDISM
Hypothyroidism (myxedema) can also produce a reversible dementia or 
chronic organic psychosis. The dementia is a global disorder characterized by 
mental slowness, memory loss, and irritability. Focal cortical deficits do not oc­
cur. Psychiatric manifestations are typically prominent and include depression, 
paranoia, visual and auditory hallucinations, mania, and suicidal behavior.
Associated neurologic symptoms and signs may be helpful in pointing to 
hypothyroidism as the cause of dementia. The most suggestive finding in this re­
gard is delayed relaxation of the tendon reflexes. Patients with myxedema may
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complain of headache, hearing loss, tinnitus, vertigo, weakness, or paresthesia. 
Examination may show deafness, dysarthria, or cerebellar ataxia.
The diagnosis of myxedema is based upon the laboratory finding of de­
creased blood levels of T4 and T3, usually associated with increased TSH. Cog­
nitive dysfunction is usually reversible with treatment.
VITAMIN B12 DEFICIENCY
Vitamin B12 deficiency is a rare cause of reversible dementia and organic 
psychosis. Like the acute confusional state associated with vitamin B12 defi­
ciency, such syndromes can occur with or without hematologic and other neu­
rologic manifestations.
The dementia consists of global cognitive dysfunction with mental slow­
ness, impaired concentration, and memory disturbance; aphasia and other focal 
cortical disorders do not occur. Psychiatric manifestations are often prominent 
and include depression, mania, and paranoid psychosis with visual and auditory 
hallucinations.
DIALYSIS DEMENTIA
A subacute progressive -  and ultimately fatal -  dementia is an uncommon 
accompaniment of chronic hemodialysis; the mean duration of hemodialysis at 
the onset of the symptom is about 3 years. The neurologic symptoms are promi­
nent dysarthria (often the earliest feature), multifocal myoclonus, and general­
ized or occasionally partial motor seizures. The symptoms are initially intermit­
tent, being maximal following dialysis; they later become permanent, and de­
mentia supervenes. The mean survival time in established cases is 6 months.
The interictal EEG is invariably abnormal, showing paroxysmal high- 
voltage slowing with intermixed spikes and slow waves. The CSF examination 
is normal. Brain CT studies show diffuse atrophy.
The ability of diazepam to reverse the clinical electroencephalographic 
features of dialysis dementia suggests an epileptic component to the disorder. 
Aluminum in the dialysate is a major etiologie suspect, since elevated aluminum 
levels have been found in the brains of patients with dialysis dementia, and re­
moving trace metals from the dialysate has markedly decreased the syndrome’s 
incidence. Reports of the therapeutic effectiveness of renal transplantation have 
been conflicting.
NON-WILSONIAN HEPATOCEREBRAL DEGENERATION
Acquired (non-Wilsonian) hepatocerebral degeneration is an uncommon 
complication of chronic hepatic cirrhosis with spontaneous or surgical portosys­
temic shunting. The mechanisms underlying cerebral symptoms are unclear but
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may be related to failure of the liver to detoxify ammonia. Neurologic symptoms 
precede hepatic symptoms in about one-sixth of patients.
Systemic manifestations of chronic liver disease are usually present. The 
neurologic syndrome is characterized by a fluctuating but generally progressive 
course over 1-9 years, often punctuated by bouts of acute hepatic encephalopa­
thy. Dementia, dysarthria, and a variety of cerebellar, extrapyramidal, and py­
ramidal signs are the most common manifestations. Dementia is marked by 
mental slowness, apathy, impaired attention and concentration, and memory dis­
turbance. The patient appears alert, in contrast to the somnolence or delirium 
seen in acute hepatic encephalopathy.
Cerebellar signs include gait and limb ataxia and dysarthria; nystagmus is 
rare. Extrapyramidal involvement may produce rigidity, resting tremor, dys­
tonia, chorea, or athetosis. Adventitious movements tend to be most marked in 
the head, face, and neck. Asterixis, intention or action myoclonus, hyperreflexia, 
and extensor plantar responses are common findings; paraparesis occurs rarely.
Because episodes of acute hepatic encephalopathy may be superimposed 
on the chronic neurologic disorder, it may be difficult to determine the relative 
contributions of acute and chronic syndromes to the clinical state of the patient. 
The diagnosis of acute hepatic encephalopathy is suggested by somnolence or 
agitated delirium, acute neurologic deterioration, or ongoing gastrointestinal 
bleeding.
Laboratory studies show abnormal hepatic blood chemistries and elevated 
blood ammonia, but the degree of abnormality bears no direct relationship to the 
severity of neurologic symptoms. The CSF is normal, except for increased 
glutamine and an occasional mild elevation of protein.
Several disorders resemble acquired hepatocerebral degeneration, but they 
can be distinguished by clinical or laboratory features. In Wilson's disease, the 
onset is typically earlier, and neurologic involvement often precedes hepatic in­
volvement. Kayser-Fleischer rings and laboratory evidence of abnormal copper 
metabolism are present, but there is no episodic encephalopathy. The ataxia of 
alcoholic cerebellar degeneration primarily affects gait rather than causing limb 
ataxia and dysarthria.
Patients may benefit from a low-protein diet, lactulose, neomycin, liver 
transplantation, or portosystemic shunting. Shunting may also precipitate or 
worsen neurologic symptoms, however. Improvement following levodopa or 
bromocriptine therapy has been described. Death ultimately results from pro­
gressive hepatic failure or variceal bleeding.
TRAUMA
Severe open or closed head injury, particularly when followed by a pro­
longed period of unconsciousness, may cause posttraumatic syndromes with im­
paired memory and concentration, personality changes, headache, focal neu­
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rologic disorders, or seizures. Cognitive impairment is nonprogressive, and the 
cause is usually obvious.
A syndrome of delayed and progressive posttraumatic dementia following 
repeated head injury (dementia pugilistica) has been described in boxers. It may 
begin-and typically continues to progressyears after the episodes of trauma have 
ceased. Dementia is characterized by cheerful or labile affect, mental slowness, 
memory deficit, and irritability. Associated neurologic abnormalities include 
tremor, rigidity, bradykinesia, dysarthria, cerebellar ataxia, pyramidal signs, and 
seizures. Neuroradiologic investigations may show cortical atrophy and cavum 
septi pellucidi.
VASCULAR DEMENTIA
Vascular dementia is the second or third most common cause of dementia, 
after Alzheimer's disease, and perhaps dementia with Lewy bodies. Most pa­
tients with this diagnosis have either multiple large cortical infarcts from occlu­
sion of major cerebral arteries or several smaller infarcts (lacunar state) affecting 
subcortical white matter, basal ganglia, or thalamus. However, the relationship 
between cerebral vascular disease and dementia has been defined only vaguely. 
Thus, the precise number of strokes, their locations, and the total infarct volume 
required for strokes to produce dementia are uncertain, making it difficult some­
times to know whether strokes are the cause of dementia or are unrelated. 
Whether dementia can result from cerebrovascular disease without frank infarc­
tion, as is commonly presumed to exist when periventricular white matter le­
sions are detected by neuroimaging, is also controversial. Thus, the absence of 
neuroradiologic signs of cerebrovascular disease argues strongly against a vas­
cular basis for dementia, but the presence of vascular lesions does not prove that 
they are causal. This is especially true when another cause of dementia, such as 
Alzheimer's disease, coexists with cerebrovascular disease.
As classically described, patients with multi-infarct dementia have a his­
tory of hypertension, a stepwise progression of deficits, a more or less abrupt 
onset of dementia, and focal neurologic symptoms or signs.
Because extensive pathologic changes may already exist at presentation, it 
is assumed that patients can remain functionally well compensated until a new 
and perhaps otherwise innocuous infarct tips the balance.
The neurologic examination commonly shows pseudobulbar palsy with 
dysarthria, dysphagia, and pathologic emotionality (pseudobulbar affect), focal 
motor and sensory deficits, ataxia, gait apraxia, hyperreflexia, and extensor plan­
tar responses.
The MRI may show multiple small subcortical lucencies. Extensive areas 
of low density in subcortical white matter are seen in Binswanger's disease (sub­
cortical arteriosclerotic encephalopathy), which may be a related condition. MRI 
is more sensitive than CT for detecting these abnormalities. Additional labora-
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tory studies should be performed to exclude cardiac emboli, polycythemia, 
thrombocytosis, cerebral vasculitis, and meningovascular syphilis as causes of 
multiple infarctions, particularly in younger patients or those without a history 
of hypertension.
Hypertension, when present, should be treated to reduce the incidence of 
subsequent infarction and to prevent other end-organ diseases.
PSEUDODEMENTIA
Depression is the disorder most commonly mistaken for dementia. Be­
cause depression is common and usually treatable, distinguishing between the 
two conditions is of obvious clinical importance.
Both dementia and the pseudodementia of depression can be characterized 
by mental slowness, apathy, self-neglect, withdrawal, irritability, difficulty with 
memory and concentration, and changes in behavior and personality. In addi­
tion, depression can be a feature of most dementing illnesses, and the two disor­
ders frequently coexist. If depression is identified as a significant problem and is 
not correctable by treatment of an underlying disease or by a change in medica­
tion, it should be treated directly. Modes of treatment include psychotherapy, 
tricyclic and related antidepressants, selective serotonin reuptake inhibitors, 
monoamine oxidase inhibitors, and electroconvulsive therapy.
AMNESTIC SYNDROMES
A disorder of memory (amnestic syndrome) may occur as one feature of 
an acute confusional state or dementia or as an isolated abnormality. Memory is 
a complex function that can be viewed as comprising phases of registration, 
storage, and retrieval. Autopsy and MR1 studies of the brains of patients with 
memory disorders suggest that the hippocampus and related structures, such as 
the dorsomedial nucleus of the thalamus, are important in memory processing. 
Bilateral damage to these regions results in impairment of short-term memory, 
which is manifested clinically by the inability to form new memories. Long-term 
memory, which involves retrieval of previously learned information, is rela­
tively preserved, perhaps because well established memories are stored diffusely 
in the cerebral cortex. Some patients with amnestic syndromes may attempt to 
fill in gaps in memory with false recollections (confabulation), which can take 
the form of elaborate contrivances or of genuine memories misplaced in time. 
The longest-standing and most deeply ingrained memories, however, such as 
one's own name, are almost always spared in organic memory disturbances. In 
contrast, such personal memories may be prominently or exclusively impaired in 
dissociative (psychogenic) amnesia.
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The cellular basis of memory is poorly understood, but repetitive neuronal 
firing produces lasting pre- and postsynaptic changes that facilitate neuro­
transmission at hippocampal synapses (long-term potentiation). These changes 
appear to involve the release of glutamate, which stimulates the entry of calcium 
into postsynaptic neurons and the production of a retrograde chemical messen­
ger (perhaps nitric oxide) that acts on presynaptic nerve terminals to increase 
transmitter release upon subsequent firing.
Causes of amnestic syndromes
Acute
Accompanying acute confusional states 
Head trauma 
Hypoxia or ischemia
Bilateral posterior cerebral artery occlusion 
Transient global amnesia 
Alcoholic blackouts 
Wernicke's encephalopathy 
Dissociative (psychogenic) amnesia 
Chronic
Accompanying dementias 
Alcoholic Korsakoff amnestic syndrome 
Postencephalitic amnesia 
Brain tumor
Paraneoplastic limbic encephalitits
HEAD TRAUMA
Head injuries resulting in loss of consciousness are invariably associated 
with an amnestic syndrome. Patients seen shortly after such an injury exhibit a 
confusional state in which they are unable to incorporate new memories (antero­
grade, or posttraumatic amnesia, although they may behave in an apparently 
normal automatic fashion. In addition, retrograde amnesia is present, covering a 
variable period prior to the trauma. Features characteristic of transient global 
amnesia (see below) may be seen.
As full consciousness returns, the ability to form new memories is re­
stored. Events occurring in the confusional interval tend to be permanently lost 
to memory, however. Exceptions are islands of memory, for a lucid interval be­
tween trauma and unconsciousness, or for periods of lesser impairment in the 
course of a fluctuating posttraumatic confusional state. The period of retrograde 
amnesia begins to shrink, with the most remote memories the first to return. The
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severity of the injury tends to correlate with the duration of confusion and with 
the extent of permanent retrograde and posttraumatic amnesia.
HYPOXIA OR ISCHEMIA
Because of the selective vulnerability of pyramidal neurons in the Som­
mer sector (hi sector of Scholz) of the hippocampus, conditions resulting in 
cerebral hypoxia or ischemia, such as cardiac arrest or carbon monoxide poison­
ing, can produce amnestic syndromes. Amnesia tends to occur in patients in 
whom coma has lasted at least 12 hours. There is severe impairment of the abil­
ity to incorporate new memories, with relative preservation of registration and 
remote memory; patients typically appear to have an isolated disorder of short­
term memory. A period of retrograde amnesia preceding the insult may occur. 
Patients exhibit a lack of concern about their impairment and sometimes con­
fabulate. Amnesia following cardiac arrest may be the sole manifestation of neu­
rologic dysfunction, or it may coexist with other cerebral watershed syndromes, 
such as bibrachial paresis, cortical blindness, or visual agnosia. Recovery often 
occurs within several days, although deficits may persist.
Amnestic syndromes from carbon monoxide poisoning are frequently as­
sociated with affective disturbances. Other associated abnormalities include fo­
cal cortical and extrapyramidal dysfunction. Acute carbon monoxide poisoning 
is suggested by cherryred coloration of the skin and mucous membranes, ele­
vated carboxyhemoglobin levels, or cardiac arrhythmia. The CT brain scan may 
show lucencies in the basal ganglia and dentate nuclei.
BILATERAL POSTERIOR CEREBRAL ARTERY OCCLUSION
The posterior cerebral artery supplies the medial temporal lobe, thalamus, 
posterior internal capsule, and occipital cortex. Ischemia or infarction in this ter­
ritory, typically when bilateral, may produce a transient or permanent amnestic 
syndrome. Emboli in the vertebrobasilar system are frequent causes of such dis­
orders.
The amnestic syndrome is usually associated with unilateral or bilateral 
hemianopia and sometimes with visual agnosia, alexia without agraphia, ano- 
mia, sensory disturbances, or signs of upper midbrain dysfunction (especially 
impaired pupillary light reflex). Recent memory tends to be selectively im­
paired, with relative preservation of remote memory and registration.
The CT scan shows lucencies -  which may or may not be enhanced by 
use of contrast material -  in any combination of the above-mentioned regions.
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TRANSIENT GLOBAL AMNESIA
Transient global amnesia is a syndrome of acute memory loss that tends to 
occur in middle-aged or elderly patients with risk factors for atherosclerotic dis­
ease, especially a prior ischemic event in the posterior cerebral circulation. The 
disorder is recurrent in fewer than 10% of patients.
A primary disorder of short-term memory that can last for minutes or 
days, it typically lasts for hours. Patients appear agitated and perplexed and may 
repeatedly inquire about their whereabouts, the time, and the nature of what they 
are experiencing. Knowledge of personal identity is preserved, as are remote 
memories and registration. New memories cannot be formed, however, which 
accounts for the patient's repetitive questions. Retrograde amnesia for a variable 
period preceding the episode may be present, but this period shrinks as the epi­
sode resolves.
The patient's obvious concern about the condition distinguishes transient 
global amnesia from most other organically based amnestic syndromes and may 
give rise to the suspicion that amnesia is psychogenic. A CT scan or MR1 may 
demonstrate focal thalamic or temporal lobe abnormalities. Recently, diffusion- 
weighted MR1 has shown signal abnormalities in the temporal lobe during spells 
of transient global amnesia. These are compatible with cellular edema and may 
be related to spreading depression a wave of cellular depolarization accompa­
nied by cellular swelling in the brain.
ALCOHOLIC BLACKOUTS
Short-term consumption of large amounts of ethanol by alcoholic or non­
alcoholic individuals may lead to "blackouts"-transient amnestic episodes that 
are not due to global confusion, seizures, head trauma, or the Wemicke- 
Korsakoff syndrome. These spells are characterized by an inability to form new 
memories, without impairment of longterm memory or immediate recall. Al­
though the cause is unknown, alcoholic blackouts may result from ethanol- 
induced depression of synaptic (especially serotonin- or glutamate-mediated) 
neurotransmission. The disorder is self-limited and no specific treatment is re­
quired, but reduction of the ethanol intake should be counseled, and thiamine 
should be given to treat possible Wernicke's encephalopathy.
WERNICKE'S ENCEPHALOPATHY
Wernicke's encephalopathy is caused by thiamine deficiency and classi­
cally produces an acute confusional state, ataxia, and ophthalmoplegia. Amnesia
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may be the major or sole cognitive disturbance, however, especially after thia­
mine treatment is begun and other cognitive abnormalities improve.
DISSOCIATIVE (PSYCHOGENIC) AMNESIA
Amnesia may be a manifestation of a dissociative disorder or of malinger­
ing. In such patients a prior psychiatric history, additional psychiatric symptoms, 
or a precipitating emotional stress can often be identified.
Dissociative amnesia is characterized by an isolated or a disproportionate 
loss of traumatic or stressful personal memories. Dissociative amnesia is usually 
localized in time to the immediate aftermath of a traumatic experience or selec­
tive for some but not other events during such a period. Less frequent patterns 
include systematized amnesia restricted to certain categories of information, 
continuous amnesia for events from some time in the past up to and including 
the present, and generalized amnesia. In some cases, the patient may be unable 
to remember even his own name -  an exceedingly rare finding in organic amne­
sia. Despite such disorientation to person, orientation to place and time may be 
preserved. In addition, recent memories may be less affected than remote memo- 
ries-the reverse of the pattern customarily seen in amnesia caused by organic 
disease. Examination under hypnosis or after administration of barbiturates may 
be helpful in establishing that amnesia is of psychogenic origin.
ALCOHOLIC KORSAKOFF AMNESTIC SYNDROME
The Korsakoff amnestic syndrome, which occurs in chronic alcoholism 
and other malnourished states, is thought to be caused by thiamine deficiency. It 
is usually preceded by one or more episodes of Wernicke's encephalopathy, but 
such a history may be lacking. The memory disorder may be related to bilateral 
degeneration of the dorsomedial thalamic nuclei.
An amnestic syndrome of variable severity follows recovery from Wer­
nicke's encephalopathy in about three-fourths of cases and is often associated 
with polyneuropathy and other residua such as nystagmus or gait ataxia. The es­
sential defect is an inability to form new memories, resulting in significant im­
pairment of short-term memory. Long-term memory is also frequently affected, 
although to a lesser extent. Registration is intact. Patients are typically apathetic 
and lack insight into their disorder. They may attempt to reassure the physician 
that no impairment exists and try to explain away their obvious inability to re­
member. Confabulation is often, but not invariably, a feature.
Korsakoff s syndrome can be prevented or its severity decreased by 
prompt administration of thiamine to patients with Wernicke's encephalopathy. 
Patients with established Korsakoff s syndrome should also receive thiamine to
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prevent the progression of deficits, although existing deficits are unlikely to be 
reversed.
POSTENCEPHALITIC AMNESIA
Patients who recover from acute viral encephalitis -  particularly that 
caused by herpes simplex virus -  may be left with a permanent and static amnes­
tic syndrome. The syndrome is similar to that produced by chronic alcoholism in 
that an inability to form new memories is its outstanding feature. Remote memo­
ries are affected to a lesser extent than are recent ones, and registration is intact. 
Confabulation may occur. Often there is total amnesia for the period of the acute 
encephalitis. Patients may also exhibit other symptoms of limbic system disease. 
These include docility, indifference, flatness of mood and affect, inappropriate 
jocularity and sexual allusions, hyperphagia, impotence, repetitive stereotyped 
motor activity, and the absence of goal-oriented activity. Complex partial sei­
zures, with or without secondary generalization, may occur.
BRAIN TUMOR
Brain tumor is a rare cause of amnestic syndrome. Tumors that can pre­
sent in this manner include those that are located in the third ventricle or that 
compress its floor or walls from without. The amnestic syndrome closely resem­
bles that of Korsakoffs syndrome. In addition, patients with deep midline tumors 
often exhibit marked lethargy, headache, endocrine disturbances, visual field 
deficits, or papilledema. The diagnosis of brain tumor is made by CT scan or 
MR1. Treatment consists of surgery or irradiation or both, depending upon the 
type of tumor and its location.
PARANEOPLASTIC LIMBIC ENCEPHALITIS
An inflammatory and degenerative disorder of gray matter regions of the 
central nervous system can occur as a remote effect of systemic cancer. When 
limbic structures are primarily affected, the clinical picture is that of an amnestic 
syndrome. The cause is not known, but as in other paraneoplastic neurologic 
syndromes, anti neuronal autoantibodies may be involved. Paraneoplastic limbic 
encephalitis is most often associated with small cell cancer of the lung, and 
symptoms typically precede diagnosis of the underlying cancer. Histopathologic 
findings include neuronal loss, reactive gliosis, microglial proliferation, and 
perivascular lymphocytic cuffing. Gray matter of the hippocampus, cingulum, 
piriform cortex, inferior frontal lobes, insula, and amygdala is characteristically
1 6 6
affected. Symptoms develop over several weeks. The disorder is characterized 
by profound impairment of recent memory, corresponding to the inability to 
learn new material. Remote memory is less impaired, and registration is unaf­
fected; confabulation occurs in some cases. Affective symptoms, either anxiety 
or depression, are common early features. Hallucinations and complex partial or 
generalized seizures may occur. In many instances, the amnestic syndrome pro­
gresses to a global dementia.
Depending upon the extent to which gray matter regions outside the lim­
bic system are involved, cerebellar, pyramidal, bulbar, and peripheral nerve dis­
turbances may coexist with the amnestic disorder.
The CSF may show a modest mononuclear pleocytosis and mildly ele­
vated protein. Diffuse slowing or bitemporal slow waves and spikes are some­
times seen on EEG. An MRI may reveal abnormal signal intensity in the medial 
temporal lobes.
The paraneoplastic amnestic syndrome can be static, it can progress, or it 
can remit. Because no specific treatment is available, excluding treatable disor­
ders is of primary importance. Korsakoff s syndrome caused by thiamine defi­
ciency should especially be considered, because patients with cancer are suscep­
tible to nutritional deficiency and thiamine administration may prevent these 
symptoms from worsening.
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СОМА
Coma is a sleeplike state in which the patient makes no purposeful re­
sponse to the environment and from which he or she cannot be aroused. The 
eyes are typically closed and do not open spontaneously. The patient does not 
speak, and there is no purposeful movement of the face or limbs. Verbal stimu­
lation produces no response. Mechanical (eg, painful) stimulation may also pro­
duce no response or may elicit nonpurposeful reflex movements mediated 
through spinal cord or brainstem pathways. Coma results from a disturbance in 
the function of either the brainstem reticular activating system above the mid­
pons or both cerebral hemispheres, since these are the brain regions that main­
tain consciousness.
The approach to diagnosis of the comatose patient consists first of emer­
gency measures to stabilize the patient and treat presumptively certain life- 
threatening disorders, followed by efforts to establish an etiologie diagnosis.
EMERGENCY MANAGEMENT
1. Ensure patency of the airway and adequacy of ventilation and cir­
culation. This is accomplished by rapid visual inspection and by measuring the 
vital signs. If the airway is obstructed, the obstruction should be cleared and the 
patient intubated. If there is evidence of trauma that may have affected the cervi­
cal spine, however, the neck should not be moved until this possibility has been 
excluded by x-rays of the cervical spine. In this case, if intubation is required, it 
should be performed by tracheostomy. Adequacy of ventilation can be estab­
lished by the absence of cyanosis, a respiratory rate 8/min, the presence of 
breath sounds on auscultation of the chest, and the results of arterial blood gas 
and pH studies (see below). If any of these suggest inadequate ventilation, the 
patient should be ventilated mechanically. Measurement of the pulse and blood 
pressure provides a rapid assessment of the status of the circulation. Circulatory 
embarrassment should be treated with intravenous fluid replacement, pressors, 
and antiarrhythmic drugs, as indicated.
2. Insert an intravenous catheter and withdraw blood for laboratory 
studies. These studies should include measurement of serum glucose and elec­
trolytes, hepatic and renal function tests, prothrombin time, partial throm­
boplastin time, and a complete blood count. Extra tubes of blood should also be 
obtained for additional studies that may be useful in certain cases, such as drug 
screens, and for tests that become necessary as diagnostic evaluation proceeds.
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3. Begin an intravenous infusion and administer dextrose, thiamine, 
and naloxone. Every comatose patient should be given 25 g of dextrose in­
travenously, typically as 50 mL of a 50% dextrose solution, to treat possible hy­
poglycemic coma. Since administration of dextrose alone may precipitate or 
worsen Wernicke's encephalopathy in thiamine-deficient patients, all comatose 
patients should also receive 100 mg of thiamine by the intravenous route. To 
treat possible opiate overdose, the opiate antagonist naloxone, 0.4-1.2 mg intra­
venously, should also be administered routinely to comatose patients. The ben­
zodiazepine antagonist flumazenil should not be used in coma of unknown 
cause.
4. Withdraw arterial blood for blood gas and pH determinations. In
addition to assisting in the assessment of ventilatory status, these studies can 
provide clues to metabolic causes of coma.
5. Institute treatment for seizures, if present. Persistent or recurrent 
seizures in a comatose patient should be considered to represent status epilepti- 
cus and treated accordingly.
After these measures have been taken, the history (if available) is obtained 
and general physical and neurologic examinations are performed.
EXAMINATION
History
The most crucial aspect of the history is the time over which coma devel­
ops. In the absence of precise details about the mode of onset, information about 
when the patient was last seen in an apparently normal state may assist in estab­
lishing the time course of the disease process.
A. A sudden onset of coma suggests a vascular origin, especially a brain­
stem stroke or subarachnoid hemorrhage.
B. Rapid progression from hemispheric signs, such as hemiparesis, hemi- 
sensory deficit, or aphasia, to coma within minutes to hours is characteristic of 
intracerebral hemorrhage.
C. A more protracted course leading to coma (days to a week or more) is 
seen with tumor, abscess, or chronic subdural hematoma.
D. Coma preceded by a confusional state or agitated delirium, without lat- 
eralizing signs or symptoms, is probably due to a metabolic derangement.
General Physical Examination
A. Signs of Trauma
1. Inspection of the head may reveal signs of basilar skull fracture, includ­
ing the following:
a. Raccoon eyes (Periorbital ecchymoses).
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b. Battle's sign (Swelling and discoloration overlying the mastoid bone 
behind the ear).
c. Hemotympanum (Blood behind the tympanic membrane).
d. Cerebrospinal fluid rhinorrhea or otorrhea (Leakage of CSF from 
the nose or ear). CSF rhinorrhea must be distinguished from other causes of rhi­
norrhea, such as allergic rhinitis. It has been suggested that CSF can be distin­
guished from nasal mucus by the higher glucose content of CSF, but this is not 
always the case. The chloride level may be more useful, since CSF chloride 
concentrations are 15-20 meq/L higher than those in mucus.
2. Palpation of the head may demonstrate a depressed skull fracture or 
swelling of soft tissues at the site of trauma.
B. Blood Pressure. Elevation of blood pressure in a comatose patient may 
reflect long-standing hypertension, which predisposes to intracerebral hem­
orrhage or stroke. In the rare condition of hypertensive encephalopathy, the 
blood pressure is above 250/150 mm Hg in chronically hypertensive patients; it 
may be lower following acute elevation of blood pressure in previously nor- 
motensive patients (eg, in acute renal failure). Elevation of blood pressure may 
also be a consequence of the process causing the coma, as in intracerebral or su­
barachnoid hemorrhage or, rarely, brainstem stroke.
C. Temperature. Hypothermia can occur in coma caused by ethanol or 
sedative drug intoxication, hypoglycemia, Wernicke's encephalopathy, hepatic 
encephalopathy, and myxedema. Coma with hyperthermia is seen in heat stroke, 
status epilepticus, malignant hyperthermia related to inhalational anesthetics, an­
ticholinergic drug intoxication, pontine hemorrhage, and certain hypothalamic 
lesions.
D. Signs of Meningeal Irritation. Signs of meningeal irritation (eg, 
nuchal rigidity or the Brudziński sign are of great importance in leading to the 
prompt diagnosis of meningitis or subarachnoid hemorrhage, but they are lost in 
deep coma.
E. Optic Fundi. Examination of the optic fundi may reveal papilledema 
or retinal hemorrhages compatible with chronic or acute hypertension or an ele­
vation in intracranial pressure. Subhyaloid (superficial retinal) hemorrhages in 
an adult strongly suggest subarachnoid hemorrhage.
Neurologic Examination
The neurologic examination is the key to etiological diagnosis in the co­
matose patient. Pupillary size and reactivity, oculocephalic and oculovestibular 
reflexes, and the motor response to pain should be evaluated in detail.
A. Pupils
1. Normal pupils. Normal pupils are 3-4 mm in diameter and equal bilat­
erally; they constrict briskly and symmetrically in response to light. Normal pu­
pils, however, are larger in children and smaller in the old.
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2. Thalamic pupils. Slightly smaller reactive pupils are present in the 
early stages of thalamic compression from mass lesions, perhaps because of the 
interruption of the descending sympathetic pathways.
3. Fixed dilated pupils. Pupils greater than 7 mm in diameter and fixed 
(nonreactive to light) usually result from compression of the oculomotor (III) 
cranial nerve anywhere along its course from the midbrain to the orbit but may 
also be seen in anticholinergic or sympathomimetic drug intoxication. The most 
common cause of a fixed dilated pupil in a comatose patient is transtentorial 
herniation of the medial temporal lobe from a supratentorial mass.
4. Fixed midsized pupils. Pupils fixed at about 5 mm in diameter are the 
result of brainstem damage at the midbrain level.
5. Pinpoint pupils. Pinpoint pupils (1-1.5 mm in diameter) in a comatose 
patient usually indicate opioid overdose or focal damage at the pontine level. 
Under these conditions, the pupils may appear unreactive to light except, per­
haps, with a magnifying glass. Pinpoint pupils are also caused by organophos- 
phate poisoning, miotic eye drops, or neurosyphilis.
6. Asymmetric pupils. Asymmetry of pupillary size (anisocoria) with a 
difference of 1 mm or less in diameter is a normal finding in 20% of the popula­
tion; the pupils constrict to a similar extent in response to light, and extraocular 
movements are not impaired. In contrast, a pupil that constricts less rapidly or to 
a lesser extent than its fellow usually implies a structural lesion affecting the 
midbrain or oculomotor nerve.
B. Extraocular Movements
1. Pathways tested. The neuronal pathways to be tested begin at the pon- 
tomedullary junction (vestibular [VIII] nerve and nucleus), synapse in the caudal 
pons (horizontal gaze center and abducens [VI] nerve nucleus), ascend through 
the central core of the brainstem reticular activating system (medial longitudinal 
fasciculus), and arrive at the midbrain level (oculomotor [III] nucleus and 
nerve).
2. Methods of testing. In the comatose patient, eye movements are tested 
by stimulating the vestibular system (semicircular canals of the middle ear) by 
means of passive head rotation (the oculocephalic reflex, or doll's-head maneu­
ver) or by the stronger stimulus of ice-water irrigation against the tympanic 
membrane (oculovestibular reflex, or cold-water calories testing).
3. Normal movements. A comatose patient without brainstem disease 
will often demonstrate full conjugate horizontal eye movements during the 
doll's-head maneuver and always exhibits tonic conjugate movement of both 
eyes to the side of the ice water irrigation during caloric testing. The presence of 
full reflex eye movements in the comatose patient attests to the integrity of the 
brainstem from the pontine to the midbrain level and excludes a mass lesion in 
the brainstem.
4. Abnormal movements
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a. With lesions of the oculomotor nerve or nucleus (such as in the rostral- 
caudal herniation syndrome), oculovestibular testing will reveal failure of ocular 
adduction with unimpaired contralateral abduction.
b. Complete absence of response on oculovestibular testing in a comatose 
patient implies either a structural lesion of the brainstem at the level of the pons 
or a metabolic disorder with a particular predilection for brain stem involve­
ment; this is usually caused by sedative drug intoxication.
c. Downward deviation of one or both eyes in response to unilateral cold- 
water irrigation is most suggestive of sedative drug intoxication.
C. Motor Response to Pain. The motor response to pain is tested by ap­
plying strong pressure on the supraorbital ridge, sternum, or nail beds. The re­
sponse to such stimuli may be helpful in localizing the level of cerebral dysfunc­
tion in comatose patients or providing a guide to the depth of coma.
1. With cerebral dysfunction of only moderate severity, patients may lo­
calize the offending stimulus by reaching toward the site of stimulation. Al­
though semi purposeful localizing responses to pain can sometimes be difficult 
to distinguish from the reflex responses described below, movements that in­
volve limb abduction are virtually never reflexive in nature.
2. A decorticate response to pain (flexion of the arm at the elbow, adduc­
tion at the shoulder, and extension of the leg and ankle) is classically associated 
with lesions that involve the thalamus directly or large hemispheric masses that 
compress it from above.
3. A decerebrate response (extension at the elbow, internal rotation at the 
shoulder and forearm, and leg extension) tends to occur when midbrain function 
is compromised. Decerebrate posturing generally implies more severe brain dys­
function than decorticate posturing, but neither response localizes the site of dis­
ease precisely.
4. Bilateral symmetric posturing may be seen in both structural and meta­
bolic disorders.
5. Unilateral or asymmetric posturing suggests structural disease in the 
contralateral cerebral hemisphere or brainstem.
6. In patients with pontine and medullary lesions, there is usually no re­
sponse to pain, but occasionally some flexion at the knee is noted (a spinal re­
flex).
PATHOPHYSIOLOGIC ASSESSMENT
The most important step in evaluating the comatose patient is to decide 
whether unconsciousness is the result of a structural brain lesion (for which 
emergency neurosurgical intervention may be critical) or a diffuse encephalopa­
thy caused by metabolic disturbance, meningitis, or seizures (for which surgical 
procedures are unnecessary and medical treatment may be required). The most
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common diagnostic dilemma is to try to differentiate between a supratentorial 
(hemispheric) mass lesion and metabolic encephalopathy.
Supratentorial Structural Lesions
When coma is the result of a supratentorial mass lesion, the history and 
physical findings early in the course usually point to a hemispheric disorder. 
Hemiparesis with hemisensory loss is typical. Aphasia occurs with dominant 
(usually left) hemispheric lesions, and agnosia (indifference to or denial of the 
deficit) with injury to the non dominant hemisphere. As the mass expands 
(commonly from associated edema), somnolence supervenes because of the 
compression of the contralateral hemisphere or downward pressure on the dien­
cephalon. Stupor progresses to coma, but the findings often remain asymmetric. 
As rostral-caudal compression progresses, the thalamus, midbrain, pons, and 
medulla become involved, and the neurologic examination reveals dysfunction 
at successively lower anatomical levels. Such segmental involvement strongly 
supports the diagnosis of a supratentorial mass with downward transtentorial 
herniation and dictates the need for neurosurgical intervention. Once the pontine 
level is reached, a fatal outcome is inevitable. Even at the fully developed mid­
brain level, chances of survival without severe neurologic impairment decrease 
rapidly, especially in adults.
When supratentorial mass lesions produce herniation of the medial portion 
of the temporal lobe (the uncus) across the cerebellar tentorium, thus exerting 
direct pressure on the rostral brainstem, signs of oculomotor nerve and midbrain 
compression such as ipsilateral pupillary dilatation and impaired adduction of 
the eye (uncal syndrome) may precede loss of consciousness. As consciousness 
is lost with progressive uncal herniation, the fully developed midbrain stage rap­
idly appears, with marked ipsilateral pupillary dilation and loss of reactivity to 
light. Neurosurgical treatment must be given early in the course of third-nerve 
involvement if useful recovery is to be achieved.
Subtentorial Structural Lesions
Coma of sudden onset with focal brainstem signs strongly supports a di­
agnosis of subtentorial structural lesion. Pupillary function and extraocular 
movements are the most helpful features of the neurologic examination, espe­
cially if the abnormalities are asymmetric. With focal midbrain lesions, pupillary 
function is lost: the pupils are midsized (about 5 mm in diameter) and nonreac- 
tive to light. Pinpoint pupils are found in pontine hemorrhage and less often in 
pontine infarction or pontine compression caused by cerebellar hemorrhage or 
infarction. Conjugate gaze deviation away from the side of the lesion and toward 
the hemiparesis -  or disconjugate eye movements, such as intemuclear ophthal­
moplegia (selective impairment of eye adduction) -  strongly suggests a subten­
torial lesion. Motor responses are generally not helpful in separating subtentorial 
from supratentorial lesions. Ventilatory patterns associated with subtentorial le­
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sions are abnormal but variable and may be ataxic or gasping. Since the fully 
developed syndrome of transtentorial herniation from a supratentorial mass is 
characterized by extensive brainstem dysfunction, its differentiation from a pri­
mary subtentorial process may be impossible except by history.
Diffuse Encephalopathies
Diffuse encephalopathies that result in coma (sometimes termed meta­
bolic coma) include not only metabolic disorders such as hypoglycemia and 
drug intoxication but other processes that affect the brain diffusely, such as men­
ingitis, subarachnoid hemorrhage, and seizures.
The clinical presentation is distinct from that of a mass lesion. There are 
usually no focal signs, such as hemiparesis, hemisensory loss, or aphasia, and— 
except in some cases of subarachnoid hemorrhage-no sudden loss of conscious­
ness. Instead, the history reveals a period of progressive somnolence or toxic de­
lirium followed by gradual descent into a stuporous and finally comatose state.
A symmetric neurologic examination supports a metabolic cause of coma. 
Hepatic encephalopathy, hypoglycemia, and hyperosmolar nonketotic hyper­
glycemia may uncommonly be accompanied by focal signs -  especially hemi­
paresis, which may alternate from side to side. Asterixis, myoclonus, and tremor 
preceding coma are important clues that suggest metabolic disease. Symmetric 
decorticate or decerebrate posturing can be seen with hepatic, uremic, anoxic, 
hypoglycemic, or sedative-drug-induced coma.
The finding of reactive pupils in the presence of otherwise impaired brain­
stem function is the hallmark of metabolic encephalopathy. Although coma with 
intact pupillary reactivity is also seen in the early stages of transtentorial herni­
ation, this latter syndrome is associated with asymmetric neurologic findings. 
The few metabolic causes of coma that also impair pupillary reflexes include 
glutethimide overdose, massive barbiturate overdose with apnea and hypoten­
sion, acute anoxia, marked hypothermia, and anticholinergic poisoning (large 
pupils); and opioid overdose (pinpoint pupils). Even in these conditions, how­
ever, completely nonreactive pupils are uncommon.
The respiratory patterns in metabolic coma vary widely, and measurement 
of arterial blood gases and pH may provide a further basis for establishing an 
etiologie diagnosis.
Summary
Examining pupillary size and reactivity and testing reflex eye movements 
and the motor response to pain help determine whether brain function is dis­
rupted at a discrete anatomic level (structural lesion) or in a diffuse manner 
(metabolic coma).
Supratentorial structural lesions compromise the brain in an orderly way, 
producing dysfunction at progressively lower anatomic levels. In patients with 
metabolic coma, such localization is not possible, and scattered, anatomically
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inconsistent findings are noted on examination. An impressive example of the 
anatomically discordant findings characteristic of metabolic encephalopathy is 
the retention of pupillary reactivity in the face of otherwise depressed brainstem 
functions: paralysis of eye movements, respiratory depression, flaccid muscle 
tone, and unresponsiveness to painful stimuli such as is typical with sedative 
drug overdose. The same degree of low brainstem dysfunction produced by a 
supratentorial mass lesion would have to first compromise the more rostrally 
situated midbrain structures that mediate pupillary reactivity before affecting the 
lower brainstem centers.
DIFFERENTIAL DIAGNOSIS
1. PSYCHOGENIC UNRESPONSIVENESS
Psychogenic unresponsiveness is a diagnosis of exclusion that should be 
made only on the basis of compelling evidence. It may be a manifestation of 
schizophrenia (catatonic type), somatoform disorders (conversion disorder or 
somatization disorder), or malingering. The general physical examination re­
veals no abnormalities; neurologic examination generally reveals symmetrically 
decreased muscle tone, normal reflexes, and a normal (flexor) response to plan­
tar stimulation. The pupils are 2-3 mm in diameter or occasionally larger and re­
spond briskly to light. Lateral eye movements on oculocephalic (doll's head) 
testing mayor may not be present, since visual fixation can suppress this reflex. 
The slow conjugate roving eye movements of metabolic coma cannot be imi­
tated, however, and, if present, are incompatible with a diagnosis of psychogenic 
unresponsiveness. Likewise, the slow, often asymmetric and incomplete eye clo­
sure commonly seen after the eyes of a comatose patient are passively opened 
cannot be voluntarily reproduced. The patient with psychogenic un­
responsiveness usually exhibits some voluntary muscle tone in the eyelids dur­
ing passive eye opening. A helpful diagnostic test is irrigation of the tympanic 
membrane with cold water. Brisk nystagmus is the characteristic response in 
conscious patients, whereas no nystagmus occurs in coma. The EEG in psy­
chogenic unresponsiveness is that of a normal awake person.
2. VEGETATIVE STATE
Some patients who are comatose because of cerebral hypoxia or ischemia- 
or structural brain lesions -  regain wakefulness but not awareness. After 1 
month, this condition is termed persistent vegetative state. Such patients exhibit 
spontaneous eye opening and sleep-wake cycles, which distinguish them from 
patients in coma, as well as intact brainstem and autonomic function. However,
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they neither comprehend nor produce language, and they make no purposeful 
motor responses. This condition may persist for years. Recovery of conscious­
ness from nontraumatic causes is rare after 3 months, and from traumatic causes 
is rare after 12 months.
3. LOCKED-IN SYNDROME
Because the portion of the reticular formation responsible for conscious­
ness lies above the level of the midpons, functional transection of the brainstem 
below this level -  by pontine infarct, hemorrhage, central pontine myelinolysis, 
tumor, or encephalitis -  can interrupt descending neural pathways to produce an 
akinetic and mute state, with preserved consciousness. Such patients appear co­
matose but are awake and alert although mute and quadriplegic. Decerebrate 
posturing or flexor spasms may be seen. The diagnosis is made by noting that 
voluntary eye opening, vertical eye movements, ocular convergence, or some 
combination of these midbrain-mediated movements is preserved. During the 
examination of any apparently comatose patient, the patient should be told to 
"open your eyes," "look up," "look down," and "look at the tip of your nose" to 
elicit such movements. The EEG is normal. Outcome is variable and related to 
the underlying cause and the extent of the brainstem lesion. Mortality is ap­
proximately 70% when the cause is a vascular disturbance and about 40% in 
nonvascular cases, usually from pneumonia. Survivors may recover partially or 
completely over a period of weeks to months.
BRAIN DEATH
Current standards for the determination of brain death, developed by the 
President's Commission for the Study of Ethical Problems in Medicine and Bio­
medical and Behavioral Research, are summarized below. Irreversible cessation 
of all brain function is required for a diagnosis of brain death. In addition, the 
diagnosis of brain death in children under 5 years of age must be made with cau­
tion.
Cessation of Brain Function
A. Unresponsiveness. The patient must be unresponsive to sensory input, 
including pain and speech.
B. Absent Brainstem Reflexes. Pupillary, corneal, and oropharyngeal re­
sponses are absent, and attempts to elicit eye movements with the oculocephalic 
and vestibulo-ocular maneuvers are unsuccessful. Respiratory responses are also 
absent, with no ventilatory effort after the patient's PC02 is permitted to rise to 
60 mm Hg, while oxygenation is maintained by giving 100% oxygen by a can­
nula inserted into the endotracheal tube (apnea test).
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Irreversibility of Brain Dysfunction
The cause of coma must be known; it must be adequate to explain the 
clinical picture, and it must be irreversible. Sedative drug intoxication, hypo­
thermia (32.2 °C), neuromuscular blockade, and shock must be ruled out, since 
these conditions can produce a clinical picture that resembles brain death but in 
which neurologic recovery may still be possible.
Persistence of Brain Dysfunction
The criteria for brain death described above must persist for an appropri­
ate length of time, as follows:
1. Six hours with a confirmatory isoelectric (flat) EEG, performed accord­
ing to the technical standards.
2. Twelve hours without a confirmatory isoelectric EEG.
3. Twenty-four hours for anoxic brain injury without a confirmatory 
isoelectric EEG.
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INTRACRANIAL PRESSURE, CEREBRAL OEDEMA, 
HYDROCEPHALUS
RAISED INTRACRANIAL PRESSURE
Pathophysiology
Intracranial pressure (ICP) may become pathologically elevated from dif­
fuse swelling of the brain (cerebral oedema or venous congestion), hydrocepha­
lus, or from other intracranial spaceoccupying lesions, including tumours, 
haematoma, or abscess. The brain is unique among the viscera in being confined 
within the rigid case, the cranium. The total volume of the intracranial contents, 
namely the brain and its coverings, the blood vessels, and the blood and CSF is 
normally constant, so that an expansion of anyone of these can only occur at the 
expense of the others. However, the intracranial contents do not respond pas­
sively to changes in their volume or pressure, but react in a number of compli­
cated ways, depending mainly on the rate at which they expand.
As an intracranial mass lesion increases in size, there is initially a com­
pensatory reduction in the volume of intracranial blood and CSF and, only when 
this compensatory process is exhausted, does the intracranial pressure increase. 
This compensation is best when the rate of expansion is very slow. In this first, 
or compensated, stage there is little change in the clinical condition of the pa­
tient but, in the second stage, as the compensatory process becomes increasingly 
ineffective, headache and a depressed level of consciousness develop. The third 
stage of increasing intracranial pressure is characterized by further depression of 
consciousness, increased systemic arterial blood pressure (SABP), bradycardia, 
and irregular respiration. In the fourth or terminal stage there is deep coma, a 
progressive fall in systemic arterial blood pressure and the pupils become fixed 
and dilated. The rise of intracranial pressure at this stage results in a fall in cere­
bral perfusion pressure (CPP) (CPP = SABP -  ICP), with reduction in cerebral 
blood flow (CBF). The fall in cerebral perfusion pressure that accompanies a 
rise in intracranial pressure is recognized as being just as important as the rise in 
intracranial pressure itself.
This fall in cerebral perfusion pressure will be particularly dangerous if 
autoreguiation of cerebral blood flow is lost. For these reasons the management 
of cerebral perfusion pressure is now considered to be more important than the 
management of intracranial pressure alone. Evidence from randomized con­
trolled trials shows that cerebral perfusion pressure should be maintained above 
60 mm Hg if secondary insults to the brain are to be avoided.
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C h o ro id  p le x u s
Fig. 12. Circulation of cerebrospinal fluid (CSF). CSF is produced by the 
choroid plexus, which consists of specialized secretory tissue located within the 
cerebral ventricles. It flows from the lateral and third ventricles through the 
cerebral aqueduct and fourth ventricle and exits the ventricular system through 
two laterally situated foramina of Luschka and a single, medially located 
foramen of Magendie. CSF then enters and circulates through the subarachnoid 
space surrounding the brain and spinal cord. It is ultimately absorbed through 
arachnoid granulations into the venous circulation. (From R. Simon, M. 
Aminoff, D. Greenberg, 1999)
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The general effects of mass lesions
Initially, a slowly growing mass plays a relatively small part in raising in­
tracranial pressure. Because of the partial division of the cranial cavity into 
compartments by the falx and tentorium, the local rise of pressure is partly con­
fined to the cranial compartment; this is in contrast to the increased pressure 
throughout the craniospinal axis, which is usually produced by diffuse cerebral 
oedema, or to that which can be produced, for instance, following intracerebral 
haemorrhage (ICH) or subarachnoid haemorrhage (SAH). A rapid rise in intrac­
ranial pressure follows a simulated intracerebral haemorrhage. The rate of ex­
pansion of the mass determines the effectiveness of the compensatory mecha­
nisms. A very slow-growing mass (e.g. a meningioma) reaches a large size 
without altering cerebral perfusion pressure or intracranial pressure, while a rap­
idly expanding mass (e.g. a haematoma) produces a large rise in intracranial 
pressure and a fall in cerebral perfusion pressure. Nevertheless, as compensation 
fails and the mass of the lesion increases, a volume/pressure curve can be de­
rived, confirming the initial slight rise in intracranial pressure followed by an 
exponential increase, as it grows larger. As the intracranial pressure rises, cere­
bral perfusion pressure falls: maintenance of higher levels of cerebral perfusion 
pressure is associated with a better outcome in patients with head injury. The in­
tracranial pressure waveform is a function of the arterial pressure waveform. 
Spectral analysis of these waves has shown six harmonic components; amplitude 
transfer functions can be clearly separated into four types, which reflect the de­
gree of vascular compliance of the cerebral circulation. The recognition of the 
importance of cerebral perfusion pressure has made it possible to correlate mar­
ginally reduced cerebral perfusion in head-injured patients with transcranial 
Doppler and jugular venous oxygen measurements.
Brain herniation
Progressive expansion of the mass leads to herniation of brain tissue from 
the compartment in which the mass lesion lies. The principal herniation sites 
are: of the cinguiate gyrus beneath the falx cerebri (subfalcine herniation); of the 
medial temporal lobe through the tentorial hiatus (tentorial herniation); or of the 
cerebellar tonsils into the foramen magnum (the cerebellar pressure cone). In 
these circumstances, pressure gradients develop between the various intracranial 
compartments, depending upon that in which the mass lesion lies. The effects of 
these lesions will be considered later. Thus an early effect of a mass lesion is to 
displace CSF from the cranial cavity. Lumbar puncture carries grave risks in any 
tumour suspect, as the removal of fluid with resultant reduced pressure in the 
lumbar theca may induce herniation. Additionally, it must be noted that mass le­
sions, depending upon their situation, can also obstruct the outflow of CSF from 
one lateral ventricle (due to pressure occlusion of the foramen of Monro), from
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the third ventricle (due to occlusion of the aqueduct), or from the fourth ventri­
cle, giving rise to hydrocephalus with dilatation of one or more of the ventricles, 
thus causing an even greater increase in intracranial pressure.
Circulatory effects
The effect of intracranial pressure upon the cerebral circulation is also im­
portant. Compression of venous sinuses and cortical veins increases venous 
pressure, thus contributing to the rise in intracranial pressure. Also, it is one fac­
tor responsible for inducing cerebral oedema, an important complication of in­
tracranial mass lesions, which is often most severe in the neighbourhood of the 
tumour. Thus, brain swelling may be due either to vascular mechanisms or to 
brain oedema. Compression of arteries may reduce blood flow focally or gener­
ally (if there is a fall in cerebral perfusion pressure) and infarction may result. A 
fall in cerebral perfusion pressure below 50 mmHg has been shown to reduce 
cerebral blood flow (CBF).
However, in head injury, subarachnoid haemorrhage, and intracerebral 
haemorrhage, normal autoregulation is lost and higher levels of cerebral perfu­
sion pressure may be needed to maintain cerebral blood flow. Arterial hyperten­
sion may develop as a compensatory mechanism, the Cushing response, partially 
in attempted compensation for the increased cerebral arterial resistance and so as 
to increase cerebral perfusion pressure. There may also be electrocardiographic 
abnormalities such as prominent V-waves, ST-T segment changes, notched T- 
waves, and prolonged (or shortened) Q-T intervals. Any arrhythmia may de­
velop, particularly if there is associated haemorrhage. The rise in systemic arte­
rial blood pressure, and perhaps the electrocardiographic changes, are thought to 
result, at least in part, from medullary ischaemia due to stretching of perforating 
branches of the basilar artery, induced in turn by downward brainstem dis­
placement. The situation may also be influenced by the cerebral vasodilatation 
induced by hypercapnia or hypoxia. These, in turn, may be a consequence of the 
respiratory irregularities induced by intracranial pressure. However, these fac­
tors, like volatile anaesthetic agents, also increase intracranial pressure. Con­
versely, hyperventilation and consequent hypocapnia reduce it, as do hypother­
mia, hyperbaric oxygen, and some drugs.
Skull rigidity
The effects of the rigidity of the skull must also be considered. That of the 
adult is rigid and unyielding. So, as the intracranial pressure rises, an important 
consequence visible radiologically is that chronic downward pressure, some­
times of a dilated third ventricle, upon the sella turcica may initially cause de­
calcification and later erosion of the posterior clinoid processes. Sometimes the 
sella enlarges, occasionally resulting in an empty sella syndrome, occasionally 
with clinical manifestations of hypopituitarism.
1 8 1
By contrast, non-union of the cranial sutures in infants provides a partial 
safety valve, so that increased intracranial pressure leads to increased head cir­
cumference. This often occurs in hydrocephalus. In children a rise in intracranial 
pressure may lead to separation of the cranial sutures. Premature union of the 
sutures (craniostenosis) causes a marked increase in intracranial pressure be­
cause skull growth is arrested while a normal brain is still increasing in size.
Symptoms
Symptoms of chronic elevation of intracranial pressure are headache, 
vomiting, papilloedema, and depression of consciousness. The headache associ­
ated with an increased intracranial pressure, especially when resulting from 
mass lesions, is mainly due to compression or distortion of the dura mater and of 
the pain-sensitive intracranial blood vessels. It is often paroxysmal, at first 
worse on waking or after recumbency, throbbing in character, corresponding 
with the arterial pressure wave. Exertion, coughing, sneezing, vomiting, strain­
ing, or sudden changes in posture accentuate it. Such headache is often frontal or 
occipital or both. Its distribution is of little localizing value, though it is occa­
sionally unilateral, occurring upon the side of the mass lesion. Lesions in the 
posterior fossa often give suboccipital headache, and may give warning of the 
presence of a cerebellar pressure cone if there is associated neck stiffness or if 
pain is increased by attempted neck flexion. The vomiting that accompanies in­
creased intracranial pressure often occurs in the mornings when the headache is 
at its height. It is generally attributed to compression or ischaemia of the vomit­
ing centre in the medulla oblongata. Similarly, the bradycardia, which is also 
common, results from dysfunction in the cardiac centre but, in some patients 
with infra tentorial lesions, tachycardia eventually develops.
Papilloedema develops more rapidly with mass lesions in the posterior 
fossa because of their especial tendency to cause sudden obstructive hydro­
cephalus. In contrast, it often appears late in patients with prefrontal lesions. Ob­
struction of CSF flow in the subarachnoid space and impaired absorption both 
appear to be important factors in patients with tumours. Papilloedema is some­
times worse on one side, but it is rarely unilateral, except in the uncommon Fos­
ter Kennedy syndrome in which a subfrontal neoplasm on one side, often a men­
ingioma, may compress the ipsilateral optic nerve, giving optic atrophy on that 
side and papilloedema on the other.
Breathing control is often impaired. Slow and deep respiratory move­
ments often accompany a sudden rise in intracranial pressure sufficient to impair 
consciousness. Later, breathing may become irregular, Cheyne-Stokes respira­
tion, and periods of apnoea then alternate with phases during which breathing 
waxes and wanes in amplitude. Central neurogenic hyperventilation, or so-called 
apneustic or ataxic breathing, are less common effects of brainstem compression 
or distortion but, in terminal coma, breathing is often rapid or shallow. These 
abnormalities of respiratory rate and rhythm may be due to compression or dis­
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tortion of the brain stem. More often they result from median raphe haemor­
rhages or infarcts in the midbrain and pons, themselves resulting from tentorial 
herniation.
'False localizing signs' may also arise as a consequence of a sustained rise 
in intracranial pressure. These include unilateral or bilateral sixth-nerve palsies 
due to compression of the trunks of one or both nerves as they cross the apex of 
the petrous temporal bone, and bilateral extensor plantar responses or grasp re­
flexes resulting from ventricular dilatation in hydrocephalus, a third-nerve palsy. 
Less common false localizing signs include facial pain or sensory loss due to 
compression of the Gasserian ganglion in tentorial herniation; an ipsilateral ex­
tensor plantar response due to compression of the opposite cerebral peduncle 
against the free tentorial edge in tentorial herniation (Kemohan's sign); signs of 
cerebellar dysfunction rarely resulting from a massive frontal lesion and due to 
downward displacement of the brainstem; and bilateral, fixed, dilated pupils or 
defects of upward conjugate gaze due to a central cerebellar lesion displacing 
the midbrain upwards.
Cerebral herniations
Subfalcine herniations
Subfalcine herniations, that is herniation of the cingulate gyrus beneath 
the free edge of the falx cerebri, can be identified by angiography or magnetic 
resonance imaging (MR1). The ipsilateral lateral ventricle is often reduced in 
size. Usually there are no specific clinical features. Focal necrosis may affect the 
cingulate gyrus, or extensive frontal infarction may result from compression of 
the pericallosal arteries.
Tentorial herniation
Tentorial herniation most often develops as a consequence of lesions in 
the temporal lobe but may complicate any supratentorial mass lesion. As the 
herniated medial temporal lobe descends in the tentorial hiatus, the midbrain is 
pushed to the opposite side and downwards, and the opposite cerebral peduncle 
is compressed against the free edge of the contralateral tentorium. As a result, 
the aqueduct becomes compressed, and the ipsilateral third nerve is compressed 
against the tentorial edge, giving first a dilated, fixed pupil and later other signs 
of a third-nerve palsy. There may be grooving of the uncus and hippocampal 
gyrus with focal necrosis or infarction.
As herniation increases, there is further downward displacement of the 
brainstem. The principal complications of this process are: paresis or paralysis 
of upward conjugate gaze due to compression of the tectal plate; pressure upon 
one or both posterior cerebral arteries, giving unilateral or bilateral occipital- 
lobe infarction with consequent hemianopia or cortical blindness; and, most im­
portantly, median raphe haemorrhages or infarction in the brainstem, due to ve­
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nous obstruction or more often to shearing effects upon perforating branches of 
the basilar artery, so that irreversible coma results from necrosis of the reticular 
substance.
Tonsillar herniation
Tonsillar herniation, a cerebellar pressure cone through the foramen mag­
num, may complicate supratentorial, or particularly infratentorial, lesions. It 
produces haemorrhagic infarction of the cerebellar tonsils and also compression 
of the medulla with respiratory and/or cardiac arrest and death, when there is as­
sociated downward displacement of the brainstem.
Infratentorial lesions
Infratentorial lesions tend to cause obstructive hydrocephalus because of 
tonsillar herniation and the effects upon the brainstem, aqueduct, and fourth ven­
tricle. Medullary or cerebellar infarction may occur due to compression of the 
medulla in the foramen magnum or compression of the posterior inferior cere­
bellar arteries. Sometimes reversed tentorial herniation occurs, with upward dis­
placement of the brainstem and of the posterior fossa contents. This causes in­
farction of the superior aspects of the cerebellar hemispheres due to compression 
of the superior cerebellar arteries. Distortion of the hippocampal gyri due to up­
ward pressure is rarely seen.
BENIGN INTRACRANIAL HYPERTENSION
This disorder was recognized in the pre-CT scan era as one in which there 
was high intracranial pressure with no mass lesion, initially called pseudotumour 
cerebri. It was sometimes known as 'otitic hydrocephalus' because of its associa­
tion with chronic ear disease. The term 'benign intracranial hypertension' was 
used to describe a persistent rise of CSF pressure in the absence of a space- 
occupying lesion and with ventricles of normal or even reduced size. Usually it 
occurs in women, with a peak incidence in the third and fourth decades. They 
are often obese, and there is an association with oral contraceptive usage, preg­
nancy, and miscarriage. In a smaller group, affecting the sexes equally, there is a 
previous history of middle-ear disease, non-specific infection, or mild head in­
jury. The condition may occur in children (1/100000 annually) and girls are 
three times more likely to be affected than boys. It has been suggested that be­
nign intracranial hypertension is associated with brain swelling, possibly related 
to increased venous pressure from raised intraabdominal pressure. Many other 
pathogenetic associations have been postulated to explain this brain swelling, 
including hypervitaminosis A, the administration of a variety of antibiotics, an 
abnormality of the cerebral microvasculature with increased water content of the
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brain, increased CSF production associated with an increase in circulating oes­
trogen, and increased CSF outflow resistance. The CT scan has shown that the 
ventricles are usually small. The brain swelling in benign intracranial hyperten­
sion is not associated with any MR1 evidence of a structural abnormality, white 
matter oedema, or cerebral venous sinus thrombosis. The cerebrospinal fluid 
(CSF) is acellular and usually has a slightly low protein content. Other causes of 
raised intracranial pressure without an intracranial mass lesion or ventricular 
enlargement include venous thrombosis of the transverse or sigmoid sinus, 
chronic infective or neoplastic meningitis, or other causes of high protein in the 
CSF. These conditions can usually be distinguished by anatomic MRI or MR 
angiography and CSF analysis. Head injury with a depressed fracture over a ve­
nous sinus may also produce intracranial hypertension.
Headache is the most commonest complaint, and often having a vascular 
character or the classical headache of raised intracranial pressure. It is some­
times associated with postural obscuration of vision and occasional vomiting. 
There can be facial numbness or diplopia related to a sixth-nerve palsy. How­
ever, apart from tinnitus, other cranial nerve abnormalities are uncommon. By 
definition, papilloedema is expected, but there may be cases of headache with 
documented raised intracranial pressure without papilloedema. In the acute stage 
papilloedema may constitute a serious threat to vision, due either to associated 
peripapillary haemorrhages or to enlargement of the blind spot, which eventu­
ally may encroach on the macula. Blindness or permanent central scotomas oc­
cur. Usually the condition is benign if appropriately treated, with a good progno­
sis.
Imaging with CT or MRI shows no abnormality and MR angiography 
helps to exclude any sinus thrombosis that may require treatment with antico­
agulants. Full blood count, and a hypercoagulable tendency should be checked. 
Frequent monitoring of the visual acuity and documentation of the visual fields 
is important to assess the response to treatment.
The mainstay of treatment in obese patients is weight reduction, and can 
be successful. Weight reduction after gastric surgery has been reported to be 
very successful in resistant cases, all showing resolution of cranial nerve dys­
function. Oral contraception should be stopped. However, if vision is threatened, 
emergency reduction of intracranial pressure is essential: this can be achieved 
simply by doing a lumbar puncture, a series of lumbar punctures, or by inserting 
a lumbar drain or lumbar-subcutaneous shunt. More permanent CSF diversion 
can be achieved with lumbarperitoneal or ventricular-peritoneal shunting, al­
though the latter may be difficult because of the very small ventricles in some 
cases. Treatment of any underlying cause is important. Acetazolamide has also 
been used with some success. In severe benign intracranial hypertension, treat­
ment with lumbar puncture and high doses of the steroid dexamethasone (4 mg 
four times a day) will rapidly reduce intracranial pressure, cerebral oedema, and 
the threat to vision. In occasional cases with severe papilloedema leading to rap­
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idly failing vision, additional shunting procedures may be needed as an emer­
gency measure. Surgical treatments include optic nerve sheath fenestration and 
subtemporal decompression. The more radical surgical interventions are for re­
fractory cases with threatened vision when less invasive interventions have 
failed.
CEREBRAL OEDEMA
Knowledge about brain oedema has changed dramatically with recent de­
velopments in MRI. Cerebral oedema accompanies many brain pathologies and 
contributes to the resultant morbidity and mortality. It plays a major role in head 
injury, stroke, and brain tumour, brain abscess, encephalitis, meningitis, lead en­
cephalopathy, hypertensive encephalopathy, hypoxia, hypo-osmolality, dialysis 
dysequilibrium, diabetic ketoacidosis, and obstructive hydrocephalus. Brain oe­
dema can now be measured accurately in vivo with MRI. The distribution of wa­
ter in neurons, glia, endothelial cells, and in the interstitial spaces can be deter­
mined with diffusion-weighted imaging (DWI). The oscillation of water mole­
cules depends upon the space available within and between cells: when space is 
limited, movement of molecules is limited and this 'squeeze' can be measured 
with MRI and expressed as activated diffusion coefficients (ADC). So, if cells 
fill with water (cytotoxic oedema), they swell and reduce the interstitial space, 
thus reducing the activated diffusion coefficient. This ability to oscillate deter­
mines the diffusion of water molecules, so that diffusion-weighted imaging 
measures the interstitial water content. When the interstitial space becomes 
filled with water, for example around a brain tumour, the activated diffusion co­
efficient increases because water molecules are free to oscillate and diffuse over 
greater distances. This type of intercellular oedema is known as vasogenic oe­
dema and is associated with an increased activated diffusion coefficient.
Brain oedema must be distinguished from engorgement due to an increase 
in the blood volume of the brain due to venous obstruction or vasodilatation. 
However, prolonged venous engorgement may lead to brain oedema. If localized 
or mildly generalized, oedema produces few symptoms and signs. If severe, it 
may cause major focal signs if it is localized to one cerebral hemisphere, and if 
generalized, it can give rise to the brain herniation described above.
Cerebral oedema was sub classified initially into vasogenic, cellular or cy­
totoxic, and interstitial (or hydrocephalic) types. A better understanding also 
comes from classifying brain oedema as open-barrier (vasogenic) and closed- 
barrier (cytotoxic) oedema
Vasogenic (open-barrier) oedema
The vasogenic variety of oedema, associated with increased capillary 
permeability and an open blood-brain barrier (BBB), is the most common form
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observed in clinical practice. It occurs in conditions such as tumour, abscess, 
haemorrhage, infarction, contusion, and purulent meningitis. The oedema is 
usually localized around the primary lesion. This produces focal symptoms and 
signs that are often more due to the oedema than to the primary lesion. It is as­
sociated with increased activated diffusion coefficients on diffusion-weighted 
imaging. Open-barrier oedema is much more likely to respond to intervention 
with steroids such as dexamethasone than the other types of cerebral oedema 
that are considered below.
Cytotoxic (closed-barrier) oedema
Cellular, or cytotoxic, oedema is characterized by swelling of all the cellu­
lar elements of the brain-neurons, glia, and endothelial cells-with an associated 
reduction in extracellular fluid but with an intact blood-brain barrier. It resem­
bles that due to water intoxication in experimental animals, or that induced ex­
perimentally by triethyl tin, in which, however, there are also vacuoles and clefts 
in the cerebral white matter. It is characterized by swelling of all the cellular ele­
ments of the brain, with an associated reduction in extracellular fluid but with an 
intact blood-brain barrier. The activated diffusion coefficient on diffusion- 
weighted imaging is reduced. It occurs clinically in diffuse brain hypoxia, acute 
hypo-osmolality due to dilutional hyponatraemia, sodium depletion, or excess 
antidiuretic hormone (ADH) secretion, or in osmotic disequilibrium syndromes, 
such as in haemodialysis or diabetic ketoacidosis. The clinical manifestations 
are usually more generalized than in vasogenic oedema, and include drowsiness, 
stupor or coma, and sometimes convulsions. In ischaemic states a combination 
of vasogenic and cytotoxic oedema is often seen. The ultrastructural and mo­
lecular mechanisms occurring in the cell membrane are now becoming under­
stood. Ischaemia results in the release of lactate and excitatory amino acids, glu­
tamate and aspartate, which open receptor-activated calcium channels. In con­
trast, lactate does not rise very much or very early in traumatic oedema, which 
may therefore be different from ischaemic oedema. The influx of calcium leads 
to the activation of a-amino-hydroxyl-methyl proprionic acid (AMPA) and me­
tabotropic receptors, with upregulation of genes, which may activate lysozymes, 
with resultant apoptosis. Massive increases in calcium lead to mitochondrial 
dysfunction, energy failure, cell membrane rupture, and necrosis. In Reye's syn­
drome, the oedema is cytotoxic and resembles that of triethyl tin intoxication.
Interstitial oedema
Interstitial or hydrocephalic oedema simply identifies the increased water 
content of the periventricular brain (largely extracellular), which is seen in hy­
drocephalus. The main site of accumulation of water is periventricular and mani­
fests itself on CT scan as periventricular lucency.
Recognition of the type of oedema has implications with respect to treat­
ment. High doses o f steroids (dexamethasone, betamethasone) are o f proven ef­
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ficacy in most forms of vasogenic oedema but not in cytotoxic oedema. In cyto­
toxic oedema, osmotherapy with hypertonic mannitol or diuretics such as 
frusemide may be useful. While neuroprotective drugs appear to protect animals 
from the most severe effects of cerebral ischaemia, their role in the management 
of brain oedema is still uncertain. This applies particularly to the oedema seen 
with head injury, where prospective randomized controlled trials of steroids, 
barbiturates, N-methyl-D-aspartate (NMDA) receptor antagonists, and calcium 
antagonists have been shown not to improve outcome.
HYDROCEPHALUS
Hydrocephalus literally means water on the brain (Greek). As a definition, 
this is non-specific because atrophic dementia results in a passive increase in the 
volume of CSF in the head and such patients also have large ventricles but do 
not have hydrocephalus. Rather, hydrocephalus should be defined as an increase 
in the volume of the CSF within the skull due to an abnormality in its produc­
tion, circulation, or absorption. This definition embraces those conditions in 
which there is at some stage an increased volume, and usually pressure, of CSF 
within the cranial cavity.
Aetiology
Hydrocephalus may be due to:
(1) increased formation of CSF;
(2) obstruction to the flow of fluid at some point between the choroid 
plexuses of the lateral ventricles from which it is secreted and the arachnoidal 
villi in the sagittal sinus through which it is reabsorbed; and
(3) impaired absorption of the fluid due to inflammation of the arachnoid 
(as in meningitis) or to thrombosis of the sagittal sinus.
Normal-pressure hydrocephalus is a clinical syndrome characterized by 
dementia, gait apraxia, and urinary incontinence.
Increased formation of CSF
Increased formation of CSF occurs with a choroid plexus papilloma. In 
such cases, removal of the tumour is usually curative, but occasionally hydro­
cephalus persists despite successful removal. Another rare syndrome of over­
production of CSF with deficient absorption is due to squamous metaplasia of 
the arachnoid villi but whether it occurs in humans remains undecided.
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Obstruction
Obstruction to the CSF circulation may occur at any point of its course. 
Within the ventricles the most common cause is a neoplasm compressing one or 
both interventricular foramina or filling the third ventricle. The cerebral aque­
duct may be obstructed by a tumour arising in the third ventricle, midbrain, or 
pineal body, or may be congenitally narrowed or even absent. Owing to its small 
calibre, slight swelling of its ependymal lining may lead to aqueduct obstruction, 
and cases have been reported in which hydrocephalus has been due to gliosis 
caused by ependymitis in this region. Aqueduct stenosis is a cause of infantile 
hydrocephalus but may give rise to increased intracranial pressure for the first 
time in adult life.
Posterior fossa tumours. Posterior fossa tumours may obstruct the fourth 
ventricle. Its foramina may be blocked by a congenital septum (the Dandy- 
Walker syndrome), by adhesions following meningitis, or by displacement of 
the medulla into the foramen magnum by the pressure of a tumour. The Dandy- 
Walker syndrome may be due to atresia of the foramina of Magendie and 
Luschka or to dysplasia of the cerebellum developing early in fetal life, as the 
cerebellar vermis is often absent or vestigial in such cases. The malformation 
may be accompanied by extra-axial leptomeningeal cysts in the posterior fossa, 
while such cysts alone may give a similar clinical and radiological picture. 
Within the subarachnoid space, obstruction may again be due to tumour, to 
traumatic adhesions, parasitic cysts, inflammation, haemorrhage, or to congeni­
tal abnormalities such as basilar impression or the Amold-Chiari malformation.
The Arnold-Chiari malformation. The Amold-Chiari malformation 
consists of congenital displacement of the cerebellar tonsils and of an elongated 
medulla oblongata downwards into the cervical canal. It prevents the egress of 
CSF from the fourth ventricle into the subarachnoid space. It is sometimes asso­
ciated with lumbosacral spina bifida and with meningocele or meningomyelo­
cele. When the caudal displacement of the cerebellar tonsils, fourth ventricle, 
and medulla into the cervical canal is associated with myelodysplasia, they may 
extend down to the mid-cervical region, and this anomaly is known as a Chiari 
type II. The Chiari type 1 anomaly is a simple ectasia of the cerebellar tonsils 
(down to Cl) without any other primary malformation of the neuraxis. Congeni­
tal narrowing of the cerebral aqueduct sufficient to cause hydrocephalus was 
found in 10 of 20 such cases. MacFarlane and Maloney (1957) suggested that a 
Chiari malformation or, less often, the Dandy-Walker syndrome may result in 
dilatation of the central canal of the spinal cord early in life (hydromyelia) and 
that this is probably the most common mechanism causing syringomyelia.
The arachnoid villi
The arachnoid villi may be obstructed by inflammatory, neoplastic, or 
leukaemic cells in infective or neoplastic meningitis. Obstruction of the su­
barachnoid space and the arachnoid villi by blood accounts for the hydrocepha­
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lus seen with subarachnoid haemorrhage and head injury. Absorption of fluid 
from the arachnoid villi may also be restricted by a rise in the intracranial ve­
nous pressure, by compression of venous sinuses by an intracranial tumour, or 
by impairment of venous drainage from the head due to raised intrathoracic 
pressure in cases of intrathoracic neoplasm or pulmonary hypertension. In gen­
eral, venous obstruction results in brain swelling with a reduction in the size of 
the ventricles. Thrombosis of the superior sagittal sinus, caused by extension of 
inflammation from the transverse sinus, is one cause of the condition 'otitic hy­
drocephalus', in which symptoms of hydrocephalus complicate otitis media or 
mastoiditis.
Classification
Hypertensive hydrocephalus can be further subdivided into:
1. Obstructive hydrocephalus (once called internal hydrocephalus, and 
also known as non-communicating hydrocephalus), in which there is an obstruc­
tion to the circulation of the CSF, either within the ventricles or aqueduct, or at 
the outlet from the fourth ventricle. It prevents free communication between the 
ventricles and the subarachnoid space.
2. Communicating hydrocephalus (once called external hydrocephalus, 
and also known as non-obstructive hydrocephalus), in which hydrocephalus is 
due either to disturbance in the formation and absorption of CSF, or to an ob­
struction to its circulation in the subarachnoid space itself.
Congenital abnormalities are the most common cause of obstructive hy­
drocephalus in autopsy series, especially in neonates and perinatally. In 100 
consecutive post-mortem examinations, malformation was the sole cause in only 
14 per cent of cases, but in association with infection or trauma it accounted for 
46 per cent. Inflammatory reaction due to infection or haemorrhage but without 
malformation accounted for another 50 per cent, the remaining 4 per cent being 
due to tumours.
In the past, a distinction was often made between 'congenital' and 'ac­
quired' hydrocephalus, but this distinction is artificial. A congenital abnormality 
alone is the most likely cause of hydrocephalus developing before birth, but 
congenital and acquired factors often both contribute to hydrocephalus in in­
fancy. Nor do congenital factors cease to operate later, since hydrocephalus de­
veloping in adult life may be the late result of aqueduct stenosis or Chiari mal­
formation.
The more common causes of hydrocephalus developing in the absence of 
congenital abnormality are meningeal adhesions following meningitis or haem­
orrhage, arachnoiditis of obscure origin, thrombosis of intracranial venous si­
nuses, and intracranial tumour. Chronic inflammatory meningitis or arach­
noiditis following tuberculosis are rare causes. Obstruction within the third or
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fourth ventricle or in the subarachnoid space, may be due occasionally to para­
sitic cysts.
Pathophysiology
The rate of at which hydrocephalus develops determines the ventricular 
size. Acute obstructive hydrocephalus produces high intracranial pressure with 
only slight ventricular enlargement. Chronic obstruction may produce massive 
ventricles with only slightly elevated ICP. When obstruction occurs in the aque­
duct, only the lateral and third ventricles are distended. When the obstruction is 
more caudal, the aqueduct and fourth ventricle may also be enlarged. Ventricu­
lar distension causes thinning of the cerebral hemispheres which, in severe 
cases, may be extreme, and is associated with marked atrophy of the white mat­
ter and loss of cortical ganglion cells. The ventricular ependyma is normal, ex­
cept in inflammatory cases, when a localized or diffuse ependymitis may be pre­
sent. Meningeal adhesions indicate previous meningitis. Distension of the ven­
tricles leads to pressure upon the calvarium, which becomes thin, especially over 
the cerebral gyri. Separation of the sutures occurs when hydrocephalus develops 
in early life, but is not seen, as a rule, after adolescence. Compression of the 
base of the skull causes erosion of the clinoid processes and excavation of the 
sella turcica. The olfactory tracts and optic nerves are often atrophic.
Symptoms and signs
These are so dependent upon age and the deformability of the skull that it 
is useful to divide symptoms and signs into infantile and post-infantile. Never­
theless, infants with hydrocephalus may grow up with or without neurological 
and cognitive impairment, depending on the effectiveness and timeliness of 
treatment. The features of infantile hydrocephalus may therefore manifest in 
later life; leading to a degree of overlap when it comes to long-term disability.
Infantile hydrocephalus
Enlargement of the head is the most conspicuous sign in infantile hydro­
cephalus. It is being diagnosed with increased frequency before birth. The disor­
der becomes evident during the first few weeks of life owing to the large head, 
prominent scalp veins, and down-turning of the eyes, 'sun-setting sign'. It is 
slowly progressive. If untreated, the head may attain a huge size with a circum­
ference of 75 cm or even more. The cranial sutures are widely separated and the 
anterior fontanelle is much enlarged. There is marked congestion of scalp veins. 
Enlargement of the head occurs in all diameters and in extreme cases it is trans­
lucent. The frontal region bulges forwards, and downward pressure upon the or­
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bital plates causes the eyes to be protruded forwards and downwards. Fortu­
nately such cases are rare today.
Owing to expansibility of the skull in infancy, symptoms of increased in­
tracranial pressure are slight or absent. Hydrocephalic children seem little trou­
bled by headache and rarely vomit. Convulsions are common. In neglected cases 
bilateral anosmia may occur. Optic atrophy due to pressure upon the nerves is 
usually present, but in rare cases there is papilloedema. Visual acuity may be 
progressively reduced until the child becomes blind. Paralysis of other cranial 
nerves may occur, and squint is not uncommon. Nystagmus may be present. In 
the limbs there are usually weakness and incoordination, generally more marked 
in the lower than in the upper limbs. Spasticity with exaggeration of tendon re­
flexes is common in the lower limbs, although sometimes tendon reflexes are 
lost. The plantar reflexes are usually extensor. There may be little or no disturb­
ance of sensibility. The mental state varies. In severe cases there is usually re­
duced cognitive function and poor memory, but in milder cases this is slight or 
absent. Intelligence in later life may be surprisingly unimpaired in some cases, 
even when ventricular dilatation has progressed such that only 1 cm thickness of 
cerebral substance remains between the ventricles and the inner skull table. In 
milder cases there may be obesity and/or diabetes insipidus, due to compression 
of the hypothalamus and pituitary, and, in more severe cases, wasting. Cerebro­
spinal fluid rhinorrhoea is a rare complication. A unique hydrocephalic 'bobble- 
head doll syndrome' is characterized by two to four oscillations of the head per 
minute with psychomotor retardation and results from obstructive lesions in or 
near the third ventricle or aqueduct.
Hydrocephalus after infancy
The clinical picture of hydrocephalus developing after infancy varies ac­
cording to its cause. In obstructive hydrocephalus, symptoms of increased in­
tracranial pressure are conspicuous. Headache and vomiting are early symptoms 
and are often followed by the development of papilloedema. The headache is 
initially paroxysmal, but later becomes constant; there are sometimes intense 
exacerbations characterized by severe headache radiating down the neck associ­
ated with head retraction and even with opisthotonos, vomiting, and impairment 
of consciousness. Giddiness is a common symptom. Some mental deterioration 
usually occurs after a time, especially in later life. Hallucinations, delusions, and 
mood changes may occur. Convulsions are less common than in the infantile va­
riety, and enlargement of the head does not occur after the age of 3 years, al­
though slight separation of the sutures may occur until teenage years. In older 
children this slight separation of the cranial sutures yields a 'cracked-pot sound' 
on percussion and may be associated with venous congestion of the scalp. The 
skull remains of normal size following onset in adulthood, for instance in de­
layed presentation of cerebral aqueduct stenosis.Cranial-nerve palsies may oc­
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cur, especially paresis of the sixth and seventh nerves, and symptomatic 
trigeminal neuralgia or facial sensory loss have been reported. Slight exoph­
thalmos is not uncommon. Gross weakness of the limbs is absent, though clum­
siness and slight incoordination are common. The tendon reflexes may be exag­
gerated or diminished. The plantar reflexes are often extensor. There is usually 
no sensory loss. Symptoms of hypopituitarism, obesity, and genital atrophy are 
common in children and adolescents.
Normal-pressure hydrocephalus
A form of late-onset communicating hydrocephalus is called 'low-pressure 
hydrocephalus' since, although the ventricles are dilated, the pressure within 
them at the time of measurement was either normal or only slightly raised. The 
clinical syndrome is characterized by the triad of progressive dementia, gait 
apraxia, and urinary incontinence. The CT scan has proved helpful but the find­
ings are not invariably conclusive. Large ventricles and small sulci shown on the 
CT or MRI, however, are suggestive of this condition and continuous intracra­
nial monitoring has shown significant В waves for at least 2 hours a day. This 
has been helpful in identifying patients who may benefit from surgery. Thus, 
while CSF pressure is usually normal or low, transient episodes of raised pres­
sure occur in many cases. With MRI scanning it is possible to measure the vol­
ume of the ventricular CSF and to compare it with the volume of CSF in the su­
barachnoid spaces and fissures. In a large prospective study, the most reliable 
predictive feature of a good response to shunting was the absence of white mat­
ter changes on MRI scan. The most widely accepted test by neurologists and 
neurosurgeons is the CSF tap test, where there is clinical improvement following 
a lumbar puncture. Of all the tests available, the response to lumbar puncture is 
thought to be the most reliable. Serial psychometric tests are useful in assessing 
the response to treatment. These, together with a simple walking test, should be 
documented carefully before and after lumbar puncture.
The condition usually presents in middle or late life, sometimes with de­
mentia alone or with the clinical picture of the parkinsonism-dementia complex 
and 'drop' attacks may occur. The cause of the communicating hydrocephalus is 
unexplained in most such cases, although it may follow subarachnoid haemor­
rhage or may develop many years after recovery from meningitis or head injury. 
Differential diagnosis from cerebral atrophy in dementia is clearly important, as 
shunting operations are of no value in the latter condition; however, no single 
method provides an absolutely reliable distinction.
Radiological diagnosis
Radiographs of the skull in hydrocephalus may show enlargement of the 
calvarium, with suture diastasis, thinning, and exaggeration of convolutional 
markings. However, this latter finding alone may be normal and is an unreliable 
guide to raised intracranial pressure. Separation of the sutures may be present in
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children. The clinoid processes are often eroded and the sella turcica is deepened 
and expanded anteroposteriorly. CT and MR imaging give a clear picture of the 
ventricular size, and often the underlying cause is identified. MRI is superior to 
CT in identifying posterior fossa causes. The use of three-dimensional fast 
asymmetric spin-echo (FASE) MR imaging sequences strongly predicts a good 
response to shunting. Other MRI techniques to evaluate CSF flow have yielded 
conflicting results.
Monitoring/compliance
The most frequent form of monitoring is measurement of the head circum­
ference in infants. This is routine in most hospitals and in primary care. Devia­
tion from the percentile for a particular child should trigger referral for further 
assessment. Also, regular measurement of head circumference allows the effi­
cacy (or otherwise) of treatment to be monitored over time.
Intracranial pressure monitoring may be useful when there is uncertainty 
about the need for CSF diversion. This may take place via the chamber of a 
shunt or reservoir inserted specifically for this purpose. In normal-pressure hy­
drocephalus, intracranial pressure monitoring may be helpful, particularly if 
pressure waveform analysis is undertaken. Non-invasive intracranial pressure 
monitoring is possible via the fontanelle in infants or with the tympanic mem­
brane displacement test in adults.
Compliance (the reciprocal of elastance) may reflect the reserve capacity 
to withstand small changes in volume. It can now be measured directly with a 
continuous compliance monitor.
Prognosis
It has been recognized for many years that untreated infantile hydrocepha­
lus is fatal during the first few years of life, on average a hydrocephalic alive at 
3 months has a 26 per cent chance of reaching adult life without surgery, and 
survival to between 1 and 2 years is associated with a 50 per cent chance of 
reaching adulthood. Some who survive have mental retardation, epilepsy, or 
blindness. Even with underlying aqueduct stenosis, the hydrocephalic process 
often arrests spontaneously. In 41 per cent of 70 cases without spina bifida the 
IQ after 6 years was over 85, in 29 per cent below 50. The severity of hydro­
cephalus bears a close relationship to IQ and physical disability such as spastic­
ity and ataxia. In the past many children with the Arnold-Chiari malformation 
and myelomeningocele died from infection of the sac or hydrocephalus.
The introduction of ventricular diversion procedures reduced the mortality 
of hydrocephalus with myelomeningocele to 30 per cent at the end of 2 years, 
and that of uncomplicated hydrocephalus to less than 20 per cent. Two-thirds of 
such cases treated surgically had an IQ of 75 or more. More recent figures have 
claimed IQs of more than 100 in 31 per cent and greater than 70 in 85 per cent. 
The prognosis of hydrocephalus after infancy depends upon its cause and how 
far this is amenable to treatment. In nontumorous hydrocephalus, IQs were 
greater than 90 in 32 per cent and greater than 70 in 60 per cent. Also, adults
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who were treated for hydrocephalus due to spina bifida had poorer verbal and 
visuospatial memory performance than those with aqueduct stenosis.
Treatment by drainage
In an emergency, obstructive hydrocephalus can be treated by ventricular 
drainage through a burrhole or twistdrill. Drainage is usually maintained for up 
to 5 days via a closed system with a fixed-height drip-chamber. By contrast, 
communicating hydrocephalus can be treated by lumbar puncture or via a lum­
bar drain, provided that imaging has excluded any intracranial mass or tonsillar 
herniation. This is often the case with subarachnoid haemorrhage or meningitis. 
Because they can be set-up under local anaesthesia, such drainage methods may 
be used in emergency situations and in patients unfit for general anaesthesia. 
Permanent CSF diversion requires a general anaesthetic.
CSF diversion and shunts
In the past many operations, including excision of the choroid plexus, 
Torkildsen's ventriculo-cistemostomy, ventriculosubdural, ventriculo-ureteric, 
ventriculo-atrial and ventriculopleural drainage, were used, with varying degrees 
of success. Now there is general agreement that the treatment of choice is use of 
various shunts inserted into the lateral ventricle, with catheter drainage into the 
peritoneum. These shunts have differing hydrodynamic properties, which have 
been carefully evaluated. Most of them have low hydrodynamic resistance so 
that flow increases due to a siphoning effect when connected to a long distal 
catheter. Some shunts are programmable but they are all susceptible to siphon­
ing. Colonization of the valves with Staphylococcus albus or diphtheroids may 
be asymptomatic for some time. The UK shunt registry has documented varying 
infection and revision rates in the 44 UK units. Revision rates ranged from 18 to 
70 per cent and infection rates from 0 to 21 per cent.
The appropriate treatment of hydrocephalus after infancy depends upon its 
cause. A causative intracranial tumour must receive appropriate surgical treat­
ment whenever possible. When there is a tumour in the third ventricle or mid­
brain or in some other area that is causing obstruction but cannot be removed or 
treated effectively by radiotherapy, temporary improvement may result from a 
shunting operation with insertion of a ventriculo-peritoneal (VP) shunt.
While early reports of ventriculo-peritoneal shunting in cases of low- 
pressure hydrocephalus were encouraging, with about two-thirds of all patients 
showing early intellectual as well as physical improvement, after 3 years less 
than half demonstrated continuing benefit. In yet another series of patients, only 
a third were improved, and 50 per cent of a similar group of patients not oper­
ated upon failed to deteriorate over a 3-year period; the surgical group also 
showed a high incidence of complications. Thus early optimism has not been 
borne out by good long-term results in all cases. In some longstanding cases,
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there are irreversible neuropathological changes somewhat similar to those of 
Alzheimer’s disease, although this is an inevitable occurrence in any large group 
of patients presenting with mild dementia. With good clinical diagnostic criteria 
and a positive CSF tap test, shunting undoubtedly leads to improvement in many 
patients.
Other treatments
Third ventriculostomy has been reintroduced with advances in endoscopic 
techniques. It is particularly useful when hydrocephalus is due to aqueduct 
stenosis. Lumbo-peritoneal shunting is as successful as VP shunting in commu­
nicating hydrocephalus, normal-pressure hydrocephalus, and benign intracranial 
hypertension, and has the advantage of not requiring ventricular cannulation 
through brain tissue.
Rare underlying causes need to be considered in all cases of hydrocepha­
lus and may need prolonged treatment in their own right. Examples include anti­
tuberculous treatment for tuberculous meningitis or praziquantel for parasitic 
cysts.
SIGNS OF MENINGEAL IRRITATION
Neck stiffness
Ask the patient to flex the neck as fully as possible to ascertain the degree 
of movement possible, and then to relax. Then passively flex the neck. The chin 
should normally touch the chest without pain.
In meningeal irritation neck flexion causes pain in the posterior part of the 
neck, sometimes radiating down the back, and the movement is resisted by 
spasm in the extensor muscles of the neck. Neck rigidity is also caused by dis­
eases of the cervical spine. Head retraction represents a marked degree of neck 
rigidity.
Kernig's sign
Kernig's sign is tested with the patient supine on the bed by passively ex­
tending the patient's knee when the hip is fully flexed. In patients with men­
ingeal irritation affecting the lower part of the spinal subarachnoid space this 
movement causes pain and spasm of the hamstrings. It is a less sensitive test 
than neck stiffness.
These two tests depend upon the fact- that stretching the spinal nerve 
roots in meningeal irritation causes reflex muscular spasm in the paraspinal and 
sacral muscles. They are both positive in meningitis and subarachnoid haemor­
rhage, and also in patients with 'meningism', a state of irritation of the meninges 
seen most commonly in young children with acute fevers. In some patients with 
raised intracranial pressure in whom herniation of the cerebellar tonsils into the
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foramen magnum has occurred, neck stiffness may also be present.
Straight leg raising
This test is useful in patients with sciatica. The sciatic nerve and its roots 
are stretched by passively elevating the patient's extended leg with the hand, 
which is placed behind the heel. The movement is restricted by sciatic pain 
when a lumbosacral spinal root is entrapped, as in lumbosacral intervertebral 
disc protrusion.
197
HEADACHE & FACIAL PAIN
Headache occurs in all age groups and is the seventh leading reason for 
medical office visits; the causes are myriad. Although most often a benign con­
dition (especially when chronic and recurrent), headache of new onset may be 
the earliest or the principal manifestation of serious systemic or intracranial dis­
ease and therefore requires thorough and systematic evaluation.
An etiologie diagnosis of headache is based on understanding the patho­
physiology of head pain; obtaining a history, with characterization of the pain as 
acute, subacute, or chronic; performing a careful physical examination; and for­
mulating a differential diagnosis.
PATHOPHYSIOLOGY
Pain-Sensitive Structures
Headache is caused by traction, displacement, inflammation, vascular 
spasm, or distention of the painsensitive structures in the head or neck. Isolated 
involvement of the bony skull, most of the dura, or most regions of brain paren­
chyma does not produce pain.
A. Pain-Sensitive Structures Within the Cranial Vault. These include 
the venous sinuses (eg, sagittal sinus); the anterior and middle meningeal ar­
teries; the dura at the base of the skull; the trigeminal (V), glossopharyngeal 
(IX), and vagus (X) nerves; the proximal portions of the internal carotid artery 
and its branches near the circle of Willis; the brain stem periaqueductal gray 
matter; and the sensory nuclei of the thalamus.
B. Extracranial Pain-Sensitive Structures. These include the perio­
steum of the skull; the skin; the subcutaneous tissues, muscles, and arteries; the 
neck muscles; the second and third cervical nerves; the eyes, ears, teeth, sinuses, 
and oropharynx; and the mucous membranes of the nasal cavity.
Radiation or Projection of Pain
The trigeminal (V) nerve carries sensation from intracranial structures in 
the anterior and middle fossae of the skull, above the cerebellar tentorium. Dis­
crete intracranial lesions in these locations produce pain that radiates in the 
trigeminal nerve distribution.
The glossopharyngeal (IX) and vagus (X) nerves supply part of the poste­
rior fossa; pain originating in this area may also be referred to the ear or throat 
(eg, glossopharyngeal neuralgia).
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Fig. 13. Innervation o f pain-sensitive intracranial compartments (A) and 
corresponding extracranial sites of pain radiation (B). The trigeminal (V) nerve, 
especially its ophthalmic (VI) division, innervates the anterior and middle 
cranial fossae; lesions in these areas can produce frontal headache. The upper 
cervical nerve roots (especially C2) innervate the posterior fossa; lesions here 
can cause occipital headache. (From R. Simon, M  Aminoff, D. Greenberg, 
1999)
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The upper cervical nerves transmit stimuli arising from infratentorial and 
cervical structures; therefore, pain from posterior fossa lesions projects to the 
second and third cervical dermatomes.
CAUSES OF HEADACHE AND FACIAL PAIN
Acute onset
Common causes
Subarachnoid hemorrhage 
Other cerebrovascular diseases 
Meningitis or encephalitis 
Ocular disorders (glaucoma, acute iritis)
Less common causes 
Seizures
Lumbar puncture 
Hypertensive encephalopathy 
Coitus
Subacute Onset
Giant cell (temporal) arteritis
Intracranial mass (tumor, subdural hematoma, abscess)
Pseudotumor cerebri (benign intracranial hypertension)
Trigeminal neuralgia (tic douloureux)
Glossopharyngeal neuralgia 
Postherpetic neuralgia
Hypertension (including pheochromocytoma and the use of monoamine 
oxidase inhibitors plus tyramine)
Atypical facial pain 
Chronic
Migraine 
Cluster headache 
Tension headache 
Cervical spine disease 
Sinusitis 
Dental disease
HISTORY
Classification & Approach to the Differential Diagnosis
A. Acute Headaches and Facial Pain. Headaches that are new in onset 
and clearly different from any the patient has experienced previously are com­
monly a symptom of serious illness and therefore demand prompt evaluation.
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The sudden onset of "the worst headache I've ever had in my life" (classic su­
barachnoid hemorrhage), diffuse headache with neck stiffness and fever (menin­
gitis), and head pain centered about one eye (acute glaucoma) are striking ex­
amples. Acute headaches may also accompany more benign processes such as 
viral syndromes or other febrile illnesses.
B. Subacute Headaches and Facial Pain. Subacute headaches occur 
over a period of weeks to months. Such headaches may also signify serious 
medical disorders, especially when the pain is progressive or when it develops in 
elderly patients. Inquiries should be made about recent head trauma (subdural 
hematoma or postconcussive syndrome); a history of malaise, fever, or neck 
stiffness (subacute meningitis); other neurologic abnormalities or weight loss 
(primary or metastatic brain tumor); symptoms of vasculitis, especially giant cell 
arteritis; and medical conditions (eg, optic neuritis in multiple sclerosis; cutane­
ous herpes zoster) or medications.
C. Chronic Headaches and Facial Pain. Headaches that have occurred 
for years (eg, migraine or tension headaches) usually have a benign cause, al­
though each acute attack may be profoundly disabling. When treating these pa­
tients, it is important to determine whether the present headache is similar to 
those suffered previously or is new -  and thus represents a different process.
Precipitating Factors
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factors include recent eye or dental surgery; acute exacerbation of chronic si­
nusitis or hay fever; systemic viral infection; tension, emotional stress, or fa­
tigue; menses; hunger; ice cream; foods containing nitrite (hot dogs, salami, 
ham, and most sausage), phenylethylamine (chocolate), or tyramine (cheddar 
cheese); and bright lights. Precipitation of headache by alcohol is especially 
typical of cluster headache. Chewing and eating commonly trigger glosso­
pharyngeal neuralgia, tic douloureux, and the jaw claudication of giant cell ar­
teritis; these activities also trigger pain in patients with temporomandibular joint 
dysfunction. The use of oral contraceptive agents or other drugs such as nitrates 
may precipitate or exacerbate migraine and even lead to stroke. Intense head­
ache can occur in response to coughing in patients with structural lesions in the 
posterior fossa; in other instances no specific cause for cough headache can be 
identified.
Prodromal Symptoms
Prodromal symptoms or auras, such as scintillating scotomas or other vis­
ual changes, often occur with migraine; they may also occur in patients with a 
seizure disorder who present with postictal headaches.
Characteristics of Pain
Headache or facial pain is most often described as throbbing; a dull,
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steady ache; or a jabbing, lancinating pain. Pulsating, throbbing pain is fre­
quently ascribed to migraine, but it is equally common in patients with tension 
headache. A steady sensation of tightness or pressure is also commonly seen 
with tension headache. The pain produced by intracranial mass lesions is typi­
cally dull and steady. Sharp, lancinating pain suggests a neuritic cause such as 
trigeminal neuralgia. Ice picklike pain may be described by patients with mi­
graine, cluster headache, or giant cell arteritis.
Headache of virtually any description can occur in patients with migraine 
or brain tumors, however, so the character of the pain alone does not provide a 
reliable etiologie guide.
Location of Pain
Unilateral headache is an invariable feature of cluster headache and oc­
curs in the majority of migraine attacks; most patients with tension headache re­
port bilateral pain.
Ocular or retroocular pain suggests a primary ophthalmologic disorder 
such as acute iritis or glaucoma, optic (II) nerve disease (eg, optic neuritis), or 
retroorbital inflammation (eg, Tolosa-Hunt syndrome). It is also common in mi­
graine or cluster headache.
Paranasal pain localized to one or several of the sinuses, often associated 
with tenderness in the overlying periosteum and skin, occurs with acute infec­
tion or outlet obstruction of these structures.
Headache from intracranial mass lesions may be focal ("it hurts right 
here"), but even in such cases it is replaced by bioccipital and bifrontal pain 
when the intracranial pressure becomes elevated.
Bandlike or occipital discomfort is commonly associated with tension 
headaches. Occipital localization can also occur with meningeal irritation from 
infection or hemorrhage and with disorders of the joints, muscles, or ligaments 
of the upper cervical spine.
Pain within the first division of the trigeminal nerve, characteristically de­
scribed as burning in quality, is a common feature of postherpetic neuralgia.
Lancinating pain localized to the second or third division of the trigeminal 
nerve suggests tic douloureux.
The pharynx and external auditory meatus are the most frequent sites of 
pain caused by glossopharyngeal neuralgia.
Associated Symptoms
Manifestations of underlying systemic disease can aid in the etiologie di­
agnosis of headache and should always be sought.
Recent weight loss may accompany cancer, giant cell arteritis, or depres­
sion.
Fever or chills may indicate systemic infection or meningitis.
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Dyspnea or other symptoms of heart disease raise the possibility of 
subacute infective endocarditis and resultant brain abscess.
Visual disturbances suggest an ocular disorder (eg, glaucoma), migraine, 
or an intracranial process involving the optic nerve or tract or the central visual 
pathways.
Nausea and vomiting are common in migraine and posttraumatic head­
ache syndromes and can be seen in the course of mass lesions. Some patients 
with migraine also report that diarrhea accompanies the attacks.
Photophobia may be prominent in migraine and acute meningitis or su­
barachnoid hemorrhage.
Myalgias often accompany tension headaches, viral syndromes, and giant 
cell arteritis.
Ipsilateral rhinorrhea and lacrimation during attacks typify cluster head­
ache.
Transient loss of consciousness may be a concomitant of both migraine 
and glossopharyngeal neuralgia.
Other Features of Headache
A. Temporal Pattern of Headache. Headaches from mass lesions are 
commonly maximal on awakening, as are sinus headaches. Headaches from 
mass lesions, however, increase in severity over time. Cluster headaches fre­
quently awaken patients from sleep; they often recur at the same time each day 
or night. Tension headaches can develop whenever stressful situations occur and 
are often maximal at the end of a workday. Migraine headaches are episodic and 
may be worse during menses.
B. Conditions Relieving Headache. Migraine headaches are frequently 
relieved by darkness, sleep, vomiting, or pressing on the ipsilateral temporal ar­
tery, and their frequency is often diminished during pregnancy. Postlumbar- 
puncture headaches are typically relieved by recumbency, while headaches 
caused by intracranial mass lesions may be less severe with the patient standing.
C. Conditions Exacerbating Headache. Discomfort exacerbated by 
rapid changes in head position or by events that transiently raise intracranial 
pressure, such as coughing and sneezing, is often associated with an intracranial 
mass but can also occur in migraine. Anger, excitement, or irritation can pre­
cipitate or worsen both migraine and tension headaches. Stooping, bending for­
ward, sneezing, or blowing the nose characteristically worsens the pain of si­
nusitis. Postural headache (maximal when upright, nearly absent when lying 
down) occurs with low CSF pressure caused by lumbar puncture, head injury, or 
spinal fluid leak.
Fluctuations in intensity and duration of the headache with no obvious 
cause, especially when associated with similar fluctuations in mental status, are 
seen with subdural hematoma.
203
D. History of Headache. The characteristics of the present headache 
should be compared with those of previous occurrences, since headache with 
features different from those previously experienced calls for careful investiga­
tion.
EXAMINATION
A general physical examination is mandatory, since headache is a nonspe­
cific accompaniment of many systemic disorders. If possible, the patient should 
be observed during an episode of headache or facial pain.
Vital Signs
A. Temperature. Although fever suggests a viral syndrome, meningitis, 
encephalitis, or brain abscess, headache from these causes can occur without fe­
ver. Moreover, headache can accompany any systemic infectious illness.
B. Pulse. Tachycardia can occur in a tense, anxious patient with a tension 
headache or accompany any severe pain. Paroxysmal headache associated with 
tachycardia and perspiration is characteristic of pheochromocytoma.
C. Blood Pressure. Hypertension per se rarely causes headache unless the 
blood pressure elevation is acute, as with pheochromocytoma, or very high, as 
with early hypertensive encephalopathy. Chronic hypertension, however, is the 
major risk factor for stroke, which can be associated with acute headache. Su­
barachnoid hemorrhage is commonly followed by marked acute blood pressure 
elevation.
D. Respiration. Hypercapnia from respiratory insufficiency from any 
cause can elevate intracranial pressure and produce headache.
General Physical Examination
A. Weight Loss. Weight loss or cachexia in a patient with headache sug­
gests the presence of cancer or chronic infection. Polymyalgia rheumatica-giant 
cell arteritis syndromes can also be accompanied by weight loss.
B. Skin. Focal cellulitis of the face or overlying the skull indicates local 
infection, which may be the source of intracranial abscess or venous sinus 
thrombosis. Cutaneous abnormalities elsewhere may suggest vasculitis (includ­
ing that from meningococcemia), endocarditis, or cancer. The neurofibromas or 
cafe-au-lait spots of von Recklinghausen's disease (neurofibromatosis) may be 
associated with benign or malignant intracranial tumors that produce headache. 
Cutaneous angiomas sometimes accompany arteriovenous malformations (A 
VMs) of the central nervous system and may be associated with chronic head­
ache -  or acute headache if they bleed. Herpes zoster that affects the face and 
head most often involves the eye and the skin around the periorbital tissue, caus­
ing facial pain.
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C. Scalp, Face, and Head. Scalp tenderness is characteristic of migraine 
headache, subdural hematoma, giant cell arteritis, and postherpetic neuralgia. 
Nodularity, erythema, or tenderness over the temporal artery suggests giant cell 
arteritis. Localized tenderness of the superficial temporal artery also accompa­
nies acute migraine. Recent head trauma or a mass lesion can cause a localized 
area of tenderness.
Paget's disease, myeloma, or metastatic cancer of the skull may produce 
head pain that is boring in quality and associated with skull tenderness. In 
Paget's disease, arteriovenous shunting within bone may make the scalp feel 
warm.
Disorders of the eyes, ears, or teeth may cause headache. Tooth percus­
sion may reveal periodontal abscess. Sinus tenderness may indicate sinusitis. A 
bruit over the orbit or skull suggests an intracranial AVM, a carotid artery- 
cavernous sinus fistula, an aneurysm, or a meningioma. Lacerations of the 
tongue raise the possibility of postictal headache. Ipsilateral conjunctival injec­
tion, lacrimation, Horner's syndrome, and rhinorrhea occur with cluster head­
ache. Temporomandibular joint disease is accompanied by local tenderness and 
crepitus.
D. Neck. Cervical muscle spasms occur with tension and migraine head­
aches, cervical spine injuries, cervical arthritis, or meningitis. Carotid bruits may 
be associated with cerebrovascular disease.
Meningeal signs must be carefully sought, especially if the headache is of recent 
onset. Meningeal irritation causes nuchal rigidity mainly in the anteroposterior 
direction, while cervical spine disorders restrict movement in all directions. Dis­
comfort or hip and knee flexion during neck flexion (Brudzinski's sign) readily 
indicates meningeal irritation.
Meningeal signs may be absent or difficult to demonstrate in the early 
stages of subacute (eg, tuberculous) meningitis, in the first few hours after su­
barachnoid hemorrhage, and in comatose patients.
E. Heart and Lung. Brain abscess may be associated with congenital 
heart disease, which is evidenced by murmurs or cyanosis. Lung abscess may 
also be a source of brain abscess.
NEUROLOGIC EXAMINATION
Mental Status Examination
During the mental status examination, patients with acute headache may 
demonstrate confusion, as is commonly seen with subarachnoid hemorrhage and 
meningitis. Dementia may be the major feature of intracranial tumor, particu­
larly one in the frontal lobe.
Cranial Nerve Examination
Cranial nerve abnormalities may suggest and localize an intracranial tu-
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mor or other mass lesion. Papilledema, the hallmark of increased intracranial 
pressure, may be seen in space-occupying intracranial lesions, carotid artery- 
cavernous sinus fistula, pseudotumor cerebri, or hypertensive encephalopathy. 
Superficial retinal (subhyaloid) hemorrhages are characteristic of subarachnoid 
hemorrhage in adults. Ischemic retinopathy may be found in patients with vascu­
litis.
Progressive oculomotor nerve palsy, especially when it causes pupillary 
dilatation, may be the presenting sign of an expanding posterior-communicating- 
artery aneurysm, or it may reflect increasing intracranial pressure and incipient 
herniation. Decreased pupillary reactivity occurs in optic neuritis. Extraocular 
muscle palsies occur in Tolosa-Hunt syndrome. Proptosis suggests an orbital 
mass lesion or carotid artery-cavernous sinus fistula.
Decreased sensation over the area of pain-most commonly the first divi­
sion of the trigeminal nerveis found in postherpetic neuralgia. Trigger areas elic­
iting pain in and about the face and pharynx suggest trigeminal and glosso­
pharyngeal neuralgia, respectively.
Motor Examination
Asymmetric motor function or gait ataxia in a patient with a history of 
subacute headache demands complete evaluation to exclude intracranial mass le­
sions.
Sensory Examination
Focal or segmental sensory impairment or diminished corneal sensation 
(corneal reflex) is strong evidence against a benign cause of pain.
ACUTE HEADACHES
Sudden onset of new headache may be a symptom of serious intracranial 
or systemic disease; it must be investigated promptly and thoroughly.
CEREBROVASCULAR DISORDERS
The classic presentation of subarachnoid hemorrhage is the sudden onset 
of an unusually severe generalized headache. The absence of headache essen­
tially precludes the diagnosis. Loss of consciousness is frequent, as are vomiting 
and neck stiffness. Symptoms may begin at any time of day and during either 
rest or exertion. The most significant feature of the headache is that it is new.
Milder but otherwise similar headaches may have occurred in the weeks prior to 
the acute event. These earlier headaches are probably the result of small pro­
dromal hemorrhages (sentinel, or warning, hemorrhages) or aneurysmal stretch.
The headache is not always severe, however, especially if the subarachnoid v
hemorrhage is from a ruptured AVM rather than an aneurysm. Although the du-
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ration of the hemorrhage is brief, the intensity of the headache may remain un­
changed for several days and subside only slowly over the next 2 weeks. A re- 
crudescent headache usually signifies recurrent bleeding.
Headache may be associated with -  or may rarely be the presenting symp­
tom of -  thrombotic or embolic stroke. Compression of pain-sensitive structures 
is the mechanism of headache in intracranial hemorrhage, while pain-sensitive 
receptors in large cerebral arteries are responsible for headache in thrombotic 
and embolic stroke. Lacunar strokes, which affect small arterial branches deep 
in the brain, are not as frequently associated with headache.
Headaches associated with ischemic stroke are typically mild to moderate 
in intensity, ipsilateral to the involved hemisphere, and nonthrobbing in char­
acter. Their location is determined by the pain projection sites of the involved 
arteries: posterior fossa strokes usually present with occipital headache, whereas 
carotid lesions usually produce frontal (trigeminal distribution) pain. Transient 
ischemic attacks may be associated with headache in as many as 50% of cases; 
in perhaps one-third of these, headaches precede the other symptoms.
Headache accompanying retinal artery embolism or posterior cerebral ar­
tery spasm or occlusion may be erroneously diagnosed as migraine because of 
the associated visual impairment.
Headache also occurs following carotid endarterectomy and may be asso­
ciated with focal sensory or motor signs of contralateral hemispheric ischemia. 
This syndrome occurs in the presence of a patent carotid artery on the second or 
third postoperative day and typically produces intense throbbing anterior head­
ache that is often associated with nausea.
Headache disorders associated with ischemic or hemorrhagic cerebral in­
farction require direct treatment of the cerebral lesion combined with the use of 
analgesics for symptomatic relief.
MENINGITIS OR ENCEPHALITIS
Headache is a prominent feature of inflammation of the brain (encephali­
tis) or its meningeal coverings (meningitis) caused by bacterial, viral, or other 
infections; granulomatous processes; neoplasms; or chemical irritants. The pain 
is caused by inflammation of intracranial pain-sensitive structures, including 
blood vessels at the base of the brain. The headache syndrome produced is 
commonly throbbing in character, bilateral, and occipital or nuchal in location. 
The headache is increased by sitting upright, moving the head, compressing the 
jugular vein, or performing other maneuvers (eg, sneezing, coughing) that tran­
siently increase intracranial pressure. Photophobia may be prominent. The head­
ache rarely presents suddenly but more commonly develops over hours to days, 
especially with subacute infections (eg, tuberculous meningitis).
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Neck stiffness and other signs of meningeal irritation must be sought with 
care, since they may not be obvious either early in the course of the illness or 
when the brain parenchyma, rather than meninges, is the predominant site of in­
volvement. Lethargy or confusion may also be a prominent feature.
The diagnosis is suggested by a CSF examination that shows an increased 
white blood cell count. Bacterial, syphilitic, tuberculous, viral, fungal, and para­
sitic infections may be distinguished by CSF VDRL, Gram's stain, acid-fast 
stain, India ink preparation and cryptococcal antibody assays, and cultures.
HYPERTENSIVE ENCEPHALOPATHY
Headache may be due to a sudden elevation in blood pressure such as is 
caused by pheochromocytoma, sexual intercourse, the combination of mono­
amine oxidase inhibitors and tyramine-containing foods such as cheddar cheese, 
or-the most important cause-malignant hypertension. Blood pressures of 
250/150 mm Hg or higher -  characteristic of malignant hypertension -  produce 
cerebral edema and displace pain-sensitive structures. The pain is described as 
severe and throbbing. Other signs of diffuse or focal central nervous system dys­
function are present, such as lethargy, hemiparesis, or focal seizures on CT or 
MRJ images, posterior white matter changes may be seen. Treatment is with an­
tihypertensive drugs, but care must be taken to avoid hypotension, which can re­
sult in cerebral ischemia and stroke.
SEIZURES
Postictal headache that follows generalized tonicclonic seizures is fre­
quently accompanied by resolving lethargy, diffuse muscle soreness, or tongue 
laceration. Although this headache requires no specific treatment, it is important 
to differentiate it from subarachnoid hemorrhage and meningitis. If doubt exists, 
lumbar puncture should be undertaken.
LUMBAR PUNCTURE
Postlumbar-puncture headache is diagnosed by a history of lumbar punc­
ture -  and by the characteristic marked increase in pain in the upright position 
and relief with recumbency. The pain is typically occipital, comes on 24-48 
hours after the procedure (although it may be later), and lasts 1-2 days, but may 
be prolonged. Headache is caused by persistent spinal subarachnoid leak with 
resultant traction on pain-sensitive structures at the base of the brain. The risk of 
this complication can be reduced by using a small-gauge needle (22 gauge or
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smaller) for the puncture and removing only as much fluid as needed for the 
studies to be performed. Lying flat afterward, for any length of time, does not 
lessen the incidence. Low-pressure headache syndromes are usually selflimited. 
When this is not the case, they may respond to the administration of caffeine so­
dium benzoate, 500 mg intravenously, which can be repeated after 45 minutes if 
headache persists or recurs upon standing. In persistent cases, the subarachnoid 
rent can be sealed by injection of autologous blood into the epidural space at the 
site of the puncture; this requires an experienced anesthesiologist. Headache 
similar in character to that caused by lumbar puncture occasionally occurs spon­
taneously. Tl-weighted, gadolinium-enhanced MRI may show smooth en­
hancement of the pachymeninges, which may be confused with leptomeningeal 
enhancement.
OCULAR DISORDERS
Pain about the eye may occur in migraine and cluster headache and is also 
the presenting feature of iritis and glaucoma. Acute iritis produces extreme eye 
pain that is associated with photophobia. The diagnosis is confirmed by slit lamp 
examination; acute management involves pharmacologic dilatation of the pupil. 
Angle-closure glaucoma produces pain within the globe that radiates to the 
forehead. When it occurs after middle age, such a pain syndrome should prompt 
diagnostic tonometry. Acute treatment is with glycerol, 1 mL/kg orally, fol­
lowed by pilocarpine, 2%, 2 drops every 15 minutes.
HEADACHES OF SUBACUTE ONSET
GIANT CELL ARTERITIS
This disorder, also known as temporal arteritis, is characterized by a 
subacute granulomatous inflammation (consisting of lymphocytes, neutrophils, 
and giant cells) that affects the external carotid arterial system, particularly the 
superficial temporal artery, and the vertebral artery. Inflammation of the pain- 
sensitive arterial wall produces the headache. Thrombosis may occur in the most 
severely affected arteries.
This syndrome, which affects women twice as frequently as men, is un­
common before age 50 and is frequently associated with nonspecific signs and 
symptoms, such as malaise, myalgia, weight loss, arthralgia, and fever (the po­
lymyalgia rheumatic a complex). The headache can be unilateral or bilateral, 
fairly severe, and boring in quality. It is characteristically localized to the scalp,
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especially over the temporal arteries. Scalp tenderness may be especially appar­
ent when lying with the head on a pillow or brushing the hair. Pain or stiffness 
in the jaw during chewing Gaw claudication) is highly suggestive of giant cell 
arteritis and is due to arterial ischemia in the muscles of mastication. Involve­
ment of the ophthalmic artery leads to permanent blindness in 50% of untreated 
patients; in half of these, blindness will become bilateral. The visual loss is most 
often sudden in onset. Although episodes of transient prodromal blindness have 
been reported, blindness is unusual as an initial symptom; however, it often oc­
curs within the first month.
The diagnosis is made by biopsy of affected temporal arteries, which are 
characteristically thickened and nonpulsatile as well as dilated and tender. The 
temporal arteries may be affected in a patchy manner, and serial sections may be 
necessary to demonstrate histologic vasculitis. The erythrocyte sedimentation 
rate (ESR) is almost invariably elevated. The mean Westergren ESR is about 
100 mm/h in giant cell arteritis (range, 29-144 mm/h) and in polymyalgia rheu- 
matica (range, 58-160 mm/h). The normal upper limit of the Westergren ESR in 
elderly patients is reported to be only as high as 40 mm/h.
Consideration of this diagnosis demands prompt inpatient evaluation if vi­
sion is to be preserved. Therapy for giant cell arteritis is prednisone, 40-60 mg/d 
orally, with decreasing dosage usually after about 3 months, depending upon the 
clinical response. The sedimentation rate returns rapidly toward normal with 
prednisone therapy and must be maintained within normal limits as the drug 
dose is tapered. Therapy should not be withheld pending biopsy diagnosis and 
should be continued despite negative biopsy findings if the diagnosis can be 
made with confidence on clinical grounds. Therapy generally has to be contin­
ued for 1-2 years. Although dramatic improvement in headache occurs within 2- 
3 days after institution of therapy, the blindness is usually irreversible.
INTRACRANIAL MASS
The new onset of headache in middle or later life should always raise con­
cern about a mass lesion. A mass lesion, such as a brain tumor, subdural hema­
toma, or abscess, may or may not produce headache depending upon whether or 
not it compresses or distorts pain-sensitive intracranial structures. Only 30% of 
patients with intracranial tumor present with headache as the first symptom, al­
though 80% have such a complaint at the time of diagnosis. Subdural hematoma 
frequently presents with conspicuous headache, since its large size increases the 
likelihood of impinging upon pain-sensitive areas. Headaches associated with 
brain tumors are most often nonspecific in character, mild to moderate in sever­
ity, dull and steady in nature, and intermittent. The pain is characteristically bi- 
frontal, worse ipsilaterally, and aggravated by a change in position or by maneu­
vers that increase intracranial pressure, such as coughing, sneezing, and strain-
210
ing at stool. The headache is classically maximal on awakening in the morning 
and is associated with nausea and vomiting.
An uncommon type of headache that suggests brain tumor is characterized 
by a sudden onset of severe pain reaching maximal intensity within seconds, 
persisting for minutes to hours, and subsiding rapidly. Altered consciousness or 
"drop attacks" may be associated. Although classically associated with third 
ventricular colloid cysts, these paroxysmal headaches can be associated with 
tumors at many different intracranial sites.
Suspicion of an intracranial mass lesion demands prompt evaluation, pref­
erably with CT scan or MRI. Lumbar puncture should not be used as a diagnos­
tic screening test, since the results are nonspecific and the procedure may aggra­
vate the symptoms of the intracerebral mass, sometimes with a fatal outcome.
PSELDOTUMOR CEREBRI
Pseudotumor cerebri (benign intracranial hypertension) is characterized 
by a diffuse increase in intracranial pressure causing headache, papilledema, and 
diminished visual acuity. Diplopia may also occur as a result of abducens nerve 
palsy. Although pseudotumor can accompany many disorders, most cases are 
idiopathic. In the idiopathic variety, women are affected much more commonly 
than men, with a peak incidence in the third decade. Diffuse headache is almost 
always a presenting symptom, and diplopia and blurred vision occur in 60% of 
cases. Although visual acuity is normal in 50% of patients at presentation, mod­
erate to severe papilledema is seen in almost 90%. Visual loss from increased 
intracranial pressure can occur even in the idiopathic form; episodes of clouded 
vision precede the loss.
The course of the idiopathic disorder is generally self-limited over several 
months, with no sequelae if intracranial pressure is maintained at a relatively 
normal level to prevent secondary optic atrophy. Differentiating idiopathic 
pseudotumor cerebri from intracerebral mass lesions and from some other disor­
ders is critical; evaluation must include MRI or CT brain scanning. These stud­
ies typically show small (slitlike) ventricles in pseudotumor cerebri. Elevation of 
intracranial pressure can be documented by lumbar puncture, if a specific cause 
is identified, it must be treated appropriately.
Treatment with acetazolamide, 250 mg orally three times daily, with or 
without a diuretic (eg, furosemide), may be adequate to control mild intracranial 
hypertension. In other instances, prednisone, 60-80 mg/d orally, may be neces­
sary. In refractory cases, repeated lumbar punctures or lumboperitoneal shunting 
procedures protect vision and decrease headache. Transorbital optic nerve sheath 
fenestration is also used to protect the optic nerve from the pressure injury that is 
thought to cause blindness.
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TRIGEMINAL NEURALGIA
Trigeminal neuralgia (tic douloureux) is a facialpain syndrome of un­
known cause that develops in middle to late life. In many instances, the trigemi­
nal nerve roots are close to some vascular structure, and microvascular compres­
sion of the nerve is believed to cause the disorder. Pain is confined mainly to the 
area supplied by the second and third divisions of the trigeminal nerve. In­
volvement of the first division or bilateral disease occurs in less than 5% of 
cases. Characteristically, lightninglike momentary jabs of excruciating pain oc­
cur and spontaneously abate. Occurrence during sleep is rare. Painfree intervals 
may last for minutes to weeks, but long-term spontaneous remission is rare. Sen- 
sorystimulation of trigger zones about the cheek, nose, or mouth by touch, cold, 
wind, talking, or chewing can precipitate the pain. Physical examination dis­
closes no abnormalities. Rarely, similar pain may occur in multiple sclerosis or 
brain stem tumors, and these possibilities should thus be considered in young 
patients and in all patients who show neurologic abnormalities on examination.
In idiopathic cases, CT scan and MR1 fail to show any abnormality, and 
arteriography is similarly normal. Any vascular structure compressing the nerve 
roots is generally too small to be seen by these means.
Remission of symptoms with carbamazepine, 400-1200 mg/d orally in 
three divided doses, occurs within 24 hours in such a high percentage of cases 
that some believe it to be diagnostic. Rarely, blood dyscrasia occurs as an ad­
verse reaction to carbamazepine. Intravenous administration of phenytoin, 250 
mg, will abort an acute attack, and phenytoin, 200-400 mg/d orally, may be ef­
fective in combination with carbamazepine if a second drug is necessary. Lamo- 
trigine 400 mg/d or baclofen 10 mg three times daily-20 mg four times daily has 
been used in refractory cases. Posterior fossa microvascular decompressive sur­
gery has been used in drug-resistant cases.
GLOSSOPHARYNGEAL NEURALGIA
Patients with glossopharyngeal neuralgia, an uncommon pain syndrome, 
present with either a paroxysmal pain that is identical in quality to that of 
trigeminal neuralgia, or a continuous burning or aching discomfort. The pain is 
localized to the oropharynx, the tonsillar pillars, the base of the tongue, or the 
auditory meatus. The trigger areas are usually around the tonsillar pillars, so that 
symptoms are initiated by swallowing or by talking. Paroxysms of pain can oc­
cur many times daily and may be accompanied by syncopal episodes caused by 
transient bradyarrhythmias. Men are affected more often than women, and 
symptoms begin at a somewhat younger age than in trigeminal neuralgia. The 
diagnosis is established by the history and by reproducing pain through stimula­
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tion of the trigger zones. Examination reveals no abnormal neurologic signs. 
Application of local anesthetics to the trigger area may block the pain response. 
Carbamazepine or phenytoin therapy (as described above for trigeminal neural­
gia) usually produces dramatic relief.
POSTHERPETIC NEURALGIA
Herpes zoster-a vesicular skin eruption in dermatomal distribution, ac­
companied and followed by local pain and tendemess-is due to reactivation of 
varicella-zoster virus in patients with a history of varicella infection. It becomes 
increasingly common with advancing age (70% in those over 70 years), in im­
munocompromised patients, and in patients with certain malignant diseases (eg, 
leukemia, lymphoma). Postherpetic neuralgia is characterized by constant, se­
vere, stabbing or burning, dysesthetic pain that may persist for months or years 
in a minority of patients, especially older ones. It occurs in the same dermatomic 
distribution as a previous bout of herpes zoster, conforming to the distribution of 
the involved nerve root, where residual scars may be present. When the head is 
involved, the first division of the trigeminal nerve is most commonly affected, 
so that pain is usually localized to the forehead on one side. Careful testing of 
the painful area reveals decreased cutaneous sensibility to pinprick. The other 
major complication of trigeminal herpes is decreased corneal sensation with im­
paired blink reflex, which can lead to corneal abrasion, scarring, and ultimate 
loss of vision.
The intensity and duration of the cutaneous eruption and the acute pain of 
herpes zoster are reduced by treatment with acyclovir, but this treatment has not 
been shown to lessen the likelihood of postherpetic neuralgia. Corti со steroids 
(60 mg/d prednisone, orally for 2 weeks, with rapid tapering) taken during the 
acute herpetic eruption also reduce the incidence of acute herpetic pain, but have 
an uncertain effect on postherpetic pain. Once the postherpetic pain syndrome is 
established, the most useful treatment has been with tricyclic antidepressants 
such as amitriptyline, 25-150 mg/d orally, which are thought to act directly on 
central nervous system pain-integration pathways (rather than via an antide­
pressant effect). Tricyclic antidepressant drugs may be more effective when 
combined with a phenothiazine, as in the commercially available preparation 
Triavil. Postherpetic neuralgia subsides within 6-12 months in many patients but 
in 50% of those over 70 years the pain persists. Lidocaine-prilocaine 2.5% 
cream, or lidocaine gel 5%, is effective topical therapy. Topical application of 
capsaicin cream, which depletes pain-mediating peptides from peripheral sen­
sory neurons, can also be helpful but is poorly tolerated.
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HYPERTENSION
Chronic hypertension is often invoked as a cause of headache, but evi­
dence to support such a connection is sparse. In contrast, headache is a well- 
established complication of paroxysmal hypertension such as is seen in patients 
with pheochromocytoma or those ingesting tyramine-rich foods while being 
treated with monoamine oxidase inhibitors. In pheochromocytoma, headache at­
tacks are brief. They last less than 15 minutes in one-half of patients and are 
characteristically associated with perspiration and tachycardia. The headache is 
usually bilateral and may be precipitated by urination if the bladder is involved.
ATYPICAL FACIAL PAIN
Constant, boring, mainly unilateral lower facial pain for which no cause 
can be found is referred to as atypical facial pain. Unlike trigeminal neuralgia, it 
is not confined to the trigeminal nerve distribution and is not paroxysmal. This 
idiopathic disorder must be distinguished from similar pain syndromes related to 
nasopharyngeal carcinoma, intracranial extension of squamous cell carcinoma of 
the face, or infection at the site of a tooth extraction. Treatment is with amitrip­
tyline, 20-250 mg/d orally, alone or in combination with phenelzine, 30-75 mg/d 
orally. Dilantin can be an effective alternative, especially if a tricyclic is inap­
propriate.
CHRONIC HEADACHES
MIGRAINE
Migraine is manifested by headache that is usually unilateral and fre­
quently pulsatile in quality; it is often associated with nausea, vomiting, photo­
phobia, phonophobia and lassitude. Visual or other neurologic auras occur in 
about 10% of patients. Two-thirds to three-fourths of cases of migraine occur in 
women; the onset is early in life-approximately 25% beginning during the first 
decade, 55% by 20 years of age, and more than 90% before age 40. A family 
history of migraine is present in most cases.
Genetics of Migraine
The aggregation of migraine within families has long been recognized, al­
though consistent mendelian patterns of inheritance have not been found among
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the collective group of familial migraineurs. Presumably this reflects a variety of 
inheritance patterns, variable penetrance, and possibly multiple genes interacting 
with environmental factors in the multigenic/multifactorial pattern characteristic 
of complex diseases. Concordance rates in monozygotic twins of only 28-52 at­
test to the genetic component, but also predict a significant environmental con­
tribution.
A rare subtype of migraine with aura, familial hemiplegic migraine, has a 
straightforward autosomal dominant, highly penetrant inheritance pattern indica­
tive of a strong genetic component. Three genetic loci for familial hemiplegic 
migraine have been identified: one on Chrl9pl3 (associated with missense mu­
tations in a brain-expressed, voltagegated P/Q calcium channel gene) and two 
neighboring loci on Chrlq.
Pathogenesis
Intracranial vasoconstriction and extracranial vasodilatation have long 
been held to be the respective causes of the aura and headache phases of mi­
graine. This theory received support from the efficacy of vasoconstrictive ergot 
alkaloids (eg, ergotaminę) in aborting the acute migraine attack and vasodilators 
such as amyl nitrite in abolishing the migraine aura. More recent studies of re­
gional cerebral blood flow during migraine attacks have demonstrated a reduc­
tion in regional flow, which begins in the occipital region, during the aura phase. 
The "spreading depression" in cerebral blood flow, however, proceeds according 
to cytoarchitectural patterns in the cerebral cortex and does not reflect the distri­
bution of major vascular territories. In addition, the areas of decreased blood 
flow do not correspond to the cortical areas responsible for the particular aura, 
and regional cerebral blood flow may remain depressed after focal neurologic 
symptoms have resolved and headache has begun. Later in the headache phase, 
blood flow increases to parts of the cortex (cingulate, auditory, and visual asso­
ciation areas) and the brainstem (serotonergic dorsal raphe nucleus and adrener­
gic nucleus ceruleus); treatment with effective agents (sumatriptan, ergotaminę) 
attenuates the cortical but not brainstem changes. These data imply that vascular 
abnormalities in migraine may be secondary to a primary disturbance in neu­
ronal function in the brainstem.
Serotonergic neurons ramify extensively throughout the brain, and many 
effective antimigraine drugs act as antagonists or partial agonists at central sero­
tonin receptors. Serotonin in platelets decreases and urinary serotonin increases 
during the acute phase of a migraine attack. Depletion of serotonin by reserpine 
may precipitate migraine. The headache and other manifestations of migraine 
may thus reflect a disorder of central serotonergic neurotransmission. The link 
between neuronal initiation and trigeminovascular-mediated pain may be calci- 
tonoin gene-related peptide (CGRP), which is a potent vasodilator increased in
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venous blood during migraine and decreased by serotonin antagonists (sumatrip­
tan).
Clinical Findings
A. Migraine with Aura (Classic Migraine). Classic migraine headache 
is preceded by transient neurologic symptoms-the aura. The most common auras 
are visual alterations, particularly hemianopic field defects and scotomas and 
scintillations that enlarge and spread peripherally. A throbbing unilateral head­
ache ensues with or following these prodromal features. The frequency of head­
ache varies, but more than 50% of patients experience no more than one attack 
per week. The duration of episodes is greater than 2 hours and less than 1 day in 
most patients. Remissions are common during the second and third trimesters of 
pregnancy and after menopause. Especially in the elderly, prodromal symptoms 
may occur without headache (migraine equivalents). Although hemicranial pain 
is a hallmark of classic migraine, headaches can also be bilateral. Bilateral head­
ache, therefore, does not exclude the diagnosis of migraine, nor does an occipital 
location-a characteristic commonly attributed to tension headaches. During the 
headache, prominent associated symptoms include nausea, vomiting, pho­
tophobia, phonophobia, irritability, osmophobia, and lassitude. Uncommonly, 
migraines are associated with frank neurologic deficits that accompany, or per­
sist beyond resolution of, the pain phase. These may include hemiparesis, hemi- 
sensory loss, speech dysfunction, or visual disturbance. Vasomotor and auto­
nomic symptoms are frequent; light-headedness, vertigo, ataxia, or altered con­
sciousness may represent vertebrobasilar ischemia. All these phenomena may be 
distinguished from stroke both by their gradual onset ("migrainous march") and 
spontaneous resolution. Stroke may very exceptionally occur as a consquence of 
migraine alone.
B. Migraine without Aura (Common Migraine). The common migraine 
headache lacks the classic aura, is usually bilateral and periorbital, and is seen 
more frequently in clinical practice. The pain may be described as throbbing. As 
the pain persists, associated cervical muscle contraction can compound the 
symptoms. Scalp tenderness is often present during the episode. Vomiting may 
occasionally terminate the headache.
A useful bedside test for both common and classic migraine is reducing 
headache severity by compressing the ipsilateral carotid or superficial temporal 
artery.
Precipitating Factors
Migraine attacks can be precipitated by certain foods (tyramine- 
containing cheeses; meat, such as hot dogs or bacon, with nitrite preservatives; 
chocolate containing phenylethylaminę but not chocolate alone) and by food ad-
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ditives such as monosodium glutamate, a commonly used flavor enhancer. Fast­
ing, emotion, menses, drugs (especially oral contraceptive agents and vasodila­
tors such as nitroglycerin), and bright lights may also trigger attacks.
Treatment
Acute migraine attacks may respond to simple analgesics (eg, aspirin, 
acetaminophen, naprosyn). If not, they usually respond to ergot preparations or 
to the 5-HT agonist sumatriptan. These drugs must be taken immediately at the 
onset of symptoms to be maximally effective. Rapidly absorbed forms (eg, sup­
pository, aerosol) are superior to oral or sublingual preparations. In severe cases, 
subcutaneous, nasal, intramuscular or intravenous administration is used. Unfor­
tunately, nausea, which is a prominent feature of migraine, is also a common 
side effect of the drugs, so that concomitant administration of an antiemetic (eg, 
metoclopramide, 10 mg subcutaneously or intravenously) may be necessary. Er­
got alkaloids and 5-HT agonists are potent vasoconstrictors and are contraindi­
cated in patients with significant hypertension or cardiac disease. Established 
migraine headaches may respond to dihydroergotamine, sumatriptan, or narcotic 
analgesics (eg, meperidine, 100 mg intramuscularly).
Several drugs are effective in the prophylactic treatment of migraine. Pro­
phylactic treatment is indicated for patients who have frequent attacks -  espe­
cially more than one per week -  and those for whom the ergot alkaloids used for 
acute treatment are poorly tolerated or contraindicated. Three structurally unre­
lated agents -  propranolol, amitriptyline, and valproic acid -  are the mainstays 
of therapy. Each is effective in a substantial fraction of patients, and patients re­
fractory to one agent may respond to another. The initial choice of medication is 
usually influenced by consideration of clinical side effects that may be es­
pecially troublesome for a particular patient. Propranolol, imipramine, and 
amitriptyline may be sedating, especially at the onset of treatment. The P- 
adrenergicreceptor-blocking properties of propranolol often preclude its use in 
patients with congestive heart failure, asthma, or insulin-dependent diabetes. It 
may also be associated with depression, hypotension, exercise intolerance, and 
impotence. The anticholinergic actions of amitriptyline may complicate glau­
coma and prostatism. Valproic acid should be introduced gradually as nausea 
can be a problem; it is also particularly contraindicated in pregnancy.
Calcium channel antagonists such as verapamil or nicardepine are also ef­
ficacious in the prophylactic treatment of migraine. Drugs available in other 
countries or approved in the United States only for other indications include ni- 
modipine and flunarizine; however, both common and classic migraine respond 
to these drugs. As discussed above, potential side effects should be taken into 
account in the choice of therapy. Verapamil, which has pronounced effects on 
cardiac and gastrointestinal calcium channels, may exacerbate atrioventricular 
nodal heart block and congestive heart failure and frequently causes constipa­
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tion. Nimodipine, which is more selective for vascular smooth muscle, is associ­
ated with a higher incidence of headache, light-headedness, hypotension, and 
peripheral edema. It should not be used in conjuction with p-blockers. Nifedip­
ine is ineffective. Surprisingly, selective serotonin reuptake inhibitors have not 
been shown to be efficacious.
Migraine during pregnancy should be treated only with opiates, eg, 
meperidine 100-150 mg orally, as all other pharmacologic agents raise concerns 
regarding teratogenicity or complications of pregnancy.
ANALGESIC WITHDRAWAL HEADACHE
A common, frequently unsuspected, cause of intractable headache is 
overuse of analgesics. The patient, in futile attempts at relief, takes increasing 
amounts of medications (both prescription and over-the-counter drugs). When 
the high blood levels drop, even slightly, the headache rebounds; the result is 
daily, virtually constant, atypical headache, which may be superimposed on an 
underlying migraine pattern. Caffeine-containing analgesics are particularly re­
sponsible. The patient should be abruptly withdrawn from all such medications 
and caffeine. After a few weeks of withdrawal symptoms the underlying, usually 
less severe, headache pattern will reveal itself and can be more appropriately 
treated.
CLUSTER HEADACHE
Cluster headache is a common headache syndrome seen much more fre­
quently in men than in women. Cluster headaches characteristically begin at a 
later age than does migraine, with a mean age at onset of 25 years. There is 
rarely a family history of such headaches. The syndrome presents as clusters of 
brief, very severe, unilateral, constant nonthrobbing headaches that last from 10 
minutes to less than 2 hours. Unlike migraine headaches, cluster headaches are 
always unilateral, and usually recur on the same side in any given patient. The 
headaches commonly occur at night, awakening the patient from sleep, and re­
cur daily, often at nearly the same time of day, for a cluster period of weeks to 
months. Between clusters, the patient may be free from headaches for months or 
years.
The headache may begin as a burning sensation over the lateral aspect of 
the nose or as a pressure behind the eye. Ipsilateral conjunctival injection, lacri- 
mation, nasal stuffiness, and Homer's syndrome are commonly associated with 
the attack. Episodes are often precipitated by the use of alcohol or vasodilating 
drugs. During a cluster siege, individual attacks may be precipitated by alcohol.
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At the onset of a headache cluster, treatment involves measures both to 
abort the acute attack and to prevent subsequent ones. Acute relief of pain within 
minutes may be achieved by sumatriptan, 100% oxygen (8-10 L/min for 10-15 
minutes), or dihydroergotamine.
Several drugs used in the treatment of migraine, including 5-HT agonists, 
ergotaminę, dihydroergotamine, methysergide, and calcium channel antagonists 
(verapamil, sustained-released), are also useful for preventing recurrent symp­
toms during an active bout of cluster headache. Ergotamine rectal suppositories 
or subcutaneous dihydroergotamine at bed-time may be especially helpful for 
nocturnal headaches. In addition, dramatic improvement is typically seen with 
administration of prednisone, 40-80 mg/d orally for I week, discontinued by ta­
pering the dose over the following week. Pain may resolve within hours, and 
most patients who respond do so within 2 days. Alternatively, lithium carbonate 
or lithium citrate syrup, 300 mg orally three times daily, is highly effective in 
many cases. Serum lithium levels should be measured at weekly intervals for the 
first several weeks to reduce the likelihood of adverse effects. These include 
disorders of the gastrointestinal (nausea, diarrhea), urinary (polyuria, renal fail­
ure), endocrine (hypothyroidism), and nervous systems (tremor, dysarthria, 
ataxia, myoclonus, seizures). Chronic rather than episodic cluster headaches 
may respond dramatically to indomethacin, 25 mg three times daily. A bilateral 
variant, hypnic headache, lacking the autonomic components, occurs in the eld­
erly. It is responsive to lithium.
TENSION-TYPE HEADACHE
Tension headache is the term used to describe chronic headaches of inap- 
parent cause that lack features characteristic of migraine or cluster headache. 
The underlying pathophysiologic mechanism is unknown, and tension is 
unlikely to be primarily responsible. Contraction of neck and scalp muscles, 
which has also been proposed as the cause, is probably a secondary phenome­
non. In its classic form, tension headache is a chronic disorder that begins after 
age 20. It is characterized by frequent (often daily) attacks of nonthrobbing, bi­
lateral occipital head pain that is not associated with nausea, vomiting, or pro­
dromal visual disturbance. The pain is sometimes likened to a tight band around 
the head. Women are more commonly affected than men. Although tension 
headache and migraine have been traditionally considered distinct disorders, 
many patients have headaches that exhibit features of both. Thus, some patients 
who are classified as having tension headaches experience throbbing headaches, 
unilateral head pain, or vomiting with attacks. In consequence, it may be more 
accurate to view tension headache and migraine as representing opposite poles 
of a single clinical spectrum.
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Drugs used in the treatment of tension headache include many of the same 
agents used for migraine. Acute attacks may respond to aspirin, other nonster­
oidal anti-inflammatory drugs, acetaminophen, ergotaminę, or dihydroergo- 
tamine. For prophylactic treatment, amitriptyline, imipramine, or selective sero­
tonin reuptake inhibitors (eg, sertraline or fluoxetine) are often effective, and 
propranolol is useful in some cases. Although many patients respond to benzo­
diazepines such as diazepam, 5-30 mg/d orally, or chlordiazepoxide, 10-75 mg/d 
orally, these drugs should be used sparingly because of their addictive potential. 
Psychotherapy, physical therapy, and relaxation techniques can provide addi­
tional benefit in selected cases.
ICE PICK PAIN
Very brief, sharp, severe pains located in the scalp outside of the trigemi­
nal distribution are named by their defining characteristic as "ice pick pains." 
They may be single or repetitive or occur in clusters, either at a single point or 
scattered over the scalp. The pains are electric-like jabs maximal in intensity in 
less than a second and then resolving rapidly; they are severe enough to cause 
involuntary flinching. They are more common in migraine and cluster patients, 
but occur in some headache-free individuals as well. Patients frequently seek 
medical attention because of the intensity of the pain. If the bouts of pain are re­
petitive, treatment may be indicated; the syndrome responds to indomethacin 
(25 mg three times daily).
CERVICAL SPINE DISEASE
Injury or degenerative disease processes involving the upper neck can 
produce pain in the occiput or referred to the orbital regions. The most important 
source of discomfort is irritation of the second cervical nerve root. In the lower 
cervical spine, disk disease or abnormalities of the articular processes refer pain 
to the ipsilateral arm or shoulder, not to the head. Cervical muscle spasm may 
occur, however. Acute pain of cervical origin is treated with immobilization of 
the neck (eg, using a soft collar) and analgesics or anti-inflammatory drugs.
SINUSITIS
Acute sinusitis can produce pain and tenderness localized to the affected 
frontal or maxillary sinus areas. Inflammation in the ethmoidal or sphenoidal si­
nuses produces a deep midline pain behind the nose. Sinusitis pain is increased 
by bending forward and by coughing or sneezing. Tenderness and accentuation
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of pain on percussion over the frontal or maxillary area are present on examina­
tion. Sinusitis is treated with vasoconstrictor nose drops (eg, phenylephrine, 
0.25%, instilled every 2-3 hours), antihistamines, and antibiotics. In refractory 
cases, sinus drainage may be necessary. Patients who complain of chronic sinus 
headache rarely have recurrent inflammation of the sinuses; they are much more 
likely to have migraine or tension headaches.
DENTAL DISEASE
Temporomandibular joint dysfunction is a poorly defined syndrome that is 
characterized by preauricular facial pain, limitation of jaw movement, tender­
ness of the muscles of mastication, and "clicking" of the jaw with movement. 
Symptoms are often associated with malocclusion, bruxism, or clenching of the 
teeth, and may result from spasm of the masticatory muscles. Some patients 
benefit from local application of heat, jaw exercises, nocturnal use of a bite 
guard, or nonsteroidal antiinflammatory drugs.
Infected tooth extraction sites can also give rise to pain, which is charac­
teristically constant, unilateral, and aching or burning in character. Although ra­
diologic studies may be normal, injection of a local anesthetic at the extraction 
site relieves the symptoms. Treatment is with jaw bone curettage and antibiotics.
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MENINGITIS & ENCEPHALITIS
BACTERIAL MENINGITIS
Bacterial meningitis is a leading cause of acute confusional states and one 
in which early diagnosis greatly improves the outcome. Conditions that pre­
dispose patients to its development include systemic (especially respiratory) or 
parameningeal infection, head trauma, anatomic meningeal defects, previous 
neurosurgical procedures, cancer, alcoholism, and other immunodeficiency 
states. The etiologie organism varies with age and with the presence of predis­
posing conditions.
Pathogenesis
Bacteria typically gain access to the central nervous system by colonizing 
the mucous membranes of the nasopharynx, leading to local tissue invasion, 
bacteremia, and hematogenous seeding of the subarachnoid space. Bacteria can 
also spread to the meninges directly, through anatomic defects in the skull or 
from parameningeal sites such as the paranasal sinuses or middle ear. Polysac­
charide bacterial capsules, lipopolysaccharides, and outer membrane proteins 
may contribute to the bacterial invasion and virulence. Low levels of antibody 
and complement in the subarachnoid space are inadequate to contain the infec­
tion. The resulting inflammatory response is associated with the release of in­
flammatory cytokines, including interleukins 1 and 6 and tumor necrosis factor 
a, that promote blood-brain barrier permeability, vasogenic cerebral edema, 
changes in cerebral blood flow, and perhaps direct neuronal toxicity.
Pathologically, bacterial meningitis is characterized by leptomeningeal 
and perivascular infiltration with polymorphonuclear leukocytes and an inflam­
matory exudate. These changes tend to be most prominent over the cerebral 
convexities in Streptococcus pneumoniae and Haemophilus infection and over 
the base of the brain when Neisseria meningitidis is the causative organism. 
Brain edema, hydrocephalus, and cerebral infarction may occur, although actual 
bacterial invasion of the brain is rare.
Clinical Findings
A. Symptoms and Signs. At the time of presentation, most patients have 
experienced symptoms of meningitis for one to seven days. The symptoms in­
clude fever, confusion, vomiting, headache, and neck stiffness, but the full syn­
drome is often not present.
Physical examination may show fever and signs of systemic or paramen­
ingeal infection, such as skin abscess or otitis. A petechial rash is seen in 50-
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60% of patients with N meningitidis meningitis. Signs of meningeal irritation are 
seen in about 80% of cases; they are often absent at the extremes of age or with 
profoundly impaired consciousness. The level of consciousness, when altered, 
ranges from mild confusion to coma. Focal neurologic signs, seizures, and cra­
nial nerve palsies may occur.
B. Laboratory Findings. Blood counts may reveal polymorphonuclear 
leukocytosis related to systemic infection or leukopenia reflecting immuno­
suppression. In associated bacteremia, the causative organism can be cultured 
from the blood in 40-90% of cases. X-rays of the chest, sinuses, or mastoid 
bones may indicate a primary site of infection. A brain CT scan may show con­
trast enhancement of the cerebral convexities, the base of the brain, or the ven­
tricular ependyma. The EEG is usually diffusely slowed, and focal abnormalities 
suggest the possibility of focal cerebritis, abscess formation, or scarring.
While these studies are helpful in some cases, the essential investigation 
in all cases of suspected meningitis is prompt lumbar puncture and CSF ex­
amination. CSF pressure is elevated in about 90% of cases, and the appearance 
of the fluid ranges from slightly turbid to grossly purulent. CSF white cell 
counts of 1000-10,000/pL are usually seen, consisting chiefly of polymorphonu­
clear leukocytes, although mononuclear cells may predominate in Listeria 
monocytogenes meningitis. Protein concentrations of 100-500 mg/dL are most 
common. The CSF glucose level is lower than 40 mg/dL in about 80% of cases; 
it may be immeasurably low. Gram-stained smears of CSF identify the causative 
organism in 70-80% of cases. CSF culture, which is positive in about 80% of 
cases, provides a definitive diagnosis and allows determination of antibiotic sen­
sitivity, The polymerase chain reaction, which amplifies viral DNA, has also 
been used with CSF specimens to diagnose bacterial meningitis, including H in­
fluenzae, N meningitidis, and L monocytogenes meningitis.
Differential Diagnosis
The signs of meningeal irritation may also be seen with subarachnoid 
hemorrhage, but the distinction is easily made when lumbar puncture shows 
bloody CSF. Early viral meningitis can produce polymorphonuclear pleocytosis 
and symptoms identical to those of bacterial meningitis, but a repeat lumbar 
puncture after 6-12 hours should demonstrate a shift to lymphocytic predomi­
nance, and the CSF glucose level is normal.
Prevention
Children should be routinely immunized against H influenzae by vaccina­
tion. A vaccine is also available for some strains of N meningitidis and is recom­
mended for travelers to areas of ongoing epidemics. The risk of contracting И 
influenzae or N meningitidis meningitis can be reduced in household and other 
close contacts of affected patients by the prophylactic administration of ri­
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fampin, 20 mg/kg/d orally, given as a single daily dose for 4 days (H influenzae) 
or as two divided doses for 2 days (N meningitidis).
Treatment
Unless the physical examination shows focal neurologic abnormalities or 
papilledema, lumbar puncture should be performed immediately; if the CSF is 
not clear and colorless, antibiotic treatment (see below) is started without delay. 
When focal signs or papilledema are present, blood and urine should be taken 
for culture, antibiotics begun, and a brain CT scan obtained. If the scan shows 
no focal lesion that would contraindicate lumbar puncture, the puncture is then 
performed. The initial choice of antibiotics is empirical, based upon the patient's 
age and predisposing factors.
Therapy is adjusted as indicated when the Gram's stain or culture and sen­
sitivity results become available. Lumbar puncture can be repeated to assess the 
response to therapy. CSF should be sterile after 24 hours, and a decrease in 
pleocytosis and the proportion of polymorphonuclear leukocytes should be ap­
parent within 3 days.
The use of corticosteroids as an adjunct to antibiotic treatment of bacterial 
meningitis is controversial, and is based primarily on their ability to reduce hear­
ing loss and neurologic sequelae in children with H influenzae meningitis. None­
theless, some authorities recommend dexamethasone, 0.15 mg/kg intravenously 
every 6 hours for the first 4 days of antibiotic therapy in children under 2 
months of age, and in adults with a positive Gram's stain and increased in­
tracranial pressure.
Prognosis
Complications of bacterial meningitis include headache, seizures, hydro­
cephalus, inappropriate secretion of antidiuretic hormone, residual neurologic 
deficits (including cognitive disturbances and cranial -  especially VIII -  nerve 
abnormalities), and death. A CT scan will confirm suspected hydrocephalus. 
Fluid and electrolyte status should be carefully monitored in patients with men­
ingitis. N meningitidis infections may be complicated by adrenal hemorrhage re­
lated to meningococcemia, resulting in hypotension and often death (Water­
house-Friderichsen syndrome).
The morbidity and mortality rates of bacterial meningitis are high. Fatali­
ties occur in about 20% of affected adults, but fatality rates are higher with some 
pathogens (eg, S pneumoniae, gram-negative bacilli) than others (eg, И influen­
zae, N meningitidis). Factors that worsen prognosis include extremes of age, de­
lays in diagnosis and treatment, a complicating illness, stupor or coma, seizures, 
and focal neurologic signs.
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TUBERCULOUS MENINGITIS
Tuberculous meningitis is an important diagnostic consideration in pa­
tients who present with a confusional state, especially if there is a history of 
pulmonary tuberculosis, alcoholism, corticosteroid treatment, HIV infection, or 
other conditions associated with impaired immune responses. It should also be 
considered if patients are from areas (eg, Asia, Africa) or groups (eg, the home­
less and inner-city drug users) with a high incidence of tuberculosis. Tubercu­
lous meningitis usually results from reactivation of latent infection with Myco­
bacterium tuberculosis. Primary infection, typically acquired by inhaling bacil­
lus-containing droplets, may be associated with metastatic dissemination of 
blood-borne bacilli from the lungs to the meninges and the surface of the brain. 
Here the organisms remain in a dormant state in tubercles that can rupture into 
the subarachnoid space at a later time, resulting in tuberculous meningitis.
Pathology
The principal neuropathologic finding is a basal meningeal exudate con­
taining mainly mononuclear cells. Tubercles may be seen on the meninges and 
surface of the brain. The ventricles may be enlarged as a result of hydrocepha­
lus, and their surfaces may show ependymal exudate or granular ependymitis. 
Arteritis can result in cerebral infarction, and basal inflammation and fibrosis 
can compress cranial nerves.
Clinical Findings
A. Symptoms and Signs. Symptoms have usually been present for less 
than 4 weeks at the time of presentation and include fever, lethargy or confu­
sion, and headache. Weight loss, vomiting, neck stiffness, visual impairment, 
diplopia, focal weakness, and seizures may also be noted. A history of contact 
with known cases of tuberculosis is usually absent.
Fever, signs of meningeal irritation, and a confusional state are the most 
common findings on physical examination, but all may be absent. Papilledema, 
ocular palsies, and hemiparesis are sometimes seen. Complications include spi­
nal subarachnoid block, hydrocephalus, brain edema, cranial nerve palsies, and 
stroke caused by vasculitis or compression of blood vessels at the base of the 
brain.
B. Laboratory Findings. Only about one-half to two-thirds of patients 
show a positive skin test or evidence of active or healed tubercular infection on 
chest x-ray. The only investigation that can establish the diagnosis is CSF analy­
sis. CSF pressure is usually increased, and the fluid is typically clear and col­
orless but may form a clot upon standing. Lymphocytic and mononuclear cell 
pleocytosis of 50-500 cells/pL is most often seen, but polymorphonuclear pleo­
cytosis can occur early and may give an erroneous impression of bacterial men­
ingitis. CSF protein is usually more than 100 mg/dL and may exceed 500
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mg/dL, particularly in patients with spinal subarachnoid block. The glucose 
level is usually decreased and may be less than 20 mg/dL. A decreased chloride 
level, formerly thought to be specifically associated with tuberculous meningitis, 
is no longer considered diagnostically useful. Acid-fast smears of CSF should be 
performed in all cases of suspected tuberculous meningitis, but they are positive 
in only a minority of cases. Definitive diagnosis is most often made by culturing 
M tuberculosis from the CSF, a process that usually takes several weeks and re­
quires large quantities of spinal fluid for maximum yield. However, the poly­
merase chain reaction has also been used for diagnosis. Finally, the CT scan 
may show contrast enhancement of the basal cisterns and cortical meninges, or 
hydrocephalus.
Differential Diagnosis
Many other conditions can cause a subacute confusional state associated 
with mononuclear cell pleocytosis, including syphilitic, fungal, neoplastic, and 
partially treated bacterial meningitis. These can be diagnosed by appropriate 
smears, cultures, and serologic and cytologic examinations.
Treatment
Treatment should be started as early as possible; it should not be withheld 
while awaiting culture results. The decision to treat is based on the CSF findings 
described above; lymphocytic pleocytosis and decreased glucose are particularly 
suggestive, even if acid-fast smears are negative. Four drugs are used for initial 
therapy, until culture and susceptibility test results are known. These are isoni- 
azid, 300 mg; rifampin, 600 mg; pyrazinamide, 25 mg/kg; and ethambutol, 15 
mg/kg, each given orally once daily. For susceptible strains, ethambutol can be 
discontinued, and triple therapy continued for 2 months, followed by 4-10 
months of treatment with isoniazid and rifampin alone. Corticosteroids (eg, 
prednisone, 60 mg/d orally in adults or 1-3 mg/kg/d orally in children, tapered 
gradually over 3-4 weeks) are indicated as adjunctive therapy in patients with 
spinal subarachnoid block. They may also be indicated in seriously ill patients 
with focal neurologic signs or with increased intracranial pressure from cerebral 
edema. The risk of using corticosteroids may be high, however, especially if tu­
berculous meningitis has been mistakenly diagnosed in a patient with fungal 
meningitis. Therefore, if fungal meningitis has not been excluded, antifungal 
therapy (see below) should be added, together with corticosteroids. Pyridoxine, 
50 mg/d, can be used to decrease the likelihood of isoniazid-induced polyneuro­
pathy. Complications of therapy include hepatic dysfunction (isoniazid, ri­
fampin, and pyrazinamide), polyneuropathy (isoniazid), optic neuritis (ethambu­
tol), seizures (isoniazid), and ototoxicity (streptomycin).
Prognosis
Even with appropriate treatment, about one-third of patients with tubercu-
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lous meningitis succumb. Coma at the time of presentation is the most signifi­
cant predictor of a poor prognosis.
SYPHILITIC MENINGITIS
Acute or subacute syphilitic meningitis usually occurs within 2 years after 
primary syphilitic infection. It is most common in young adults, affects men 
more often than women, and requires prompt treatment to prevent the irreversi­
ble manifestations of tertiary neurosyphilis. In about one-fourth of patients with 
Treponema pallidum infection, treponemes gain access to the central nervous 
system, where they produce a meningitis that is usually asymptomatic (asymp­
tomatic neurosyphilis). Asymptomatic invasion of the central nervous system is 
associated with CSF pleocytosis, elevated protein, and positive serologic tests 
for syphilis.
Clinical Findings
A. Symptoms and Signs. In a few patients, syphilitic meningitis is a 
clinically apparent acute or subacute disorder. At the time of presentation, symp­
toms such as headache, nausea, vomiting, stiff neck, mental disturbances, focal 
weakness, seizures, deafness, and visual impairment have usually been present 
for up to 2 months.
Physical examination may show signs of meningeal irritation, confusion 
or delirium, papilledema, hemiparesis, and aphasia. The cranial nerves most fre­
quently affected are (in order) the facial (VII), acoustic (VIII), oculomotor (111), 
trigeminal (V), abducens (VI), and optic (II) nerves, but other nerves may be in­
volved as well. Fever is typically absent.
B. Laboratory Findings. The diagnosis is established by CSF findings. 
Opening pressure is normal or slightly elevated. Pleocytosis is lymphocytic or 
mononuclear in character, with white cell counts usually in the range of 100- 
1000/pL. Protein may be mildly or moderately elevated (<200 mg/dL) and glu­
cose mildly decreased. CSF VDRL and serum FT A or MHA-TP tests are usu­
ally positive. Protein electrophoretograms of CSF may show discrete gamma 
globulin bands (oligoclonal bands) not visible in normal CSF.
Treatment
Acute syphilitic meningitis is usually a self-limited disorder with no or 
minimal sequelae. Subsequent development of more advanced manifestations of 
neurosyphilis, including vascular and parenchymatous disease (eg, tabes dor­
salis, general paresis, optic neuritis, myelitis), can be prevented by adequate 
treatment of the early syphilitic infection.
Syphilitic meningitis is treated with aqueous penicillin G, 2-4 x 106 units 
intravenously every 4 hours for 10 days. For penicillin-allergic patients, tetracy-
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cline or erythromycin, 500 mg orally every 6 hours for 20 days, can be substi­
tuted. The CSF should be examined every 6 months until all findings are nor­
mal. Another course of therapy must be given if the CSF cell count or protein 
remains elevated.
LYME DISEASE
Lyme disease is a tick-borne disorder that results from systemic infection 
with the spirochete Borrelia burgdorferi. The disease occurs in Europe, the 
northeastern and western United States, and Australia; most cases occur during 
the summer months. Primary infection may be manifested by an expanding ery­
thematous annular skin lesion (erythema migrans) that usually appears over the 
thigh, groin, or axilla. Less distinctive symptoms include fatigue, headache, fe­
ver, neck stiffness, joint or muscle pain, anorexia, sore throat, and nausea. Neu­
rologic involvement may be delayed for up to 10 weeks and is characterized by 
meningitis or meningoencephalitis and disorders of the cranial or peripheral 
nerves or nerve roots. Cardiac abnormalities (conduction defects, myocarditis, 
pericarditis, cardiomegaly, or heart failure) can also occur at this stage. Lyme 
meningitis usually produces prominent headache that may be accompanied by 
signs of meningeal irritation, photophobia, pain when moving the eyes, nausea, 
and vomiting. When encephalitis is present, it is usually mild and characterized 
by insomnia, emotional lability, or impaired concentration and memory. The 
CSF usually shows a lymphocytic pleocytosis with 100-200 cells/pL, slightly 
elevated protein, and normal glucose. Oligoclonal IgG bands may be detected. 
Definitive diagnosis is usually made by serologic testing for В burgdorferi, pref­
erably by enzyme-linked immunosorbent assay (ELISA) followed by Western 
blot, but the polymerase chain reaction, which can amplify spirochetal DNA in 
synovial fluid, blood, or CSF, has also been used. For patients with Bell's palsy, 
treatment is with doxycycline (100 mg twice daily), tetracycline (500 mg four 
times daily), or amoxacillin (250-500 mg three times daily), each given orally 
for 1 month. With meningitis of other CNS involvement, intravenous treatment 
is indicated with ceftriaxone (2 g intravenously daily), penicillin G (20 million 
units intravenously daily in six divided doses), or cefotaxime (2 g intravenously 
every 8 hours), continued for 3-4 weeks. Symptoms typically resolve within 10 
days in treated cases. Untreated or inadequately treated infections may lead to 
recurrent oligoarthritis, and chronic neurologic disorders including memory, 
language, and other cognitive disturbances; focal weakness; and ataxia. In such 
cases, a CT scan or MRI may show hydrocephalus, lesions in white matter re­
sembling those seen in multiple sclerosis, or abnormalities suggestive of cere­
bral infarction. Subtle chronic cognitive or behavioral symptoms should not be 
attributed to Lyme encephalitis in the absence of serologic evidence of В 
burgdorferi exposure, CSF abnormalities, or focal neurologic signs.
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VIRAL MENINGITIS & ENCEPHALITIS
Viral infections of the meninges (meningitis) or brain parenchyma (en­
cephalitis) often present as acute confusional states. Children and young adults 
are frequently affected. Viral meningitis is most often caused by enteric viruses. 
Although the etiologie agent is not identified in most cases of viral encephalitis, 
childhood exanthems, arthropodborne agents, and herpes simplex type 1 are the 
more commonly recognized causes.
Pathology
Viral infections can involve the central nervous system in three ways, 
through hematogenous dissemination of systemic viral infection (eg, arthropod- 
borne viruses); the neuronal spread of the virus (eg, herpes simplex, rabies) by 
axonal transport; and autoimmune responses causing postinfectious demyeli- 
nation (eg, varicella, influenza).
Pathologic changes in viral meningitis consist of an inflammatory men­
ingeal reaction mediated by lymphocytes. Encephalitis is characterized by 
perivascular cuffing, lymphocytic infiltration, and microglial proliferation 
mainly involving subcortical gray matter regions. Intranuclear or intracytoplas- 
mic inclusions are often seen.
Clinical Findings
A. Symptoms and Signs. Clinical manifestations of viral meningitis in­
clude fever, headache, neck stiffness, photophobia, pain with eye movement, 
and mild impairment of consciousness. Patients usually do not appear as ill as 
those with bacterial meningitis. Systemic viral infection may be reflected by 
skin rash, pharyngitis, lymphadenopathy, pleuritis, carditis, jaundice, or­
ganomegaly, diarrhea, or orchitis. Such associations often suggest a particular 
etiologie agent. Because viral encephalitis involves the brain directly, marked 
alterations of consciousness, seizures, and focal neurologic signs can occur. 
When signs of meningeal irritation and brain dysfunction coexist, the condition 
is termed meningoencephalitis.
B. Laboratory Findings. CSF analysis is the most important laboratory 
investigation. CSF pressure is normal or increased, and a lymphocytic or mono­
cytic pleocytosis is present, with cell counts usually less than 1000/pL. (Higher 
counts can be seen in lymphocytic choriomeningitis or herpes simplex encepha­
litis.) A polymorphonuclear pleocytosis can occur early in viral meningitis, 
while red blood cells may be seen with herpes simplex encephalitis. Protein is 
normal or slightly increased (usually 80-200 mg/dL). Glucose is usually normal; 
it may be decreased in mumps, herpes zoster, or herpes simplex encephalitis. 
Gram's stains and bacterial, fungal, and acid-fast bacillius (AFB) cultures are
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negative. Oligoclonal bands and CSF protein electrophoresis abnormalities may 
be present. An etiologie diagnosis can often be made by virus isolation or by 
acute- and convalescent-phase CSF antibody titers.
Blood counts may show a normal white cell count, leukopenia, or mild 
leukocytosis. Atypical lymphocytes in blood smears and a positive heterophil 
(Monospot) test suggest infectious mononucleosis. Serum amylase is frequently 
elevated in mumps; abnormal liver function tests are associated with both hepa­
titis viruses and infectious mononucleosis. The EEG is diffusely slowed, espe­
cially if there is direct cerebral involvement; more characteristic findings can be 
found in encephalitis caused by herpes simplex infection.
Differential Diagnosis
The differential diagnosis of meningitis with mononuclear cell pleocytosis 
includes partially treated bacterial meningitis as well as syphilitic, tuberculous, 
fungal, parasitic, neoplastic, and other meningitides. Evidence of systemic viral 
infection and CSF wet mounts, stained smears, cultures, and cytologic examina­
tion can distinguish among these possibilities. When presumed early viral men­
ingitis is associated with a polymorphonuclear pleocytosis o f less than 1000 
white blood cells/pL and normal CSF glucose, one of two strategies can be used. 
The patient can be treated for bacterial meningitis until the results of CSF cul­
tures are known, or treatment can be withheld and lumbar puncture repeated in 
6-12 hours. If the meningitis is viral in origin, the second sample should show a 
mononuclear cell pleocytosis. The syndrome of viral encephalitis may clinically 
resemble that from metabolic disorders, but it can be distinguished by spinal 
fluid findings.
A disorder that may be clinically indistinguishable from viral encephalitis 
is the immune-mediated encephalomyelitis that may follow viral infections such 
as influenza, measles, or chickenpox. Progressive neurologic dysfunction typi­
cally begins a few days after the viral illness but can also occur either simulta­
neously or up to several weeks later. Neurologic abnormalities result from 
perivenous demyelination, which often severely affects the brain stem. The CSF 
shows a lymphocytic pleocytosis, usually with cell counts of 50-150/|iL, and 
mild protein elevation.
Treatment
Except for herpes simplex encephalitis, which is discussed separately (see 
below), no specific therapy for viral meningitis and encephalitis is available. 
Corticosteroids are of no benefit except in immune-mediated postinfectious syn­
dromes. Headache and severe hyperthermia can be treated with acetaminophen; 
mild fever requires no treatment and may even contribute to the host response to 
the virus. Seizures usually respond to phenytoin or phenobarbital. Supportive 
measures in comatose patients include mechanical ventilation and intravenous or 
nasogastric feeding.
Prognosis
Symptoms of viral meningitis usually resolve spontaneously within 2 
weeks regardless of the causative agent, although residual deficits may be seen. 
The outcome of viral encephalitis varies with the specific virus, however; east­
ern equine and herpes simplex virus infections are associated with severe mor­
bidity and high mortality rates. Mortality rates as high as 20% have also been 
reported in immune-mediated encephalomyelitis following measles infections.
HERPES SIMPLEX VIRUS (HSV) ENCEPHALITIS
Specific antiviral therapy is available for this disorder, which is the most 
common type of sporadic fatal encephalitis in the United States. About two- 
thirds of cases involve patients over 40 years of age. Primary herpes infections 
most often present as stomatitis (HSV type 1) or a venereally transmitted genital 
eruption (HSV type 2). The virus migrates along nerve axons to sensory ganglia, 
where it persists in a latent form -  and may be subsequently reactivated. It is not 
clear whether HSV type 1 encephalitis, the most common type in adults, repre­
sents a primary infection or a reactivation of latent infection. Neonatal HSV en­
cephalitis usually results from acquisition of type 2 virus during passage through 
the birth canal of a mother with active genital lesions. Central nervous system 
involvement by HSV type 2 in adults usually causes meningitis, rather than en­
cephalitis.
Pathology
The pathologic picture of HSV type 1 encephalitis is that of an acute, ne­
crotizing, asymmetric hemorrhagic process with lymphocytic and plasma cell re­
action, which usually involves the medial temporal and inferior frontal lobes. 
Intranuclear inclusions may be seen in the neurons and glia. In patients who re­
cover, the chronic state is characterized by cystic necrosis of the involved re­
gions.
Clinical Findings
A. Symptoms and Signs. The clinical syndrome may include headache, 
stiff neck, vomiting, behavioral disorders, memory loss, anosmia, aphasia, 
hemiparesis, and focal or generalized seizures. Active herpes labialis is seen oc­
casionally, but its presence does not increase the likelihood that the encephalitis 
is due to HSV. The encephalitis is usually rapidly progressive over several days 
and may result in coma or death. The most common sequelae in patients who 
survive HSV encephalitis are memory and behavior disturbances, reflecting the 
predilection of the process for limbic structures.
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В. Laboratory Findings. The CSF in HSV type 1 encephalitis most often 
shows increased pressure, lymphocytic or mixed lymphocytic and poly­
morphonuclear pleocytosis (50-100 white blood cells/pL), mild protein eleva­
tion, and normal glucose. Red blood cells, xanthochromia, and decreased glu­
cose are seen in some cases. The virus generally cannot be isolated from the 
CSF, but viral DNA has been detected by the polymerase chain reaction in some 
cases. The EEG may show periodic slow-wave complexes arising from one or 
both temporal lobes, and CT scans and MRI may show abnormalities in one or 
both temporal lobes. These can extend to frontal or parietal regions and are 
sometimes enhanced with the infusion of contrast material. It should be noted 
that imaging studies may also be normal. Definitive diagnosis is typically made 
by biopsy of affected brain areas, with the choice of biopsy site guided by the 
EEG, CT, or MRI findings.
Differential Diagnosis
The symptoms and signs are not specific for herpes virus infection. The 
greatest diagnostic difficulty is distinguishing between HSV encephalitis and 
brain abscess. The latter is suggested by systemic bacterial infection, a slower 
progression of deficits, less-marked CSF pleocytosis, a continuous polymorphic 
slow-wave disturbance in the EEG, and symmetric contrast enhancement of the 
rim of the lesion seen on CT scan. The two disorders often cannot be differen­
tiated on clinical grounds alone, however. Final diagnoses in patients undergo­
ing brain biopsy for suspected HSV encephalitis have included vasculitis, other 
viral infections, bacterial abscess, fungal infections, tumor, Reye's syndrome, 
parasitic infections, and tuberculosis. Because many of these conditions require 
specific therapy and none are favorably affected by the treatment used for HSV 
encephalitis, some clinicians argue that all patients with suspected HSV en­
cephalitis should undergo brain biopsy to establish a definitive diagnosis. The 
most commonly accepted approach, however, is to treat patients with probable 
HSV encephalitis as described below and to reserve biopsies for those who fail 
to improve.
Treatment
The most effective drug is acyclovir, given intravenously at a dosage of 
30 mg/kg/d, divided into three daily doses, each given over 1 hour. Treatment is 
continued for 14-21 days. Complications reported include erythema at the intra­
venous infusion site, gastrointestinal disturbances, headache, skin rash, tremor, 
seizures, and encephalopathy or coma. Treatment is started as early as possible, 
since outcome is greatly influenced by the severity of dysfunction at the time 
treatment is initiated. Treatment is discontinued if a subsequent brain biopsy es­
tablishes another diagnosis.
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Prognosis
Prognosis is influenced by the patient's age and level of consciousness at 
presentation and by the treatment. Patients under the age of 30 years and those 
who are only lethargic at the onset of treatment are more likely to survive than 
are older or comatose patients. Reported mortality rates are 44% at six months in 
vidarabine-treated patients and 28% at 18 months in patients given acyclovir. 
Acyclovir also increases the fraction of patients with no or only minor neu­
rologic sequelae from 5% to 38%, compared with vidarabine. It is not known 
whether a combination of acyclovir and vidarabine has greater efficacy than ei­
ther drug used alone.
ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
AIDS is a disorder caused by systemic infection with human immunodefi­
ciency virus-1 (HIV-1) and characterized by opportunistic infections, malignant 
neoplasms (typically non-Hodgkin's lymphoma or Kaposi's sarcoma), and a va­
riety of neurologic disturbances. Transmission occurs through sexual activity or 
by transfer of virus-contaminated blood or blood products. Individuals at par­
ticular risk of infection include homosexual and bisexual men, intravenous drug 
users who share needles, hemophiliacs who have received factor VIII transfu­
sions, and the sexual partners of all the foregoing. Neurologic complications of 
AIDS include dementia, myelopathy, neuropathy, myopathy, and stroke. In ad­
dition, patients with AIDS are at increased risk for developing acute confusional 
states resulting from direct viral involvement of the nervous system, opportunis­
tic infections, and tumors associated with AIDS.
I. HIV-1 MENINGITIS
Patients infected with HIV-1 can develop a syndrome characterized by 
headache, fever, signs of meningeal irritation, cranial nerve (especially VII) pal­
sies, other focal neurologic abnormalities, or seizures. This usually occurs at 
about the time of HIV-1 seroconversion. An acute confusional state is occasion­
ally also present. HIV-1 meningitis is associated with mononuclear pleocytosis 
of up to about 200 cells/pL and may represent the initial immunologic response 
of the nervous system to HIV-1 infection. A similar CSF profile has been found 
in some asymptomatic patients undergoing lumbar puncture shortly after HIV-1 
seroconversion. Symptoms usually resolve spontaneously within about 1 month. 
Other causes of pleocytosis associated with AIDS, including cryptococcal men­
ingitis, herpes simplex encephalitis, and cerebral toxoplasmosis, must be ex­
cluded; specific treatments exist for these conditions.
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2. CRYPTOCOCCAL MENINGITIS
Cryptococcal meningitis occurs in 5-10% of patients with AIDS. Clinical 
features include headache, confusion, stiff neck, fever, nausea and vomiting, 
seizures, and cranial nerve palsies. Because the CSF is otherwise normal in 
about 20% of patients with AIDS and cryptococcal meningitis, CSF cryptococ­
cal antigen titers should always be obtained. Laboratory abnormalities and rec­
ommended treatment are discussed in the section on fungal meningitis.
3. HERPES SIMPLEX & VARICELLA-ZOSTER ENCEPHALITIS
The features of herpes simplex virus (HS V) encephalitis (discussed above 
in detail) can differ in patients with AIDS. While HSV encephalitis in im­
munocompetent adults is almost always due to type 1 virus, either type 1 or type 
2 HSV can produce the disorder in patients with AIDS. The focal neurologic 
signs and CSF abnormalities usually associated with HSV encephalitis may be 
absent in AIDS, and the disorder may follow a more indolent course. Varicella- 
zoster virus, a herpesvirus that rarely causes encephalitis in immunocompetent 
individuals, may do so in patients with AIDS. Treatment is as described above 
for HSV encephalitis.
4. CYTOMEGALOVIRUS ENCEPHALITIS
Cytomegalovirus, another herpesvirus, has been implicated as a cause of 
retinitis and polyradiculomyelitis in patients with AIDS. Cytomegalovirus can 
also be identified in CSF and biopsy specimens from patients with AIDS who 
are neurologically asymptomatic, acutely confused, or demented. In some symp­
tomatic cases, autopsy shows microglial nodules and cytomegalovirus inclu­
sions. Death usually occurs within a few weeks, although therapeutic responses 
to antiviral treatment with ganciclovir and foscamet have been reported.
5. CEREBRAL TOXOPLASMOSIS
Cerebral toxoplasmosis produces intracerebral mass lesions in patients 
with AIDS, although its frequency appears to be declining as anti toxoplasma 
drugs such as trimethoprim-sulfamethoxazole are widely used for prophylaxis 
against Pneumocystis carinii pneumonia in patients with AIDS. A confusional 
state lasting days to weeks exists at the time of presentation in about 30% of pa­
tients. Other clinical features include fever, focal neurologic abnormalities such 
as cranial nerve palsies or hemiparesis, seizures, headache, and signs of men­
ingeal irritation. Serologic tests for toxoplasmosis are unreliable in patients with 
AIDS. CT scanning typically reveals one or more lesions, which often show a 
contrast enhancement of the rim and are commonly located in the basal ganglia;
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MRI is more sensitive than CT in revealing the lesions. Because toxoplasmosis 
is readily treatable, patients with AIDS and intracerebral mass lesions that are 
not obviously due to stroke should be treated for presumed toxoplasmosis, as 
described in the section on parasitic infections (below). Up to 90% of patients 
respond favorably to therapy within the first few weeks and the majority survive 
longer than 6 months.
FUNGAL MENINGITIS
In a small fraction of patients with systemic fungal infections (mycoses), 
fungi invade the central nervous system to produce meningitis or focal intra- 
parenchymal lesions. Several of these fungi are opportunistic organisms that 
cause infection in patients with cancer, patients receiving corticosteroids or 
other immunosuppressive drugs, and other debilitated hosts. Intravenous drug 
abuse is a potential route for infection with Candida and Aspergillus. Diabetic 
acidosis is strongly correlated with rhinocerebral mucormycosis. In contrast, 
meningeal infections with Coccidioides, Blastomyces, and Actinomyces usually 
occur in previously healthy individuals. Cryptococcus (the most common cause 
of fungal meningitis in the United States) and Histoplasma infection can occur 
in either healthy or immunosuppressed patients. Cryptococcal meningitis is the 
most common fungal infection of the nervous system in AIDS, but Coccidioides 
and Histoplasma infections can also occur in this setting. Geographic factors are 
also important in the epidemiology of certain mycoses.
Pathogenesis
Organisms reach the central nervous system by hematogenous spread 
from the lungs, heart, gastrointestinal or genitourinary tract, or skin or by direct 
extension from parameningeal sites such as the orbits or paranasal sinuses. Inva­
sion of the meninges from a contiguous focus of infection is particularly com­
mon in mucormycosis but may also occur in aspergillosis and actinomycosis.
Pathology
Pathologic findings in fungal infections of the nervous system include a 
primarily mononuclear meningeal exudative reaction, focal abscesses or granu­
lomas in the brain or spinal epidural space, cerebral infarction related to vascu­
litis, and ventricular enlargement caused by communicating hydrocephalus.
Clinical Findings
Fungal meningitis is usually a subacute illness that clinically resembles 
tuberculous meningitis. A history of such predisposing conditions as carcinoma, 
hematologic cancer, AIDS, diabetes, organ transplantation, treatment with corti-
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costeroids or cytotoxic agents, prolonged antibiotic therapy, or intravenous drug 
use increases the suspicion of opportunistic infection. Questions should be asked 
about recent travel through areas where certain fungi are endemic.
A. Symptoms and Signs. Common symptoms include headache and leth­
argy or confusion. Nausea, vomiting, visual loss, seizures, or focal weakness 
may be noted, while fever may be absent. In a diabetic patient with acidosis, 
complaints of facial or eye pain, nasal discharge, proptosis, or visual loss should 
urgently alert the physician to the likelihood of Mucor infection.
Careful examination of the skin, orbits, sinuses, and chest may reveal evi­
dence of systemic fungal infection. Neurologic examination may show signs of 
meningeal irritation, a confusional state, papilledema, visual loss, ptosis, exoph­
thalmos, ocular or other cranial nerve palsies, and focal neurologic abnormalities 
such as hemiparesis. Because some fungi (most commonly Cryptococcus) can 
cause spinal cord compression, there may be evidence of spine tenderness, 
paraparesis, pyramidal signs in the legs, and loss of sensation over the legs and 
trunk.
B. Laboratory Findings. Blood cultures should be obtained. Serum glu­
cose and arterial blood gas levels should be determined in diabetic patients. The 
urine should be examined for Candida. Chest x-ray may show hilar lymphade- 
nopathy, patchy or miliary infiltrates, cavitation, or pleural effusion. The CT 
scan or MR1 may demonstrate intracerebral mass lesions associated with 
Cryptococcus or other organisms, a contiguous infectious source in the orbit or 
paranasal sinuses, or hydrocephalus.
CSF pressure may be normal or elevated, and the fluid is usually clear. It 
may be viscous in the presence of numerous cryptococci, but the presence of al­
cohol (once considered indicative of cryptococcal infection) is not a reliable 
finding. Lymphocytic pleocytosis of up to 1000 cells/pL is common, but a nor­
mal cell count or polymorphonuclear pleocytosis can be seen in early fungal 
meningitis and normal cell counts are common in immunosuppressed patients. 
Aspergillus infection typically produces a polymorphonuclear pleocytosis. CSF 
protein, which may be normal initially, subsequently rises, usually to levels not 
exceeding 200 mg/dL. Fligher levels (<1 g/dL) suggest possible subarachnoid 
block. Glucose is normal or decreased but rarely below 10 mg/dL. Microscopic 
examination of Gram-stained and acid-fast smears and India ink preparations 
may reveal the infecting organism. Fungal cultures of CSF and other body fluids 
and tissues should be obtained, but they are often negative. In suspected mucor­
mycosis, biopsy of the affected tissue (usually nasal mucosa) is essential. Useful 
CSF serologic studies include cryptococcal antigen and Coccidioides comple­
ment-fixing antibody. Cryptococcal antigen is more sensitive than India ink for 
detecting Cryptococcus, and should always be looked for in both CSF and serum 
when that organism is suspected (in patients with AIDS, for example).
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Differential Diagnosis
Fungal meningitis may mimic brain abscess and other subacute or chronic 
meningitides, such as those due to tuberculosis or syphilis. CSF findings and 
contrast CT scans are useful in differential diagnosis.
Treatment & Prognosis
For most organisms causing fungal meningitis, treatment is begun with 
amphotericin В deoxycholate, 1 mg intravenously as a test dose given over 20- 
30 minutes, followed the next day by 0.3 mg/kg intravenously in 5% dextrose, 
given over 2-3 hours. The dose is then increased daily in 5- to 10-mg increments 
until a maximal dose of 0.5-1.5 mg/kg/d is reached. Treatment is usually contin­
ued for 12 weeks. Nephrotoxicity is common with amphotericin В and may 
force interruption of therapy for 2-5 days. Newer, lipid-based formulations (eg, 
amphotericin В lipid complex, amphotericin В cholesteryl sulfate, liposomal 
amphotericin B) are less nephrotoxic, and can be used in patients who develop 
such toxicity on amphotericin В deoxycholate.
In patients with Coccidioides meningitis or those not responding to intra­
venous therapy, intrathecal amphotericin В (usually administered via an Om- 
maya reservoir) is added. The drug is given as a 0.1-mg test dose diluted in 10 
mL of CSF, with or without added corticosteroids, and increased to 0.25-0.5 mg 
every other day. Because administration of amphotericin into the CSF may pro­
duce side effects, may require instillation at multiple sites, and may be unsuc­
cessful, another approach is to give fluconazole, 400-600 mg/d, or itraconazole, 
200 mg twice daily with meals, by the oral route. In this case, treatment must be 
continued indefinitely.
In cryptococcal meningitis, flucytosine, 100 mg/kg/d orally, added to am­
photericin В and given in four divided doses, reduces the duration of therapy 
from 12 to 6 weeks. The dose of flucytosine must be reduced in renal failure; the 
major side effect is bone marrow suppression, which is usually reversible. Be­
cause of this toxicity, flucytosine is usually omitted when treating cryptococcal 
meningitis in patients with AIDS. For patients with AIDS and cryptococcal 
meningitis who do not respond to amphotericin В alone, fluconazole can be 
added at an initial dose of 400 mg, followed by 200 mg/d, orally or intra­
venously, for at least 10-12 weeks after CSF cultures are negative. Long-term 
maintenance therapy with fluconazole, 100-200 mg/d orally, may also reduce 
the likelihood of recurrence following successful treatment of cryptococcal men­
ingitis in patients with AIDS.
Rapid correction of hyperglycemia and acidosis must be combined with 
amphotericin В treatment and surgical debridement of necrotic tissue in diabet­
ics with mucormycosis. Mortality rates remain high in fungal meningitis. The 
complications of therapy are frequent, and neurologic residua are common.
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PARASITIC INFECTIONS
Protozoal and helminthic infections are important causes of central nerv­
ous system disease, particularly in immunosuppressed patients (including those 
with AIDS), and in certain regions of the world. Rickettsias, the parasitic bacte­
ria that cause Rocky Mountain spotted fever, rarely affect the nervous system.
1. MALARIA
Malaria is caused by the protozoan Plasmodium falciparum or another 
Plasmodium species that is transferred to humans by the female Anopheles mos­
quito. Clinical features include fever, chills, myalgia, nausea and vomiting, 
anemia, renal failure, hypoglycemia, and pulmonary edema. Although malaria 
is, worldwide, the most common parasitic infection of humans, cerebral in­
volvement is rare. Plasmodia reach the central nervous system in infected red 
blood cells and cause occlusion of cerebral capillaries. Neurologic involvement 
becomes apparent weeks after infection. In addition to acute confiisional states, 
cerebral malaria can produce seizures and, rarely, focal neurologic abnormali­
ties. The diagnosis is made by finding plasmodia in red blood cells of peripheral 
blood smears. The CSF may show increased pressure, xanthochromia, mononu­
clear pleocytosis, or mildly elevated protein.
Prophylaxis
Malaria prophylaxis is recommended for travelers to areas where the dis­
ease is endemic and consists of chloroquine phosphate, 500 mg orally, weekly. 
If exposure to chloroquine-resistant strains is expected, mefloquine (250 mg 
orally weekly for 4 weeks, then every other week for 4 weeks) should be given 
instead. Both regimens are started one week before the initial exposure and con­
tinued for 4 weeks after exposure ends.
T reatment
Chloroquine-sensitive cerebral malaria is treated with chloroquine, 10 mg 
base/kg by continuous intravenous infusion over 8 hours followed by 15 mg 
base/kg over 24 hours, or 3.5 mg base/kg by the intramuscular or subcutaneous 
route every 6 hours to a cumulative dose of ~25 mg base/kg. Chloroquine- 
resistant cerebral malaria is treated with quinidine, 10 mg base/kg by intrave­
nous infusion over 1 hour followed by 0.02 mg base/kg/min, or with quinine di- 
hydrochloride, 20 mg/kg by intravenous infusion over 4 hours followed by 10 
mg/kg infused over 2-8 hours every 8 hours. Each of these regimens is contin­
ued until oral therapy with chloroquine, amodiaquine, or sulfadoxine and 
pyrimethamine (for chloroquine-sensitive malaria) or with mefloquine, quinine, 
or quinidine (for chloroquine-resistant malaria) can be substituted. Cerebral 
edema is not a consistent finding in cerebral malaria, and corticosteroids are not
238
helpful and may, in fact, be deleterious. The mortality rate in cerebral malaria is 
20-50% and reaches 80% in cases complicated by coma and seizures.
2. TOXOPLASMOSIS
Acquired (as opposed to congenital) toxoplasmosis results from ingestion 
of Toxoplasma gondii cysts in raw meat or cat excrement and is usually asymp­
tomatic. Symptomatic infection is associated with underlying malignant disease 
(especially Hodgkin's disease), immunosuppressive therapy, or AIDS. Systemic 
manifestations include skin rash, lymphadenopathy, myalgias, arthralgias, cardi­
tis, pneumonitis, and splenomegaly. Central nervous system involvement can 
take several forms.
Clinical Findings
The CSF may be normal, or it may show mild mononuclear cell pleocyto­
sis or slight protein elevation. A CT scan may show one or more ring-enhancing 
lesions, especially if a double dose of contrast material is used. Lesions revealed 
by CT scan may fail to enhance, however, and autopsy-proved lesions may not 
be detected by CT. MR1 is superior to CT scanning for demonstrating cerebral 
toxoplasmosis. The diagnosis is made by blood tests demonstrating a high (> 
1:32,000) or rising Sabin-Feldman dye test titer or IgM antibodies to 
Toxoplasma by indirect immunofluorescence techniques. Accurate diagnosis re­
quires appropriate serologic studies in the immunosuppressed patient who de­
velops neurologic symptoms.
Treatment
Treatment is with pyrimethamine, 25-100 mg/d orally and sulfadiazine, 1- 
1.5 g orally four times daily, and is continued for 3-4 weeks in immuno­
competent patients and for at least several months in patients with AIDS or other 
immunodeficiency states. Clindamycin, 600 mg orally four times a day, may be 
substituted for sulfonamides in patients who develop drug sensitivity rashes. Fo- 
linic acid (leucovorin), 10 mg orally daily, is added to prevent pyrimethamine- 
induced leukopenia and thrombocytopenia.
3. PRIMARY AMEBIC MENINGOENCEPHALITIS
The free-living 'ameba Naegleria fowleri causes primary amebic menin­
goencephalitis in previously healthy young patients exposed to polluted water. 
Amebas gain entry to the central nervous system through the cribriform plate, 
producing a diffuse meningoencephalitis that affects the base of the frontal lobes 
and posterior fossa. It is characterized by headache, fever, nausea and vomiting, 
signs of meningeal irritation, and disordered mental status. Seizures and focal 
neurologic signs are rare. The CSF shows a polymorphonuclear pleocytosis with
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elevated protein and low glucose; highly motile, refractile trophozoites can be 
seen on wet mounts of centrifuged CSF. The disease is usually fatal within 1 
week, although treatment with amphotericin В, 1 mg/kg/d intravenously, may be 
effective, as may a combination of amphotericin B, rifampin, and chlorampheni­
col or ketoconazole.
4. GRANULOMATOUS AMEBIC ENCEPHALITIS
Granulomatous amebic encephalitis results from infection with the Acan- 
thamoeba/Hartmanella species and commonly occurs in the setting of chronic 
illness or immunosuppression. The disorder typically lasts for periods from 1 
week to 2 or 3 months and is characterized by subacute or chronic meningitis 
and granulomatous encephalitis. The cerebellum, brain stem, basal ganglia, and 
cerebral hemispheres are affected. An acute confusional state is the most com­
mon clinical finding. Although fever, headache, and meningeal signs are less 
common than in primary amebic meningoencephalitis (each occurring in only 
about half of patients), seizures and hemiparesis are more common. Cranial 
nerve palsies, cerebellar ataxia, and aphasia may occur. Pleocytosis may be pri­
marily lymphocytic or polymorphonuclear; protein is elevated, and glucose is 
low or normal. Sluggishly motile trophozoites may be seen on wet mounts. Suc­
cessful treatment has not been reported.
5. CYSTICERCOSIS
Cysticercosis is common in Mexico, Central and South America, and cer­
tain regions of Africa, Asia, and Europe. The disease follows ingestion of larvae 
of the pork tapeworm (Taenia solium) and affects the brain in 60-90% of cases. 
Larvae undergo hematogenous dissemination, forming cysts in the brain, ven­
tricles, and subarachnoid space. Neurologic manifestations of cysticercosis re­
sult from the mass effect of intraparenchymal cysts, obstruction of CSF flow by 
intraventricular cysts, or inflammation that causes basilar meningitis. They in­
clude seizures, headache, focal neurologic signs, hydrocephalus, myelopathy, 
and subacute meningitis. Peripheral blood eosinophilia, soft tissue calcifications 
on x-ray, or the presence of parasites in the stool suggests the diagnosis. The 
CSF typically shows a lymphocytic pleocytosis (< 100 cells/pL), with eosino­
phils usually but not always present. Opening pressure is often increased but 
may be decreased with spinal subarachnoid block. Protein is increased to 50-100 
mg/dL, and glucose is 20-50 mg/dL in most cases. Complement fixation and 
hemagglutination studies can assist in the diagnosis. The CT scan may show 
contrast-enhanced mass lesions with surrounding edema, intracerebral calcifica­
tions, or ventricular enlargement. Myelography should be performed in sus­
pected spinal subarachnoid block.
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The indications for treatment of cerebral cysticercosis are controversial. 
However, patients with symptomatic neurologic involvement (usually seizures) 
and either meningitis or one or more noncalcified intraparenchymal cysts should 
be treated. Intraventricular, subarachnoid, and racemose cysts respond poorly to 
treatment, and calcified cysts do not require treatment. Albendazole, 15 mg/kg/d 
in three doses taken with meals, and continued for 8 days, is the preferred ther­
apy. Praziquantel, 50 mg/kg/d in three divided doses, can also be used, but blood 
levels are reduced by anticonvulsants and corticosteroids, which are often also 
required in these patients. Patients with seizures should also receive anticonvul­
sants. Corticosteroids are indicated for increased intracranial pressure or lesions 
near the cerebral aqueduct or intraventricular foramina; these may progress to 
cause obstructive hydrocephalus. Single accessible intraparenchymal lesions can 
be removed surgically, and shunting is required for intraventricular lesions caus­
ing hydrocephalus.
6. ANGIOSTRONGYLUS CANTONENSIS MENINGITIS
Angiostrongylus cantonensis is endemic to Southeast Asia and to Hawaii 
and other Pacific islands. Infection is transmitted by ingestion of infected raw 
mollusks and produces meningitis with CSF eosinophilia. Most patients com­
plain of headache, and about half report stiff neck, vomiting, fever, and pares­
thesias. Most patients have a CSF leukocytosis of 150-1500/pL, mild elevation 
of protein, and normal glucose. The acute illness usually resolves spontaneously 
in 1-2 weeks, although paresthesias may persist longer. Levamisole, albenda­
zole, thiabendazole, mebendazole, and ivermectin have been used for treatment, 
and mebendazole 100 mg twice daily orally for 5 days may be preferred. Anal­
gesics, corticosteroids, and reduction of CSF pressure by repeated lumbar punc­
tures may be of value.
7. ROCKY MOUNTAIN SPOTTED FEVER
Rocky Mountain spotted fever is caused by Rickettsia rickettsii, an intra­
cellular parasite transmitted to humans by tick bites. R rickettsii damages endo­
thelial cells, leading to vasculitis, microinfarcts, and petechial hemorrhage. Ini­
tial symptoms include fever, headache, and a characteristic rash that involves the 
palms and soles and spreads centrally. Neurologic involvement, which is un­
common, produces a confusional state and, less often, coma or focal neurologic 
abnormalities. The CSF is normal or shows a mild mononuclear pleocytosis. 
Treatment is with chloramphenicol, 25-50 mg/kg/d orally or intravenously in 
four divided doses, or doxycycline, 200 mg/d orally or intravenously, and is 
continued for 7 days. Neurologic residua may occur.
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PERIPHERAL NERVE LESIONS
Classification
A. Mononeuropathy Simplex. This term signifies involvement of a sin­
gle peripheral nerve.
B. Mononeuropathy Multiplex. In this disorder, several individual 
nerves are affected, usually at random and noncontiguously. Clinical examina­
tion reveals a clinical deficit attributable to involvement of one or more isolated 
peripheral nerves, except when mononeuropathy multiplex is extensive and the 
resulting deficits become confluent.
Causes of peripheral neuropathy
Idiopathic inflammatory neuropathies
Acute idiopathic polyneuropathy (Guillain-Barre syndrome)
Chronic inflammatory demyelinating polyneuropathy 
Metabolic and nutritional neuropathies 
Diabetes
Other endocrinopathies 
Hypothyroidism 
Acromegaly 
Uremia 
Liver disease 
Vitamin Bt2 deficiency 
Infective and granulomatous neuropathies 
AIDS 
Leprosy 
Diphtheria 
Sarcoidosis
Sepsis and multiorgan failure 
Vasculitic neuropathies 
Polyarteritis nodosa 
Rheumatoid arthritis 
Systemic lupus erythematosus 
Neoplastic and paraproteinemic neuropathies 
Compression and infiltration by tumor 
Paraneoplastic syndromes 
Paraproteinemias 
Amyloidosis
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Drug-induced and toxic neuropathies
Alcohol 
Other drugs 
Dapsone 
Hydralazine 
Isoniazid 
Phenytoin 
Pyridoxine 
Vincristine 
Toxins
Organic compounds 
Hexacarbons 
Organophosphates 
Heavy metals 
Arsenic 
Lead 
Thallium 
Gold 
Platinum
Tryptophan (contaminant)
Hereditary neuropathies
Idiopathic
Hereditary motor and sensory neuropathies 
Hereditary sensory neuropathies 
Friedreich's ataxia 
Familial amyloidosis 
Metabolic
Porphyria
Metachromatic leukodystrophy 
Krabbe's disease 
Abetalipoproteinemia 
Tangier's disease 
Refsum's disease 
Fabry's disease 
Entrapment neuropathies
C. Polyneuropathy. This term denotes a disorder in which the function of 
numerous peripheral nerves is affected at the same time. This leads to a pre­
dominantly distal and symmetric deficit with loss of tendon reflexes. Polyneuro­
pathies are sometimes subclassified according to the primary site at which the 
nerve is affected. In distal axonopathies, the axon is the principal pathologic 
target; most polyneuropathies fall into this category. Myelinopathies are condi­
tions that involve the myelin sheath surrounding the axon. These disorders in-
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elude acute idiopathic polyneuropathy (Guillain-Barre syndrome), chronic in­
flammatory demyelinating neuropathy, diphtheria, certain paraneoplastic and 
paraproteinemic states, and some hereditary metabolic conditions (metachro- 
matic leukodystrophy, type III hereditary motor and sensory neuropathy, 
Krabbe's disease). Finally, certain disorders -  termed neuronopathies -  princi­
pally affect nerve cell bodies in the anterior horn of the spinal cord or dorsal root 
ganglion. Examples are type 11 hereditary motor and sensory neuropathy, pyri- 
doxine-induced neuropathy, and some paraneoplastic syndromes.
Clinical Findings
A. Sensory Disturbances. Involvement of sensory fibers can lead to 
numbness and impaired sensation. It can also lead to abnormal spontaneous sen­
sations, such as pain and paresthesias, and to perverted sensations such as hy- 
perpathia.
1. Pain is a conspicuous feature of certain neuropathies, especially if 
small fibers within the nerves are affected. The precise mechanism of its genesis 
is unclear. Polyneuropathies associated with prominent pain include those re­
lated to diabetes, alcoholism, porphyria, Fabry's disease, amyloidosis, rheuma­
toid arthritis, and AIDS, as well as dominantly inherited sensory neuropathy and 
paraneoplastic sensory neuronopathy. Pain is also a feature of many entrapment 
neuropathies and of idiopathic brachial plexopathy.
2. Dissociated sensory loss is impairment of some sensory modalities, 
such as pain and temperature, with preservation of others, such as light touch, 
vibration, and joint position sense. Although the presence of a dissociated sen­
sory loss often indicates a spinal cord lesion, it also occurs in peripheral neu­
ropathies when there is selective involvement of peripheral nerve fibers of a cer­
tain size, such as occurs in amyloid neuropathy, leprous neuritis, or hereditary 
sensory neuropathy. In such cases, preferential involvement of small fibers is 
commonly associated with disproportionate impairment of pain and temperature 
appreciation, spontaneous pain, and autonomic dysfunction. Large-fiber disease, 
on the other hand, results in defective touch, vibration, and joint position sense, 
early loss of tendon reflexes, and prominent motor symptoms.
B. Motor Deficits. The motor deficit that occurs with a peripheral nerve 
lesion consists of weakness of muscles innervated by the nerve, accompanied in 
severe cases by wasting and fasciculation. There may be difficulty in the per­
formance of fine tasks; this is compounded by any accompanying sensory loss. 
The clinical findings reflect a lower motor neuron deficit, and it is the distribu­
tion of these signs and the presence of accompanying sensory and reflex changes 
that suggest they may be due to peripheral nerve involvement.
C. Tendon Reflexes. These are impaired or lost if reflex arcs are inter­
rupted on either the afferent or efferent side (C5-6, biceps and brachioradialis;
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С7-8, triceps; L3-4, knee; SI, ankle). The ankle jerks are usually the first to be 
lost in patients with polyneuropathies.
D. Autonomic Disturbances. Autonomic disturbances may be particu­
larly conspicuous in some peripheral neuropathies -  especially Guillain-Barre 
syndrome and neuropathies related to diabetes, renal failure, porphyria, or amy­
loidosis. Symptoms include postural hypotension, coldness of the extremities, 
impaired thermoregulatory sweating, disturbances of bladder and bowel func­
tion, and impotence.
E. Enlarged Nerves. Palpably enlarged peripheral nerves raise the possi­
bility of leprosy, amyloidosis, hereditary motor and sensory neuropathies, Ref- 
sum's disease, acromegaly, or chronic inflammatory demyelinating polyneuropa­
thy.
Evaluation of Patients
A. Time Course. Polyneuropathy that develops acutely over a few days 
usually relates to an inflammatory process, as in the Guillain-Barre syndrome. It 
may also relate to an underlying neoplasm, to infections such as diphtheria, to 
metabolic disorders such as acute intermittent porphyria, or to exposure to such 
toxic substances as thallium or triorthocresyl phosphate. A chronic course with a 
gradual evolution over several years is typical of many hereditary or metabolic 
polyneuropathies but also characterizes chronic inflammatory demyelinating 
polyneuropathy.
Mononeuropathy of acute onset is likely to be traumatic or ischemic in 
origin, while one evolving gradually is more likely to relate to entrapment (ie, 
compression by neighboring anatomic structures) or to recurrent minor trauma.
B. Age at Onset. Polyneuropathies that develop during childhood or early 
adult life often have a hereditary basis, but they may also relate to an underlying 
inflammatory disorder. Those developing in later life are more likely to be due 
to a metabolic, toxic, or inflammatory disorder or to an underlying neoplasm.
Mononeuropathy presenting in the neonatal period is likely to be devel­
opmental in origin or related to birth injury; one developing in later life may re­
late to entrapment or injury that is often occupationally determined.
C. Occupational History. Various industrial substances can lead to pe­
ripheral neuropathy, including carbon disulfide, n-hexane, ethylene oxide, 
methyl bromide, acrylamide, triorthocresyl phosphate and certain other organo- 
phosphates, DDT, arsenic, lead, and thallium. A mononeuropathy is sometimes 
the first clinical manifestation of an occupationally related polyneuropathy, but 
it may also develop in response to entrapment or recurrent minor occupational 
trauma. For example, carpal tunnel syndrome is more common in persons who 
do heavy manual labor or develop repetitive motion injury as a result of com­
puter terminal use, and a lesion of the deep palmar branch of the ulnar nerve 
may relate to repeated pressure on the palm of the hand by, for example, punch-
ing down heavily on a stapler or using heavy equipment such as a pneumatic 
road drill.
D. Medical History:
1. Peripheral neuropathy may relate to metabolic disorders such as dia­
betes mellitus, uremia, liver disease, myxedema, acromegaly, metachromatic 
leukodystrophy, or Fabry's disease. That caused by diabetes is especially impor­
tant and may take the form of an entrapment mono neuropathy, acute ischemic 
mononeuritis, distal sensorimotor polyneuropathy, subacute proximal motor 
polyradiculopathy (diabetic amyotrophy), thoracoabdominal radiculopathy, or 
autonomic neuropathy.
2. A peripheral neuropathy may also relate to an underlying malignant 
neoplasm. The peripheral nerves, spinal nerves, and limb plexuses may be com­
pressed or infiltrated by extension of primary tumors or metastatic lymph nodes. 
Neoplastic disease can also lead to a nonmetastatic (paraneoplastic) sensory or 
sensorimotor polyneuropathy or to Lambert-Eaton syndrome.
3. Certain connective tissue disorders, especially polyarteritis nodosa, 
rheumatoid arthritis, Churg-Strauss syndrome, and Wegener's granulomatosis, 
may be associated with mononeuropathy multiplex or, less commonly, polyneu­
ropathy or cranial neuropathy. Polyneuropathy is more common in systemic lu­
pus erythematosus. Patients with rheumatoid arthritis are particularly likely to 
develop focal entrapment or compressive mononeuropathies in the vicinity of 
the affected joints.
4. AIDS is commonly associated with a distal, symmetric, primarily sen­
sory polyneuropathy. Peripheral nerve involvement in AIDS less frequently 
takes the form of an acute or chronic inflammatory demyelinating polyneuropa­
thy, polyradiculopathy, mononeuropathy multiplex, or autonomic neuropathy. 
Neuropathies are also seen in patients with AIDS-related complex, asympto­
matic human immunodeficiency virus-1 (HIV-1) infection, and HIV-1 serocon­
version.
E. Drug and Alcohol History. Some of the drugs that cause peripheral 
neuropathy are shown in table; there may be selective involvement of motor or 
sensory fibers with some drugs:
Sensory neuropathy
Chloramphenicol
Cisplatin
Pyridoxine
Taxotere
Predominantly sensory neuropathy
Ethambutol
Hydralazine
Misonidazole
Metronidazole
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Motor neuropathy 
Dapsone 
Imipramine 
Certain sulfonamides
Mixed sensory and motor neuropathy 
Amiodarone 
Chloroquine 
Disulfiram 
Gold
Indomethacin
Isoniazid
Nitrofurantoin
Penicillamine
Perhexilene
Phenytoin
Thalidomide
Tryptophan (contaminant)
Vincristine
F. Family Background. Certain polyneuropathies have a he­
reditary basis. These are discussed later in this chapter in the section on heredi­
tary neuropathies.
Differential Diagnosis
Peripheral neuropathies can lead to a motor or sensory deficit or both. The 
preservation of sensation and tendon reflexes distinguishes the motor deficit that 
results from pure pyramidal lesions or is associated with spinal muscular atro­
phies, myopathies, or disorders of neuromuscular transmission from that caused 
by peripheral nerve involvement.
Myelopathies are characterized by a pyramidal deficit below the level of 
the lesion as well as by distal sensory loss.
In tabes dorsalis, there is often a history of syphilitic infection, and ex­
amination reveals other stigmas of syphilis. In addition, tactile sensation is pre­
served.
Radiculopathies are distinguished from peripheral neuropathies by the dis­
tribution of motor or sensory deficits. The presence of neck or back pain that ra­
diates to the extremities in a radicular distribution also suggests a root-lesion.
Investigative Studies
Laboratory studies in patients with peripheral neuropathy are directed at 
confirming the diagnosis and revealing any underlying cause. Electromyography 
may reveal evidence of denervation in the affected muscles and can be used to 
determine whether any motor units remain under voluntary control. Nerve con-
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duction studies permit conduction velocity to be measured in motor and sensory 
fibers. On the basis of electrodiagnostic or histopathologic studies, peripheral 
neuropathies can be divided into demyelinating or axonal neuropathies. In the 
former, electromyography typically reveals little or no evidence of denervation 
but there is conduction block or marked slowing of maximal conduction velocity 
in affected nerves. In the axonal neuropathies, electromyography shows that 
denervation has occurred, especially distally in the extremities, but maximal 
nerve conduction velocity is normal or slowed only slightly.
In patients with electrophysiologically confirmed peripheral neuropathy, 
laboratory studies should include a complete blood count; erythrocyte sedimen­
tation rate; serum urea nitrogen and creatinine, fasting blood glucose, and serum 
vitamin BI2; serum protein, protein electrophoresis, and immunoelectrophoresis; 
liver and thyroid function blood tests; serologic tests for syphilis (FTA or MHA- 
TP), rheumatoid factor, and antinuclear antibody; and chest x-ray. If toxic 
causes are suspected, a 24-hour urine collection followed by analysis for heavy 
metals may be necessary, and hair and fingernail clippings can be analyzed for 
arsenic. Examination of a fresh specimen of urine for porphobilinogen and 5- 
aminolevulinic acid is necessary if porphyria is suspected.
Treatment
Treatment of the underlying cause may limit the progression of or even 
reverse the neuropathy. Nursing care is important in patients with severe motor 
or sensory deficits to prevent decubitus ulcers, joint contractures, and additional 
compressive peripheral nerve damage. Respiratory function must also be moni­
tored carefully-particularly in acute idiopathic polyneuropathy (Guillain-Barre 
syndrome), chronic inflammatory demyelinating polyneuropathy, and diphther­
itic neuropathy-and preparations must be made to assist ventilation if the vital 
capacity falls below about 1 L. In patients with severe dysesthesia, a cradle (in­
verted metal bar frame) can be used to keep the bedclothes from touching sensi­
tive areas of the skin. Treatment with phenytoin, 300 mg/d; carbamazepine, up 
to 1200 mg/d; or mexiletine, 600-900 mg/d is sometimes helpful in relieving the 
lancinating pain of certain neuropathies. If the pain is more constant, burning, or 
dysesthetic, amitriptyline 25-100 mg at bedtime is often helpful. Gabapentin 
(300 mg three times daily) has not been definitively evaluated but many patients 
report symptom amelioration with it when the first-line drugs are not tolerated.
Extremities with sensory loss must be protected from repeated minor 
trauma, such as thermal injury, that can destroy tissues. The temperature of hot 
surfaces should be checked with a part of the body in which sensation is pre­
served, and the setting of water heaters must be reduced to prevent scalding. The 
skin and nails must be cared for meticulously.
Dysautonomic symptoms may be troublesome, especially in diabetic or 
alcoholic polyneuropathy. Waist-high elastic hosiery, dietary salt supplementa-
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tion, and treatment with fludrocortisone, 0.1-1 mg/d orally, may help relieve 
postural hypotension, but the patient must be monitored carefully to prevent re­
cumbent hypertension. Instructing the patient to sleep in a semierect rather than 
a recumbent position is helpful because dysautonomic patients are often unable 
to conserve salt and water when recumbent at night.
POLYNEUROPATHIES
IDIOPATHIC INFLAMMATORY NEUROPATHIES
Acute Idiopathic Polyneuropathy (Guillain-Barre Syndrome)
Guillain-Barre syndrome is an acute or subacute polyneuropathy that can 
follow minor infective illnesses, inoculations, or surgical procedures-or may oc­
cur without obvious precipitants. Clinical and epidemiologic evidence suggests 
an association with preceding Campylobacter jejuni infection. Its precise cause 
is unclear, but it appears to have an immunologic basis. Both demyelinating and 
axonal forms have been recognized, with distinctive clinical and electro- 
physiologic features. The demyelinative form is more common in the United 
States, but an axonal variant is encountered occasionally (acute motor sensory 
axopal neuropathy). In northern China a related axonal form occurs frequently 
and has been designated acute motor axonal neuropathy.
A. Clinical Features. The features useful for diagnosing Guillain-Barre 
syndrome are summarized below. Patients generally present with weakness that 
is symmetric, usually begins in the legs, is often more marked proximally than 
distally, and is sometimes so severe that it is life-threatening, especially if the 
muscles of respiration or swallowing are involved. Muscle wasting develops if 
axonal degeneration has occurred. Sensory complaints, while usually less 
marked than motor symptoms, are also frequent. The deep tendon reflexes are 
typically absent. There may be marked autonomic dysfunction, with tachycardia, 
cardiac irregularities, labile blood pressure, disturbed sweating, impaired pul­
monary function, sphincter disturbances, paralytic ileus, and other abnormalities.
Diagnostic criteria for Guillain-Barre syndrome:
Required for diagnosis
Progressive weakness of more than one limb
Distal areflexia with proximal areflexia or hyporeflexia
Supportive of diagnosis
Progression for up to 4 weeks 
Relatively symmetric deficits
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Mild sensory involvement
Cranial nerve (especially VII) involvement
Recovery beginning within 4 weeks after progression stops
Autonomic dysfunction
No fever at onset
Increased CSF protein after 1 week 
CSF white blood cell count < 10/pl 
Nerve conduction slowing or block by several weeks
Against diagnosis
Markedly asymmetric weakness
Bowel or bladder dysfunction (at onset or persistent)
CSF white blood cell count >50 or PMN count >0/pl 
Well-demarcated sensory level
Excluding diagnosis
Isolated sensory involvement
Another polyneuropathy that explains clinical picture
B. Investigative Studies. The CSF often shows a characteristic abnormal­
ity, with increased protein concentration but a normal cell count; abnormalities 
may not be found in the first week, however. Electrophysiologic studies may re­
veal marked slowing of motor and sensory conduction velocity, or evidence of 
denervation and axonal loss. The time course of the electrophysiologic changes 
does not necessarily parallel any clinical developments.
C. Treatment. Plasmapheresis appears to reduce the time required for re­
covery and may decrease the likelihood of residual neurologic deficits. It is best 
instituted early, and it is indicated especially in patients with a severe or rapidly 
progressive deficit or respiratory compromise. Intravenous immunoglobulin 
(400 mg/kg/d for 5 days) appears to be equally effective and should be used in 
preference to plasmapheresis in adults with cardiovascular instability and in 
children; the two therapies are not additive.
In the past, corticosteroids were often prescribed for patients with a pro­
gressive downhill course, but recent studies have shown that these agents may 
affect the outcome adversely and even increase the time necessary for recovery. 
Therapy is otherwise symptomatic, the aim being to prevent such complications 
as respiratory failure or vascular collapse. For this reason, patients who are se­
verely affected are best managed in intensive care units, where facilities are 
available for monitoring and assisted respiration if necessary (eg, if the vital ca­
pacity falls below about 1 L, the patient is short of breath, or the blood oxygen 
saturation declines). Volume replacement or treatment with pressor agents is 
sometimes required to counter hypotension, and low-dose heparin may help to 
prevent pulmonary embolism.
D. Prognosis. Symptoms and signs cease to progress by about 4 weeks 
into the illness. The disorder is self-limiting, and improvement occurs over the
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weeks or months following onset. About 70-75% of patients recover completely, 
25% are left with mild neurologic deficits, and 5% die, usually as a result of res­
piratory failure. The prognosis is poorer when there is evidence of preceding 
Campylobacter jejuni infection, and a more protracted course and less complete 
recovery are also likely when axonal degeneration rather than demyelination is 
the primary pathology. Advanced age, the need for ventilatory support, or more 
rapid onset of symptoms may also predict a poorer prognosis.
Chronic Inflammatory Demyelinating Polyneuropathy
Chronic inflammatory demyelinating polyneuropathy is clinically similar 
to Guillain-Barre syndrome except that it follows a chronic progressive course -  
or a course characterized by relapses -  and no improvement is apparent within 
the 6 months after onset. Its cause is not known. Examination of the CSF reveals 
findings resembling those in Guillain-Barre syndrome. The electrophysiologic 
findings indicate a demyelinative neuropathy with superimposed axonal degen­
eration.
Clinical features:
Hyporeflexia or areflexia 
Weakness
Distal upper extremity 
Dista llower extremity 
Proximal upper extremity 
Proximal lower extremity 
Respiratory muscles 
Neck 
Face
Sensory deficit on examination
Distal lower extremity 
Distal upper extremity 
Paresthesia
Upper extremity 
Lower extremity 
Face
Pain
Lower extremity 
Upper extremity 
Dysarthria 
Dysphagia 
Impotence 
Incontinence
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The disorder is often responsive to treatment with corticosteroids (pred­
nisone, 60-100 mg/d for 2-4 weeks, then gradually tapered to 5-20 mg every 
other day), which may have to be continued on a long-term basis. In nonre- 
sponsive patients, treatment with azathioprine or cyclophosphamide may be 
helpful. In other instances, plasmapheresis or intravenous immunoglobulin ther­
apy (400 mg/kg/d) is beneficial, although the response is usually short-lived; 
treatment therefore has to be continued intermittently to maintain benefit.
METABOLIC & NUTRITIONAL NEUROPATHIES
Diabetes Mellitus
Peripheral nerve involvement in diabetes is common and may be charac­
terized by polyneuropathy, which is of mixed (sensory, motor, and autonomic;) 
character in about 70% of cases and predominantly sensory in about 30%; 
mononeuropathy multiplex; or mononeuropathy simplex. Such clinical manifes­
tations can occur in isolation or in any combination. The incidence of peripheral 
nerve involvement may be influenced by the adequacy of diabetes control, 
which should, in any event, be optimal.
A. Clinical Features. The most common manifestation is a distal sensory 
or mixed polyneuropathy, which is sometimes diagnosed, before it becomes 
symptomatic, from the presence of depressed tendon reflexes and impaired ap­
preciation of vibration in the legs. Symptoms are generally more common in the 
legs than in the arms and consist of numbness, pain, or paresthesias. In severe 
cases, there is distal sensory loss in all limbs and some accompanying motor dis­
turbance. Diabetic dysautonomia leads to many symptoms, including postural 
hypotension, disturbances of cardiac rhythm, impaired thermoregulatory sweat­
ing, and disturbances of bladder, bowel, gastric, and sexual function. Diabetic 
mononeuropathy multiplex is usually characterized by pain and weakness and 
often has a vascular basis. The clinical deficit will depend on the nerves that are 
affected. Diabetic amyotrophy is due to radiculoplexopathy, polyradiculopathy, 
or polyradiculoneuropathy. Pain, weakness, and atrophy of pelvic girdle and 
thigh muscles are typical, with absent quadriceps reflexes and little sensory loss. 
Diabetic mononeuropathy simplex is typically abrupt in onset and often painful. 
CSF protein is typically increased in diabetic polyneuropathy and mononeuropa­
thy multiplex.
B. Treatment and Prognosis. No specific treatment exists for the periph­
eral nerve complications of diabetes except when the patient has an entrapment 
neuropathy and may benefit from a decompressive procedure. Phenytoin (200- 
400 mg/d orally), mexiletine (600-900 mg/d), or carbamazepine (100-600 mg 
orally twice daily) may help to relieve shooting or stabbing neuropathic pain, 
while amitriptyline (75-150 mg orally at bedtime) or a combination of ami-
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triptyline and fluphenazine may be useful for treating deep, constant, aching 
pain.
Postural hypotension may respond to treatment with salt supplementation; 
sleeping in an upright position; wearing waist-high elastic hosiery; fludrocor­
tisone, 0.1-1 mg/d; and midodrine (an a-agonist), 10 mg three times daily. 
Treatment is otherwise symptomatic. Diabetic amyotrophy and mononeuropathy 
simplex usually improve or resolve spontaneously.
Other Endocrinopathies
Hypothyroidism is a rare cause of polyneuropathy. More commonly, hy­
pothyroidism is associated with entrapment neuropathy, especially carpal tunnel 
syndrome. Polyneuropathy may be mistakenly diagnosed in patients with 
proximal limb weakness caused by hypothyroid myopathy or in patients with 
delayed relaxation of tendon reflexes, a classic manifestation of hypothyroidism 
that is independent of neuropathy. Other neurologic manifestations of hypothy­
roidism such as acute confusional state, dementia, and cerebellar degeneration 
are discussed elsewhere.
Acromegaly also frequently produces carpal tunnel syndrome and, less of­
ten, polyneuropathy. Since many acromegalic patients are also diabetic, it may 
be difficult to determine which disorder is primarily responsible for polyneuro­
pathy in a given patient.
Uremia
A symmetric sensorimotor polyneuropathy, predominantly axonal in type, 
may occur in uremia. It tends to affect the legs more than the arms and is more 
marked distally than proximally. Restless legs, muscle cramps, and burning feet 
have been associated with it. The extent of any disturbance in peripheral nerve 
function appears to relate to the severity of impaired renal function. The neu­
ropathy itself may improve markedly with renal transplantation. Carpal tunnel 
syndrome (see below) has also been described in patients with renal disease and 
may develop distal to the arteriovenous fistulas placed in the forearm for access 
during hemodialysis. In patients on chronic hemodialysis, it often relates to 
amyloidosis and the accumulation of fS2-microglobulin.
Liver Disease
Primary biliary cirrhosis may lead to a sensory neuropathy that is proba­
bly of the axonal type. A predominantly demyelinative polyneuropathy can oc­
cur in patients with chronic liver disease. There does not appear to be any corre­
lation between the neurologic findings and the severity of the hepatic dys­
function.
Vitamin B,2 Deficiency
Vitamin B,2 deficiency is associated with many features that are charac-
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teristic of polyneuropathy, including symmetric distal sensory and motor impair­
ment and loss o f tendon reflexes. Because controversy exists about the relative 
importance of polyneuropathy and myelopathy in producing this syndrome, 
however, vitamin B)2 deficiency is considered in more detail below in the sec­
tion on myelopathies.
INFECTIVE & GRANULOMATOUS NEUROPATHIES
AIDS
Neuropathy is a common complication of HIV-1 infection; involvement of 
peripheral nerves is seen at autopsy in about 40% of patients with AIDS.
Distal symmetric sensorimotor polyneuropathy is the most common 
neuropathy associated with HIV-1 infection. Axons, rather than myelin, are pri­
marily affected. The cause is unknown, but in some patients vitamin BI2 defi­
ciency or exposure to neurotoxic drugs may be responsible in part. HIV-1 is 
rarely identified in the affected nerves. Sensory symptoms predominate and in­
clude pain and paresthesias that affect the feet especially. Weakness is a minor 
or late feature. Ankle and sometimes knee reflexes are absent. The course is 
typically progressive and no treatment is available, but pain may be controlled 
pharmacologically, as described above for diabetic neuropathy. Plasmapheresis 
is of no benefit.
Inflammatory demyelinating polyneuropathy may occur early in HIV- 
1 infection and may follow an acute or chronic course. The neuropathy may be 
immune-mediated, but sometimes results from direct, secondary viral infection, 
as from cytomegalovirus. It is characterized by proximal, and sometimes distal, 
weakness with less-pronounced sensory disturbances and areflexia or hypore- 
flexia. The CSF is abnormal, with an elevated protein concentration and often a 
lymphocytic pleocytosis (unlike the findings in Guillain-Barre syndrome or 
chronic inflammatory demyelinating polyneuropathy in patients without HIV-1 
infection). Some patients improve spontaneously or stabilize, and others may re­
spond to corticosteroids, plasmapheresis, or intravenous immunoglobulins.
Lumbosacral polyradiculopathy occurs late in the course of HIV-1 in­
fection, usually in patients with prior opportunistic infections. Cytomegalovirus 
infection is thought to be the cause, at least in some instances. Clinical features 
usually develop over several weeks and include diffuse, progressive leg weak­
ness, back pain, painful paresthesias of the feet and perineum, lower extremity 
areflexia, and early urinary retention. The course may be fulminant, with as­
cending paralysis leading to respiratory failure. The course is more benign in 
some patients, however, especially when the etiology is unclear. CSF findings
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include mononuclear or polymorphonuclear pleocytosis, elevated protein, and 
decreased glucose. It is always important to exclude meningeal lymphomatosis, 
cord compression, or syphilis as the underlying cause, as these require specific 
treatment and affect the prognosis. Patients with cytomegalovirus infection may 
respond to ganciclovir, 2.5 mg/kg intravenously every 8 hours for 10 days, then 
7.5 mg/kg/d 5 days per week.
Mononeuropathy multiplex affects multiple cranial and peripheral 
nerves, resulting in focal weakness and sensory loss. Some cases may have an 
autoimmune basis, whereas others result from neoplastic or infectious causes 
(eg, cytomegalovirus infection) or from vasculopathy. In early HIV-1 infection, 
mononeuropathy multiplex may be a self-limited disorder restricted to a single 
limb, with spontaneous stabilization or improvement. Late in AIDS, multiple 
limbs may be affected in a progressive fashion.
Mononeuropathy simplex tends to occur acutely in early HIV-1 infection 
and improve spontaneously. A vascular cause is probable.
Autonomic neuropathy tends to occur late in the course of HIV-1 infec­
tions and may lead to syncopal episodes, orthostatic hypotension, disturbances 
of sphincter or sexual function, impaired thermoregulatory sweating, and diar­
rhea. The dysautonomia may relate to central or peripheral pathology. Treatment 
is symptomatic (as discussed earlier under diabetic neuropathy).
Diphtheria
Corynebacterium diphtheriae infects tissues of the upper respiratory tract 
and produces a toxin that causes demyelination of peripheral nerves. Within 
about I month after infection, patients may develop a cranial motor neuropathy 
with prominent impairment of ocular accommodation. Blurred vision is the 
usual presenting complaint. Extraocular muscles and the face, palate, pharynx, 
and diaphragm may also be affected, but the pupillary light reflex is preserved. 
Recovery typically occurs after several weeks. A more delayed syndrome that 
commonly has its onset 2-3 months following the primary infection takes the 
form of a symmetric distal sensorimotor polyneuropathy. Most patients recover 
completely.
Sarcoidosis
Sarcoidosis can produce mononeuropathy or, rarely, polyneuropathy. The 
mononeuropathy commonly involves cranial nerves, especially the facial nerve, 
in which case the resulting syndrome may be indistinguishable from idiopathic 
facial paralysis (Bell's palsy). X-rays of the lungs and bones and determination 
of serum levels of angiotensin-converting enzyme are helpful in establishing the 
diagnosis. Treatment with prednisone, 60 mgld orally followed by tapering 
doses, may speed recovery.
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NEUROPATHIES IN VASCULITIS & COLLAGEN VASCULAR 
DISEASE
Systemic vasculitides and collagen vascular diseases can produce 
polyneuropathy, mononeuropathy simplex, mononeuropathy multiplex, or 
entrapment neuropathy.
Systemic necrotizing vasculitis includes polyarteritis nodosa and allergic 
angiitis and granulomatosis (Churg-Strauss syndrome). Neuropathy occurs in 
about 50% of patients, most often as mononeuropathy multiplex, which may 
manifest itself with the acute onset of pain in one or more cranial or peripheral 
nerves. Distal symmetric sensorimotor polyneuropathy is less common. Treat­
ment should begin as soon as the diagnosis is made; it includes prednisone, 60- 
100 mg/d orally, and cyclophosphamide, 2-3 mg/d orally. Plasmapheresis may 
also be helpful.
Wegener's granulomatosis is associated with mononeuropathy multiplex 
or polyneuropathy in up to 30% of cases. Treatment is the same as for systemic 
necrotizing vasculitis.
Giant cell arteritis. Mononeuropathy affecting cranial nerves innervating 
the extraocular muscles can occur.
Rheumatoid arthritis produces entrapment neuropathy (most commonly 
involving the median nerve) in about 45% of patients and distal symmetric sen­
sorimotor polyneuropathy in about 30%. Mononeuropathy multiplex is a fre­
quent feature in cases complicated by necrotizing vasculitis.
Systemic lupus erythematosus. Neuropathy occurs in up to 20% of pa­
tients. The most common pattern is a distal, symmetric sensorimotor polyneuro­
pathy. An ascending, predominantly motor polyneuropathy (Guillain-Barre syn­
drome, see above) can also occur, as may mononeuropathy simplex or multi­
plex, which often affects the ulnar, radial, sciatic, or peroneal nerve.
Sjogren's syndrome involves the peripheral nerves in about 20% of 
cases. Distal symmetric sensorimotor polyneuropathy is most common, entrap­
ment neuropathy (affecting especially the median nerve) is also frequent, and 
mononeuropathy multiplex can occur.
Progressive systemic sclerosis (scleroderma) and mixed connective 
tissue disease may produce cranial mononeuropathy, which most often involves 
the trigeminal (V) nerve.
NEOPLASTIC & PARAPROTEINEMIC NEUROPATHIES 
Compression & Infiltration by Tumor
Nerve compression is a common complication of multiple myeloma, lym­
phoma, and carcinoma. Tumorous invasion of the epineurium may occur with 
leukemia, lymphoma, and carcinoma of the breast or pancreas.
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Paraneoplastic Syndromes
Carcinoma (especially oat-cell carcinoma of the lung) and lymphoma may 
be associated with neuropathies that are thought to be immunologicaily me­
diated, based on the detection of autoantibodies to neuronal antigens in several 
cases.
Sensory or sensorimotor polyneuropathy occurs with both carcinoma 
and lymphoma. This can be either an acute or chronic disorder; it is sometimes 
asymmetric and may be accompanied by prominent pain.
Carcinoma can also cause sensory neuronopathy, a polyneuropathy that 
primarily affects the cell bodies of sensory neurons in the dorsal root ganglion. 
This rare condition may be the presenting manifestation of cancer. Initial symp­
toms of pain and numbness usually begin distally but sometimes begin prox- 
imally or in the face. The disorders often progress over days or several weeks, 
leading to marked sensory ataxia and impairment of all sensory modalities. Mo­
tor involvement is late, and autonomic dysfunction is uncommon. The CSF may 
have an inflammatory formulation. Treatment, even of the underlying tumor, is 
usually unrewarding.
Lymphoma may be complicated by motor neuronopathy, a disorder of 
anterior horn cells. Hodgkin's disease and angioimmunoblastic lymphadenopa- 
thy are sometimes associated with Guillain-Barre syndrome.
Paraproteinemias
Polyneuropathy is a common complication of multiple myeloma. Patients 
affected by lytic myeloma are usually men. The clinical picture is of a distal 
symmetric sensorimotor polyneuropathy. All sensory modalities are affected, 
pain is a frequent feature, and the reflexes are depressed. The disorder is usually 
progressive and leads to death within 2 years. Sclerotic myeloma may be ac­
companied by a chronic demyelinating polyneuropathy. Motor involvement pre­
dominates, but vibration and position sense may also be impaired, and the re­
flexes are depressed. Pain is less common than in the neuropathy of lytic mye­
loma, and symptoms may improve with treatment of the underlying cancer or by 
plasmapheresis. The POEMS syndrome (polyneuropathy, organomegaly, en- 
docrinopathy, M protein, and skin changes) may complicate plasma cell dyscra- 
sias, especially osteosclerotic myeloma. The sensorimotor polyneuropathy may 
respond to treatment with corticosteroids or cyclophosphamide; irradiation of 
solitary osteosclerotic lesions may also be worthwhile.
A sensorimotor polyneuropathy similar to that observed with lytic mye­
loma may also occur in Waldenstrom's macroglobulinemia or benign mono­
clonal gammopathy. Treatment with immunosuppressant drugs and plas­
mapheresis is sometimes helpful.
Amyloidosis
Nonhereditary amyloidosis occurs as an isolated disorder (primary gener-
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aiized amyloidosis) or in patients with multiple myeloma and may be associated 
with polyneuropathy. Polyneuropathy is also a feature of hereditary amyloidosis. 
Amyloid neuropathies are considered below in the section on hereditary neu­
ropathies.
DRUG-INDUCED & TOXIC NEUROPATHIES
Alcohol
Polyneuropathy is one of the most common neurologic complications of 
chronic alcoholism; it can occur alone or in combination with other alcohol-re­
lated neurologic disorders, such as Wernicke's encephalopathy or the Korsakoff 
amnestic syndrome. Controversy exists concerning the relative contributions of 
direct neurotoxicity of alcohol and associated nutritional (especially thiamine) 
deficiency in producing polyneuropathy.
Alcoholic polyneuropathy is typically a symmetric distal sensorimotor 
neuropathy. The legs are particularly likely to be affected, resulting in defective 
perception of vibration and touch and depressed or absent ankle reflexes. In 
some cases, distal weakness is also pronounced and autonomic dysfunction may 
occur. When pain is a prominent feature, it may respond to the same treatment 
described above for painful diabetic neuropathy. Abstinence from alcohol and 
thiamine repletion can halt the progression of symptoms.
Other Drugs
A large number of drugs have been reported to cause neuropathies.
Hydralazine, an antihypertensive drug, is associated on rare occasions 
with a predominantly sensory polyneuropathy that has been attributed to drug- 
induced pyridoxine deficiency and that resolves after the drug is discontinued.
Isoniazid is a widely used antituberculous agent that interferes with pyri­
doxine metabolism and produces a polyneuropathy that principally affects the 
sensory neurons. High doses, hereditary variations in drug metabolism, and 
malnutrition predispose to this complication. Spontaneous recovery is the rule 
when administration of the drug is halted. Isoniazid-induced neuropathy can be 
prevented by concurrent administration of pyridoxine, 100 mg/d orally.
Phenytoin is often mentioned as a cause of polyneuropathy, but evidence 
for phenytoin treatment as a cause of symptomatic neuropathy is sparse.
Pyridoxine (vitamin B6) toxicity has been implicated as the cause of a 
sensory neuronopathy that disproportionately impairs vibration and position 
sense. This disorder occurs in patients taking at least 200 mg of pyridoxine daily 
-  about 100 times the minimum daily requirement. Sensory ataxia, Romberg's 
sign, Lhermitte's sign, and ankle areflexia a^e common findings. Pain is less 
common, and motor involvement is unusual. Symptoms are usually reversible
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over months to years if the abuse ceases, but an irreversible syndrome has also 
been reported following intravenous administration of high doses of pyridoxine.
Vincristine produces a polyneuropathy in most patients who receive the 
drug for treatment of (usually hematologic) cancer. The earliest manifestations 
are distal sensory symptoms and loss of reflexes. Motor deficits may predomi­
nate later in the course, however. Constipation is a common finding and may be 
due to autonomic involvement. Discontinuing the drug or administering it at a 
reduced dosage often leads to improvement.
Toxins
Organic compounds implicated as causes of polyneuropathy include 
hexacarbons present in solvents and glues (eg, n-hexane, methyl n-butyl ketone) 
and organophosphates used as plasticizers or insecticides (eg, triorthocresyl- 
phosphate). Sensory involvement is most striking in n-hexane neuropathy, 
whereas neuropathy caused by triorthocresyl phosphate primarily affects motor 
nerves.
Heavy metals may also be responsible for polyneuropathy. Neuropathy 
caused by lead, arsenic, and thallium. Gold, which is used to treat rheumatoid 
arthritis, may cause a symmetric polyneuropathy, and cisplatin (a platinum ana­
logue with anticancer activity) may produce a sensory neuropathy.
Eosinophilia-myalgia syndrome was first identified in 1989 in patients 
taking L-tryptophan who developed disabling myalgias with blood eosinophil 
counts above 1,000/pL. About 85% of patients are women. The cause appears to 
be l,T-ethylidenebis [tryptophan], a contaminant in certain commercial prepara­
tions of L-tryptophan, which have since been withdrawn. Symptoms include 
myalgia, arthralgia, dyspnea, cough, rash, fever, and sclerodermiform skin 
changes. Neurologic findings include weakness of distal and proximal limb and 
bulbar muscles, distal sensory loss, and areflexia. Eosinophilia, leukocytosis, 
and elevated liver enzymes are typical. Nerve conduction studies and electro­
myography may show evidence of polyneuropathy, myopathy, or both. In­
flammation is prominent in skin biopsy specimens, but less so in nerve and mus­
cle, which show primarily axonal degeneration and muscle fiber atrophy. Treat­
ment is discontinuation of L-tryptophan and administration of corticosteroids, 
nonsteroidal antiinflammatory drugs, and analgesics. Most patients improve or 
recover fully, but deaths have been reported.
HEREDITARY NEUROPATHIES 
Idiopathic
Hereditary motor and sensory neuropathies (HMSN) include the hyper­
trophic (HMSN type I) and neuronal (HMSN type II) forms of CharcotMarie- 
Tooth disease as well as Dejerine-Sottas disease (HMSN type III). HMSN type I
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is a slowly progressive demyelinating neuropathy that occurs either sporadically 
or with a dominant, X-linked, or recessive mode of inheritance. Dominant in­
heritance is the most common pattern, and genetic studies have shown linkage to 
the short arm of chromosome 17, the long arm of chromosome 1, or the X 
chromosome. When chromosome 17 is involved (as occurs in most cases), there 
is duplication of the PMP-22 gene that can be detected in single affected indi­
viduals and therefore forms the basis of a useful diagnostic test. On chromosome 
1, the myelin protein zero (PO) gene has been implicated, whereas point muta­
tions of the connexin 32 gene have been incriminated in the X-linked form. The 
nerves may be palpably enlarged. HMSN type II, which is less common, affects 
the anterior horn cells and thus resembles progressive spinal muscular atrophy. 
Genetic studies of the autosomal dominant form have shown linkage to chromo­
some lp in some cases. HMSN type III is a slowly progressive demyelinating 
disorder that usually has a recessive mode of inheritance and progresses from its 
onset in infancy or childhood to cause severe disability by the third decade of 
life. The nerves are typically enlarged.
Hereditary sensory and autonomic neuropathies (HSAN) also take a vari­
ety of forms. In HSAN type I, there is a dominant inheritance, a gradually pro­
gressive course from onset in early adulthood, and symmetric loss of distal pain 
and temperature perception, with relative preservation of light touch. Perforating 
ulcers over pressure points and painless infections of the extremities are com­
mon. The tendon reflexes are depressed, but there is little, if any, motor distur­
bance. In HSAN type II, inheritance is recessive, onset is in infancy or early 
childhood, all sensory modalities are affected, and tendon reflexes are lost. 
HSAN type III (Riley-Day syndrome, familial dysautonomia) is a recessive dis­
order that commences in infancy and is characterized by conspicuous autonomic 
dysfunction (absent tearing, labile temperature and blood pressure), ac­
companied by absent taste sensation, impaired pain and temperature sensation, 
and areflexia. HSAN type IV is associated with congenital insensitivity to pain 
and absent sweating.
Polyneuropathy can occur in both the hereditary and nonhereditary forms 
of amyloidosis. Because small-diameter sensory and autonomic nerve fibers are 
especially likely to be involved, pain and temperature sensation and autonomic 
functions are prominently affected. Clinical presentation is commonly with dis­
tal paresthesias, dysesthesias, and numbness; postural hypotension; impaired 
thermoregulatory sweating; and disturbances of bladder, bowel, or sexual func­
tion. Distal weakness and wasting eventually occur. The tendon reflexes are of­
ten preserved until a relatively late stage. Entrapment neuropathy -  especially 
carpal tunnel syndrome -  may develop as a consequence of amyloid deposits. 
There is no specific treatment.
Friedreich's ataxia usually has a recessive mode of inheritance but occa­
sionally occurs with dominant inheritance. It is caused in many cases by a triplet 
repeat expansion in a noncoding region of the frataxin gene (X25) on chromo-
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some 9ql3-q21.1, but there is some heterogeneity of phenotype and variation in 
age of onset among patients with this expansion. This expansion has not been 
found in all cases, suggesting that other genetic or environmental factors are 
sometimes responsible. An ataxic gait develops, followed by clumsiness of the 
hands and other signs of cerebellar dysfunction. Involvement of peripheral sen­
sory fibers leads to sensory deficits of the limbs, with depressed or absent ten­
don reflexes. There may also be leg weakness and extensor plantar responses 
from central motor involvement.
Hereditary neuropathy with liability to pressure palsies is a genetically 
heterogeneous disorder that relates most commonly to deletion of the PMP-22 
gene on chromosome 17. Inheritance is as an autosomal dominant trait with 
variable expression. Patients present with simple or multiple mononeuropathies 
that occur after mild pressure or stretch of nerves, and electrophysiologic studies 
reveal that abnormalities are more widespread than is evident clinically.
Metabolic
In acute intermittent porphyria, which is transmitted by recessive inheri­
tance, the initial neurologic manifestation is often a polyneuropathy that (usu­
ally) involves motor more than sensory fibers. Sensory symptoms and signs may 
be predominantly proximal or distal. The peripheral nerves may also be affected 
in variegate porphyria.
Two recessive lipidoses are associated with polyneuropathy with a typical 
onset in infancy or childhood. These are metachromatic leukodystrophy, which 
results from deficiency of the enzyme arylsulfatase A, and Krabbe's disease, 
which is due to galactocerebroside p-galactosidase deficiency. Both are inherited 
in an autosomal recessive fashion.
Lipoprotein deficiencies that cause polyneuropathy include abetalipopro- 
teinemia, which is associated with acanthocytosis, malabsorption, retinitis pig­
mentosa, and cerebellar ataxia; and Tangier disease, which produces cataract, 
orange discoloration of the tonsils, and hepatosplenomegaly. These are autoso­
mal recessive conditions.
Refsum's disease is an autosomal recessive disorder related to impaired 
metabolism of phytanic acid. It produces polyneuropathy, cerebellar ataxia, 
retinitis pigmentosa, and ichthyosis. It can be treated by restricting dietary intake 
of phytol. Plasmapheresis to reduce body stores of phytanic acid may also be 
helpful at the initiation of treatment.
Fabry's disease is an X-linked recessive deficiency of the enzyme a- 
galactosidase-A. It results in a painful sensory and autonomic neuropathy, angi­
okeratomas, renal disease, and an increased incidence of stroke. The responsible 
gene has been localized to the long arm of the X chromosome; mutations caus­
ing the disease have been recognized and include gene rearrangements, an RNA- 
splicing defect, and various exotic lesions. Phenytoin or carbamazepine may be
2 6 1
helpful in treating the pain that characterizes the disorder. Enzyme replacement 
therapy is under investigation.
ENTRAPMENT NEUROPATHIES
Certain peripheral nerves are particularly susceptible to mechanical injury 
at vulnerable sites. The term entrapment neuropathy is used when the nerve is 
compressed, stretched, or angulated by adjacent anatomic structures to such an 
extent that dysfunction occurs. There are numerous entrapment neuropathies, 
and in many the initial or most conspicuous clinical complaints are of sensory 
symptoms or pain. Some of the more common syndromes are described below.
ENTRAPMENT SYNDROMES OF UPPER LIMBS
Median Nerve Compression
Compression of the median nerve can occur in the carpal tunnel at the 
wrist. Carpal tunnel syndrome is common during pregnancy and can occur as a 
complication of trauma, degenerative arthritis, tenosynovitis, myxedema, and 
acromegaly. Early symptoms are pain and paresthesias confined to a median 
nerve distribution in the hand, ie, involving primarily the thumb, index, and 
middle fingers and the lateral half of the ring finger. There may be pain in the 
forearm and, in occasional patients, even in the upper arm, shoulder, and neck. 
Symptoms are often particularly troublesome at night and may awaken the pa­
tient from sleep. As the neuropathy advances, weakness and atrophy may even­
tually develop in the thenar muscles. Examination reveals impaired cutaneous 
sensation in the median nerve distribution in the hand and, with motor involve­
ment, weakness and wasting of the abductor pollicis brevis and opponens polli- 
cis muscles. There may be a positive Tinel sign (percussion of the nerve at the 
wrist causes paresthesias in its distribution) or a positive response to Phalen's 
maneuver (flexion of the wrist for I minute exacerbates or reproduces symp­
toms). The diagnosis can generally be confirmed by electrophysiologic studies, 
showing sensory or motor conduction velocity to be slowed at the wrist; there 
may be signs of chronic partial denervation in median-supplied muscles of the 
hand. If the symptoms fail to respond to local corticosteroid injections or simple 
maneuvers such as wearing a nocturnal wrist splint, surgical decompression of 
the carpal tunnel may be necessary.
Interdigital Neuropathy
Interdigital neuropathy may lead to pain in one or two fingers, and exami­
262
nation reveals hyperpathia or impaired cutaneous sensation in the appropriate 
distribution of the affected nerve or nerves. Such a neuropathy may result from 
entrapment in the intermetacarpal tunnel of the hand, direct trauma, tenosynovi­
tis, or arthritis. Treatment by local infiltration with corti со steroids is sometimes 
helpful, but in severe cases neurolysis may be necessary.
Ulnar Nerve Dysfunction
Ulnar nerve dysfunction at the elbow leads to paresthesias, hypes the 
paresthesias, and nocturnal pain in the little finger and ulnar border of the hand. 
Pain may also occur about the elbow. Symptoms are often intensified by elbow 
flexion or use of the arm. Examination may reveal sensory loss on the ulnar as­
pect of the hand and weakness of the adductor pollicis, the deep flexor muscles 
of the fourth and fifth digits, and the intrinsic hand muscles. The lesion may re­
sult from external pressure, from entrapment within the cubital tunnel, or from 
cubitus valgus deformity causing chronic stretch injury of the nerve. Electrodi­
agnostic studies may be helpful in localizing the lesion.
Avoiding pressure on or repetitive flexion and extension of the elbow, 
combined in some instances with splinting the elbow in extension, is sometimes 
sufficient to arrest progression and alleviate symptoms. Surgical decompression 
or ulnar nerve transposition to the flexor surface of the arm may also be helpful, 
depending on the cause and severity of the lesion and the duration of symptoms.
An ulnar nerve lesion may develop in the wrist or palm of the hand in as­
sociation with repetitive trauma, arthritis, or compression from ganglia or benign 
tumors. Involvement of the deep terminal branch in the palm leads to a motor 
deficit in ulnarinnervated hand muscles other than the hypothenar group, while a 
more proximal palmar lesion affects the latter muscles as well; there is no sen­
sory deficit. With lesions at the wrist involving either the ulnar nerve itself or its 
deep and superficial branches, both sensory and motor changes occur in the 
hand. Sensation over the dorsal surface of the hand is unaffected, however, be­
cause the cutaneous branch to this region arises proximal to the wrist. Surgical 
treatment is helpful in relieving compression from a ganglion or benign tumor.
Radial Nerve Compression
The radial nerve may be compressed in the axilla by pressure from 
crutches or other causes; this is frequently seen in alcoholics and drug addicts 
who have fallen asleep with an arm draped over some hard surface. The result­
ing deficit is primarily motor, with weakness or paralysis occurring in the mus­
cles supplied by the nerve, but sensory changes may also occur, especially in a 
small region on the back of the hand between the thumb and index finger. 
Treatment involves preventing further compression of the nerve. Recovery usu­
ally occurs spontaneously and completely except when a very severe injury has 
resulted in axonal degeneration. Physical therapy and a wrist splint may be help­
ful until recovery occurs.
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ENTRAPMENT SYNDROMES OF LOWER LIMBS
Peroneal Nerve Lesions
Peroneal nerve lesions can occur secondary to trauma or to pressure about 
the knee at the head of the fibula. The resulting weakness or paralysis of foot 
and toe extension -  and foot eversion -  is accompanied by impaired sensation 
over the dorsum of the foot and the lower anterior aspect of the leg. The ankle 
reflex is preserved, as is foot inversion. Treatment is purely supportive. It is im­
portant to protect the nerve from further injury or compression. Patients with 
foot drop may require a brace until recovery occurs. Recovery occurs spontane­
ously with time and is usually complete unless the injury was severe enough to 
cause marked axonal degeneration.
Tarsal Tunnel Syndrome
The posterior tibial nerve or its branches can be compressed between the 
floor and the ligamentous roof of the tarsal tunnel, which is located at the ankle 
immediately below and behind the medial malleolus. The usual complaint is of 
burning in the foot -  especially at night -  sometimes accompanied by weakness 
of the intrinsic foot muscles. The diagnosis can usually be confirmed electro- 
physiologically. If treatment with local injection of steroids is not helpful, surgi­
cal decompression may be necessary.
Femoral Neuropathy
Isolated femoral neuropathy may occur in association with diabetes melli- 
tus, vascular disease, bleeding diatheses (eg, hemophilia, treatment with antico­
agulant drugs), or retroperitoneal neoplasms. The most conspicuous symptoms 
and signs relate to weakness of the quadriceps muscle, with reduced or absent 
knee reflex, but there may also be sensory disturbances in the anterior and me­
dial aspects of the thigh and the medial part of the lower leg. Treatment is of the 
underlying cause.
Saphenous Nerve Injury
The saphenous nerve is the terminal sensory branch of the femoral nerve 
and supplies cutaneous sensation to the medial aspect of the leg about and below 
the knee. Mechanical injury to the nerve can occur at several points along its 
course; patients then complain of pain or impaired sensation in the distribution 
of the nerve. Weakness in quadriceps function (ie, extension at the knee) reflects 
femoral nerve involvement. There is no specific treatment, but the nerve should 
be protected from further injury.
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Lateral Femoral Cutaneous Nerve Dysfunction
The lateral femoral cutaneous nerve supplies sensation to the outer border 
of the thigh. Its function can be impaired by excessive angulation or compres­
sion by neighboring anatomic structures, especially in pregnancy or other condi­
tions that cause exaggerated lumbar lordosis. This leads to pain and paresthesias 
in the lateral thigh, and examination reveals impaired sensation in this region. 
This syndrome, known as meralgia paresthetica, is best treated with sympto­
matic measures, since its course is often self-limited.
Obturator Nerve Injury
Trauma to the obturator nerve -  eg, by pelvic fracture or a surgical proce­
dure -  can lead to pain radiating from the groin down the inner aspect of the 
thigh. An obturator hernia or osteitis pubis may cause a similar disorder; there is 
accompanying weakness of the adductor thigh muscles.
ROOT & PLEXUS LESIONS
BACK & NECK PAIN
Spinal disease occurs most commonly in the neck or low back and can 
cause local or root pain or both. It can also lead to pain that is referred to other 
parts of the involved dermatomes. Pain from the lower lumbar spine, for exam­
ple, is often referred to the buttocks. Conversely, pain may be referred to the 
back from the viscera, especially the pelvic organs. Local pain may lead to pro­
tective reflex muscle spasm, which in turn causes further pain and may result in 
abnormal posture, limitation of movement, and local spinal tenderness.
The history may provide clues to the underlying cause, and physical ex­
amination will define any neurologic involvement. Diagnostic studies that can 
help in evaluating patients include x-rays of the affected region and a complete 
blood count and erythrocyte sedimentation rate (especially if infective or in­
flammatory disorders or myeloma is suspected); determination of serum protein 
and protein electrophoresis; and measurement of serum calcium, phosphorus, 
alkaline and acid phosphatase, and uric acid. Electromyography may be helpful 
in determining the extent and severity of root involvement; it also provides a 
guide to prognosis. A CT scan, MRI of the spine, or a myelogram may be neces­
sary, especially if neoplasm is suspected, neurologic deficits are progressive, 
pain persists despite conservative treatment measures, or there is evidence of 
cord involvement. At myelography, CSF can be obtained for laboratory exami­
nation.
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1. LOW BACK PAIN
Low back pain is a common cause of time lost from work. It has many 
causes.
Trauma
Unaccustomed exertion or activity -  or lifting heavy objects without ade­
quate bracing of the spine -  can cause musculoskeletal pain that improves with 
rest. Clinical examination commonly reveals spasm of the lumbar muscles and 
restricted spinal movements. Management includes local heat, bed rest on a firm 
mattress, nonsteroidal anti-inflammatory drugs or other analgesics, and muscle- 
relaxant drugs, eg, diazepam, 2 mg three times daily, increased gradually until 
symptoms are relieved (or to the highest dose tolerated). Vertebral fractures that 
follow more severe injury and lead to local pain and tenderness can be visual­
ized at radiography. If cord involvement is suspected -  eg, because of leg weak­
ness following injury -  the patient must be immobilized until radiographed to 
determine whether fracture -  dislocation of the vertebral column has occurred.
Prolapsed Lumbar Intervertebral Disk
This most commonly affects the L5-S1 or the L4-5 disk. The prolapse 
may relate to injury, but in many patients it commonly follows minor strain or 
normal activity. Protruded disk material may press on one or more nerve roots 
and thus produce radicular pain, a segmental motor or sensory deficit, or a 
sphincter disturbance in addition to a painful stiff back. The pain may be repro­
duced by percussion over the spine or sciatic nerve, by passive straight leg rais­
ing, or by extension of the knee while the hip is flexed. The presence of bilateral 
symptoms and signs suggests that disk material has protruded centrally, and this 
is more likely to be associated with sphincter involvement than is lateral protru­
sion. An L5 radiculopathy causes weak dorsiflexion of the foot and toes, while 
an SI root lesion leads to a depressed ankle jerk and weakness of plantar flexion 
of the foot. In either case, spinal movements are restricted, there is local tender­
ness, and Lasegue's sign (reproducing the patient's pain on stretching the sciatic 
nerve by straight leg raising) is positive. The L4 root is occasionally affected, 
but involvement of a higher lumbar root should arouse suspicion of other causes 
of root compression. Pelvic and rectal examination and plain x-rays of the spine 
help to exclude other diseases, such as local tumors or metastatic neoplastic de­
posits. Symptoms often resolve with simple analgesics, diazepam, and bed rest 
on a firm mattress for 1-2 weeks, followed by gradual mobilization. Nonster­
oidal anti-inflammatory drugs may be helpful for acute back pain but are often 
ineffective or provide only minor or transient benefits in patients with symptoms 
or signs of root compression.
Persisting pain, an increasing neurologic deficit, or any evidence of 
sphincter dysfunction should lead to MRI, CT scanning, or myelography, and 
surgical treatment if indicated by the results of these procedures. The detection
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of structural abnormalities by these imaging procedures does not mandate surgi­
cal treatment unless the clinical circumstances are appropriate -  degenerative 
abnormalities are common in asymptomatic subjects, especially with advancing 
age, and may therefore be of no clinical relevance.
The persistence of low back and root pain despite surgery may have sev­
eral causes including inadequate decompression, recurrent herniation of disk 
material, root compression or damage as a result of the operative procedure, sur­
gery at the wrong level, infective or inflammatory complications of surgery, or 
spinal instability. In many instances, however, no specific cause can be identi­
fied and most patients do not require further surgery. Chronic pain in this setting 
may, however, respond to spinal cord stimulation.
Lumbar Osteoarthropathy
This tends to occur in later life and may cause low back pain that is in­
creased by activity. Radiologic abnormalities vary in severity. In patients with 
mild symptoms, a surgical corset is helpful, while in more severe cases operative 
treatment may be necessary. Even minor changes may cause root or cord dys­
function in patients with a congenitally narrowed spinal canal (spinal stenosis), 
leading to the syndrome of intermittent claudication of the cord or cauda equina. 
This is characterized by pain -  sometimes accompanied by weakness or radicu­
lar sensory disturbances in the legs -  that occurs with activity or with certain 
postures and is relieved by rest. In such circumstances, spinal decompression is 
indicated.
Ankylosing Spondylitis
Backache and stiffness, followed by progressive limitation of movement, 
characterize this disorder, which occurs predominantly in young men. Charac­
teristic early radiologic findings consist of sclerosis and narrowing of the sacro­
iliac joints. Treatment is with nonsteroidal anti-inflammatory agents, especially 
indomethacin or aspirin. Physical therapy, including postural exercises, is also 
important.
Neoplastic Disease
Extradural malignant tumors are an important cause of back pain and 
should be suspected if there is persistent pain that worsens despite bed rest. They 
may eventually lead to cord compression or a cauda equina syndrome, depend­
ing upon the level of involvement. There may initially be no change on plain ra­
diographs of the spine, but a bone scan is sometimes revealing. Benign osteo­
genic tumors also produce back pain, and plain x-rays then show a lytic lesion; 
treatment is by excision.
Infections
Tuberculous and pyogenic infections of the vertebrae or intervertebral
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disks can cause progressive low back pain and local tenderness. While there are 
sometimes no systemic signs of infection, the peripheral white cell count and 
erythrocyte sedimentation rate are raised. X-rays may show disk space narrow­
ing and a soft tissue mass, but they are frequently normal initially.
The osteomyelitis requires long-term antimicrobial therapy; surgical de­
bridement and drainage may also be needed. Spinal epidural abscess similarly 
presents with localized pain and tenderness, sometimes associated with osteo­
myelitis. Cord compression may occur with the onset of a rapidly progressive 
flaccid paraplegia. MRI, CT scanning, or myelography and operative treatment 
are undertaken urgently if there is evidence of cord compression. In early cases 
without neurologic involvement, treatment with antibiotics alone may be suffi­
cient.
Osteoporosis
Low back pain is a common complaint in patients with osteoporosis, and 
vertebral fractures may occur spontaneously or after trivial trauma. Pain may be 
helped by a brace to support the back. It is important that patients keep active 
and take a diet containing adequate amounts of calcium, vitamin D, and protein. 
Estrogen therapy may be helpful in postmenopausal women. In special circum­
stances, calcitonin, sodium fluoride, or phosphate supplements are helpful.
Congenital Anomalies
Minor spinal anomalies can cause pain because of altered mechanics or 
alignment or because reduction in the size of the spinal canal renders the cord or 
roots more liable to compression by degenerative or other changes. Children or 
young adults with congenital defects in spinal fusion (spinal dysraphism) occa­
sionally present with pain, a neurologic deficit in one or both legs, or sphincter 
disturbances. Treatment is of the underlying disorder. Congenital spinal stenosis 
may lead to the syndrome of neurogenic claudication, but symptoms usually de­
velop only in later life when minor degenerative changes have come to be super­
imposed on the congenital anomaly.
Arachnoiditis
Severe pain in the back and legs can result from inflammation and fibrosis 
of the arachnoid layer of the spinal meninges (arachnoiditis), which may be 
idiopathic or causally related to previous surgery, infection, myelography, or 
long-standing disk disease. There is no adequate treatment, but operation may be 
possible if the arachnoiditis is localized. Spinal cord stimulation may provide 
symptomatic relief.
Referred Pain
Disease of the hip joints may cause pain in the back and thighs that is en­
hanced by activity; examination reveals limitation of movement at the joint with
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a positive Patrick sign (hip pain on external rotation of the hip), and x-rays show 
degenerative changes. Aortic aneurysms, cardiac ischemia, visceral and genitou­
rinary disease (especially pelvic disorders in women), and retroperitoneal 
masses also cause back pain. There are often other symptoms and signs that 
suggest the underlying disorder. Moreover, there is no localized spinal tender­
ness or restriction of motility. Treatment is of the underlying cause.
Nonspecific Chronic Back Pain
In many patients whose chronic back pain poses a difficult management 
problem, there are no objective clinical signs or obvious causes of pain despite 
detailed investigations. In some cases, the pain may have a postural basis; in 
others, it may be a somatic manifestation of a psychiatric disorder. Pain that ini­
tially had an organic basis is often enhanced or perpetuated by nonorganic fac­
tors and leads to disability out of proportion to the symptoms.
Nonsteroidal anti-inflammatory drugs may provide short-term sympto­
matic relief. There is some controversy about the chronic use of narcotic anal­
gesics in patients with persisting low back pain, but such agents are generally 
best avoided. Treatment with tricyclic antidepressant drugs is sometimes help­
ful, and psychiatric evaluation may be worthwhile. Unnecessary surgical proce­
dures must be avoided.
2. NECK PAIN
Neck pain is a common problem in the general population; surveys indi­
cate that approximately one-third of the adult population have experienced it 
over the previous year and in many instances it lasts for more than 6 months.
Congenital abnormalities of the cervical spine, such as hemivertebrae or 
fused vertebrae, basilar impression, and instability of the atlantoaxial joint, can 
cause neck pain. The traumatic, infective, and neoplastic disorders mentioned 
above as causes of low back pain can also affect the cervical spine and then pro­
duce pain in the neck. Rheumatoid arthritis may involve the spine, especially in 
the cervical region, leading to pain, stiffness, and reduced mobility; cord com­
pression may result from displacement of vertebrae or atlantoaxial subluxation 
and can be life-threatening if not treated by fixation.
Cervical injuries are an important cause of neck pain. Whiplash flexion- 
extension injuries have become especially common as a result of automobile ac­
cidents. Other occult cervical injuries such as disk clefts and fissures may be re­
sponsible for symptoms in some instances, but are difficult to recognize. Man­
agement of persistent symptoms following whiplash injuries is controversial. 
Conservative therapeutic measures are appropriate. Other approaches sometimes 
advocated include block of cervical facet joints with bupivacaine and injection
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into the joints of depot corticosteroids, but the response is variable and often 
short-lived. Subluxed cervical facet joints are another well-recognized complica­
tion of automobile accidents. Even minor trauma may lead to cervical fractures 
in an apparently ankylosed region in patients with diffuse idiopathic skeletal hy­
perostosis, but major neurologic deficits are common in such circumstances.
Acute Cervical Disk Protrusion
Patients may present with neck and radicular arm pain that is exacerbated 
by head movement. The mechanism responsible for the pain is unclear; pressure 
on nerve roots is unlikely to be the sole cause because pain may resolve with 
time and conservative measures despite persisting compression. With lateral 
herniation of the disk, there may also be segmental motor, sensory, or reflex 
changes, usually at the C6 or C7 level, on the affected side. With more centrally 
directed herniations, spastic paraparesis and a sensory disturbance in the legs, 
sometimes accompanied by impaired sphincter function, can occur as a result of 
cord involvement. The diagnosis is confirmed by CT scan, MRI, or myelogra­
phy. However, these imaging studies may show abnormalities in asymptomatic 
subjects in middle or later life, so that any disk protrusion may be incidental and 
unrelated to patients' symptoms. Electromyography may help to establish that 
anatomic abnormalities are of functional relevance.
In mild cases, bed rest or intermittent neck traction, followed by immobi­
lization of the neck in a collar for several weeks, often helps. If these measures 
fail or if there is a significant neurologic deficit, surgical treatment may be nec­
essary.
Cervical Spondylosis
This is an important cause of pain in the neck and arms, sometimes ac­
companied by a segmental motor or sensory deficit in the arms or by spastic 
paraparesis.
3. HERPES ZOSTER (SHINGLES)
This viral disorder becomes increasingly common with advancing age, 
causing an inflammatory reaction in one or more of the dorsal root or cranial 
nerve ganglia, in the affected root or nerve itself, and in the CSF. There seems to 
be spontaneous reactivation of varicella virus that remained latent in sensory 
ganglia after previous infection. Herpes zoster is common in patients with lym­
phoma, especially following regional radiotherapy. The initial complaint is of a 
burning or shooting pain in the involved dermatome, followed within 2-5 days 
by the development of a vesicular erythematous rash. The pain may diminish in 
intensity as the rash develops. The rash becomes crusted and scaly after a few
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days and then fades, leaving small anesthetic scars. Secondary infection is 
common. The pain and dysesthesias may last for several weeks or, in some in­
stances, may persist for many months (postherpetic neuralgia) before subsiding, 
especially in the elderly. The increased incidence and severity of postherpetic 
neuralgia with age may reflect an age-related reduction in virus-specific cell- 
mediated immunity. It is not clear whether immunocompromise secondary to 
HIV infection or connective tissue disease predisposes to postherpetic neuralgia. 
Pain is exacerbated by touching the involved area. Superficial sensation is often 
impaired in the affected dermatome, and focal weakness and atrophy can also 
occur. Signs are usually limited to one dermatome, but more are occasionally 
involved. Mild pleocytosis and an increased protein concentration sometimes 
occur in the CSF. The most commonly involved sites are the thoracic derma­
tomes, but involvement of the first division of the fifth cranial nerve, also com­
mon, is especially distressing and may lead to comeal scarring and anesthesia, as 
well as to a variety of other ocular complications. Facial (VII) nerve palsy oc­
curring in association with a herpetic eruption that involves the ear, palate, phar­
ynx, or neck is called Ramsay Hunt syndrome. Other rare complications of her­
pes zoster include other motor neuropathies, meningitis, encephalitis, myelopa­
thy, and cerebral angiopathy.
There is no specific treatment. Analgesics provide symptomatic relief. 
Corticosteroids or acyclovir may reduce the duration and severity of the acute 
eruption, but neither reduces the likelihood that postherpetic neuralgia will oc­
cur. Although postherpetic neuralgia can be very distressing, it sometimes re­
sponds to treatment with carbamazepine, up to 1200 mg/d; phenytoin, 300 mg/d; 
or amitriptyline, 10-100 mg at bedtime. Attempts at relieving postherpetic neu­
ralgia by peripheral nerve section are generally unrewarding, but treatment with 
topically applied local anesthetics is sometimes helpful.
BELL’S PALSY
Bell's palsy is, by definition, an acute lower motor neuron facial palsy of 
unknown cause. It is generally accepted that there is inflammation and oedema 
of the nerve in the facial canal but, not surprisingly, there have been few patho­
logical studies. A viral aetiology is suspected. There are conflicting reports of 
clustering of cases, suggesting an infective aetiology, and recurring reports im­
plicating herpes viruses.
The incidence of Bell's palsy is about 23/100000/annum. It affects both 
sexes equally and is less frequent in children than adults. It shows relatively 
weak associations with hypertension and diabetes, particularly in older patients. 
Recurrence, on the same or opposite side, is relatively common.
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The major causes of non-idiopathic acute facial palsy are head injury, 
multiple sclerosis, sarcoidosis, Guillain-Barre syndrome, and infection, includ­
ing herpes zoster (Ramsay Hunt syndrome), Lyme disease, and HIV infection. 
Some of these may cause simultaneous bilateral facial palsies, whereas bilateral 
idiopathic (i.e. Bell's) palsy is very rare.
Clinical features
The entire course of Bell's palsy may be painless, but frequently patients 
complain of pain behind the ipsilateral ear, in the mastoid region, for a day or 
two before the onset of weakness, and this may continue for a week or more. Pa­
ralysis develops rapidly and may reach maximum severity within a few hours. 
Continuing progression for 24-48 hours is not uncommon and rarely may be 
over as long as 5 days.
All of the muscles on the affected side of the face are involved, but the 
degree of weakness may range in severity from mild to complete (about 70 per 
cent of patients). The appearance of even an incomplete palsy, is striking and it 
is not surprising that it causes the patient and sometimes their medical attendant 
considerable alarm. In elderly patients, presumably due to greater laxity of sup­
porting tissues, the resultant facial deformity is more evident than in younger pa­
tients. The eyebrow droops and cannot be elevated, and the brow looses its fur­
rows and becomes smooth. The lower eyelid everts (ectropion) causing impaired 
drainage of the tears, which overflow onto the cheek. The eye cannot close vol­
untarily or on blinking but there will be some lowering of the upper lid due to 
reflex inhibition of levator palpebrae superioris. The nasolabial fold becomes 
shallower, the angle of the mouth droops and cannot be retracted, the cheek bil­
lows on respiration, and food tends to accumulate between the cheek and teeth. 
There is mild dysarthria. If the nerve is involved proximal to the point where it 
is joined by the chorda tympani, or higher still, affecting the nerve to stapedius, 
then the patient may complain of impaired taste sensation or hyperacusis (an un­
pleasant quality to louder sounds).
Many patients complain of numbness over the affected side of the face 
and, sometimes, tongue. This may be objective, in the sense that the patient will 
say that light-touch and pinprick sensation are less on the affected side. The cor­
neal reflex is always preserved. There is no obvious anatomical explanation for 
such sensory symptoms and they are usually attributed to distorted perception 
caused by the drooping musculature, skin, and associated tissues.
Prognosis
In about 80 per cent of patients improvement starts early and there is full 
recovery within a few weeks from the onset. Pathologically it is presumed that 
the weakness in these cases is due entirely to conduction block, from segmental 
demyelination, from which recovery is rapid. In the remaining 20 per cent of pa­
tients, in addition to conduction block, there is Wallerian degeneration of some
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or all of the axons, and full recovery will not occur, although most patients have 
a satisfactory cosmetic outcome. Nerve regeneration starts from the point of in­
terruption but re-innervation, and thus functional recovery, does not develop un­
til at least 3 months after the onset of the palsy, and is never complete, leaving 
some residual weakness. Some of the regenerating axons become misdirected 
and innervate muscles that they did not originally supply. Thus, movement in 
one area may be accompanied by associated movement (synkinesis) elsewhere. 
This and other complications are discussed below.
An incomplete palsy is the most favourable prognostic sign. Adverse fea­
tures may include advanced age, diabetes, hypetension, severe pain, loss of taste, 
and hyperacusis, but none is a reliable indicator of prognosis. Neurophysiologi­
cal studies, particularly if performed more than 1 week after onset, may offer 
prognostic information. Whether the findings indicate a good or poor prognosis 
doesn't alter management, and so they are rarely performed in clinical practice.
Complications
Associated movements (synkinesis) are the result of aberrant re­
innervation by regenerating axons. Common patterns include eye closure on lip 
movement, or elevation of the angle of the mouth on blinking or when the eye­
brow is raised. Occasionally the synkinetic movements may be very extensive.
There may also be aberrant parasympathetic nerve re-innervation, giving 
rise to the phenomenon of crocodile tears-profuse watering of the affected eye 
when eating. The simplest explanation is that regenerating fibres destined to in­
nervate the submandibular salivary glands become misdirected and reach the 
lacrimal gland. An alternative explanation is that glossopharyngeal nerve fibres, 
destined for the parotid gland, in the lesser superficial petrosal nerve send 
branches to the greater superficial petrosal nerve, where they lie close together, 
and then innervate the lacrimal gland.
When recovery is incomplete there is often some contracture of the af­
fected muscles. This may be evident as narrowing of the palpebral fissure or 
deepening of the nasolabial fold.
Treatment
It is likely that the outcome of Bell's palsy is determined within days of 
the onset. If the inflammation and oedema of the facial nerve causes only con­
duction block, then full recovery will occur independent of treatment. If the in­
flammatory process is more severe and results in axonal degeneration, then re­
covery will be incomplete. Thus, the aim of treatment must be to reduce the oe­
dema and self-compression of the nerve within its bony canal before axonal de­
generation occurs. It is impossible, on available evidence, to commend surgical 
decompression. To be effective it would have to be performed within days of the 
onset of the palsy. There are no clinical or neurophysiological pointers in those 
first few days to which patients are going to have a poor prognosis, and it would
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clearly be unjustified to operate on all patients given that the vast majority will, 
in any case, have a satisfactory outcome.
Whether or not corticosteroids are helpful remains an unanswered ques­
tion. In the absence of contraindications it is very common practice for patients 
seen within 1 week of onset of the palsy to be given a short course of oral ster­
oids. A typical regimen might start with prednisolone 1 mg/kg body weight/day, 
with gradually diminishing doses over the next 10-14 days.
The normal tear film is disturbed in Bell's palsy. Despite anatomical con­
siderations, a dry eye or underproduction of tears due to denervation of the lac­
rimal gland is very uncommon. Rather, tear drainage is affected due to the ec­
tropion and this, together with reduced blinking, often causes mistiness of vision 
and associated patient anxiety. Corneal sensation is normal and corneal damage 
is rare in Bell's palsy. Tarsorrhaphy is rarely required but the patient may find it 
more comfortable to tape the eye closed in bed, and to use glasses to protect the 
eye from dust and wind. If tear production is impaired, methylcellulose eye 
drops should be used.
There is no effective treatment for synkinetic movements. In those few 
patients with severe residual weakness, various plastic surgery procedures can 
improve the cosmetic appearance. Because of the slow rate of nerve regenera­
tion, no surgical intervention, except occasionally tarsorrhaphy, should be con­
sidered until at least 6, and probably 12, months after the onset of the palsy.
Crocodile tears may be treated by section of the tympanic nerve which 
carries the glossopharyngeal salivary fibres.
A major element in the management of Bell's palsy is reassurance of the 
patient and detailed explanation of what has happened and the generally favour­
able prognosis. There is no good evidence that physiotherapy or electrical stimu­
lation are of specific value. However, some patients benefit from taking an ac­
tive part in the management of their problem, for example by regularly massag­
ing their face or exercising it in front of a mirror.
TRIGEMINAL NEURALGIA
This is the most frequently encountered disorder of the trigeminal nerve. 
It may be symptomatic of an underlying structural disorder affecting the nerve, 
but in the majority of patients no specific cause is identified. It is more common 
in the second half of life, cases in younger people more often being symp­
tomatic, is slightly more frequent in women, and has an overall prevalence of 
the order of 3-5 per 100 000 population.
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Clinical features
These are highly characteristic, but despite this the diagnostic label is fre­
quently applied erroneously to many other causes of facial pain, particularly 
atypical facial pain and dental disease. In trigeminal neuralgia, pain, typically 
very severe, occurs in paroxysms, each episode lasting only a few seconds. The 
frequency of attacks may vary from several in a minute to days between epi­
sodes, and in the early stages spontaneous remission for months or years may 
occur. Unfortunately, permanent remission is rare and with time the bouts of 
pain become more frequent. Patients often provide graphic descriptions which 
indicate the severity and quality of the pain-like a dagger, or red hot needle, or 
poker. Clinicians use the word lancinating. When attacks are frequent, secon­
dary depression is common. Many patients identify one or more triggers to their 
attacks. These include touching a very specific part of the face, a cold draught, 
talking, swallowing, chewing, and brushing their teeth. Tactile triggers may pre­
vent the patient washing their face or shaving.
The pain is strictly within the trigeminal distribution, most commonly in 
the maxillary and mandibular divisions. The ophthalmic division is involved in 
less than 10 per cent of cases. Typically, pain is felt in only part of the region 
supplied by the affected division, at least initially, but may then spread to the 
rest of the divisional area. In later stages both the mandibular and maxillary ar­
eas may become involved, but spread to the ophthalmic area is unusual.
Between the paroxysms, particularly if they are frequent, there may be a 
dull background ache that is not severe. Trigeminal neuralgia never causes con­
tinuous discomfort without the characteristic paroxysms. The stabs of pain may 
be accompanied by involuntary contraction of the facial muscles, giving rise to 
the synonymous term 'tic douloureux'. Occasional patients develop typical 
symptoms bilaterally but do not experience bilateral pain at the same time. 
Physical examination is normal in idiopathic trigeminal neuralgia. Abnormal 
physical signs suggest symptomatic trigeminal neuralgia.
Aetiology
It has long been recognized that trigeminal neuralgia may be symptomatic 
of underlying disease. Thus, about 4 per cent of patients with multiple sclerosis 
experience it, although it is very rare as a presenting symptom. Primary tumours 
of the trigeminal nerve and compression of the nerve (e.g. by a tumour or aneu­
rysm) very rarely produce symptoms identical to those of trigeminal neuralgia, 
but more commonly produce complaints of continuous pain or numbness, and 
on examination abnormal physical signs can be detected.
Excluding these rare causes of symptomatic trigeminal neuralgia one is 
left with a majority of patients in whom no physical cause is readily apparent, 
and thus the disorder might be considered to be one of altered function rather
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than structure. However, it has been suggested that in a significant number of 
these patients (over 90 per cent) the cause is a misdirected or ectatic blood ves­
sel in the posterior fossa compressing the trigeminal sensory roots, and that 
symptomatic improvement can be gained by surgically separating the root from 
the aberrant blood vessels. In another series, vascular compression was found in 
only 11 per cent of patients. Increasingly sensitive MRI techniques may shed 
further light on this issue-scans may show vessels apparently impinging on the 
trigeminal nerve, but a cause-effect relationship remains to be proved.
Differential diagnosis
Rare symptomatic causes of trigeminal neuralgia have been discussed 
above and it was noted that they are often accompanied by abnormal physical 
signs. A substantial number of patients initially diagnosed as having trigeminal 
neuralgia prove to have other conditions. By far the most common confusion 
centres around the teeth. Dental disease, such as apical abscess, may cause par­
oxysmal as well as continuous pain, but the overall features and specific trigger 
factors should readily distinguish this from trigeminal neuralgia. Conversely, 
every specialist will have seen patients with trigeminal neuralgia who have had 
healthy teeth removed. Apart from dental disease, referred facial pain may be 
caused by sinus disease and eye disease (e.g. glaucoma). Angina may cause 
lower jaw pain.
Other causes of trigeminal nerve-related pain, which can be distinguished 
from trigeminal neuralgia on the basis of the history and physical signs, include 
brainstem lesions, postherpetic neuralgia, and tabes dorsalis. Local irritative le­
sions and trauma in the regions of exit from the skull of the supraorbital and in­
fraorbital nerves can cause localized neuralgic pain.
Facial pains attributed to temporomandibular joint dysfunction (Costen's 
syndrome) and maladjustment of the bite are possibly overdiagnosed. Atypical 
facial pain, despite its name, is a characteristic disorder seen mainly in young 
and middle-aged women. They complain of a dull, constant ache in the upper 
jaw/cheek region which may extend to the whole of the side of the head and 
down into the neck. Often, but not always, there is clear evidence of an anxiety 
or depressive disorder. There may be a response to antidepressant drugs.
Cluster headache (migrainous neuralgia) is a highly characteristic condi­
tion that really should not be confused with trigeminal neuralgia, but sometimes 
is. The duration, distribution and characteristics of the pain, the different trigger­
ing factors, the accompanying symptoms, and the pattern of attacks distinguish 
the condition from trigeminal neuralgia. Glossopharyngeal neuralgia causes at­
tacks of identical character but in a different distribution.
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Treatment
Carbamazepine gives good or excellent symptomatic relief in up to 70 per 
cent of patients. A reasonable starting dose is 100 mg twice daily increasing, as 
required, over a 1-2 week period to either the lowest effective dose or the maxi­
mal tolerable dose. This is a much more rapid increase than would be used for 
treating epilepsy (and is done because of the frequency and severity of the at­
tacks) and consequently side-effects are more common, although patients may 
be happy to trade these off against the relief from pain. Common dose-related 
sideeffects include nausea, unsteadiness, and visual disturbance. Up to 10 per 
cent of patients develop an idiosyncratic drug rash which usually necessitates 
stopping the drug.
If carbamazepine does not work or cannot be tolerated, other drugs that 
can be tried include sodium valproate, phenytoin, lamotrigine, clonazepam, and 
baclofen, but success rates are much lower than with carbamazepine.
Spontaneous remission may occur, especially in the early stages. There­
fore, if drug treatment leads to resolution of symptoms, it is appropriate to at­
tempt discontinuing treatment when the patient has been pain free for several 
weeks.
In some patients even very determined attempts with drug treatment prove 
unsuccessful, whereas in others there may be partial or complete relief but only 
at the cost of unacceptable side-effects. In such circumstances some form of 
surgical intervention should be considered.
If the pain is localized within the distribution of a single peripheral nerve 
(e.g. supraorbital or infraorbital), relief for up to 18 months may be obtained by 
sectioning the nerve or by injecting the nerve or trigeminal ganglion with alco­
hol or phenol. Such techniques have largely been superseded by radio frequency 
thermal coagulation of the trigeminal ganglion, in which an electrode is inserted 
percutaneously, through the foramen ovale, into the ganglion. Pain appreciation 
may be abolished, while preserving light-touch. Most patients have good initial 
relief of pain but late recurrence is not uncommon. The procedure can be re­
peated.
Posterior fossa exploration, looking for neurovascular abnormalities, has 
been discussed above. Success rates over 90 per cent have been reported, but 
others have been less impressed and recurrence rates may be high. If a 
neurovascular abnormality is not identified, an alternative approach during pos­
terior fossa surgery is partial trigeminal nerve root section, which will produce 
complete numbness in the relevant areas.
A recent review concluded that radio frequency rhizotomy is the treatment 
of choice for most patients undergoing a first operative procedure for V2 and V3 
neuralgia, but that microvascular decompression is more appropriate for VI neu­
ralgia because there is a lower risk of corneal anaesthesia.
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An area of numbness rather than pain might seem to be an acceptable ex­
change, but up to 10 per cent of patients develop extremely distressing dysaes- 
thesiae in the anaesthetic area and this is very resistant to treatment. A further 
complication is that of keratitis, if the surgical treatment produces anaesthesia in 
the ophthalmic nerve territory. These complications are more likely to occur if 
there is extensive surgically induced sensory loss, but conversely the less sen­
sory impairment there is, the higher the risk of recurrence of trigeminal neural­
gia.
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STROKE AND VASCULAR DEMENTIA
Stroke is the third or second most common cause of death in different 
countries and the most common disabling neurologic disorder. Its incidence in­
creases with age and is somewhat higher in men than in women and in African- 
Americans than in Caucasians. Risk factors for stroke include systolic or dia­
stolic hypertension, hypercholesterolemia, cigarette smoking, heavy alcohol 
consumption, and oral contraceptive use. Despite its importance as a leading 
cause of disability and death, the incidence of stroke has decreased in recent 
decades, largely because of improved treatment of hypertension.
Stroke is a syndrome characterized by the acute onset of a neurologic 
deficit that persists for at least 24 hours, reflects focal involvement of the central 
nervous system, and is the result of a disturbance of the cerebral circulation. The 
acute onset and subsequent duration of symptoms are documented by the his­
tory. The site of central nervous system involvement is suggested by the nature 
of the symptoms. It is delineated more precisely by the neurologic examination 
and confirmed by imaging studies (CT scans or MRI). A vascular etiology may 
be inferred from the acute onset of symptoms and often from the patient's age, 
the presence of risk factors for stroke, and the occurrence of symptoms and signs 
referable to the territory of a particular cerebral blood vessel. When this is con­
firmed by imaging studies, further investigations can be undertaken to identify a 
specific cause.
Acute Onset
Strokes begin abruptly. Neurologic deficits may be maximal at onset, as is 
common in embolic stroke, or may progress over seconds to, hours (or occa­
sionally days), which is characteristic of progressive arterial thrombosis or re­
current emboli. A stroke that is actively progressing as a direct consequence of 
the underlying vascular disorder (but not because of associated cerebral edema) 
or has done so in recent minutes is termed stroke in evolution or progressing 
stroke. Focal cerebral deficits that develop slowly (over weeks to months) are 
unlikely to be due to stroke and are more suggestive of tumor or inflammatory 
or degenerative disease.
Duration of Deficits
By definition, stroke produces neurologic deficits that persist for at least 
24 hours. When symptoms and signs resolve completely after briefer periods 
(usually within 30 minutes), the term transient ischemic attack (TIA) is used. 
Recurrent TIAs with identical clinical features are usually caused by thrombosis 
or embolism arising within the cerebral circulation. TIAs that differ in character
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from event to event suggest recurrent emboli from a cardiac source. Although 
TIAs do not themselves produce lasting neurologic dysfunction, they are im­
portant to recognize because about one-third of patients with TIAs will go on to 
have a stroke within 5 years -  and because this risk may be reduced with treat­
ment.
In some cases, deficits last for longer than 24 hours but resolve com­
pletely or almost completely within a few days; the term reversible ischemic 
neurological deficit (RIND) or minor stroke is sometimes used to describe these 
events. As their names imply, TIAs and RINDs are uniquely associated with 
cerebral ischemia, as opposed to hemorrhage.
Focal Involvement
Stroke produces focal symptoms and signs that correlate with the area of 
the brain supplied by the affected blood vessel. In ischemic stroke, occlusion of 
a blood vessel interrupts the flow of blood to a specific region of the brain, inter­
fering with neurologic functions dependent on that region and producing a more 
or less stereotyped pattern of deficits. Hemorrhage produces a less predictable 
pattern of focal involvement because complications such as increased intracra­
nial pressure, cerebral edema, compression of brain tissue and blood vessels, or 
dispersion of blood through the subarachnoid space or cerebral ventricles can 
impair brain function at sites remote from the hemorrhage.
Cerebrovascular disorders can also affect the brain in more diffuse fashion 
and produce global cerebral dysfunction, but the term stroke should not be ap­
plied in these cases. These disorders include global cerebral ischemia (usually 
from cardiac arrest) and subarachnoid hemorrhage. In most cases of stroke, 
the history and neurologic examination provide enough information to localize 
the lesion to one side of the brain (eg, to the side opposite a hemiparesis or 
hemisensory deficit or to the left side if aphasia is present) and to the anterior or 
posterior cerebral circulation.
A. Anterior Circulation. The anterior cerebral circulation, which sup­
plies most of the cerebral cortex and subcortical white matter, basal ganglia, and 
internal capsule, consists of the internal carotid artery and its branches: the ante­
rior choroidal, anterior cerebral, and middle cerebral arteries. The middle cere­
bral artery in turn gives rise to deep, penetrating lenticulostriate branches. The 
specific territory of each of these vessels is shown in Table. Anterior circulation 
strokes are commonly associated with symptoms and signs that indicate hemi­
spheric dysfunction, such as aphasia, apraxia, or agnosia. They also produce 
hemiparesis, hemisensory disturbances, and visual field defects, which can also 
occur with posterior circulation strokes.
B. Posterior Circulation. The posterior cerebral circulation supplies the 
brainstem, cerebellum, and thalamus and portions of the occipital and temporal 
lobes. It consists of the paired vertebral arteries, the basilar artery, and their 
branches: the posterior inferior cerebellar, anterior inferior cerebellar, superior
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cerebellar, and posterior cerebral arteries. The posterior cerebral artery also 
gives off thalamoperforate and thalamogeniculate branches. Posterior circulation 
strokes produce symptoms and signs of brainstem dysfunction, including coma, 
drop attacks (sudden collapse without loss of consciousness), vertigo, nausea 
and vomiting, cranial nerve palsies, ataxia, and crossed sensorimotor deficits 
that affect the face on one side of the body and the limbs on the other. Hemi- 
paresis, hemisensory disturbances, and visual field deficits also occur, but are 
not specific to posterior circulation strokes.
Vascular Origin
Although other pathologic processes such as hypoglycemia or other meta­
bolic disturbances, trauma, and seizures can produce focal central neurologic 
deficits that begin abruptly and last for at least 24 hours, the term stroke is used 
only when such events are caused by cerebrovascular disease. The underlying 
pathologic process in stroke can be either ischemia or hemorrhage, usually from 
an arterial lesion. In recent series, ischemia accounted for about two-thirds and 
hemorrhage for about one-third of strokes. It may not be possible to distinguish 
between ischemia and hemorrhage from the history and neurologic examination, 
but CT scan or MRI permits a definitive diagnosis.
A. Ischemia. Interruption of blood flow to the brain deprives neurons and 
other cells of substrate glucose and oxygen and, unless blood flow is promptly 
restored, leads ultimately to cell death. The pattern of cell death depends on the 
severity of ischemia. With mild ischemia, as may occur in cardiac arrest with 
reperfusion, selective vulnerability of certain neuronal populations results in 
their preferential loss. More severe ischemia produces selective neuronal necro­
sis, in which all neurons die but glia and endothelial cells are preserved. Com­
plete, permanent ischemia causes pannecrosis, affecting all cell types, and re­
sults in the chronic cavitary brain lesions seen after clinical stroke.
Ischemic neuronal injury is an active biochemical process that evolves 
over time. Lack of glucose and oxygen depletes the cellular energy stores re­
quired to maintain membrane potentials and transmembrane ion gradients. Po­
tassium leaks out of cells, causing depolarization-induced calcium entry, and 
also stimulates the release of glutamate through glial glutamate transporters. 
Synaptic glutamate activates excitatory amino acid receptors coupled to cal­
cium- and sodium-preferring ion channels. The resulting influx of sodium into 
postsynaptic neuronal cell bodies and dendrites causes depolarization and acute 
swelling. Calcium influx that exceeds the ability of the cell to extrude, sequester, 
or buffer calcium activates calcium-dependent enzymes (pro teases, lipases, and 
nucleases). These enzymes and their metabolic products, such as eicosanoids 
and oxygen free radicals, cause the breakdown of plasma membranes and cy- 
toskeletal elements, leading to cell death. This sequence of events has been 
termed excitotoxicity because of the pivotal role of excitatory amino acids such 
as glutamate.
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Where ischemia is incomplete and therefore permits more prolonged cell 
survival -  as in the border zone or penumbra surrounding the core of an is­
chemic brain region-other biochemical processes that regulate cell death may be 
set into motion. These include the expression of proteins involved in pro­
grammed cell death, such as Bel (В-cell Iymphoma)-2-family proteins and cas- 
pases (proenzymes for cysteine proteases that cleave at aspartate residues). The 
action of these proteins leads to apoptosis, a form of cell death that is distinct 
from necrosis, and is characterized by margination of nuclear chromatin, cleav­
age of DNA into fragments of defined length (nucleosomes), relative preserva­
tion of cell membrane integrity, blebbing of the plasma membrane to form apop- 
totic bodies, and phagocytosis without inflammation.
If the blood flow to ischemic brain tissue is restored before neurons are ir­
reversibly injured, the clinical symptoms and signs are transient. Prolonged in­
terruption of blood flow, however, leads to irreversible ischemic injury (infarc­
tion) and persistent neurologic deficits.
Two pathogenetic mechanisms can produce ischemic stroke-thrombosis 
and embolism. While about two -  thirds of ischemic strokes are attributed to 
thrombosis and about one-third to embolism, the distinction is often difficult or 
impossible to make on clinical grounds.
1. Thrombosis produces stroke by occluding large cerebral arteries (espe­
cially the internal carotid, middle cerebral, or basilar), small penetrating arteries 
(as in lacunar stroke), cerebral veins, or venous sinuses. Symptoms typically 
evolve over minutes to hours. Thrombotic strokes are often preceded by TIAs, 
which tend to produce similar symptoms because they affect the same territory 
recurrently.
2. Embolism produces stroke when cerebral arteries are occluded by the 
distal passage of thrombus from the heart, aortic arch, or large cerebral arteries. 
Emboli in the anterior cerebral circulation most often occlude the middle cere­
bral artery or its branches, since about 85% of the hemispheric blood flow is car­
ried by this vessel. .Emboli in the posterior cerebral circulation usually lodge at 
the apex of the basilar artery or in the posterior cerebral arteries. Embolic 
strokes characteristically produce neurologic deficits that are maximal at onset. 
When TIAs precede embolic strokes, especially those arising from a cardiac 
source, symptoms typically vary between attacks since different vascular territo­
ries are affected.
B. Hemorrhage. Hemorrhage may interfere with cerebral function 
through a variety of mechanisms, including destruction or compression of brain 
tissue and compression of vascular structures, leading to secondary ischemia and 
edema. Intracranial hemorrhage is classified by its location as intracerebral, su­
barachnoid, subdural, or epidural, all of which-except subdural hemorrhage-are 
usually caused by arterial bleeding.
1. Intracerebral hemorrhage causes symptoms by compressing adjacent 
tissue (which can then produce local ischemia) and, to a lesser extent, by de­
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stroying tissue. Unlike ischemic stroke, intracerebral hemorrhage tends to cause 
more severe headache and depression of consciousness as well as neurologic 
deficits that do not correspond to the distribution of any single blood vessel.
2. Subarachnoid hemorrhage leads to cerebral dysfunction by elevating 
intracranial pressure as well as by exerting still poorly understood toxic effects 
of subarachnoid blood on brain tissue. In addition, subarachnoid hemorrhage 
may be complicated by vasospasm (leading to ischemia), rebleeding, extension 
of blood into brain tissue (producing an intracerebral hematoma), or hydro­
cephalus. Subarachnoid hemorrhage typically presents with headache rather than 
focal neurologic deficits.
3. Subdural or epidural hemorrhage produces a mass lesion that can 
compress the underlying brain. These hemorrhages are often traumatic in origin, 
and usually present with headache or altered consciousness.
FOCAL CEREBRAL ISCHEMIA 
Etiology
A variety of disorders of the blood, blood vessels, and heart can lead to 
focal cerebral ischemia. Conditions associated with focal cerebral ischemia:
Vascular disorders
Atherosclerosis 
Fibromuscular dysplasia 
Inflammatory disorders 
Giant cell arteritis 
Systemic lupus erythematosus 
Polyarteritis nodosa 
Granulomatous angiitis 
Syphilitic arteritis 
AIDS
Carotid or vertebral artery dissection 
Lacunar infarction 
Drug abuse 
Migraine
Multiple progressive intracranial occlusions (moyamoya syndrome) 
Venous or sinus thrombosis 
Cardiac disorders
Mural thrombus 
Rheumatic heart disease 
Arrhythmias 
Endocarditis
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Mitral valve prolapse 
Paradoxic embolus 
Atrial myxoma 
Prosthetic heart valves 
Hematologic disorders 
Thrombocytosis 
Polycythemia 
Sickle cell disease 
Leukocytosis 
Hypercoagulable states
A. Vascular Disorders
1. Atherosclerosis. In most cases, atherosclerosis of the large extracranial 
arteries in the neck and at the base of the brain is the underlying cause of focal 
cerebral ischemia. The sites of predilection are the origin of the common carotid 
artery, the internal carotid artery just above the common carotid bifurcation and 
within the cavernous sinus, the origin of the middle cerebral artery, the vertebral 
artery at its origin and just above where it enters the skull, and the basilar artery.
The pathogenesis of atherosclerosis is incompletely understood, but injury 
to vascular endothelial cells is thought to be an early step. Endothelial cells may 
be injured by the accumulation of cholesterol esters derived from circulating 
low-density lipoproteins or by other mechanical, biochemical, or inflammatory 
mechanisms. Blood monocytes, macrophages, and T lymphocytes adhere to the 
sites of endothelial injury or denudation and subsequently migrate subendothe- 
lially, where they are transformed into lipid-laden foam cells. The resulting le­
sion is called a fatty streak. The release of growth and chemotactic factors from 
endothelial cells and monocytic. macrophages stimulates the proliferation and 
migration of intimal smooth muscle cells, and leads to formation of a fibrous 
plaque. Further endothelial injury or denudation ensues, promoting the adher­
ence of platelets, which also release growth and chemotactic factors. The result­
ing atheromatous lesion may enlarge to occlude the vessel lumen, or it may pro­
vide a source of atheromatous or platelet emboli. Ulcerated atheromas may be 
especially likely sources of emboli.
The most important risk factor for atherosclerosis leading to stroke is sys­
tolic or diastolic hypertension. In one study of more than 5000 symptom-free 
men and women aged from 30 to 60 years followed prospectively for 18 years, 
the likelihood of hypertensive subjects developing stroke was seven times that 
of the nonhypertensives. Furthermore, the incidence of all the major cardiac and 
cerebrovascular sequelae of hypertension increased in direct proportion to the 
blood pressure even in the nonhypertensive range, without any identifiable criti­
cal or safe value. A blood pressure of 160 mm Hg systolic or 95 mm Hg dia­
stolic observed during any clinic visit tripled the risk of stroke, suggesting that 
such patients should receive antihypertensive treatment.
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Atherosclerosis can also occur in the absence of hypertension. In such 
cases, other factors such as diabetes, elevated serum cholesterol and triglyc­
erides, hyperhomocysteinemia, cigarette smoking, hereditary predisposition, and 
the use of oral contraceptives may be implicated. Genetic disorders associated 
with accelerated atherosclerosis include homocystinuria and dyslipoproteine- 
mias.
2. Fibromuscular dysplasia. This is a segmental nonatherosclerotic con­
dition of large arteries characterized by segmental thinning of the media and 
fragmentation of the elastic lamina, alternating with rings of fibrous and muscu­
lar hyperplasia within the media. In at least some families, fibromuscular dys­
phasia is inherited in autosomal dominant fashion and has been mapped to a site 
on chromosome 2 (2q31). Systemic involvement may produce limb claudica­
tion, hypertension from renal artery hyperplasia, or myocardial infarction. Ex­
tracranial vessels are involved more often than intracranial ones, and the cervical 
portion of the internal carotid is involved more than is the vertebral artery. Le­
sions are often bilateral, and women are more often affected than men. Transi­
tory or fixed cerebral ischemic deficits may occur, although complete occlusion 
of involved arteries is rare, suggesting that symptoms may be due to the emboli­
zation of vascular thrombi. There is a characteristic string-ofbeads appearance 
on angiography, indicating the presence of saccular dilations of involved arter­
ies. The disorder is associated with saccular aneurysms of the cerebral arteries, 
which can in turn produce subarachnoid hemorrhage. Cerebral ischemic compli­
cations of fibromuscular dysplasia may be reduced by treatment with aspirin or 
by graduated intraluminal dilation of the affected extracranial vessels in symp­
tomatic cases.
3. Inflammatory disorders
a. Giant cell arteritis, also called temporal arteritis or cranial arteritis, 
sometimes produces signs of cerebral ischemia. Inflammatory changes affect the 
branches of the external carotid, cervical internal carotid, posterior ciliary, ex­
tracranial vertebral, and intracranial arteries. Inflammatory changes in the arte­
rial wall may stimulate platelet adhesion and aggregation on damaged surfaces, 
leading to thrombosis or distal embolism. Physical examination may show ten­
der, nodular, or pulseless temporal arteries. Laboratory findings include an in­
creased erythrocyte sedimentation rate and evidence of vascular stenosis or oc­
clusion on angiography or color duplex ultrasonography. Definitive diagnosis is 
by temporal artery biopsy. Although it is an uncommon cause of cerebral 
ischemic symptoms, giant cell arteritis should be considered in patients with 
transient monocular blindness or transient cerebral ischemic attacks -  especially 
elderly patients -  because the disorder is responsive to corticosteroid therapy 
and its complications (especially permanent blindness) may thus be avoided.
b. Systemic lupus erythematosus is associated with a vasculopathy that 
involves small cerebral vessels and leads to multiple microinfarctions. Inflam­
matory changes characteristic of true vasculitis are absent. There is no correla-
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tion between cerebral microinfarcts and verrucous (Libman-Sacks) endocarditis; 
cardiac emboli therefore appear to play little or no role in the genesis of cerebral 
symptoms.
c. Polyarteritis nodosa is a segmental vasculitis of small and medium­
sized arteries that affects multiple organs. Transient symptoms of cerebral 
ischemia, including typical spells of transient monocular blindness, can occur.
d. Granulomatous angiitis (also called primary angiitis of the central 
nervous system) is an idiopathic inflammatory disease that affects small arteries 
and veins in the central nervous system and can cause transient or progressive 
multifocal lesions. Clinical features include headache, hemiparesis and other fo­
cal neurologic abnormalities, and cognitive disturbances. The CSF usually 
shows pleocytosis and elevated protein, but the erythrocyte sedimentation rate is 
typically normal. The diagnosis should be suspected in any patient with multifo­
cal central nervous system dysfunction and CSF pleocytosis. Angiography dem­
onstrates focal and segmental narrowing of small arteries and veins, and a men­
ingeal biopsy is diagnostic. Treatment with corticosteroids, alone or in combina­
tion with cyclophosphamide, may be beneficial.
e. Syphilitic arteritis is uncommon but is being seen with increasing fre­
quency in the male homosexual and other at-risk populations. It generally occurs 
within 5 years after the initial infection and reflects the underlying meningeal 
inflammatory process. It is important to recognize and treat the disorder at this 
early stage to prevent the later development of tertiary parenchymal neuro­
syphilis (general paresis or tabesdorsalis). Medium-sized penetrating vessels are 
typically involved, producing punctate areas of infarction in the deep white mat­
ter of the cerebral hemisphere, that can be seen on CT scan or MR1.
f. AIDS is associated with an increased incidence of TIAs and ischemic 
stroke. The reason for this association is unclear, but the toxic effects of HIV -  1 
on blood vessels or the deposition of immune complexes may be involved. In 
some cases, ischemic neurologic complications of AIDS are associated with en­
docarditis or with opportunistic infections of the central nervous system, such as 
toxoplasmosis or cryptococcal meningitis.
4. Carotid or vertebral artery dissection. Dissection of the carotid or 
vertebral artery is associated with hemorrhage into the vessel wall, which can 
occlude the vessel or predispose to thrombus formation and embolization. Post- 
traumatic carotid dissections present little difficulty in diagnosis. Certain pa­
tients, however -  usually young men -  suffer cerebral infarction after apparently 
spontaneous carotid artery dissection. Internal carotid artery dissections usually 
originate near the carotid bifurcation and can extend to the base of the skull. The 
underlying pathologic process is usually cystic medial necrosis. Prodromal tran­
sient hemispheric ischemia or monocular blindness sometimes precedes a devas­
tating stroke. Carotid dissection may be accompanied by pain in the jaw or neck, 
visual abnormalities akia to those that occur in migraine, or Homer's syndrome.
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Dissection of the vertebral or basilar artery is less common. The clinical 
features of this disorder include headache, posterior neck pain, and the sudden 
onset of signs of brainstem dysfunction.
The treatment of carotid or vertebral artery dissection is controversial. 
Approaches include no treatment, removal of the intramural hematoma, and 
measures to prevent embolization from the site of dissection (aspirin, anticoagu­
lants, or occlusion of the vessel distal to the dissection). Recurrent dissection is 
uncommon and usually occurs within 1 month of the initial event.
5. Lacunar infarction. Lacunar infarction of the brain results from the 
occlusion of small penetrating branches of the major cerebral arteries, especially 
those that supply the basal ganglia, thalamus, internal capsule, and pons. Lacu­
nar infarcts are believed to be caused by either atherosclerosis or degenerative 
changes in arterial walls (including lipohyalinosis and fibrinoid necrosis) that 
are related to long-standing hypertension. Both hypertension and diabetes appear 
to predispose to this type of stroke.
6. Drug abuse. Recreational use of cocaine hydrochloride, alkaloidal 
(crack) cocaine, amphetamines, or heroin appears to be a common risk factor for 
stroke in patients less than 35 years old. Patients who take these agents intrave­
nously may develop infective endocarditis (see below) leading to embolic 
stroke. Stroke also occurs in drug users without endocarditis, however, including 
those who take drugs only intranasal ly or by smoke or vapor inhalation, and of­
ten has its onset within hours of drug use. Mechanisms that have been proposed 
to explain these events include drug-induced vasospasm, vasculitis, and the rup­
ture of preexisting aneurysms or vascular malformations. Cocaine hydrochloride 
is most often associated with intracerebral hemorrhage but can also cause su­
barachnoid hemorrhage or ischemic stroke. Stroke from crack cocaine is most 
commonly ischemic in origin, but intracerebral or subarachnoid hemorrhage also 
occurs. Amphetamines can produce vasculitis, with necrosis of the vessel wall 
leading to intracerebral hemorrhage; ischemic stroke and subarachnoid hemor­
rhage are less frequent. Heroin is associated primarily with embolic stroke re­
sulting from endocarditis.
7. Multiple progressive intracranial arterial occlusions (moyamoya).
This syndrome has two essential features: bilateral narrowing or occlusion of the 
distal internal carotid arteries and the adjacent anterior and middle cerebral ar­
tery trunks; and the presence of a fine network of collateral channels at the base 
of the brain. The term moyamoya derives from a Japanese word meaning smoke 
or haze, which characterizes the angiographic appearance of these fine collat­
erals. Moyamoya is most common in Japanese girls and is sometimes inherited 
as an autosomal recessive disorder, but occurs in all ethnic groups and in pa­
tients with atherosclerosis, sickle cell anemia, or a history of basilar meningitis. 
The term therefore denotes an angiographic pattern of collateral vessels rather 
than a clinical or pathologic syndrome. Children tend to present with ischemic
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strokes; adults present with intracerebral, subdural, or subarachnoid hemorrhage. 
Transient episodes of cerebral ischemia are infrequent.
8. Migraine. Stroke is a rare complication of migraine. Migrainous stroke 
occurs during an attack of classic migraine and in the same vascular territory af­
fected by previous migraine attacks. The anterior (especially middle cerebral ar­
tery) and posterior (especially posterior cerebral artery) cerebral circulations are 
affected about equally often. Investigative studies show no other cause of stroke 
(eg, occlusion of large cerebral arteries), suggesting that migraine itself is the 
cause, although other stroke risk factors (eg, oral contraceptive use) may exist.
9. Venous or sinus thrombosis. This uncommon cause of stroke is typi­
cally associated with a predisposing condition such as otitis or sinusitis, a post­
partum state, dehydration, or coagulopathy. Clinical features include headache, 
papilledema, impaired consciousness, seizures, and focal neurologic deficits. 
CSF pressure is typically increased, and in cases of septic thrombosis, pleocyto­
sis may occur. A CT scan may demonstrate hemorrhage associated with venous 
infarction, and in superior sagittal sinus thrombosis a CT scan with contrast 
sometimes shows a filling defect corresponding to the clot (delta sign). How­
ever, MRI with contrast is the diagnostic procedure of choice in most cases. The 
diagnosis may be confirmed by MR angiography, but conventional intra-arterial 
x-ray angiography is now rarely indicated. In patients presenting with headache 
and papilledema, venous or sinus thrombosis must be differentiated from intrac­
ranial mass lesions and idiopathic pseudotumor cerebri. The radiologic studies 
mentioned above are useful in this regard. Septic thromboses are treated with 
antibiotics. Anticoagulation has been used for aseptic thrombosis, but its effi­
cacy has not been proved, and it may precipitate intracranial hemorrhage.
B. Cardiac Disorders
1. Mural thrombus. Mural thrombus complicating myocardial infarction 
or cardiomyopathy is a recognized source of cerebral embolism. The risk of 
stroke in the first weeks after myocardial infarction is related to the size of the 
cardiac lesion. More extensive myocardial damage may increase the tendency 
for mural thrombi to form; it may exacerbate the generalized hypercoagulable 
state that accompanies the infarct -  or it may do both. Accordingly, patients with 
large transmural myocardial infarcts require anticoagulation therapy to substan­
tially reduce the incidence of early thromboembolic events, including stroke.
2. Rheumatic heart disease. The incidence of focal cerebral ischemia is 
increased in patients with rheumatic heart disease -  particularly those with mi­
tral stenosis and atrial fibrillation -  presumably as a result of embolization. In 
other cases, symptoms are temporally related to exertion, suggesting hypoperfu­
sion as the cause.
3. Arrhythmias. Atrial fibrillation (especially when associated with 
rheumatic heart disease) and the bradycardia-tachycardia (sick-sinus) syndrome 
are well-recognized causes of embolic stroke. Other cardiac arrhythmias are
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more likely to produce pancerebral hypoperfusion with diffuse rather than focal 
symptoms (eg, syncope, dimming of vision, nonspecific lightheadedness, gener­
alized seizures) unless severe carotid artery stenosis is also present.
4. Endocarditis
a. Infective (bacterial or fungal) endocarditis is a cause of transient 
cerebral ischemia and embolic cerebral infarction during the active phase of in­
fection and during the first few months following antibiotic cure. At autopsy, 
cerebral emboli are identified in 30% and systemic emboli in 60% of such pa­
tients. The middle cerebral artery is the most common site of cerebral emboliza­
tion. Intracerebral or subarachnoid hemorrhage can also occur as a result of 
bleeding into an infarct or rupture of a mycotic aneurysm. Infective endocarditis 
is seen most often in intravenous drug users and patients with valvular heart dis­
ease or prosthetic valves. Streptococci and staphylococci are the most common 
causes, but gram-negative bacilli (eg, Pseudomonas) and fungi (especially Can­
dida and Aspergillus) are also frequent pathogens in intravenous drug users and 
prosthetic valve recipients.
Signs of infective endocarditis include heart murmurs, petechiae, subun­
gual splinter hemorrhages, retinal Roth's spots (red spots with white centers), 
Osier's nodes (painful red or purple digital nodules), Janeway's lesions (red 
macules on the palms or soles), and clubbing of the fingers or toes. The diag­
nosis is usually made by culturing the responsible organism from the blood. 
Treatment is with antibiotics; valve replacement is sometimes required. Antico­
agulation should be avoided because of the risk of intracranial hemorrhage.
b. Nonbacterial (marantic) endocarditis is most frequent in patients 
with cancer and is responsible for the vast majority of ischemic strokes in this 
population. The tumors most often associated with this type of stroke are adeno­
carcinomas of the lung or gastrointestinal tract. Vegetations are present on the 
mitral or aortic valves; associated murmurs are rare. Identification of valvular 
vegetations by two-dimensional echocardiography may be diagnostic, but failure 
to demonstrate vegetations does not exclude the diagnosis. Anticoagulation with 
heparin may be useful in patients with treatable tumors or with other treatable 
causes of marantic endocarditis, such as sepsis.
5. Mitral valve prolapse. Buckling of the mitral valve due to stretching 
of the mitral annulus (mitral valve prolapse) is common, occurring in 4-8% of 
young adults, and usually produces no symptoms. However, in some cases it is 
associated with significant mitral regurgitation, infective endocarditis, cardiac 
arrhythmias, or cerebral ischemic events. Mitral valve prolapse may be seen in 
association with coronary artery disease, cardiomyopathy, atrial septal defect, or 
connective tissue diseases, or as a familial disorder with autosomal dominant in­
heritance, but is usually idiopathic. Auscultation of the heart classically reveals a 
midsystolic click, and a holo- or late systolic murmur, and M-mode echocardi­
ography shows abnormal motion of the mitral valve, which results from stretch­
ing of the mitral annulus. While there appears to be a genuine association of mi-
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tral valve prolapse with cerebral ischemia, the degree to which the disorder in­
creases the risk of stroke is apparently small, and massive strokes related to mi­
tral valve prolapse are rare.
6. Paradoxic embolus. Congenital cardiac anomalies associated with a 
pathologic communication between the right and left sides of the heart, such as 
atrial septal defect or patent foramen ovale, permit the passage of embolic mate­
rial from the systemic venous circulation to the brain. Under these circum­
stances, venous thrombi can give rise to embolic stroke.
7. Atrial myxoma. This rare disorder can lead to either embolization 
(producing stroke) or cardiac outflow obstruction (producing syncope). Embolic 
events occur in one-fourth to one-half of patients with nonhereditary left atrial 
myxoma; some cases, however, are familial. Hemorrhagic strokes may occur. 
Diagnosis is by echocardiography.
8. Prosthetic heart valves. Patients with prosthetic heart valves are at 
particular risk for cerebral emboli and are generally treated with anticoagulants 
on a long-term basis.
C. Hematological Disorders
1. Thrombocytosis. Thrombocytosis occurs in myeloproliferative disor­
ders, in other systemic malignant neoplastic diseases or infections, and follow­
ing splenectomy. Thrombocytosis may predispose to focal cerebral ischemia, 
particularly when the platelet count exceeds 1,000,000/pL. While hyperaggre- 
gability of platelets has also been described in association with focal cerebral 
ischemia, it is uncertain whether this is primary and causal or a result of the 
cerebrovascular disorder.
2. Polycythemia. The occurrence of neurologic signs and symptoms in 
patients with polycythemia has long been recognized. In addition to nonspecific 
signs such as headache, dizziness, and blurred vision, patients may have focal 
neurological symptoms that often respond to venesection. Hematocrits above 
46% may be associated with reduced cerebral blood flow, but there is a poor 
correlation between blood viscosity measured in vitro and the risk of stroke. 
This risk increases with hematocrits of more than 50%, however, and rises dra­
matically above 60%.
3. Sickle cell disease. Sickle cell (hemoglobin S) disease results from a 
single amino acid substitution (Glu-6-Val) in the hemoglobin beta locus on 
chromosome 11 (11 p 15.5) that results in an abnormal beta hemoglobin chain. 
Persons of African, especially West African, descent are most frequently af­
fected. The mutation causes the sickle-shaped deformation of erythrocytes when 
the partial pressure of oxygen in blood is reduced, and produces hemolytic ane­
mia and vascular occlusions, which may be extremely painful (sickle cell cri­
ses). Homozygotes are more severely affected than heterozygotes. The most fre­
quent neurological complication is stroke, which characteristically affects the 
intracranial internal carotid or proximal middle or anterior cerebral artery. De-
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tection of increased cerebral blood flow velocity by transcranial Doppler studies 
may help to identify individuals at increased risk for stroke. Therapies in clinical 
or experimental use include hydration and analgesia for painful crises, blood 
transfusion, hydroxyurea (which increases levels of fetal hemoglobin), and bone 
marrow or hematopoietic stem cell transplantation. In patients with sickle cell 
disease who must undergo angiography, the level of hemoglobin S should be re­
duced by exchange transfusion to less than 20%, since radiologic contrast media 
may induce sickling.
4. Leukocytosis. Transient cerebral ischemia has been reported in asso­
ciation with leukocytosis, usually in patients with leukemia and white blood cell 
counts in excess of 150,000/pL.
5. Hypercoagulable states. Hyperviscosity of the serum from parapro­
teinemia (especially macroglobulinemia) is an infrequent cause of focal cerebral 
ischemia. Stasis of blood in these conditions can lead to cerebral infarction or 
diffuse encephalopathy.
Many conditions, such as estrogen therapy or the use of oral contracep­
tives, postpartum and postoperative states, and cancer, are accompanied by co­
agulation abnormalities. Patients with such coagulopathies may exhibit symp­
toms of cerebral thrombosis or embolism.
Antiphospholipid antibodies, including lupus anticoagulants and anticar- 
diolipin antibodies, may be associated with an increased incidence of ischemic 
stroke. The mechanism by which anti phospholipid antibodies promote throm­
bosis is uncertain.
Stroke has also been reported in patients with hereditary coagulopathies, 
including heparin cofactor II deficiency, protein C deficiency, defective release 
of plasminogen activator, and factor XII deficiency.
Pathology'
A. Infarction in Major-Cerebral-Artery Distribution. On gross inspec­
tion at autopsy, a recent infarct is a swollen, softened area of brain that usually 
affects both gray and white matter. Microscopy shows acute ischemic changes in 
neurons (shrinkage, microvacuolization, dark staining), destruction of glial cells, 
necrosis of small blood vessels, disruption of nerve axons and myelin, and ac­
cumulation of interstitial fluid from vasogenic edema. In some cases, perivascu­
lar hemorrhages are observed in the infarcted area.
Cerebral infarcts are typically associated with cerebral edema, which is 
maximal during the first 4 or 5 days after onset. Most deaths that occur within I 
week after massive cerebral infarction are attributable to cerebral edema, with 
swelling of the affected hemisphere causing herniation of the ipsilateral cin­
gulate gyrus across the midline beneath the free edge of the dural falx, followed 
by downward displacement of the brain through the tentorial incisure.
B. Lacunar Infarction. In contrast to infarcts associated with major cere­
bral blood vessels, smaller lacunar infarcts result from lipohyaiinosis of small
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resistance vessels, usually in patients with chronic hypertension. Lacunar in­
farcts -  often multiple -  are found in about 10% of brains at autopsy. The patho­
logic appearance is of small cavities ranging in size from 0.5 to 15 mm in di­
ameter.
Clinicoanatomic Correlation
A rational clinical approach to cerebral ischemia depends on the ability to 
identify the neuroanatomic basis of clinical deficits.
A. Anterior Cerebral Artery
1. Anatomy. The anterior cerebral artery supplies the parasagittal cerebral 
cortex, which includes portions of motor and sensory cortex related to the con­
tralateral leg and the so-called bladder inhibitory or micturition center.
2. Clinical syndrome of anterior cerebral artery occlusion. Anterior 
cerebral artery strokes are uncommon, perhaps because emboli from the ex­
tracranial vessels or the heart are more apt to enter the larger-caliber middle 
cerebral artery, which receives the bulk of cerebral blood flow. There is a con­
tralateral paralysis and sensory loss affecting the leg. Voluntary control of mic­
turition may be impaired because of failure to inhibit reflex bladder contractions, 
resulting in precipitate micturition.
B. Middle Cerebral Artery
1. Anatomy. The middle cerebral artery supplies most of the remainder of 
the cerebral hemisphere and deep subcortical structures. The cortical branches of 
the middle cerebral artery include the superior division, which supplies the en­
tire motor and sensory cortical representation of the face, hand, and arm; and the 
expressive language (Broca's) area of the dominant hemisphere. The inferior di­
vision supplies the visual radiations, the region of visual cortex related to macu­
lar vision, and the receptive language (Wernicke's) area of the dominant hemi­
sphere. Lenticulostriate branches of the most proximal portion (stem) of the 
middle cerebral artery supply the basal ganglia as well as motor fibers related to 
the face, hand, arm, and leg as they descend in the genu and the posterior limb 
of the internal capsule.
2. Clinical syndrome of middle cerebral artery occlusion. The middle 
cerebral artery is the vessel most commonly involved in ischemic stroke. De­
pending on the site of involvement, several clinical syndromes can occur.
a. Superior division stroke results in contralateral hemiparesis that af­
fects the face, hand, and arm but spares the leg; contralateral hemisensory deficit 
in the same distribution; but no homonymous hemianopia. If the dominant hemi­
sphere is involved, these features are combined with Broca's (expressive) apha­
sia, which is characterized by impairment of language expression with intact 
comprehension.
b. Inferior division stroke is less common in isolation and results in con­
tralateral homonymous hemianopia that may be denser inferiorly; marked im­
pairment of cortical sensory functions, such as graphesthesia and stereognosis
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Fig. 14. Arteries of the anterior and posterior cerebral circulation in relation to 
the circle of Willis. Sites of predilection for atherosclerosis in the intracranial 
arterial circulation.
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Fig. 15. Anatomic basis of middle cerebral artery syndromes.
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on the contralateral side of the body; and disorders of spatial thought, including 
a lack of awareness that a deficit exists (anosognosia), neglect of and failure to 
recognize the contralateral limbs, neglect of the contralateral side of external 
space, dressing apraxia, and constructional apraxia. If the dominant hemisphere 
is involved, Wernicke's (receptive) aphasia occurs and is manifested by impaired 
comprehension and fluent but often nonsensical speech. With involvement of 
the nondominant hemisphere, an acute confusional state may occur.
c. Occlusion at the bifurcation or trifurcation of the middle cerebral 
artery involves a lesion situated at the point where the artery splits into two (su­
perior and inferior) or three (superior, middle, and inferior) major divisions. This 
severe stroke syndrome combines the features of superior and inferior division 
stroke. Its clinical features include contralateral hemiparesis and hemisensory 
deficit involving the face and arm far more than the leg; homonymous hemiano- 
pia; and, if the dominant hemisphere is affected, global (combined expressive 
and receptive) aphasia.
d. Occlusion of the stem of the middle cerebral artery occurs proximal 
to the origin of the lenticulostriate branches. Since the entire territory of the ar­
tery is affected, this is the most devastating of middle cerebral artery strokes. 
The resulting clinical syndrome is similar to that seen following occlusion at the 
trifurcation except that, in addition, infarction of motor fibers in the internal cap­
sule causes paralysis of the contralateral leg. The result is a contralateral hemi­
plegia and sensory loss affecting the face, hand, arm, and leg.
C. Internal Carotid Artery
1. Anatomy. The internal carotid artery arises where the common carotid 
artery divides into internal and external carotid branches in the neck. In addition 
to its anterior cerebral and middle cerebral branches discussed above, the inter­
nal carotid artery also gives rise to the ophthalmic artery, which supplies the ret­
ina. The severity of internal carotid artery strokes is highly variable, depending 
on the adequacy of collateral circulation, which tends to develop in compensa­
tion for a slowly evolving occlusion.
2. Clinical syndrome of internal carotid artery occlusion. Intra- or ex­
tracranial internal carotid artery occlusion is responsible for about one-fifth of 
ischemic strokes. In approximately 15% of cases, progressive atherosclerotic 
occlusion of the internal carotid artery is preceded by premonitory TIAs or by 
transient monocular blindness caused by ipsilateral retinal artery ischemia.
Carotid artery occlusion may be asymptomatic. Symptomatic occlusion 
results in a syndrome similar to that of middle cerebral artery stroke (contralat­
eral hemiplegia, hemisensory deficit, and homonymous hemianopia; aphasia is 
also present with dominant hemisphere involvement).
D. Posterior Cerebral Artery
1. Anatomy. The paired posterior cerebral arteries arise from the tip of 
the basilar artery and supply the occipital cerebral cortex, medial temporal lobes, 
thalamus, and rostral midbrain. Emboli carried up the basilar artery tend to lodge
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at its apex, where they can occlude one or both posterior cerebral arteries. These 
emboli can subsequently break up and produce signs of asymmetric or patchy 
posterior cerebral artery infarction.
2. Clinical syndrome of posterior cerebral artery occlusion. Occlusion 
of a posterior cerebral artery produces homonymous hemianopia affecting the 
contralateral visual field. Macular vision may be spared, however, because of 
the dual (middle and posterior cerebral artery) blood supply to the portion of the 
visual cortex representing the macula. In contrast to visual field defects from in­
farction in the middle cerebral artery territory, those caused by posterior cerebral 
artery occlusion may be denser superiorly. With occlusions near the origin of the 
posterior cerebral artery at the level of the midbrain, ocular abnormalities can in­
clude vertical gaze palsy, oculomotor (III) nerve palsy, intemuclear ophthalmo­
plegia, and vertical skew deviation of the eyes. When posterior cerebral artery 
occlusion affects the occipital lobe of the dominant (usually left) hemisphere, 
patients may exhibit anomic aphasia (difficulty in naming objects), alexia with­
out agraphia (inability to read, with no impairment of writing), or visual agnosia. 
The last is a failure to identify objects presented in the left side of the visual 
field, caused by a lesion of the corpus callosum that disconnects the right visual 
cortex from language areas of the left hemisphere. Bilateral posterior cerebral 
artery infarction may result in cortical blindness, memory impairment (from 
temporal lobe involvement), or the inability to recognize familiar faces (pro- 
sooaenosial as well as a varietv of exotic visual and behavioral svndromes.■ " r  " o .... / з  ■■■ .............. j  J
E. Basilar Artery
1. Anatomy. The basilar artery usually arises from the junction of the 
paired vertebral arteries, though in some cases only a single vertebral artery is 
present. The basilar artery courses over the ventral surface of the brainstem to 
terminate at the level of the midbrain, where it bifurcates to form the posterior 
cerebral arteries (see above). Branches of the basilar artery supply the occipital 
and medial temporal lobes, the medial thalamus, the posterior limb of the inter­
nal capsule, and the entire brainstem and cerebellum.
2. Clinical syndromes of basilar artery occlusion.
a. Thrombosis. Thrombotic occlusion of the basilar artery -  a serious 
event that is often incompatible with survival -  produces bilateral neurologic 
signs referable to involvement of multiple branch arteries. Occlusion of both 
vertebral arteries or of a lone unpaired vertebral artery produces a similar syn­
drome. Temporary occlusion of one or both vertebral arteries can also occur in 
relation to rotation of the head in patients with cervical spondylosis, leading to 
transient symptoms and signs of brainstem dysfunction.
Major stenosis or occlusion of the subclavian artery before it has given 
rise to the vertebral artery can lead to the subclavian steal syndrome, in which 
blood passes from the vertebral artery into the distal subclavian artery with 
physical activity of the ipsilateral arm. The syndrome is a manifestation of gen­
eralized atherosclerosis and is not predictive of stroke in the vertebrobasilar sys-
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tern. Patients are usually asymptomatic, and stroke, when it occurs, is typically 
due to coexisting carotid lesions.
Basilar thrombosis usually affects the proximal portion of the basilar ar­
tery, which supplies the pons. Involvement of the dorsal portion (tegmentum) of 
the pons produces unilateral or bilateral abducens (VI) nerve palsy; horizontal 
eye movements are impaired, but vertical nystagmus and ocular bobbing may be 
present. The pupils are constricted as a result of the involvement of descending 
sympathetic pupillodilator fibers in the pons, but they may remain reactive. 
Hemiplegia or quadriplegia is usually present, and coma is common. Although 
the syndrome of basilar occlusion in unconscious patients may be confused with 
pontine hemorrhage, a CT or MRI brain scan will differentiate the two.
In some patients with basilar occlusion, the ventral portion of the pons 
(basis pontis) is infarcted and the tegmentum is spared. Such patients remain 
conscious but quadriplegic. The term locked-in syndrome has been applied to 
this state. Locked-in patients may be able to signify that they are conscious by 
opening their eyes or moving their eyes vertically on command. In other cases, a 
conventional EEG with stimulation may be needed to distinguish the locked-in 
state (in which the EEG is normal) from coma.
b. Embolism. Emboli small enough to pass through the vertebral arteries 
into the larger basilar artery are usually arrested at the top of the basilar artery, 
where it bifurcates into the posterior cerebral arteries. The resulting reduction in 
blood flow to the ascending reticular formation of the midbrain and thalamus 
produces immediate loss or impairment of consciousness. Unilateral or bilateral 
oculomotor (III) nerve palsies are characteristic. Hemiplegia or quadriplegia 
with decerebrate or decorticate posturing occurs because of the involvement of 
the cerebral peduncles in the midbrain. Thus, the top of the basilar syndrome 
may be confused with midbrain failure caused by transtentorial uncal herniation. 
Less commonly, an embolus may lodge more proximally in an atheromatous 
narrowed portion of the basilar artery, producing a syndrome indistinguishable 
from basilar thrombosis.
Smaller emboli may occlude the rostral basilar artery transiently before 
fragmenting and passing into one or both posterior cerebral arteries. In such 
cases, portions of the midbrain, thalamus, and temporal and occipital lobes can 
be infarcted. If conscious, these patients display a variety of visual (homony­
mous hemianopia, cortical blindness), visuomotor (impaired convergence, pa­
ralysis of upward or downward gaze, diplopia), and behavioral (especially con­
fusion) abnormalities without prominent motor dysfunction. Sluggish pupillary 
responses are a helpful sign of midbrain involvement.
F. Long Circumferential Vertebrobasilar Branches.
1. Anatomy. The long circumferential branches arising from the vertebral 
and basilar arteries are the posterior inferior cerebellar, the anterior inferior 
cerebellar, and the superior cerebellar arteries. These vessels supply the dorso­
lateral brainstem, including dorsolaterally situated cranial nerve nuclei (V, VII,
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VIII) and pathways entering and leaving the cerebellum in the cerebellar pedun­
cles.
2. Clinical syndrome of long circumferential artery occlusion. Occlu­
sion of one of the circumferential branches produces infarction in the dor­
solateral area of the medulla or pons.
a. Posterior inferior cerebellar artery occlusion results in the lateral 
medullary (Wallenberg's) syndrome. This syndrome varies in its presentation 
with the extent of infarction, but it can include ipsilateral cerebellar ataxia, 
Homer's syndrome, and facial sensory deficit; contralateral impaired pain and 
temperature sensation; and nystagmus, vertigo, nausea, vomiting, dysphagia, dy­
sarthria, and hiccup. The motor system is characteristically spared because of its 
ventral location in the brain stem.
b. Anterior inferior cerebellar artery occlusion leads to infarction of 
the lateral portion of the caudal pons and produces a syndrome with many of the 
same features. Homer's syndrome, dysphagia, dysarthria, and hiccup do not oc­
cur, however, but ipsilateral facial weakness, gaze palsy, deafness, and tinnitus 
are common findings.
c. The syndrome of lateral rostral pontine infarction from superior cere­
bellar artery occlusion resembles that associated with anterior inferior cerebel­
lar artery lesions, but impaired optokinetic nystagmus or skew deviation of the 
eyes may occur. Auditory function is unaffected, and the contralateral sensory 
disturbance may involve touch, vibration, and position sense as well as pain and 
temperature sense.
G. Long Penetrating Paramedian Vertebrobasilar Branches.
1. Anatomy. Long penetrating paramedian arteries supply the medial 
brainstem from its ventral surface to the floor of the fourth ventricle. Structures 
located in this region include the medial portion of the cerebral peduncle, sen­
sory pathways, the red nucleus, the reticular formation, and the midline cranial 
nerve nuclei (III, IV, VI, XII).
2. Clinical syndrome of long penetrating paramedian artery occlu­
sion. Occlusion of a long penetrating artery causes paramedian infarction of the 
brainstem and results in contralateral hemiparesis if the cerebral peduncle is af­
fected. Associated cranial nerve involvement depends on the level of the brain­
stem at which occlusion occurs. Occlusion in the midbrain results in ipsilateral 
third nerve palsy, which may be associated with contralateral tremor or ataxia 
from involvement of pathways connecting the red nucleus and cerebellum. Ipsi­
lateral 6th and 7th nerve palsies are seen in the pons, and 12th nerve in­
volvement can occur in the medulla.
If the lesion appears patchy or involves both sides of the brainstem (as 
manifested by coma or quadriparesis), the differential diagnosis includes occlu­
sion of a main trunk vessel (both vertebral arteries or the basilar artery); in­
tramedullary lesions such as hemorrhage, pontine glioma, or multiple sclerosis;
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and compression of the brainstem by a cerebellar mass (hemorrhage, infarct, or 
tumor).
H. Short Basal Vertebrobasilar Branches.
I. Anatomy. Short branches arising from the long circumferential arteries 
(discussed above) penetrate the ventral brainstem to supply the brainstem motor 
pathways.
2. Clinical syndrome of basal brainstem infarction. The most striking 
finding is contralateral hemiparesis caused by corticospinal tract involvement in 
the cerebral peduncle or basis pontis. Cranial nerves (eg, III, VI, VII) that 
emerge from the ventral surface of the brainstem may be affected as well, giving 
rise to ipsilateral cranial nerve palsies.
I. Lacunar Infarction. Small penetrating arteries located deep in the 
brain may become occluded as a result of changes in the vessel wall induced by 
chronic hypertension. The resulting lacunar infarcts are most common in deep 
nuclei of the brain (putamen, 37%; thalamus, 14%; caudate nucleus, 10%), the 
pons (16%), and the posterior limb of the internal capsule (10%). They occur in 
lesser numbers in the deep cerebral white matter, the anterior limb of the internal 
capsule, and the cerebellum. Because of their small size and their frequent loca­
tion in relatively silent areas of the brain, many lacunar infarctions are not rec­
ognized clinically. In as many as three-fourths of autopsy-proved cases, there is 
no history of stroke or clear evidence of neurologic deficit on antemortem ex­
aminations.
In many cases, the isolated nature of the neurologic deficit makes the 
clinical picture of lacunar infarction distinctive. The onset of lacunar stroke may 
be gradual, developing over several hours or days. Headache is absent or minor, 
and the level of consciousness is unchanged.
Recognition of lacunar stroke syndromes is important because the progno­
sis for complete or nearly complete recovery is good. In addition, the likelihood 
of future lacunar strokes can be reduced by treating the hypertension that is usu­
ally associated with and causally related to them. Because the arteries involved 
are small, angiography is normal (for that reason, it is not required). The CSF is 
also normal, and it is possible that a CT brain scan or MRI will not disclose the 
lesion. CT scanning or MRI should be performed to exclude other causes of 
stroke, however. Anticoagulation is not indicated since there is no evidence that 
it confers any benefit in this context. Aspirin is also of uncertain benefit, but it is 
often given because of the low risk of serious complications. Although a wide 
variety of deficits can be produced, there are four classic and distinctive lacunar 
syndromes.
1. Pure motor hemiparesis. This consists of hemiparesis affecting the 
face, arm, and leg to a roughly equal extent, without an associated disturbance of 
sensation, vision, or language. When lacunar in origin, it is usually due to a le­
sion in the contralateral internal capsule or pons. Pure motor hemiparesis may
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also be caused by internal carotid or middle cerebral artery occlusion, subdural 
hematoma, or intracerebral mass lesions.
2. Pure sensory stroke. This is characterized by hemisensory loss, which 
may be associated with paresthesia, and results from lacunar infarction in the 
contralateral thalamus. It may be mimicked by occlusion of the posterior cere­
bral artery or by a small hemorrhage in the thalamus or midbrain.
3. Ataxic hemiparesis. In this syndrome (sometimes called ipsilateral 
ataxia and crural (leg) paresis), pure motor hemiparesis is combined with ataxia 
of the hemiparetic side and usually predominantly affects the leg. Symptoms re­
sult from a lesion in the contralateral pons, internal capsule, or subcortical white 
matter.
4. Dysarthria -  clumsy hand syndrome. This consists of dysarthria, fa­
cial weakness, dysphagia, and mild weakness and clumsiness of the hand on the 
side of facial involvement. When the syndrome is caused by a lacunar infarct, 
the lesion is in the contralateral pons or internal capsule. Infarcts or small in­
tracerebral hemorrhages at a variety of locations can produce a similar syn­
drome, however. In contrast to the lacunar syndromes described above, pre­
monitory TIAs are unusual.
Clinical Findings
A. History
1. Predisposing factors. In patients with cerebrovascular disorders, pos­
sible risk factors such as TIAs, hypertension, and diabetes should be sought. In 
women, the use of oral contraceptives has been associated with cerebral arterial 
and venous occlusive disease, especially in the presence of hypertension and 
cigarette smoking. The presence of such medical conditions as ischemic or val­
vular heart disease or cardiac arrhythmias must also be ascertained. A variety of 
systemic disorders involving the blood or blood vessels also increase the risk of 
stroke. Antihypertensive drugs can precipitate cerebrovascular symptoms if the 
blood pressure is lowered excessively in patients with nearly total cere­
brovascular occlusion and poor collateral circulation.
2. Onset and course. The history must address whether the clinical pic­
ture is that of TIA, stroke in evolution, or completed stroke. In some cases, it 
may also be possible to evaluate whether a stroke is likely to be thrombotic or 
embolic in origin from the clinical history.
a. Features suggesting thrombotic stroke. Patients with thrombotic vas­
cular occlusion often present with stepwise incremental neurologic deficits; the 
occlusion may be preceded by a series of TIAs. TIAs, for example, precede in­
farction in 25-50% of patients with occlusive atherosclerotic disease of the ex­
tracranial internal carotid arteries. In approximately one-third of such patients,
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however, the onset of infarction is abrupt, suggesting that embolization from the 
distal extracranial artery to the intracranial artery may be the cause of stroke.
b. Features suggesting embolic stroke. Cerebral embolism typically 
causes neurologic deficits that occur abruptly with no warning and are maximal 
at onset. In many patients, a cardiac origin of emboli is suggested by signs of 
multifocal cerebral infarction, cardiac valvular disease, cardiomegaly, arrhyth­
mias, or endocarditis.
3. Associated symptoms
a. Seizures accompany the onset of stroke in a small number of cases; in 
other instances, they follow the stroke by weeks to years. The presence of sei­
zures does not definitively distinguish embolic from thrombotic strokes, but sei­
zure at the onset of stroke may be more common with embolus. If patients with 
vertebrobasilat stroke or an additional condition predisposing to seizures are not 
considered, the incidence of epilepsy after stroke is about 10%. The risk of epi­
lepsy increases to about 25% with cortical strokes and to 50% when cortical 
strokes are associated with a persistent motor deficit.
b. Headache occurs in about 25% of patients with ischemic stroke, possi­
bly because of the acute dilation of collateral vessels.
B. Physical Examination
1. General physical examination. The general physical examination of a 
patient with a cerebrovascular disorder should focus on searching for an under­
lying systemic cause, especially a treatable one.
a. The blood pressure should be measured to ascertain whether hyperten­
sion -  a known risk factor for stroke -  is present.
b. Comparison of blood pressure and pulse on the two sides can reveal 
differences related to atherosclerotic disease of the aortic arch or coarctation o f  
the aorta.
c. Ophthalmoscopic examination of the retina can provide evidence of 
embolization in the anterior circulation in the form of visible embolic material in 
retinal blood vessels.
d. Examination of the neck may reveal the absence of carotid pulses or the 
presence of carotid bruits. Reduced carotid artery pulsation in the neck is a poor 
indicator of internal carotid artery disease, however. Although carotid bruits 
have been associated with cerebrovascular disease, significant carotid stenosis 
can occur without an audible bruit; conversely, a loud bruit can occur without 
stenosis.
e. A careful cardiac examination is essential in order to detect arrhythmias 
or murmurs related to valvular disease, either of which may predispose to em­
bolization from heart to brain.
f. Palpation of the temporal arteries is useful in the diagnosis of giant cell 
arteritis, in which these vessels may be tender, nodular, or pulseless.
2. Neurologic examination. Patients with cerebrovascular disorders 
mayor may not have abnormal neurologic findings on examination. A normal
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examination is expected, for example, after a TIA has resolved. Where deficits 
are found, the goal of the neurologic examination is to define the anatomic site 
of the lesion, which may suggest the cause or optimal management of the stroke. 
Thus, clear evidence that the anterior circulation is involved may lead to angio­
graphic evaluation in contemplation of possible surgical correction of an internal 
carotid lesion. Establishing that the symptoms are referable to the vertebrobasi­
lar circulation or to a lacunar infarction is likely to dictate a different course of 
action.
a. Cognitive deficits that indicate cortical lesions in the anterior circula­
tion should be sought. For example, if aphasia is present, the underlying disorder 
cannot be in the posterior circulation and is unlikely to represent lacunar infarc­
tion. The same is true for nondominant hemisphere lesions producing parietal 
lobe syndromes such as unilateral neglect or constructional apraxia (see discus­
sion of inferior division middle cerebral artery stroke, above).
b. The presence of visual field abnormalities similarly excludes lacunar 
infarction. Hemianopia may occur, however, with involvement of either the an­
terior or posterior cerebral arteries. Isolated hemianopia suggests posterior cere­
bral artery infarction.
c. Ocular palsies, nystagmus, or intemuclear ophthalmoplegia assign the 
underlying lesion to the brainstem and thus to the posterior circulation.
d. Hemiparesis can be due to lesions in cerebral cortical regions supplied 
by the anterior circulation, descending motor pathways in the brainstem supplied 
by the vertebrobasilar system, or lacunae at subcortical (corona radiata, internal 
capsule) or brainstem sites. However, hemiparesis affecting the face, hand, and 
arm more than the leg is characteristic of lesions within the distribution of the 
middle cerebral artery. Hemiparesis that is nonselective with respect to the face, 
arm, and leg is consistent with occlusion of the internal carotid artery or the 
stem of the middle cerebral artery, lacunar infarction in the internal capsule or 
basal ganglia, or brainstem disease. A crossed hemiparesis -  ie, one that in­
volves the face on one side and the rest of the body on the other -  means that the 
abnormality must lie between the level of the facial nerve nucleus in the pons 
and the decussation of the pyramids in the medulla.
e. Cortical sensory deficits such as astereognosis and agraphesthesia with 
preserved primary sensory modalities imply a cerebral cortical deficit within the 
territory of the middle cerebral artery. Isolated hemisensory deficits without as­
sociated motor involvement are usually lacunar in origin. Crossed sensory defi­
cits result from brainstem lesions in the medulla, as seen in the lateral medullary 
plate syndrome.
f. Hemiataxia usually points to a lesion in the ipsilateral brainstem or 
cerebellum but can also be produced by lacunae in the internal capsule.
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A. Blood Tests. These should be obtained routinely to detect treatable 
causes of stroke and to exclude conditions that can mimic stroke. The recom­
mended studies are listed below.
1. Complete blood count to investigate such possible causes of stroke as 
thrombocytosis, thrombocytopenia, polycythemia, anemia (including sickle cell 
disease), and leukocytosis (eg, leukemia).
2. Erythrocyte sedimentation rate to detect elevations indicative of gi­
ant cell arteritis or other vasculitides.
3. Serologic assay for syphilis -  treponemal assay in blood, such as the 
FTA-ABS or MHA-TP, or the CSF VDRL test.
4. Serum glucose to document hypoglycemia or hyperosmolar nonketotic 
hyperglycemia, which can present with focal neurologic signs and thereby mas­
querade as stroke.
5. Serum cholesterol and lipids to detect elevations that can represent 
risk factors for stroke.
B. ECG. An ECG should be obtained routinely to detect unrecognized 
myocardial infarction or cardiac arrythmias, such as atrial fibrillation, which 
predispose to embolic stroke.
C. CT Scan or MRI. A CT scan or MRI should be obtained routinely to 
distinguish between infarction and hemorrhage as the cause of stroke, to exclude 
other lesions (eg, tumor, abscess) that can mimic stroke, and to localize the le­
sion. CT is usually preferred for initial diagnosis because it is widely available 
and rapid and can readily make the critical distinction between ischemia and 
hemorrhage. MRI may be superior to CT scan for demonstrating early ischemic 
infarcts, showing ischemic strokes in the brainstem or cerebellum, and detecting 
thrombotic occlusion of venous sinuses.
D. Lumbar Puncture. This should be performed in selected cases to ex­
clude subarachnoid hemorrhage (manifested by xanthochromia and red blood 
cells) or to document meningovascular syphilis (reactive VDRL) as the cause of 
stroke.
E. Cerebral Angiography. Inta-arterial angiography is used to identify 
operable extracranial carotid lesions in patients with anterior circulation TIAs 
who are good surgical candidates. It is also useful in the diagnosis of certain 
vascular disorders associated with stroke, including vasculitis, fibromuscuiar 
dysplasia, and carotid or vertebral artery dissection. Transfemoral arch aortogra­
phy with selective catheterization of the carotid (and, if indicated, vertebral) ar­
teries is the procedure of choice. Magnetic resonance angiography may detect 
stenosis of large cerebral arteries, aneurysms, and other vascular lesions, but its 
sensitivity is generally inferior to that of conventional angiography.
F. Ultrasonography. Doppler ultrasonography can detect stenosis or oc­
clusion of the internal carotid artery, but it lacks the sensitivity of angiography.
Investigative Studies
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In cases where the likelihood of finding operable symptomatic carotid stenosis is 
insufficient to justify the risk of angiography or where the risk is especially high 
because of coexisting illness or the lack of angiographic expertise, the finding of 
normal carotid blood flow or complete occlusion by Doppler studies can obviate 
the need for angiography. Transcranial doppler ultrasonography is sometimes 
used in the evaluation of suspected stenosis of the intracranial internal carotid 
artery, middle cerebral artery, or basilar artery and for detecting and following 
the course of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
G. Echocardiography. Echocardiography may be useful for demonstrat­
ing the cardiac lesions responsible for embolic stroke in patients' with clinically 
evident cardiac disease, such as atrial fibrillation.
H. EEG. The EEG is rarely useful in evaluating stroke. It may, however, 
help differentiate between a seizure disorder and TIAs or between lacunar and 
cortical infarcts in the occasional patient in whom these possibilities cannot oth­
erwise be distinguished.
Differential Diagnosis
In patients presenting with focal central nervous system dysfunction of 
sudden onset, ischemic stroke must be distinguished from structural and meta­
bolic processes that can mimic it. An underlying process other than focal cere­
bral ischemia should be suspected when the resulting neurologic deficit does not 
conform to the distribution of any single cerebral artery. In addition, strokes do 
not typically impair consciousness in the absence of profound focal deficits, 
while other cerebral disorders may do so.
Vascular disorders mistaken for ischemic stroke include intracerebral 
hemorrhage, subdural or epidural hematoma, and subarachnoid hemorrhage 
from rupture of an aneurysm or vascular malformation. These conditions can of­
ten be distinguished by a history of trauma or of excruciating headache at onset, 
a more marked depression of consciousness, or by the presence of neck stiffness 
on examination. They can be excluded by CT scan or MRI.
Other structural brain lesions such as tumor or abscess can also produce 
focal cerebral symptoms of acute onset. Brain abscess is suggested by concur­
rent fever, and both abscess and tumor can usually be diagnosed by CT scan or 
MRI. Metabolic disturbances, particularly hypoglycemia and hyperosmolar 
nonketotic hyperglycemia, may present in strokelike fashion. The serum glucose 
level should therefore be determined in all patients with apparent stroke.
Treatment
A. Asymptomatic Carotid Bruit or Stenosis. Carotid bruits are com­
monly detected during routine examinations of asymptomatic patients, with a 
frequency that reaches 7% above age 65. Carotid artery stenosis is also common,
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and can be demonstrated by ultrasonography in as many as 30% of men over age 
75. Because the natural history of carotid artery stenosis is variable, the relation­
ship of asymptomatic bruit or stenosis to an individual's risk for stroke is diffi­
cult to assess. In large studies, severe stenosis is associated with increased stroke 
risk (2.5% per year for ipsilateral stroke with 75% stenosis), but the risk of con­
tralateral stroke is increased as well, and the risk of myocardial ischemia in these 
patients is even higher. Moreover, carotid endarterectomy -  which has been ad­
vocated in this setting -  carries significant perioperative risk of stroke or death, 
and this risk varies widely across institutions. Although asymptomatic patients 
with high-grade carotid stenosis have appeared to benefit from endarterectomy 
in some studies, this effect was dependent on an extremely low surgical morbid­
ity and mortality rate. For these reasons, antiplatelet therapy with aspirin (see 
below) is probably the approach of choice for asymptomatic carotid bruit or 
stenosis at present.
B. Transient Ischemic Attack. Because TIAs can indicate an impending 
stroke and because it may be possible to prevent such an event by appropriate 
treatment, TIAs must be accurately and promptly diagnosed and treatment insti­
tuted.
1. Antiplatelet therapy. Of the various medical treatments proposed for 
stroke prophylaxis in patients with noncardiogenic TIAs, antiplatelet agents ap­
pear to have the best benefit-to-risk ratio. The rationale for this approach is that 
embolism from platelet-fibrin thrombi on arterial surfaces may be responsible 
for many cases of TIA and stroke. Antiplatelet agents interfere with platelet 
function by irreversibly inhibiting the enzyme cyclooxygenase-I, which cata­
lyzes the synthesis of thromboxane A2 an eicosanoid with procoagulant and 
platelet-aggregating properties.
Aspirin, when administered to patients with TIAs or minor stroke (de­
fined as little or no neurologic deficit after 1 week), has been shown to reduce 
the incidence of subsequent TIAs, stroke, or death in several studies. Although 
most studies have focused on noncardiogenic TIA or stroke, aspirin is also bene­
ficial for preventing recurrent cerebral ischemia caused by cardiac emboli. In 
some cases (eg, patients with artificial heart valves), the combination of aspirin 
and anticoagulation may be more effective than anticoagulation alone. Doses of 
aspirin between 80 and 1300 mg orally daily (one baby aspirin to four adult as­
pirin tablets) appear to be effective, and daily oral administration of 325 mg of 
aspirin is probably used most often in North America. A sex-related difference 
in benefit favoring men has been observed, but only inconsistently. Ad­
ministration of low-dose aspirin (325 mg orally every other day) to men age 40 
and older without a history of TIA or stroke does not reduce the risk of stroke, 
although it decreases the incidence of myocardial infarction. Adverse effects of 
aspirin include dyspepsia, nausea, abdominal pain, diarrhea, skin rash, peptic ul­
cer, gastritis, and gastrointestinal bleeding.
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Ticlopidine (250 mg orally twice daily), another antiplatelet agent, may be 
somewhat more effective than aspirin in preventing stroke and reducing mor­
tality in patients with TIAs or mild stroke. However, ticlopidine is more expen­
sive than aspirin and appears to be associated with such side effects as diarrhea, 
skin rash, and occasional cases of severe but reversible neutropenia.
Clopidogrel (75 mg orally daily), which inhibits platelet aggregation by 
binding irreversibly to adenosine diphosphate (ADP) receptors on the platelet 
surface, has also been shown to reduce the incidence of ischemic stroke, myo­
cardial infarction, or death from other vascular causes in patients with recent 
ischemic stroke, myocardial infarction, or symptomatic peripheral arterial dis­
ease. Diarrhea and skin rash were more common than with aspirin, but neutro­
penia and thrombocytopenia occurred at the same rate.
Other antiplatelet drugs such as sulfinpyrazone and dipyridamole are 
commonly used to treat thrombotic vascular disease. Some evidence indicates 
that the combination of aspirin (25 mg) and extended-release dipyridamole (200 
mg), taken orally twice daily, reduces the risk of stroke in patients with prior 
T1A or stroke to a greater extent than aspirin alone. Glycoprotein llb/llla an­
tagonists are also under investigation as platelet aggregation inhibitors.
2. Anticoagulation. Anticoagulation is indicated for patients with TIAs 
caused by cardiac embolus and is typically continued indefinitely or for as long 
as the cause of embolization (eg, atrial fibrillation or prosthetic heart valve) per­
sists. The value of anticoagulation for TIAs from arterial thrombosis is uncer­
tain.
Heparin is the drug of choice for acute anticoagulation, while warfarin is 
used for long-term therapy. Heparin is usually administered by continuous intra­
venous infusion at 1000-2000 units/h. The activated partial thromboplastin time 
(aPTT) is measured at least daily, and the dose of heparin is adjusted to maintain 
the aPTT at about 1.5 to 2.5 times the pretreatment value.
Warfarin (the usual maintenance dose is 5-15 mg/d orally) can be started 
simultaneously with heparin therapy. About 2 days after the prothrombin time 
(PT) reaches roughly one and one-half times the pretreatment value (typically 
about 5 days), heparin can be discontinued. The PT or international normalized 
ratio (INR) should be measured at least every 2 weeks and the dose of warfarin 
adjusted to maintain PT = 1.5 times control or INR = 3.0-4.0.
Enthusiasm for the use of anticoagulant therapy should be tempered by an 
appreciation of its potential hazards. The risk o f intracranial hemorrhage is 
greatest in hypertensive patients and those over 65 years of age.
3. Carotid endarterectomy. Carotid endarterectomy involves the surgical 
removal of thrombus from a stenotic common or internal carotid artery in the 
neck. In patients with anterior-circulation TIAs and moderate (50-70%) or high- 
grade (70-99%) carotid stenosis on the side appropriate to account for the symp­
toms, the combination of endarterectomy and aspirin is superior to aspirin alone 
for preventing stroke. Endarterectomy has no place in the treatment of vertebro­
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basilar TIAs or those related to intracranial arterial disease or complete carotid 
occlusion. The value of carotid endarterectomy for minimally stenotic but ulcer­
ated carotid lesions is uncertain. The operative mortality rate for carotid en­
darterectomy has ranged from 1 to 5% or more.
4. Intralumenal stents. Surgical placement of tubular metal stents to
maintain lumen patency in stenotic cerebral arteries is under investigation.
5. Extracranial-intracranial bypass. Many patients with TIAs referable 
to the carotid circulation have stenoses in intracranial portions of the artery not 
accessible through the neck, or they exhibit tandem lesions in both the extracra­
nial and intracranial cerebral circulations. Because carotid endarterectomy does 
not correct these problems, an alternative approach has been explored involving 
anastomosis of the extracranial (temporal artery) and intracranial (middle cere­
bral artery) circulations distal to the stenosis. The bulk of current evidence sug­
gests that this bypass procedure is ineffective.
6. Conclusions. In experienced hands, carotid endarterectomy can be a 
safe procedure that reduces the risk of subsequent TIAs or stroke in patients 
with carotid TIAs. Angiography should be used with these patients to define 
surgically accessible moderate to high-grade (50-99%) stenotic lesions.
Medical treatment with aspirin should be instituted with both nonsurgical 
and postoperative patients. For patients who continue to have TIAs despite aspi­
rin treatment, increasing the dose of aspirin, substituting ticlopidine or clopido- 
grel, or adding sulfinpyrazone or dipyridamole should be considered. Alterna­
tively, a 3-month course of warfarin should be substituted unless there are con­
traindications such as active peptic ulcer disease or severe hypertension. The 
prothrombin time should be maintained at one and one-half times the control 
value (1NR = 3.0-4.0). In addition to the above measures, such contributory risk 
factors as hypertension and cardiac disease should be treated and cigarette 
smoking discontinued.
C. Stroke in Evolution. The optimal treatment for stroke in evolution is 
uncertain. The onset of aspirin's antiplatelet effect is delayed after oral admin­
istration, and endarterectomy also involves considerable delay in treatment.
The most widely used treatment is anticoagulation with heparin and sub­
sequent administration of warfarin at the doses described above, although the 
efficacy of this approach has not been proved.
Thrombolytic agents such as tissue plasminogen activator might also be 
of value for stroke in evolution, but require further study in this context.
D. Completed Stroke
1. Thrombolytic agents. Tissue plasminogen activator (t-PA) is a serine 
protease that maps to chromosome 8 (8pl2) in humans and catalyzes the conver­
sion of plasminogen to plasmin. This accounts for its ability to lyse fibrin- 
containing clots such as those found in cerebrovascular thrombotic lesions. 
Some but not all controlled clinical data suggest that the intravenous administra­
tion of recombinant t-PA (rt-PA) within 3 hours of the onset of symptoms re­
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duces disability and mortality from ischemic stroke (technically, from T1A, 
since stroke is defined by a deficit that persists for at least 24 hours). The drug is 
administered at a dose of 0.9 mg/kg, up to a maximum total dose of 90 mg; 10% 
of the dose is given as an intravenous bolus and the remainder as a continuous 
intravenous infusion over 60 minutes. The efficacy of rt-PA given more than 3 
hours after symptoms begin, of other thrombolytic agents such as urokinase, or 
of intra-arterial administration of these agents has not been demonstrated in 
stroke.
The major complication of rt-PA treatment is hemorrhage, which may af­
fect the brain or other tissues. The lack of proven benefit when rt-PA is given 
after 3 hours, the risk of bleeding complications, and the importance of a correct 
diagnosis when treatment is potentially dangerous dictate that rt-PA not be given 
in certain settings. It is important that the time of onset of symptoms can be es­
tablished with confidence. The CT scan should not already show evidence of a 
large ischemic stroke or of hemorrhage. Patients whose coagulation function has 
been compromised by the administration of warfarin or heparin or by thrombo­
cytopenia (platelet count <100,000/mm3) should not receive rt-PA, nor should 
those who are at increased risk of hemorrhage because of seizures at the onset of 
symptoms, prior intracranial hemorrhage, another intracranial disorder (includ­
ing stroke or trauma) within 3 months, a major surgical procedure within 14 
days, bleeding from the gastrointestinal or urinary tract within 21 days, or 
marked hypertension (systolic blood pressure >185 mm Hg or diastolic blood 
pressure >110 mm Hg). To avoid treating TIAs that are already resolving or 
other conditions unlikely to respond to rt-PA, or for which the risk exceeds 
likely benefit, patients whose deficits are improving rapidly and spontaneously, 
patients with mild and isolated deficits, and those with blood glucose concentra­
tions consistent with a hypo- or hypergycemic origin of symptoms <50 mg/dl or 
>400 mg/dl) should be excluded.
Patients receiving rt-PA for stroke should be managed in facilities where 
the capacity exists to diagnose stroke with a high degree of certainty and to 
manage bleeding complications. Within the first 24 hours after administration of 
rt-PA, anticoagulants and antiplatelet agents should not be given, blood pressure 
should be carefully monitored, and arterial puncture and placement of central 
venous lines, bladder catheters, and nasogastric tubes should be avoided.
2. Antiplatelet agents. As noted above in discussing the treatment of 
TIAs, some but not all studies have shown a decrease in the incidence of subse­
quent stroke when aspirin is administered chronically following a stroke. The 
regimen is as described in the section on treatment of TIA.
3. Anticoagulation. Anticoagulation has not been shown to be useful in 
most cases of completed stroke. An exception is where a persistent source of 
cardiac embolus is present; anticoagulation is then indicated to prevent subse­
quent embolic strokes, although it does not affect the course of the stroke that 
has already occurred. Recent evidence indicates that while immediate anticoagu­
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lation of such patients may result in hemorrhage into the infarct, this rarely af­
fects the ultimate outcome adversely unless the infarct is massive. The risk of 
hemorrhage is more than offset by the particularly high risk of recurrent em­
bolization soon after an embolic stroke, and anticoagulation should not be de­
layed in this setting. Heparin and warfarin are administered as described in the 
section on treatment of TIA.
4. Surgery. The indications for surgical treatment of completed stroke are 
extremely limited. When patients deteriorate as a consequence of brainstem 
compression following cerebellar infarction, however, posterior fossa decom­
pression with evacuation of infarcted cerebellar tissue can be lifesaving.
5. Antihypertensive agents. Although hypertension contributes to the 
pathogenesis of stroke and many patients with acute stroke have elevated blood 
pressures, attempts to reduce the blood pressure in stroke patients can have dis­
astrous results, since the blood supply to ischemic but as yet uninfarcted brain 
tissue may be further compromised. Therefore, such attempts should not be 
made. In the usual course of events, the blood pressure declines spontaneously 
over a period of hours to a few days.
6. Antiedema agents. Antiedema agents such as mannitol and corticos­
teroids have not been shown to be of benefit for cytotoxic edema (cellular swell­
ing) associated with cerebral infarction.
7. Neuroprotective agents. A variety of drugs with diverse pharma­
cologic actions have been proposed as neuroprotective agents that might reduce 
ischemic brain injury by decreasing cerebral metabolism or interfering with the 
cytotoxic mechanisms triggered by ischemia. These include barbiturates and the 
opioid antagonist naloxone, neither of which appears to be beneficial in stroke.
Drugs that block voltage-gated or excitatory amino acid receptor-gated 
calcium channels have potential value in the treatment of stroke because cellular 
calcium overload may be an important mediator of irreversible ischemic neu­
ronal injury. Clinical trials with these and related agents have yielded disap­
pointing results thus far, however.
Prognosis
Outcome following stroke is influenced by a number of factors, the most 
important being the nature and severity of the resulting neurologic deficit. The 
patient's age, the cause of stroke, and coexisting medical disorders also affect 
prognosis. Overall, somewhat less than 80% of patients with stroke survive for 
at least 1 month, and 10-year survival rates in the neighborhood of 35% have 
been cited. The latter figure is not surprising, considering the advanced age at 
which stroke commonly occurs. Of patients who survive the acute period, about 
one-half to two-thirds regain independent function, while approximately 15% 
require institutional care.
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GLOBAL CEREBRAL ISCHEMIA
Etiology
Global cerebral ischemia occurs when the blood flow is inadequate to 
meet the metabolic requirements of the brain, as in cardiac arrest. The result is a 
spectrum of neurologic disorders. The greater severity of neurologic involve­
ment in ischemia than in pure anoxia may be due to the fact that in the former 
condition, the delivery of glucose and removal of potentially toxic metabolites 
are also impaired.
Pathology
Neuropathologic changes depend on the degree and duration of cerebral 
ischemia.
A. Distribution. Complete interruption of cerebral blood flow followed 
by reperfusion, such as occurs in cardiac arrest with resuscitation, produces 
damage that selectively affects metabolically vulnerable neurons of the cerebral 
cortex, basal ganglia, and cerebellum.
With less profound hypotension for prolonged periods, the damage is con­
centrated in the anatomically vulnerable border zones between the territories 
supplied by the major arteries of cerebral cortex, cerebellum, basal ganglia, and 
spinal cord. It is most severe in the watershed region between the territories sup­
plied by the anterior, middle, and posterior cerebral arteries.
B. Modifying Factors. Reducing cerebral energy requirements, such as 
with deep anesthesia or hypothermia, can minimize or prevent brain damage 
from ischemic insults. Hyperglycemia or hypermetabolic states such as status 
epilepticus, on the other hand, can increase ischemic damage. Superimposed oc­
clusive atherosclerotic disease of the craniocervical arteries may lead to asym­
metries in the distribution of cerebral damage from panhypoperfusion.
Clinical Findings
A. Brief Ischemic Episodes. Reversible encephalopathies are common 
following brief episodes of systemic circulatory arrest. In such cases, coma per­
sists for less than 12 hours. Transient confusion or amnesia may occur on awak­
ening, but recovery is rapid and complete. Some patients show a severe an­
terograde and variable retrograde amnesia and a bland, unconcerned affect with 
or without confabulation. Recovery often occurs within 7-10 days but may be 
delayed by 1 month or longer. This syndrome may reflect reversible bilateral 
damage to the thalamus or hippocampus.
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Anterior/middle cerebral watershed
Anterior/middle cerebral watershed
Middle/posterior cerebral watershed
Fig. 16. Distribution of watershed cerebral infarctions.
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В. Prolonged Ischemic Episodes
1. Focal cerebral dysfunction. Patients are usually comatose for at least 
12 hours and may have lasting focal or multifocal motor, sensory, and cognitive 
deficits if they awaken. Full recovery may not occur or may require weeks to 
months. Some such patients are eventually capable of leading an independent 
existence, while those who are more severely disabled may require institutional 
care.
Focal neurologic signs after cardiac arrest include partial or complete cor­
tical blindness, weakness of both arms (bibrachial paresis), and quadriparesis. 
Cortical blindness is usually transient but can rarely be permanent. It probably 
results from disproportionate ischemia of the occipital poles because of their lo­
cation in the border zone between the middle and posterior cerebral arteries. Bi­
brachial paresis (man-in-a-barrel syndrome) results from bilateral infarction of 
the motor cortex in the border zone between the anterior and middle cerebral ar­
teries.
2. Persistent vegetative state. Some patients who are initially comatose 
following cardiac arrest survive and awaken but remain functionally decorticate 
and unaware of their surroundings. They typically regain spontaneous eye­
opening, sleep-wake cycles, and roving eye movements and brainstem and spi­
nal cord reflexes. The persistent vegetative state is thus distinct from coma and 
appears to be associated with destruction of the neocortex. A persistent vege­
tative state associated with an isoelectric (flat) EEG is termed neocortical death. 
Persistent vegetative states must be distinguished from brain death, in which 
both cerebral and brainstem function are absent.
3. Spinal cord syndromes. The spinal cord seems to be more resistant to 
transient ischemia than the brain, so that cord damage from hypoperfusion is 
usually accompanied by profound cerebral involvement. Fiypoperfusion does 
occasionally lead to isolated spinal cord infarction, however. In such cases, the 
anterior and central structures of the spinal cord are more involved because of 
their location in the critical border zones between territories supplied by the an­
terior and posterior spinal arteries. These watersheds, especially in the upper and 
lower levels of the thoracic cord, are vulnerable to profound drops in perfusion 
pressure. In the acute period, spinal stroke from hypotension produces a flaccid 
paraplegia and urinary retention. The sensory level in the thoracic region is 
characterized more by marked impairment of pain and temperature sensation 
than of light touch. With time, flaccid paralysis is replaced by spastic paraplegia 
with brisk tendon reflexes in the legs and extensor plantar responses.
Treatment
A. Established Measures. The clinical management of patients in coma 
caused by global cerebral ischemia involves immediate restoration of adequate 
cerebral circulation, elimination of cardiac dysrhythmias, maintenance of effec­
tive systemic blood pressure, and correction of acid-base or electrolyte abnor­
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malities. Ventilatory assistance may be necessary if either medullary depression 
or injury to the chest wall prevents adequate ventilation, and supplemental oxy­
gen can also be administered.
Beyond these measures, there are no other uniformly satisfactory methods 
of treatment. Attempts to prevent cerebral edema in this setting have not been 
successful, and treatment with corticosteroids, dehydrating agents, calcium 
channel antagonists, hypothermia, and hyperventilation have not improved the 
prognosis.
B. Experimental Measures. Although barbiturates have a protective ef­
fect in some experimental models of global cerebral ischemia, a similar benefit 
does not appear to occur in patients.
Excitatory amino acid receptor antagonists may find application in the 
treatment of cerebral anoxic ischemia but are at present experimental. The ratio­
nale for considering the use of these drugs lies in existing evidence that ischemia 
or hypoxia may trigger the release of excitatory amino acid neurotransmitters, 
which may in turn interact with vulnerable neurons to promote cell death.
INTRACEREBRAL HEMORRHAGE
Hypertensive Hemorrhage
Hypertension is the most common underlying cause of nontraumatic in­
tracerebral hemorrhage.
A. Pathophysiology
1. Cerebral autoregulation. Autoregulation of cerebral blood flow, 
which is achieved by changes in the caliber of small resistance cerebral arteries, 
maintains constant cerebral blood flow as systemic blood pressure rises and 
falls. The range of autoregulated blood pressures is variable.
In normotensive individuals, the lowest mean blood pressure at which 
autoregulation is effective is approximately 60 mm Hg. Below this level, 
changes in the caliber of cerebral arteries cannot compensate for decreased per­
fusion pressure; cerebral blood flow therefore declines, producing symptoms of 
hypoxia, such as lightheadedness, confusion, and dimming of vision. These 
symptoms are followed by somnolence and loss of consciousness if the mean 
blood pressure falls below 35-40 mm Hg. In contrast, at blood pressures above 
the upper limit of the range of autoregulation (150-200 mm Hg), cerebral blood 
flow is increased, which can produce hypertensive encephalopathy.
In chronically hypertensive individuals, the lower limit of the autoregula- 
tory range is higher, which may be due to damage to small arterial walls. As a 
result, cerebral blood flow declines when the mean arterial blood pressure falls 
below about 120 mm Hg. The clinical relevance of this observation is that blood
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pressure should be reduced rarely, if ever -  and never to hypotensive levels -  in 
patients with stroke.
2. Chronic hypertension. Chronic hypertension appears to promote 
structural changes in the walls of penetrating arteries, predisposing them to in­
tracerebral hemorrhage. In 1888, Charcot and Bouchard found minute aneu­
rysms on the small intraparenchymal arteries of hypertensive patients and postu­
lated that aneurysmal rupture led to intracerebral hemorrhage. Subsequently, 
Ross Russell showed micro aneurysms of small resistance arteries in cerebral 
sites at which hypertensive hemorrhages occur most commonly. Some aneu­
rysms were surrounded by small areas of hemorrhage, and the aneurysmal walls 
often showed changes of lipohyalinosis or fibrinoid necrosis. These processes 
are characterized by destruction of the vessel wall with deposition of fibrinoid 
material, focal aneurysmal expansion of the involved vessel, thrombotic occlu­
sion, and extravasation of red cells. There is now general agreement that mas­
sive cerebral hemorrhage often follows the rupture of either a microaneurysmal 
or lipohyalinotic segment of a small resistance artery and that the underlying le­
sion is caused by chronic hypertension.
3. Acute hypertension. In addition to structural changes in the cerebral 
arterial wall produced by chronic hypertension, acute elevation of blood pres­
sure appears to play a role in the pathogenesis of intracerebral hemorrhage. Al­
though most patients with intracerebral hemorrhage are hypertensive following 
the event, many have no history of hypertension and lack such signs of hyper­
tensive end-organ disease as left ventricular hypertrophy, retinopathy, or neph­
ropathy. It has therefore been suggested that a sudden increase in blood pressure 
may itself be sufficient to cause intracerebral hemorrhage, as with amphetamine 
or cocaine abuse. Acute elevation of blood pressure may also be the immediate 
precipitating cause of intracerebral hemorrhage in chronically hypertensive pa­
tients with Charcot-Bouchard aneurysms.
B. Pathology. Most hypertensive hemorrhages originate in certain areas 
of predilection, corresponding to long, narrow, penetrating arterial branches 
along which Charcot-Bouchard aneurysms are found at autopsy. These include 
the caudate and putaminal branches of the middle cerebral arteries (42%); 
branches of the basilar artery supplying the pons (16%); thalamic branches of 
the posterior cerebral arteries (15%); branches of the superior cerebellar arteries 
supplying the dentate nuclei and the deep white matter of the cerebellum (12%); 
and some white matter branches of the cerebral arteries (10%), especially in the 
parieto-occipital and temporallobes.
C. Clinical Findings. Hypertensive hemorrhage occurs without warning, 
most commonly while the patient is awake. Headache is present in 50% of pa­
tients and may be severe; vomiting is common. Blood pressure is elevated after 
the hemorrhage has occurred. Thus, normal or low blood pressure in a patient 
with stroke makes the diagnosis of hypertensive hemorrhage unlikely, as does 
onset before 50 years of age.
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Following the hemorrhage, edema surrounding the area of hemorrhage 
produces clinical worsening over a period of minutes to days. The duration of 
active bleeding, however, is brief. Once the deficit stabilizes, improvement oc­
curs slowly. Since the deficit is caused principally by hemorrhage and edema, 
which compress rather than destroy brain tissue, considerable return of neu­
rologic function can occur.
Massive hypertensive hemorrhages may rupture through brain tissue into 
the ventricles, producing bloody CSF; direct rupture through the cortical mantle 
is unusual. A fatal outcome is most often due to herniation caused by the com­
bined mass effect of the hematoma and the surrounding edema.
Clinical features vary with the site of hemorrhage.
1. Deep cerebral hemorrhage. The two most common sites of hyperten­
sive hemorrhage are the putamen and the thalamus, which are separated by the 
posterior limb of the internal capsule. This segment of the internal capsule is 
traversed by descending motor fibers and ascending sensory fibers, including the 
optic radiations. Pressure on these fibers from an expanding lateral (putaminal) 
or medial (thalamic) hematoma produces a contralateral sensorimotor deficit. In 
general, putaminal hemorrhage leads to a more severe motor deficit and tha­
lamic hemorrhage to a more marked sensory disturbance. Homonymous he- 
mianopia may occur as a transient phenomenon after thalamic hemorrhage and 
is often a persistent finding in putaminal hemorrhage. In large thalamic hemor­
rhages, the eyes may deviate downward, as in staring at the tip of the nose, be­
cause of impingement on the midbrain center for upward gaze. Aphasia may oc­
cur if hemorrhage at either site exerts pressure on the cortical language areas. A 
separate aphasic syndrome has been described with localized hemorrhage into 
the thalamus; it carries an excellent prognosis for full recovery.
2. Lobar hemorrhage. Hypertensive hemorrhages also occur in subcorti­
cal white matter underlying the frontal, parietal, temporal, and occipital lobes. 
Symptoms and signs vary according to the location; they can include headache, 
vomiting, hemiparesis, hemisensory deficits, aphasia, and visual field abnor­
malities. Seizures are more frequent than with hemorrhages in other locations, 
while coma is less so.
3. Pontine hemorrhage. With bleeding into the pons, coma occurs within 
seconds to minutes and usually leads to death within 48 hours. Ocular findings 
typically include pinpoint pupils. Horizontal eye movements are absent or im­
paired, but vertical eye movements may be preserved. In some patients, there 
may be ocular bobbing, a bilateral downbeating excursion of the eyes at about 5- 
second intervals. Patients are commonly quadriparetic and exhibit decerebrate 
posturing. Hyperthermia is sometimes present. The hemorrhage usually ruptures 
into the fourth ventricle, and rostral extension of the hemorrhage into the mid­
brain with resultant midposition fixed pupils is common. In contrast to the clas­
sic presentation of pontine hemorrhage described above, small hemorrhages that
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spare the reticular activating system -  and that are associated with less severe 
deficits and excellent recovery -  also occur.
4. Cerebellar hemorrhage. The distinctive symptoms of cerebellar hem­
orrhage (headache, dizziness, vomiting, and the inability to stand or walk) begin 
suddenly, within minutes after onset of bleeding. While patients may initially be 
alert or only mildly confused, large hemorrhages lead to coma within 12 hours 
in 75% of patients and within 24 hours in 90%. When coma is present at the on­
set, the clinical picture is indistinguishable from that of pontine hemorrhage.
Common ocular findings include impairment of gaze to the side of the le­
sion or forced deviation away from the lesion caused by pressure on the pontine 
lateral gaze center. Skew deviation may also occur, in which case the eye ipsi- 
lateral to the lesion is depressed. The pupils are small and reactive. Ipsilateral 
facial weakness of lower motor neuron type occurs in about 50% of cases, but 
strength in the limbs is normal. Limb ataxia is usually slight or absent. Plantar 
responses are flexor early in the course but become extensor as the brainstem 
becomes compromised and the patient deteriorates. Impairment of voluntary or 
reflex upward gaze indicates upward transtentorial herniation of the cerebellar 
vermis and midbrain, leading to compression of the pretectum. It implies a poor 
prognosis.
D. Differential Diagnosis. Putaminal, thalamic, and lobar hypertensive 
hemorrhages may be difficult to distinguish from cerebral infarctions. To some 
extent, the presence of severe headache, nausea and vomiting, and impairment 
of consciousness are useful clues that a hemorrhage may have occurred; the CT 
scan identifies the underlying disorder definitively.
Brainstem stroke or cerebellar infarction can mimic cerebellar hemor­
rhage. When cerebellar hemorrhage is a possibility, CT scan or MRI is the most 
useful diagnostic procedure, since hematomas can be quickly and accurately lo­
calized. If neither CT nor MRI is available, vertebral angiography should be per­
formed. The angiogram shows a cerebellar mass effect in about 85% of cases, 
but the procedure is time-consuming. Bloody CSF will confirm the diagnosis of 
hemorrhage, but a clear tap does not exclude the possibility of an intracerebellar 
hematoma-and lumbar puncture may hasten the process of herniation. Lumbar 
puncture is therefore not advocated if a cerebellar hemorrhage is suspected.
Like cerebellar hemorrhage, acute peripheral vestibulopathy also produces 
nausea, vomiting, and gait ataxia. Severe headache, impaired consciousness, el­
evated blood pressure, or later age at onset, however, strongly favors cerebellar 
hemorrhage.
E. Treatment
1. Surgical treatment
a. Cerebellar decompression. The most important therapeutic interven­
tion in hypertensive hemorrhage is surgical decompression for cerebellar hema­
tomas. Unless this step is taken promptly, there may be a fatal outcome or unex­
pected deterioration. Note that this procedure may also reverse the neurologic
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deficit. Since surgical results are much better for responsive than unresponsive 
patients, surgery should be performed early in the course when the patient is still 
conscious.
b. Cerebral decompression. Surgery can be useful when a superficial 
hemorrhage in the cerebral white matter is large enough to cause a mass effect 
with shift of midline structures and incipient herniation. The prognosis is di­
rectly related to the level of consciousness before the operation, and surgery is 
usually fruitless in an already comatose patient.
c. Contraindications to surgery. Surgery is not indicated for pontine or 
deep cerebral hypertensive hemorrhages, since in most cases spontaneous de­
compression occurs with rupture into the ventricles-and the areas in question are 
accessible only at the expense of normal overlying brain.
2. Medical measures. The use of antihypertensive agents in acute in­
tracerebral hemorrhage is controversial. Attempts to lower systemic blood pres­
sure may compromise cerebral blood flow and lead to infarction, but continued 
hypertension may exacerbate cerebral edema. On this basis, it seems reasonable 
to lower blood pressure to diastolic levels of approximately 100 mm Hg follow­
ing intracerebral hemorrhage, but this must be done with great care because the 
cerebral vasculature may be unusually sensitive to antihypertensive agents. The 
use of nitroglycerin paste (1/2-1 in topically) has an advantage in that if the 
blood pressure declines excessively, the drug can be wiped off the skin and its 
effect rapidly terminated. If volume overload is considered to contribute to the 
hypertension, the judicious use of a diuretic such as furosemide (from 10 mg in­
travenously in patients unused to the drug to 40 mg intravenously in patients ac­
customed to receiving it) can be helpful.
There is no other effective medical treatment for intracerebral hemor­
rhage. Rebleeding at the site of a hypertensive intracerebral hemorrhage is un­
common, and anti fibrinolytic agents are not indicated. Corticosteroids are 
commonly prescribed to reduce vasogenic edema in patients with intracerebral 
hemorrhage, but the evidence of their benefit is poor. Antiedema agents provide 
only temporary benefit.
Other Causes of Intracerebral Hemorrhage
A. Trauma. Intracerebral hemorrhage is a frequent consequence of 
closed-head trauma. Such hemorrhages may occur under the skull at the site of 
impact or directly opposite the site of impact (contrecoup injury). The most 
common locations are the frontal and temporal poles. The appearance of trau­
matic hemorrhages on CT scans may be delayed for as much as 24 hours after 
injury; MRI permits earlier detection.
B. Vascular Malformations. Bleeding from cerebral angiomas and aneu­
rysms can lead to both intracerebral and subarachnoid hemorrhage. Angiomas 
may come to medical attention because of seizures, in which case anticonvul­
sants are the treatment of choice, or because of bleeding. In the latter instance,
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surgical removal is indicated to prevent rebleeding -  provided the malformation 
is surgically accessible. Aneurysms usually present with intracranial hemorrhage 
but occasionally with compressive focal deficits such as third-nerve palsy.
C. Hemorrhage into Cerebral Infarcts. Some cases of cerebral infarc­
tion, especially when embolic in origin, are accompanied by hemorrhage into 
the infarct.
D. Amphetamine or Cocaine Abuse. Intravenous, intranasal, and oral 
amphetamine or cocaine use can result in intracerebral hemorrhage, which typi­
cally occurs within minutes to hours after the drug is administered. Most such 
hemorrhages are located in subcortical white matter and may be related to either 
acute elevation of blood pressure, leading to spontaneous hemorrhage or rupture 
of a vascular anomaly, or drug-induced arteritis.
E. Cerebral Amyloid Angiopathy. Cerebral amyloid (congophilic) an­
giopathy is a rare cause of intracerebral hemorrhage. Amyloid deposits are pres­
ent in the walls of small cortical blood vessels and in the meninges. The disorder 
is most common in elderly patients (a mean age of 70 years) and typically pro­
duces lobar hemorrhages at multiple sites. Some cases are familial.
F. Acute Hemorrhagic Leukoencephalitis. This is a demyelinating and 
hemorrhagic disorder that characteristically follows a respiratory infection and 
has a fulminant course resulting in death within several days. Multiple small 
hemorrhages are found in the brain, and red blood cells may be present in CSF.
G. Hemorrhage into Tumors. Bleeding into primary or metastatic brain 
tumors is an occasional cause of intracerebral hemorrhage. Tumors associated 
with hemorrhage include glioblastoma multiforme, melanoma, choriocarcinoma, 
renal cell carcinoma, and bronchogenic carcinoma. Bleeding into a tumor should 
be considered when a patient with known cancer experiences acute neurologic 
deterioration; it may also be the presenting manifestation of cancer.
H. Coagulopathies. Intracerebral hemorrhage is a complication of disor­
ders of both clotting factors and platelets, such as hemophilia (factor VIII defi­
ciency) and idiopathic thrombocytopenic purpura. Acute myelogenous leukemia 
with white blood cell counts greater than 150,000/pL may also predispose to in­
tracerebral hemorrhage.
I. Anticoagulation. Patients receiving heparin or warfarin are at increased 
risk for developing spontaneous or traumatic intracerebral hemorrhage.
SUBARACHNOID HEMORRHAGE
Spontaneous (nontraumatic) subarachnoid hemorrhage (bleeding into the 
subarachnoid space) is usually the result of a ruptured cerebral arterial aneurysm 
or an AVM. Rupture of a berry aneurysm accounts for about 75% of cases and 
occurs most often during the fifth and sixth decades, with an approximately
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Anterior communicating artery (15%)
Fig. 17. Frequency and distribution of intracranial aneurysms.
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equal sex distribution. Hypertension has not been conclusively demonstrated to 
predispose to the formation of aneurysms, but acute elevation of blood pressure 
(eg, at orgasm) may be responsible for their rupture. Intracranial AVMs, a less 
frequent cause of subarachnoid hemorrhage (10%), occur twice as often in men 
and usually bleed in the second to fourth decades, although a significant inci­
dence extends into the 60s. Blood in the subarachnoid space can also result from 
intracerebral hemorrhage, embolic stroke, and trauma.
Pathology
Cerebral artery aneurysms are most commonly congenital "berry" aneu­
rysms, which result from developmental weakness of the vessel wall, especially 
at sites of branching. These aneurysmal dilatations arise from intracranial arter­
ies about the circle of Willis at the base of the brain and are multiple in about 
20% of cases. Other congenital abnormalities, including polycystic kidney dis­
ease and coarctation of the aorta, may be associated with berry aneurysms. Oc­
casionally, systemic infections such as infective endocarditis disseminate to a 
cerebral artery and cause aneurysm formation; such "mycotic" aneurysms ac­
count for 2-3% of aneurysmal ruptures. Mycotic aneurysms are usually more 
distal (along the course of cerebral arteries) than are berry aneurysms.
AVMs consist of abnormal vascular communications that permit arterial 
blood to enter the venous system without passing through a capillary bed. They 
are most common in the middle cerebral artery distribution.
Pathophysiology
Rupture of an intracranial artery elevates intracranial pressure and distorts 
pain-sensitive structures, producing headache. Intracranial pressure may reach 
systemic perfusion pressure and acutely decrease cerebral blood flow; together 
with the concussive effect of the rupture, this is thought to cause the loss of con­
sciousness that occurs at the onset in about 50% of patients. Rapid elevation of 
intracranial pressure can also produce subhyaloid retinal hemorrhages.
Because aneurysmal hemorrhage is usually confined to the subarachnoid 
space, it does not produce a focal cerebral lesion. Prominent focal findings on 
neurologic examination are accordingly uncommon except with middle cerebral 
artery aneurysms. Ruptured AVMs, however, produce focal abnormalities that 
correspond to their parenchymal location.
Clinical Findings
A. Symptoms and Signs. The classic (but not invariable) presentation of 
subarachnoid hemorrhage is the sudden onset of an unusually severe generalized 
headache ("the worst headache I ever had in my life"). The absence of headache 
essentially precludes the diagnosis. Loss of consciousness is frequent, as are
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vomiting and neck stiffness. Symptoms may begin at any time of day and during 
either rest or exertion.
The most significant feature of the headache is that it is new. Milder but 
otherwise similar headaches may have occurred in the weeks prior to the acute 
event. These earlier headaches are probably the result of small prodromal hem­
orrhages (sentinel, or warning, hemorrhages) or aneurysmal stretch.
The headache is not always severe, however, especially if the subarach­
noid hemorrhage is from a ruptured AVM rather than an aneurysm. Although 
the duration of the hemorrhage is brief, the intensity of the headache may remain 
unchanged for several days and subside only slowly over the next 2 weeks. A re- 
crudescent headache usually signifies recurrent bleeding.
Blood pressure frequently rises precipitously as a result of the hemor­
rhage. Meningeal irritation may induce temperature elevations to as high as 
39°C during the first 2 weeks. There is frequently confusion, stupor, or coma. 
Nuchal rigidity and other evidence of meningeal irritation are common, but 
these signs may not occur for several hours after the onset of the headache. Pre- 
retinal globular subhyaloid hemorrhages (found in 20% of cases) are most sug­
gestive of the diagnosis. Because bleeding occurs mainly in the subarachnoid 
space in patients with aneurysmal rupture, prominent focal signs are uncommon 
on neurologic examination. When present, they may bear no relationship to the 
site of the aneurysm. An exception is oculomotor nerve palsy occurring ipsilat- 
eral to a posterior communicating artery aneurysm. Bilateral extensor plantar re­
sponses and VI nerve palsies are frequent in such cases. Ruptured AVMs may 
produce focal signs, such as hemiparesis, aphasia, or a defect of the visual fields, 
that help to localize the intracraniallesion.
B. Laboratory Findings. Patients presenting with subarachnoid hemor­
rhage are generally investigated first by CT scan, which will usually confirm 
that hemorrhage has occurred and may help to identify a focal source. CT brain 
scanning will detect subarachnoid blood in more than 90% of patients with 
aneurysmal rupture. The test is highly sensitive on the day bleeding occurs; it is 
most sensitive in patients with altered consciousness. Intracerebral or intraven­
tricular blood, associated hydrocephalus, and infarction can also be identified. 
Aneurysms may not be evident on the CT scan, but most AVMs can be seen 
with contrast. MR1 is especially useful in detecting small AVMs localized to the 
brain stem (an area poorly seen on CT scan). If the CT scan fails to confirm the 
clinical diagnosis of subarachnoid hemorrhage, lumbar puncture is performed.
The CSF examination usually reveals markedly elevated pressure, often 
above the maximum recordable value (600 mm H20) using the standard CSF 
manometer; the fluid is grossly bloody and contains from 100,000 to more than 
1 million red cells/pL. As a result of the breakdown of hemoglobin from red 
cells, the supernatant of the centrifuged CSF becomes yellow (xanthochromic) 
within several hours (certainly by 12 hours) following the hemorrhage. White 
cells are initially present in the spinal fluid in the same proportion to red cells as
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in the peripheral blood. The chemical meningitis caused by blood in the su­
barachnoid space, however, may produce a pleocytosis of several thousand 
white blood cells during the first 48 hours and a reduction in CSF glucose be­
tween the fourth and eighth days after the hemorrhage. In the absence of pleocy­
tosis, CSF glucose following subarachnoid hemorrhage is normal. The periph­
eral blood white count is often modestly elevated but rarely exceeds 15,000 
cells/pL. The ECG may reveal a host of abnormalities: peaked or deeply in­
verted T waves, short PR interval, or tall U waves.
Once the diagnosis is confirmed, four-vessel cerebral arteriography is un­
dertaken. Cerebral angiography of both the carotid and vertebral arteries should 
be performed to visualize the entire cerebral vascular anatomy, since multiple 
aneurysms occur in 20% of patients and AVMs are frequently supplied from 
multiple sources. Angiography can be performed at the earliest time convenient 
for radiology department personnel; emergency studies in the middle of the 
night are rarely indicated. Angiography is a prerequisite to the rational planning 
of surgical treatment and is therefore not necessary for patients who are not sur­
gical candidates, eg, those who are deeply comatose.
Differential Diagnosis
The history of a sudden severe headache with confusion or obtundation, 
nuchal rigidity, a nonfocal neurologic examination, and bloody spinal fluid is 
highly specific for subarachnoid hemorrhage.
Hypertensive intracerebral hemorrhage is also manifested by obtundation 
and hemorrhagic spinal fluid, but there are prominent focal findings. Bacterial 
meningitis is excluded by the CSF examination. Ruptured mycotic aneurysm is 
suggested by other signs of endocarditis. Traumatic spinal puncture can be ex­
cluded as the cause of bloody CSF by examination of the centrifuged CSF 
specimen. Since blood that results from traumatic lumbar puncture has not yet 
undergone enzymatic breakdown to bilirubin, centrifugation of the spinal fluid 
specimen reveals a colorless supernatant.
Complications & Sequelae
A. Recurrence of Hemorrhage. Recurrence of aneurysmal hemorrhage 
(20% over 10-14 days) is the major acute complication and roughly doubles the 
mortality rate. Recurrence of hemorrhage from AVM is less common in the 
acute period.
B. Intraparenchymal Extension of Hemorrhage. While it is common 
for hemorrhages from an AVM to involve the cerebral parenchyma, this is far 
less common with aneurysm. Nevertheless, rupture of an aneurysm of the ante­
rior cerebral or middle cerebral artery may direct a jet of blood into brain paren­
chyma, producing hemiparesis, aphasia, and sometimes transtentorial herniation.
C. Arterial Vasospasm. Delayed arterial narrowing, termed vasospasm, 
occurs in vessels surrounded by subarachnoid blood and can lead to parenchy-
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mal ischemia in more than one-third of cases. Clinical ischemia typically does 
not appear before day 4 after the hemorrhage, peaks at day 10-14, and then 
spontaneously resolves. The diagnosis can be confirmed by transcranial Doppler 
or cerebral angiography. The severity of spasm is related to the amount of su­
barachnoid blood, and therefore is less common where less blood is usually 
seen, such as in traumatic subarachnoid hemorrhage or AVM.
D. Acute or Subacute Hydrocephalus. Acute or subacute hydrocephalus 
may develop during the first day-or after several weeks-as a result of impaired 
CSF absorption in the subarachnoid space. Progressive somnolence, nonfocal 
findings, and impaired upgaze should suggest the diagnosis.
E. Seizures. Seizures occur in fewer than 10% of cases and only follow­
ing damage to the cerebral hemisphere. Decorticate or decerebrate posturing is 
common, however, and may be mistaken for seizures.
F. Other Complications. Although inappropriate secretion of antidiuretic 
hormone and resultant diabetes insipidus can occur, they are uncommon.
Treatment
A. Medical Treatment. Medical treatment is traditionally directed toward 
preventing elevation of arterial or intracranial pressure that might rerupture the 
aneurysm or AVM. Typical measures include absolute bed rest with the head of 
the bed elevated 15-20 degrees, mild sedation, and analgesics for headache. 
Drugs impairing platelet function (eg, aspirin) should be avoided. Since patients 
who are hypertensive on admission have an increased mortality risk, reducing 
the blood pressure (to approximately 160/100 mm Hg) is prudent. Bed rest and 
mild sedation are often adequate in this regard. Hypotension should be pre­
vented, however, to ensure adequate cerebral perfusion. Intravenous fluids 
should be administered with care, since overhydration can exacerbate cerebral 
swelling. Intravenous fluids should be iso-osmotic to minimize free water exac­
erbating brain edema. Normal saline can be given in amounts to ensure normo­
volemia. Hyponatremia is frequently seen, and usually represents, at least in 
part, cerebral salt-wasting; it should be managed with sodium replacement such 
as NaCI orally or 3% normal saline intravenously rather than fluid restriction. 
Prophylactic use of the calcium channel antagonist drug nimodipine, 60 mg 
orally (or by nasogastric tube) every 4 hours for 21 days, may reduce the 
ischemic sequelae of cerebral vasospasm in patients with a ruptured aneurysm. 
Vasospasm is treated by induced hypertension with phenylephrine or dopamine; 
this intervention is more safely performed after definitive surgical treatment of 
the aneurysm. Although seizures are uncommon after aneurysmal rupture, the 
hypertension accompanying a seizure increases the risk of rerupture; a prophy­
lactic anticonvulsant (eg, phenytoin, 300 mg/d) is therefore recommended rou­
tinely.
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В. Surgical Treatment:
1. Aneurysm. Definitive surgical therapy consists of clipping the neck of 
the aneurysm or the endovascular placement of a coil to induce clotting. The 
neurologic examination is used to grade the patient's clinical state relative to 
surgical candidacy. In patients who are fully alert (grades I and II) or only 
mildly confused (grade III), surgery has been shown to improve the clinical out­
come. In contrast, stuporous (grade IV) or comatose (grade V) patients do not 
appear to benefit from the procedures. Although there is some controversy about 
the optimal timing of surgery, current evidence supports early intervention, 
within about 2 days following the hemorrhage. This approach reduces the period 
at risk for rebleeding and permits aggressive treatment of vasospasm with vol­
ume expansion and pharmacologic elevation of blood pressure.
2. AVMs. Surgically accessible AVMs may be removed by en bloc resec­
tion or obliterated by ligation of feeding vessels or embolization via local intra­
arterial catheter. Because the risk of an early second hemorrhage is much less 
with AVMs than with aneurysms, surgical treatment can be undertaken elec- 
tively at a convenient time after the bleeding episode.
Prognosis
The mortality rate from aneurysmal subarachnoid hemorrhage is high. 
About 20% of patients die before reaching a hospital, 25% die subsequently 
from the initial hemorrhage or its complications, and 20% die from rebleeding if 
the aneurysm is not surgically corrected. Most deaths occur in the first few days 
after the hemorrhage. The probability of survival following aneurysmal rupture 
is related to the patient's state of consciousness and the elapsed time since the 
hemorrhage. On day I, the prognosis for survival for symptom-free and somno­
lent patients is, respectively, 60% and 30%; such patients still alive at 1 month 
have survival probabilities of 90% and 60%, respectively. Recovery from su­
barachnoid hemorrhage resulting from rupture of intracerebral AVMs occurs in 
nearly 90% of patients, and although recurrent hemorrhage remains a danger, 
conservative management compares favorably with surgical therapy.
VASCULAR DEMENTIA
Impairment of blood supply to the brain used to be considered to be the 
main cause of dementia in the elderly, until it was recognized that such a 
mechanism is rarely, if ever, implicated. Multiple small strokes, referred to as 
multi-infarct dementia, were subsequently identified as the principal mechanism,
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both clinically and at autopsy. In most neuropathological and clinical series, 
vascular dementia is the most common cause after Alzheimer's disease, account­
ing for some 10-20 per cent of dementia cases alone, and an important concomi­
tant of Alzheimer's disease or other degenerative dementias. The incidence of 
vascular dementia may be falling with better management of vascular risk fac­
tors. It is also believed that many cases of dementia with Lewy bodies were pre­
viously diagnosed clinically as vascular dementia. If cases of dementia where 
there is a vascular component are considered, then there is no doubt that vascu­
lar disease is a major cause or contributor to cognitive. The term ’vascular de­
mentia’ is preferable to 'multiinfarct dementia' as it reflects the considerable het­
erogeneity of the condition and includes cases due to haemorrhage, small lacu­
nar infarcts, large cortical infarcts, and vasculitides. In comparison to Alz­
heimer's disease, there is a paucity of epidemiological data on vascular demen­
tia. In part, this is due to the fact that patients with major strokes are often ex­
cluded, and yet, in one study, up to 25 per cent of patients 3 months after a 
stroke were considered to have dementia using DSM-IV criteria, and up to 60 
per cent had cognitive impairment.
Clinical criteria for the diagnosis of vascular dementia have been domi­
nated by the development of criteria for Alzheimer's disease. Thus, memory re­
mains as a key component and yet may be relatively less important in vascular 
dementia. Early criteria assumed that stepwise deterioration and motor abnor­
malities would be characteristic, and from this was developed the Hachinski 
score. Patients with a score of 4 or less were considered likely to be degenera­
tive by contrast to those with a score of 7 or more, who were thought to have a 
multi-infarct dementia. This remains a useful guide, and series have been veri­
fied pathologically. More recently, the NINCDS-AIREN criteria have been de­
veloped, which require the appearance of cognitive impairment within 3 months 
of a stroke, or sudden onset and fluctuation of cognitive impairment. In view of 
the potential contribution of focal neuropsychological deficits from a discrete 
stroke, the cognitive criteria for dementia are that there should be memory im­
pairment plus at least two other domains. There should also be relevant vascular 
changes on imaging which are thought to be directly related. However, very dif­
ferent proportions of cases are diagnosed as vascular dementia, depending upon 
the use of NINCDS-AIREN, DSM-IV, or ICD10 criteria.
Three main vascular pathologies are believed to be associated with vascu­
lar dementia; namely, single discrete cortical infarcts, multiple infarcts (multi­
infarct dementia), and subcortical arteriosclerotic encephalopathy (Binswanger's 
disease). In reality, these may overlap.
Single discrete infarcts, for example, in right middle cerebral and poste­
rior cerebral artery territories and thalamic infarcts, can present with a picture 
suggestive of dementia. Much more common, however, is the accumulation of 
deficits from multiple single cortical and/or subcortical infarcts. Men are more 
commonly affected than women, and there is usually a vascular history, particu­
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larly of hypertension. There is a gradual accumulation of cognitive deficits with 
episodes of confusion or focal neurology. If there are mainly subcortical in­
farcts, patients tend to have a subcortical pattern of cognitive deficit with cogni­
tive slowing and additional motor features. Some may develop an extrapyrami- 
dal syndrome, and in others a pseudobulbar palsy can be prominent with patho­
logical laughing and crying. Neuropathologically, multiple small subcortical in­
farcts appear to be more important in vascular dementia than single large in­
farcts.
Subcortical arteriosclerotic encephalopathy (Binswanger's disease)
Binswanger originally described eight cases of periventricular demyelina- 
tion and dementia. This was considered a rarity until the advent of neuroimag­
ing, and many patients with white matter changes on scanning acquired this di­
agnosis. Clinically, the features are very similar to those seen in patients with 
multiple subcortical infarcts, namely frontal and subcortical cognitive features, 
dysarthria, and pseudobulbar palsy. Gait impairment may occur early and is 
characterized by a widebased shuffling gait, in contrast to the narrower base 
seen in Parkinson's disease. Criteria have been suggested for the diagnosis of 
Binswanger's disease.
Much confusion has arisen from attempts to diagnose Binswanger's dis­
ease from neuroimaging. Non-specific periventricular white matter abnormali­
ties are common both in patients with dementia and in the non-demented eld­
erly, and the term leuko-araiosis has been proposed. Leuko-araiosis appears as 
low attenuation on CT scan, particularly around the frontal and occipital horns, 
and as increased signal on T2-weighted MRI. Neuropathologically, there is de- 
myelination, gliosis, and hyalinosis, with fibrinoid necrosis of small blood ves­
sels, similar to that seen in hypertension. Minor degrees of white matter disease 
are also seen in pure Alzheimer's disease.
Treatment is primarily that of management of vascular disease risk factors 
such as hypertension, smoking, diabetes, carotid stenosis, and heart disease. 
There have been few control trials of management of risk factors and its affect 
on cognition, but treatment of isolated systolic hypertension in the elderly may 
reduce the incidence of dementia.
Other causes of vascular dementia
Significant cognitive impairment, sufficient to justify the criteria of de­
mentia, can occur after subarachnoid haemorrhage, subdural haematomas, and 
global ischaemia following cardiac arrest with laminar necrosis and hippocam­
pal cell loss. A variety of vasculitides can also be associated with the early de­
velopment of cognitive impairment and even present as a dementia; these in­
clude systemic lupus erythematosus (SLE) and primary cerebral angiitis, which 
is usually accompanied by headaches. Sneddon's syndrome is the association of 
livedo reticularis with cerebrovascular disease, and can present with cognitive
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impairment. A number, but not all, are associated with anticardiolipin antibod­
ies.
The rare cases of hereditary cerebral amyloidosis, both of the Icelandic 
and the Dutch and the Flemish type, can be associated with cognitive impair­
ment, although the salient clinical feature is that of recurrent cerebral haemor­
rhage. Cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leucoencephalopathy (CADASIL) is characterized by recurrent subcortical is­
chaemic events with the subsequent development of a pseudobulbar palsy and 
cognitive impairment. Early symptoms include migraine-like headache and psy­
chiatric disturbance. The MRI scan shows a striking leucoencephalopathy in ad­
dition to multiple small infarcts. This condition, which is increasingly recog­
nized, is linked to mutations in the Notch 3 gene.
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EPILEPSY, SEIZURES & SYNCOPE
EPISODIC LOSS OF CONSCIOUSNESS
Consciousness is lost when the function of both cerebral hemispheres or 
of the brainstem reticular activating system is compromised. Episodic dys­
function of these anatomic regions produces transient, and often recurrent, loss 
of consciousness. There are two major causes of episodic loss of consciousness.
Seizures. These are disorders characterized by excessive or oversynchro­
nized discharges of cerebral neurons.
Syncope. This loss of consciousness is due to a reduced supply of blood 
to the cerebral hemispheres or brainstem. It can result from pancerebral hypop­
erfusion caused by vasovagal reflexes, orthostatic hypotension, or decreased 
cardiac output or from selective hypoperfusion of the brainstem resulting from 
vertebrobasilar ischemia. It is important to distinguish seizures from syncope 
because they have different causes, diagnostic approaches, and treatment.
The initial step in evaluating a patient who has suffered a lapse of con­
sciousness is to determine whether the setting in which the event occurred-or as­
sociated symptoms or signs-suggests that it was a direct result of a disease re­
quiring prompt attention, such as hypoglycemia, meningitis, head trauma, car­
diac arrhythmia, or acute pulmonary embolism. The number of spells and their 
similarity or dissimilarity should be established. If all spells are identical, then a 
single pathophysiologic process can be assumed, and the following major differ­
ential features should be ascertained.
Phenomena at Onset of Spell
A detailed inquiry should always be made about prodromal and initial 
symptoms. The often brief, stereotyped premonitory symptoms (aura) at the on­
set of some seizures may localize the central nervous system abnormality re­
sponsible for the seizures.
A. An unambiguous description of a sudden onset of unconsciousness 
without prodromal features is highly suggestive of seizure.
B. Focal sensory or motor phenomena (eg, involuntary jerking of one 
hand, hemifacial paresthesias, forced head turning) suggest a seizure originating 
in the contralateral frontoparietal cortex.
C. A sensation of fear, olfactory or gustatory hallucinations, or visceral or 
deja vu sensations are commonly associated with seizures originating in the 
temporal lobe.
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D. Progressive lightheadedness, dimming of vision, and faintness, which 
indicate diffuse central nervous system dysfunction, are associated with de­
creased cerebral blood flow from any cause (simple faints, cardiac arrhythmias, 
orthostatic hypotension).
Events During the Spell
A. Generalized tonic-clonic (grand mal, or majormotor) seizures are char­
acterized by loss of consciousness, accompanied initially by tonic stiffening and 
subsequently by clonic (jerking) movements of the extremities.
B. Cerebral hypoperfusion usually produces flaccid unresponsiveness.
C. Cerebral hypoperfusion can also result in stiffening or jerking move­
ments, especially if hypoperfusion is enhanced because the patient is prevented 
from falling or otherwise assuming a recumbent posture. Such circulatory events 
are self-limited and do not require anticonvulsant treatment. Loss of con­
sciousness rarely lasts more than 15 seconds and is not followed by postictal 
confusion unless prolonged brain ischemia has occurred.
Posture When Loss of Consciousness Occurs
Orthostatic hypotension and simple faints occur in the upright or sitting 
position. Episodes also (or only) occurring in the lying position suggest seizure 
or cardiac arrhythmia as a likely cause, although syncope induced by strong 
emotional stimuli may be responsible.
Relationship to Physical Exertion
Syncope associated with exertion is usually due to cardiac outflow ob­
struction (eg, aortic stenosis, obstructive hypertrophic cardiomyopathy, atrial 
myxoma) or arrhythmias.
Phenomena Following the Spell
A. A period of confusion, disorientation, or agitation (postictal state) fol­
lows a generalized tonicclonic seizure. The period of confusion is usually brief- 
lasting only for minutes. While such behavior is often strikingly evident to wit­
nesses, it may not be recalled by the patient.
B. Prolonged alteration of consciousness (prolonged postictal state) may 
follow status epilepticus. It may also occur after a single seizure in patients with 
diffuse structural cerebral disease (eg, dementia, mental retardation or encepha­
litis) or metabolic encephalopathy.
C. Recovery from a simple faint is characterized by a prompt return to 
consciousness with full lucidity.
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SEIZURES
A seizure is a transient disturbance of cerebral function caused by an ab­
normal neuronal discharge. Epilepsy, a group of disorders characterized by re­
current seizures, is a common cause of episodic loss of consciousness; idiopathic 
epilepsy affects 0.2-0.4% of the general population.
An actively convulsing patient or a reported seizure in a known epileptic 
usually poses no diagnostic difficulty. Since most seizures occur outside the hos­
pital unobserved by medical personnel, however, the diagnosis must usually be 
established retrospectively. The two historic features most suggestive of a sei­
zure are the aura associated with seizures of focal onset and the postictal confu- 
sional state that follows generalized tonic-clonic seizures (see below). Neither 
urinary incontinence nor the occurrence of a few tonic or jerking movements is 
significant in distinguishing seizures from other causes of transient loss of con­
sciousness, since either can occur also with loss of consciousness from cerebral 
hypoperfusion.
ETIOLOGY
Seizures can result from either primary central nervous system dysfunc­
tion or an underlying metabolic derangement or systemic disease. This distinc­
tion is critical, since therapy must be directed at the underlying disorder as well 
as at seizure control. A list of common neurologic and systemic disorders that 
induce seizures is presented below. The age of the patient may help in establish­
ing the cause of seizures.
Common causes of seizures of new onset
Primary neurologic disorders
Benign febrile convulsions of childhood 
Idiopathic epilepsy 
Head trauma
Stroke or vascular malformations 
Mass lesions
Meningitis or encephalitis 
HIV encephalopathy 
Systemic disorders 
Hypoglycemia 
Hyponatremia 
Hyperosmolar states 
Hypocalcemia 
Uremia
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Hepatic encephalopathy
Porphyria
Drug overdose
Drug withdrawal
Global cerebral ischemia
Hypertensive encephalopathy
Eclampsia
Hyperthermia
Primary Neurologic Disorders
A. Benign febrile convulsions of childhood are seizures that occur in 2- 
4% of children 3 months to 5 years old, usually during the first day of a febrile 
illness, and in the absence of central nervous system infection (meningitis or en­
cephalitis). There may be a family history of benign febrile convulsions or other 
types of seizures. Benign febrile convulsions usually last for less than 15 min­
utes and lack focal features. About two-thirds of patients experience a single 
seizure, and fewer than one-tenth have more than three. Seizures occurring dur­
ing the first hour of fever in children less than 18 months old or in children with 
a family history of febrile seizures are associated with a significant risk for re­
currence; 90% of recurrences occur within 2 years of the initial episode. The dif­
ferential diagnosis includes meningitis and encephalitis and brain abscess; if 
present, these should be treated as described elsewhere in this volume. Since be­
nign febrile convulsions are usually self-limited, treatment is often unnecessary; 
prolonged convulsions (15 minutes) can be treated with diazepam, 0.3 mg/kg 
orally, intramuscularly, or intravenously or 0.6 mg/kg rectally. Such treatment 
may decrease the risk of recurrence. The probability of developing a chronic 
seizure disorder is 2-6% and is highest in patients with persistent neurologic ab­
normalities; prolonged, focal, or multiple seizures; or a family history of nonfeb- 
rile seizures. Long-term administration of phenobarbital to reduce the risk of 
subsequent afebrile seizures is not indicated, since the efficacy of such prophy­
lactic therapy is disputed, and cognitive impairment is a common side effect of 
treatment.
B. Idiopathic epilepsy for which no specific cause can be established ac­
counts for more than 75% of seizure disorders. Idiopathic epilepsy usually be­
gins between the ages of 5 and 25 years, with more than 75% of patients having 
their first seizure before age 18 years. Less frequently, idiopathic epilepsy be­
gins in later life, although in this age group seizures are also commonly associ­
ated with strokes, tumors, trauma, and systemic or metabolic disorders. Not all 
patients with a single idiopathic seizure go on to develop recurrent seizures: re­
currence rates vary from about 30% to as high as 70% in different series, and 
may be higher in patients with electroencephalographic abnormalities such as a 
generalized spike-and-wave pattern, postictal Todd's paralysis (see below), per­
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sistent neurologic abnormalities, status epilepticus, or a family history of afeb­
rile seizures.
C. Head trauma is a common cause of epilepsy, especially when it oc­
curs perinatally or is associated with a depressed skull fracture or intracerebral 
or subdural hematoma. Seizures that occur within the first week after nonpene­
trating head injuries are not predictive of a chronic seizure disorder, however. 
Although patients with serious head injuries are often treated prophylactically 
with anticonvulsant drugs, this practice has been questioned, since a reduction in 
the incidence of posttraumatic seizures has not been consistently observed be­
yond one week of treatment.
D. Stroke affecting the cerebral cortex produces seizures in 5-15% of pa­
tients and can occur following thrombotic or embolic infarction or intracerebral 
hemorrhage. As with head trauma, early seizures are not necessarily indicative 
of chronic epilepsy, and long-term anticonvulsant therapy is not required. Even 
without rupturing, vascular malformations may be associated with seizures, pre­
sumably as a result of their irritative effects on adjacent brain tissue.
E. Mass lesions, such as brain tumors or abscesses, can present with sei­
zures or produce them later in the course. Glioblastomas, astrocytomas, and 
meningiomas are the most common tumors associated with seizures, reflecting 
their high prevalence among tumors that affect the cerebral hemispheres.
F. Meningitis or encephalitis caused by bacterial (eg, Haemophilus in­
fluenzae), tuberculous, viral (eg, herpes simplex), fungal, or parasitic (eg, cysti- 
cercosis) infections can also cause seizures. Seizures in patients with AIDS are 
most often associated with AIDS dementia complex, but also with toxoplasmo­
sis or cryptococcal meningitis.
Systemic Disorders
Metabolic and other systemic disorders, including drug-overdose and 
drug-withdrawal syndromes, may be associated with seizures that abate with 
correction of the underlying abnormality. In these cases, the patient is not con­
sidered to have epilepsy.
A. Hypoglycemia can produce seizures, especially with serum glucose 
levels of 20-30 mg/dL, but neurologic manifestations of hypoglycemia are also 
related to the rate at which serum glucose levels fall.
B. Hyponatremia may be associated with seizures at serum sodium levels 
below 120 meq/L or at higher levels following rapid decline.
C. Hyperosmolar states, including both hyperosmolar nonketotic hyper­
glycemia and hypernatremia, may lead to seizures when serum osmolality rises 
above about 330 mosm/L.
D. Hypocalcemia with serum calcium levels in the range of 4.3-9.2 
mg/dL can produce seizures with or without tetany.
E. Uremia can cause seizures, especially when it develops rapidly, but 
this tendency correlates poorly with absolute serum urea nitrogen levels.
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F. Hepatic encephalopathy is sometimes accompanied by generalized or 
multifocal seizures.
G. Porphyria is a disorder of heme biosynthesis that produces both neu­
ropathy and seizures. The latter may be difficult to treat because most anticon­
vulsants can exacerbate the disorder. As a result, seizures caused by porphyria 
have traditionally been treated with bromides, 1-2 g orally three times daily 
(therapeutic serum levels 10-20 meq/L). Toxicity (manifested by rash, gastroin­
testinal symptoms, psychiatric disturbances, or impaired consciousness) is 
common. In vitro studies suggest the safety of vigabatrine and gabapentin.
H. Drug overdose can exacerbate epilepsy or cause seizures in nonepilep­
tic patients. Generalized tonic-clonic seizures are most common, but focal or 
multifocal partial seizures can also occur. The drugs most frequently associated 
with seizures are antidepressants, antipsychotics, cocaine, insulin, isoniazid, li- 
docaine, and methylxanthines.
I. Drug withdrawal, especially withdrawal from ethanol or sedative 
drugs, may be accompanied by one or more generalized tonic-clonic seizures 
that usually resolve spontaneously. Alcohol withdrawal seizures occur within 48 
hours after cessation or reduction of ethanol intake in 90% of cases, and are 
characterized by brief flurries of one to six attacks that resolve within 12 hours. 
Acute abstinence from sedative drugs can also produce seizures in patients ha­
bituated to more than 600-800 mg/d of secobarbital or equivalent doses of other 
short-acting sedatives. Seizures from sedative drug withdrawal typically occur 
2-4 days after abstinence but may be delayed for up to 1 week. Focal seizures 
are rarely due to alcohol or sedative drug withdrawal alone; they suggest an ad­
ditional focal cerebral lesion that requires evaluation.
J. Global cerebral ischemia from cardiac arrest, cardiac arrhythmias, or 
hypotension may produce, at onset, a few tonic or tonic-clonic movements that 
resemble seizures, but they probably reflect abnormal brainstem activity instead. 
Global ischemia may also be associated with spontaneous myoclonus or, after 
consciousness returns, with myoclonus precipitated by movement (action myo­
clonus). Partial or generalized tonic-clonic seizures also occur; these may be 
manifested only by minor movements of the face or eyes and must be treated. 
Nonetheless, isolated seizures following global cerebral ischemia do not neces­
sarily indicate a poor outcome.
K. Hypertensive encephalopathy may be accompanied by generalized 
tonic-clonic or partial seizures.
L. Eclampsia refers to the occurrence of seizures or coma in a pregnant 
woman with hypertension, proteinuria, and edema (preeclampsia). As in hyper­
tensive encephalopathy in nonpregnant patients, cerebral edema, ischemia, and 
hemorrhage may contribute to neurologic complications. Magnesium sulfate has 
been widely used to treat eclamptic seizures, and may be superior for this pur­
pose to anticonvulsants such as phenytoin.
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M. Hyperthermia can result from infection, exposure (heat stroke), hy­
pothalamic lesions, or drugs such as phencyclidine, as well as anticholinergics 
or neuroleptics (neuroleptic malignant syndrome) and inhalational anesthetics or 
neuromuscular blocking agents (malignant hyperthermia). Clinical features of 
severe hyperthermia (42°C) include seizures, confusional states or coma, shock, 
and renal failure. Treatment is with antipyretics and artificial cooling to reduce 
body temperature immediately to 39°C and anticonvulsants and more specific 
therapy (eg, antibiotics for infection, dantrolene for malignant hyperthermia) 
where indicated. Patients who survive may be left with ataxia as a result of the 
special vulnerability of cerebellar neurons to hyperthermia.
CLASSIFICATION & CLINICAL FINDINGS
Generalized seizures
■ Tonic-clonic (grand mal)
■ Absence (petit mal)
• Other types (tonic, clonic, myoclonic)
Partial seizures
■ Simple partial
■ Complex partial (temporal lobe, psychomotor)
Generalized Seizures
A. Generalized tonic-clonic seizures are attacks in which consciousness 
is lost, usually without aura or other warning. When a warning does occur, it 
usually consists of nonspecific symptoms.
1. Tonic phase -  The initial manifestations are unconsciousness and tonic 
contractions of limb muscles for 10-30 seconds, producing extension of the ex­
tremities and arching of the body in apparent opisthotonos. Tonic contraction of 
the muscles of respiration may produce an expiration induced vocalization (cry 
or moan) and cyanosis, and contraction of masticatory muscles may cause 
tongue trauma. The patient falls to the ground and may be injured.
2. Clonic phase -  The tonic phase is followed by a clonic (alternating 
muscle contraction and relaxation) phase of symmetric limb jerking that persists 
for an additional 30-60 seconds-or longer. Ventilatory efforts return immediately 
after cessation of the tonic phase, and cyanosis clears. The mouth may froth with 
saliva. With time, the jerking becomes less frequent, until finally all movements 
cease and the muscles are flaccid. Sphincteric relaxation or detrusor muscle con­
traction may produce urinary incontinence. The patient then remains uncon­
scious for a variable period that is seldom longer than 30 minutes.
3. Recovery -  As the patient regains consciousness, there is postictal con­
fusion and often headache. Full orientation commonly takes 10-30 minutes -  or
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even longer in patients with status epilepticus (see below) or preexisting struc­
tural or metabolic brain disorders. Physical examination during the postictal 
state is usually otherwise normal in idiopathic epilepsy or seizures of metabolic 
origin, except that plantar responses may be transiently extensor (Babinski's 
sign). The pupils always react to light, even when the patient is unconscious. 
Transient unilateral weakness (hemiparesis) in the postictal period (Todd's pa­
ralysis) should be sought, because such a finding suggests a focal brain lesion as 
the cause and calls for further investigation.
4. Status epilepticus -  In this condition, seizures fail to cease spontane­
ously or recur so frequently that full consciousness is not restored between suc­
cessive episodes. Status epilepticus is a medical emergency because it can lead 
to permanent brain damage -  from hyperpyrexia, circulatory collapse, or excito- 
toxic neuronal damage -  if untreated.
B. Absence (petit mal) seizures are genetically transmitted seizures that 
always begin in childhood and usually do not persist after age 20 years. The 
spells are characterized by brief loss of consciousness (for 5-10 seconds) with­
out loss of postural tone. Subtle motor manifestations, such as eye blinking or a 
slight head turning, are common. Automatisms are rare. Full orientation imme­
diately follows cessation of the seizure. There may be as many as several hun­
dred spells daily, leading to impaired school performance and social interac­
tions, so that children may be mistakenly thought to be mentally retarded before 
the diagnosis of petit mal epilepsy is made. The spells are characteristically in­
ducible by hyperventilation. The EEG shows a characteristic 3/s spike-andwave 
pattern during the seizures. In most patients with normal intelligence and normal 
background activity on EEG, absence spells occur only during childhood; in 
other cases, however, the attacks continue into adult life, either alone or in as­
sociation with other types of seizures.
C. Other types of generalized seizures include tonic seizures (not fol­
lowed by a clonic phase), clonic seizures (not preceded by a tonic phase), and 
myoclonic seizures.
1. Tonic seizures are characterized by continuing muscle contraction that 
can lead to fixation of the limbs and to deviation of the head and eyes to one 
side; the accompanying arrest of ventilatory movements leads to cyanosis. Con­
sciousness is lost, and there is no clonic phase to these seizures.
2. Clonic seizures are characterized by repetitive clonic jerking accompa­
nied by loss of consciousness. There is no initial tonic component.
3. Myoclonic seizures are characterized by sudden, brief, shocklike con­
tractions that may be localized to a few muscles or one or more extremities or 
that may have a more generalized distribution. Myoclonic seizures may be idio­
pathic or associated with a variety of rare hereditary neurodegenerative disor­
ders, including Unverricht-Lundborg disease, Lafora body disease, neuronal 
ceroid lipofuscinosis (late infantile, juvenile, and adult forms), sialidosis, and
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mitochondrial encephalomyopathy (myoclonus epilepsy with ragged red fibers 
on skeletal muscle biopsy). Not all myoclonic jerks have an epileptic basis.
Partial Seizures
A. Simple partial seizures begin with motor, sensory, or autonomic phe­
nomena, depending on the cortical region affected. For example, clonic move­
ments of a single muscle group in the face, a limb, or the pharynx may occur and 
may be self-limited; they may be recurrent or continuous or may spread to in­
volve contiguous regions of the motor cortex (Jacksonian march).
Autonomic symptoms may consist of pallor, flushing, sweating, piloerec- 
tion, pupillary dilatation, vomiting, borborygmi, and incontinence. Psychic 
symptoms include dysphasia, distortions of memory (eg, deja vu, the sensation 
that a new experience is being repeated), forced thinking or labored thought 
processes, cognitive deficits, affective disturbances (eg, fear, depression, an in­
appropriate sense of pleasure), hallucinations, or illusions. During simple partial 
seizures, consciousness is preserved unless the seizure discharge spreads to 
other areas of the brain, producing tonic-clonic seizures (secondary general­
ization). The aura is the portion of the seizure that precedes loss of conscious­
ness and of which the patient retains some memory. The aura is sometimes the 
sole manifestation of the epileptic discharge.
In the postictal state, a focal neurologic deficit such as hemiparesis 
(Todd's paralysis) that resolves over a period of 'Л-36 hours is a manifestation of 
an underlying focal brain lesion.
B. Complex partial seizures, formerly called temporal lobe or psycho­
motor seizures, consist of episodes in which consciousness is impaired but not 
lost. The seizure discharge usually arises from the temporal lobe or medial fron­
tal lobe. The symptoms take many forms but are usually stereotyped for the in­
dividual patient. Epigastric sensations are most common, but affective (fear), 
cognitive (deja vu), and sensory (olfactory hallucinations) symptoms also occur. 
Consciousness is then impaired. Seizures generally persist for less than 30 min­
utes (on the average, 1-3 minutes). The motor manifestations of complex partial 
seizures are characterized by coordinated involuntary motor activity, termed 
automatism, which takes the form of orobuccolingual movements in about 75% 
of patients and other facial or neck movements in about 50%. Sitting up or 
standing, fumbling with objects, and bilateral limb movements are less common. 
Secondary generalization may occur.
DIAGNOSIS
The diagnosis of seizures is based on clinical recognition of one of the 
seizure types described above. The EEG can be a helpful confirmatory test in 
distinguishing seizures from other causes of loss of consciousness. On the other
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hand, however, a normal or nonspecifically abnormal EEG never excludes the 
diagnosis of seizures. Specific EEG features that suggest epilepsy include ab­
normal spikes, polyspike discharges, and spike-wave complexes.
A standard diagnostic evaluation of patients with recent onset of seizures 
is presented below. Metabolic and toxic disorders should be excluded, because 
they do not require anticonvulsants.
Seizures with a clearly focal onset or those that begin after age 25 years 
require prompt evaluation to exclude the presence of a structural brain lesion. 
MRI is essential for this purpose (CT is not adequate). If no cause is found, the 
decision to begin chronic anticonvulsant therapy should be based on the prob­
ability of recurrence. Following a single generalized tonic-clonic seizure, recur­
rence can be expected within 3-4 years in 30-70% of untreated adult patients.
Evaluation of a new seizure disorder in a stable patient
History (including medications or drug exposure)
General physical examination
Complete neurologic examination
Blood studies
Fasting glucose 
Serum calcium 
Serum FT A-ABS 
Serum electrolytes 
Complete blood count 
Erythrocyte sedimentation rate 
Renal function studies 
Hepatic function studies
EEG
CT brain scan or MRI (especially with abnormal examination, progressive
disorder, or onset of seizures after 25 years of age)
SELECTION OF THERAPY
Therapy should be directed toward the cause of the seizures, if known. 
Seizures associated with metabolic and systemic disorders usually respond 
poorly to anticonvulsants but cease with correction of the underlying abnormal­
ity. Acute withdrawal from alcohol and other sedative drugs produces self-lim­
ited seizures that, in general, require no anticonvulsant drug therapy. Acute head 
trauma and other structural brain lesions that result in seizures must be rapidly 
diagnosed and treated, and the associated seizures controlled by anticonvulsant 
drug therapy. Idiopathic epilepsy is treated with anticonvulsant medications.
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Anticonvulsant Drug Treatment
Commonly used anticonvulsant drugs and their dosages and methods of 
administration are listed below. There are four key principles of management:
Establish the diagnosis of epilepsy before starting drug therapy. 
Therapeutic trials of anticonvulsant drugs intended to establish or reject a diag­
nosis of epilepsy may yield incorrect diagnoses.
Choose the right drug for the seizure type. Absence seizures, for exam­
ple, do not respond to most drugs used for complex partial or generalized tonic- 
clonic seizures.
Treat the seizures, rather than the serum drug levels. Control of sei­
zures is achieved at different drug levels in different patients.
Evaluate one drug at a time. In most cases, seizures can be controlled 
with a single drug. Therefore, beginning therapy with multiple drugs may ex­
pose patients to increased drug toxicity without added therapeutic benefit.
Most patients with epilepsy fall into one of the following treatment cate­
gories.
A. New Seizures. Most epileptologists do not recommend chronic anti­
convulsant drug treatment following a single seizure unless an underlying cause 
is found that is not correctable and is likely to produce recurrent seizures (eg, 
brain tumor). However, recurrent seizures do require anticonvulsant treatment, 
and if such therapy is to be administered, the oral loading schedules can be used. 
Note that starting a drug at its daily maintenance dose produces stable serum 
drug levels only after approximately five half-lives have elapsed. Therefore, 
loading doses should be given whenever possible to achieve therapeutic drug 
levels promptly in patients with frequent seizures. Phenytoin, carbamazepine, or 
valproic acid is the current drug of first choice for treating generalized tonic- 
clonic or partial seizures in adults, and valproic acid or carbamazepine is pre­
ferred for children. Phenobarbital is also very effective in treating generalized 
tonicclonic seizures in adults, but it is less helpful for treatment of complex par­
tial seizures.
The newer anticonvulsants gabapentin, lamotrigine, topiramate, vi- 
gabatrin, and tiagabine may be helpful for patients who respond suboptimally to 
conventional anticonvulsant drugs.
Absence attacks of the petit mal variety are treated with valproic acid or 
ethosuximide. The former has the advantage of also providing protection against 
tonic-clonic seizures but has caused fatalities from hepatic damage in children 
under 10 (usually under 2) years of age.
Myoclonic seizures are treated with valproic acid or clonazepam.
B. Recurrent Seizures on Drug Therapy:
1. Determining serum levels of drugs. Blood levels of the anticonvulsant 
drugs the patient has been taking should be measured in samples taken just prior 
to a scheduled dose. For a single seizure no acute change in medication is man­
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dated even if there has been no interruption of drug therapy and anticonvulsant 
drug levels are in the therapeutic range, but a slight increase in prescribed dose 
may be considered. If the history or serum drug levels suggest that treatment has 
been interrupted, the prescribed drug should be started again as for new seizures.
2. Changing to a second drug. A second anticonvulsant should be intro­
duced only if seizures continue to occur after maximum therapeutic benefit has 
been achieved with the initial drug. This means not only that blood levels of the 
drug are in the therapeutic range but also that drug toxicity precludes further 
dosage increments. An anticonvulsant that has failed to alter seizure frequency 
should be discontinued gradually once therapeutic levels of the second drug 
have been achieved. If the first drug has produced partial control of the seizure 
disorder, however, it is often continued along with the second drug.
3. Treating refractory seizures. In some patients, disabling seizures per­
sist despite trials of all major anticonvulsants, alone and in combination -  and at 
the highest doses the patient can tolerate. When no treatable cause can be found, 
seizures are not due to a progressive neurodegenerative disease, and medical 
treatment has been unsuccessful for at least 2 years, evaluation for possible sur­
gical therapy should be considered. Presurgical evaluation begins with a detailed 
history and neurologic examination to explore the cause of seizures and their site 
of origin within the brain and to document the adequacy of prior attempts at 
medical treatment. MRI and electrophysiologic studies are performed to identify 
the epileptogenic zone within the brain. Several electrophysiologic techniques 
can be used: EEG, in which cerebral electrical activity is recorded from the 
scalp; stereotactic depth electrode EEG, in which activity is recorded from elec­
trodes inserted into the brain; and electrocorticography, which involves intraop­
erative recording from the surface of the brain. When an epileptogenic zone can 
be identified in this manner and its removal is not expected to produce undue 
neurologic impairment, surgical excision may be indicated. Patients with com­
plex partial seizures arising from a single temporal lobe are the most frequent 
surgical candidates; unilateral anterior temporal lobectomy abolishes seizures in 
about 50% of these patients and significantly reduces their frequency in another 
25%. Hemispherectomy and corpus callosum section are also sometimes used to 
treat intractable epilepsy.
C. Multiple Seizures or Status Epilepticus.
1. Early management
a. Immediate attention should be given to ensuring that the airway is pat­
ent and the patient positioned to prevent aspiration of stomach contents.
b. The laboratory studies listed earlier should be ordered without delay.
c. Dextrose, 50 mL of 50% solution, should be given intravenously.
d. If fever or meningeal signs are present, immediate lumbar puncture is 
mandatory, and a gramstained smear of spinal fluid should be examined to ex­
clude bacterial meningitis. Patients without these signs should also undergo 
lumbar puncture if the cause of the seizures has not been determined (eg, by
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their cessation upon administration of dextrose), unless signs of increased intrac­
ranial pressure or of focal brain dysfunction are present. It should be noted that 
postictal pleocytosis is detectable in CSF in approximately 2% of patients with 
single generalized tonic-clonic seizures (and about 15% of those with status epi­
leptic us) in the absence of infection. The white blood cell count may be as high 
as 80/pL, with either polymorphonuclear or mononuclear predominance. Serum 
protein content may be slightly elevated, but glucose concentration is normal, 
and Gram's stain is negative. The postictal pleocytosis resolves in 2-5 days.
2. Drug therapy to control seizures. Every effort must be made to estab­
lish a precise etiologie diagnosis so that treatment of the underlying disorder can 
be started. Because generalized seizure activity per se damages the brain if it 
persists for more than 1-2 hours, drug therapy to terminate seizures should be 
instituted immediately.
Anticonvulsants
Drugs Preparation,
mg
Dosage
Loading
Mg/d
Maintenance
Mg/d
Phenytoin 100 1000 300-400
Carbamazepine 200, 400 400 600-1600
Phenobarbital 100 90-180
Valproic acid 250 750-3000 750-3000
Ethosuximide 250 15 mg/kg/d 15-40 mg/kg/d
Clonazepam 0.5 1.5 1.5-20
Gabapentin 100, 400 300 900-4800
Lamotrigine 50, 100,200 25 200-500
Vigabatrin 500 1000 2-4 g
Topiramate 25, 100, 200 25 200-400
Oxcarbazepine 150, 300, 600 600 1200
Levetiracetam 250, 500 1000 1000-3000
Emergency evaluation of serial seizures, or status epilepticus
■ Treatment with anticonvulsants should be instituted immediately, while the 
following measures are taken
■ Vital signs:
о Blood pressure: exclude hypertensive encephalopathy and shock 
о Temperature: exclude hyperthermia 
о Pulse: exclude life-threatening cardiac arrhythmia
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* Draw venous blood for serum glucose, calcium, electrolytes, hepatic and re­
nal function blood studies, complete blood count, erythrocyte sedimentation 
rate, and toxicology
■ Insert intravenous line
■ Administer glucose (50 mL of 50% dextrose) intravenously
■ Obtain any available history
■ Rapid physical examination, especially for
о Signs of trauma
о Signs of meningeal irritation or systemic infection 
о Papilledema 
о Focal neurologic signs
о Evidence of metastatic, hepatic, or renal disease
■ Arterial blood gases
* Lumbar puncture, unless the cause of seizures has already been determined 
or signs of increased intracranial pressure or focal neurologic signs are pre­
sent
■ ECG
* Calculate serum osmolality: 2 (serum sodium concentration) + serum glu- 
cose/20 + serum urea nitrogen/3 (normal range: 270-290)
■ Urine sample for toxicology, if indicated
3. Management of hyperthermia. The metabolic consequences of status 
epilepticus are related to increased motor activity and high levels of circulating 
catecholamines; they include hyperthermia (to 42-43 °C), lactic acidosis (to pH 
<7.00), and peripheral blood leukocytosis (to 60,000 cells/pL). These derange­
ments typically resolve over a few hours after cessation of the seizures. Only 
hyperthermia, which is known to increase the risk of brain damage from status 
epilepticus, requires specific attention.
Severe hyperthermia must be treated with a cooling blanket and, if neces­
sary, the induction of motor paralysis with a neuromuscular blocking agent such 
as curare. Mild or moderate hyperthermia, not requiring specific intervention, 
may persist for 24-48 hours. Lactic acidosis resolves spontaneously over 1 hour 
and should not be treated. Infection should, of course, be excluded.
Discontinuance of Anticonvulsants
Patients (usually children) with epilepsy who are seizure-free on medica­
tion for 2-5 years may wish to discontinue anticonvulsant drugs. In patients with 
normal intelligence and a normal neurologic examination, the risk of seizure re­
currence may be as low as 25%. Risk factors for recurrence include slowing or 
spikes (maximum risk with both present) on EEG. When anticonvulsants are to 
be withdrawn, one drug is eliminated at a time by tapering the dose slowly over 
6 weeks. Recurrence of seizures has been reported in approximately 20% of
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children and 40% of adults following medication withdrawal, in which case 
prior medication should be reinstituted at the previously effective levels.
COMPLICATIONS OF EPILEPSY & ANTICONVULSANT
THERAPY
Complications of Epilepsy
When the diagnosis of epilepsy is made, the patient should be warned 
against working around moving machinery or at heights and reminded of the 
risks of swimming alone. The issue of driving must also be addressed. Many 
state governments have notification requirements when a diagnosis of epilepsy 
is made.
Side Effects of Anticonvulsant Drugs
All anticonvulsant drugs may lead to blood dyscrasias, but carbamazepine 
and valproic acid have been associated with the highest incidence of hema­
tologic -  and hepatic -  toxicity. For this reason, a complete blood count and 
liver function tests should be obtained before initiating administration of these 
drugs and at intervals during the course of treatment. The authors recommend 
performing these tests at 2 weeks, 1 month, 3 months, 6 months, and every 6 
months thereafter. Carbamazepine should be discontinued if the total neutrophil 
count falls below 1,500/ml or if aplastic anemia is suspected. Valproic acid 
should be terminated if symptoms of hepatotoxicity, such as nausea, vomiting, 
anorexia or jaundice occur. Lamotrigine has a 1:1,000 incidence of Stevens- 
Johnson syndrome in the first 8 weeks. Most anticonvulsant drugs (especially 
barbiturates) affect cognitive function to some degree, even in therapeutic doses.
A variety of drugs alter the absorption or metabolism of anticonvulsants 
when given concomitantly.
Epilepsy & Anticonvulsant in Pregnancy
The incidence of stillbirth, microcephaly, mental retardation, and seizure 
disorders is increased in children born to epileptic mothers. Anticonvulsant ther­
apy during pregnancy, however, is also associated with a greater than normal 
frequency of congenital malformations -  specially cleft palate, cleft lip, and car­
diac anomalies. Such malfonnations are about twice as common in the offspring 
of medicated as of unmedicated epileptic mothers, but since patients with more 
severe epilepsy are more likely to be treated, it is difficult to know whether epi­
lepsy or its treatment is the more important risk factor.
Among commonly used anticonvulsants, valproic acid and to some degree 
carbamazepine are associated with an increased incidence of neural tube defects 
(2% and 0.5%, respectively). Phenobarbital and phenytoin pose some terato­
genic risk, but the extent of the risk is controversial. The fetal risks of the newer 
anticonvulsants are not known.
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When an epileptic patient who has been seizurefree for several years is 
contemplating pregnancy, an attempt should be made to withdraw anticonvul­
sants prior to conception. If anticonvulsant drugs are absolutely required, car- 
bamazepine is thought to have the lowest fetal risk and continues to be recom­
mended for generalized tonic-clonic seizures, and ethosuximide for absence sei­
zures. In contrast to generalized tonic-clonic seizures, partial and absence sei­
zures present little risk to the fetus, and it may be possible to tolerate imperfect 
control of these seizures during pregnancy to avoid fetal drug exposure. 
Clonazepam can also be used; but phenytoin, phenobarbital, and primidone 
should be avoided if possible, and trimethadione and valproic acid should not be 
used. Every effort should be made to control the seizures with a single drug. 
Status epilepticus is treated as described above for nonpregnant patients.
Plasma levels of anticonvulsant drugs may decrease during pregnancy be­
cause of the patient's enhanced metabolism, and higher doses may be required to 
maintain control of seizures. It is therefore important to monitor drug levels 
closely in this setting.
PROGNOSIS
After a single unprovoked seizure, only one-third to one-half of patients 
will have a recurrence (develop epilepsy). If a second seizure occurs, however, 
the recurrence rate approaches 75% and anticonvulsants should therefore be 
started. With appropriate anticonvulsant drug treatment, seizures can be well 
controlled, although not always eliminated, in most epileptic patients. At the on­
set of treatment patients should be seen every few months to monitor seizure 
frequency and make dose adjustments.
PSEUDOSEIZURES
Attacks that resemble seizures (psychogenic seizures, or pseudoseizures) 
may be manifestations of a psychiatric disturbance such as conversion disorder, 
somatization disorder, factitious disorder with physical symptoms, or malinger­
ing. In conversion or somatization disorder, the patient is unaware of the psy­
chogenic nature of symptoms and the motivation for their production. In facti­
tious disorder, the patient recognizes that the spells are self-induced, but not the 
reason for doing so. In malingering, there is conscious awareness of both the 
production of symptoms and the underlying motivation.
Pseudoseizures can usually be distinguished both clinically and by the 
EEG findings. In patients with pseudoseizures resembling tonic-clonic attacks, 
there may be warning and preparation before the attack; there is usually no tonic 
phase, and the clonic phase consists of wild thrashing movements during which 
the patient rarely comes to harm or is incontinent. In some instances, there are 
abnormal movements of all extremities without loss of consciousness; in others,
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there is shouting or obscene utterances during apparent loss of consciousness or 
goal-directed behavior. There is no postictal confusion or abnormal clinical 
signs following the attack. The EEG recorded during the episode does not show 
organized seizure activity, and postictal slowing does not occur. The differential 
diagnosis should include, however, frontal lobe seizures, which may be marked 
by unusual midline movements (pelvic thrusting, bicycling) and by very brief 
postictal states, lctal EEG abnormalities may escape detection as well.
It is important to appreciate that many patients with pseudoseizures also 
have genuine epileptic attacks that require anticonvulsant medications, but these 
should be prescribed at an empirically appropriate dose. Psychiatric referral may 
be helpful.
SYNCOPE
VASOVAGAL SYNCOPE (SIMPLE FAINTS)
Vasovagal disorders, which are exceedingly common, occur in all age 
groups and affect men and women equally. Precipitating factors include emo­
tional stimulation, pain, the sight of blood, fatigue, medical instrumentation, 
blood loss, or prolonged motionless standing. Vagally mediated decreases in ar­
terial blood pressure and heart rate combine to produce central nervous system 
hypoperfusion and subsequent syncope. Severe cerebral ischemia resulting in 
tonic-clonic movements can occur if the unconscious patient remains in an up­
right position during the episode (eg, fainting in a toilet stall).
Vasovagal episodes generally begin while the patient is in a standing or 
sitting position and only rarely in a horizontal position (eg, with phlebotomy or 
IUD insertion). A prodrome lasting 10 seconds to a few minutes usually pre­
cedes syncope and can include lassitude, lightheadedness, nausea, pallor, di­
aphoresis, salivation, blurred vision, and tachycardia. The patient, who then 
loses consciousness and falls to the ground, is pale and diaphoretic and has di­
lated pupils. Bradycardia replaces tachycardia as consciousness is lost. During 
unconsciousness, abnormal movements may occur; these are mainly tonic or op- 
isthotonic, but seizurelike tonic-clonic activity is occasionally seen, which can 
lead to a misdiagnosis of epilepsy. Urinary incontinence may also occur.
The patient recovers consciousness very rapidly (seconds to a few min­
utes) after assuming the horizontal position, but residual nervousness, dizziness, 
headache, nausea, pallor, diaphoresis, and an urge to defecate may be noted. A 
postictal confusional state with disorientation and agitation either is very brief « 
30 seconds) or does not occur. Syncope may recur, especially if the patient 
stands up within the next 30 minutes.
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Reassurance and a recommendation to avoid precipitating factors are usu­
ally the only treatment necessary.
Recurrent vasovagal syncope (often termed neurocardiogenic syncope) 
can be documented by head-up tilt-testing. The bradycardia and hypotension can 
be ameliorated by oral metoprolol, theophylline, or disopyramide; artificial pac­
ing is ineffective against the syncope.
CARDIOVASCULAR SYNCOPE
A cardiovascular cause is suggested when syncope occurs with the patient 
in a recumbent position, during or following physical exertion, or in a patient 
with known heart disease. Loss of consciousness related to cardiac disease is 
most often due to an abrupt decrease in cardiac output with subsequent cerebral 
hypoperfusion. Such cardiac dysfunction can result from cardiac arrest, rhythm 
disturbances (either brady- or tachyarrhythmias), cardiac inflow or outflow ob­
struction, intracardiac right-to-left shunts, leaking or dissecting aortic aneu­
rysms, or acute pulmonary embolus.
1. CARDIAC ARREST
Cardiac arrest (ventricular fibrillation, or asystole) from any cause will 
cause loss of consciousness in 3-5 seconds if the patient is standing or within 15 
seconds if the patient is recumbent. Seizurelike activity and urinary and fecal in­
continence may be seen as the duration of cerebral hypoperfusion increases.
2. TACHY ARRHYTHMIAS
Supraventricular Tachyarrhythmias
Supraventricular tachyarrhythmias (atrial or junctional tachycardia, atrial 
flutter, or atrial fibrillation) may be paroxysmal or chronic and can occur in all 
age groups -  and in persons with or without clinical heart disease. Such rhythm 
disturbances may be spontaneous, or they may be secondary to metabolic ab­
normalities, hypoxia, drug overdose, and many systemic and cardiovascular dis­
orders.
Heart rates faster than 160-200/min reduce cardiac output by decreasing 
the ventricular filling period or inducing myocardial ischemia. Prolonged tachy­
cardia of 180-200 beats or more per minute will produce syncope in 50% of 
normal persons in the upright posture; in patients with underlying heart disease, 
a heart rate of 135/min may impair cardiac output enough to induce loss of con­
sciousness. In addition, patients with sinus node dysfunction (sick-sinus syn­
drome) may develop profound sinus, junctional, or idioventricular bradycardias
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-  or even asystole -  upon termination of their tachyarrhythmias. This can cause 
syncope, atrial fibrillation, and other forms of atrioventricular dissociation and 
further reduce cardiac output by loss of coordinated atrial activity.
Routine ECGs, even if abnormal, are often not helpful in establishing a 
diagnosis, which is firmly established only when arrhythmias are demonstrated 
during a symptomatic episode. Continuous ECG monitoring or outpatient port­
able Holter monitoring may be required. Event monitors triggered by the patient 
at the onset of prodromal symptoms are often particularly helpful.
Ventricular Tachyarrhythmias
Ventricular tachyarrhythmias (ventricular tachycardia or multiform, fre­
quent, or paired premature ventricular contractions) are found on prolonged 
ECG monitoring in some patients with syncope. The syncope associated with 
ventricular tachycardia is characterized by a very brief prodrome (less than 5 
seconds). Frequent or repetitive premature ventricular contractions alone do not 
often coincide with syncopal symptoms but are predictive of sudden death.
Mitral Valve Prolapse
Mitral valve prolapse (click-murmur syndrome) is a common disorder as­
sociated with supraventricular and ventricular arrhythmias. In one series, 25% of 
patients reported lightheadedness or dizziness and 4% had syncope. The condi­
tion is twice as frequent in women as in men. Atypical chest pain that is char­
acteristically nonexertional, left precordial, sharp in quality, and of variable du­
ration is the most common complaint, followed by dyspnea and fatigue. Serious 
ventricular arrhythmias and profound bradycardia may occur.
Auscultation of the heart may reveal midsystolic clicks, mid-to-late sys­
tolic murmurs that vary with specific maneuvers, or a classic mitral regurgitation 
murmur. The ECG may be entirely normal or may show nonspecific ST-T wave 
changes. Frequent premature ventricular contractions are often noted. The diag­
nosis can be established by echocardiography.
Prolonged QT Syndrome
The congenital prolonged QT-interval syndrome consists of paroxy smal 
ventricular arrhythmias (often torsade de pointes), syncope, and sudden death 
and is inherited either as an autosomal recessive condition associated with deaf­
ness or in an autosomal dominant form without deafness. Sporadic nonfamilial 
cases have also been reported. Drugs such as quinidine and electrolyte distur­
bances such as hypocalcemia or hypokalemia can also produce QT prolongation.
Symptoms generally begin in infancy, but patients may be asymptomatic 
until the second or third decade, especially in the dominantly inherited disorder. 
Recurrent spells have been confused with epilepsy. The ECG may occasionally 
show a normal QTc interval at rest that becomes abnormally prolonged with ex­
ercise. Treatment with propranolol is often effective.
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3. BRADYARRHYTHMIAS
Sinoatrial Node Disease
Sinoatrial node disease may present as profound sinus bradycardia, pro­
longed sinus pauses, or sinus arrest with the appearance of a slow atrial, junc­
tional, or idioventricular escape rhythm. Patients with sinus node dysfunction 
may also develop profound bradycardia or asystole sufficient to produce syn­
cope upon termination of a supraventricular tachycardia. Sinus node dysfunction 
may be idiopathic or the result of fibrosis, vascular occlusion, infiltrative proc­
esses, or drug therapy (especially propranolol). All such patients should be 
promptly evaluated by a cardiologist, since a permanent pacemaker is necessary 
in many cases.
Complete Heart Block
Complete heart block (third-degree atrioventricular block) is the most 
common bradyarrhythmia that produces syncope. Permanent atrioventricular 
conduction abnormalities are easily noted on a routine ECG, but intermittent 
conduction abnormalities may not be present on a random tracing. Transient 
complete heart block is suggested as the cause of syncope by an ECG demon­
strating bundle branch block with or without a prolonged PR interval or by a 
syncopal prodrome of less than 5 seconds. A normal PR interval on an ECG ob­
tained after the episode does not exclude the diagnosis of transient complete 
heart block. Patients with syncope and documented or suspected complete heart 
block should be promptly hospitalized. Patients with acute inferior myocardial 
infarctions are at high risk for atrioventricular block.
4. CARDIAC INFLOW OBSTRUCTION
Atrial or ventricular myxomas and atrial thrombi usually present with em­
bolic events, but they may also produce a left ventricular inflow or outflow ob­
struction that results in a sudden decrease in cardiac output, followed by syn­
cope. Physical examination of the patient with left atrial myxoma often suggests 
mitral stenosis, but a mitral regurgitation murmur is occasionally heard. Fever, 
petechiae, and an elevated sedimentation rate may also be present. A history of 
syncope occurring with change in position is classic but uncommon. Echocardi­
ography can confirm the diagnosis. Surgical removal of the myxoma is indi­
cated. With constrictive pericarditis or pericardial tamponade, any maneuver or 
drug that decreases heart rate or venous return can result in suddenly inadequate 
cardiac output and syncope.
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5. CARDIAC OUTFLOW OBSTRUCTION
Aortic Stenosis
Loss of consciousness from congenital or acquired severe aortic stenosis 
occurs in all age groups, usually following exercise, and is often associated with 
dyspnea, angina, and diaphoresis. Several pathophysiologic processes have been 
hypothesized, including acute left ventricular failure resulting in coronary hy­
poperfusion, with subsequent ventricular fibrillation. Alternatively, abrupt in­
creases in left ventricular pressure may stimulate baroreceptors, leading to re­
flexive peripheral vascular dilation. Physical findings include a characteristic 
systolic murmur (often associated with a palpable thrill), a sustained and pro­
longed left ventricular lift, and a paradoxically split second heart sound. Calcifi­
cation of the valve is usually evident in imaging studies in patients over age 35 
years. Echocardiography can help confirm the diagnosis. Symptomatic aortic 
stenosis associated with angina, congestive heart failure, or syncope requires 
valve replacement, and all such patients should be promptly hospitalized. The 
average survival following syncope from aortic stenosis is 18 months to 3 years 
without treatment.
Pulmonary Stenosis
Severe pulmonary stenosis can produce syncope, especially following ex­
ertion. A hemodynamic process similar to that occurring in aortic stenosis is re­
sponsible.
Obstructive Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy in its obstructive form (asymmetric septal 
hypertrophy, hypertrophic cardiomyopathy, idiopathic hypertrophic subaortic 
stenosis) comprises a group of congenital cardiomyopathies inherited as auto­
somal dominant conditions of variable severity. Symptoms most often have their 
onset between the second and fourth decades; dyspnea is the most common pre­
senting complaint (60% of patients), but syncope occurs in 30% and is the pre­
senting complaint in 10%. Syncope characteristically develops during or follow­
ing exercise, but orthostatic and posttussive episodes also occur. Loss of con­
sciousness has been attributed to left ventricular outflow obstruction caused by 
abnormal movement of the anterior mitral leaflet against the septum in midsys­
tole, by inflow obstruction from decreased ventricular compliance, or by tran­
sient arrhythmias.
Suggestive features on physical examination include a double apical and 
carotid impulse, a precordial thrill, a prominent fourth heart sound, and a left 
ventricular heave. The classic long systolic ejection murmur is heard best at the 
lower left sternal border or apex, radiates poorly into the neck, and has a promi­
nent midsystolic accentuation. Mitral valve prolapse is common, and a mitral
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regurgitation murmur may be noted. Unlike valvular aortic stenosis, the murmur 
increases under circumstances that reduce the volume of the ventricle or in­
crease its contractility (eg, Valsalva's maneuver, amyl nitrite inhalation, or a 
premature ventricular contraction). If obstructive hypertrophic cardiomyopathy 
is suspected, the diagnosis can be confirmed by echocardiography. Propranolol 
has been used successfully to control symptoms.
6. DISSECTING AORTIC ANEURYSM
Approximately 5-10% of patients with acute aortic dissections present 
with isolated syncope; other neurologic abnormalities mayor may not be present. 
In 15% of patients, the dissection is painless.
7. PULMONARY HYPERTENSION & PULMONARY EMBOLUS
Syncope, often exertional, may be the presenting symptom of pulmonary 
hypertension. Signs of right ventricular failure (parasternal heave, increased sec­
ond heart sound, murmur of pulmonary insufficiency), electrocardiographic evi­
dence of right ventricular hypertrophy, and tachypnea may be found. Unrecog­
nized showers of pulmonary emboli can cause pulmonary hypertension, as can a 
host of systemic, cardiac, and primary pulmonary diseases. A history of exer­
tional dyspnea is usual, and hypoxemia on blood gas analysis is present even at 
rest. Syncope is the presenting symptom in about 20% of patients experiencing a 
massive pulmonary embolus; it is uncommonly a result of small pulmonary em­
boli. Upon recovery from syncope, such patients often complain of pleuritic 
chest pain, dyspnea, and apprehension. Hypotension, tachycardia, tachypnea, 
and significant arterial hypoxia frequently accompany these large emboli.
CEREBROVASCULAR SYNCOPE
Cerebrovascular disease is an often suspected but actually uncommon 
cause of episodic unconsciousness.
1. BASILAR ARTERY INSUFFICIENCY
Basilar artery transient ischemic attacks usually occur after the sixth dec­
ade. The symptom complex of diplopia, vertigo, dysphagia, dysarthria, various 
sensory or motor symptoms, drop attacks, and occipital headaches suggests dif­
fuse brainstem ischemia. Attacks are typically sudden in onset and brief in du­
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ration (seconds to minutes), but when consciousness is lost, recovery is fre­
quently prolonged (30-60 minutes or longer). Isolated unconsciousness without 
other symptoms of brainstem ischemia is rarely due to basilar artery insuffi­
ciency. Two-thirds of patients have recurrent attacks, and strokes eventually oc­
cur in about one-fifth of all cases.
2. SUBCLAVIAN STEAL SYNDROME
The subclavian steal syndrome results from subclavian or innominate ar­
tery stenosis that causes retrograde blood flow in the vertebral artery, with sub­
sequent brainstem hypoperfusion. The degree of subclavian artery stenosis that 
will produce symptoms is quite variable, and a minor (40%) stenosis may cause 
the syndrome in some patients. A difference between blood pressures measured 
in the two arms is nearly always found, the average difference being a 45-mm 
Hg decrease in systolic pressure in the arm supplied by the stenotic vessel. In 
one series of cases, while syncope was described in 18% of patients, vertigo, 
diplopia, limb paresis and paresthesias, and ataxia were more common manifes­
tations. Stroke resulting from this condition is rare. If this diagnosis is suspected, 
arteriography and subsequent surgical correction may be indicated.
3. MIGRAINE
Syncope occurs in 10% of migrainous patients during the headache, often 
upon rapid rising to a standing position, suggesting that loss of consciousness is 
due to orthostatic hypotension. In some patients, basilar migraine produces 
symptoms similar to those of basilar artery transient ischemic attacks. Antimi­
graine drug therapy is often effective in preventing attacks.
4. TAKAYASU'S DISEASE
Takayasu's disease (aortic arch syndrome, pulseless disease) is a panar­
teritis of the great vessels that is most common in Asian women. Symptoms of 
central nervous system hypoperfusion such as impaired vision, confusion, or 
syncope are often prominent. In one reported series, syncope was noted in 75% 
of patients, particularly following exercise, standing, or head movement. Physi­
cal examination reveals decreased or absent brachial pulses with low blood pres­
sures in both arms. The erythrocyte sedimentation rate is moderately elevated 
during the acute stage. Hospitalization for evaluation and initiation of corticos­
teroid treatment is indicated.
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5. CAROTID SINUS SYNCOPE
Carotid sinus syncope is uncommon. Men are affected twice as often as 
women, and most affected individuals are over 60 years of age. Drugs known to 
predispose to carotid sinus syncope include propranolol, digitalis, and methyl- 
dopa. Classically, pressure on the carotid sinus by a tight collar, a neck mass, en­
larged cervical lymph nodes, or a tumor causes vagal stimulation, which inhibits 
the cardiac sinoatrial and atrioventricular nodes and reduces sympathetic vas­
cular tone. The resultant bradycardia or systemic hypotension may then produce 
syncope; pure cardioinhibitory or vasodepressor syncope also occurs. The bra­
dycardia can be abolished or prevented by administration of atropine.
Carotid sinus syncope may be mistakenly diagnosed when symptoms re­
sult from compression of a normal carotid artery contralateral to an occluded in­
ternal carotid. Under these circumstances, unilateral compression transiently in­
terrupts the entire anterior cerebral circulation. Performing carotid sinus mas­
sage in an attempt to diagnose carotid sinus syncope in patients with carotid 
atherosclerotic disease produces a risk of distal embolization of atheromatous 
material.
MISCEI1ANEOUS CAUSES OF SYNCOPE
1. ORTHOSTATIC HYPOTENSION
Orthostatic hypotension occurs more often in men than in women and is 
most common in the sixth and seventh decades. It may, however, appear even in 
teenagers. Loss of consciousness usually occurs upon rapidly rising to a standing 
position, standing motionless for a prolonged period (especially following exer­
cise), and standing after prolonged recumbency (especially in elderly patients).
Numerous conditions can produce orthostatic hypotension, which gener­
ally results from either reduced blood volume or autonomic nervous system dys­
function. The latter may be due to sympathetic drugs, autonomic neuropathy, or 
central nervous system disorders affecting sympathetic pathways in the hypo­
thalamus, brainstem, or spinal cord. Two neurogenic causes of orthostatic hy­
potension deserve special consideration. Idiopathic orthostatic hypotension is 
associated mainly with the degeneration of postganglionic sympathetic neurons 
without other neuropathologic changes. In Shy-Drager syndrome, orthostatic 
hypotension appears to be related to degeneration of preganglionic sympathetic 
neurons; this occurs in combination with parkinsonian, pyramidal, cerebellar, or 
lower motor neuron signs.
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The diagnosis of orthostatic hypotension is established by demonstrating a 
drop in blood pressure of at least 30 mm Hg systolic or 10 mm Hg diastolic 
when the patient changes from the lying to the standing position. In equivocal 
cases, tilt-table testing may be necessary. A detailed general physical and neuro­
logic examination and laboratory studies (hematocrit, stool occult blood, serum 
glucose and electrolytes, FTA-ABS, nerve conduction studies) should be di­
rected toward establishing the cause of the disorder.
Any medication that might be responsible should be discontinued if pos­
sible, and the patient should be instructed to stand up gradually, to elevate the 
head of the bed on blocks, and to use waist-high elasticized support hosiery. 
Other therapy is dictated by the specific cause of hypotension. The potent miner- 
alocorticoid fludrocortisone has been effective in idiopathic cases and in diabetic 
patients in doses beginning with 0.1 mg/d orally and increased gradually, as 
necessary, up to 1 mg/d orally. Its mode of action is unclear, but its benefit may 
relate to increased responsiveness to circulating norepinephrine, as well as to an 
increased plasma volume. Side effects include recumbent hypertension, but to 
treat this compounds the primary problem of orthostasis.
2. HYPERVENTILATION SYNCOPE
Hyperventilation is a frequent cause of faintness or dizziness but rarely 
culminates in syncope. Common symptoms include lightheadedness, shortness 
of breath, circumoral numbness and tingling, and muscular twitching. Patho- 
physiologically, hypocapnia produces cerebral vasoconstriction and results in 
central nervous system hypoperfusion. Patients are usually between 20 and 40 
years of age, and women are affected far more frequently than men. The disor­
der is usually benign, with anxiety a prominent precipitant, but serious cardio­
pulmonary causes of hyperventilation or subjective dyspnea must be excluded. 
Symptoms commonly occur in the lying position, which can be diagnostically 
helpful. Patients often report prolonged unconsciousness, but upon close ques­
tioning this rarely proves to be true. Hyperventilation at the examiner's request 
often reproduces the symptoms.
3. COUGH SYNCOPE
Cough syncope occurs chiefly in middle-aged men with chronic obstruc­
tive pulmonary disease but has also been reported in children. Coughing need 
not be prolonged and immediately precedes unconsciousness, which may occur 
while the patient is supine. Prodromal symptoms are absent, and the duration of 
unconsciousness is brief -  often only a few seconds. Full recovery of conscious­
ness occurs immediately. A history of similar episodes is common, and symp­
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toms may be reproduced by having the patient cough on request. The cause may 
be a decrease in cerebral blood flow from increased intracranial pressure, which 
results from transmission of increased intrathoracic pressure to the intracranial 
compartment via the spinal fluid or venous connections. The condition is usually 
benign, and there is no specific treatment except for antitussive drugs such as 
dextromethorphan.
4. MICTURITION SYNCOPE
Micturition syncope occurs almost exclusively in men, probably because 
of the standing position for urination. Episodes can occur immediately before, 
during, or after micturition. They are more likely to occur at night following the 
prolonged recumbency of sleep and are due to peripheral pooling of blood plus a 
vagally induced bradycardia. Urination in a sitting position usually eliminates 
the symptoms.
5. GLOSSOPHARYNGEAL NEURALGIA
Glossopharyngeal neuralgia is a rare syndrome of intermittent, agonizing 
paroxysmal pain localized to the tonsillar pillar or occasionally to the external 
auditory meatus. The pain is triggered by contact with or movement of the ton­
sillar pillars, especially during swallowing or talking. Syncope occurs as a con­
sequence of the activation of a glossopharyngealvagal reflex arc, producing a 
transient bradyarrhythmia with resultant cerebral hypoperfusion. Car- 
bamazepine, 400-1000 mg/d orally, will prevent pain and bradycardia in most 
patients.
6. PSYCHOGENIC SYNCOPE
Psychogenic syncope is a diagnosis of exclusion and is often made erro­
neously. Suggestive features are lack of any prodrome, possible secondary gain, 
bizarre postures and movements, lack of pallor, and a prolonged period of ap­
parent unresponsiveness. Psychogenic spells rarely occur when the patient is 
alone and they rarely are associated with incontinence or result in injury. Most 
patients are young or have a well-documented history of conversion disorder. 
Without such a history, diagnosis after the third decade is suspect. The EEG dur­
ing psychogenic unconsciousness is normal, without the slowing that typically 
follows unconsciousness from a seizure. Caloric testing, which produces nys­
tagmus in conscious patients, and tonic eye deviation in unconscious patients, 
can distinguish psychogenic unresponsiveness from coma caused by a metabolic 
or structural lesion.
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MULTIPLE SCLEROSIS AND DEMYELINATING 
DISEASES
Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the 
central nervous system (CNS). MS lesions, characterized by perivascular infil­
tration of monocytes and lymphocytes, appear as indurated areas in pathologic 
specimens; hence, the term "sclerosis in plaques."
MS is a dynamic disease, with almost constant lesion formation and a 
progressive clinical course leading to physical disability. For every 8-10 new le­
sions detected on magnetic resonance imaging (MRI), only one clinical manifes­
tation typically can be demonstrated. Patients with relapsing remitting MS have 
an average of 20 new lesions per year and one or two clinical exacerbations.
With the advent of MRI, the ability to confirm the diagnosis of MS has 
improved dramatically. MRI characteristically shows lesions of high T2 signal 
intensity of variable location in the white matter of the brain, brain stem, optic 
nerves, or spinal cord. In typical cases, the lesions tend to occur in periventricu­
lar areas and may occur in the corpus callosum. Newer MRI techniques (eg, 
magnetization transfer, fluid attenuated inversion recovery [FLAIR], MR spec­
troscopy [MRS]) promise to yield important information regarding MS hetero­
geneity, prognosis, and treatment effects.
Despite intensive efforts at finding the source of the disease, no etiologie 
agent for MS has been identified. The disease presumably can be exacerbated by 
hormonal changes during the postpartum period. Some argue that MS could be a 
heterogeneous disorder triggered by several different environmental agents. In 
fact, only 1 of every 4 MS attacks is associated with a viral infection.
The disease can present in different forms, such as primary progressive, 
relapsing remitting, relapsing progressive, and secondary progressive pheno­
types. Genetic susceptibility factors may play a role, as the disease is more 
common in Caucasian populations living in northern latitudes. This susceptibil­
ity may be part of a complex and heterogeneous group of factors that have an 
impact, along with environmental factors, on the initiation and maintenance of 
disease. In addition, migration to high-risk areas before age 15 years is known to 
increase the risk of developing MS, lending further support to the environmental 
factor hypothesis.
Pathophysiology
MS is characterized by perivenular infiltration of lymphocytes and 
macrophages in the parenchyma of the brain, brain stem, optic nerves, and spi­
nal cord. Expression of adhesion molecules on the surface seems to underlie the 
ability of these inflammatory cells to penetrate the blood-brain barrier. The ele-
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vated immunoglobulin G (IgG) level in the cerebrospinal fluid (CSF), which can 
be demonstrated by an oligoclonal band pattern on electrophoresis, suggests an 
important humoral (ie, В cell activation) component to MS. In fact, variable de­
grees of antibody-producing plasma cell infiltration have been demonstrated in 
MS lesions.
Molecular studies of the white matter plaque tissue have shown that inter­
leukin (IL)-12, a potent pro-inflammatory substance, is expressed at high levels 
in early formed lesions.
■ A molecule required to stimulate lymphocytes to release pro- 
inflammatory cytokines, B7-1, also is expressed at high levels in early MS 
plaques.
• Evidence exists of higher frequencies of activated myelin-reactive T cell 
clones in the circulation of patients with relapsing remitting MS and 
higher IL-12 production in immune cells of patients with progressive MS, 
when compared to healthy controls.
■ The favorable clinical responses to the newer disease-modifying immu­
nomodulatory agents (ie, interferon beta-la and -lb, glatiramer acetate) 
suggest that these medications modify disease progression on the basis of 
their ability to counteract the pro-inflammatory phenotype of immune 
cells. However, MS is a complex and heterogeneous disease, and our un­
derstanding of the disease initiation mechanism and its wide clinical vari­
ability is limited.
Frequency
MS has a prevalence of nearly 350,000 cases in the United States alone. 
Every year, approximately 10,000 persons are newly diagnosed with MS. More 
than 1 million worldwide are affected. MS causes considerable disability in the 
working age group. People with MS usually die of complications rather than of 
MS itself, including recurrent infections (especially in bedridden patients). Pa­
tients with MS have an average life expectancy 7 years shorter than that of the 
general population. MS presents more often in populations of northern European 
ancestry. Whether disease severity also may be accounted for by racial differ­
ences is controversial. The concordance rate for MS is 20-40% among monozy­
gotic twins, suggesting the presence of predisposing genetic factors of non- 
Mendelian inheritance. MS affects females more than males (1.6-2:1), but the 
basis for this difference is unknown. This ratio is even higher (3:1) among pa­
tients in whom onset of MS is before age 15 years or after age 50 years, suggest­
ing a hormonal component to the disease process. Males have a greater tendency 
to develop primary progressive MS, while females tend to experience more re­
lapses. MS most commonly afflicts people between the ages of 18 and 50 years, 
but any age group can be affected.
355
Clinical presentation
Attacks or exacerbations of MS are characterized by new symptoms that 
reflect CNS involvement. These symptoms typically are separated in time (eg, 
weeks, months or years) and in anatomical location (eg, one or more limbs, optic 
nerve, sensory symptoms). Recognizing that physical and cognitive disability in 
MS may occur in the absence of clinical exacerbations is important.
Patients who improve after acute attacks have relapsing remitting MS 
(RRMS). However, during the natural course of RRMS, approximately 75-85% 
of patients enter a stage referred to as secondary progressive MS (SPMS).
Patients with primary progressive MS (PPMS) tend to accumulate disabil­
ity without interruption (ie, without remissions). Some of these patients first pre­
sent with weakness of only one limb, which gradually progresses to involve 
other limbs and culminates in total paralysis. Patients with PPMS typically re­
spond poorly to the current therapeutic options for MS, accumulate disability 
faster than other patients, and tend to have more weakness of the legs as well as 
incontinence (a reflection of greater spinal cord involvement).
Patients with PPMS tend to have more involvement of the spinal cord by 
demyelinating plaques. These cases must be differentiated from SPMS.
Patients who have RRMS but accumulate disability between and during 
attacks can be defined as having relapsing progressive disease (RPMS), a term 
not widely used by neurologists.
Although most patients have a wide range of symptoms from lesions in 
different areas of the brain and spinal cord, others may present with predomi­
nantly visual, cognitive, or cerebellar symptoms.
Patients with MS are now thought to reach a clinical threshold (itself a re­
flection of immune system dysfunction and axonal involvement), after which 
deterioration occurs in a continuous course and more ominous MRI signs be­
come apparent (eg, T1 hypointensities, brain atrophy). These T1 "holes" and 
signs of brain or spinal cord atrophy are a manifestation of a neurodegenerative 
process, indicating that MS is not only an inflammatory disease. The history will 
reflect these processes, as patients often report short-term memory problems, 
difficulty executing sequential tasks, or visuospatial disturbances.
Use of the term "benign MS" should be discouraged, since practically all 
patients have relentless progression of the disease, even in the absence of clini­
cal attacks. Not uncommonly, detailed examination of a patient with so-called 
"benign MS" encounters clear evidence of short-term memory difficulties, cog­
nitive dysfunction, or brain atrophy on MRI of the head. In the author's view, the 
use of the term "benign MS" leads to false expectations of disease outcome by 
the patients and their relatives, improper counseling, and inappropriate delay of 
treatment with disease-modifying drugs.
Patients with MS tend to experience variable degrees of fatigue. This 
symptom typically is described as either physical exhaustion or mental/cognitive 
slowing. It must be differentiated from depression (which may, however, coex­
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ist), lack of sleep, and exertional exhaustion due to disability. Patients may feel 
particularly fatigued after taking a hot shower or after strenuous activity in 
heated environments. Heat exposure also may lead to episodes of optic nerve 
dysfunction (ie, Uhthoff phenomenon), the mechanisms of which remain poorly 
understood.
Multiple sclerosis may present in an acute and clinically fulminant form 
(termed Marburg variant of MS) or may present with concomitant optic nerve 
involvement and necrotizing myelopathy (ie, neuromyelitis optica or Devic dis­
ease, considered by some to be an MS variant). However, MS must be distin­
guished from other neuroinflammatory disorders, including acute disseminated 
encephalomyelitis (ADEM), Schilder disease, and Baly concentric sclerosis.
■ ADEM is considered an isolated postinfectious or postvaccinial auto­
immune attack on the CNS that leads to diffuse demyelination. It is of­
ten devastating, and occasionally has a fulminant hemorrhagic compo­
nent (in which case it is termed acute hemorrhagic encephalomyelitis 
or leukoencephalitis of Weston Hurst).
■ Schilder disease is characterized in children and young adolescents by 
massive demyelination, presenting often as asymmetrical foci (often 
the size of an entire lobe) in the white matter by MRI, and presenting 
with a malignant course (ie, deterioration over months or a few years 
with cortical blindness, hemiplegia, or paraplegia). Some patients, 
however, may respond to steroids and immunosuppressive therapy.
■ Baly concentric sclerosis is considered by some authors to be a variant 
of Schilder disease, with MRI lesions showing a characteristic alternat­
ing pattern of spared and damaged white matter that suggests progres­
sion of the disease process from the ventricles outward. Baly disease 
often is associated with a more inflammatory CSF and a more fulmi­
nant progression than typical MS.
MS may present in various forms. Some patients have a predominance of 
cognitive changes, while others present with prominent ataxia, hemiparesis or 
paraparesis, depression, or visual symptoms. Bipolar disorder and frank demen­
tia may appear late in the disease course, but sometimes are found at the time of 
initial diagnosis. Symptoms can be exacerbated by intercurrent illness, including 
viral or bacterial upper respiratory or urinary tract infections. Trauma has no 
impact on disease exacerbation. The impact of emotional stress on exacerbations 
is probably minimal and remains controversial.
Optic neuritis presents clinically as orbital pain, at rest or during eye 
movement, and loss of vision. Patients may complain of "patchy loss of vision," 
and upon examination, a cecocentral scotoma and an afferent pupillary defect 
may be found. Patients may experience color desaturation even with normal vis­
ual acuity, usually manifested as the perception of red color as different shades 
of orange or gray.
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Patients with MS may present with facial palsies or trigeminal neuralgia. 
In fact, the presence of bilateral facial weakness or trigeminal neuralgia strongly 
suggests the diagnosis of MS. Facial myokymia also may be a presenting symp­
tom. Nystagmus (direction-changing) and internuclear ophthalmoplegia signs 
are other manifestations.
Painful limb syndromes are important to recognize. Commonly, patients 
complain of numbness or tingling in one or more limbs, variable weakness, or 
sensory level-related symptoms. Some have difficulty describing weakness or 
numbness, as these symptoms are obscured by incapacitating fatigue.
Episodes of central (as opposed to peripheral) vertigo are not uncommon. 
The nystagmus accompanying central vertigo has a rapid onset, does not fatigue 
easily, and changes with direction of gaze. CNS vertigo usually is accompanied 
by other complaints that can be directly attributed to brainstem or cerebellar 
pathway involvement (eg, diplopia, dysarthria).
An often overlooked manifestation of MS is the pseudobulbar affect, 
whereby patients have difficulty controlling their emotions (laughing, crying) 
and are perceived to act inappropriately by co-workers or friends. Behav- 
ioral/cognitive symptoms also may include social disinhibition, dementia, or de­
pression. A greater tendency for attempting and committing suicide in MS is not 
related exclusively to a reactive depression, since this tendency is higher than 
that of patients with other devastating neurological disorders such as chronic in­
flammatory demyelinating polyradiculopathy (CIDP). The neurologist should be 
aware that patients with conversion reactions and inappropriate affect, such as 
"la belle indifference," may on occasion have an underlying organic illness such 
as MS.
Urinary retention and incontinence are common. Bowel habit changes 
may occur, but bowel incontinence is less frequent.
Sexual dysfunction affects the great majority of patients with MS and in­
cludes symptoms such as lack of desire, erectile dysfunction, impaired sexual 
responsiveness, premature ejaculation, impaired genital sensation, or inability to 
physically interact with the partner due to painful leg adductor muscle spasms.
The Kurtzke Expanded Disability Status Scale (EDSS) is used as a meas­
ure of disease progression by assigning a severity score (0-10) to the patient's 
clinical status. Although the scale does not correspond linearly to common pro­
gression points for many patients, its widespread use and ease of implementation 
allow its utilization as a standardization measure for clinical trials (Kurtzke, 
1983).
Causes
The cause of MS is unknown. An environmental agent (eg, virus, bacteria, 
chemicals) has been hypothesized to act in concert with a specific genetic pre­
disposition (ie, a set of genes or polymorphisms) to result in immune dysfunc­
358
tion. For instance, different variants of genes normally found in the general 
population, commonly referred to as polymorphisms, may lead to different gra­
dations of cellular expression of those genes and, thus, of the proteins that they 
encode. Therefore, an individual with a polymorphism within the promoter re­
gion of a gene that is involved in immune reactivity may generate an exagger­
ated response (eg, elevated gene expression of a pro-inflammatory gene) to a 
given antigen, leading to uncontrolled immune cell proliferation and autoimmu­
nity.
Research on cytokine gene polymorphisms in MS is just beginning but 
promises to yield important clues about the pathogenesis of this disease. Genes 
encoding antigen presentation molecules such as the human leukocyte (HLA) 
antigens are highly polymorphic and have been shown to play a role in mediat­
ing MS susceptibility. For instance, MS has been associated, although not exclu­
sively, with the HLA-DR2 allele, and linkage of MS to genetic regions where 
the HLA genes lie also suggests a component of genetic predisposition.
Other molecules involved in activation of T and В cells have been impli­
cated in MS. For instance, the co-stimulatory molecule B7-1, necessary for acti­
vation of T cells as a second signal to antigen presentation, has been found to be 
elevated in early MS lesions, suggesting a triggering role for inflammation 
within the CNS. Other factors elevated in MS brain tissues include the pro- 
inflammatory interferon gamma and the pro-demyelinative tumor necrosis factor 
alpha molecule. In addition, interactions between molecules on the surface of В 
and T cells, such as CD40 and CD40 ligand, may mediate elevated levels of IL- 
12 (a pro-inflammatory cytokine) in the circulation of patients with MS.
The molecular mimicry hypothesis refers to the possibility that peripheral 
blood T cells may become activated to attack a foreign antigen, then erroneously 
direct their attack toward brain proteins that share similar protein epitopes.
Others support the hypothesis that a virus may infect the immune system, 
activating self-reactive T cells (myelin reactive) that would otherwise remain 
quiescent.
Different Diagnosis
Acute Disseminated Encephalomyelitis 
Atypical Facial Pain 
Brainstem Gliomas 
Central Pontine Myelinolysis 
Essential Tremor
HIV-1 Associated CNS Complications
HIV-1 Associated Opportunistic Infections: PML
HIV-1 Associated Opportunistic Neoplasms: CNS Lymphoma
HIV-1 Associated Vacuolar Myelopathy
HIV-1 Encephalopathy and AIDS Dementia Complex
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Hemifacial Spasm
Inherited Metabolic Disorders
Lyme Disease
Lysosomal Storage Disease
Metabolic Disease & Stroke: MELAS
Myokymia
Paraneoplastic Encephalomyelitis 
Primary CNS Lymphoma 
Primary Lateral Sclerosis 
Spinal Cord Infarction 
Sudden Visual Loss
Workout
Cerebrospinal fluid examination
Oligoclonal bands are distinct electrophoretic patterns that reflect substan­
tial elevation of IgG produced by a restricted set of plasma cells and are demon­
strated in CSF samples of approximately 85% of patients with MS.
Glucose level is usually normal. Protein level can be normal or slightly 
elevated. WBC count can be slightly to moderately elevated (6-40 x 109/L) but 
is usually <5 (predominantly mononuclear cells).
IgG index usually is elevated. This index is derived from the following 
formula: IgG Index= [IgGCsF/aIbumincsF]/[IgGserum/albuminscnim]
Although the sensitivity of measurements may vary among various laboratories, 
a typically normal CSF IgG is <4.7 mg/dL (less than 12% of serum protein), and 
the normal IgG index is <0.77. Most patients with MS have an elevated IgG 
index (>1.7).
Myelin basic protein (MBP) is a major component of myelin and may be 
elevated in the CSF of patients with MS. However, its clinical utility as a marker 
of disease activity or progression is limited.
Blood tests
Patients with MS and atypical features initially should be tested for B |2 
and folate levels or antinuclear antibody (ANA) titers. For instance, rapid cogni­
tive deterioration or evidence of subacute combined degeneration of the spinal 
cord by clinical examination should prompt testing for folate and B12 levels.
Anti-cardiolipin antibodies should be tested in patients with evidence of 
blood dyscrasia or in women with unexplained miscarriages.
An elevated erythrocyte sedimentation rate (ESR) and positive titers of 
rheumatoid factor (RF) should help identify the presence of a vasculitic disorder 
that may be mimicking MS.
If patients come from an endemic region for Lyme disease or have been 
exposed to tick bites, the physician should check Lyme titers. Evaluation by a
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rheumatologist should be sought if positive Lyme or ANA titer, elevated ESR, 
or evidence of vasculitis is uncovered.
If clinical suspicion for a peripheral neuropathy arises, electrophysiologi- 
cal studies and blood tests for metabolic or toxic neuropathies should be done.
Imaging Studies
MRI of head or spine, with and without gadolinium, should be performed 
according to clinical suspicion for lesion localization.
Typical MS lesions appear as T2 hyperintensities in the periventricular 
regions; they have an ovoid appearance with their largest axis oriented perpen­
dicular to the ventricular surface; they involve only the white matter, and several 
arise from the corpus callosum. This characteristic configuration has been dem­
onstrated in pathologic specimens and sometimes is referred to as "Dawson fin­
gers" on the basis of neuropathologic work done in 1916 at the University of Ed­
inburgh by James Dawson, who identified the perivascular distribution of in­
flammatory cells and the resulting fingerlike appearance of affected veins and 
venules in MS brain tissues.
The most common infratentorial locations for plaque formation are the 
surface of the pons, the cerebellar peduncles, and white matter regions adjacent 
to the fourth ventricle.
Lesions that enhance with gadolinium are thought to reflect active disease, 
as enhancement may correspond to breakdown of the blood-brain barrier from 
an ongoing subacute inflammatory process (few days to a few weeks). Usually a 
combination of enhancing and non-enhancing lesions is seen, reflecting the 
chronicity of the demyelinating process.
In a patient with a first clinical attack who presents with numerous (ie, 
>10) lesions by MRI, the presence of gadolinium enhancement in most or all the 
lesions is highly suggestive of ADEM; it is less likely to represent an extremely 
aggressive presentation of MS. A history of recent exposure to a vaccine or viral 
illness may be helpful in supporting the diagnosis of ADEM. However, note that 
exceptions occur and some patients with MS present with a fulminant and active 
demyelinative disease form from the onset.
Hypointensity of lesions in T1 images may reflect some degree of axonal 
damage or more chronic tissue damage resulting in gliosis. The clinician should 
attempt to correlate lesions with high T2 signal intensity with their correspond­
ing T1 images to assess chronicity. Although a lesion may appear old (low Tl), 
it may exhibit a ringlike enhancement around the hypointense region after gado­
linium, suggesting that even old lesions may have a component of active in­
flammation, especially at the advancing edge of lesion formation. Additionally, 
a new lesion may present with Tl hypointensity, reflecting marked edema. Le­
sions range from a few millimeters to more than a centimeter in diameter with 
occasional large, rounded, tumorlike lesions. The latter are seen as areas of pro­
nounced gliosis and demyelination on pathologic inspection.
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The application of modern MRI techniques to detection and characteriza­
tion of early lesions is changing rapidly. Recent MRI techniques such as FLAIR 
have increased the ability to detect demyelinating lesions due to MS. A disad­
vantage of FLAIR remains the less-than-optimal visualization of the posterior 
fossa. Other recent techniques such as fast FLAIR and fast spin-echo may in­
crease the sensitivity of prediction for diagnostic and prognostic purposes. Mag­
netization transfer ratio (MTR) abnormalities may precede the appearance of 
T2-weighted and proton-density high-intensity lesions. Finally, MRS, which can 
identify neutral fat, helps identify the appearance of myelin breakdown products 
that result from the active inflammatory response. Axonal loss is identified by 
the detection of reduced levels of A-acetylaspartate (NAA), a marker of neu­
ronal integrity/metabolism, on MRS.
Other Tests
Evoked potential testing (visual, auditory, or somatosensory) is especially 
helpful in 1) detecting clinically silent lesions, and 2) documenting an organic 
basis for vague complaints. The most sensitive are the visual evoked potentials 
(50-80% sensitivity), followed by the somatosensory potentials (50-70% sensi­
tivity).
Histologic Findings
Histopathologic examination reveals that MS lesions are caused by 
perivenular infiltration of lymphocytes (most of which are CD4+ T cells) and 
macrophages. Some lesions may have more infiltration by В cells. In fact, recent 
immunostaining reports by Lucchinetti et al show that MS lesions have consid­
erable heterogeneity of microscopic appearance, with some lesions exhibiting 
oligodendrocyte apoptosis and others marked complement and antibody pres­
ence. Luxol fast blue stains (which stain myelin with an intense blue) reveal de- 
myelinated areas as pale and confluent patches, with variable degrees of associ­
ated inflammation. Transected axons may be found in chronic and sometimes in 
acute MS lesions, as demonstrated by recent studies by Trapp and collaborators; 
these recent studies have helped refocus neurologists' attention to the issue of 
axonal loss in MS. Expression of interferon gamma, IL-12, and B7 molecules is 
increased, especially in early MS lesions; this reflects the inflammatory nature 
of plaque formation.
Treatment
Medical Care
Patients with MS have multiple needs, and the neurologist should be re­
ceptive and cooperative and try to allay fears, facilitate access to rehabilitation 
and orthotic equipment .and home evaluations, and solve transportation issues. 
Bone densitometry studies are indicated for patients with MS who have received
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long-term corticosteroid treatment or are at higher osteoporosis risk from meno­
pause or chronic immobility.
Patients with more advanced forms of the disease who have lost all family 
support, are separated from their spouses, require constant psychiatric and nurs­
ing assistance, and are unable to walk are not rare. These patients create a chal­
lenge for the physician who is not trained in handling these demanding (admin­
istrative or ancillary) aspects of medical care.
The physician should not underestimate the impact of fatigue symptoms 
on the patients daily activities. Treatment with amantadine (Symmetrel) or mo- 
dafinil (Provigil) should be attempted if no contraindications exist. Pemoline 
should be used with caution for the treatment of fatigue because of reports of 
rare fatal liver damage events in patients taking this medication.
Patients who have progressed beyond EDSS scores of 5.5-6 tend to re­
spond poorly to the current treatments.
The impact of this disease on quality of life is reflected in the high suicide 
rate (7.5 times higher than in the general population). As already stated, how­
ever, reactive depression by itself does not fully account for this higher suicide 
incidence. Many believe that the accumulation of lesions in the brain eventually 
has an impact on mood.
Thus, preventing disease progression by using available medications is 
imperative in MS treatment, especially for patients who have been diagnosed 
early and probably will respond to treatment.
Prevent disease progression by using the “ABC” immunomodulatory 
drugs (ie, interferon beta-la [Avonex], interferon beta-lb [Betaseron], and glati- 
ramer acetate [Copaxone]). These 3 medications have been approved by the US 
FDA and are currently used in the United States as therapies for MS. Although 
no specifically designed large-scale studies have been completed to date to 
compare the relative benefits of each drug, as a rule of thumb the ABC medica­
tions tend to decrease the rate of appearance of new MRI lesions by approxi­
mately one third.
Interferon beta-lb (8 MIU every other day) was shown in a 2-year, dou­
ble-blind, placebo-controlled trial of 372 patients with RRMS to decrease the 
frequency of relapses from 1.27/year to 0.84/year, a 34% reduction in the re­
lapse rate compared to placebo. Five-year follow-up data show that disease pro­
gression rate was 35% in the interferon beta-lb group and 46% in the placebo 
group. A 30% decrease in the yearly exacerbation rate in the treated group over 
5 years also was demonstrated. While the placebo group had a median MRI le­
sion burden of 30.2% over 5 years, no significant increase (3.6%) was detected 
in the patients treated with interferon beta-lb. Interferon beta-lb is of benefit in 
delaying disability in early SPMS.
Interferon beta-la was studied in a double-blind placebo-controlled study 
in 301 patients with RRMS receiving weekly intramuscular (IM) injections of 6 
million units (30 micrograms). Over 2 years the annual exacerbation (ie, relapse)
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rate was 0.90 in the placebo group and 0.61 in the Avonex-treated group, a 29% 
reduction. At 2 years, the mean MRI lesion volume was 122.4 in the placebo 
group and 74.1 in the Avonex-treated group. The mean number of MRI enhanc­
ing lesions over 2 years was 1.65 in the placebo group and 0.80 in the Avonex- 
treated group. By the end of 104 weeks, the proportion of patients progressing 
was 34.9% in the placebo group and 21.9% in the Avonex group. Also, 22% of 
patients on treatment developed neutralizing antibodies.
Recent results suggest that Avonex may help delay brain atrophy and 
cognitive decline in patients with MS, but more long-term data are needed to as­
sess the significance of its clinical impact.
Interferon beta-la was shown by the CHAMPS and ETOMS trials to de­
lay the onset of disease (ie, recurrent attacks) if administered to patients after an 
isolated demyelination event. Considerable controversy exists regarding whether 
the delay in onset of new attacks by these drugs ultimately has a long-term im­
pact on neurodegeneration and disability; these issues need to be addressed in 
future trials.
Controversy has also existed regarding the eventual clinical impact (posi­
tive or negative) of raising the dose of these medications to maximally tolerated 
levels — studies (INCOMIN trial study group) that compared the effects of in­
terferon beta-la administered subcutaneously (SC) and interferon beta-la ad­
ministered IM suggest that higher and more frequent doses correlate with higher 
efficacy. The EVIDENCE trial, which compared interferon beta-la SC (Rebif) 
to interferon beta-la IM, also found that higher dosing and more frequent ad­
ministration lead to more efficacy. However, in some patients, higher doses may 
increase the chance of generating neutralizing antibodies. Studies of combina­
tions of interferons with drugs such as methotrexate and glatiramer acetate are 
also underway.
Glatiramer acetate showed positive effects in a large randomized double­
blind trial in 251 patients with RRMS. Patients on Copaxone had a 2-year re­
lapse rate of 1.19, while patients on placebo had a rate of 1.68. The relapse rate 
reduction was 29% over 2 years for patients on Copaxone. Extension data show 
that over 140 weeks, 21.6% of patients treated with Copaxone worsened, while 
41% of those on placebo worsened. Recent results of an 18-month study exam­
ining the impact of Copaxone on MRI outcome show a 35% reduction in the 
number of new T2 lesions.
Acute exacerbations. No highly effective treatment is currently available 
to counteract MS attacks after their onset. The most widely used treatment is in­
travenous (IV) methylprednisolone, 1 g IV qd for 3-5 days. This medication may 
help expedite the timing of recovery but will not affect the actual degree of re­
covery.
High-dose IV steroids may work more effectively than oral steroids for 
the acute attack, and home IV therapy is recommended if the patient does not
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require hospitalization. Alternatively, high-dose oral methylprednisolone should 
be used, when feasible.
Secondary progressive forms. These patients may be treated with Beta- 
seron, especially when the clinical course reflects an early phase of progression 
(EDSS score <6). Betaseron is also effective for RRMS.
Mitoxantrone is approved in North America and Europe for use in patients 
with MS. Patients on mitoxantrone need to be monitored with echocardiograms 
prior to and during treatment, as the drug carries a risk of cardiomyopathy.
No head-to-head study has yet compared the efficacy of mitoxantrone and 
cyclophosphamide (Cytoxan) in large numbers of patients. When studied indi­
vidually, mitoxantrone seems effective for all ages tested. The data on cyclo­
phosphamide, in contrast, indicate that this drug may be more helpful to male 
patients younger than 40 years. Controversy exists whether patients with dra­
matic and rapid progression of disease (regardless of the type and timing of MS) 
should be treated with immunosuppressive agents to try and arrest the ongoing 
inflammatory cascade.
Azathioprine and methotrexate also may be used as immunosuppressive 
treatments for MS, but these drugs should not substitute for ABC drugs as first- 
line agents in newly diagnosed RRMS. They are considered less suppressive 
than mitoxantrone or cyclophosphamide, and are being considered increasingly 
as combination partners for the ABC drugs.
Surgical Care
Surgical procedures that relate to MS are directed primarily at alleviating 
symptoms such as dysphagia, significant limb spasticity or contractures, or se­
vere neuropathic pain. Measures include gastrojejunal tube placement, adductor 
leg muscle tendon release, and rhizotomy, respectively. Intrathecal pumps for 
delivery of antispasticity medications (eg, baclofen) can be implanted surgically. 
Penile prostheses are an alternative for patients with erectile dysfunction that 
does not respond to medical management.
Consultations
Because of the disseminated CNS involvement, patients with MS may re­
quire multiple consultations to rule out other causes for their symptoms. For in­
stance, patients with dysphonia may need an evaluation by an otolaryngologist 
(ie, ear, nose, and throat specialist) to rule out laryngeal lesions unrelated to MS. 
In addition, having MS does not exclude the possibility of concomitant periph­
eral neuropathy or other illnesses that may cause pain.
Listed below are the most common consultant services involved in refer­
rals from an MS clinic (Otolaryngology, Neuropsychology, Ophthalmology, 
Physical therapy and rehabilitation, Psychiatry, Gastroenterology, Urology). 
Gastric tube (G-tube) placement for feeding in advanced cases is an example. 
Urologie consultation might be warranted to help assess and treat incontinence. 
Neuropsychological evaluation, especially in patients with primary cognitive in­
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volvement, is advisable so that a baseline assessment for future reference can be 
obtained.
Diet
No specific dietary restrictions apply to patients with MS; patients are en­
couraged to eat a balanced diet. Oral intake of calcium and multivitamin sup­
plements is encouraged, as are adequate vitamin D sources. Although more stud­
ies are needed, recent observations suggest a role for vitamin D-related path­
ways in MS susceptibility.
Activity
Patients are encouraged to exercise regularly. Strenuous exercise and ex­
cessive exposure to heat and or physical exhaustion probably should be avoided; 
however, no studies have addressed this issue comprehensively in patients with 
MS. Patients with MS should avoid exposure to hot showers or saunas, as in­
creased body temperature has been associated with MS exacerbations. Sunlight 
by itself is not considered to be deleterious, but excessive exposure may mimic 
the effects seen with hot showers or high temperatures.
Medication
In the past 5 years, neuroimmunology has witnessed an unprecedented 
expansion in treatment options for CNS autoimmunity. Multiple MS drug trials 
are ongoing throughout the world, with many disappointments but occasional 
positive results.
Drugs for MS discussed in this article have been evaluated in clinical tri­
als that measure one or several of the following primary endpoints:
■ Delay in progression to disability
■ Reduction in relapse rate
■ Increase in the number of relapse-free patients
* Increase in the time to first relapse
■ Decreased MRI lesion burden, atrophy, and "T1 holes," or presence of 
new lesions
Patients should be educated and warned that these medications are pre­
ventive, not curative. Patients need to understand that mild sensory attacks may 
not warrant acute intervention with corticosteroids. Treatment of acute attacks 
should be reserved for functionally disabling symptoms and findings.
Therapeutic approaches such as combination therapy, intravenous immu­
noglobulin (IVIg), hormonal treatment, bone marrow transplantation, and plas­
mapheresis are not discussed here, as larger trials are needed for definitive rec­
ommendations. Combination therapy may be beneficial for some patients, how­
ever, and this practice may become commonplace within a few years. Treat­
ments that can be used as combination partners include methotrexate, azathio- 
prine, IVIg, and plasmapheresis. Briefly, treatments of choice include the fol­
lowing:
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■ Depression -  Fluoxetine (Prozac), sertraline (Zoloft), amitriptyline 
(Elavil)
■ Spasticity -  Baclofen, tizanidine, dantrolene, diazepam (Valium), 
intrathecal baclofen delivered via programmable pump
■ Painful tonic spasms -  Baclofen, carbamazepine (Tegretol), gabapentin 
(Neurontin), phenytoin
• Fatigue -  Amantadine, fluoxetine, methylphenidate (Ritalin), 
pemoline, selegiline, modafmil
■ Urinary dysfunction -  Propantheline bromide (Pro-Banthine), 
tolterodine tartrate, oxybutynin (Ditropan), imipramine (Tofranil); 
intermittent self-catheterization
■ Tremors/ataxia -  Clonazepam (Klonopin), primidone (Mysoline), 
propranolol (Inderal), gabapentin; weighted bracelets
■ Erectile dysfunction -  Sildenafil (Viagra), alprostadil (Muse), 
intracorporeal papaverine (not FDA approved), penile prostheses. Note 
that baclofen, fluoxetine, diazepam, and amitriptyline may contribute 
to sexual dysfunction (eg, decreased libido, erectile dysfunction, 
abnormal ejaculation).
Injection site reactions seen with the ABC (Avonex, Betaseron, Co­
paxone) drugs can be minimized by applying a topical steroid at the intended 
site a few hours prior to administration of the drug. These reactions include mild 
to severe erythema, skin induration or necrosis, and tissue loss or fibrosis, and 
may be complicated by superimposed bacterial infection.
Flu-like symptoms (commonly experienced with Avonex and Betaseron) 
can be minimized by taking over-the-counter acetaminophen or ibuprofen 3-4 
hours prior and 3-4 hours following the injection.
Acute exacerbations that lead to constant pain or to physical impairment 
may be treated with IV methylprednisolone. If available, alternative high-dose 
oral methylprednisolone treatment may circumvent the need for hospitalization.
Follow up
Prevention
Patients must understand that the ABC immunomodulatory drugs are pre­
ventive, not curative. Early treatment is thus essential. Patients should avoid ex­
posure to extreme heat. The impact of stress on MS exacerbations is thought to 
be minimal or noncontributory, and trauma has absolutely no impact on the dis­
ease course.
Complications
Complications in patients with MS include the following: Adverse drug 
reactions; Rare cases in which large, tumorlike demyelinating lesions necessitate 
brain biopsy to rule out malignancy. For bedridden patients, preventive meas­
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ures regarding decubitus ulcers, atelectasis, pneumonia, and aspiration should be 
addressed.
Seizures are rare in MS but may occur at a higher rate than in the general 
population. Patients with seizures who work in conditions of high risk for self- 
injury (eg, operating heavy machinery) should exercise caution, taking into ac­
count specific state laws. This also pertains to driving a motor vehicle.
Patients with ataxia and weakness are at increased risk of falls and per­
sonal injury; the physician should recognize these patients early and provide any 
needed assistance.
Prognosis
If untreated, more than 30% of patients with MS will develop significant 
physical disability within 20-25 years from onset. This prognosis is changing for 
these patients with the advent of new treatments. Male patients with PPMS have 
the worst prognosis, responding less favorably to treatment and rapidly accumu­
lating disability. The higher incidence of spinal cord lesions in PPMS is also a 
factor in the rapid development of disability. Fewer than 5-10% of patients have 
the benign MS phenotype, in which no significant physical disability accumu­
lates despite several decades passing since onset (sometimes in spite of multiple 
new lesions by MRI). Detailed examination of these patients in many instances 
reveals some degree of cognitive deterioration. The physician should remind pa­
tients that early treatment with some agents may help counteract the progressive 
brain atrophy seen on MRI.
Medical/Legal Pitfalls
Treatment of "presumed MS" is not indicated. The neurologist should 
have a fairly reasonable diagnosis based on history, clinical examination, and 
MRI findings. Treatment based on a suspected diagnosis can lead to unnecessary 
emotional and financial costs and should be avoided. Results of the CHAMPS 
trial suggest that interferon beta-1 a treatment of patients with a head MRI highly 
suggestive of advanced MS and an isolated clinical attack leads to some degree 
of protection from a second attack.
A common misconception is that any attack of demyelination means a di­
agnosis of acute MS and its implications for management. If a patient has the 
first attack of demyelination, the physician should not rush to diagnose MS. 
Postinfectious demyelination or other diseases that mimic MS should be consid­
ered carefully. Follow-up should be performed to ascertain whether the episode 
was self-limited. Although the CHAMPS and other trials suggest a benefit from 
early treatment, therapy for isolated demyelinating episodes with ABC medica­
tions has not yet become standard practice. The new McDonald diagnostic crite­
ria are helpful in the decision to treat patients early during the course of MS.
Clinicians who specialize in MS commonly see patients referred for mul­
tiple, ill-defined, vague complaints who had recent head or spine MRIs in which 
T2 hyperintense lesions have been demonstrated. Careful questioning reveals 
that symptoms have been stereotyped and vague or do not truly qualify as exac­
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erbations (eg, scintillating scotomas in a patient who also admits to concomitant 
migraines; symptoms consistent with carpal tunnel syndrome). A history of 
meningoencephalitis during childhood occasionally emerges and an explanation 
for the lesions may become obvious.
A third common problem is the presence of small T2 hyperintensities, 
typically referred to as "unidentified bright objects" (UBOs) by neuroradiolo­
gists. These nonspecific lesions are present to a large degree in the general popu­
lation, and clinical correlation (ie, a high degree of suspicion based on clinical 
evidence) becomes important in the diagnosis. The neurologist seeking to con­
firm MS should look for sites of involvement that are rare localities for UBOs 
(eg, corpus callosum or throughout the spinal cord).
Special Concerns
For the patient with MS who wants to become pregnant, ABC drugs 
should be discontinued. If the patient becomes pregnant during treatment, the 
drug should be discontinued immediately. The treatment can be resumed a few 
weeks after delivery or after the patient finishes her period of lactation.
ACUTE DISSEMINATED ENCEPHALOMYELITIS
This occurs as a single episode of neurologic symptoms and signs that de­
velop over a few days in association with a viral infection, especially measles or 
chickenpox. The neurologic deficit resolves, at least in part, over the succeeding 
few weeks. Pathologically, perivascular areas of demyelination are scattered 
throughout the brain and spinal cord, with an associated inflammatory reaction. 
A similar disorder may also occur independently, with no apparent infection; it 
may then represent the initial manifestation of multiple sclerosis.
The initial symptoms often consist of headache, fever, and confusion; sei­
zures may also occur, and examination reveals signs of meningeal irritation. 
Flaccid weakness and sensory disturbance of the legs, extensor plantar re­
sponses, and urinary retention are common manifestations of cord involvement. 
Other neurologic signs may indicate involvement of the optic nerves, cerebral 
hemispheres, brainstem, or cerebellum.
Examination of the CSF may show an increased mononuclear cell count, 
with normal protein and glucose concentrations.
Corticosteroids are often prescribed, but there is little evidence of benefit. 
A mortality rate of 5-30% is reported, and survivors often have severe residual 
deficits.
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AMYOTROPHIC LATERAL SCLEROSIS
Clinical features
Amyotrophic lateral sclerosis is the most feared motor neuron disease of 
adults, usually causing death within a few years. The first symptoms generally 
appear in the limbs but are bulbar in a quarter. Definite diagnosis requires the 
presence of both upper and lower motor neuron signs in the bulbar, arm, and leg 
musculature, with clear evidence of progression. But earlier on, particularly at 
the time of initial presentation, the disease is often more focal, only affecting 
one of these three regions of the body musculature.
Bulbar involvement causes dysphagia, drooling of saliva, dysphonia, or 
inhalation of foodstuffs due to varying combinations of weakness of the tongue, 
pharynx, or larynx. Lower motor neuron degeneration affecting the tongue 
shows as atrophy, fasciculation, and weakness. The tongue should be observed 
resting in the floor of the mouth, since attempts at protrusion produce pseudo- 
fasciculations in many normal people. Less frequently, weakness of the facial or 
trigeminal muscles causes leakage from the mouth or difficulty in chewing, re­
spectively. Predominantly upper motor neuron lesions cause spasticity of the 
tongue and dysarthria, resulting in 'hot potato speech'. Such patients may show 
other evidence of a pseudobulbar palsy, such as a brisk jaw jerk or incontinence 
of emotional expression, with bouts of laughter or tearfulness. Eventually these 
bulbar symptoms lead to anarthria, aphagia, choking, and a'spiration. Death 
eventually results from malnutrition, unless alternative routes for feeding are es­
tablished, or from respiratory failure, asphyxiation, or pneumonia.
The early symptoms of limb muscle denervation are usually cramps and 
fatigue, associated with observable fasciculations. Frequently such symptoms 
are ignored until symptomatic weakness and wasting of one hand or foot devel­
ops. Wasted small hand muscles or a foot drop are common early features. It is 
less common for proximal muscles, such as the shoulders, to be involved ini­
tially. Usually this first symptomatic limb remains that most severely affected 
until late in the disease. In the early stages of monomelic involvement, the pa­
tient may be investigated for alternative diagnoses, such as focal compressive 
neuropathy or a root lesion. However, clinical or electrophysiological evidence 
of denervation in muscles of other limbs is often detectable even in the very 
early stages. Over months, obvious weakness spreads to the opposite limb and 
eventually to remaining limbs and to the bulbar musculature. Eventually the pa­
tient becomes wheelchair- or bedbound, or unable to use the arms for grooming 
or feeding.
It is rare for spastic weakness due to upper motor neuron loss to be the 
dominant early symptom in the limbs. None the less, signs of upper motor neu­
ron involvement, such as extensor plan tars, hyperreflexia, or spastic catches, are
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often detectable early on. They are particularly valuable diagnostically if they 
coexist in a muscle, or a part of a limb, also affected by obvious lower motor 
neuron degeneration. In general, the tendon reflexes are retained until a muscle 
is almost completely denervated or the uncommon complication of fibrous re­
placement has supervened. An extensor plantar response cannot be elicited in 
severe extensor hallucis longus denervation, thereby sometimes masking the up­
per motor neuron involvement so necessary for diagnosing amyotrophic lateral 
sclerosis.
Respiratory muscle failure usually occurs in the wake of noteworthy bul­
bar muscle failure. Early and selective diaphragm involvement may occur in 
amyotrophic lateral sclerosis, occasionally as the presenting feature, and often 
merits ventilatory assistance in such cases. Exertional dyspnoea, orthopnoea, or 
difficulty in coughing out chest secretions are the common symptoms Less 
commonly symptoms such as concentration difficulty, headache, or giddiness 
occur from carbon dioxide retention due to ventilatory failure. Diaphragm 
weakness is signalled by orthopnoea, and the forced vital capacity is lower when 
lying down compared to standing, because the weight of the liver no longer aids 
diaphragm descent when supine. Less frequently, respiratory symptoms are due 
to intercostal muscle weakness which may be associated with severe weakness 
of other axial muscles. If there is weakness of neck extension the chin drops 
onto the sternum with resultant dysphagia, dysarthria, and visual difficulties 
Weakness of the abdominal wall leads to distension, difficulty in coughing pow­
erfully, and inability to build up intra-abdominal pressure for defecation.
Other neuronal systems apart from motor neurons are commonly involved 
m amyotrophic lateral sclerosis, although generally subclinically. Paraesthesia or 
other short-lived minor somatosensory phenomena are noted in the early stages 
m up to 10 per cent of patients. Longitudinal electrophysiological studies show 
progressive loss of sensory nerve fibre function during the course of the disease 
but none the less sensoiynerve action potentials usually remain within the nor­
mal range. Autopsy studies show loss of spinocerebellar tract neurons from 
C arke s nucleus, but one can only conclude that any corresponding clinical ef­
fects are overshadowed by the more severe limb weakness. Neuropsychological 
and positron emission tomography studies show impairments of cognitive func­
tion in up to 50 per cent of patients. However, these are rarely sufficient to pro­
duce thought deficits of everyday significance, nor indeed to blunt the patient's 
distressing awareness of being imprisoned within a body that can no longer 
move. Occasionally, rapidly progressive dementia occurs in association with 
motor neuron disease; or Parkinsonian features may develop simultaneously.
Micturition, defecation, and sexual function are not affected in amyotro­
phic lateral sclerosis, except in so far that trunk and limb muscle weakness may 
make such activities awkward or impractical. Despite this evidence of other neu­
ronal involvement on detailed investigation, as a general rule, any clear clinical
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evidence of neuronal involvement outside the motor system should raise ques­
tions about the validity of a diagnosis of amyotrophic lateral sclerosis.
Differential diagnosis and investigation
The diagnosis of amyotrophic lateral sclerosis is usually depressingly ob­
vious on simple clinical grounds by the time the patient sees a neurologist, and 
often nothing needs to be considered in the differential diagnosis. The usual di­
agnostic problem lies in differentiating amyotrophic lateral sclerosis from other 
motor neuron diseases, polyneuropathies, or myopathies. Electrophysiological 
investigation is necessary to confirm denervation rather than myopathy, to detect 
clinically inapparent denervation in asymptomatic limbs, and to rule out a poten­
tially treatable demyelinating or conduction block neuropathy. Patients present­
ing with the combination of arm muscle denervation coupled with upper motor 
neuron signs in the legs, require magnetic resonance imagining of the cervical 
spinal cord to rule out a compressive lesion, most usually spondylitic radiculo- 
myelopathy.
Paraproteinaemia is found in up to 5 per cent of motor neuron diseases, 
sometimes raising the question of an underlying lymphoid neoplasm. However, 
most paraproteinaemia-related motor neuron diseases are pure lower motor neu­
ron disorders, often motor neuropathies, rather than amyotrophic lateral sclero­
sis. An amyotrophic lateral sclerosislike disorder is seen occasionally to accom­
pany underlying lymphoproliferative disorders, treatment of which does not 
seem to help the neurological disease. Thyrotoxicosis or hyperparathyroidism 
are reported to simulate motor neuron disease occasionally, but this rarely 
proves to be an issue in everyday neurological practice. The serum creatine 
kinase level is often measured because of the question of myopathy, particularly 
in predominantly proximal and symmetric weakness, but it should be noted that 
moderate rises in this enzyme level often accompany the denervation of amy­
otrophic lateral sclerosis. If the question of myopathy persists, muscle biopsy 
should be undertaken; this can be particularly valuable where the presence of 
mild bulbar symptoms in patients with proximal weakness raises the question of 
an inclusion body myositis. Examination of the spinal fluid is rarely helpful in 
diagnosing motor neuron disease, and slight rises in the protein content occur in 
a few patients with amyotrophic lateral sclerosis. However, spinal fluid protein 
levels exceeding 1 g/1, especially if accompanied by lymphocytosis, should raise 
the question of an underlying tumour.
Inherited forms
Five to 10 per cent of amyotrophic lateral sclerosis is inherited, generally 
displaying autosomal dominance. There are no particular clinical features, or 
differences in survival, which distinguish the inherited forms. Usually the clini­
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cal phenotype is constant through the generations, but occasional pedigrees 
show mixtures of amyotrophic lateral sclerosis with spinal muscular atrophy or 
primary lateral sclerosis. Roughly 20 per cent of familial amyotrophic lateral 
sclerosis is associated with the 40 different missense mutations of the Cu/Zn su­
peroxide dismutase (SOD1) gene on chromosome 21, which catalyses conver­
sion of toxic superoxide anion radicals to hydrogen peroxide. The disease asso­
ciated with various SOD1 mutations shows varying degrees of penetrance and a 
variable phenotype. A slowly progressive form of amyotrophic lateral sclerosis 
occurs in Tunisia, with onset at 12 years of age (range 3-25 years), autosomal 
recessive inheritance, and usually with prominent bulbar involvement. It bears 
similarities to an early onset and relatively benign form seen in India, the so- 
called Madras form. A similar autosomal dominant form of juvenile onset amyo­
trophic lateral sclerosis, without significant bulbar or respiratory muscle weak­
ness and only slowly progressive, has been described in a large Maryland family 
and linked to chromosome 9, whereas the autosomal recessive forms have been 
linked to chromosome 2 or 15.
Pathology and aetiology
The most striking neuropathological change is loss of large motor neurons 
from the anterior horns of the cervical and lumbar enlargements of the spinal 
cord. Similar loss occurs from the hypoglossal and other motor nuclei of the 
brainstem but the ocular motor nuclei are rarely affected.
Spheroids, composed of interwoven bundles of disorganized neurofila­
ments, are evident in the proximal axons of motor neurons in the anterior horn in 
two-thirds of sporadic cases. These spheroids within the proximal axon are a 
distinctive feature, appearing as an early pathological change in motor neurons. 
Intracytoplasmic inclusions in motor neurons, known as Bunina bodies, are also 
characteristic. Loss or shrinkage of giant Betz cells from the precentral gyrus of 
the cerebral cortex is associated with fibre loss from the pyramidal tracts, par­
ticularly obviously in the spinal cord and lower brainstem. At autopsy of ad­
vanced cases there is often evidence of a lesser degree of neuronal loss from 
other areas of the nervous system, including dorsal root ganglia and the dorsal 
(Clarke's) nuclei of the spinal cord.
The cause of sporadic amyotrophic lateral sclerosis is unknown. There is 
evidence for various risk factors, but none are invariably associated and it is 
possible that motor neuron degeneration is a singular expression of diverse 
aetiological factors. Particular associations with rural populations and with 
trauma have been noted. Many have searched inconclusively for a viral cause 
for amyotrophic lateral sclerosis; recent tantalizing evidence, yet to be con­
firmed, showed enterovirus nucleic acid sequences in anterior horn neurons in 
88 per cent of affected spinal cords, compared to only 3 per cent o f  controls. 
Given the superoxide dismutase (SOD1) mutation underlying some cases of he­
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reditary amyotrophic lateral sclerosis, it will be interesting to discover whether 
acquired disorders of free-radical detoxication underlie the sporadic form of the 
disease. A motor neuron degeneration occurs in transgenic mice expressing hu­
man mutant SOD1; such models provide the potential for screening new thera­
pies. Transgenic mice overexpressing a neurofilament subunit develop progres­
sive weakness with massive accumulations within motor neurons of neurofila­
ments resembling spheroids. Synaptosomes derived from affected regions of 
spinal cord in amyotrophic lateral sclerosis show defective uptake of the poten­
tially toxic excitatory amino-acid neurotransmitter, glutamate. This observation 
led to the glutamate excitotoxicity hypothesis from which the drug riluzole was 
developed.
Epidemiology
Amyotrophic lateral sclerosis occurs throughout the world. Traditionally 
the incidence has been considered to lie between 0.4 and 1.8 per 100000, and the 
prevalence 4-6 per 100000. More contemporary studies with more confident as­
certainment note that many elderly patients are diagnosed often outside neurol­
ogy departments, and that there is an increasing incidence with age, leading to 
incidences of 2.25-2.6 per 100 000 in Denmark and Scotland. Case-control stud­
ies do not identify any ubiquitous risk factor, although the odds ratios are in­
creased by previous long-bone fractures, manual work, and occupational expo­
sures to lead, solvents, or chemicals. Men are up to twice as commonly affected 
as women. On the Pacific island of Guam, the incidence of motor neuron dis­
ease, often associated with parkinsonism and dementia, has fallen from 87 per 
100000 in 1962 to 5 per 100000 in 1985. The reasons for the previous high inci­
dence in Guam are unknown, speculation has centred around the possible role of 
a dietary excitotoxin found in the locally consumed Gycas circinalis flour and 
upon dietary consumption of calcium and aluminium.
Prognosis and treatment
The severity and extensiveness of muscular weakness progress remorse­
lessly in amyotrophic lateral sclerosis. Death results generally from ventilatory 
respiratory failure; inhalational pneumonia, or choking and malnutrition may 
contribute. Bedsores are relatively infrequent despite the immobility of many 
patients. There is an increased vulnerability to longbone fractures.
Patients with a bulbar onset have the worst prognosis. Their median sur­
vival is approximately 20 months from the onset of bulbar symptoms, with only 
5 per cent surviving at 5 years. Median survival for those with spinal onset is 
somewhat better, at 29 months, with nearly 15 per cent surviving at 5 years. It 
seems that mortality has increased in recent decades and that this cannot be ex­
plained solely by the increasing age of the population. Alternative diagnoses,
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such as X-linked bulbospinal neuronopathy, should be considered in those pa­
tients surviving for an unexpectedly long time. Occasional patients have a 
subacute and reversible syndrome resembling the spinal form of amyotrophic 
lateral sclerosis without bulbar involvement, and recover spontaneously within 
5-12 months of symptom onset. Such cases are so extraordinarily rare that they 
should not affect the physician's prognostication.
Trials of drug therapy have concentrated upon slowing the downhill pro­
gression of disability or improving survival. The antiglutamate agent riluzole, 
administered orally, has been licensed for treatment of amyotrophic lateral scle­
rosis. The 100 mg dosage improved the chance of tracheostomy-free survival at 
18 months by an extra 35 per cent, although there was no significant benefit on 
muscle function. Criticisms of this study have included the nature of the Cox 
model statistical adjustment, and it should be noted that more of the placebo 
group had bulbar features at entry to the study. Riluzole is generally well toler­
ated by patients; nausea, gastrointestinal upset, and raised transaminase enzyme 
levels may occur, and usually resolve with dosage reduction. Ineffective thera­
peutic trials have included mixtures of branched-chain amino acids, dextro­
methorphan, total lymphoid irradiation, and the free-radical scavenger, acetyl­
cysteine.
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SPINAL CORD DISORDERS
Cord lesions can lead to motor, sensory, or sphincter disturbances or to 
some combination of these deficits. Depending upon whether it is unilateral or 
bilateral, a lesion above C5 may cause either an ipsilateral hemiparesis or quad- 
riparesis. With lesions located lower in the cervical cord, involvement of the up­
per limbs is partial, and a lesion below T1 affects only the lower limbs on one or 
both sides. The unilateral involvement of the posterior columns of the cord leads 
to ipsilateral loss of position and vibration sense. In addition, any disturbance in 
function of the spinothalamic tracts in the anterolateral columns impairs contra­
lateral pain and temperature appreciation below the level of the lesion.
Spasticity is a common accompaniment of upper motor neuron lesions 
and may be especially troublesome below the level of the lesion in patients with 
myelopathies. When the legs are weak, the increased tone of spasticity may help 
to support the patient in the upright position. Marked spasticity, however, may 
lead to deformity, interfere with toilet functions, and cause painful flexor or ex­
tensor spasms. Pharmacologic management includes treatment with diazepam, 
baclofen, dantrolene, or tizanidine, but reduction in tone may lead to increased 
disability from leg weakness.
TRAUMATIC MYELOPATHY
While cord damage may result from whiplash (recoil) injury, severe injury 
to the cord usually relates to fracture-dislocation in the cervical, lower thoracic, 
or upper lumbar region.
Clinical Findings
A. Total Cord Transection. Total transection results in immediate per­
manent paralysis and loss of sensation below the level of the lesion. Although 
reflex activity is lost for a variable period after the injury, a persistent increase in 
reflex function follows.
1. In the acute stage, there is flaccid paralysis with loss of tendon and 
other reflexes, accompanied by sensory loss and by urinary and fecal retention. 
This is the stage of spinal shock.
2. Over the following weeks, as reflex function returns, the clinical picture 
of a spastic paraplegia or quadriplegia emerges, with brisk tendon reflexes and 
extensor plantar responses; however, a flaccid, atrophic (lower motor neuron) 
paralysis may affect muscles innervated by spinal cord segments at the level of
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the lesion, where anterior horn cells are damaged. The bladder and bowel now 
regain some reflex function, so that urine and feces are expelled at intervals.
3. Flexor or extensor spasms of the legs may become increasingly trou­
blesome and are ultimately elicited by even the slightest cutaneous stimulus, es­
pecially in the presence of bedsores or a urinary tract infection. Eventually, the 
patient assumes a posture with the legs in flexion or extension, the former being 
especially likely with cervical or complete cord lesions.
B. Less Severe Injury. With lesser degrees of injury, the neurologic defi­
cit is less severe and less complete, but patients may be left with a mild para­
paresis or quadriparesis or a distal sensory disturbance. Sphincter function may 
also be impaired urinary urgency and urgency incontinence are especially com­
mon. Hyperextension injuries of the neck can lead to focal cord ischemia that 
causes bibrachial paresis (weakness of both arms) with sparing of the legs and 
variable sensory signs.
Treatment
A. Immobilization. Initial treatment consists of immobilization until the 
nature and extent of the injury are determined. If there is cord compression, ur­
gent decompressive surgery will be necessary. An unstable spine may require 
surgical fixation, and vertebral dislocation may necessitate spinal traction.
B. Corticosteroids. Corticosteroids (eg, methylprednisolone, 30 mg/kg 
intravenous bolus, followed by intravenous infusion at 5.4 mg/kg/h for 24 hours) 
can improve motor and sensory function at 6 months when treatment is begun 
within 8 hours of traumatic spinal cord injury. The mechanism of the action is 
unknown, but it may involve the inhibition of lipid peroxidation and the im­
provement of blood flow to the injured spinal cord.
C. Painful Spasms. Painful flexor or extensor spasms can be treated with 
drugs that enhance spinal inhibitory mechanisms (baclofen, diazepam) or un­
couple muscle excitation from contraction (dantrolene). Baclofen should be 
given 5 mg orally twice daily to 30 mg four times daily; diazepam, 2 mg orally 
twice daily up to as high as 20 mg three times daily; and dantrolene, 25 mg/d 
orally to 100 mg four times daily. Tizanidine, a central a2-agonist, is as effective 
as these other agents but its precise mechanism of action is unclear. The daily 
dose is built up gradually, usually to 8 mg three times daily. Side effects include 
dryness of the mouth, somnolence, and hypotension, but the drug is usually well 
tolerated. Patients who fail to benefit from or who cannot tolerate sufficient 
doses of oral medications may respond to intrathecal infusion of baclofen.
All these drugs may increase functional disability by reducing tone. Dan­
trolene may also increase weakness and should be avoided in patients with se­
verely compromised respiratory function.
D. Skin Care. Particular attention must be given to skin care, avoiding 
continued pressure on any single area.
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E. Bladder and Bowel Disorders. Depending on the severity of the in­
jury, catheterization may be necessary initially. Subsequently, the urgency and 
frequency of the spastic bladder may respond to a parasympatholytic drug such 
as oxybutinin, 5 mg three times daily. Suppositories and enemas will help main­
tain regular bowel movements and may prevent or control fecal incontinence.
CHRONIC ADHESIVE ARACHNOIDITIS
This inflammatory disorder is usually idiopathic but can follow subarach­
noid hemorrhage; meningitis; intrathecal administration of penicillin, radiologic 
contrast materials, and certain forms of spinal anesthetic; trauma; and surgery.
The usual initial complaint is of constant radicular pain, but in other cases 
there is lower motor neuron weakness because of the involvement of anterior 
nerve roots. Eventually, a spastic ataxic paraparesis develops, with sphincter in­
volvement. CSF protein is elevated, and the cell count may be increased. Mye­
lography shows a characteristic fragmentation of the contrast material into pock­
ets; MRI may disclose inflammation. Treating this aseptic inflammatory lepto- 
meningeal process with steroids or with nonsteroidal anti-inflammatory analge­
sics may be helpful. Surgery may be indicated in cases with localized cord in­
volvement.
VASCULAR MYELOPATHIES
Infarction of the Spinal Cord
This rare event generally occurs only in the territory of the anterior spinal 
artery. This artery, which supplies the anterior two-thirds of the cord, is itself 
supplied by only a limited number of feeding vessels, while the paired posterior 
spinal arteries are supplied by numerous feeders at many different levels. Thus, 
anterior spinal artery syndrome usually results from interrupted flow in one of 
its feeders. Causes include trauma, dissecting aortic aneurysm, aortography, 
polyarteritis nodosa, and hypotensive crisis. Since the anterior spinal artery is 
particularly well supplied in the cervical region, infarcts almost always occur 
more caudally.
The typical clinical presentation is with the acute onset of a flaccid, are- 
flexic paraparesis that, as spinal shock wears off after a few days or weeks, 
evolves into a spastic paraparesis with brisk tendon reflexes and extensor plantar 
responses. In addition, there is dissociated sensory impairment-pain and tem­
perature appreciation are lost, but there is sparing of vibration and position sense 
because the posterior columns are supplied by the posterior spinal arteries.
Hematomyelia
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Hemorrhage into the spinal cord is rare; it is caused by trauma, a vascular 
anomaly, a bleeding disorder, or anticoagulant therapy. A severe cord syndrome 
develops acutely and is usually associated with blood in the CSF. The prognosis 
depends on the extent of the hemorrhage and the rapidity with which it occurs.
Epidural or Subdural Hemorrhage
Spinal epidural or subdural hemorrhage can occur in relation to trauma or 
tumor and as a complication of anticoagulation, aspirin therapy, thrombocytope­
nia, coagulopathy, epidural catheters, or lumbar puncture. It occasionally occurs 
spontaneously. The likelihood of hemorrhage following lumbar puncture -  usu­
ally epidural in location -  is increased when a disorder of coagulation is present. 
Therefore the platelet count, prothrombin time, and partial thromboplastin time 
should be determined before lumbar puncture is performed, and if anticoagulant 
therapy is to be instituted, it should be delayed for at least 1 hour following the 
procedure. Patients with less than 20,000 platelets/mm3 or those with rapidly fal­
ling counts (as high as 50,000) should be transfused prior to lumbar puncture. 
Spinal epidural hemorrhage usually presents with back pain that may radiate in 
the distribution of one or more spinal nerve roots; it is occasionally painless. 
Paraparesis or quadriparesis, sensory disturbances in the lower limbs, and bowel 
^ b l a d d e r  dysfunction may develop rapidly, necessitating urgent CT scan 
MRI, or myelography, and surgical evacuation of the hematoma.
Arteriovenous Malformation (AVM)
This may present with subarachnoid hemorrhage or with myelopathy 
Most of these lesions involve the lower part of the cord. Symptoms include mo­
tor and sensory disturbances in the legs and disorders of sphincter function. Pain 
in the legs or back is often conspicuous. On examination, there may be an upper 
a lower, or a mixed motor deficit in the legs, while sensory deficits are usually 
extensive but occasionally radicular; the signs indicate an extensive lesion in the 
ongitudinal axis of the cord. In patients with cervical lesions, symptoms and 
signs may also be present in the arms. A bruit is sometimes audible over the 
spine, and there may be a cutaneous angioma. The diagnosis is suggested by the 
MRI appearance and the myelographic finding of serpiginous filling defects 
caused by enlarged vessels, and it is confirmed by selective spinal arteriography. 
Spinal MRI is sometimes normal despite the presence of an AVM and therefore 
cannot be relied upon to exclude this diagnosis.
Most lesions are extramedullary and posterior to the cord; they can be 
treated by embolization or by ligation of feeding vessels and excision of the 
anomalous arteriovenous nidus of the malformation, which is usually dural in 
location. Left untreated, the patient is likely to become increasingly disabled un­
til chair or bed-bound.
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CERVICAL SPONDYLOSIS
Cervical spondylosis is characterized by any or all of the following: pain 
and stiffness in the neck; pain in the arms, with or without a segmental motor or 
sensory deficit in the arms; and an upper motor neuron deficit in the legs. It re­
sults from chronic cervical disk degeneration, with herniation of disk material, 
secondary calcification, and associated osteophytic outgrowths. It can lead to in­
volvement of one or more nerve roots on either or both sides and to myelopathy 
related to compression, vascular insufficiency, or recurrent minor trauma to the 
cord.
Patients often present with neck pain and limitation of head movement or 
with occipital headache. In some cases, radicular pain and other sensory distur­
bances occur in the arms, and there may be weakness of the arms or legs. Ex­
amination commonly reveals restricted lateral flexion and rotation of the neck. 
There may be a segmental pattern of weakness or dermatomal sensory loss in 
one or both arms, along with depression of those tendon reflexes mediated by 
the affected root(s). Cervical spondylosis tends to affect particularly the C5 and 
C6 nerve roots, so there is commonly weakness of muscles (eg, deltoid, supra- 
and infraspinatus, biceps, brachioradialis) supplied from these segments, pain or 
sensory loss about the shoulder and outer border of the arm and forearm, and 
depressed biceps and brachioradialis reflexes. If there is an associated myelopa­
thy, upper motor neuron weakness develops in one or both legs, with concomi­
tant changes in tone and reflexes. There may also be posterior column or spi­
nothalamic sensory deficits.
Plain x-rays show osteophyte formation, narrowing of disk spaces, and 
encroachment on the intervertebral foramina. MRI, CT scanning, or even mye­
lography may be necessary to confirm the diagnosis and exclude other structural 
causes of myelopathy. The CSF obtained at the time of myelography is usually 
normal, but the protein concentration may be increased, especially if there is a 
block in the subarachnoid space. Electrophysiologic studies, especially needle 
electromyography, are helpful in identifying a radiculopathy and in determining 
whether degenerative anatomic abnormalities of the cervical spine are of any 
clinical relevance.
Spondylotic myelopathy may resemble myelopathy caused by such disor­
ders as multiple sclerosis, motor neuron disease, subacute combined degenera­
tion, cord tumor, syringomyelia, or hereditary spastic paraplegia. Moreover, de­
generative changes in the spine are common in the middle-aged and elderly and 
may coincide with one of these other disorders.
Treatment with a cervical collar to restrict neck movements may relieve 
any pain. Operative treatment may be necessary to prevent further progression if 
there is a significant neurologic deficit; it may also be required if the root pain is 
severe, persistent, and unresponsive to conservative measures.
380
CONGENITAL ANOMALIES
A combination of corticospinal and cerebellar signs may be found in the 
limbs of patients with congenital skeletal abnormalities such as platybasia (flat­
tening of the base of the skull) or basilar invagination (an upward bulging of the 
margins of the foramen magnum). Syringomyelia (cavitation of the cord), which 
can be congenital or acquired, may lead to a lower motor neuron deficit, a disso­
ciated sensory loss in the arms, and upper motor neuron signs in the legs. Be­
cause the sensory findings are so characteristic, this disorder, which is fre­
quently associated with Arnold-Chiari malformation.
SYRINGOMYELIA
Syringomyelia is cavitation of the spinal cord. Communicating syringo­
myelia -  with communication between the central canal of the cord and the cav­
ity -  is a hydrodynamic disorder of the CSF pathways. In noncommunicating 
syringomyelia, there is cystic dilation of the cord, which is not in communi­
cation with the CSF pathways. The precise clinical disturbance that results de­
pends upon the site of cavitation. Typically, there is a dissociated sensory loss 
at the level of the lesion; pinprick and temperature appreciation are impaired, 
but light touch sensation is preserved. The sensory loss may be reflected by the 
presence of painless skin ulcers, scars, edema, hyperhidrosis, neuropathic joints, 
resorption of the terminal phalanges, and other disturbances. Weakness and 
wasting of muscles occur at the level of the lesion because of the involvement of 
the anterior horns of the cord. A pyramidal deficit and sphincter disturbances 
sometimes occur below the level of the lesion because of gliosis or compression 
of the corticospinal pathways in the lateral columns of the cord. The tendon re­
flexes may be depressed at the level of the lesion -  because of interruption of 
their afferent, central, or efferent pathways -  and increased below it. Scoliosis is 
a common accompaniment of cord cavitation. Cavitation commonly occurs in 
the cervical region; this can cause a cape-like distribution of sensory loss over 
one or both shoulders, diffuse pain in the neck, and radicular pain in the arms; 
involvement of the T1 segment frequently leads to ipsilateral Homer's syn­
drome. If the cavitation involves the lower brainstem (syringobulbia), there may 
also be ipsilateral tongue wasting, palatal weakness, vocal cord paralysis, disso­
ciated trigeminal sensory loss, and other evidence of brainstem involvement.
Communicating syringomyelia is often associated with developmental 
anomalies of the brainstem and foramen magnum region (Arnold-Chiari mal­
formation) or with chronic arachnoiditis of the basal cisterns. Amold-Chiari 
malformation can lead to hydrocephalus, cerebellar ataxia, pyramidal and sen­
sory deficits in the limbs, and abnormalities of the lower cranial nerves, alone or
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in any combination. Myelography, MR1, or CT scanning of the foramen mag­
num region confirms the diagnosis. Treatment is surgical.
Noncommunicating syringomyelia is often due to trauma, intrame­
dullary tumors, or spinal arachnoiditis. Posttraumatic syringomyelia generally 
occurs in patients with preexisting, severe neurologic deficits from spinal trauma 
after an interval of several years, although rarely it may develop only a few 
months after the original injury. Presentation is with increase in a previously 
stable deficit; weakness, impaired sensation, and spasticity are often conspicu­
ous, and radicular pain may be distressing.
Treatment depends upon the underlying cause. Decompression of a dis­
tended syrinx may provide transient benefit. In the case of communicating sy­
ringomyelia associated with Amold-Chiari malformation, removal of the poste­
rior rim of the foramen magnum and amputation of the cerebellar tonsils are 
sometimes helpful. The cord cavity should be drained, and, if necessary, an out­
let should be made for the fourth ventricle. Posttraumatic syringomyelia is 
treated by surgery if it is causing a progressive neurologic deficit or intolerable 
pain. A variety of surgical approaches have been used, including various drain­
ing procedures from the cord cavity, myelotomy, and formation of surgical men­
ingocele. Radicular pain and sensory disturbances are usually helped, whereas 
spasticity responds less satisfactorily.
SUBACUTE COMBINED DEGENERATION (VITAMIN BI2
DEFICIENCY)
Vitamin B12 deficiency may result from impaired absorption by the gas­
trointestinal tract such as occurs in pernicious anemia or because of gastrointes­
tinal surgery, sprue, or infection with fish tapeworm; it can also be caused by a 
strictly vegetarian diet. It may affect the spinal cord, giving rise to the syndrome 
of subacute combined degeneration. Onset is with distal paresthesias and weak­
ness in the extremities (involvement of the hands occurs relatively early), fol­
lowed by the development of spastic paraparesis, with ataxia from the impair­
ment of postural sensation in the legs. Lhermitte's sign may be present, and ex­
amination reveals a combined posterior column (vibration and joint position 
sense) and pyramidal deficit in the legs. Plantar responses are extensor, but ten­
don reflexes may be increased or depressed, depending on the site and severity 
of the involvement. Signs of cord involvement can be accompanied by centroce- 
cal scotoma or optic atrophy from optic (II) nerve involvement, by behavioral or 
psychiatric changes, or by peripheral neuropathy. The neurologic manifestations 
are often accompanied by macrocytic megaloblastic anemia, but this is not in­
variably present.
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The serum vitamin B|2 level is low in untreated cases. If malabsorption of 
vitamin B|2 is the cause, the Schilling test is abnormal, and there is usually gas­
tric achlorhydria with pernicious anemia. Hematologic findings may be normal, 
however, especially if folic acid supplements have been given.
Treatment is with vitamin B,2 given by intramuscular injection daily (50- 
1000 pg) for 2 weeks, then weekly (100 pg) for 2 months, and monthly (100 pg) 
thereafter. Note that folic acid supplements do not help the neurologic disorder; 
in addition, they may mask associated anemia.
TABES DORSALIS
This type of neurosyphilis, now rare, is characterized mainly by sensory 
symptoms and signs that indicate marked involvement of the posterior roots, es­
pecially in the lumbosacral region, with resulting degeneration in the posterior 
columns of the spinal cord. Common complaints are of unsteadiness, sudden 
lancinating somatic pains, and urinary incontinence. Visceral crises character­
ized by excruciating abdominal pain also occur. Examination reveals marked 
impairment of vibration and joint position sense in the legs, together with an 
ataxic gait and Romberg's sign. Deep pain sensation is impaired, but superficial 
sensation is generally preserved. The bladder is often palpably enlarged; because 
it is flaccid and insensitive, there is overflow incontinence. Tendon reflexes are 
lost, and the limbs are hypotonic. Sensory loss and hypotonicity may lead to the 
occurrence of hypertrophic (Charcot) joints. In many patients there are other 
signs of neurosyphilis, including Argyll Robertson pupils, optic atrophy, ptosis, 
a variable ophthalmoplegia, and, in some cases, pyramidal and mental changes 
from cerebral involvement (taboparesis). Treatment is of the underlying infec­
tion.
TUMORS & CORD COMPRESSION
Common causes of cord compression are disk protrusion, trauma, and tu­
mors; in certain parts of the world, tuberculous disease of the spine is also a fre­
quent cause. Rare but important causes include epidural abscess and hematoma.
Classification
Tumors can be divided into two groups: intramedullary (10%) and ex­
tramedullary (90%). Ependymomas are the most common type of intramedullary 
tumor, and the various types of gliomas make up the remainder. Extramedullary 
tumors can be either extradural or intradural in location. Among the primary ex­
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tramedullary tumors, neurofibromas and meningiomas are relatively common 
and are benign; they can be intra- or extradural. Carcinomatous metastases (es­
pecially from bronchus, breast, or prostate), lymphomatous or leukemic depos­
its, and myeloma are usually extradural.
Clinical Findings
Irrespective of its nature, a tumor can lead to cord dysfunction and a neu­
rologic deficit by direct compression, ischemia secondary to arterial or venous 
obstruction, or, in the case of intramedullary lesions, by invasive infiltration.
A. Symptoms. Symptoms may develop insidiously and progress gradu­
ally or -  as is often the case with spinal cord compression from metastatic carci­
noma-exhibit a rapid course.
Pain is a conspicuous feature -  and usually the initial abnormality -  in 
many patients with extradural lesions; it can be radicular, localized to the back, 
or experienced diffusely in an extremity and is characteristically aggravated by 
coughing or straining.
Motor symptoms (heaviness, weakness, stiffness, or focal wasting of one 
or more limbs) may develop, or there may be paresthesias or numbness, espe­
cially in the legs. When sphincter disturbances occur, they usually are particu­
larly disabling.
B. Signs. Examination sometimes reveals localized spinal tenderness. In­
volvement of anterior roots leads to an appropriate lower motor neuron deficit, 
and involvement of posterior roots leads to dermatomal sensory changes at the 
level of the lesion. Involvement of pathways traversing the cord may cause an 
upper motor neuron deficit below the level of the lesion and a sensory deficit 
with an upper level on the trunk. The distribution of signs varies with the level 
of the lesion and may take the form of Brown-Sequard or central cord syndrome.
Investigative Studies
The CSF is often xanthochromic, with a greatly increased protein concen­
tration, a normal or elevated white blood cell count, and normal or depressed 
glucose concentration; Queckenstedt's test at lumbar puncture may reveal a par­
tial or complete block. A plain x-ray of the spine mayor may not be abnormal, 
and myelography, CT scanning, or MRI is necessary to delineate the lesion and 
localize it accurately.
Treatment
Treatment depends upon the nature of the lesion. Extradural metastases 
must be treated urgently. Depending upon the nature of the primary neoplasm, 
they are best managed by analgesics, corticosteroids, radiotherapy, and hormo­
nal treatment; decompressive laminectomy is often unnecessary. Intradural (but 
extramedullary) lesions are best removed if possible. Intramedullary tumors are
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treated by decompression and surgical excision when feasible and by radiother­
apy.
Prognosis
The prognosis depends upon the cause and severity of the cord compres­
sion before it is relieved. Cord compression by extradural metastasis is usually 
manifested first by pain alone and may progress rapidly to cause permanent im­
pairment of motor, sensory, and sphincter function. Therefore, the diagnosis 
must be suspected early in any patient with cancer and spinal or radicular pain, 
who must be investigated immediately. Reliance on motor, sensory, or sphincter 
disturbances to make the diagnosis will unnecessarily delay treatment and 
worsen the outcome.
ANTERIOR HORN CELL DISORDERS
Disorders that predominantly affect the anterior horn cells are character­
ized clinically by wasting and weakness of the affected muscles without accom­
panying sensory changes. Electromyography shows changes that are characteris­
tic of chronic partial denervation, with abnormal spontaneous activity in resting 
muscle and a reduction in the number of motor units under voluntary control; 
signs of reinnervation may also be present. Motor conduction velocity is usually 
normal but may be slightly reduced, and sensory conduction studies are normal. 
Muscle biopsy shows the histologic changes of denervation. Serum CPK may be 
slightly elevated, but it never reaches the extremely high values seen in some 
muscular dystrophies. The clinical features and outlook depend in part on the 
patient's age at onset. The cause of these disorders is unknown, but the genetic 
basis for some of them is being clarified. The infantile and intermediate spinal 
muscular atrophies are now recognized to represent allelic mutations of a gene 
localized to the long arm of chromosome 5.
Infantile Spinal Muscular Atrophy (Werdnig-Hoffmann Disease)
This autosomal recessive disorder usually manifests itself within the first 
3 months of life. The infant is floppy and may have difficulty with sucking, 
swallowing, or ventilation. In established cases, examination reveals impaired 
swallowing or sucking, atrophy and fasciculation of the tongue, and muscle 
wasting in the limbs that is sometimes obscured by subcutaneous fat. The tendon 
reflexes are normal or depressed, and the plantar responses may be absent. There 
is no sensory deficit. The disorder is rapidly progressive, generally leading to 
death from respiratory complications by about age 3 years. The cause is un­
known, and there is no effective treatment.
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Intermediate Spinal Muscular Atrophy (Chronic Werdnig-Hoffmann
Disease)
This also has an autosomal recessive mode of inheritance but usually be­
gins in the latter half of the first year of life. Its main clinical features are wast­
ing and weakness of the extremities; bulbar weakness occurs less commonly. 
The disorder progresses slowly, ultimately leading to severe disability with ky­
phoscoliosis and contractures, but its course is more benign than the infantile va­
riety described above, and many patients survive into adulthood. Treatment is 
essentially supportive and directed particularly at the prevention of scoliosis and 
other deformities.
Juvenile Spinal Muscular Atrophy (Kugelberg-Welander Disease)
Generally this disorder develops in childhood or early adolescence, on ei­
ther a hereditary or sporadic basis. The usual mode of inheritance is autosomal 
recessive, but cases with autosomal dominant or X-linked recessive inheritance 
also occur. It particularly tends to affect the proximal limb muscles, while there 
is generally little involvement of the bulbar musculature. It follows a gradually 
progressive course, leading to disability in early adult life. The proximal weak­
ness may lead to a mistaken diagnosis of muscular dystrophy, but serum CPK 
determination, electromyography, and muscle biopsy will differentiate the dis­
orders. There is no effective treatment.
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MOVEMENT DISORDERS
ESSENTIAL TREMOR
A postural tremor may be prominent in otherwise normal subjects. Al­
though the pathophysiologic basis of this disorder is uncertain, it often has a fa­
milial basis with an autosomal dominant mode of inheritance. Two responsible 
genes have been identified.
Symptoms may develop in the teenage or early adult years but often do 
not appear until later. The tremor usually involves one or both hands or the head 
and voice, while the legs tend to be spared. Examination usually reveals no other 
movement disorders or some other abnormalities. Although the tremor may be­
come more conspicuous with time, it generally leads to little disability other 
than cosmetic and social embarrassment. In occasional cases, tremor interferes 
with the ability to perform fine or delicate tasks with the hands; handwriting is 
sometimes severely impaired. Speech is affected when the laryngeal muscles are 
involved. Patients commonly report that a small quantity of alcohol provides 
remarkable but transient relief; the mechanism is not known.
If treatment is warranted, propranolol, 40-120 mg orally twice daily, can 
be prescribed-but it will need to be taken for an indefinite period. Alternatively, 
if tremor is particularly disabling under certain predictable circumstances, it can 
be treated with a single oral dose of 40-120 mg of propranolol taken in anticipa­
tion of the precipitating circumstances. Primidone has also been effective, but 
patients with essential tremor are often very sensitive to this drug, so that it must 
be introduced more gradually than when it is used to treat epilepsy. Patients are 
therefore started on 50 mg/d and the daily dose increased by 50 mg every 2 
weeks until benefit occurs or side effects limit further increments. A dose of 100 
or 150 mg three times a day is often effective. Occasional patients respond to 
alprazolam, up to 3 mg/d in divided doses.
Some patients have disabling tremor that is unresponsive to pharma­
cologic measures. Thalamotomy may be helpful, but a significant morbidity is 
associated with bilateral procedures. High-frequency thalamic stimulation by an 
implanted electrode is an effective alternative to thalamotomy and has a low 
morbidity. It may be particularly useful for treatment of the unoperated side in 
patients who have already undergone unilateral thalamotomy.
PARKINSONISM
Parkinsonism occurs in all ethnic groups; in the United States and western 
Europe it has a prevalence of 1-2/1000 population, with an approximately equal
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sex distribution. The disorder becomes increasingly common with advancing 
age. It is characterized by tremor, hypokinesia, rigidity, and abnormal gait and 
posture. Etiology of parkinsonism may be different.
A. Idiopathic. A very common variety of parkinsonism occurs without 
obvious cause; this idiopathic form is called Parkinson's disease or paralysis agi- 
tans.
B. Encephalitis Lethargica. In the first half of the twentieth century, 
parkinsonism often developed in patients with a history of von Economo's en­
cephalitis. Since this type of infection is not now encountered, cases of posten­
cephalitic parkinsonism are becoming increasingly rare.
C. Drug- or Toxin-Induced Parkinsonism.
1. Therapeutic drugs-Many drugs, such as phenothiazines, butyrophe- 
nones, metoclopramide, reserpine, and tetrabenazine, can cause a reversible 
parkinsonian syndrome.
2. Toxic substances. Toxins such as manganese dust or carbon disulfide 
can also lead to parkinsonism, and the disorder may appear as a sequela of se­
vere carbon monoxide poisoning.
3. MPTP (l-Methyl-4-phenyl-l,2,5,6-tetrahydropyridine). A drug-induced 
form of parkinsonism has been described in individuals who synthesized and 
self-administered a meperidine analogue, MPTP. This compound is metabolized 
to a toxin that selectively destroys dopaminergic neurons in the substantia nigra 
and adrenergic neurons in the locus ceruleus and induces a severe form of park­
insonism in humans and in subhuman primates. The ability of this drug to repro­
duce neurochemical, pathologic, and clinical features of Parkinson's disease 
suggests that an environmental toxin could be responsible for the idiopathic dis­
order. MPTP-induced parkinsonism may provide a model that could assist in 
development of new drugs for treatment of this disease.
D. Parkinsonism Associated with Other Neurologic Diseases. Parkin­
sonism that occurs in association with symptoms and signs of other neurologic 
disorders is considered briefly below.
E. Familial Parkinsonism. Rarely, parkinsonism occurs on a familial ba­
sis. The responsible (alpha-synuclein) gene has recently been identified on the 
long arm of chromosome 4 in one large kindred in which the disorder was inher­
ited in an autosomal dominant manner.
Pathology. In idiopathic parkinsonism, pathologic examination shows 
loss of pigmentation and cells in the substantia nigra and other brainstem cen­
ters, cell loss in the globus pallidus and putamen, and the presence of eosino­
philic intraneural inclusion granules (Lewy bodies) in the basal ganglia, brain 
stem, spinal cord, and sympathetic ganglia. These inclusion bodies are not seen 
in postencephalitic parkinsonism; instead there may be nonspecific neurofibril­
lary degeneration in a number of diencephalic structures as well as changes in 
the substantia nigra.
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A. Norm al В. Parkinsonism
V
Brainstem 
Spinal cord
Fig. 18. A model of the basal ganglia and its connections under normal condi­
tions (A) and in the setting of parkinsonism (В). I refers to the indirect pathway 
and D refers to the direct pathway. Blue arrows indicate inhibitory connections; 
white arrows indicate excitatory connections. The thickness of the arrows indi­
cates the amount of activity in the various projections. GPe, external segment of 
globus pallidus; GPi, internal segment of globus pallidus; SNr, substantia nigra 
pars reticulata; SNc, substantia nigra pars compacta; STN, subthalamic nucleus; 
VL, ventrolateral thalamus. (From Wichmann T, Vitej J, Delong M, 1995)
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Pathogenesis. Both dopamine and acetylcholine are present in the corpus 
striatum, where they act as neurotransmitters. In idiopathic parkinsonism, it is 
generally believed that the normal balance between these two antagonistic neu­
rotransmitters is disturbed because of dopamine depletion in the dopaminergic 
nigrostriatal system. Other neurotrans mitters, such as norepinephrine, are also 
depleted in the brains of patients with parkinsonism, but the clinical relevance of 
this deficiency is less clear.
Disorder of the balance of inhibition and excitation within the basal gan­
glia and its connections via direct and indirect pathways has been proposed to 
explain the impaired motor function in Parkinson's disease.
Clinical Findings
A. Tremor. The 4- to 6-Hz tremor of parkinsonism is characteristically 
most conspicuous at rest; it increases at times of emotional stress and often im­
proves during voluntary activity. It commonly begins in the hand or foot, where 
it takes the fonn of rhythmic flexion-extension of the fingers or of the hand or 
foot—or of rhythmic pronation-supination of the foreann. It frequently involves 
the face in the area of the mouth as well. Although it may ultimately be present 
in all of the limbs, it is not uncommon for the tremor to be confined to one limb- 
—°r to the two limbs on one side-for months or years before it becomes more 
generalized. In some patients tremor never becomes prominent.
B. Rigidity. Rigidity, or increased tone -  ie, increased resistance to pas­
sive movement -  is a characteristic clinical feature of parkinsonism. The dis­
turbance in tone is responsible for the flexed posture of many patients with park­
insonism. The resistance is typically unifonn throughout the range of movement 
at a particular joint and affects agonist and antagonist muscles alike -  in contrast 
to the findings in spasticity, where the increase in tone is often greatest at the 
beginning of the passive movement (claspknife phenomenon) and more marked 
in some muscles than in others. In some instances, the rigidity in parkinsonism 
is described as cogwheel rigidity because of ratchetlike interruptions of passive 
movement that may be due, in part, to the presence of tremor.
C. Hypokinesia. The most disabling feature of this disorder is hypokine­
sia (sometimes called bradykinesia or akinesia)-a slowness of voluntary move­
ment and a reduction in automatic movement, such as swinging the arms while 
walking. The patient's face is relatively immobile (masklike fades), with wid­
ened palpebral fissures, infrequent blinking, a certain fixity of facial expression, 
and a smile that develops and fades slowly. The voice is of low volume (hypo- 
phonia) and tends to be poorly modulated. Fine or rapidly alternating move­
ments are impaired, but power is not diminished if time is allowed for it to de­
velop. The handwriting is small, tremulous, and hard to read.
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D. Abnormal Gait and Posture. The patient generally finds it difficult to 
get up from bed or an easy chair and tends to adopt a flexed posture on standing 
(Figure 8-6). It is often difficult to start walking: so that the patient may lean far­
ther and farther forward while walking in place before being able to advance. 
The gait itself is characterized by small, shuffling steps and absence of the arm 
swing that normally accompanies locomotion; there is generally some unsteadi­
ness on turning, and there may be difficulty in stopping. In advanced cases, the 
patient tends to walk with increasing speed to prevent a fall (festinating gait) be­
cause of the altered center of gravity that results from the abnormal posture.
E. Other Clinical Features. There is often mild blepharoclonus (flutter­
ing of the closed eyelids) and occasionally blepharospasm (involuntary closure 
of the eyelids). The patient may drool, perhaps because of impairment of swal­
lowing. There is typically no alteration in the tendon reflexes, and the plantar 
responses are flexor. Repetitive tapping (about twice per second) over the bridge 
of the nose produces a sustained blink response (Myerson's sign); the response is 
not sustained in normal subjects. Cognitive decline sometimes occurs but is usu­
ally mild and late. Depression and visual hallucinations are frequent.
Differential Diagnosis
The diagnosis may be difficult to make in mild cases. Depression may be 
accompanied by a somewhat expressionless face, poorly modulated voice, and 
reduction in voluntary activity; it can thus simulate parkinsonism. Moreover, the 
two diseases often coexist in the same patient. A trial of antidepressant drug 
treatment may be helpful if diagnostic uncertainty cannot be resolved by the 
presence of more widespread neurologic signs indicative of parkinsonism.
Essential (benign, familial) tremor has been considered separately (see 
earlier). An early age at onset, a family history of tremor, a beneficial effect of 
alcohol on the tremor, and a lack of other neurologic signs distinguish this dis­
order from parkinsonism. Furthermore, essential tremor commonly affects the 
head (causing a nod or head shake); parkinsonism typically affects the face and 
lips rather than the head.
Diffuse Lewy body disease is a disorder of recently evolving definition. It 
is marked clinically by the combination of a rapidly progressing neurobehavioral 
syndrome of dementia and hallucinations and extrapyramidal motor features 
characteristic of Parkinson's disease. Myoclonus may also be seen. There is only 
an incomplete response to levodopa, but patients are extremely sensitive to park­
insonian complications of neuroleptics as well as to the side effects of anti park­
insonian drugs.
Wilson's disease can also lead to a parkinsonian syndrome, but other va­
rieties of abnormal movements are usually present as well. Moreover, the early 
age at onset and the presence of Kayser-Fleischer rings should distinguish Wil­
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son's disease from Parkinson's disease, as should the abnormalities in serum and 
urinary copper and serum ceruloplasmin that occur in Wilson's disease.
Huntington's disease may occasionally be mistaken for parkinsonism 
when it presents with rigidity and akinesia, but a family history of Huntington's 
disease or an accompanying dementia, if present, should suggest the correct di­
agnosis, which can be confirmed by genetic studies.
Shy-Drager syndrome is a degenerative disorder characterized by parkin­
sonian features, autonomic insufficiency (leading to postural hypotension, an­
hidrosis, disturbance of sphincter control, impotence, etc), and signs of more 
widespread neurologic involvement (pyramidal or lower motor neuron signs and 
often a cerebellar deficit). There is no treatment for the motor deficit, but the 
postural hypotension may respond to a liberal salt diet; fludrocortisone, 0.1-1 
mg/d; midodrine (an a-agonist) 10 mg three times daily; wearing waist-high 
elastic hosiery; and sleeping with the head up at night.
Striatonigral degeneration is a rare disorder that is associated with neu­
ronal loss in the putamen, globus pallidus, and caudate nucleus, and presents 
with bradykinesia and rigidity. Antiparkinsonian drugs are typically ineffective. 
Striatonigral degeneration may be associated with olivopontocerebellar degen­
eration, in which case the term multiple system atrophy or Shy-Drager syndrome 
is applied.
Progressive supranuclear palsy is a disorder in which there may be bra­
dykinesia and rigidity, but its characteristic features are loss of voluntary control 
of eye movements (especially vertical gaze), dementia, pseudobulbar palsy, dy­
sarthria, and axial dystonia. The disorder responds poorly, if at all, to antiparkin­
sonian drugs.
Cortical basal ganglionic degeneration is characterized clinically by both 
cortical and basal ganglionic dysfunction. Rigidity, bradykinesia, tremor, pos­
tural disturbances, and dystonia are accompanied by such additional deficits as 
cortical sensory loss, apraxia, focal reflex myoclonus, dementia, or aphasia. 
Symptoms are often strikingly asymmetric. Treatment with antiparkinsonian 
medication is usually unrewarding, although some patients do respond to Si- 
nemet.
Creutzfeldt-Jakob disease may be accompanied by parkinsonian features, 
but dementia is usually present, myoclonic jerking is common, and ataxia is 
sometimes prominent; there may be pyramidal signs and visual disturbances, 
and the EEG findings of periodic discharges are usually characteristic.
Normal-pressure hydrocephalus leads to a gait disturbance (often mistak­
enly attributed to parkinsonism), urinary incontinence, and dementia. CT scan­
ning reveals dilation of the ventricular system of the brain without cortical atro­
phy. The disorder may follow head injury, intracranial hemorrhage, or menin­
goencephalitis, but the cause is often obscure. Surgical shunting procedures to 
bypass any obstruction to the flow of CSF are often beneficial.
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Treatment
Early parkinsonism requires no drug treatment, but it is important to dis­
cuss with the patient the nature of the disorder and the availability of medical 
treatment if symptoms become more severe and to encourage activity. Treat­
ment, when indicated, is directed toward restoring the dopaminergic: cholinergic 
balance in the striatum by blocking the effect of acetylcholine with anticholiner­
gic drugs or by enhancing dopaminergic transmission.
Drugs used in the treatment of Parkinson's disease
Anticholinergics
Benztropine (Cogentin)
Trihexyphenidyl (Artane)
Amantadine (Symmetrel)
Levodopa (Sinemet)
Dopamine agonists 
Ergolides
Bromocriptine (Parlodel)
Pergolide (Permax)
Nonergolides
Pramipexole (Mirapex)
Ropinirole (Requip)
MAO-B inhibitor
Selegiline (Eldepryl)
COMT inhibitor
Tolcapone (Tasmar)
A. Anticholinergic Drugs. Muscarinic anticholinergic drugs are more 
helpful in alleviating tremor and rigidity than hypokinesia but are generally less 
effective than dopaminergic drugs (see below). A number of preparations are 
available, and individual patients tend to favor different drugs. Among the most 
commonly prescribed drugs are trihexyphenidyl and benztropine. Common side 
effects include dryness of the mouth, constipation, urinary retention, and defec­
tive pupillary accommodation; these are caused by muscarinic receptor blockade 
in parasympathetic end organs. Confusion, especially in the elderly, is due to an- 
timuscarinic effects in the brain. Treatment is started with a small dose of one of 
the anticholinergics; the dosage is then gradually increased until benefit occurs 
or side effects limit further increments. If treatment is not helpful, the drug is 
withdrawn and another anticholinergic preparation is tried.
B. Amantadine. Amantadine can be given for mild parkinsonism either 
alone or in combination with an anticholinergic agent. Its precise mode of action
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is unclear. Its advantages are that it improves all the clinical features of parkin­
sonism, its side effects (restlessness, confusion, skin rashes, edema, disturbances 
of cardiac rhythm) are relatively uncommon, its effects are exerted rapidly, and 
it is given in a standard dose of 100 mg orally twice daily. Unfortunately, how­
ever, many patients fail to respond to this drug, or its benefit is short-lived.
C. Levodopa. Levodopa, which is converted in the body to dopamine 
(Figure 8-8), ameliorates all the major clinical features of parkinsonism and, 
unlike the anticholinergic drugs, is often particularly helpful against hypokine­
sia. There is controversy about the best time to introduce dopaminergic therapy. 
Concerns that levodopa loses its effectiveness with time in some patients are 
probably misplaced, but response fluctuations sometimes occur after it has been 
used for several years, and these may be particularly disabling and difficult to 
manage. It may be wise to defer its introduction as long as possible and then use 
dopamine agonists (discussed below) in conjunction with it to keep the levodopa 
dose as low as possible.
The most common side effects of levodopa are nausea, vomiting, hy­
potension, abnormal movements (dyskinesias), restlessness, and confusion. Car­
diac arrhythmias occur occasionally. The late dyskinesias and behavioral side 
effects occur as dose-related phenomena, but reduction in dose may diminish 
any therapeutic benefit. Treatment with clozapine, a dibenzodiazepine derivative 
that does not block the therapeutic effects of dopaminergic medication, may re­
lieve confusion and psychotic mental disturbances and, in some instances, the 
dyskinesias. Clozapine requires regular monitoring of the leukocyte count. Olan- 
zepine and risperidol are alternative agents that may be less effective but do not 
affect the blood count. Another late complication of levodopa therapy is re­
sponse fluctuation such as the wearing-off effect, in which deterioration occurs 
shortly before the next dose is to be taken, or the on-off phenomenon, in which 
abrupt but transient fluctuations in the severity of parkinsonism occur at fre­
quent intervals during the day, apparently without any relationship to the last 
dose of levodopa. This sometimes disabling problem is unaffected by concomi­
tant administration of carbidopa. It can be controlled only partly by varying the 
dosing intervals, administering levodopa 1 hour before meals, restricting dietary 
protein intake, or providing treatment with dopamine agonists.
Carbidopa is a drug that inhibits dopa decarboxylase, the enzyme respon­
sible for the breakdown of levodopa to its active metabolite, dopamine, but does 
not cross the blood-brain barrier. Accordingly, if levodopa is given in combina­
tion with carbidopa, the breakdown of levodopa is limited outside the central 
nervous system. The daily dose of levodopa required for benefit and the inci­
dence of nausea, vomiting, hypotension, and cardiac irregularities can be re­
duced if levodopa is taken in combination with carbidopa. Carbidopa is gener­
ally combined with levodopa in a fixed proportion (1: 10 or 1:4) as Sinemet. 
Treatment is started with a small dose, such as Sinemet 10/100 (mg) or Sinemet 
251100 (mg) orally three times daily, and the dose is gradually increased, de­
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pending on the response. Most patients ultimately require Sinemet 25/250 (mg) 
three or four times daily. Carbidopa should total at least 75 mg/d.
Levodopa therapy (either alone or in conjunction with carbidopa) is con­
traindicated in patients with narrow-angle glaucoma or psychotic illness and 
should be avoided in patients receiving monoamine oxidase A inhibitors. It 
should also be used with care in patients with active peptic ulcers or suspected 
malignant melanomas.
A controlled-release (CR) formulation of Sinemet may reduce response 
fluctuations and the dosing frequency.
D. Dopamine Agonists. The older agonists are ergot derivatives. Bro­
mocriptine stimulates dopamine Dz receptors. It is perhaps slightly less effective 
than levodopa in relieving the symptoms of parkinsonism but is less likely to 
cause dyskinesias or the on-off phenomenon. In consequence, it has been rec­
ommended that when dopaminergic therapy is to be introduced, the patient be 
started on Sinemet, 25/100 three times daily, with bromocriptine then added and 
gradually increased. The starting dose of bromocriptine is 1.25 mg/d for I week 
and 2.5 mg/d for the next week, after which the daily dose is increased by 2.5- 
mg increments every 2 weeks, depending on the response and the development 
of side effects. Maintenance doses are usually between 2.5 and 10 mg orally 
three times daily. Side effects are similar to those associated with levodopa ther- 
aPУ' but psychiatric effects such as delusions or hallucinations are especially 
common, and bromocriptine is therefore contraindicated in patients with a his­
tory of psychotic disorders. Relative contraindications to its use are recent myo­
cardial infarction, severe peripheral vascular disease, and active peptic ulcera­
tion.
Pergolide also is an ergot derivative and dopamine receptor agonist; 
unlike bromocriptine, it activates both D, and D2 receptors. Its indications, side 
effects, and contraindications are similar to those described above for bro­
mocriptine, and it is unclear whether either compound is clinically superior to 
the other. The starting dose is 0.05 mg orally daily for 2 days, increased by 0.1-
0.15 mg/d every 3 days for 12 days and by 0.25 mg/d every 3 days thereafter. 
The average maintenance dose is 1 mg orally three times daily.
The new dopamine agonists, pramipexole and ropinirole, are not ergot de­
rivatives. They seem more effective than the older agonists and may be used in 
early or advanced Parkinson's disease. Pramipexole is started at 0.125 mg three 
times daily, the daily dose is doubled after one week and again after another 
week; it is then increased by 0.75 mg each week according to response and tol­
erance. A common maintenance dose is between 0.5 and 1.5 mg three times 
daily. Ropinirole is started at 0.25 mg three times daily and the total daily dose 
increased at weekly intervals by 0.75 mg until the fourth week and by 1.5 mg 
thereafter. Most patients need between 2 and 8 mg three times daily for benefit. 
Adverse effects of these medications include fatigue, somnolence, nausea, pe­
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ripheral edema, dyskinesias, confusion, hallucinations, and orthostatic hypoten­
sion.
E. Tolcapone. Tolcapone, recently approved by the FDA, is a catechol-O- 
methyltransferase inhibitor. Such inhibitors may be used to reduce the dose re­
quirements of and any response fluctuations to Sinemet. Its use leads to more 
sustained plasma levels of levodopa, with improved transport into the blood and 
across the blood-brain barrier. Side effects include diarrhea, confusion, dyskine­
sias, and abnormalities of liver function tests. Most patients require a dose of 
100 mg three times daily.
F. Selegiline. Selegiline (also called eldepryl or deprenyl) is a monoamine 
oxidase type В inhibitor and therefore inhibits the metabolic breakdown of do­
pamine. It thus enhances the antiparkinsonian effect of levodopa and may reduce 
mild on-off fluctuations in responsiveness. Some clinical studies suggest that se­
legiline may also delay the progression of Parkinson's disease, although the evi­
dence is incomplete in this regard; when used for neuroprotection, selegiline is 
best kept for patients with mild disease. The dose is 5 mg orally twice daily, 
usually given early in the day to avoid insomnia.
G. Surgery. Surgical treatment of parkinsonism by thalamotomy or palli­
dotomy is often helpful when patients become unresponsive to pharmacologic 
measures or develop intolerable adverse reactions to antiparkinsonian medica­
tion. Lesions of the internal segment of the globus pallidus (GPi), for example, 
will attenuate its unbalanced inhibitory output. Treatment by surgery is some­
times helpful in relatively young patients with predominantly unilateral tremor 
and rigidity that have failed to respond to medication; thalamotomy is more 
helpful for tremor and pallidotomy for hypokinesia. Diffuse vascular disease or 
dementia is a contraindication to this approach. The rate of significant complica­
tions is less than 5% after unilateral pallidotomy or thalamotomy, but about 20% 
or more after bilateral procedures, which are therefore best avoided.
Autologous or fetal adrenal medullary tissue or fetal substantia nigra has 
been transplanted to the caudate nucleus, in the belief that the transplanted tissue 
can continue to synthesize and release dopamine. Results from preliminary stud­
ies have been contradictory, and this approach is highly controversial. The pre­
cise mechanism of benefit, if it occurs, is unclear.
H. Deep Brain Stimulation. High-frequency thalamic stimulation is ef­
fective for the relief of parkinsonian tremor. Pallidal stimulation is currently un­
der study as an alternative to pallidotomy in patients with other parkinsonian 
deficits, as is deep brain stimulation at other sites. This approach has the advan­
tage of being reversible and causing minimal or no damage to the brain.
I. Physical Therapy and Aids for Daily Living. Physical therapy and 
speech therapy are beneficial to many patients with parkinsonism, and the qual­
ity of life can often be improved by providing simple aids to daily living. Such 
aids may include extra rails or banisters placed strategically about the home for 
additional support, table cutlery with large handles, nonslip rubber table mats,
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devices to amplify the voice, and chairs that will gently eject the occupant at the 
push of a button.
PROGRESSIVE SUPRANUCLEAR PALSY
Progressive supranuclear palsy is an idiopathic degenerative disorder that 
primarily affects subcortical gray matter regions of the brain. The principal neu- 
ropathologic finding is neuronal degeneration with the presence of neurofibril­
lary tangles in the midbrain, pons, basal ganglia, and dentate nuclei of the cere­
bellum. Associated neurochemical abnormalities include decreased concentra­
tions of dopamine and its metabolite homovanillic acid in the caudate nucleus 
and putamen. The classic clinical features are supranuclear ophthalmoplegia, 
pseudobulbar palsy, axial dystonia with or without extrapyramidal rigidity of the 
limbs, and dementia. Men are affected twice as often as women, and the disorder 
has its onset between ages 45 and 75 years.
Supranuclear ophthalmoplegia is characterized by prominent failure of 
voluntary vertical gaze, with later paralysis of horizontal gaze; oculocephalic 
and oculovestibular reflexes are preserved. Postural instability and unexplained 
falls also occur early. In addition, the neck often assumes an extended posture 
(axial dystonia in extension), with resistance to passive flexion. Rigidity of the 
limbs and bradykinesia may mimic Parkinson's disease, but tremor is rare. A co­
existing pseudobulbar palsy produces facial weakness, dysarthria, dysphagia, 
and often exaggerated jaw jerk and gag reflexes; there may also be exaggerated 
and inappropriate emotional responses (pseudobulbar affect). Hyperreflexia, ex­
tensor plantar responses, and cerebellar signs are sometimes seen. The dementia 
of progressive supranuclear palsy is characterized by forgetfulness, slowed 
thought processes, alterations of mood and personality, and impaired calculation 
and abstraction. Focal cortical dysfunction is rare.
Parkinson's disease differs in that voluntary downward and horizontal 
gaze are not usually lost, axial posture tends to be characterized by flex ion 
rather than extension, tremor is common, the course is less fulminant, and anti­
parkinsonian medications are more often effective.
Dopaminergic preparations are occasionally of benefit for rigidity and 
bradykinesia. Anticholinergics such as amitriptyline, 50-75 mg orally at bed­
time, or benztropine, 6-10 mg/d orally, have been reported to improve speech, 
gait, and pathologic laughing or crying, and methysergide, 8-12 mg/d orally, 
may ameliorate dysphagia. There is no treatment for the dementia.
The disorder typically follows a progressive course, with death from aspi­
ration or inanition within 2-12 (usually 4-7) years.
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CORTICAL BASAL GANGLIONIC DEGENERATION
Cortical basal ganglionic degeneration is a rare, nonfamilial, degenerative 
disorder of unknown cause that occurs in middle-aged or elderly persons of ei­
ther sex. It sometimes simulates Parkinson's disease when bradykinesia and ri­
gidity are conspicuous features. Postural-action tremor may also occur, but the 
usual cause of profound disability is apraxia and clumsiness rather than ex- 
trapyramidal deficits. Other features of the established disorder include speech 
disturbances (aphasic, apraxic, or dysarthric), cortical sensory deficits (such as 
neglect syndromes), stimulus-sensitive myoclonus, dysphagia, postural distur­
bances, dystonic features, and ultimately cognitive decine and behavioral 
changes. Frontal release signs, brisk tendon reflexes, and extensor plantar re­
sponses may also be encountered.
The disorder is distinguished from Parkinson's disease by the marked 
apraxia that often leads to a useless limb, difficulty in opening or closing the 
eyes, or speech disturbances. The presence of pyramidal and cortical deficits in 
addition to any extrapyramidal dysfunction and the relative preservation of cog­
nitive function, at least until late in the course of the disorder, also help in this 
regard, but definitive diagnosis can be made only at autopsy.
Antiparkinsonian medication is generally unhelpful but is certainly wor­
thy of trial. No specific therapy exists.
The disorder follows a progressive course, leading to increasing disability 
and dependence. Death typically follows within 10 years, often sooner, from as­
piration pneumonia.
HUNTINGTON'S DISEASE
Huntington's disease, characterized by the gradual onset and subsequent 
progression of chorea and dementia, is a hereditary disorder of the nervous sys­
tem that has been traced to a single gene defect on the short arm of chromosome 
4; there is an expanded and unstable CAG trinucleotide repeat at 4pl6.3. The 
disorder is inherited in an autosomal dominant manner, so that the offspring of 
an affected patient have a 50% chance of developing the disorder. In the few 
homozygous cases that have been identified, the clinical features are identical to 
those seen in heterozygotes. Huntington's disease occurs throughout the world 
and in all ethnic groups. Its prevalence rate is about 5 per 100,000 population. 
Symptoms usually do not appear until adulthood (typically between 30 and 50 
years of age), by which time these patients have often started families of their 
own; thus, the disease continues from one generation to the next.
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Pathogenesis
The manner in which the Huntington gene produces its devastating conse­
quences is unknown. Postmortem examination of patients with the disease re­
veals cell loss, particularly in the cerebral cortex and corpus striatum. In the lat­
ter region, medium-sized spiny neurons that contain y-aminobutyric acid 
(GABA) and enkephalin and project to the external segment of the globus pal- 
lidus are affected earliest, but other classes of neurons are eventually involved as 
well. Biochemical studies have shown that the concentrations of the inhibitory 
neurotransmitter GAB A, its biosynthetic enzyme glutamic acid decarboxylase 
(GAD), and acetylcholine and its biosynthetic enzyme choline acetyltransferase 
are all reduced in the basal ganglia of patients with Huntington's disease. The 
concentration of dopamine is normal or slightly increased. Changes in the con­
centrations of neuropeptides in the basal ganglia have also been found, including 
decreased substance P, methionine enkephalin, dynorphin, and cholecystokinin 
and increased somatostatin and neuropeptide Y. Neurons containing NADPH 
diaphorase activity are spared. Positron emission tomography has shown re­
duced glucose utilization in an anatomically normal caudate nucleus.
Clinical Findings
Symptoms usually begin in the fourth or fifth decade, and the disease is 
progressive, with an average life span after onset of about 15 years.
A. Initial Symptoms. Either abnormal movements or intellectual changes 
may be the initial symptom, but ultimately both are present.
1. Dementia. The earliest mental changes often consist of irritability, 
moodiness, and antisocial behavior, but a more obvious dementia subsequently 
develops.
2. Chorea. Movement disturbance may be characterized initially by no 
more than an apparent fidgetiness or restlessness, but grossly abnormal chorei­
form movements are eventually seen.
3. Atypical forms. Especially in cases developing during childhood-but 
occasionally in adult-onset cases as well-the clinical picture is dominated by 
progressive rigidity and akinesia, with little or no chorea. This is known as the 
Westphal variant, and the correct diagnosis is suggested by the accompanying 
dementia and positive family history.
Epilepsy and cerebellar ataxia are frequent features of the juvenile form 
but not of adult cases.
B. Family History. In cases where a positive family history cannot be ob­
tained, it must be remembered that the early death of a parent may make the his­
tory incomplete and that relatives often conceal the familial nature of the disor­
der. In addition, a certain degree of eccentric behavior, clumsiness, or restless­
ness may be regarded as normal by lay people and medical personnel unfamiliar 
with the disorder. The family history cannot therefore be regarded as negative
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until all close relatives of the patient have been examined by the physician per­
sonally. Nevertheless, apparently sporadic cases are occasionally encountered.
C. Genetic Testing. Genetic testing now provides an accurate and defini­
tive means of establishing the diagnosis and also permits the presymptomatic 
detection of the disease.
D. Imaging. CT scanning or MRI often demonstrates atrophy of the cere­
bral cortex and caudate nucleus in established cases.
Differential Diagnosis
Drug-induced chorea, which is most common, can usually be identified 
from the history. Laboratory studies can exclude most medical disorders associ­
ated with chorea. Other hereditary disorders in which chorea is a conspicuous 
feature are described below.
Benign hereditary chorea is a recently recognized disorder that is inherited 
in either an autosomal dominant or recessive manner and is characterized by 
choreiform movements that develop in early childhood, do not progress during 
adult life, and are not associated with dementia.
Familial chorea sometimes occurs in association with circulating acantho- 
cytes (spiny red blood cells), but examination of a wet blood film will clearly 
distinguish this disorder. Other clinical features of chorea-acanthocytosis in­
clude orolingual ticlike dyskinesias, vocalizations, mild intellectual decline, sei­
zures, peripheral neuropathy, and muscle atrophy. Parkinsonian features are 
sometimes present. Unlike certain other disorders associated with circulating 
acanthocytes, there is no disturbance of —lipoprotein concentration in the pe­
ripheral blood.
Paroxysmal choreoathetosis may occur on a familial basis, but the inter­
mittent nature of the symptoms and their relationship to movement or emotional 
stress usually distinguish this disorder from Huntington's disease.
The age at onset of symptoms usually distinguishes Huntington's disease 
from certain rare inherited childhood disorders characterized by choreoathetosis. 
Wilson's disease can be distinguished from Huntington's disease by the mode of 
inheritance, the presence of Kayser-Fleischer rings, and abnormal serum copper 
and ceruloplasmin levels.
When the early symptoms constitute progressive intellectual failure, it 
may not be possible to distinguish Huntington's disease from other varieties of 
dementia unless the family history is characteristic or the movement disorder 
becomes noticeable.
Treatment & Prognosis
There is no cure for Huntington's disease, which, as a rule, terminates fa­
tally 10-20 years after clinical onset. There is no treatment for the dementia, but 
the movement disorder may respond to drugs that interfere with dopaminergic 
inhibition of striatal output neurons. These include dopamine D2-receptor-
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blocking drugs such as haloperidol, 0.5-4 mg orally four times daily, or chlor- 
promazine, 25-50 mg orally three times daily; and drugs that deplete dopamine 
from nerve terminals, such as reserpine, 0.5-5 mg/d orally, or tetrabenazine 
12.5-50 mg orally three times daily. Drugs that potentiate GABAergic or cho­
linergic neurotransmission are generally ineffective.
Patients should be advised of the risk of transmitting the disease, and liv­
ing offspring should receive genetic counseling. Genetic markers for detection 
of presymptomatic Huntington's disease should be used.
SYDENHAM’S CHOREA
This disorder occurs principally in children and adolescents as a compli­
cation of a previous group A hemolytic streptococcal infection. The underlying 
patholOgic feature is probably arteritis. In about 30% of cases, it appears 2 or 3 
months after an episode of rheumatic fever or polyarthritis, but in other patients 
no such history can be obtained. There is usually no recent history of sore throat 
and no fever. The disorder may have an acute or insidious onset, usually subsid­
ing within the following 4-6 months. It may recur during pregnancy, however, 
or in patients taking oral contraceptive preparations.
Sydenham's chorea is characterized by abnormal choreiform movements 
that are sometimes unilateral and, when mild, may be mistaken for restlessness 
or fidgetiness. There may be accompanying behavioral changes, with the child 
becoming irritable or disobedient. Obsessive-compulsive symptoms and emo- 
tionallability also occur. In 30% of cases there is evidence of cardiac involve­
ment, but the sedimentation rate and antistreptolysin 0 titer are usually normal. 
The traditional treatment is bed rest, sedation, and prophylactic antibiotic ther­
apy even if there are no other signs of acute rheumatism. A course of intra­
muscular penicillin is generally recommended, and continuous prophylactic oral 
penicillin daily until about age 20 years is also frequently advised to prevent 
streptococcal infections. The prognosis is essentially that of the cardiac compli­
cations.
IDIOPATHIC TORSION DYSTONIA
This disorder is characterized by dystonic movements and postures and an 
absence of other neurologic signs. The birth and developmental histories are 
normal. Before the diagnosis can be made, other possible causes of dystonia 
must be excluded on clinical grounds and by laboratory investigations.
Idiopathic torsion dystonia may be inherited as an autosomal dominant, 
autosomal recessive, or X-linked recessive disorder, and the defective genes 
have been localized in some cases. Molecular genetic techniques permit identifi­
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cation of carriers of the gene for the dominantly inherited disorder, which has 
been identified and is named DYT1. Other cases seem to occur on a sporadic ba­
sis. Changes in the concentrations of norepinephrine, serotonin, and dopamine 
have been demonstrated in a variety of brain regions, but their role in the patho­
genesis of dystonia is uncertain. Onset may be in childhood or later life, and this 
disorder remains as a lifelong affliction. The diagnosis is made on clinical 
grounds.
Clinical Findings
A. History. When onset is in childhood, a family history is usually ob­
tainable. Symptoms generally commence in the legs. Progression is likely, and it 
leads to severe disability from generalized dystonia.
With onset in adult life, a positive family history is not likely to be obtained. 
The initial symptoms are usually in the arms or axial structures. Generalized 
dystonia may ultimately develop in about 20% of patients with adult-onset 
dystonia, but severe disability does not usually occur.
B. Examination. The disorder is characterized by abnormal movements 
and postures that are typically exacerbated by voluntary activity. For example, 
the neck may be twisted to one side (torticollis), the arm held in a hyperpronated 
position with the wrist flexed and fingers extended, the leg held extended with 
the foot plantar-flexed and inverted, or the trunk held in a flexed or extended po­
sition. There is often facial grimacing, and other characteristic facial abnor­
malities may also be encountered, including blepharospasm (spontaneous, in­
voluntary forced closure of the eyelids for a variable period of time) and oro- 
mandibular dystonia. This consists of spasms of the muscles about the mouth, 
causing, for example, involuntary opening or closing of the mouth; pouting, 
pursing, or retraction of the lips; retraction of the platysma muscle; and roving 
or protruding movements of the tongue.
Differential Diagnosis
It is important to exclude other causes of dystonia before a diagnosis of 
idiopathic torsion dystonia is made. A normal developmental history prior to the 
onset of abnormal movements, together with the absence of other neurologic 
signs and normal results of laboratory investigations, is important in this regard.
Treatment
The abnormal movements may be helped, at least in part, by drugs. A 
dramatic response to levodopa suggests a variant of classic torsion dystonia, dis­
cussed separately below. Anticholinergic drugs given in the highest doses that 
can be tolerated (typically, trihexyphenidyl, 40-50 mg/d orally in divided doses) 
may be very effective. Diazepam is occasionally helpful. Phenothiazines, halop- 
eridol, or tetrabenazine may be worthwhile; however, at effective doses, these 
drugs usually lead to a mild parkinsonian syndrome. Other drugs that are some­
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times helpful are baclofen and carbamazepine. Stereotactic thalamotomy may 
help patients with predominantly unilateral dystonia that particularly involves 
the limbs. If all cases are considered together, about one-third of patients even­
tually become so severely disabled that they are confined to chair or bed, while 
another one-third are affected only mildly. In general, severe disability is more 
likely to occur when the disorder commences in childhood.
Dopa-responsive dystonia
Inherited in an autosomal dominant manner, the gene causing this disorder 
maps to chromosome 14q. Symptom onset is typically in childhood but may oc­
cur later. Girls are affected more commonly than boys. Disabling dystonia is ac­
companied by bradykinesia and rigidity that may lead to a mistaken diagnosis of 
juvenile Parkinson's disease. Remarkable recovery occurs with low doses of 
levodopa, to which patients are particularly sensitive.
FOCAL TORSION DYSTONIA
A number of the dystonic features of idiopathic torsion dystonia may also 
occur as isolated phenomena. They are probably best regarded as focal dystonias 
that occur as formes frustes of idiopathic torsion dystonia in patients with a posi­
tive family history or that represent a focal manifestation of its adult-onset form 
when there is no family history.
Both blepharospasm and oromandibular dystonia can occur as isolated 
focal dystonias.
Spasmodic torticollis usually begins in the fourth or fifth decade and is 
characterized by a tendency for the neck to twist to one side. This often occurs 
episodically in early stages, but eventually the neck is held continuously to one 
side. Although the disorder is usually lifelong once it develops, spontaneous re­
mission does occur occasionally, especially in the first 18 months after onset. 
Medical treatment is generally unsatisfactory. A trial of the drugs used in treat­
ing idiopathic torsion dystonia is worthwhile, since some patients do obtain un­
doubted benefit. Selective section of the spinal accessory nerve (cranial nerve 
XI) and the upper cervical nerve roots is sometimes helpful for patients in whom 
the neck is markedly deviated to the side, but recurrence of the abnormal posture 
is frequent. Local injection of botulinum toxin into the overactive muscles may 
also produce benefit for up to several months; it can be repeated as needed. It is 
the most effective treatment available for this disorder.
Writer's cramp is characterized by dystonic posturing of the hand and 
forearm when the hand is used for writing and sometimes other tasks such as 
playing the piano or using a screwdriver or table cutlery.
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Drug treatment is usually unrewarding, and it is often necessary for pa­
tients to learn to use the other hand for these tasks. Injections of botulinum toxin 
into the involved muscles are sometimes helpful.
WILSON'S DISEASE
Wilson's disease is an autosomal recessive disorder of copper metabolism 
that produces neurologic and hepatic dysfunction. The gene localizes in the re­
gion of chromosome 13ql4-21, but the disease is caused by a number of differ­
ent mutations, two of which are encountered fairly frequently in affected pa­
tients. While the precise nature of the biochemical abnormality in Wilson's dis­
ease is unknown, its pathogenesis appears to involve decreased binding of cop­
per to the transport protein ceruloplasmin. As a result, large amounts of unbound 
copper enter the circulation and are subsequently deposited in tissues, including 
the brain, liver, kidney, and cornea.
Clinical Findings
A. Mode of Presentation. Wilson's disease usually presents in childhood 
or young adult life. The average age at onset is about 11 years for patients pre­
senting with hepatic dysfunction and 19 years for those with initial neurologic 
manifestations, but the disease may begin as late as the sixth decade. Hepatic 
and neurologic presentations are about equally common, and most patients, if 
untreated, eventually develop both types of involvement. Rare presentations in­
clude joint disease, fever, hemolytic anemia, and behavioral disturbances.
B. Nonneurologic Findings. Ocular and hepatic abnormalities are the 
most prominent nonneurologic manifestations of Wilson's disease. The most 
common ocular finding is Kayser-Fleischer rings: bilateral brown corneal rings 
that result from copper deposition in Descemet's membrane. The rings are pre­
sent in virtually all patients with neurologic involvement but may be detectable 
only by slit lamp examination. Hepatic involvement leads to chronic cirrhosis, 
which may be complicated by splenomegaly, esophageal varices with hemate- 
mesis, or fulminant hepatic failure. Splenomegaly may cause hemolytic anemia 
and thrombocytopenia.
C. Neurologic Findings. Neurologic findings in Wilson's disease reflect 
the disproportionate involvement of the caudate nucleus, putamen, cerebral cor­
tex, and cerebellum. Neurologic signs include resting or postural tremor, chorei­
form movements of the limbs, facial grimacing, rigidity, hypokinesia, dysarthria, 
dysphagia, abnormal (flexed) postures, and ataxia. Seizures may also occur. 
Psychologic disorders in Wilson's disease include dementia, characterized by 
mental slowness, poor concentration, and memory impairment; disorders of af­
fect, behavior, or personality; and (rarely) psychosis with hallucinations. There
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is a tendency for a dystonic or parkinsonian picture with hyperreflexia and ex­
tensor plantar responses to predominate when the disease begins before age 20 
yearsand for older patients to exhibit wild tremor, chorea, or ballismus. Symp­
toms may progress rapidly, especially in younger patients, but are more often 
gradual in development with periods of remission and exacerbation.
Differential Diagnosis
When Wilson's disease presents as a neurologic disorder, other conditions 
that must be considered in the differential diagnosis include multiple sclerosis 
and juvenile-onset Huntington’s disease.
Investigative Studies
Investigation may reveal abnormal liver function blood tests and amino­
aciduria as a result of renal tubular damage. The levels of serum copper and ce­
ruloplasmin (an a2-globulin to which 90% of the circulating copper is bound) are 
low, and 24-hour urinary copper excretion is generally increased. Liver biopsy 
reveals a huge excess of copper; it also usually reveals cirrhosis. Brain CT scan­
ning or MR1 may show cerebrocortical atrophy and abnormalities in the basal 
ganglia.
Treatment
Wilson's disease is treated with penicillamine, a copper-chelating agent 
that promotes extraction of copper from tissue deposition sites. Treatment 
should be started as early as possible and customarily employs 1.5-2 g/d of 
orally administered penicillamine. The response to treatment may take several 
months and can be monitored by serial slit lamp examinations and blood chem­
istries. Side effects of penicillamine include nausea, nephrotic syndrome, myas­
thenia gravis, arthropathy, pemphigus, diverse blood dyscrasias, and a lupuslike 
syndrome; moreover, penicillamine may cause an additional worsening of neu­
rologic symptoms. Treatment with tetrathiomolybdate is sometimes helpful. Re­
striction of dietary copper and administration of zinc sulfate (200 mg/d orally) 
can decrease copper absorption. Treatment must be continued for the lifetime of 
the patient, and most patients treated early can expect a complete or nearly com­
plete recovery.
Siblings of affected patients should be screened for presymptomatic Wil­
son’s disease with neurologic and slit lamp examinations and determination of 
serum ceruloplasmin levels. If no abnormalities are found, serum copper and 
urinary copper excretion should be assayed and liver biopsy performed if nec­
essary. If these investigations reveal preclinical Wilson's disease, therapy should 
be instituted as described above for symptomatic disease.
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DRUG-INDUCED MOVEMENT DISORDERS
Parkinsonism
Parkinsonism frequently complicates treatment with dopamine-depleting 
agents such as reserpine or antipsychotic dopamine-receptor antagonists such as 
phenothiazines or butyrophenones. In the case of antipsychotic drugs, the risk of 
this complication is greatest when agents are used that are potent D2-receptor an­
tagonists with little anticholinergic effect, such as piperazine phenothiazines, bu­
tyrophenones, and thioxanthenes. In addition, women and elderly patients ap­
pear to be at somewhat increased risk. Tremor is relatively uncommon, while 
hypokinesia tends to be symmetric and the most conspicuous neurologic feature 
of parkinsonism. These points, together with the history of drug ingestion, often 
point to the iatrogenic nature of the disorder. Signs usually develop within 3 
months after starting the offending drug and disappear over weeks or months 
following discontinuance.
Depending on the severity of symptoms and the necessity for continuing 
antipsychotic drug therapy, several strategies are available for treating drug-in­
duced parkinsonism. These include discontinuing the antipsychotic drug, substi­
tuting a less potent dopamine receptor antagonist, or adding an anticholinergic 
drug such as trihexyphenidyl or benztropine. Levodopa is of no help if the neu­
roleptic drugs are continued; it may be helpful if these drugs are discontinued 
but may aggravate the psychotic disorder for which they were originally pre­
scribed.
Acute Dystonia or Dyskinesia
Acute dystonia or dyskinesia (such as blepharospasm, torticollis, or facial 
grimacing) is an occasional complication of dopamine receptor antagonist 
treatment, generally occurring within 1 week after introduction of such medica­
tion and often within 48 hours. Men and younger patients show increased sus­
ceptibility to this complication. The pathophysiologic basis of the disturbance is 
unclear, but intravenous treatment with an anticholinergic drug (eg, benztropine, 
2 mg, or diphenhydramine, 50 mg) usually alleviates it.
Akathisia
Akathisia is a state of motor restlessness characterized by an inability to 
sit or stand still, which is relieved by moving about. It is a very common move­
ment disorder induced by chronic treatment with antipsychotic drugs and occurs 
more often in women than in men. Akathisia is treated in the same manner as 
drug-induced parkinsonism.
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Tardive Dyskinesia
Tardive dyskinesia may develop after long-term treatment with antipsy­
chotic (dopamine-receptor-antagonist) drugs. It is commonly encountered in 
chronically institutionalized psychiatric patients, and the risk of developing 
tardive dyskinesia appears to increase with advancing age. The manner in which 
chronic drug treatment promotes a movement disorder is unknown.
Drug-induced supersensitivity of striatal dopamine receptors has been 
proposed but is unlikely to be responsible for several reasons. Supersensitivity 
always accompanies chronic antipsychotic drug treatment, whereas tardive dy­
skinesia does not. Supersensitivity may occur early in the course of treatment, 
while tardive dyskinesia does not develop for at least 3 months. In addition su­
persensitivity is invariably reversible when drugs are discontinued; tardive dy­
skinesia is not. The clinical features of tardive dyskinesia, particularly its persis­
tent nature, are more suggestive of an underlying structural abnormality. Such 
an abnormality may involve GABA-neurons, because GABA and its synthesiz­
ing enzyme, glutamic acid decarboxylase, are depleted in the basal ganglia fol­
lowing chronic treatment of animals with antipsychotic drugs and GABA levels 
in CSF are decreased in patients with tardive dyskinesia. No consistent patho­
logic features have been found in the brains of patients with tardive dyskinesia, 
although inferior olive atrophy, degeneration of the substantia nigra, and swell­
ing of large neurons in the caudate nucleus have been described in some cases. 
The clinical disorder is characterized by abnormal choreoathetoid movements 
that are often especially conspicuous about the face and mouth in adults and 
tend to be more obvious in the limbs in children. The onset of dyskinesia is gen­
erally not until months-or years-after the start of treatment with the responsible 
agent. Tardive dyskinesia may be impossible to distinguish from such disorders 
as Huntington's disease or idiopathic torsion dystonia unless a history of drug 
exposure is obtained.
Tardive dyskinesia is easier to prevent than to cure. Antipsychotic drugs 
should be prescribed only on clear indication, and their long-term use should be 
monitored, with periodic drug holidays to determine whether the need for treat­
ment continues. Drug holidays may also help to unmask incipient dyskinesias — 
which, curiously, tend to worsen when the drug is withdrawn. Antipsychotic 
medication should be stopped if possible when dyskinesia appears during a drug 
holiday, for in such circumstances the abnormal movements occasionally will 
remit.
Treating the established disorder is generally unsatisfactory, though it 
sometimes resolves spontaneously, especially in children or young adults. Anti- 
dopaminergic agents such as haloperidol or phenothiazines suppress the abnor­
mal movements, but their use for this purpose is not recommended since they 
may aggravate the underlying disorder. Treatment with reserpine, 0.25 mg
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gradually increased to 2-4 mg/d orally, or tetrabenazine 12.5 mg gradually in­
creased to as much as 200 mg/d orally, may be helpful. Both these drugs deplete 
monoamine neurotransmitters, including dopamine. A number of other pharma­
cologic approaches have been suggested, but there are conflicting reports re­
garding their utility.
A variety of other late and often persistent movement disorders may ap­
pear during the course of antipsychotic drug treatment. Tardive dystonia is usu­
ally segmental (affecting two or more contiguous body parts, such as the face 
and neck or arm and trunk) in nature. It is less often focal; when this is the case, 
the head and neck are particularly apt to be affected, producing blepharospasm, 
torticollis, or oromandibular dystonia. Generalized dystonia is least common and 
tends to occur in younger patients. Treatment is with tetrabenazine (if available) 
as described for tardive dyskinesia or with anticholinergic drugs as described 
earlier for idiopathic torsion dystonia. Tardive akathisia can also occur; it is 
treated in the same manner as drug-induced parkinsonism. Tardive tic, a drug- 
induced disorder resembling Gilles de la Tourette's syndrome (see later), is char­
acterized by multifocal motor and vocal tics and can be similarly treated with 
clonidine (as described later) if symptoms do not remit spontaneously.
Neuroleptic Malignant Syndrome
This rare complication of treatment with antipsychotic drugs (neurolep­
tics) is manifested by rigidity, fever, altered mental status, and autonomic dys­
function. Haloperidol is implicated most often, but the syndrome can complicate 
treatment with any antipsychotic drug; whether concomitant treatment with lith­
ium or anticholinergic drugs increases the risk is uncertain. Symptoms typically 
develop over 1-3 days and can occur at any time during the course of treatment. 
The differential diagnosis includes infection, which must be excluded in any 
febrile patient. Neuroleptic malignant syndrome resembles malignant hyper­
thermia, but the latter disorder develops over minutes to hours rather than days 
and is associated with the administration of inhalational anesthetics or neuro­
muscular blocking agents rather than antipsychotics. Treatment of neuroleptic 
malignant syndrome includes withdrawal of antipsychotic drugs, lithium, and 
anticholinergics; reduction of body temperature with antipyretics and artificial 
cooling; and rehydration. Dantrolene may be beneficial, as may bromocriptine, 
levodopa preparations, or amantadine. The mortality rate is as high as 20%.
Other Drug-Induced Movement Disorders
Levodopa produces a wide variety of abnormal movements as a dose- 
related phenomenon in patients with parkinsonism. They can be reversed by 
withdrawing the medication or reducing the dose. Chorea may also develop in 
patients receiving bromocriptine, anticholinergic drugs, phenytoin, carba-
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mazepine, amphetamines, lithium, and oral contraceptives; it resolves with dis­
continuance of the responsible drug. Dystonia has resulted from administration 
of bromocriptine, lithium, carbamazepine, and metoclopramide; and postural 
tremor from administration of theophylline, caffeine, lithium, thyroid hormone, 
tricyclic antidepressants, valproic acid, and isoproterenol.
GILLES DE LA TOURETTE'S SYNDROME
Gilles de la Tourette's syndrome, characterized by chronic-typically life- 
long-multiple motor and verbal tics, is of unknown cause and does not relate to 
social class, ethnic group, perinatal abnormalities, birth trauma, or birth order. 
Symptoms begin before 21 years of age, and the course is one of remission and 
relapse. Most cases are sporadic, although there is occasionally a family history, 
and partial expression of the trait may occur in siblings or offspring of patients! 
Inheritance has been attributed to an autosomal dominant gene with variable 
penetrance. Males are affected more commonly than females. The prevalence in 
the United States has been estimated to be 0.05%.
The pathophysiology is obscure. Dopaminergic excess in the brains of pa­
tients with Gilles de la Tourette's syndrome has been postulated, mainly because 
of the beneficial effects that dopamine-blocking drugs can have on the tics. The 
administration of dopamine receptor agonists often fails to produce the exacer­
bation of symptoms that might be anticipated from this hypothesis, however. No 
structural basis for the clinical disorder has been recognized.
Clinical Findings
Symptoms usually commence between ages 2 and 21 years. The first 
signs consist of motor tics in 80% of cases and vocal tics in 20%; there may be 
either a single tic or multiple tics. When the initial sign is a motor tic, it most 
commonly involves the face, taking the form of sniffing, blinking, forced eye 
closure, etc. It is generally not possible to make the diagnosis at this stage.
All patients ultimately develop a number of different motor tics and in­
voluntary vocal tics, the latter commonly consisting of grunts, barks, hisses, 
throat-clearing or coughing, and the like, and sometimes taking the form of ver­
bal utterances including coprolalia (vulgar or obscene speech). There may also 
be echolalia (parroting the speech of others), echopraxia (imitation of others' 
movements), and palilalia (repetition of words or phrases). The tics vary over 
time in severity, character, and the muscle groups involved. In 40-50% of cases, 
some of the tics involve self-mutilation with such activities as severe nail-biting 
or hair-pulling, picking at the nose, or biting the lips or tongue. Sensory tics, 
consisting of pressure, tickling, and warm or cold sensations, also occur. Behav­
ioral disorders, including obsessive-compulsive disorder and attention deficit
409
hyperactivity disorder, are common in patients with Gilles de la Tourette's syn­
drome, but their precise relationship to the tic disorder is uncertain. Physical ex­
amination usually reveals no other abnormalities, but there is a higher than ex­
pected incidence of left-handedness or ambidexterity.
Differential Diagnosis
The differential diagnosis includes the various movement disorders that 
can present in childhood. Other disorders characterized by tics are distinguished 
by resolution of the tics by early adulthood or by the restricted number of tics.
Wilson's disease can simulate Gilles de la Tourette's syndrome; it must be 
excluded because it responds well to medical treatment. In addition to a move­
ment disorder, Wilson's disease produces hepatic involvement, Kayser-Fleischer 
corneal rings, and abnormalities of serum copper and ceruloplasmin, which are 
absent in Gilles de la Tourette's syndrome.
Sydenham's chorea can be difficult to recognize if there is no recent his­
tory of rheumatic fever or polyarthritis and no clinical evidence of cardiac in­
volvement, but this disorder is a self-limiting one, usually clearing in 3-6 
months.
Bobble-head syndrome, which can be difficult to distinguish from Gilles 
de la Tourette's syndrome, is characterized by rapid, rhythmic bobbing of the 
head in children with progressive hydrocephalus.
Complications
Gilles de la Tourette's syndrome is often unrecognized for years, the tics 
being attributed to psychiatric illness or mistaken for some other form of ab­
normal movement. Indeed, in many cases the correct diagnosis is finally made 
by the family rather than the physician. In consequence, patients are often sub­
jected to unnecessary and expensive treatment before the true nature of the dis­
order is recognized. Psychiatric disturbances, sometimes culminating in suicide, 
may occur because of the cosmetic and social embarrassment produced by the 
tics. Drug therapy can lead to a number of side effects.
Treatment
Treatment is symptomatic and, if effective, must be continued indefi­
nitely. Clonidine has been reported to ameliorate motor or vocal tics in roughly 
50% of children so treated. It may act by reducing activity in noradrenergic neu­
rons arising in the locus ceruleus. It is started in a dose of 2-3 pg/kg/d, increas­
ing after 2 weeks to 4 pg/kg/d and then, if necessary, to 5 pg/kg/d. It may cause 
an initial transient fall in blood pressure. The most frequent side effect is seda­
tion. Other adverse reactions include reduced or excessive salivation and diar­
rhea.
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Haloperidol is often effective. It is started at a low daily dose (0.25 mg) 
which is gradually increased by 0.25 mg every 4 or 5 days until there is maxi­
mum benefit with a minimum of side effects or until side effects limit further in­
crements. A total daily dose of 2-8 mg is usually optimal, but higher doses are 
sometimes necessary. Side effects include extrapyramidal movement disorders, 
sedation, dryness of the mouth, blurred vision, and gastrointestinal disturbances. 
Pimozide, another dopaminergic-receptor antagonist, may be helpful in patients 
who are either unresponsive to or cannot tolerate haloperidol, but the longterm 
safety of pimozide is unknown. Treatment is started with 1 mg/d and the dose 
increased by 2 mg every 10 days; most patients require 7-16 mg/d. Phenothiazi- 
nes such as fluphenazine may help, but patients who are unresponsive to halop­
eridol usually fail with these drugs as well.
Patients occasionally respond favorably to clonazepam or carbamazepine, 
but diazepam, barbiturates, tricyclic antidepressants, phenytoin, and cholinergic 
agonists (such as deanol) are usually not helpful.
RESTLESS LEGS SYNDROME
Restless legs syndrome is characterized by an unpleasant creeping dis­
comfort that is perceived as arising deep within the legs and occasionally in the 
arms as well. Such symptoms tend to occur when patients are relaxed, especially 
while lying down or sitting, and lead to a need to move about. They are often 
particularly troublesome at night and may delay the onset of sleep. A sleep dis­
order associated with periodic movements during sleep may also occur and can 
be documented by polysomnographic recording. The cause is unknown, al­
though the disorder seems especially common among pregnant women arid is 
not uncommon among uremic or diabetic patients with neuropathy. Most pa­
tients, however, have no obvious predisposing cause. Symptoms sometimes re­
solve following correction of coexisting iron-deficiency anemia, and they may 
respond to treatment with drugs such as levodopa, bromocriptine, diazepam, 
clonazepam, or opiates. When opiates are required, those with long half-lives or 
low addictive potential should be used.
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MYASTHENIA GRAVIS
Myasthenia gravis can occur at any age and is sometimes associated with 
thymic tumor, thyrotoxicosis, rheumatoid arthritis, or disseminated lupus ery­
thematosus. More common in females than males, it is characterized by fluctuat­
ing weakness and easy fatigability of voluntary muscles; muscle activity cannot 
be maintained, and initially powerful movements weaken readily. There is a 
predilection for the external ocular muscles and certain other cranial muscles, 
including the masticatory, facial, pharyngeal, and laryngeal muscles. Respiratory 
and limb muscles may also be affected. Weakness is due to a variable block of 
neuromuscular transmission related to an immune-mediated decrease in the 
number of functioning acetylcholine receptors. A similar disorder in patients re­
ceiving penicillamine for rheumatoid arthritis frequently remits when the drug is 
discontinued.
Clinical Findings
Although the onset of the disease is usually insidious, the disorder is 
sometimes unmasked by a concurrent infection, which leads to an exacerbation 
of symptoms. Exacerbations may also occur in pregnancy or before menses. 
Symptoms may be worsened by quinine, quinidine, procainamide, propranolol, 
phenytoin, lithium, tetracycline, and aminoglycoside antibiotics, which should 
therefore be avoided in such patients. Myasthenia follows a slowly progressive 
course. Patients present with ptosis, diplopia, difficulty in chewing or swallow­
ing, nasal speech, respiratory difficulties, or weakness of the limbs. These symp­
toms often fluctuate in intensity during the day, and this diurnal variation is su­
perimposed on longer-term spontaneous relapses and remissions that may last 
for weeks.
Clinical examination confirms the weakness and fatigability of affected 
muscles. The weakness does not conform to the distribution of any single nerve, 
root, or level of the central nervous system. In more than 90% of cases the ex­
traocular muscles are involved, leading to often asymmetric ocular palsies and 
ptosis. Pupillary responses are not affected. The characteristic feature of the dis­
order is that sustained activity of affected muscles leads to temporarily increased 
weakness. Thus, sustained upgaze for 2 minutes can lead to increased ptosis, 
with power in the affected muscles improving after a brief rest. In advanced 
cases, there may be some mild atrophy of affected muscles. Sensation is normal, 
and there are usually no reflex changes.
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Diagnosis
The diagnosis of myasthenia gravis can generally be confirmed by the 
benefit that follows administration of anticholinesterase drugs: the power of af­
fected muscles is influenced at a dose that has no effect on noi ,ial muscles and 
slight, if any, effect on muscles weakened by other causes.
The most commonly used pharmacological test is the edrophonium (Ten­
silon) test. Edrophonium is given intravenously in a dose of 10 mg (1 mL), of 
which 2 mg is given initially and the remaining 8 mg about 30 seconds later if 
the test dose is well tolerated. In myasthenic patients, there is an obvious im­
provement in the strength of weak muscles that lasts for about 5 minutes.
Alternatively, 1.5 mg of neostigmine can be given intramuscularly, with a 
response that lasts for about 2 hours; atropine sulfate (0.6 mg) should be avail­
able to counteract the muscarinic cholinergic side effects of increased salivation, 
diarrhea, and nausea. Atropine does not affect nicotinic cholinergic function at 
the neuromuscular junction. The longer-acting neostigmine reduces the inci­
dence of false-negative evaluations.
Investigative Studies
X-rays and CT scans of the chest may reveal a coexisting thymoma. Im­
paired neuromuscular transmission can be detected electrophysiologically by a 
decremental response of muscle to repetitive supramaximal stimulation (at 2 or 
3 Hz) of its motor nerve, but normal findings do not exclude the diagnosis. Sin­
gle-fiber electromyography shows increased variability in the interval between 
two muscle fiber action potentials from the same motor unit in clinically weak 
muscles. Measuring serum acetylcholine receptor antibody levels is often help­
ful, since increased values are found in 80-90% of patients with generalized my­
asthenia gravis.
Treatment
Medications (referred to earlier) that impair neuromuscular transmission 
should be avoided. The following approaches to treatment are recommended.
A. Anticholinesterase Drugs. Treatment with these drugs provides symp­
tomatic benefit without influencing the course of the underlying disease. The 
mainstay of treatment is pyridostigmine, at doses individually determined but 
usually between 30 and 180 mg (average, 60 mg) four times daily. The older 
drug neostigmine may still be used, in rare instances, by parenteral administra­
tion. Small doses of atropine may attenuate side effects such as bowel hypermo­
tility or hypersalivation. Overmedication can lead to increased weakness, which, 
unlike myasthenic weakness, is unaffected or enhanced by intravenous edropho­
nium. Such a cholinergic crisis may be accompanied by pallor, sweating, nau­
sea, vomiting, salivation, colicky abdominal pain, and miosis.
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Presynaptic nerve terminal
Fig. 19. Sites of involvement in disorders of neuromuscular transmission. At 
left, normal transmission involves depolarization-induced influx of calcium (Ca) 
through voltage-gated channels. This stimulates release of acetylcholine (ACh) 
from synaptic vesicles at the active zone and into the synaptic cleft. ACh binds 
to ACh receptors and depolarizes the postsynaptic muscle membrane. At right, 
disorders of neuromuscular transmission result from blockage of Ca channels 
(Lambert-Eaton syndrome or aminoglycoside antibiotics), impairment of Ca- 
mediated ACh release (botulinum toxin), or antibody-induced internalization 
and degradation of ACh receptors (myasthenia gravis). (From R. Simon, M. 
Aminoff, D. Greenberg, 1999)
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B. Thymectomy. Thymectomy should be performed in patients under 60 
years of age, and considered in those older, with weakness that is not restricted 
to the extraocular muscles. Although thymectomy usually leads to symptomatic 
benefit or remission, the mechanism by which it confers benefit is unclear, and 
its beneficial effect may not be evident immediately.
C. Corticosteroids. Corticosteroids are indicated for patients who have 
responded poorly to anticholinesterase drugs and have already undergone thy­
mectomy. Treatment is initiated with the patient in the hospital, since weakness 
may initially be exacerbated. An initial high dose of prednisone (60-100 mg/d 
orally) can gradually be tapered to a relatively low maintenance level (5-15 
mg/d) as improvement occurs. Alternate-day treatment is helpful in reducing the 
incidence of side effects.
D. Azathioprine. This drug can be used in patients with severe or pro­
gressive disease despite thymectomy and treatment with anticholinesterases and 
corticosteroids. It can also be given in place of high doses of corticosteroids to 
patients who show no sustained benefit with low doses. The usual dose is 2-3 
mg/kg/d, increased from a lower initial dose.
E. Plasmapheresis. Plasmapheresis may be used to achieve temporary 
improvement in patients deteriorating rapidly or in myasthenic crisis, and in cer­
tain special circumstances, such as prior to surgery that is likely to produce 
postoperative respiratory compromise.
F. Intravenous Immunoglobulins. Intravenous immunoglobulins have 
also been used to provide temporary benefit in circumstances similar to those in 
which plasmapheresis is used.
Prognosis
Most patients can be managed successfully with drug treatment. The dis­
ease may have a fatal outcome because of respiratory complications such as as­
piration pneumonia;
MYASTHENIC SYNDROME (LAMBERT-EATON SYNDROME)
This disorder has a well-recognized association with an underlying neo­
plasm and may occasionally be associated with such autoimmune diseases as 
pernicious anemia; occasionally no cause is found. In the paraneoplastic disor­
der, antibodies directed against tumor antigens cross-react with voltage-gated 
calcium channels involved in acetylcholine release, leading to a disturbance of 
neuromuscular transmission.
Clinically there is weakness, especially of the proximal muscles of the 
limbs. Unlike myasthenia gravis, however, the extraocular muscles are charac­
teristically spared, and power steadily increases if a contraction is maintained. 
Autonomic disturbances, such as dry mouth, constipation, and impotence, may 
also occur.
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The diagnosis is confirmed electrophysioiogically by the response to re­
petitive nerve stimulation. There is a remarkable increase in the size of the mus­
cle response to stimulation of its motor nerve at high rates -  even in muscles that 
are not clinically weak. The presence of autoantibodies to the P/Q subtype of 
voltage-gated calcium channels, found on the presynaptic membrane of the neu­
romuscular junction, is highly sensitive and specific to the Lambert-Eaton syn­
drome of any etiology.
Immunosuppressive drug therapy (corticosteroids and azathioprine as de­
scribed earlier for myasthenia gravis) and plasmapheresis or intravenous im­
munoglobulin therapy may lead to improvement. Guanidine hydrochloride, 25- 
50 mg/kg/d in three or four divided doses, is sometimes helpful in seriously dis­
abled patients, but adverse effects of the drug include bone marrow suppression 
and renal failure. The response to treatment with anticholinesterase drugs such 
as pyridostigmine or neostigmine, alone or in combination with guanidine, is 
variable. 3,4-Diaminopyridine (investigational), at doses up to 25 mg orally four 
times daily, may improve weakness and autonomic dysfunction; paresthesia is a 
common side effect, and seizures may occur. The disease improves with treat­
ment of the underlying condition.
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MYOPATHIC DISORDERS
MUSCULAR DYSTROPHIES
The muscular dystrophies are a group of inherited myopathic disorders 
characterized by progressive muscle weakness and wasting. They are subdivided 
by their mode of inheritance, age at onset, distribution of involved muscles, rate 
of progression, and long-term outlook.
There is no specific treatment for the muscular dystrophies. It is important 
to encourage patients to lead as normal a life as possible. Deformities and con­
tractures can often be prevented or ameliorated by physical therapy and ortho­
pedic procedures. Prolonged bed rest must be avoided, as inactivity often leads 
to worsening of disability.
A. Duchenne's Dystrophy. The most common form of muscular dystro­
phy, it is an X-linked disorder that affects predominantly males. Symptoms be­
gin by age 5 years, and patients are typically severely disabled by adolescence, 
with death occurring in the third decade. Toe walking, waddling gait, and an in­
ability to run are early symptoms. Weakness is most pronounced in the proximal 
lower extremities but also affects the proximal upper extremities. In attempting 
to rise to stand from a supine position, patients characteristically must use their 
arms to climb up their bodies (Gowers' sign). Pseudohypertrophy of the calves 
caused by fatty infiltration of muscle is common. The heart is involved late in 
the course, and mental retardation is a frequent accompaniment. Serum CPK 
levels are exceptionally high.
No definitive treatment is available, but some studies suggest that predni­
sone, 1.5 mg/kg/d orally, may improve muscle strength in the short term (up to 6 
months). Side effects include weight gain, Cushingoid appearance, and hir­
sutism; the long-term effects of prednisone in this disorder are uncertain.
A genetic defect responsible for Duchenne's dystrophy has been identified 
and forms the basis of a diagnostic test. The gene in question is located on the 
short arm of the X chromosome and codes for the protein dystrophin, which is 
absent or profoundly reduced in muscle from patients with the disorder. The ab­
sence of dystrophin from synaptic regions of cerebral cortical neurons may con­
tribute to mental retardation in patients with Duchenne's dystrophy. Gene ther­
apy has not proven effective at this time for treating this muscular dystrophy.
B. Becker's Dystrophy. This is also X-linked and associated with a pat­
tern of weakness similar to that observed in Duchenne's dystrophy. Its average 
onset (II years) and age at death (42 years) are later, however. Cardiac and cog­
nitive impairment do not occur, and CPK levels are less strikingly elevated than 
in Duchenne's dystrophy. In contrast to Duchenne's dystrophy, dystrophin levels
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in muscle are normal in Becker's dystrophy, but the protein is qualitatively al­
tered.
C. Limb-Girdle Dystrophy. Previously a catchall designation that 
probably subsumed a variety of disorders, including undiagnosed cases of other 
dystrophies, it is (in classic form) inherited in autosomal recessive fashion, and 
in some affected families the defective gene has been localized to the long arm 
of chromosome 15. The disorder begins clinically between late childhood and 
early adulthood. In contrast to Duchenne's and Becker's dystrophies, the shoul­
der and pelvic girdle muscles are affected to a more nearly equal extent. Pseu­
dohypertrophy is not seen, and CPK levels are less elevated.
D. Facioscapulohumeral Dystrophy. An autosomal dominant disorder 
that usually has its onset in adolescence, this is compatible with a normal life 
span. The genetic defect is a rearrangement of a homeobox gene localized to the 
telomere of the long arm of chromosome 4. The clinical severity of this condi­
tion is highly variable. Weakness is typically confined to the face, neck, and 
shoulder girdle, but foot drop can occur. Winged scapulae are common. The 
heart is not involved, and serum CPK levels are normal or only slightly elevated. 
Scapuloperoneal dystrophy is probably a variant, but genetic studies have shown 
linkage to chromosome 12 in some instances.
E. Distal myopathy. This autosomal dominant dystrophy typically pre­
sents after age 40, although onset may be earlier and symptoms more severe in 
homozygotes. Small muscles of the hands and feet, wrist extensors, and the dor- 
siflexors of the foot are affected. The precise pattern of involvement varies in 
the different subtypes of the disorder. The course is slowly progressive. Distal 
myopathies with autosomal recessive inheritance or occurring sporadically are 
also described and present with progressive leg weakness in adolescents or 
young adults.
F. Ocular Dystrophy. This is typically an autosomal dominant disorder, 
although recessive and sporadic cases also occur. Some cases are associated 
with deletions in mitochondrial DNA. Onset is usually before age 30 years. 
Ptosis is the earliest manifestation, but progressive external ophthalmoplegia 
subsequently develops; facial weakness is also common, and subclinical in­
volvement of limb muscles may occur. The course is slowly progressive. The 
extent to which ocular dystrophy is distinct from oculopharyngeal dystrophy 
(see below) is unclear in many cases.
G. Oculopharyngeal Dystrophy. An autosomal dominant disorder, this 
is found with increased frequency in certain geographic areas, including Quebec 
and the southwestern United States. It most often begins in the third to fifth dec­
ade. Findings include ptosis, total external ophthalmoplegia, dysphagia, facial 
weakness, and often proximal limb weakness. CPK is mildly elevated. Dys­
phagia is particularly incapacitating and may require nasogastric feeding or gas­
trostomy.
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H. Paraspinal Dystrophy. Progressive paraspinal weakness may develop 
after the age of 40 in patients of either gender, some of whom may have a family 
history of the disorder. Back pain and a marked kyphosis ("bent spine syn­
drome") are characteristic. The CPK is mildly elevated. CT scans show fatty re­
placement of paraspinal muscles.
MYOTONIC DISORDERS
In myotonia, an abnormality of the muscle fiber membrane (sarcolemma) 
leads to marked delay before the affected muscles can relax after a contraction; 
this leads to apparent muscle stiffness. In at least some cases, the disorder ap­
pears to be related to a decrease in chloride ion conductance across the sar­
colemma. On examination, it is frequently possible to demonstrate myotonia by 
difficulty in relaxing the hand after sustained grip or by persistent contraction 
after percussion of the belly of a muscle. Electromyography of affected muscles 
may reveal characteristic high-frequency discharges of potentials that wax and 
wane in amplitude and frequency, producing over the EMG loudspeaker a sound 
like that of a dive bomber or chain-saw.
Myotonic Dystrophy
Myotonic dystrophy is a dominantly inherited disorder that usually is 
manifest in the third or fourth decade, although it may appear in early childhood. 
The gene defect is an expanded trinucleotide (CTG) repeat in a gene localized to 
the centromeric region of chromosome 19 (19cen-ql3.2), and this expanded tri­
nucleotide repeat forms the basis of a diagnostic test. The protein encoded by 
this gene has been designated myotonin-protein kinase. Occasional patients, 
however, have clinical features resembling myotonic dystrophy but no repeat 
expansion of the myotonin-protein kinase gene. Myotonia accompanies weak­
ness and wasting of the facial, stemomastoid, and distal limb muscles. There 
may also be cataracts, frontal baldness, testicular atrophy, diabetes mellitus, car­
diac abnormalities, and intellectual changes.
Myotonia can be treated with quinine sulfate, 300-400 mg three times 
daily; procainamide, 0.5-1 g four times daily; or phenytoin, 100 mg three times 
daily. In myotonic dystrophy, phenytoin is perhaps the drug of choice, since the 
other drugs may have undesirable effects on cardiac conduction. There is no 
treatment for the weakness that occurs, and pharmacologic maneuvers do not in­
fluence the natural history.
Myotonia Congenita
Myotonia congenita is usually inherited as a dominant trait that relates to 
a mutation on chromosome 7. Generalized myotonia without weakness is usu­
ally present from birth, but symptoms may not develop until early childhood.
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Muscle stiffness is enhanced by cold and inactivity and relieved by exercise. 
Muscle hypertrophy, sometimes pronounced, is also a feature. A recessive form 
with later onset is associated with slight weakness and atrophy of distal muscles. 
Treatment with quinine sulfate, procainamide, tocainide, mexilitene, or pheny- 
toin may help the myotonia.
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TRAUMATIC BRAIN INJURY
Traumatic brain injury (TBI) continues to be an enormous public health 
problem, even with modern medicine in the 21st century. Most patients with 
TBI (75-80%) have mild head injuries; the remaining injuries are divided 
equally between the moderate and severe categories.
The cost to society of TBI is staggering, from both an economic and an 
emotional standpoint. Almost 100% of persons with severe head injury and as 
many as two thirds of those with moderate head injury will be permanently dis­
abled and will not return to their premorbid level of function. In the United 
States, the direct cost of care for patients with TBI, excluding inpatient care, is 
estimated at more than $25 billion annually. The impact is even greater when 
one considers that most severe head injuries occur in adolescents and young 
adults.
Frequency
The annual incidence of TBI in some western countries has been esti­
mated to be 180-220 cases per 100,000 population. In the United States, with a 
population of almost 300 million, approximately 600,000 new TBIs occur per 
year. As many as 10% of these injuries are fatal, resulting in almost 550,000 
persons hospitalized annually with head injuries.
Etiology
While various mechanisms may cause TBI, the most common causes in­
clude motor vehicle accidents (collisions between vehicles, pedestrians struck by 
motor vehicles, bicycle accidents), falls, assaults, sports-related injuries, and 
penetrating trauma. Motor vehicle accidents account for almost half of the TBIs 
and in suburban/rural settings, they account for most TBIs. In cities with popula­
tions greater than 100,000, assaults, falls, and penetrating trauma are more 
common etiologies of head injury. The male-to-female ratio for TBI is nearly 
2:1, and TBI is much more common in persons younger than 35 years.
Pathophysiology
Appropriate management of TBI requires an understanding of the patho­
physiology of head injury. In addition to the obvious functional differences, the 
brain has several features that distinguish it from other organ systems. The most 
important of these differences is that the brain is contained within the skull, a 
rigid and inelastic container. Because the brain is housed within this inelastic 
container, only small increases in volume within the intracranial compartment
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can be tolerated before pressure within the compartment rises dramatically. This 
concept is defined by the Monro-Kellie doctrine, which states that the total in­
tracranial volume is fixed because of the inelastic nature of the skull. The intrac­
ranial volume (Vi/c) is equal to the sum of its components, as follows:
Vi/c = V (brain) + V (cerebrospinal fluid) + V (blood)
In the typical adult, the intracranial volume is approximately 1500 mL, of 
which the brain accounts for 85-90%, intravascular cerebral blood volume ac­
counts for 10%, and cerebrospinal fluid (CSF) accounts for the remainder 
(<3%). When a significant head injury occurs, cerebral edema often develops, 
which increases the relative volume of the brain. Because the intracranial vol­
ume is fixed, the pressure within this compartment rises unless some compensa­
tory action occurs, such as a decrease in the volume of one of the other intracra­
nial components. This is intimately related to the concept of intracranial compli­
ance, which is defined as the change in pressure due to changes in volume.
Compliance = Change in volume / change in pressure
Compliance is based on the pressure volume index (PVI) within the in­
tracranial compartment. The PVI describes the change in intracranial pressure 
(ICP) that occurs when a small amount of fluid is added to or withdrawn from 
the intracranial compartment. Simply stated, the brain has very limited compli­
ance and cannot tolerate significant increases in volume that can result from dif­
fuse cerebral edema or from significant mass lesions such as a hematoma. The 
rationale for each treatment of head injury is based on the concept of the Monro- 
Kellie doctrine and how a particular intervention affects the intracranial compli­
ance. When the volume of any of the components of the total intracranial vol­
ume is decreased, the ICP may be decreased.
A second crucial concept in TBI pathophysiology is the concept of cere­
bral perfusion pressure (CPP). CPP is defined as the difference between the 
mean arterial pressure (MAP) and the ICP.
CPP = MAP - ICP
In practical terms, CPP is the net pressure of blood delivery to the brain. 
In the noninjured brain in individuals without long-standing hypertension, cere­
bral blood flow (CBF) is constant in the range of MAPs of 50-150 mm Hg. This 
is due to autoregulation by the arterioles, which will constrict or dilate within a 
specific range of blood pressure to maintain a constant amount of blood flow to 
the brain.
When the MAP is less than 50 mm Hg or greater than 150 mm Hg, the ar­
terioles are unable to autoregulate and blood flow becomes entirely dependent
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on the blood pressure, a situation defined as pressure-passive flow. The CBF is 
no longer constant but is dependent on and proportional to the CPP. Thus, when 
the MAP falls below 50 mm Hg, the brain is at risk of ischemia due to insuffi­
cient blood flow, while a MAP greater than 160 mm Hg causes excess CBF that 
may result in increased ICP. While autoregulation works well in the noninjured 
brain, it is impaired in the injured brain. As a result, pressure-passive flow oc­
curs within and around injured areas and, perhaps, globally in the injured brain.
TBI may be divided into 2 categories, primary brain injury and secondary 
brain injury. Primary brain injury is defined as the initial injury to the brain as a 
direct result of the trauma. This is the initial structural injury caused by the im­
pact on the brain, and, like other forms of neural injury, patients recover poorly. 
Secondary brain injury is defined as any subsequent injury to the brain after the 
initial insult. Secondary brain injury can result from systemic hypotension, hy­
poxia, elevated ICP, or as the biochemical result of a series of physiologic 
changes initiated by the original trauma. The treatment of head injury is directed 
at either preventing or minimizing secondary brain injury.
Elevated ICP may result from the initial brain trauma or from secondary 
injury to the brain. In adults, normal ICP is considered 0-15 mm Hg. In young 
children, the upper limit of normal ICP is lower, and this limit may be consid­
ered 10 mm Hg. Elevations in ICP are deleterious because they can result in de­
creased CPP and decreased CBF, which, if severe enough, may result in cerebral 
ischemia. Severe elevations of ICP are dangerous because, in addition to creat­
ing a significant risk for ischemia, uncontrolled ICP may cause herniation. Her­
niation involves the movement of the brain across fixed dural structures, result­
ing in irreversible and often fatal cerebral injury.
CLINICAL PRESENTATION
TBI may be divided into 2 broad categories, closed head injury and pene­
trating head injury. This is not purely a mechanistic division because some as­
pects of the treatment of these 2 types of TBIs differ. The clinical presentation 
of the patient with TBI varies significantly, from an ambulatory patient com­
plaining of a sports-related head injury to the moribund patient arriving via heli­
copter following a high-speed motor vehicle accident. The Glasgow Coma Scale 
(GCS) developed by Jennett and Teasdale is used to describe the general level of 
consciousness of patients with TBI and to define broad categories of head in­
jury. The GCS is divided into 3 categories, eye opening (E), motor response 
(M), and verbal response (V). The score is determined by the sum of the score in 
each of the 3 categories, with a maximum score of 15 and a minimum score of 3, 
as follows: GCS score = E + M + V.
Patients who are intubated are unable to speak, and their verbal score can­
not be assessed. They are evaluated only with eye opening and motor scores,
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and the suffix T is added to the score to indicate that the patient is intubated. In 
intubated patients, the maximal GCS score is 10T and the minimum score is 2T. 
The GCS is often used to help define the severity of TBI. Mild head injuries are 
generally defined as those associated with a GCS score of 13-15, and moderate 
head injuries are those associated with a GCS score of 9-12. A GCS score of 8 
or less defines a severe head injury. These definitions are not rigid and should be 
considered as a general guide to the level of injury.
Relevant Anatomy
Several aspects of neuroanatomy and neurophysiology require review in a 
discussion of TBI. Although a comprehensive review of neuroanatomy is be­
yond the scope of this discussion, a few key concepts are reviewed.
The brain essentially floats within the CSF; as a result, the brain can un­
dergo significant translation and deformation when the head is subjected to sig­
nificant forces. In a deceleration injury, in which the head impacts a stationary 
object such as the windshield of a car, the skull stops moving almost instantly. 
However, the brain continues to move within the skull toward the direction of 
the impact for a very brief period after the head has stopped moving. This results 
in significant forces acting on the brain as it undergoes both translation and de­
formation.
In an acceleration injury, as in a direct blow to the head, the force applied 
to the skull causes the skull to move away from the applied force. The brain 
does not move with the skull, and the skull impacts the brain, causing translation 
and deformation of the brain. The forces that result from either deceleration or 
acceleration of the brain can cause injury by direct mechanical effects on the 
various cellular components of the brain or by shear-type forces on axons. In 
addition to the translational forces, the brain can experience significant rota­
tional forces, which can also lead to shear injuries.
The intracranial compartment is divided into 3 compartments by 2 major 
dural structures, the falx cerebri and the tentorium cerebelli. The tentorium cere- 
belli divides the posterior fossa or infratentorial compartment (the cerebellum 
and the brainstem) from the supratentorial compartment (cerebral hemispheres). 
The falx cerebri divides the supratentorial compartment into 2 halves and sepa­
rates the left and right hemispheres of the brain. Both the falx and the tentorium 
have central openings and prominent edges at the borders of each of these open­
ings. When a significant increase in ICP occurs, caused by either a large mass 
lesion or significant cerebral edema, the brain can slide through these openings 
within the falx or the tentorium, a phenomenon known as herniation. As the 
brain slides over the free dural edges of the tentorium or the falx, it is frequently 
injured by the dural edge.
Several types of herniation exist, as follows: (1) transtentorial herniation, 
(2) subfalcine herniation, (3) central herniation, (4) upward herniation, and (5)
424
tonsillar herniation. Transtentorial herniation occurs when the medial aspect of 
the temporal lobe (uncus) migrates across the free edge of the tentorium. This 
causes pressure on the third cranial nerve, interrupting parasympathetic input to 
the eye and resulting in a dilated pupil. This unilateral dilated pupil is the classic 
sign of transtentorial herniation and usually (80%) occurs ipsilateral to the side 
of the transtentorial herniation. In addition to pressure on the third cranial nerve, 
transtentorial herniation compresses the brainstem.
Subfalcine herniation occurs when the cingulate gyrus on the medial as­
pect of the frontal lobe is displaced across the midline under the free edge of the 
falx. This may compromise the blood flow through the anterior cerebral artery 
complexes, which are located on the medial side of each frontal lobe. Subfalcine 
herniation does not cause the same brainstem effects as those caused by tran­
stentorial herniation.
Central herniation occurs when a diffuse increase in ICP occurs and each 
of the cerebral hemispheres is displaced through the tentorium, resulting in sig­
nificant pressure on the upper brainstem.
Upward, or cerebellar, herniation occurs when either a large mass or in­
creased pressure in the posterior fossa is present and the cerebellum is displaced 
in an upward direction through the tentorial opening. This also causes significant 
upper brainstem compression.
Tonsillar herniation occurs when increased pressure develops in the poste­
rior fossa. In this form of herniation, the cerebellar tonsils are displaced in a 
downward direction through the foramen magnum, causing compression on the 
lower brainstem and upper cervical spinal cord as they pass through the foramen 
magnum.
Another aspect of the intracranial anatomy that has a significant role in 
TBI is the irregular surface of the skull underlying the frontal and temporal 
lobes. These surfaces contain numerous ridges that can cause injury to the infe­
rior aspect of the frontal lobes and the temporal lobes as the brain glides over 
these irregular ridges following impact. Typically, these ridges cause cerebral 
contusions. The roof of the orbit has many ridges, and, as a result, the inferior 
frontal lobe is one of the most common sites of traumatic cerebral contusions.
INVESTIGATIVE STUDIES 
Lab Studies
After the patient has been stabilized and an appropriate neurologic exami­
nation has been conducted, the diagnostic evaluation may begin. Patients with 
TBI do not require any additional blood tests beyond the standard panel of tests 
obtained in all trauma patients. A urine toxicology screen and an assessment of 
the blood alcohol level are important for any patient who has an altered level of
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consciousness because any central nervous system depressant can impair con­
sciousness.
Imaging Studies
Skull radiographs. Once an important part of the head injury evaluation, 
skull radiographs have been replaced by CT scans and are rarely used in patients 
with closed head injury. Skull radiographs are occasionally used in the evalua­
tion of penetrating head trauma, and they can help provide a rapid assessment of 
the degree of foreign body penetration in nonmissile penetrating head injuries 
(eg, stab wounds). Skull radiographs are sometimes used in patients with gun­
shot wounds to the head to screen for retained intracranial bullet fragments.
CT scan. A CT scan is the diagnostic study of choice in the evaluation of 
TBI because it has a rapid acquisition time, is universally available, is easy to 
interpret, and is reliable. When first introduced more than 25 years ago, CT 
scans of the brain required almost 30 minutes to complete. This acquisition time 
has decreased steadily; the current generation of ultrafast CT scanners can per­
form a head CT scan in less than 1 minute, faster than the time required to enter 
patient's demographic data into the scanner.
The standard CT scan for the evaluation of acute head injury is a noncon­
trast scan that spans from the base of the occiput to the top of the vertex in 5- 
mm increments. Three data sets are obtained from the primary scan, (1) bone 
windows, (2) tissue windows, and (3) subdural windows. These different types 
of exposure are necessary because of the significant difference in exposure nec­
essary to visualize various intracranial structures. The bone windows allow for a 
detailed survey of the bony anatomy of the skull, and the tissue windows allow 
for a detailed survey of the brain and its contents. The subdural windows pro­
vide better visualization of intracranial hemorrhage, especially those hemor­
rhages adjacent to the brain (eg, subdural hematomas).
Each intracranial structure has a characteristic density, which is expressed 
in Hounsfield units. These units are defined according to a scale that ranges 
from (-) 1000 units to (+) 1000 units. Air is assigned a density of (-) 1000 units, 
water is assigned a density of 0 units, and bone has a density of (+) 1000 units. 
On this scale, CSF has a density of (+) 4 to (+) 10 units, white matter has a den­
sity of (+) 22 to (+) 36 units, and gray matter has a density of (+) 32 to (+) 46 
units. Extravascular blood has a density of (+) 50 to (+) 90 units, and calcified 
tissue and bone have a density of (+) 800 to (+) 1000 units.
When reviewing a CT scan, using a systematic approach and following 
this same protocol each time are important. Consistency is much more important 
than the specific order used. First, examine the bone windows for fractures, be­
ginning with the cranial vault and then examining the skull base and the facial 
bones. Next, examine.the tissue windows for the presence of (1) extra-axial 
hematomas (eg, epidural hematomas, subdural hematomas), (2) intraparenchy­
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mal hematomas, or (3) contusions. Next, survey the brain for any evidence of 
pneumocephalus, hydrocephalus, cerebral edema, midline shift, or compression 
of the subarachnoid cisterns at the base of the brain. Finally, examine the sub­
dural windows for any hemorrhage that may not be visualized easily on the tis­
sue windows.
Skull fractures may be classified as either linear or comminuted fractures. 
Linear skull fractures are sometimes difficult to visualize on the individual axial 
images of a CT scan. The scout film of the CT scan, which is the equivalent of a 
lateral skull x-ray film, often demonstrates linear fractures. The intracranial su­
tures are easily mistaken for small linear fractures. However, the sutures have 
characteristic locations in the skull and have a symmetric suture line on the op­
posite side. Small diploic veins, which traverse the skull, may also be interpreted 
as fractures. Comminuted fractures are complex fractures with multiple compo­
nents. Comminuted fractures may be displaced inwardly; this is defined as a de­
pressed skull fracture.
Extra-axial hematomas include epidural and subdural hematomas. Epidu­
ral hematomas are located between the inner table of the skull and the dura. 
They are typically biconvex in shape because their outer border follows the in­
ner table of the skull and their inner border is limited by locations at which the 
dura is firmly adherent to the skull. Epidural hematomas are usually caused by 
injury to an artery, although 10% of epidural hematomas may be venous in ori­
gin. The most common cause of an epidural hematoma is a linear skull fracture 
that passes through an arterial channel in the bone. The classic example of this is 
the temporal epidural hematoma caused by a fracture through the course of the 
middle meningeal artery. Epidural hematomas, especially those of arterial ori­
gin, tend to enlarge rapidly.
Subdural hematomas are located between the dura and the brain. Their 
outer edge is convex, while their inner border is usually irregularly concave. 
Subdural hematomas are not limited by the intracranial suture lines; this is an 
important feature that aids in their differentiation from epidural hematomas. 
Subdural hematomas are usually venous in origin, although some subdural he­
matomas are caused by arterial injuries. The classic cause of a posttraumatic 
subdural hematoma is an injury to one of the bridging veins that travel from the 
cerebral cortex to the dura. As the brain atrophies over time, the bridging veins 
become more exposed and, as a result, are more easily injured. Occasionally, the 
distinction between a subdural and an epidural hematoma can be difficult. The 
size of an extra-axial hematoma is a more important factor than whether the 
blood is epidural or subdural in location. In addition, a mixed hematoma with 
both a subdural and an epidural component is not uncommon.
Intra-axial hematomas are defined as hemorrhages within the brain paren­
chyma. These hematomas include intraparenchymal hematomas, intraventricular 
hemorrhages, and subarachnoid hemorrhages. Subarachnoid hemorrhages that 
occur because of trauma are typically located over gyri on the convexity of the
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brain. The subarachnoid hemorrhages that result from a ruptured cerebral aneu­
rysm are usually located in the subarachnoid cisterns at the base of the brain. 
Cerebral contusions are posttraumatic lesions in the brain that appear as irregu­
lar regions, in which high-density changes (ie, blood) and low-density changes 
(ie, edema) are present. Frequently, 1 of these 2 types of changes predominates 
within a particular contusion. Contusions are most often caused by the brain 
gliding over rough surfaces, such as the rough portions of the skull that are pre­
sent under the frontal and temporal lobes.
CT scans may be used for classification and for diagnostic purposes. Mar­
shall et al published a classification scheme that classifies head injuries accord­
ing to the changes demonstrated on CT scan images. This system defines 4 cate­
gories of injury, from diffuse injury I to diffuse injury IV.
In diffuse injury I, evidence of any significant brain injury is lacking.
In diffuse injury II, either no midline shift or a shift of less than 5 mm is 
present and the CSF cisterns at the base of the brain are widely patent. In addi­
tion, no high-density or mixed-density lesions (contusions) of greater than 25 
mL in volume are present.
In diffuse injury III, a midline shift of less than 5 mm is present, with par­
tial compression or absence of the basal cisterns. No high- or mixed-density le­
sions with a volume greater than 25 mL are present.
Diffuse injury IV is defined as midline shift greater than 5 mm with com­
pression or absence of the basal cisterns and no lesions of high or mixed density 
greater than 25 mL.
MRI. MR1 has a limited role in the evaluation of acute head injury. Al­
though MRI provides extraordinary anatomic detail, it is not commonly used to 
evaluate acute head injuries because of its long acquisition times and the diffi­
culty in obtaining MRIs in persons who are critically ill. However, MRI is used 
in the subacute setting to evaluate patients with unexplained neurologic deficits.
MRI is superior to CT scan for helping identify diffuse axonal injury 
(DAI) and small intraparenchymal contusions. DAI is defined as neuronal injury 
in the subcortical gray matter or the brainstem as a result of severe rotation or 
deceleration. DAI is often the reason for a severely depressed level of con­
sciousness in patients who lack evidence of significant injury on CT scan images 
and have an ICP that is within the reference range. Magnetic resonance an­
giography may be used in some patients with TBI to assess for arterial injury or 
venous sinus occlusion.
Angiography. Once a common diagnostic study in persons with acute 
head injury, angiography is rarely used in the evaluation of acute head injury to­
day. Prior to the development of the CT scan, cerebral angiography provided a 
reliable means for demonstrating the presence of an intracranial mass lesion. 
Currently, angiography in used in acute head injury only when a vascular injury 
may be present. This includes patients with unexplained neurologic deficits, es­
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pecially in the setting of temporal bone fractures, and patients with clinical evi­
dence of a potential carotid injury (eg, hemiparesis, Horner syndrome).
Other Tests
Initial evaluation. The initial evaluation of patients with TB1 involves a 
thorough systemic trauma evaluation according to the advanced trauma life sup­
port (ATLS) guidelines. Once this has been completed and the patient is stable 
from a cardiopulmonary standpoint, attention may be directed to a focused head 
injury evaluation.
The evaluation of the spine for potential injury is critically important in 
patients with TB1 because approximately 10% of those with severe head injuries 
have a concomitant spine injury. Many of these injuries are cervical spine inju­
ries.
Attempt to obtain a thorough history of the mechanism of the trauma and 
the events immediately preceding the trauma. Specific information, such as the 
occurrence of syncope or the onset of a seizure prior to a fall or a motor vehicle 
accident, prompts a more extended evaluation of the etiology of such an event. 
Because many patients with TBI have altered levels of consciousness, the his­
tory is often provided by family members, police officers, paramedics, or wit­
nesses.
Neurologic assessment
After sufficient information has been obtained regarding patient history, 
appropriate physical and neurologic examinations are performed. The neu­
rologic assessment begins with ascertaining the GCS score. This is a screening 
examination and does not substitute for a thorough neurologic examination. In 
addition to determining the GCS score, the neurologic assessment of patients 
with TBI should include the following:
■ Brainstem examination - Pupillary examination, ocular movement ex­
amination, corneal reflex, gag reflex
■ Motor examination
■ Sensory examination
■ Reflex examination
Many patients with TBI have significant alterations of consciousness 
and/or pharmaceuticals present that limit the scope of the neurologic examina­
tion. When such factors limit the neurologic examination, noting their presence 
is important.
Pupillary examination
A careful pupillary examination is a critical part of the evaluation of pa­
tients with TBI, especially in patients with severe injuries. When muscle relax- 
ants have been administered to a patient, the only aspect of the neurologic ex­
amination that may be evaluated is the pupillary examination.
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Several factors can alter the pupillary examination results. Narcotics cause 
pupillary constriction (meiosis), and medications or drugs that have sympath­
omimetic properties cause pupillary dilation (mydriasis). These effects are often 
strong enough to blunt or practically eliminate pupillary' responses. Prior eye 
surgery, such as cataract surgery, can also alter or eliminate pupillary reactivity.
Proper assessment of the pupillary response requires the use of a strong 
light source to override any of the potential factors that may affect pupillary re­
action. Each pupil must be assessed individually, with at least 10 seconds be­
tween assessment of each eye to allow consensual responses to fade prior to 
stimulating the opposite eye.
A normal pupillary examination result consists of bilaterally reactive pu­
pils that react to both direct and consensual stimuli. Bilateral small pupils can be 
caused by narcotics, pontine injury (due to disruption of sympathetic centers in 
the pons), or early central herniation (mass effect on the pons).
Bilateral fixed and dilated pupils are secondary to inadequate cerebral per­
fusion. This can result from diffuse cerebral hypoxia or severe elevations of ICP 
preventing adequate blood flow into the brain.
Pupils that are fixed and dilated usually indicate an irreversible injury. If 
due to systemic hypoxia, the pupils sometimes recover reactivity when adequate 
oxygenation is restored.
A unilateral fixed (unresponsive) and dilated pupil has many potential 
causes. A pupil that does not constrict when light is directed at the pupil but 
constricts when light is directed into the contralateral pupil (intact consensual 
response) is indicative of atraumatic optic nerve injury.
A unilateral dilated pupil that does not respond to either direct or consen­
sual stimulation usually indicates transtentorial herniation.
Unilateral constriction of a pupil is usually secondary to Horner syn­
drome, in which the sympathetic input to the eye is disrupted and the pupil con­
stricts due to more parasympathetic than sympathetic stimulation. In patients 
with TB1, Homer syndrome may be caused by an injury to the sympathetic chain 
at the apex of the lung or a carotid artery injury. A unilateral constricted pupil 
can be caused by a unilateral brainstem injury, but this is quite rare.
A core optic pupil is a pupil that appears irregular in shape. This is caused 
by a lack of coordination of contraction of the muscle fibers of the iris and is as­
sociated with midbrain injuries.
Ocular movement examination
When the patient's level of consciousness is altered significantly, a loss of 
voluntary eye movements often occurs and abnormalities in ocular movements 
are frequently present. These abnormalities can provide specific clues to the ex­
tent and location of injury.
Ocular movements involve the coordination of multiple centers in the 
brain, including the frontal eye fields, the paramedian pontine reticular forma­
tion (PPRF), the medial longitudinal fasciculus (MLF), and the nuclei of the
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third and sixth cranial nerves. In patients in whom voluntary eye movements 
cannot be assessed, oculocephalic and oculovestibular testing may be per­
formed.
Oculocephalic testing
Oculocephalic testing (doll's eyes) involves observation of eye move­
ments when the head is turned from side to side. This maneuver helps assess the 
integrity of the horizontal gaze centers.
Before performing oculocephalic testing, the status of the cervical spine 
must be established. If a cervical spine injury has not been excluded reliably, 
oculocephalic testing should not be performed. When assessing oculocephalic 
movements, the head is elevated to 30° from horizontal and is rotated briskly 
from side to side. A normal response is for the eyes to turn away from the direc­
tion of the movement as if they are fixating on a target that is straight ahead. 
This is similar to the way a doll's eyes move when the head is turned; this is the 
origin of the term doll's eyes. If the eyes remain fixed in position and do not ro­
tate with the head, this is indicative of dysfunction in the lateral gaze centers and 
is referred to as negative doll's eyes. Some patients may have negative doll's 
eyes and normal oculovestibular reflexes.
Oculovestibular testing
Oculovestibular testing, also known as cold calorics, is another method 
for assessment of the integrity of the gaze centers. Oculovestibular testing is per­
formed with the head elevated to 30° from horizontal to bring the horizontal 
semicircular canal into the vertical position.
Oculovestibular testing requires the presence of an intact tympanic mem­
brane; this must be assessed before beginning the test. In oculovestibular testing, 
20 mL of ice-cold water is instilled slowly into the auditory canal. If is no re­
sponse occurs within 60 seconds, the test is repeated with 40 mL of cold water. 
When cold water is irrigated into the external auditory canal, the temperature of 
the endolymph falls and the fluid begins to settle. This causes an imbalance in 
the vestibular signals and initiates a compensatory response.
Cold-water irrigation in the ear of an alert patient results in a fast nystag­
mus away from the irrigated ear and a slow compensatory nystagmus toward the 
irrigated side. If warm water is used, the opposite will occur; the fast component 
of nystagmus will be toward the irrigated side, and the slow component will be 
away from the irrigated side. This is the basis for the acronym COWS, which 
stands for cold opposite, warm same. This refers to the direction of the fast 
component of nystagmus. As the level of consciousness declines, the fast com­
ponent of nystagmus fades gradually. Thus, in unconscious patients, only the 
slow phase of nystagmus may be evaluated. A normal oculocephalic response to 
cold-water calorics (ie, eye deviation toward the side of irrigation) indicates that 
the injury spares the PPRF, the MLF, and third and sixth cranial nerve nuclei. 
This means that the level of injury must be rostral to the reticular activating sys­
tem in the upper brainstem. If a unilateral frontal lobe injury is present, the eyes
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are deviated toward the side of injury prior to caloric testing. Cold-water irriga­
tion of the opposite ear results in a normal response to caloric testing (ie, eye 
deviation toward the irrigated side) because the injury is in the frontal region 
and spares the pontine gaze centers. When a pontine injury is present, the eyes 
often deviate away from the side of injury. In this situation, cold-water irrigation 
of the contralateral ear does not cause the gaze to deviate toward the irrigated 
ear because an injury has occurred at the level of the pons and the pontine gaze 
centers are compromised. A dysconjugate response to caloric testing suggests an 
injury to either the third or sixth cranial nerves or an injury to the MLF, resulting 
in an internuclear ophthalmoplegia. If caloric testing causes a skew deviation, in 
which the eyes are dysconjugate in the vertical direction, this indicates a lesion 
in the brainstem. The exact location of injury that results in skew deviation is 
not known.
Motor examination
After completing the brainstem examination, a motor examination should 
be performed. A thorough motor or sensory examination is difficult to perform 
in any patient with an altered level of consciousness. When a patient is not alert 
enough to cooperate with strength testing, the motor examination is limited to an 
assessment of asymmetry in the motor examination findings. This may be dem­
onstrated by an asymmetric response to central pain stimulation or a difference 
in muscle tone between the left and right sides. A finding of significant asymme­
try during the motor examination may be indicative of a hemispheric injury and 
raises the possibility of a mass lesion.
Sensory examination
Performing a useful sensory examination in patients with TBI is often dif­
ficult. Patients with altered levels of consciousness are unable to cooperate with 
sensory testing, and findings from a sensory examination are not reliable in pa­
tients who are intoxicated or comatose.
Peripheral reflex examination
A peripheral reflex examination can be useful to help identify gross 
asymmetry in the neurologic examination. This may indicate the presence of a 
hemispheric mass lesion.
TREATMENT
Medical therapy: The treatment of head injury may be divided into the 
treatment of closed head injury and the treatment of penetrating head injury. 
While significant overlap exists between the treatments of these 2 types of in­
jury, some important differences are discussed. Closed head injury treatment is 
divided further into the treatment of mild, moderate, and severe head injuries.
432
Closed head injury
Mild head injury
Most head injuries are mild head injuries. Most people presenting with 
mild head injuries will not have any progression of their head injury; however, 
up to 3% of mild head injuries progress to more serious injuries. Mild head inju­
ries may be separated into low-risk and moderate-risk groups. Patients with 
mild-to-moderate headaches, dizziness, and nausea are considered to have low- 
risk injuries. Many of these patients require only minimal observation after they 
are assessed carefully, and many do not require radiographic evaluation. These 
patients may be discharged if a reliable individual can monitor them.
Patients who are discharged after mild head injury should be given an in­
struction sheet for head injury care. The sheet should explain that the person 
with the head injury should be awakened every 2 hours and assessed neurologi­
cally. Caregivers should be instructed to seek medical attention if patients de­
velop severe headaches, persistent nausea and vomiting, seizures, confusion or 
unusual behavior, or watery discharge from either the nose or the ear.
Patients with mild head injuries typically have concussions. A concussion 
is defined as physiologic injury to the brain without any evidence of structural 
alteration. Concussions are graded on a scale of I-V. A grade I concussion is one 
in which a person is confused temporarily but does not display any memory 
changes. In a grade II concussion, brief disorientation and anterograde amnesia 
of less than 5 minutes’ duration are present. In a grade III concussion, retrograde 
amnesia and loss of consciousness for less than 5 minutes are present, in addi­
tion to the 2 criteria for a grade II concussion. Grade IV and grade V concus­
sions are similar to a grade III, except that in a grade IV concussion, the duration 
of loss of consciousness is 5-10 minutes, and in a grade V concussion, the loss 
of consciousness is longer than 10 minutes.
As many as 30% of patients who experience a concussion develop post- 
concussive syndrome (PCS). PCS consists of a persistence of any combination 
of the following after a head injury: headache, nausea, emesis, memory loss, 
dizziness, diplopia, blurred vision, emotional lability, or sleep disturbances. 
Fixed neurologic deficits are not part of PCS, and any patient with a fixed deficit 
requires careful evaluation. PCS usually lasts 2-4 months. Typically, the symp­
toms peak 4-6 weeks following the injury. On occasion, the symptoms of PCS 
last for a year or longer. Approximately 20% of adults with PCS will not have 
returned to full-time work 1 year after the initial injury, and some are disabled 
permanently by PCS. PCS tends to be more severe in children than in adults. 
When PCS is severe or persistent, a multidisciplinary approach to treatment may 
be necessary. This includes social services, mental health services, occupational 
therapy, and pharmaceutical therapy.
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After a mild head injury, those displaying persistent emesis, severe head­
ache, anterograde amnesia, loss of consciousness, or signs of intoxication by 
drugs or alcohol are considered to have a moderate-risk head injury. These pa­
tients should be evaluated with a head CT scan. Patients with moderate-risk mild 
head injuries can be discharged if their CT scan findings reveal no pathology, 
their intoxication is cleared, and they have been observed for at least 8 hours.
Moderate and severe head injury
The treatment of moderate and severe head injuries begins with initial 
cardiopulmonary stabilization by ATLS guidelines. The initial resuscitation of a 
patient with a head injury is of critical importance to prevent hypoxia and hy­
potension. In the Traumatic Coma Data Bank study, patients with head injury 
who presented to the hospital with hypotension had twice the mortality rate of 
patients who did not present with hypotension. The combination of hypoxia and 
hypotension resulted in a mortality rate 2.5 times greater than if neither of these 
factors was present.
Once a patient has been stabilized from the cardiopulmonary standpoint, 
evaluation of their neurologic status may begin. The initial GCS score provides 
a classification system for patients with head injuries but does not substitute for 
a neurologic examination. After assessment of the coma score, a neurologic ex­
amination should be performed. If a patient has received muscle relaxants, the 
only neurologic response that may be evaluated is the pupillary response.
After a thorough neurologic assessment has been performed, a CT scan of 
the head is obtained. The results of the CT scan help determine the next step. If a 
surgical lesion is present, arrangements are made for immediate transport to the 
operating room. Fewer than 10% of patients with TBI have an initial surgical le­
sion.
Although no strict guidelines exist for defining surgical lesions in persons 
with head injury, most neurosurgeons consider any of the following to represent 
indications for surgery in patients with head injuries: extra-axial hematoma with 
midline shift greater than 5 mm, intra-axial hematoma with volume greater than 
30 mL, an open skull fracture, or a depressed skull fracture with more than 1 cm 
of inward displacement. In addition, any temporal or cerebellar hematoma that is 
larger than 3 cm in diameter is considered a high-risk hematoma because these 
regions of the brain are smaller and do not tolerate additional mass as well as the 
frontal, parietal, and occipital lobes. These high-risk temporal and cerebellar 
hematomas are usually evacuated immediately
If no surgical lesion is present on the CT scan image, or following surgery 
if one is present, treatment of the head injury begins. The first phase of treatment 
is to institute general measures. Once appropriate fluid resuscitation has been 
completed and the volume status is determined to be normal, intravenous fluids
434
are administered to maintain the patient in a state of euvolemia or mild hyper­
volemia. A previous tenet of head injury treatment was fluid restriction, which 
was believed to limit the development of cerebral edema and increased ICP. 
Fluid restriction decreases intravascular volume and, therefore, decreases car­
diac output. A decrease in cardiac output often results in decreased cerebral 
flow, which results in decreased brain perfusion and may cause an increase in 
cerebral edema and ICP. Thus, fluid restriction is contraindicated in patients 
with TBI.
Another supportive measure used to treat patients with head injuries is 
elevation of the head. When the head of the bed is elevated to 20-30°, the ve­
nous outflow from the brain is improved, thus helping to reduce ICP. If a patient 
is hypovolemic, elevation of the head may cause a drop in cardiac output and 
CBF; therefore, the head of the bed is not elevated in hypovolemic patients. In 
addition, the head should not be elevated (1) in patients in whom a spine injury 
is a possibility or (2) until an unstable spine has been stabilized.
Sedation is often necessary in patients with traumatic injury. Some pa­
tients with moderate head injuries have significant agitation and require seda­
tion. In addition, patients with multisystem trauma often have painful systemic 
injuries that require pain medication, and many intubated patients require seda­
tion. Short-acting sedatives and analgesics should be used to accomplish proper 
sedation without eliminating the ability to perform periodic neurologic assess­
ments. This requires careful titration of medication doses and periodic weaning 
or withholding of sedation to allow periodic neurologic assessment.
The use of anticonvulsants in patients with TBI is a controversial issue. 
No evidence exists that the use of anticonvulsants decreases the incidence of 
late-onset seizures in patients with either closed head injury or TBI. Temkin et al 
demonstrated that the routine use of Dilantin in the first week following TBI de­
creases the incidence of early-onset (within 7 d of injury) seizures but does not 
change the incidence of late-onset seizures. In addition, the prevention of early 
posttraumatic seizures does not improve the outcome following TBI. Therefore, 
the prophylactic use of anticonvulsants is not recommended for more than 7 
days following TBI and is considered optional in the first week following TBI.
After instituting general supportive measures, the issue of ICP monitoring 
is addressed. ICP monitoring has consistently been shown to improve outcome 
in patients with head injuries. ICP monitoring is indicated for any patient with a 
GCS score less than 9, any patient with a head injury who requires prolonged 
deep sedation or pharmacologic relaxants for a systemic condition, or any pa­
tient with an acute head injury who is undergoing extended general anesthesia 
for a nonneurosurgical procedure.
ICP monitoring involves placement of an invasive probe to measure the 
ICP. Unfortunately, noninvasive means of monitoring ICP do not exist, although 
they are under development. ICP may be monitored by means of an intraparen- 
chymal monitor, an intraventricular monitor (ventriculostomy), or an epidural
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monitor. These devices measure ICP by fluid manometry, strain-gauge technol­
ogy, or fiberoptic technology.
Intraparenchymal ICP monitors are devices that are placed into the brain 
parenchyma to measure ICP by means of fiberoptic, strain-gauge, or other tech­
nologies. The intraparenchymal monitors are very accurate; however, they do 
not allow for drainage of CSF. Epidural devices measure ICP via a strain-gauge 
device placed through the skull into the epidural space. This is an older form of 
ICP measurement and is rarely used today because the other technologies avail­
able are more accurate and more reliable.
A ventriculostomy is a catheter placed through a small twist drill hole into 
the lateral ventricle. The ICP is measured by transducing the pressure in a fluid 
column. Ventriculostomies allow for drainage of CSF, which can be effective in 
decreasing the ICP.
Once an ICP monitor has been placed, ICP is monitored continuously. No 
absolute value of ICP exists for which treatment is implemented automatically. 
In adults, the reference range of ICP is 0-15 mm Hg. The normal ICP waveform 
is a triphasic wave, in which the first peak is the largest peak and the second and 
third peaks are progressively smaller. When intracranial compliance is abnor­
mal, the second and third peaks are usually larger than the first peak. In addition, 
when intracranial compliance is abnormal and ICP is elevated, pathologic waves 
may appear.
Lundberg described 3 types of abnormal ICP waves, A, B, and C waves. 
Lundberg A waves, known as plateau waves, have a duration of 5-20 minutes 
and an amplitude of 50 mm Hg over the baseline ICP. After an episode of A 
waves dissipates, the ICP is reset to a baseline level that is higher than when the 
waves began. Lundberg A waves are a sign of severely compromised intracra­
nial compliance. The rapid increase in ICP caused by these waves can result in a 
significant decrease in CPP and may lead to herniation.
Lundberg В waves have a duration of less than 2 minutes, and they have 
an amplitude of 10-20 mm Hg above the baseline ICP. В waves are also related 
to abnormal intracranial compliance. Because of their smaller amplitude and 
shorter duration, В waves are not as deleterious as A waves.
C waves, known as Hering-Traube waves, are low-amplitude waves that 
may be superimposed on other waves. They may be related to increased ICP; 
however, C waves can also occur in the setting of normal ICP and compliance.
When treating elevated ICP, remember that the goal of treatment is to op­
timize conditions within the brain to prevent secondary injury and to allow the 
brain to recover from the initial insult. Maintaining ICP within the reference 
range is part of an approach designed to optimize both CBF and the metabolic 
state of the brain. Treatment of elevated ICP is a complex process that should be 
tailored to each particular patient's situation and should not be approached in a 
“cookbook” manner. Many potential interventions are used to lower ICP, and
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each of these is designed to improve intracranial compliance, which results in 
improved CBF and decreased ICP.
The Monro-Kellie doctrine provides the framework for understanding and 
organizing the various treatments for elevated ICP. In patients with head inju­
ries, the total intracranial volume is composed of the total volume of the brain, 
the CSF, intravascular blood volume, and any intracranial mass lesions. The 
volume of one of these components must be reduced to improve intracranial 
compliance and to decrease ICP. The discussion of the different treatments for 
elevated ICP is organized according to which component of intracranial volume 
they affect.
The first component of total intracranial volume to consider is the blood 
component. This includes all intravascular blood, both venous and arterial, and 
comprises approximately 10% of total intracranial volume. Elevation of the head 
increases venous outflow and decreases the volume of venous blood within the 
brain. This results in a small improvement in intracranial compliance and, there­
fore, has only a modest effect on ICP.
The second component of intracranial vascular volume is the arterial 
blood volume. This may be reduced by mild-to-moderate hyperventilation, in 
which the PCO2 is reduced to 30-35 mm Hg. This decrease in PCO2 causes 
vasoconstriction at the level of the arteriole, which decreases blood volume 
enough to reduce ICP. The effects of hyperventilation have a duration of action 
of approximately 48-72 hours, at which point the brain resets to the reduced 
lvvel o fP ^ 0 2. This is sn important point because once hyperventilation is used, 
the PC02 should not be returned to normal rapidly. This may cause rebound 
vasodilatation, which can result in increased ICP.
At one time, severe hyperventilation was an important component of the 
treatment of increased ICP. Reducing PC02 to less than 25 mm Hg has been 
shown to cause enough vasoconstriction that CBF is reduced to the point at 
which a high probability exists of developing cerebral ischemia. Therefore, pro­
longed severe hyperventilation is not used routinely to treat elevated ICP. Brief 
periods of severe hyperventilation may be used to treat patients with transient 
ICP elevations due to pressure waves or in the initial treatment of patients in 
neurologic distress until other measures can be instituted.
CSF represents the next component of total intracranial volume and ac­
counts for 2-3% of total intracranial volume. In adults, total CSF production is 
approximately 20 mL/h or 500 mL/d. In many patients with TBI who have ele­
vated ICP, a ventriculostomy may be placed and CSF may be drained. Removal 
of small amounts of CSF hourly can result in improvements in compliance that 
result in significant improvements in ICP.
The third and largest component of total intracranial volume is the brain 
or tissue component, which comprises 85-90% of the total intracranial volume. 
When significant brain edema is present, it causes an increase in the tissue com­
ponent of the total intracranial volume and results in decreased compliance and
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increased ICP. Treatments for elevated ICP that reduce total brain volume in­
clude diuretics, perfusion augmentation (CPP strategies), metabolic suppression, 
and decompressive procedures.
Diuretics are powerful in their ability to decrease brain volume and, there­
fore, decrease ICP. Mannitol, an osmotic diuretic, is the most common diuretic 
used. Mannitol is a sugar alcohol that draws water out from the brain into the in­
travascular compartment. It has a rapid onset of action and a duration of action 
of 2-8 hours. Mannitol is usually administered as a bolus because it is much 
more effective when given in intermittent boluses than when used as a continu­
ous infusion. The standard dose ranges from 0.25-1 g/kg, administered every 4-6 
hours. Because mannitol causes significant diuresis, electrolytes and serum os­
molality must be monitored carefully during its use. In addition, careful atten­
tion must be given to providing sufficient hydration to maintain euvolemia. The 
limit for mannitol is 4 g/kg/d. At daily doses higher than this, mannitol can 
cause renal toxicity. Mannitol should not be given if the patient's serum sodium 
level is greater than 145 or serum osmolality is greater than 315 mOsm.
Other diuretics that sometimes are used in patients with TBI include fu- 
rosemide, glycerol, and urea. Mannitol is preferred over furosemide because it 
tends to cause less severe electrolyte imbalances than a loop diuretic. Interest­
ingly, mannitol and furosemide have a synergistic effect when combined; how­
ever, this combination tends to cause severe electrolyte disturbances. Urea and 
glycerol have also been used as osmotic diuretics. Both of these compounds are 
smaller molecules than mannitol and, as a result, tend to equilibrate within the 
brain sooner than mannitol; therefore, they have a shorter duration of action than 
mannitol. Urea has the additional problem that it can cause severe skin slough­
ing if it infiltrates into the skin.
CPP management involves artificially elevating the blood pressure to in­
crease the MAP and the CPP. Because autoregulation is impaired in the injured 
brain, pressure-passive CBF develops within these injured areas. As a result, 
these injured areas of the brain often have insufficient blood flow, and tissue 
acidosis and lactate accumulation occur. This causes vasodilation, which in­
creases cerebral edema and ICP. When the CPP is raised to greater than 65-70 
mm Hg, the ICP is often lowered because increased blood flow to injured areas 
of the brain decreases the tissue acidosis. This often results in a significant de­
crease in ICP.
Metabolic therapies are designed to decrease the cerebral metabolic rate, 
which decreases ICP. Metabolic therapies are powerful means of reducing ICP, 
but they are reserved for situations in which other therapies have failed to con­
trol ICP. This is because metabolic therapies have diffuse systemic effects and 
often result in severe adverse effects, including hypotension, immunosuppres­
sion, coagulopathies, arrhythmias, and myocardial suppression. Metabolic sup­
pression may be achieved through drug therapies or induced hypothermia.
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Barbiturates are the most common class of drugs used to suppress cerebral 
metabolism. Barbiturate coma is typically induced with pentobarbital. A loading 
dose of 10 mg/kg is administered over 30 minutes, and then 5 mg/kg/h is admin­
istered for 3 hours. A maintenance infusion of 1-2 mg/kg/h is begun after load­
ing is completed. The infusion is titrated to provide burst suppression on con­
tinuous electroencephalogram monitoring and a serum level of 3-4 mg/dL. 
Typically, the barbiturate infusion is continued for 48 hours, and then the patient 
is weaned off the barbiturates. If the ICP again escapes control, the patient may 
be reloaded with pentobarbital and weaned again in several days.
Hypothermia may also be used to suppress cerebral metabolism. The use 
of mild hypothermia involves decreasing the core temperature to 34-35°C for 
24-48 hours and then slowly rewarming the patient over 2-3 days. Patients with 
hypothermia are also at risk for hypotension and systemic infections.
Another treatment that may be used in patients with TBI with refractory 
ICP elevation is decompressive craniectomy. In this surgical procedure, a large 
section of the skul! is removed and the dura is expanded, This increases the total 
intracranial volume and, therefore, decreases ICP. Which patients benefit from 
decompressive craniectomy has not been established. Some believe that patients 
with refractory ICP elevation who have diffuse injury but do not have significant 
contusions or infarctions will benefit from decompressive craniectomy.
Management of elevated ICP involves using a combination of treatments. 
Each patient represents a slightly different set of circumstances, and treatment 
must be tailored to each patient. Although no rigid protocols have been estab­
lished for the treatment of head injury, many published algorithms provide 
treatment schemas.
The American Association of Neurologic Surgeons published a compre­
hensive evidence-based review of the treatment of TBI, called the "Guidelines 
for the Management of Severe Head Injury." In these guidelines, 3 different 
categories of treatments, standards, guidelines, and options are outlined. Stan­
dards are the accepted principles of management that reflect a high degree of 
clinical certainty. Guidelines are a particular strategy or a range of management 
options that reflect a high degree of clinical certainty. Options are strategies for 
patient management for which clinical certainty is unclear.
Penetrating trauma
The treatment of penetrating brain injuries involves 2 main aspects. The 
first is the treatment of the TBI caused by a penetrating object. Penetrating brain 
injuries, especially from high-velocity missiles, frequently result in severe ICP 
elevations. This aspect of penetrating brain injury treatment is identical to the 
treatment of closed head injuries.
The second aspect of penetrating head injury treatment involves debride­
ment and removal of the penetrating objects. Penetrating injuries require careful
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debridement because these wounds are frequently dirty. When objects penetrate 
the brain, they introduce pathogens into the brain from the scalp surface and 
from the surface of the penetrating object.
Penetrating injuries may be caused by high-velocity missiles (eg, bullets), 
penetrating objects (eg, knives, tools), or fragments of bone driven into the 
brain. Bullet wounds are treated with debridement of as much of the bullet tract 
as possible, dural closure, and reconstruction of the skull as needed. If the bullet 
can be removed without significant risk of neurologic injury, it should be re­
moved to decrease the risk of subsequent infection. Penetrating objects such as 
knives require removal to prevent further injury and infection. If the penetrating 
object either is near or traverses a major vascular structure, an angiogram is nec­
essary to assess for potential vascular injury. When the risk of vascular injury is 
present, penetrating objects should be removed only after appropriate access has 
been obtained to ensure that vascular control is easily achieved.
Penetrating brain injuries are associated with a high rate of infection, both 
early infections and delayed abscesses. Appropriate debridement and irrigation 
of wounds helps to decrease the infection rate. Some of the risk factors for infec­
tion following penetrating brain injury include extensive bony destruction, per­
sistent CSF leak, and an injury pathway that violates an air sinus.
Late-onset epilepsy is a common consequence of penetrating brain inju­
ries and can occur in up to 50% of patients with penetrating brain injuries. No 
evidence exists that prophylactic anticonvulsants decrease the development of 
late-onset epilepsy. During the Vietnam War, prophylactic anticonvulsants were 
used, and the rate of late-onset epilepsy was not different from that of previous 
wars, when prophylactic anticonvulsants were not used.
HEAD INJURY IN CHILDREN
Head injuries in children differ from head injuries in adults in several 
ways. Children tend to have more diffuse injuries than adults, and traumatic in­
tracerebral hematomas are less common in children than in adults. In addition, 
early posttraumatic seizures are more common in children than in adults. Over­
all, children have much lower morbidity and mortality rates from traumatic head 
injury compared to adults.
When a child with a head injury is being evaluated, nonaccidental trauma 
must be excluded. In the United States, as many as 1 million cases of nonacci­
dental trauma in children may occur annually. TBI is the most common cause of 
morbidity and mortality in nonaccidental trauma in children.
Radiographic signs of nonaccidental trauma include unexplained multiple 
or bilateral skull fractures, subdural hematomas of different ages, cortical contu­
sions and shearing injures, cerebral ischemia, and retinal hemorrhages. If any of 
these are present, the case should be referred to the proper child welfare agency.
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COMPLICATIONS
Complications resulting from TBI are common and can be divided into 2 
categories, systemic and neurologic complications. The systemic complications 
of TBI are typical of any severe injury and depend on the types of intensive 
treatments used. Be aware of the complications of intensive care treatment when 
considering systemic complications of head injury. The neurologic complica­
tions of TBI include focal neurologic deficits, global neurologic deficits, sei­
zures, CSF fistulae, hydrocephalus, vascular injuries, infections, and brain death.
Focal neurologic deficits
Focal neurologic deficits are quite common following TBI. Cranial nerves 
are affected often because of their anatomic location at the base of the brain. 
When the brain shifts within the skull as it undergoes either acceleration or de­
celeration forces, significant force is often placed on the entire brain and the 
cranial nerves. The cranial nerves are tethered at their exit sites from the skull, 
and, as a result, they may be stretched when the brain shifts as a result of accel­
eration or deceleration forces. In addition, the cranial nerves are very susceptible 
to injury as they course through narrow bony canals and grooves. The cranial 
nerves that are injured most commonly in patients with TBI are cranial nerves I, 
IV, VII, and VIII.
Anosmia caused by traumatic injury to the first cranial nerve occurs in 2- 
38% of patients with TBI. It is more common in those with frontal fractures and 
in those with posttraumatic rhinorrhea. Posttraumatic anosmia improves slowly, 
and as many as one third of patients do not show any improvement in olfaction.
Injuries to the fourth cranial nerve, the trochlear nerve, are also quite 
common. This nerve is often injured in patients with head trauma because it has 
the longest intracranial course of the cranial nerves. Injury to the trochlear nerve 
causes a positional diplopia, in which those affected experience diplopia when 
they look down and toward the eye in which the trochlear nerve is injured. As a 
result, to compensate, the head is tilted up and away from the side of the injury. 
Trochlear nerve injuries resolve fully in approximately two thirds of those with 
unilateral injury and in one fourth of those with bilateral injuries.
Facial nerve injuries often occur with head injuries in which the temporal 
bone is fractured. From 10-30% of persons with longitudinal fractures of the 
temporal bone and 30-50% of those with transverse fractures of the temporal 
bone have either acute or delayed facial nerve injury. Immediate facial nerve in­
jury suggests direct injury to the nerve, while delayed injury suggests progres­
sive edema within the nerve. In severely injured patients, a delay in the diagno­
sis of facial nerve injuries occurs frequently because facial nerve function is dif­
ficult to assess in obtunded patients.
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Cochlear nerve injury (cranial nerve VIII) is also a common occurrence in 
patients with head injury, especially in patients with temporal bone fractures. In 
addition, vestibular disorders, including vertigo, dizziness, and tinnitus, are ex­
tremely common in patients with head injuries.
Hydrocephalus
Hydrocephalus is a common late complication of TBI. Posttraumatic hy­
drocephalus may present as either ventriculomegaly with increased ICP or as 
normal pressure hydrocephalus. In patients with increased ICP secondary to 
posttraumatic hydrocephalus, the typical signs of hydrocephalus are often ob­
served and include headaches, visual disturbances, nausea/vomiting, and altera­
tions in the level of consciousness. Normal pressure hydrocephalus usually 
manifests as memory problems, gait ataxia, and urinary incontinence.
The diagnosis of normal pressure hydrocephalus may be difficult to make 
in patients with TBI because they often have memory difficulties and gait ab­
normalities secondary to their head injury. In addition, as many as 86% of pa­
tients with TBI demonstrate some degree of ventriculomegaly on follow-up CT 
scan images. This ventriculomegaly is often secondary to diffuse brain atrophy, 
and radiographic features rarely help make the distinction between atrophy and 
normal pressure hydrocephalus. Any patient who develops neurologic deteriora­
tion weeks to months following TBI should be evaluated for the possibility of 
normal pressure hydrocephalus. When CT scan findings cannot help distinguish 
between normal pressure hydrocephalus and ventriculomegaly secondary to 
brain atrophy, a high-volume lumbar puncture tap test is performed to ascertain 
if CSF drainage would improve the patient's neurologic condition.
Seizures
Posttraumatic seizures are a frequent complication of TBI and are divided 
into 3 categories. Early seizures occur within 24 hours of the initial injury, in­
termediate seizures occur 1-7 days following injury, and late seizures occur 
more than 7 days after the initial injury. Posttraumatic seizures are very common 
in those with a penetrating cerebral injury, and late seizures occur in as many as 
half of these patients.
Cerebrospinal fluid fistulae
Cerebrospinal fistulae, either in the form of rhinorrhea or otorrhea, may 
occur in as many as 5-10% of patients with TBI. They may present either imme­
diately or in a delayed fashion and are more frequent in patients with basilar 
skull fractures. Approximately 80% of acute cases of CSF rhinorrhea resolve 
spontaneously within 1 week. A 17% risk of meningitis exists when CSF rhinor­
rhea is present. Prophylactic antibiotics have not been demonstrated to decrease 
this meningitis risk, althpugh very few studies have examined this issue. More
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than 95% of acute episodes of CSF otorrhea resolve spontaneously within 1 
week, and CSF otorrhea is complicated by meningitis in fewer than 4% of cases.
When acute CSF fistulae do not resolve spontaneously, a lumbar su­
barachnoid drain may be placed for several days in an attempt to divert CSF and 
allow the fistula to close. If this fails, radiographic dye is introduced into the su­
barachnoid space via lumbar puncture (metrizamide cistemogram), and a high- 
resolution CT scan is performed in an attempt to identify the origin of the CSF 
fistula. A craniotomy is performed, and the fistula site is repaired. Delayed CSF 
fistulae may occur from 1 week after the initial injury to years later. These de­
layed fistulae are more difficult to treat and frequently require surgical interven­
tion.
Vascular injuries
Vascular injuries are uncommon sequelae of TBls. Arterial injuries that 
may occur following head trauma include arterial transactions, thromboembolic 
phenomena, posttraumatic aneurysms, dissections, and carotid-cavernous fistu­
lae (CCF).
Arterial occlusions secondary to transactions or thromboembolism follow­
ing closed head injuries are uncommon occurrences.
Posttraumatic intracranial aneurysms, which are also rare, differ from 
congenital aneurysms because the posttraumatic aneurysms tend to be located 
distally, as opposed to the congenital aneurysms, which are typically proximal in 
location.
Arterial dissections are more common than the aforementioned arterial in­
juries and should be considered if significant injury has occurred to the petrous 
portion of the temporal bone, through which the carotid artery passes, or when 
an unexplained neurologic deficit is present. A cerebral angiogram is often nec­
essary to help exclude arterial injury in these cases.
Posttraumatic CCF occur when the internal carotid artery is injured within 
the cavernous sinus, resulting in a direct connection between the carotid artery 
and the veins of the cavernous sinus. This overloads the venous system and re­
sults in chemosis and proptosis on the affected side. Other signs of CCF include 
diplopia, ophthalmoplegia, visual disturbances, and headaches. Some high-risk 
fistulae may cause intracerebral hemorrhage. CCF are treated with endovascular 
balloon occlusion of the fistula origin.
Specific intracranial venous injuries are uncommon following TBI if one 
excludes the injury to the bridging veins, which are the most common source of 
subdural hematomas. Depressed skull fractures overlying any of the major in­
tracranial venous sinuses may cause injury to the sinus. When these venous si­
nus injuries require treatment, substantial, and sometimes life-threatening, blood 
loss can occur.
A second type of venous injury following TBI involves venous sinus 
thrombosis. Although very rare following head injury, this is a potentially life-
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threatening injury because the impaired venous drainage often causes severe ICP 
elevations and venous infarction. The treatment for venous sinus thrombosis is 
anticoagulation, which presents significant risk in those with acute head injuries. 
If the thrombosis progresses despite systemic anticoagulation, direct intracranial 
intravenous thrombolysis is necessary.
Infections
Intracranial infections are another potential complication of TB1. In un­
complicated closed head injury, infection is uncommon. When basilar skull frac­
tures and/or CSF fistulae are present, the risk of infection is increased. In addi­
tion, if a patient has had a ventriculostomy for ICP monitoring, the risk of infec­
tion is also increased, for either a ventriculitis or meningitis. Other intracranial 
infections such as subdural or epidural empyema and intraparenchymal ab­
scesses are rare following closed head injury. As one would expect, the inci­
dence of infection in penetrating cerebral injuries and open depressed skull frac­
tures increases.
Brain death
Brain death can result from either massive initial injury or as the result of 
prolonged severe elevations of ICP. Brain death is defined as the absence of 
brain function. A rigid protocol is necessary to prove that brain death has oc­
curred. It must be established that no sedating medications or neuromuscular 
blocking agents are present. The patient's electrolyte levels, blood count, body 
temperature, and arterial blood gas values must be within the reference ranges. 
The neurologic examination should demonstrate fixed nonreactive pupils, lack 
of corneal and gag reflexes, fixed position of the eyes during rotation of the head 
(ie, negative doll's eyes), no response to supraorbital pain, and no movement of 
the eyes to cold-water calorics.
A lack of any neurologic response is not sufficient to establish brain 
death, and confirmatory testing must be performed. One of these tests is an ap­
nea test, which involves removing a patient from the ventilator for a brief period 
to assess any sign of spontaneous respiration. This is performed after a 30- 
minute preoxygenation period with 100% oxygen. At the conclusion of the test­
ing period, if the patient has not had any spontaneous respirations and the arte­
rial blood gas measurements demonstrate a PC02 of greater than 65 mm Hg, the 
test results are consistent with brain death. Two neurologic examinations and 2 
apnea tests 12 hours apart are sufficient for determining brain death. A nuclear 
blood flow study or a cerebral angiogram may be performed instead of one of 
the apnea tests for brain death determination. The results of these studies dem­
onstrate the absence of CBF when brain death has occurred. In most states, brain 
death is considered to be death.
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OUTCOME AND PROGNOSIS
The outcome of ТВ I is related to the initial level of injury. While the ini­
tial GCS score provides a description of the initial neurologic condition, it does 
not correlate tightly with outcome. Various methods have been used in an at­
tempt to predict the outcome of TBI, and these are beyond the scope of this dis­
cussion. However, one simplified model uses 3 factors, ie, age, motor score of 
the GCS, and pupillary response (ie, normal, unilateral unresponsive pupil, bi­
lateral unresponsive pupils), to provide a probability of outcome.
The Traumatic Coma Data Bank analyzed 780 patients with head injuries 
and identified 5 factors that correlated with a poor outcome, as follows: (1) age 
older than 60 years, (2) initial GCS score of less than 5, (3) presence of a fixed 
dilated pupil, (4) prolonged hypotension or hypoxia early after injury, and (5) 
presence of a surgical intracranial mass lesion.
Many methods exist for evaluating the outcome of TBI. A simple and 
commonly used method is the Glasgow outcome scale. This divides outcome 
into 5 categories, as follows: (1) good, (2) moderate disability, (3) severe dis­
ability, (4) vegetative, and (5) dead. The scale can be divided further into good 
outcomes (eg, good plus moderate disability) and poor outcomes (eg, severe dis­
ability, vegetative, dead).
Future and controversies
The treatment of TBI has undergone significant change in the last 20 
years. A tremendous national effort has been undertaken to promote head injury 
prevention. Mandatory air bags in automobiles and the helmet laws have signifi­
cantly reduced the incidence of serious head injuries.
The future of head injury treatment has several major goals. One of these 
goals is to develop a noninvasive ICP monitor. Transcranial low-frequency ul­
trasound has shown promise as a potential noninvasive ICP monitor; however, it 
has not undergone clinical testing. Significant efforts have been directed toward 
the development of a noninvasive CBF monitor. Cerebral oxygen monitoring as 
an adjunct to ICP monitoring is under active investigation. The need also exists 
for a more effective treatment to control ICP that is refractory to standard thera­
pies.
The most significant controversy today in the treatment of TBI is the 
minimum desirable CPP to achieve in the patient with a head injury. Previously, 
a CPP of 79 mm Hg was considered the minimum; however, many now believe 
that a CPP of 60 mm Hg is sufficient. Further controversy also exists as to 
whether elevated ICP or decreased CPP is a more important prognostic factor. 
This is an important distinction because it directs the main goals of therapy in 
severely injured patients. If ICP elevations are considered a more important fac­
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tor, then efforts may be directed at lowering ICP as a primary goal and improv­
ing CPP as a secondary goal. If one considers CPP to be the more important fac­
tor, then the primary goal of treatment should be to maintain an appropriate 
CPP.
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BRAIN TUMORS
Approximately 20,000 primary central nervous system (CNS) tumors are 
diagnosed each year in the United States. These tumors tend to affect younger 
patients and are the second most frequent cause of cancer-related death among 
children, the third most frequent cause of cancer-related death among patients 15 
to 35 years of age, and the fourth most frequent cause of cancer-related death 
among patients 36 to 45 years of age. However, the incidence of the histologi­
cally more malignant tumors seems to be rising, especially among the elderly.
Primary CNS tumors are thought to arise from precursor cells to nervous 
system elements. In tumor cells, an accumulation of aberrant genetic events al­
lows dysregulation of differentiation and growth; the result is neoplastic prolif­
eration. This proliferation results in the development of a mass, which becomes 
clinically apparent with neurologic symptoms. This chapter discusses some of 
the more frequent tumors, including glioma (astrocytoma, anaplastic astrocy­
toma, glioblastoma, and oligodendroglioma), primitive neuroectodermal tumor 
(medulloblastoma), ependymoma, and meningioma. Also discussed is primary 
CNS lymphoma, which is being seen with increasing frequency in the immuno­
compromised and immunocompetent population.
CLINICAL FEATURES AND IMAGING DIAGNOSIS
From a clinical and imaging viewpoint, brain tumours are most easily di­
vided by site and relationship to the cranial fossae:
1. extracranial but involving neural tissue (e.g. head and neck lesions)
2. intracranial but extracerebral
■ anterior cranial fossa (olfactory groove)
■ middle cranial fossa (pituitary region and sphenoid wing)
■ posterior cranial fossa (cerebello-pontine angle, craniocervical 
junction)
3. within the brain substance (primary or secondary intracerebral tumours) 
Head and neck lesions
Patients with tumours of the head and neck most commonly present with 
headache, lower cranial neuropathies, or facial pain. Where the involvement is 
in the nasopharynx one should consider nasopharyngeal carcinoma, adenoid cys­
tic carcinoma, and metastatic tumours. Where there is involvement of the carotid 
body region, glomus jugulare should be considered. Patients with glomus jugu-
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lare tumours commonly present with lower cranial nerve palsies, e.g. dysphonia, 
dysphagia with wasted tongue or weak palate, but, if extensive, it can also cause 
pulsatile tinnitus, headaches, and hearing loss. Glomus jugulare tumours are 
usually large when eventually discovered. Plain radiographs (submento-vertex 
view) will best demonstrate the enlargement of the jugular foramen. CT scan­
ning shows the strongly enhancing tumour mass with erosion of the adjacent 
bone. MR1 will demonstrate the 'salt and pepper1 appearance caused by the flow 
voids within the tumour. Gadolinium-enhanced coronal MRI scan is particularly 
useful to delineate the extent of the tumour and the relationship to the brainstem. 
Where there is occipital headache, and lower cranial neuropathies, tumour in­
volvement of the skull base should be considered. In the midline, chordoma, 
chondroma, and chondrosarcoma are all possible. Imaging of the head/neck by 
CT scan or MRI scan may demonstrate a lesion with or without soft-tissue in­
volvement. CT scanning is superior when bony involvement is present (e.g. 
skull osteomas, Paget's disease, fibrous dysplasia) and MRI, with its multiplanar 
capabilities, is superior for soft-tissue visualization (e.g. nasopharyngeal carci­
noma, metastases, and glomus jugulare tumours). Contrast enhancement will 
better delineate blood vessels from surrounding soft-tissue structures, and ENT 
opinion, angiography, and simple blood tests (e.g. alkaline phosphatase and 
myeloma screen) may also be helpful.
Intracranial extracerebral lesions
Anterior cranial fossa
Patients with olfactory groove meningiomas usually present late when the 
tumour is large enough to cause headache, seizures, or personality changes. An­
osmia is rarely complained of in the absence of other symptoms, being usually 
unilateral.
Middle cranial fossa including pituitary region
Pituitary tumours may present because of endocrine effects (hormone ex­
cess or hypopituitarism) or mass effect. Women with prolactinomas commonly 
present with amenorrhoea and galactorrhoea and are referred to gynaecologists. 
Men with prolactinomas usually present later than women and may complain of 
headache, reduced sexual function, and visual field defects. The presence of ac­
romegaly or steroid excess will point to a diagnosis of a growth-hormone- or 
ACTH-secreting macroadenoma, respectively, and should stimulate a request for 
imaging of the pituitary region. Plain lateral skull radiographs may show a 'dou­
ble floor' or erosion of the sella tursica in the presence of a pituitary macroade­
noma. Skull radiography, however, may be entirely normal in macroadenoma 
and is always normal in microadenomas, and is insufficient to exclude any in­
tracranial tumour. Investigations for hormone-secreting pituitary tumour include 
prolactin levels, growth hormone levels, and serum or urinary cortisols, plus im­
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aging of the pituitary gland by multiplanar, contrast-enhanced MRI, or contrast- 
enhanced coronal CT with fine cuts through the pituitary gland.
Craniopharyngiomas commonly present with symptoms and signs of mild 
hypopituitarism or diabetes insipidus. Almost 90 per cent of men complain of 
impotence, while most women complain of amenorrhoea. Children present with 
short stature, and 40 per cent of patients will be hypothyroid at presentation 
while 25 per cent have adrenal insufficiency. Fifty per cent of patients will have 
diabetes insipidus and headache. Craniopharyngiomas are usually a complex 
combination of cysts and solid tumour with calcification. There is generally no 
surrounding oedema in the brain. Craniopharyngiomas can be difficult to differ­
entiate from dermoid or epidermoid tumours or Rathke's pouch cysts but they 
generally have more complex cysts than epidermoids, thicker irregular walls, 
and more calcification on CT scan. Hypopituitarism is also found in 20 per cent 
of patients with epidermoid and dermoid cysts in the suprasellar or parasellar ar­
eas.
Patients with visual-field loss due to optic nerve or chiasm compression 
and will be referred to ophthalmologists, physicians, or neurologists. The visual 
impairment may be due to pathology in the nerve (e.g. glioma), or pressure on 
the nerve from a tumour (pituitary tumour, craniopharyngioma, meningioma, 
metastasis) or cyst (dermoid, epidermoid, Rathke's pouch cyst). Symptoms will 
lead to imaging of the anterior visual pathway. Multiplanar gadolinium- 
enhanced MRI imaging is the investigation of choice. The coronal images will 
provide useful information about expansion of the optic nerves consistent with 
an optic nerve glioma or meningioma, and about the parasellar region and the 
relationship with any extrinsic pressure on the optic chiasm. Pituitary macroade­
nomas usually cause expansion of the pituitary fossa and displace the optic chi­
asm upwards, producing a bitemporal field loss which starts in the superior tem­
poral quadrants. The visual field defects with pituitary macroadenomas will 
vary, depending on whether the optic chiasm is prefixed or postfixed. Cranio­
pharyngiomas expand downwards from the hypothalamus and cause a bitempo­
ral hemianopia, most frequently involving the inferior temporal quadrants, but 
can also cause a variety of visual field defects, depending on where the tumour 
presses on the visual apparatus. Epidermoid and dermoid cyst generally appear 
on CT scanning as well-circumscribed lesions with low density, between that of 
CSF and brain, due to cholesterol or keratin granules. The wall of epidermoid 
cysts may be thinly calcified, and since the contents are avascular they do not 
enhance with contrast. Dermoids are more heterogeneous, have a thicker wall, 
rarely enhance, and more commonly demonstrate calcification. There is gener­
ally no surrounding oedema in the brain. On Tl-weighted MRI sequences, epi­
dermoids exhibit a variable signal (white when the lipid content is high or black 
if the lipid content is low). Classically, epidermoids have low signal on Tl- 
weighted images and very high signal on T2-weighted images. Dermoids give 
high signal on Tl-weighted images in areas containing fat and variable signal
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where there is a combination of fat, muscle, and bone, and they may be mistaken 
for a craniopharyngioma or mixed germ cell tumour (teratoma). Mixed germ cell 
tumours are more heterogeneous than germ cell tumours (germinomas) because 
they contain a variety of tissues, including bone, cartilage, hair, and fatty tissue. 
Enhancement following contrast is common in germ cell tumours. Tumours 
such as hypothalamic astrocytomas and oligodendrogliomas can also extend 
downwards to cause chiasmal or optic nerve compression and hypopituitarism. 
These tumours are usually solid with areas of calcification but can also some­
times be exophytic. Rathke's cleft cysts are simple intrasellar cysts containing 
CSF. Meningiomas are usually easily differentiated from cysts and other tu­
mours; however, en plaque meningioma of the optic nerve may be difficult to 
visualize, even with gadolinium-enhanced MRI, and should always be consid­
ered as a potential diagnosis in patients with progressive optic nerve disease 
even in the absence of a clear mass lesion on MRI.
Patients who present with periorbital pain, ocular muscle paralysis, or 
ptosis may have tumours in the orbit (e.g. metastases, lymphoma, lacrimal gland 
carcinoma) or tumours of the sphenoid wing (e.g. meningioma, carcinoma, der­
moid, epidermoid or large pituitary tumours, or craniopharyngioma). Differen­
tial diagnosis will depend on the speed of onset of symptoms and the imaging 
appearance.
Posterior fossa
If the presenting complaint is facial numbness or weakness, or deafness, 
tinnitus or vertigo, patients are likely to be sent by their family practitioners to 
see a physician or ENT surgeon. The differential diagnosis includes acoustic 
neuroma, meningioma, haemangioblastoma, meningioma, dermoid, epider­
moid,lipoma, and metastasis.
The most common tumour of the cerebellopontine angle is an acoustic 
neuroma. Patients most commonly present with deafness, tinnitus, or vertigo. 
Patients with meningiomas less commonly have acoustic nerve symptoms and 
more commonly present with other cranial nerve involvement (especially facial 
numbness and facial weakness); however, differentiating on clinical grounds is 
unreliable. MRI is the most sensitive imaging technique to delineate lesions of 
the middle or posterior cranial fossae. Acoustic neuromas usually expand the 
acoustic nerve and may cause expansion of the internal auditory meatus. Small 
tumours enhance I uniformly and are usually easy to distinguish from other tu­
mours; however, if acoustic neuromas are very large, it may be difficult to iden­
tify the origin of the tumour and distinguish it from a meningioma. Meningio­
mas strongly enhance uniformly on CT, reflecting the vascularity of these tu­
mours, but necrosis, cysts, and calcification can alter the signal characteristics 
on MRI, making differentiation from dermoids or even haemangioblastomas 
rather difficult. Cholesteatomas and epidermoids can commonly be differenti-
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ated from meningiomas and acoustic neuromas by their relative lack of en­
hancement.
If the lower cranial nerves are involved, it is imperative to get good imag­
ing of the base of the skull, neural exit foramina, and extracranial soft tissues in 
the neck.
Intracerebral lesions
Headache, memory or personality changes, and seizures are the most 
common initial symptoms in patients with primary intracerebral tumours; how­
ever, patients are commonly referred to hospital only when focal symptoms or 
signs become obvious (e.g. seizures, hemiparesis papilloedema, dysphasia, or 
hemianopia). Hemiparesis or hemisensoty loss are the most common symptoms.
Nearly all patients who have weakness or numbness complain of these 
symptoms, thus directing the clinician to the abnormality on examination. Only 
7 per cent of patients with malignant glioma complain of visual symptoms, yet 
over 20 per cent have signs of visual field loss and 23 per cent have papil­
loedema, therefore, careful examination of the visual fields and fundi is impor­
tant in anyone complaining of headaches or symptoms suggestive of disturbance 
of higher mental function. Most commonly the upper motor neuron weakness is 
mild initially and affects fine manipulation first and mild progressive lower limb 
weakness (hip flexion, knee flexion, and ankle dorsiflexion). Clinical follow-up 
using quick, sensitive, simple tests such as the timed nine-hole peg test, timed 10 
m walk, and a test of memory and grading of dysphasia are usually sufficient to 
assess clinical response to treatment. The Barthel Activities of Daily Living In­
dex may be a useful measure in elderly patients or in patients with metastases 
where the weakness is commonly severe, but it is insensitive, and its 'ceiling ef­
fect' precludes its use in trials of glioma in general and it does not record cogni­
tive disability or dysphasia. The Kamofsky Performance Scale is useful for 
grading patients for entry into studies, but in practice a three-point grading scale 
(>60, 60-50, <50) rather than an 11-point scale (100, 90, 80 ... 10, 0) is usually 
used. It can be used to follow individual patients, although intra-observer and 
inter-observer errors limit its usefulness.
Stroke-like onset or collapse with coma, occurs in about 5 per cent of pa­
tients with intracerebral tumours and is most commonly related to haemorrhage 
into a malignant brain tumour (malignant glioma or metastasis). Stroke-like 
presentations and subacute presentations with cognitive deficits, visualfield dis­
orders, or dysphasia are more common in the elderly, and most commonly sug­
gest a poor prognosis. Late-onset epilepsy (first seizure after age 18) is a com­
mon presentation in patients who have low-grade gliomas and meningiomas. It 
has been estimated that between 3 and 10 per cent of patients with late-onset 
epilepsy have an underlying tumour of some form. Seizures are the first present­
ing symptom in 54 per cent of low-grade gliomas, 50 per cent of anaplastic as­
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trocytomas, 26 per cent of meningiomas, 19 per cent of glioblastomas, 15 per 
cent of metastases, and 11 per cent of primary CNS lymphomas. Over a follow­
up period of 3 years, the prevalence of seizures rises to 70 per cent in low-grade 
glioma, 56 per cent in anaplastic astrocytoma, 48 per cent in glioblastoma, 44 
per cent in meningioma, 39 per cent in primary CNS lymphoma, and 31 per cent 
in metastases. Tumour-associated epilepsy is partial (focal) in approximately 50 
per cent of patients, partial epilepsy with secondary generalization in 25 per 
cent, and tonic-clonic seizures without warning in 25 per cent of patients. Chil­
dren are more likely to have posterior fossa, or deep thalamic region tumours 
and present with cerebellar symptoms or, more frequently, symptoms of raised 
intracranial pressure.
CT and MR1 brain scanning have improved the management of patients 
with brain tumours dramatically, but diagnostic interpretation is not without its 
difficulties. The addition of MRI spectroscopy may increase the specificity of 
diagnostic imaging, although this requires further prospective study. The three 
levels of diagnosis are: 1. Is it a tumour?; 2. What type of tumour is it?; 3. If it is 
a glioma, what grade of glioma is it?
Is it a tumour?
Neuroradiologists will correctly predict an intracerebral tumour in about 
90-95 per cent of cases. However, approximately 10 per cent of patients will 
have had a previous CT or MRI scan that has been reported as either normal or 
an alternative pathology. In these cases, MRI will usually demonstrate an ab­
normality but the aetiology of the lesion may not be clear. Even in the best cen­
tres 5-10 per cent of CT scans reported by a radiologist as being an intracerebral 
tumour will later be found to have non-malignant pathologies. The differential 
diagnosis of non-contrast-enhancing lesions, with standard doses of contrast, in­
clude demyelination, encephalitis, infarct, post-traumatic, and non-specific 
changes. The differential diagnosis in patients with contrast-enhancing lesions 
includes demyelination, arteriovenous malformation, haemorrhagic stroke, and 
cerebral abscess. In some cases who present with a stroke-like onset, it may not 
be evident that the haemorrhage has occurred into an existing mass lesion. The 
common tumours to present with intratumoural haemorrhage are glioblastoma, 
metastatic lung cancer, melanoma, and choriocarcinoma.
What type of tumour is it?
Errors in reporting of CT or MRI are even more common when attempts 
are made to predict the type of malignancy. The main areas of difficulty are 
where tumours have an exophytic extension with involvement of the meninges, 
intense contrast enhancement, or sometimes calcification of meningeal/vascular 
origin (e.g. meningioma/haemangiopericytoma) or of glial origin (e.g. glioblas­
toma or oligodendroglioma). In these cases it may be very difficult to say
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whether the tumour is extracerebral and invading the brain, or intrinsic and be­
coming exophytic.
It has been estimated that 5 per cent of brain images reported as multiple 
metastases by experienced neuroradiologists will actually turn out to be primary 
brain tumours (glioma or primary CNS lymphoma). In one study of single brain 
metastasis, 11 per cent of patients with known systemic malignancy with a soli­
tary brain lesion thought on imaging to be a metastasis turned out to have a dif­
ferent pathology (in some cases the pathology was not a tumour at all). Primary 
CNS lymphoma can be unifocal (60 per cent) or multifocal (40 per cent). Cells 
are densely packed and generally homogeneously enhance and thus are com­
monly mistaken for metastases.
I. Glioma is the most common intracranial tumor, comprising about 60% 
of all primary CNS neoplasms. Although there are several grading systems cur­
rently in use, the three-tiered classification system has become the most popular. 
Astrocytoma is the most well-differentiated and lowest-grade tumor. Anaplastic 
astrocytoma is an intermediate-grade tumor, and glioblastoma is the most ma­
lignant and poorly differentiated glioma. The most malignant form, glioblas­
toma, is the most common, representing 50% to 60% of cases of glioma diag­
nosed. Most studies of all grades of glioma show either no sex preponderance or 
a slight male bias. These tumors do not tend to be inherited, except in a few rare 
syndromes (e.g., neurofibromatosis, Li-Fraumeni syndrome, tuberous sclerosis, 
and ataxia-telangiectasia). No definite environmental association of these tumors 
has been found in comparisons of urban and rural populations.
A. Astrocytoma
1. Course of disease. Approximately 30% of cases of glioma diagnosed 
are astrocytoma. This low-grade neoplasm tends to occur among younger pa­
tients, typically in the fourth decade of life or earlier. There is a paucity of pro­
spective information regarding the course of astrocytoma. Retrospective analysis 
has shown age to be an important predictive factor; younger patients, especially 
those younger than 20 years, have the highest 5-year survival rate. The incidence 
of malignant transformation and response to therapy are not well known. Total 
surgical resection and good postoperative performance status have been associ­
ated retrospectively with prolonged survival. One exception to the lack of in­
formation on low-grade tumors is pilocytic astrocytoma, which occurs most of­
ten in children and occasionally in adults. With only surgical intervention, these 
tumors have an excellent prognosis and only rarely transform to malignant neo­
plasms. Other tumors that fit into the rubric of low-grade astrocytoma include 
ganglioglioma and neurocytoma. These tumors tend to behave in a benign man­
ner and to require only surgical intervention.
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2. Therapy. Except as noted, no prospective studies have evaluated the 
efficacy of therapeutic intervention in low-grade astrocytoma. It is accepted that 
surgical excision is a reasonable initial approach to these tumors, although any 
further therapy is based only on anecdotal or retrospective analyses. Currently 
there are no generally accepted guidelines for radiation therapy for low-grade 
astrocytoma, although many clinicians believe that for some older patients, 
treatment with high-dose radiation (6,000 cGy) is appropriate. At least initially, 
chemotherapy is not believed to playa part in treatment of these patients because 
of the slow growth of these tumors. However, many astrocytomas progress to 
higher-grade neoplasms, in which case therapy is referable to the more malig­
nant tumor. Follow-up computed tomography (CT) or magnetic resonance imag­
ing (MRI) typically is performed every 6 months and when the patient has clini­
cal changes.
3. Prognosis. Patients with astrocytoma who have the best prognosis are 
young, have undergone gross total tumor resection, and have minimal or no 
postoperative neurologic or other deficits. Among these patients, the 5-year sur­
vival rate is greater than 80%. Further specific prognostic assessment in other 
patient subgroups is difficult, but at least a fraction of astrocytomas in such pa­
tients progress to higher-grade neoplasms that necessitate other types of therapy. 
For any patient with a diagnosis of astrocytoma (with the exception of pilocytic 
astrocytoma, ganglioglioma, and neurocytoma), continual follow-up evaluation 
is necessary, because malignant transformation can occur at any time.
B. Anaplastic astrocytoma
1. Course of disease. Anaplastic astrocytoma is diagnosed much less fre­
quently than are its lower- and higher-grade counterparts. Part of the reason for 
this revolves around the pathologic criteria for anaplastic astrocytoma compared 
with those for glioblastoma (anaplasia without necrosis in the specimen). Even 
with these criteria, there may still be an overestimation of the incidence of 
anaplastic astrocytoma because of sampling errors that occur when specimens 
from subtotal resection or stereotactic biopsy are sent to pathologists for review. 
It has been estimated that as many as 30% of tumors diagnosed as anaplastic as­
trocytoma at stereotactic biopsy are of higher grade (glioblastoma). Apart from 
difficulties with histologic grading, few prospective analyses of these tumors 
have been performed. Retrospective studies have shown anaplastic astrocytoma 
to occur typically in the fifth decade of life, usually with a long (more than 1 
year) history of neurologic symptoms. The most important favorable prognostic 
factors include young age and good performance status. Surgery has not been 
found to influence survival, perhaps because anaplastic tumors tend to be dif­
fusely infiltrating. A high percentage of these tumors recur at higher pathologic 
grade.
2. Therapy. Patients with anaplastic astrocytoma need a multidisciplinary 
approach similar to that used for glioblastoma.
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a. Surgery and corticosteroids. Surgery should be considered if the diag- 
nosis is in question, if there would be benefit from cytoreduction (reduction of 
mass effect), or if surgery is indicated because of emergency clinical conditions 
Surgery does not seem to affect survival per se. Corticosteroids may be neces- 
sary to decrease symptoms of increased intracranial pressure. Dexamethasone 
often is given at a starting dosage of 4 mg four times a day, titrated for relief of 
symptoms. Doses greater than 32 mg/d are rarely useful. Minimizing doses of 
corticosteroids because of known side effects should be an important goal after 
radiation treatment.
b. Radiation therapy is an important aspect of management of anaplastic 
astrocytoma, with a current recommended dose of approximately 6,000 cGy. 
The fractionation schedule of radiation therapy usually ranges from 180 to 200 
cGy/d. Focal radiation of 4,500 cGy within a 3-cm margin with a boost of 1 500 
cGy for the 1.5-cm margin surrounding the area of enhancement of the tumor 
has been found as effective as whole-brain irradiation. Highly focused radiation 
such as stereotactic radiosurgery may be of palliative benefit at recurrence.
c. Chemotherapy. Anaplastic astrocytoma is managed with both adjuvant 
and recurrent chemotherapy. Adjuvant chemotherapy (given within 2 weeks af­
ter the completion of radiation) usually consists of a combined regimen of pro­
carbazine (60 mg/m2 by mouth on days 8 to 21), lomustine (CCNU; 110 mg/m2 
by mouth on day 1), and vincristine (PCV; 1.4 mg/m2 intravenously [i. v.l on 
days 8 and 29) every 6 to 8 weeks for 1 year or until tumor recurrence At recur­
rence, high-dose intravenous carmustine (BCND; 250 mg/m2) is administered 
every 6 to 8 weeks until further tumor progression. Administration of these 
drugs requires that specific laboratory values and clinical cautions be assessed 
periodically. Further therapy after this point usually revolves around phase I or 
phase II drugs or other experimental therapies. Consultation with a neuroon­
cologist often is necessary. Follow-up CT or MR1 evaluation should be per­
formed 6 weeks after completion of radiation therapy and before each cycle of 
chemotherapy.
3. Prognosis. With implementation of surgery, radiation therapy, and 
chemotherapy, patients with anaplastic astrocytoma have a median survival pe­
riod of more than 3 years. Typical time to first tumor recurrence is approxi­
mately 2.5 years, and time to death after progression is 8 months. Patients 
younger than 40 years have the highest likelihood for response to treatment and 
prolonged survival. Few patients older than 60 years respond to this multimodal 
approach to therapy, and patients in this age group have the highest incidence of 
serious side effects. Clinical judgment and careful consideration of the patient’s 
wishes are necessary before any decision regarding therapeutic intervention es- 
pecially chemotherapy.
C. Glioblastoma
1. Course of disease. Glioblastoma is the most frequently diagnosed pri­
mary CNS neoplasm. Its course, unlike those of astrocytoma and anaplastic as­
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trocytoma, is well defined. This tumor is the most malignant of the gliomas and 
has a poor prognosis with inexorable progression to death. Patients with 
glioblastoma usually come to medical attention in the sixth decade of life with a 
short history (less than 6 months) of neurologic symptoms. The best predictors 
of survival and response to chemotherapy are the same as those for anaplastic 
astrocytoma-patient age and performance status. A shorter duration of symptoms 
before diagnosis has been associated with longer survival periods. Currently it is 
unclear whether extent of surgery is an important prognostic factor.
2. Therapy for glioblastoma is similar to that for anaplastic astrocytoma. 
Maximal surgical debulking usually is suggested for patients who can undergo 
the procedure safely. Subsequent high-dose radiation therapy (6,000 cGy or 
more) is as described for anaplastic tumors. Adjuvant chemotherapy with car- 
mustine usually is initiated within 2 weeks after completion of radiation treat­
ment and is given every 6 to 8 weeks. Recurrence is managed with procarbazine, 
CCNU, and vincristine, high-dose oral procarbazine alone (each cycle consisting 
of 150 mg/m2/day for 28 days, followed by a 28-day rest), or experimental ther­
apy. Consultation with a neurooncologist is necessary at this point. CT or MRI 
should be performed before each cycle of chemotherapy.
3. The prognosis for patients with glioblastoma is poor. Patients treated 
with surgery alone have a median survival time of 14 to 26 weeks. The addition 
of radiation therapy increases the survival period to 40 weeks. Administration of 
chemotherapy with nitrosoureas such as procarbazine and carmustine further in­
creases the median survival time to 50 weeks and increases the proportion of pa­
tients surviving 18 months. Nevertheless, with multimodality therapy, the me­
dian survival time is less than 1 year and fewer than 15% of patients survive 2 
years.
D. Oligodendroglioma
1. Course of disease. Oligodendroglioma arises from presumed oligoden- 
droglial precursors and usually manifests in the fourth or fifth decade of life. 
These tumors occur in proportion to the volume of white matter, and hence the 
frontal lobes are the areas most frequently affected. There is an inconsistent rela­
tion between histologic grade and malignant behavior. Few data are available 
regarding the frequency of malignant degeneration, although it is well known 
that some oligodendrogliomas transform into glioblastomas. Better prognostic 
factors include relatively benign histologic features, postoperative radiation 
therapy, complete surgical resection, and good preoperative and postoperative 
performance status. Close follow-up care is necessary in the treatment of these 
patients, especially given the long-term survival of particular subsets.
2. Therapy. Management of the different types of oligodendroglioma is 
evolving. Maximal surgical excision is considered the initial step in manage­
ment of these tumors. Radiation therapy can follow surgery in a manner similar 
to that of anaplastic astrocytoma or glioblastoma. Although there is no strict re­
lation between histologic anaplasia and malignant potential, most neuro­
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oncologists suggest that patients with anaplastic oligodendroglioma be treated 
with multiagent chemotherapy, that is, procarbazine, CCNU, and vincristine. Pa­
tients with nonanaplastic oligodendroglioma typically are observed without fur­
ther therapy after radiation therapy and are given multiagent chemotherapy only 
at recurrence. For the first year, MR1 or CT should be performed before admini­
stration of chemotherapy and every 6 to 8 weeks for anaplastic tumors or every 
3 months for nonanaplastic oligodendroglioma. Ifthere is no evidence of recur­
rence, imaging can be performed every 6 months thereafter.
3. The prognosis for oligodendroglioma is more favorable than that for 
either anaplastic astrocytoma or glioblastoma. Overall, the median survival pe­
riod is more than 5 years, and the 10-year survival rate is 24%. Selected patients 
with the particularly good prognostic factors have the likelihood of longer sur­
vival.
11. Primitive neuroectodermal tumor (PNET)
A. Course of disease. PNETs are primarily neoplasms of children. These 
tumors constitute the most frequently diagnosed soft-tissue malignant tumors in 
the pediatric ages but account for fewer than 1% of all adult tumors. In adults, 
the median age at diagnosis is 24 years. The most often diagnosed PNET is me­
dulloblastoma, which typically occurs in the posterior fossa. There is a male-to- 
female ratio of 2: 1. These tumors are graded according to the Chang criteria 
(TM system), although there is no influence per se on prognosis. Medulloblas­
toma can metastasize throughout the craniospinal axis, as well as outside the 
nervous system, for as long as 10 years after the initial diagnosis. Bone, lymph 
nodes, lung, pleura, liver, and breast are the most frequent sites of seeding out­
side the nervous system. Prolonged survival is associated with high-dose poste­
rior fossa radiation accompanied by additional radiation therapy to the entire 
brain, spinal cord, and coverings as well as with early treatment. There may be 
improved survival among female patients. The extent of surgery is important in 
relapse-free, but not overall, survival.
B. Therapy. Maximal surgical resection and radiation are the mainstays 
of therapy for medulloblastoma. Radiation doses of 5,200 to 5,500 cGy to the 
posterior fossa and 3,600 cGy to the remaining neuraxis are considered appro­
priate and have been associated with prolonged progression-free survival, par­
ticularly in low-stage disease. Management of recurrent disease typically re­
volves around chemotherapy, although the most beneficial regimen has yet to be 
defined. However, most neurooncologists recommend a multidrug protocol with 
drugs such as the nitrosoureas, a platinum-based compound, and steroids. Con­
sultation is required to determine the most current regimen. Imaging studies 
should be performed after radiation therapy and before each cycle of chemother­
apy. Because recurrences are not uncommon, follow-up evaluation of these pa­
tients, including periodic radiographic examinations, should be performed for at 
least 10 years after completion of therapy.
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C. Prognosis. With maximal treatment (radiation being paramount in im­
portance), the 5-year survival rate is 50% to 76%, and the 10-year survival rate 
is 33% to 60%. Recurrence, when it is found, is typically in the posterior fossa. 
Some patients with more extensive tumors may benefit from chemotherapy in 
either an adjuvant or a recurrence setting. Those patients with metastatic lesions, 
especially outside the nervous system, have a worse prognosis than do those 
who have solitary recurrences in the posterior fossa.
III. Ependymoma
A. Course of disease. Ependymoma, like PNET, is a tumor of the young 
and is uncommon in adults. The tumor arises most frequently in the central canal 
of the spinal cord or the filum terminale as well as in white matter adjacent to a 
ventricular surface. Like medulloblastoma, ependymoma tends to seed through­
out the nervous system, although the likelihood of such seeding is defined by the 
grade of the tumor. Ependymoma is graded in a variety of ways but can be most 
conveniently divided into differentiated (low-grade, myxopapillary) and 
anaplastic (high-grade) ependymoma. Anaplastic tumors are most often associ­
ated with neuraxial spread. A particular subtype of ependymoma, ependy- 
moblastoma, has an especially high frequency of seeding. However, the usual 
area of recurrence for all ependymomas is the primary site, although seeding can 
accompany local treatment failure in the higher grades. Better prognostic factors 
include low grade, treatment with surgery with little residual tumor remaining 
postoperatively, and high-dose radiation therapy.
B. Therapy. Evaluation of the entire nervous system and cerebrospinal 
fluid for malignant cells often is recommended in the management of ependy­
moma. Maximal surgical resection and radiation therapy are the necessary initial 
treatments, because local control of disease is a major predictor of outcome. For 
low-grade tumors, a dose of 5,400 cGy to the primary tumor is considered stan­
dard, with no additional treatment of the rest of the nervous system. For anaplas­
tic tumors, 5,400 cGy is applied to the primary tumor site and 3,500 to 4,000 
cGy to the neuraxis. Chemotherapy is given at recurrence, although only anec­
dotal data on the most beneficial regimen are available. Hence, the chemothera­
peutic protocol to be followed for recurrence therapy should be determined in 
consultation with a neurooncologist to determine the most current regimen. Im­
aging should be performed after radiation therapy and before each chemothera­
peutic intervention. Continual follow-up evaluation is necessary because of the 
possibility of late recurrence.
C. Prognosis. Patients with ependymoma of low grade treated maximally 
with surgery, radiation, and chemotherapy have a 5-year survival rate of 60% to 
80%. Higher-grade disease has a significantly worse prognosis: 10% to 47% of 
patients survive for 5 years. As with medulloblastoma, seeding carries a worse 
prognosis.
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IV. Meningioma
A. Course of disease. Meningioma is a common nervous system tumor, 
constituting approximately 15% of all CNS neoplasms. There is a slight female 
preponderance. Although the peak age at diagnosis is 45 years, asymptomatic 
tumors are common in older adults as well. These neoplasms grow slowly and 
typically are benign in behavior. However, the recurrence rate for totally re­
sected tumors is still 10%. Fifteen percent of meningiomas recur if a dural at­
tachment remains after surgery, and 39% recur if only subtotal resection can be 
accomplished. These tumors occur most frequently in the parasagittal and falx 
regions, and can be associated with inherited syndromes (e.g., neurofibro­
matosis). Malignant meningioma, which is rare, has anaplastic pathologic fea­
tures and behavior and necessitates continual monitoring and treatment.
B. Therapy. Surgical removal is the therapy of choice for meningioma. 
Cauterization or embolization has been performed on particularly vascular tu­
mors to ease removal. Radiation and chemotherapy play no role in the manage­
ment of typical meningioma, although malignant tumors may necessitate these 
additional interventions. Imaging studies should be performed yearly for at least 
3 years and if symptoms develop.
C. The prognosis for meningioma is good. Tumors can recur, however, 
and recurrence necessitates additional surgery or, for malignant meningioma, 
radiation therapy and chemotherapy.
V. Primary CNS lymphoma
A. Course of disease. Primary CNS lymphoma (PCNSL) is a rare tumor 
in the immunocompetent population, comprising less than 2% of all brain tu­
mors and extranodal lymphomas. Pathologically, these tumors are typically non- 
Hodgkin s В-cell tumors, although T-cell tumors are occasionally found. The in­
cidence of PCNSL has been rising, both in the immunocompetent population 
and, primarily, because of the increasing population of patients with acquired 
immunodeficiency syndrome (AIDS). Moreover, other immunocompromised 
patients such as recipients of renal transplants are acquiring PCNSL with in­
creasing frequency. Other immunodeficiency diseases reported in association 
with PCNSL include Wiskott-Aldrich syndrome, agammaglobulinemia, and 
ataxia-telangiectasia. Although concurrent non-Hodgkin's lymphoma at other 
extranodal sites is uncommon in these patients, staging evaluation of a patient 
found to have PCNSL should include radiographic imaging (CT or MRI) of the 
chest, abdomen, and pelvis as well as examination o f a bone marrow aspirate. 
Because PCNSL can occur in ocular and meningeal tissues, slit-lamp and cere­
brospinal fluid examinations should be performed. Finally, human immunodefi­
ciency virus testing should be performed on all patients with a diagnosis of 
PCNSL. Combination chemotherapy and radiation therapy has been found to 
prolong survival significantly in comparison with surgery and radiation alone.
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B. Therapy. Use of biopsy alone to establish the diagnosis of PCNSL is 
the sole surgical intervention required. No additional benefit is derived from 
subtotal or total resection of any visualized mass. Radiation therapy can be 
given either initially after biopsy or at recurrence after adjuvant chemotherapy. 
The optimal regimen has yet to be defined, but combination therapy with both 
radiation and chemotherapy has been successful in prolonging median survival 
to more than 40 months, although in some regimens leukoencephalopathy and 
cognitive changes have been found. Although treatment of patients AIDS and 
PCNSL has shown tumor regression, ultimately there has been no increase in 
overall survival rate among these patients.
In the management of PCNSL, the two most successful regimens have en­
tailed large doses of chemotherapy. In the first, disruption of the blood-brain 
barrier with mannitol has been used with efficacy. Intravenous cyclophos­
phamide (15 mglkg) and intraarterial methotrexate (2.5 g) are administered with 
the disruption, oral leucovorin (20 mg every 6 hours) is given 36 hours after 
completion of the infusion of methotrexate and continued for 5 days, and pro­
carbazine (100 mg/d by mouth) and dexamethasone (24 mg/d by mouth) are 
given for 14 days after the disruption. This cycle is repeated every 28 days for 1 
year. Radiation therapy is given at relapse. In the second regimen, chemotherapy 
is combined with radiation therapy as adjuvant treatment. Dexamethasone (16 
mg/kg by mouth) is given until an Ommaya reservoir has been placed, and then 
intravenous administration of methotrexate (1 g/m2) is begun, given on days 1 
and 8. Intrathecal methotrexate (12 mg through the Ommaya reservoir) is ad­
ministered on days 1, 4, 8, 11, 15, and 18 with a dexamethasone taper. Whole- 
brain radiation (4,000 cGy) with a cone-down boost (1,440 cGy) is then given. 
Three weeks later, cytarabine (Ara-C; 3 g/m2) is given intravenously for 2 days 
and repeated 3 weeks later. Both regimens have high response rates; the median 
survival period is more than 40 months. Imaging (preferably MRI) should be 
performed before each intervention and every 6 to 8 weeks thereafter.
C. The prognosis for PCNSL is better than that for the malignant glial 
tumors. With radiation and chemotherapy, the median survival of patients with 
PCNSL can be expected to be greater than 3.5 years. Although each of the regi­
mens has been associated with limited side effects, some studies of high-dose 
chemotherapy with radiation for PCNSL have shown both leukoencephalopathy 
and cognitive changes with treatment. Thus, careful assessment and follow-up 
evaluation of neurologic status is extremely important. Patients with AIDS re­
spond to such regimens; however, prognosis in that patient population is related 
to the underlying disease.
VI. Treatment toxicity
A. Radiation toxicity can be conveniently classified according to the time 
of presentation into acute reactions, early delayed reactions, and late delayed re­
actions.
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1. Acute reactions occur during the course of treatment. They consist of 
symptoms of increased intracranial pressure or worsening of existing neurologic 
symptoms. These symptoms usually are mild and transient and are thought to 
result from radiation-induced edema. Occasionally it is temporarily necessary to 
administer a corticosteroid or to increase the dose.
2. Early delayed reactions occur several weeks to months after comple­
tion of radiation treatment. These reactions may manifest as worsening symp­
toms or as increasing somnolence and fatigue. It is believed that these symptoms 
are caused by temporary inhibition of myelin synthesis. Although this syndrome 
is typically temporary and mild, there have been reports of severe reactions ne­
cessitating intensive medical support. Careful consideration is necessary to 
avoid interpreting an early delayed reaction as a treatment failure without 
enlargement of tumor mass on images.
3. Late delayed reactions may occur months to years after completion of 
radiation therapy. The main type of late delayed reaction is radiation necrosis, 
which can mimic tumor recurrence in that it can be progressive, irreversible, and 
fatal. Higher doses of external beam radiation, used in treating patients with 
glioblastoma and with stereotactic radiosurgery, are most frequently associated 
with radiation necrosis. This effect may be a result of damage to small and me­
dium-sized arterioles or a direct effect on glial cells. Radiation necrosis is diffi­
cult to diagnose without biopsy. Use of a variety of anatomic (MRI and CT) and 
functional (positron emission tomography and single photon emission CT) im­
aging modalities has not facilitated reliable differentiation of necrosis from tu­
mor recurrence. Management of suspected or confirmed radiation necrosis usu­
ally entails surgery; however, only total resection (compared with biopsy) is 
clinically beneficial. There is anecdotal evidence that anticoagulants (heparin 
and warfarin) may be useful therapy for radiation necrosis at dosages used in 
stroke management.
B. Chemotherapy toxicity. All drugs used in the management of glioma 
can cause myelosuppression, which in the case of the alkylating agents, is typi­
cally delayed and cumulative. Because of this, weekly blood counts, measure­
ment of electrolytes, including calcium and magnesium, and liver function tests 
should be performed weekly during each cycle. Procarbazine inhibits monoam­
ine oxidase and thus predisposes patients to autonomic sensitivity. Avoidance of 
foods containing high amounts of tyramine (e.g., red wine, cheese, and toma­
toes) and of any sympathomimetic drugs (tricyclic antidepressants, hypnotics, 
antihista mines, narcotics, and phenothiazines) is necessary during therapy. The 
nitrosoureas (carmustine and lomustine) can cause hepatic necrosis and pulmo­
nary fibrosis, which are related to cumulative dosing (more than 1,500 mg/m2). 
Current recommendations include avoiding nitrosourea therapy in the care of pa­
tients with marked pulmonary disease and monitoring of pulmonary function 
tests every few cycles. Nitrosoureas should be discontinued when a cumulative 
dose of 1,500 mg/m2 is attained. Vincristine causes sensorimotor neuropathy and
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can produce changes in mental status, result in the syndrome of inappropriate 
secretion of antidiuretic hormone (SIADH), and diminish levels of phenytoin. 
Methotrexate-leucovorin may be associated with stomatitis. Cytarabine has been 
shown to cause cholestasis and mucositis in some patients. Cyclophosphamide 
can cause a hemorrhagic cystitis, water retention, and alopecia.
VII. Ancillary support
A. Diagnosis and recurrence. With the exception of the more benign tu­
mors (e.g., meningioma, pilocytic astrocytoma, gangiioglioma, and neurocy­
toma), most primary CNS tumors recur and necessitate terminal care. Because 
cancer, especially cancer of the brain, is such a devastating diagnosis, it is im­
portant to realize and understand the anxiety of the patient and family. Most 
neurooncologists are members of a multidisciplinary team of physicians, nurses, 
and social workers who specialize in the care of patients with brain tumors and 
their families. Each member of the health care team should speak with the pa­
tient and concerned family members and provide both practical and emotional 
support. A mutual understanding of the disease and management of long-term 
expectations provides a better overall working relationship and maximizes the 
quality of life for the patient and family. At recurrence, the patient and family 
may need additional support.
These issues can be addressed by either the nursing or social work staff in 
addition to the physician. Patient care concerns have to be especially identified 
in this aspect of treatment. Education is a particularly important aspect of patient 
care. It includes teaching the patient and family about chemotherapeutic inter­
vention, daily medications, and specific nutritional or equipment requirements. 
Support staff can act as facilitators in identification and accessing of community 
resources and services such as home care nursing and cancer support groups.
B. Terminal care. In the United States, once terminal care is needed, it is 
appropriate to contact local hospice services. Hospice provides the patient and 
family with emotional support, respite care, equipment, and supply services 
when death is imminent. The importance of hospice care, in conjunction with 
frequent contact with the health care team, cannot be overemphasized because of 
the emotional consequences of such an impending loss. This combination of 
care can be helpful in making the patient as comfortable as possible and can aid 
in the transition of the family after death.
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LUMBAR DISC DISEASE
Introduction
Lumbar disc disease accounts for a large amount of lost productivity in 
the workforce. Accurate diagnosis can be difficult and often requires interpreta­
tion. Treatment is controversial. Surgical treatment can be technically simple 
and professionally gratifying for the surgeon. Treatment failures are not un­
common, are often related to posttraumatic or work-related injuries, and may re­
sult in litigation. As a consequence, this disease can generate distrust of physi­
cians on the part of patients and vice versa.
History of the Procedure
The first published report of lumbar disc herniation with radiculopathy 
was written by Mixter and Barr in 1934. Surgical treatment was not widespread 
until the 1950s. Today, lumbar discectomy is one of the most commonly per­
formed elective operations in western countries.
Problem: Lumbar disc disease is a rather encompassing term. For exam­
ple, some physicians include back pain alone as a symptom of disc disease. Oth­
ers make the diagnosis without evidence of disc disease on MRI. The discussion 
of this article is limited to well-defined lumbar disc herniation. The pathophysi­
ology, clinical presentation, radiographic diagnosis, treatment, and outcome are 
discussed.
Frequency: Although most people experience back pain during their life­
time, only a fraction experience lumbar radiculopathy or sciatica as a conse­
quence of root compression or irritation. Almost 5% of males and 2.5% of fe­
males experience sciatica at some time in their lifetime.
Etiology
A herniated disk fragment comes from the nucleus pulposus of the disc (a 
remnant of the embryonic notochord). In the normal condition, this nucleus is in 
the disk center securely contained by the annulus fibrosus.
When a fragment of nucleus herniates, it irritates and/or compresses the 
adjacent nerve root. This can cause the pain syndrome known as sciatica and, in 
severe cases, dysfunction of the nerve.
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Clinical presentation
Most lumbar disc herniations are preceded by bouts of varying degrees 
and duration of back pain. In many cases, an inciting event cannot be identified. 
Pain eventually may radiate into the leg. It may be characterized as less achy, 
burning, or similar to an electrical shock and is often described as a shooting or 
stabbing pain. The distribution of the leg pain is somewhat dependent on the 
level of nerve root irritation. Higher herniations (third or fourth lumbar levels) 
can radiate into the groin or anterior thigh. Lower radiculopathies (first sacral 
level) cause pain in the calf and bottom of the foot.
Fifth lumbar radiculopathy, which occurs most commonly, causes lateral 
and anterior thigh and leg pain. Often, accompanying numbness or tingling oc­
curs with a distribution similar to the pain. Accompanying muscle weakness 
may be unrecognized if the pain is incapacitating. The pain usually improves 
when the patient is in the supine position with the legs slightly elevated. Patients 
are more comfortable when changing positions. Short walks can bring relief. 
Long walks or extended sitting (especially driving) can aggravate the pain.
On examination, patients may be neurologically normal, may have a pro­
found radiculopathy, or may even demonstrate a cauda equina syndrome. A 
positive straight-leg raising sign is almost always present. However, a crossed 
straight-leg raising sign may be even more predictive of a lumbar disc herni­
ation. The back may appear scoliotic. Gait is often abnormal. Muscle weakness 
may be revealed particularly when testing walking on heels and toes.
Indications
The indications for surgical treatment of symptomatic lumbar disc disease 
are not clearly delineated. Nevertheless, situations exist in which most spine 
surgeons would probably agree on operative intervention. These situations 
include the following:
• A patient with cauda equina syndrome
■ A patient demonstrating progressive neurologic deficit during a period 
of observation
■ A patient with persistent bothersome sciatic pain, despite conservative 
management, for a period of 6-12 weeks (a time period that varies 
from surgeon to surgeon)
Notably missing from this list is a patient presenting with a profound mo­
tor deficit of varying duration. In the absence of pain, whether such patients 
benefit from surgery is unclear. No consensus has been reached concerning how 
urgent surgery is for a patient who presents with a clinical picture of painful disk 
herniation. Unfortunately, the decision to operate emergently is often based on 
fear of legal repercussions rather than on scientific evidence of actual patient 
benefit.
464
Relevant anatomy and contraindications
Relevant Anatomy
A disc herniation most frequently irritates the displaced nerve root. One of 
the more difficult concepts for beginning medical students to grasp is the anat­
omic relationship of the fifth lumbar (L5) nerve root to the L4-5 disc herniation.
Equally important to understand is the concept of the far lateral or forami- 
nal disc herniation in which the root above the disc herniation is irritated.
With very large herniations, the entire cauda equina can be compressed 
and functionally compromised. This causes saddle anesthesia and can cause uri­
nary retention and incontinence.
Contraindications
Any claim of absolute contraindication would invariably be challenged. 
Most spine surgeons adhere to some guidelines, including the following:
A patient with unrelenting back pain. Patients who have back pain after a 
bout of sciatica has resolved are not good candidates for operative treatment. Of­
ten, these patients are the most insistent and difficult to manage. Occasionally, 
these are patients whose back pain improved after discectomy for a large central 
disc herniation.
A patient with an incomplete workup. When diagnosis is uncertain, post­
pone surgery. Disc herniations are so ubiquitous that being cavalier in diagnosis 
is easy. Ensure the completeness of the workup prior to proceeding with the op­
eration. All surgeons can recall several cases in which a diabetic plexopathy or 
an epidural metastasis was missed.
A patient not provided adequate conservative treatment. Spine surgeons 
rarely commit a patient with a short period of sciatica and without bedrest and a 
steroid trial to an operation that will permanently alter the patient's back me­
chanics and strength.
Investigative Studies
Imaging Studies
MRI is by far the most commonly ordered test to evaluate patients with 
sciatica. Often, MRI is performed prior to plain radiographs. MRI is very sensi­
tive in delineating lumbar disc herniations. Far lateral discs are best evaluated 
with this test. In reoperations, MRI can delineate the full extent of scar tissue 
and, with moderate reliability, differentiate it from recurrent disc herniation.
CT scan myelography may be preferred by surgeons for evaluating pa­
tients before reoperation or for evaluating patients who have severely spondy- 
lotic changes. This is because CT scan myelography can delineate bony struc­
tures better than MRI.
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Plain radiographs, especially with weight-bearing flexion and extension 
views, can be a useful adjunct to other radiographic evaluations. Some spine tu­
mors, instabilities, malalignments, and congenital anomalies can be identified 
best with plain radiographs. Obtain plain films on all patients prior to surgery.
Other Tests
Electromyography is rarely helpful in the diagnosis or management of 
lumbar disc disease. Occasionally, a diabetic patient can be identified as having 
a polyradiculopathy or plexopathy. On this basis, some surgeons proceed to sur­
gery with more caution.
Some surgeons continue to submit disc material for histologic diagnosis. 
The yield of this is exceedingly low and of questionable benefit.
Treatment
Medical therapy
Almost all patients with sciatica and disc herniations deserve a trial of 
medical therapy. The one obvious exception is a patient presenting with cauda 
equina syndrome or profound motor deficits.
Most practitioners are well versed in the initial management of cases of 
sciatica. Counseling and education about the disease helps the patient commit to 
a successful trial of nonoperative management. Encourage bedrest and prescribe 
anti-inflammatory agents (steroidal and/or nonsteroidal) with analgesics that are 
sufficiently strong enough to relieve pain. Muscle relaxants aid in relieving as­
sociated muscle spasm. After 7-14 days, slow mobilization is started.
Once the patient has recovered from the worst radicular pain, physical 
therapy can be instituted. Return to work (either limited or full) is important at 
this point. Stop steroidal medications. Reevaluate patients about a month after 
the onset of sciatica. At this time, studies can be ordered or a more intense back 
rehabilitation program can be designed so appropriate referrals can be made.
Epidural steroid injections can be employed at almost any time.
Surgical therapy
What constitutes surgical therapy is open to discussion. The standard 
lumbar microdiscectomy has numerous variations. Percutaneous discectomies 
are still performed frequently. Lately, endoscopic techniques have gained in 
popularity. Chemonucleolysis, although in principle an excellent alternative, is 
no longer performed. Other procedures, such as thermal ablation, are also per­
formed.
Preoperative details. A complete workup is essential. Based on the pa­
tient’s age group and comorbidities, perform the appropriate laboratory examina­
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tions, radiographic examinations, and further tests, as needed, to ensure a safe 
anesthetic period.
Intraoperative details. The standard lumbar microdiscectomy is de­
scribed. Variations in technique exist between institutions, regions, and sur­
geons.
The patient is anesthetized and placed in the prone position. The hips are 
flexed to open the interlaminar spaces. A protuberant belly should hang as freely 
as possible to reduce venous hypertension. The ulnar nerves at the elbow are 
padded to prevent neuropathy. The legs cannot be overflexed. The back is paral­
lel to the ground. A preoperative radiograph with a spinal needle is obtained to 
confirm localization. The back is shaved and prepared.
After injection of a long-acting local anesthetic agent, a 3-cm incision is 
made over the disc space (as determined by radiograph). Unipolar cautery is 
used to dissect down through midline subcutaneous fat. The lumbodorsal fascia 
is opened paramedially. Muscles are stripped from the lamina. Obtain a repeat 
radiograph to confirm the appropriate location.
A small laminotomy is created with a drill or rongeurs. The ligament is 
excised with rongeurs or a knife. An operating microscope is now used. The 
medial facet is partially resected in most patients. The root is then identified and 
retracted. The disc fragment is evident below the retracted root.
The annulus is incised and the disc removed with pituitary rongeurs. Re­
move loose fragments of the disc in the space. Palpate the course of the nerve 
root with an angled instrument along its entirety to ensure adequate decompres­
sion. Bleeding is stopped, the wound is irrigated, and then it is closed in inter­
rupted absorbable sutures layer by layer. A light dressing is applied.
Postoperative details. The patient is treated with oral narcotics and IV 
supplementation for pain. Antiemetics are administered as needed. The patient is 
mobilized 4-6 hours after surgery and should be able to void without help. Once 
the patient tolerates fluids, he or she may leave the hospital with an ample sup­
ply of narcotics, antispasmodic agents, and stool softeners. Rarely, the patient 
may remain in the hospital 24 hours after the operation.
Follow-up care. The patient is seen in follow-up one month after surgery. 
For uncomplicated cases, the patient is then released from the surgeon's care. 
The patient is usually released to work 6-10 weeks postoperatively, depending 
on the occupation.
Complications
The overall complication rate is 2-4% for the surgery. Despite endless re­
ports of misadventures, surgeons still operate on the wrong level. Therefore, re­
liance on intraoperative radiographic confirmation of the intended level is 
strongly encouraged.
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Bleeding intraoperatively can be copious and is almost invariably due to 
malpositioning. Engorged venous epidural channels can make the operation 
more difficult and far more dangerous. Very rarely, the anterior annulus is vio­
lated and a retroperitoneal vessel is injured. Awareness of this complication is 
essential. Should this occur, the back is closed while a vascular surgeon prepares 
to repair the vessel via laparotomy.
Infections, usually skin infections, can occur. The authors' protocol is to 
administer one dose of a preoperative antibiotic within one hour of surgery. 
Very rarely, postoperative discitis can cripple a patient who is recovering. Sus­
pect discitis in the setting of an increasing sedimentation rate, fevers, severe lo­
calized pain, and recurrent symptoms.
Increased neurologic deficit is usually mild and is due to excessive retrac­
tion of the root. If a nerve root is mistaken for a disc herniation and is removed, 
the resultant injury can be severe. If possible, identify the root and disc in the 
same field. On occasion, a conjoined root can add significant technical complex­
ity to the case.
Outcome and prognosis
Almost every study measures the outcome from lumbar disc surgery dif­
ferently. A good outcome may be defined as the decreased use of narcotics, 
prompt return to work, or reported reduction in pain. Understandably, outcome 
studies can be misinterpreted or misrepresented.
Approximately 75% of patients who undergo a microdiscectomy have 
long-term reduction of sciatic pain and, thus, are considered cured. Reported re­
sults vary from 65-95%. Predominance of leg pain is the best determinant of 
good outcome from surgery for lumbar disc herniation.
Unfortunately, a rather large fraction of individuals who have had surgery 
for lumbar disc disease have recurrent or residual pain, which can be a signifi­
cant challenge to treat. A methodical postoperative evaluation is necessary, fo­
cusing on symptom clarification, careful examination, and repeat radiographic 
examinations and MRI with contrast.
Also, some patients who are surgically treated are more prone to further 
problems such as recurrent herniations, arachnoiditis, and vertebral instability.
Future and controversies
The duration of conservative management has been debated since the dis­
ease was identified. As surgical treatments become less invasive and medica­
tions change, the role and duration of conservative management will change as 
well. Endoscopic operations are becoming safer and more prevalent. Although 
many microdiscectomies are now being performed in the outpatient setting, the 
impetus for even less invasive procedures continues. The role of stabilization in
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lumbar disc surgery is very unclear. An increasing number of patients are having 
extensive fusions as the first-line management of lumbar radiculopathy secon­
dary to disc herniations. However, the indications for stabilization need to be 
better established.
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NEUROLOGIC EXAMINATION
DIFFUSE CORTICAL FUNCTION: MENTAL STATUS
1. LEVEL OF CONSCIOUSNESS
The level of consciousness is the first state evaluated in the neurologic ex­
amination. Consciousness may be assessed as normal (patient awake and alert, 
attentive to surroundings and to the examiner), depressed (patient sleepy, lethar­
gic, stuporous-arousing only briefly in response to pain stimulation; or coma- 
tose-not arousable by pain stimulation); or hyperalert (patient distractible, jit­
tery, "jumpy").
2. COGNITIVE FUNCTIONING
Assessment of cognitive functioning aims not to determine "how smart 
the patient is" but how the patient's cognitive capacity has changed from a recent 
baseline. The examiner must have some way (recent work history, observations 
of family, other physicians, etc) of assessing the patient's cognitive status before 
onset of the present illness. Assessment should include (at a minimum) informal 
evaluation of the following.
Cognitive Functioning Checklist
A. Orientation to person, place, and time
B. Fund of common knowledge as judged by the response to such ques­
tions as "Who is the president?" or "How many nickels are there in a dollar?"
C. Memory. Short-term-name three common objects, then name them 
again them after 5 minutes; long-term-recount verifiable events from the past.
D. Insight and judgment. "Why have you come to see me?"
E. Concentration. Can often be tested along with calculations (see be­
low) or by instructing the patient (for example) to repeat a series of four to seven 
digits, arrange the letters in "world" in alphabetical order, or spell "world" 
backward.
F. Calculations. The conventional test is serial sevens, but informal "real- 
life" problems may yield a more objective result:
1. Serial sevens. Count backward from 100, taking away 7 each time
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2. Real-life problem. For example, "If an apple costs 20 cents, how many 
can you buy for $1.50?" Then, "How much change do you have left over?"
G. Abstract thought. Examples are proverb interpretation or "compare- 
and-contrast" tasks such as, "How is an apple different from-[or the same as]-an 
orange?"
H. Verbal fluency. Can be judged by listening to the patient talk or by 
asking such questions as, "How many words can you say that start with the letter 
B?" (Time for 30 seconds.)
I. Other. The examiner should now be able to form an impression of the 
patient's mood, content of thought, and appropriateness of behavior.
FUNCTION OF SPECIFIC HEMISPHERES
1. DOMINANT HEMISPHERE
The most important function of the dominant hemisphere is language. 
Language skills include comprehension, repetition, naming, reading, and writ­
ing. Language mastery can be lost as a consequence of diffuse transient (eg, 
metabolic derangements) or degenerative disease (eg, dementia), but language 
impairment with otherwise normal cognitive function almost always suggests a 
focal lesion.
Aphasias
Impairments of the expression or understanding of language are tradition­
ally divided into categories depending on the pattern of the language deficit and 
the site of the damage. There are three most frequently seen syndromes of clini­
cal significance: Broca's aphasia, Wernicke's aphasia, and conduction aphasia. 
The three syndromes are tested for as follows.
A. Fluency. Listen to spontaneous speech. Assess for fluency, errors of 
grammar or vocabulary, neologisms (meaningless words), or word substitutions 
(paraphasias). Determine whether the patient's speech makes sense in the current 
context. Alternatively, give the patient paper and pencil and say, "Write your 
name." "Write, The boy and the girl are happy about the dog." "Please write 
down your reason for being here."
B. Comprehension. Using only words (no gestures), instruct the patient 
to follow commands of increasing complexity: "Close your eyes." "Show me 
your left hand." "With your left hand, put a finger in your right ear.” Alterna­
tively, present a written command ("Go to the door, knock three times, and 
come back") and assess whether the task is performed properly. If the patient 
does not comply, assess cooperation and physical capacity by repeating the com­
mands with demonstration and miming.
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C. Repetition. Ask the patient to repeat three common nouns ("bread, 
coffee, pencil") and then to say, "No ifs, ands, or buts."
D. Writing
With rare exceptions, every patient aphasic in speech is also aphasic in 
writing (agraphic). A patient who cannot speak but can write is mute, and the le­
sion is not in Broca's area. Muteness occurs in a wide variety of disorders, in­
cluding severe rigidity, vocal cord paralysis, bilateral corticobulbar lesions, and 
psychiatric disease.
E. Naming
Difficulty in naming familiar objects (anomia) may occur in expressive 
aphasia or other aphasic syndromes but by itself is not diagnostic of any specific 
entity. It is more likely a consequence of diffuse cerebral dysfunction of struc­
tural or metabolic origin. Ask patients to name or mute patients to point to a 
wrist watch, a typewriter keyboard, etc.
2. THE NON DOMINANT HEMISPHERE
Tests for lesions of the nondominant hemisphere are chiefly concerned 
with the interpretation of incoming stimuli (other than language), visuospatial 
orientation, and perception of the contralateral body in space. (Lesions of the 
dominant hemisphere can also produce abnormalities in these areas, but they are 
usually masked by aphasia.)
Assessment of Sensory
Interpretation
Defects of sensory interpretation can be evaluated in a number of ways, 
though all require reasonably intact primary sensation.
A. Graphesthesia. Ask the patient to identify a letter or number written 
on the palm.
B. Object identification (stereognosis). Have the patient name a com­
mon object placed in the hand (key, paper clip, coin, etc).
C. Neglect. Misperception of one side of space results in a number of ab­
normalities collectively called neglect. The patient may not heed information in­
coming from the side contralateral to the lesion (right brain affecting left side of 
body). For example, the patient may hunt eagerly for the examiner's face on the 
right when the voice is calling from the left -  or may eat only the food on the 
right side of a plate. Patients may deny that the left side of the body exists (even 
a dense hem.paresis may be cheerfully "overlooked"), fail to acknowledge as 
one's own the left arm held up in plain view by the examiner, or, most dramati­
cally, fail to properly clothe or groom the left side of the body. Clumsiness or
disuse out of proportion to actual weakness-or a pronounced lag in initiating
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movement on the involved side-suggests motor apraxia as a manifestation of 
neglect. There are several classic tests, as follows.
Spatial Orientation
Approach the patient quietly on the weak side (particularly when the head 
and gaze are turned away), enunciate a greeting and observe whether the pa­
tient's head turns ("orients") to the source of the voice or searches only on the 
wrong side. Then move over to the "good" side and repeat the exercise.
Double Simultaneous Stimulation
Touch the patient gently first on one hand and then the other while identi­
fying the side. Then randomly vary the stimulus, asking the patient to say, with 
both eyes closed, "left," "right," or "both." Mute patients should be asked to 
raise the touched hand. If the patient correctly identifies each side in isolation 
but "extinguishes" the touch on the involved side when both are touched, neglect 
is present.
Clockface Exercise
Draw (or have the patient draw) a large circle and ask the patient to write 
in the numbers of the hours of the day. Note if the patient writes all 12 numbers 
into the hemicircle opposite the neglected side. If the numbers are placed cor­
rectly, the patient should then be asked to draw in the hands to indicate a speci­
fied time such as "a quarter to four."
Reading, Writing
Ask the patient to read from a book or write on a sheet of paper. The pa­
tient may read only the right side of the page or squeeze the sentence into the 
right half. Give the patient a sheet of lined notebook paper and say, "Cross out 
all the lines." Note whether lines on the left side of the page are ignored.
Ideomotor Apraxia
Ask the patient to manipulate some familiar object (dial a phone number, 
hold a pencil in the position of writing) or to raise one arm in the air.
CRANIAL NERVES 
1. OLFACTORY (I)
Ask the patient to identify common scents such as coffee, vanilla, etc, 
with eyes closed. Do not use irritants. In testing olfactory nerve function, it is 
less important to determine whether the patient can correctly identify a particu­
lar odor than whether the presence or absence of the stimulus is perceived.
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2. OPTIC (11)
Visual Acuity
A pocket card or wall chart -  or any reading matter -  may be used to ob­
serve the focal distance (normally, small newspaper print can be read at 32 
inches). Patients with refractive errors may wear spectacle lenses or be given a 
pinhole.
Visual Fields
Visual fields are a measure of the integrity of the optic nerves and the 
postthalamic optic radiations through the hemispheres. They are tested as fol­
lows.
A. Confrontation Testing. Patient and examiner stand at eye level at 
about arm's length. Have the patient cover the left eye. With right arm extended 
and then brought forward from the side, have the patient say how many fingers 
are shown. The patient and examiner should see the fingers at the same time. 
Then repeat with the left hand to the patient's right eye. Test all four quadrants in 
each eye in this way.
B. Threat Testing. Flick an extended finger obliquely toward the patient's 
pupil from each temporal field and observe for blinking. This crude test is occa­
sionally useful when the patient is less than fully alert or is uncooperative.
Fundus (Ophthalmoscopic) Examination
Look for blurring of the disk margins, loss of venous pulsations, retinal 
lesions, abnormalities of the vessels, and color of the optic nerve head.
3. PUPILLARY REFLEXES (II, III)
A normal pupil will constrict (1) in response to direct light, (2) as a con­
sensual response to light in the opposite eye, and (3) to accommodation (conver­
gence to focus on a close object). A pupil that reacts to accommodation but not 
to light is an Argyll-Robertson pupil, signifying a lesion in the tectum of the 
midbrain. A Marcus-Gunn pupil is one with impaired constriction to direct light 
with preservation of the consensual response; in this case, an afferent light 
stimulus does not reach the lateral geniculate nucleus and a lesion should be 
sought in the optic tract, preoptic chiasm, optic nerve, or retina.
Constriction to Accommodation
The patient is instructed to gaze at the wall over the examiner's shoulder 
and then quickly focus on the examiner's forefinger held in front of the patient’s 
nose. Look for subtle constriction when the patient changes from far vision to 
very near. To see the constriction, use a dimmer light, held obliquely.
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Consensual Constriction (Swinging Flashlight Test)
After shining a flashlight into one eye to constrict the pupil, switch to the 
other eye and observe if that pupil constricts further (normal response) or dilates 
(abnormal response).
4. CONTROL OF EXTRAOCULAR MUSCLE MOVEMENTS
Extraocular muscle movements are controlled by the oculomotor (111), 
trochlear (IV), and abducens (V) nerves-innervating the lateral, medial, superior, 
and inferior rectus muscles (LR, MR, SR, IR) and the superior and inferior 
oblique muscles (SO, 10).
Movements need to be checked in all six directions of gaze: LR (VI) for 
lateral gaze, MR (111) for medial gaze, IR and SR (III) for down gaze and up 
gaze with the eye laterally deviated, and SO (IV) and 10 (III) for down gaze and 
up gaze with the eye medially deviated. Ask about diplopia, as the patient's per­
ception is more sensitive than the examination results.
Abnormalities of eye movements can result from lesions other than those 
involving the cranial nerves-anything from muscular or neuromuscular disease 
to central lesions in the cortex or brain stem. For example, if the patient has had 
a stroke, horizontal movements may remain conjugate (with eyes moving 
smoothly yoked together) but gaze at rest may be directed to one side-toward the 
lesion if the lesion is cortical, away from the site of damage if the lesion is in the 
brain stem.
If the patient is unresponsive or otherwise unable to perform voluntary 
eye movements, the doll's eye (doll's head) maneuver (oculocephalic reflex) 
should be performed (see below).
Nystagmus is rhythmic oscillation of the eyes; it can be either conjugate 
or asymmetric. It can be a normal phenomenon (eg, at the extremes of lateral 
gaze) or may relate to weakness of an eye muscle or to lesions in the brain stem, 
cerebellum, or anywhere in the peripheral or central vestibular systems; each 
type has its characteristic pattern. Nystagmus is most easily observed-as are all 
disorders of smooth coordinated eye movements-while the patient is following 
the examiner's finger.
Tests for control of extraocular muscle movements include the following.
Primary Gaze (Straight Ahead)
Look for symmetry of position of the light reflection off the two corneas.
Volitional Eye Movements
Face the patient and put a hand on the patient's forehead and say, "Follow 
my finger, just with your eyes." Then move the index finger of the other hand 
horizontally, then up and down on either side, tracing the letter H.
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Doll's Head (Oculocephalic) Maneuver
The patient's head is held firmly and rotated from side to side, then up and 
down. (It may be necessary to hold the eyelids open as well.) If the brain stem is 
intact, the eyes will move conjugately away from the direction of turning (as if 
still looking at the examiner rather than fixed straight ahead).
5. TRIGEMINAL NERVE (V)
Facial Sensation
Simultaneously touch both sides of the forehead, then the cheek, and then 
the jaw and ask if they feel the same. Check for temperature perception in the 
same sequence, using the cool surface of a tuning fork or other appropriate 
stimulus. The stimulus will be perceived as warmer on the side of impaired sen­
sation.
Corneal Reflex
Sweep a wisp of cotton lightly across the lateral surface of the eye (out of 
the direct visual field) from sclera to cornea. As soon as the stimulus reaches the 
sensitive cornea, the patient will wince and blink vigorously if nerves V and VII 
are both intact. Compare the sides for symmetry.
Motor V Testing
Observe the symmetry of opening and closing of the mouth; the jaw will 
fall faster and farther on the side of the lesion, so that the face looks askew. For 
more subtle weakness, ask the patient to clench the teeth and then attempt to 
force jaw opening or lateral jaw displacement. Normal strength cannot be over­
come.
6. FACIAL STRENGTH (VII)
A central "supranuclear" lesion, such as a hemispheric stroke, will pre­
serve forehead wrinkling and cause only mild weakness of eye closure, while 
the lower face is more severely involved. If there is a peripherallesion of the 
cranial nerve (or nucleus), the entire hemiface will be flaccid and the eyelids 
will gape open.
Some cranial neuropathies or neuromuscular diseases cause bilateral fa­
cial weakness, and in such cases the usual criterion of facial asymmetry as a 
marker of weakness will not apply.
Facial Symmetry
Observe the patient’s face for symmetry of the palpebral fissures and na­
solabial folds at rest. Ask the patient to wrinkle the forehead, then to squeeze the
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eyes tightly shut (looking for asymmetry in the extent to which the eyelashes 
protrude), then to smile or snarl, saying, "Show me your teeth."
Bilateral Facial Weakness
Ask the patient to squeeze the eyes tightly shut, then press the lips tightly 
together, then puff air into the checks. If strength is normal, one should not be 
able to pry the eyelids open, force the lips apart, or forcibly expel air from the 
mouth.
7. AUDITORY (VIII)
Auditory acuity can be tested crudely by rubbing thumb and forefinger to­
gether about 2 inches from each ear. If there are complaints of deafness or if the 
patient cannot hear the finger rub, proceed to the following tests.
Rinne Test
Hold the base of a lightly vibrating high-pitched (512 Hz) tuning fork on 
the mastoid process until the sound is no longer perceived, then bring the still vi­
brating fork up close to (not touching) the ear. Normally-or if the hearing loss is 
sensorineural-air conduction is greater than bone conduction and the patient will 
again hear the tone. If there is significant conductive loss, the patient will not be 
able to hear the air-conducted tone longer than the bone-conducted tone.
Weber Test
Lightly strike a high-pitched (512 Hz) tuning fork and place the handle on 
the midline of the forehead. If there is conductive loss, the tone will sound 
louder in the affected ear; if the loss is sensorineural, the tone will be louder in 
the unaffected ear.
Vestibular Function
Vestibular function needs to be tested only if there are complaints of diz­
ziness or vertigo or evidence of nystagmus. The Nylen-Barany (Dix-Hallpike) 
maneuver tests for positional vertigo. In this disorder, as in other types of ver­
tigo of peripheral origin, nystagmus will come on after at least 3-5 seconds, will 
decrease with time, and will become less prominent with repetition of the test.
Nylen-Barany (Dix-Hallpike) Maneuver
The patient sits with legs extended on a table while the examiner supports 
the head and shoulders. Rapidly lower the patient to the supine position with 
neck hyperextended (head hanging off the table) and rotated to one side; repeat 
with the head turned to the other side. Look for nystagmus and ask the patient to 
report vertigo. The patient may need encouragement to keep the eyes open.
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8. GLOSSOPHARYNGEAL (IX) & VAGUS (X)
Some useful tests for detection of deficiencies in motor function of the 
palate, pharynx, and larynx are described below. Sensory function needs to be 
checked if one suspects cranial neuropathy or a brain stem lesion.
Palatal Elevation
Ask the patient to say "ah". Look for full and symmetric palatal elevation 
(not deviation of the uvula). If one side is weak, it will fail to elevate and will be 
pulled toward the strong side.
Gag Reflex (Afferent IX, Efferent X)
Gently touch each side of the posterior pharyngeal wall with a cotton 
swab and compare the vigor of the gag.
Sensory Function
Lightly touch each side of the soft palate with the tip of a cotton swab.
Voice Quality
Listen for hoarseness or "breathiness," suggesting laryngeal weakness.
9. ACCESSORY (XI)
Sternocleidomastoid
Press a hand against the patient's jaw and have the patient rotate the head 
against resistance. Pressing against the right jaw tests the left sternocleidomas­
toid and vice versa.
Trapezius
Have the patient shrug shoulders against resistance and assess weakness.
10. HYPOGLOSSAL (XII)
Dysarthria is a defect in the mechanical production of speech sounds. 
Testing for dysarthria provides a quick functional assessment of the lower cra­
nial nerves, cerebellum, and basal ganglia. Facial weakness (see VII above) can 
be assessed by asking for labial sounds ("mee-mee-mee"). Pharyngeal weakness 
(see IX and X above) results in a nasal voice as assessed by asking for guttural 
sounds ("kay-kay-kay"). Laryngeal dysfunction (see IX and X above) presents 
as hoarseness or "breathy" speech. Maximal difficulty is found with a high- 
pitched sound, as this requires vocal cord adduction. Tongue weakness (XII) is 
manifested by pronounced slurring, particularly of lingual sounds ("la-la-la"). 
Bilateral corticobulbar tract lesions are manifested by strangled, spastic, labored
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speech or, if severe enough, no speech at all (along with inability to open the 
mouth or protrude the tongue and a hyperactive gag reflex).
Tests for hypoglossal nerve function include the following.
Atrophy or Fasciculations
With the patient's tongue resting in the floor of the mouth, first inspect for 
atrophy or fasciculations (worm-like quivers and twitches). Then ask the patient 
to protrude the tongue, and observe for deviation to the weak side. Be sure the 
deviation is real and not just apparent because of facial weakness. Mark the mid­
line of nose and chin with thumb and forefinger. Then ask the patient to move 
the tongue rapidly from side to side.
Subtle Weakness
If subtle weakness is suspected, have the patient push the tongue into each 
cheek against external resistance. Strength of protrusion to one side is a measure 
of the power of the opposite hypoglossal muscle.
Subtle Dysarthria
Ask the patient to repeat difficult phrases such as "methodist episcopal" or 
"administrative assistant."
MOTOR COORDINATION
The cerebellar hemispheres are responsible for coordinating and fine- 
tuning movements already set in motion and for correcting speed, accuracy of 
direction, and intensity of force to meet the intended purpose. The cerebellar 
hemispheres control the ipsilateral appendages, particularly the arms.
The following are some tests for cerebellar hemispheric function.
Finger-to-Nose
Ask the patient to alternately touch his or her nose and then the examiner's 
extended forefinger, held far enough away to require reaching. Look for over­
shoot or for an oscillatory "hunting" tremor that increases in amplitude as the 
target is neared. Abnormalities are referred to as dysmetria.
Finger-Tapping, Toe-Tapping
Demonstrate and then ask the patient to tap as evenly and rhythmically as 
possible. Look and listen for irregularities of rhythm or force.
Rapid Alternating Movements
Have the patient strike the thighs rhythmically and rapidly, alternating be­
tween the palms and the backs of the hands; rapidly touch the thumb to each 
finger in succession; or rapidly wiggle the protruded tongue from side to side.
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Dysdiadochokinesia is the technical term for dysrhythmias in performing any of 
these tasks.
Rebound
The patient flexes an arm as strongly as possible or holds the arm ex­
tended against resistance. The examiner then suddenly lets go. If the arm flies 
upward or toward the face, this signifies that the patient is unable to check the 
abrupt imbalance between flexors and extensors.
Heel-Knee-Shin
The supine or seated patient is instructed to place one heel against the op­
posite knee, tap the knee with the heel, then run the heel smoothly down the 
tibia to the ankle.
Cerebellar Vermis
The cerebellar vermis is concerned with postural stability and axial func- 
tion-particularly stance and gait. In patients with lesions in this area, the gait will 
be wide-based and ataxic (staggering) and it may be difficult to sit upright with­
out support. There may be irregular back-and-forth rocking or shaking of the 
head (titubation), and speech may be "scanning," ie, irregular in force and pitch, 
with words distinctly broken into "syl-Iuh-bles." Integrity of the vermis can be 
tested by asking the patient to stand "naturally" while one observes how far apart 
the feet are positioned for a stable base. The examiner then extends the arms (for 
reassurance and to prevent falls) and asks the patient to bring the feet together 
until they touch.
Basal Ganglia
Disorders of the basal ganglia (extrapyramidal system) may result in in­
ability either to initiate motor activity (bradykinesia, loss of associated move­
ments such as arm swinging), correct for postural imbalance, or control move­
ments such as tremor or chorea. Tremor or other abnormal movements should be 
observed with the patient at rest, during arm extension, and during performance 
of a goal-directed action such as drinking from an imaginary cup.
Other Tests of Motor Coordination
A. Turning Around. How many steps does the patient need to "about 
face”? A normal turn is made with a one- or two-step pivot. A patient with park­
insonism may require up to 20 small steps ("en bloc turn") or may freeze alto­
gether.
B. Drawing Spirals. The patient is asked to draw a copy of an expanding 
(Archimedes) spiral. In parkinsonism, there is difficulty enlarging the figure's 
successive loops.
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C. Retropulsion. The examiner stands behind the patient, announces 
what is about to happen, then vigorously pulls the patient backward by the 
shoulders. Normally, the subject will regain the center of gravity with a step or 
two backward and truncal flexion. The patient with parkinsonism cannot do so 
and may stagger rigidly backward or fall into the examiner's arms.
MOTOR FUNCTION
The motor examination includes evaluation of muscle tone, bulk, and 
strength.
1. MUSCLE TONE
Tone is defined as resistance of muscle to passive movement at a joint. 
Tone can be decreased, normal, or increased.
The hardest part of evaluating tone is getting the patient to relax. Diver­
sionary tactics may be required. Once the patient is seen to be relaxed, the fol­
lowing maneuvers can be used.
Arm Muscle Tone
Support the patient's bent arm with one hand cupping the elbow, then 
smoothly flex and extend the forearm, then pronate and supinate. Grasp the 
forearm and flop the wrist back and forth, briskly raise the arms as if tossing 
them into the air, and then abruptly let go and watch how fast and symmetrically 
they drop.
Leg Muscle Tone
With the patient lying prone and relaxed, place a hand under the knee, then 
abruptly pull vigorously upward. With normal or reduced tone, the heel lifts 
only momentarily off the bed or remains in contact with the surface as it slides 
up toward the buttocks. The hypertonic leg lifts off the bed. With the patient 
seated, grasp the knee and bounce the foot up and down off the floor.
Axial Rotation
Passively rotate the patient's head and observe if the shoulders also move, 
or gently but firmly flex and extend the neck and assess resistance.
2. MUSCLE BULK
Some loss of muscle bulk may be seen with disuse, but significant atrophy 
("wasting") is characteristic of denervation from lower motor neuron lesions. At­
rophy may also be associated with fasciculations, or rapid twitching. These
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spontaneous contractions of a muscle fascicle may resemble worm-like writhing 
under the skin, or occasionally may be coarse enough to move a small joint. 
Asymmetric atrophy can best be assessed by comparing sides or by careful mea­
surement when in doubt. If atrophy is diffuse, one can compare the patient's 
muscle to a "normal" muscle by palpating one's own corresponding muscle 
mass.
3. MUSCLE STRENGTH
Strength is measured by the ability to contract the muscle against force or 
gravity. The classic grading system scores as follows: 5, full strength; 4, move­
ment against gravity and resistance; 3, movement against gravity only; 2, 
movement only if gravity is eliminated (eg, horizontally along the surface of the 
bed); I, palpable contraction but little visible movement ("flicker"); 0, no con­
traction.
Exactly which muscles are tested-and how carefully-will depend on the 
patient’s complaints and the examiner's suspicions. Tests of strength should be 
conducted with the following in mind:
(1) "Normal" means "to be expected of this patient." A frail elderly man is 
expected to be less strong than a young weight lifter.
(2) The examiner should be on equal footing with the patient. If testing 
shoulder abduction, the examiner should stand facing the patient and use only 
the upper arms to oppose the patient rather than standing above a seated patient 
and pressing down with full body weight. When testing finger extension, only 
the equivalent finger should be used, not the whole arm and shoulder strength.
(3) The patient is a more sensitive observer than the examiner and may 
have more subtle weakness than is detectable through formal testing. This is par­
ticularly true in the legs. If indicated, follow formal testing with "functional" 
tests such as squatting and rising, walking on the heels, and rising from a low 
stool with arms crossed.
A pattern frequently seen after a stroke is pyramidal weakness, in which 
abductors and extensors of the arm and flexors of the leg are preferentially af­
fected, so that the arm has a tendency to be held in adducted flexion and the leg 
in adducted extension.
Tests of strength are as follows.
General Strength
Isolate the specific agonist muscle action and then apply an equal and op­
posite force in gradually increasing intensity. For example, support the patient's 
elbow with one hand underneath and attempt to extend the arm by pressing 
down on the forearm, telling the patient to "bend your elbow up as tightly as you 
can-don't let me pull it down."
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Pyramidal Weakness
Check for weakness of finger or forearm extension by attempting to push 
down the extended fingers or flex the half-extended elbow. In contrast, the 
strength of the biceps or hand grip is an insensitive index of pyramidal weak­
ness.
Pronator Drift
Ask the patient to hold the arms straight out with palms up and then to 
close the eyelids. A weak arm will begin to drift downward and the hand will 
begin to pronate.
SENSORY FUNCTION
A basic screening examination should assess both large-fiber and small- 
fiber modalities in the fingers and toes.
I. LARGE-FIBER & DORSAL COLUMN FUNCTIONS
Lesions of large fiber nerves and of the dorsal column of the spinal cord 
are investigated by tests of vibration and joint position sense. Normal joint posi­
tion sense is exquisitely sensitive, and the patient should detect any movement 
no matter how fine. If joint position sense is diminished distally, test more 
proximal limb joints. Functional tests for joint position sense include Romberg's 
test and the finger-to-finger test.
Vibration Sense
Strike a low-pitched (128 Hz) tuning fork gently and place the base firmly 
on a bony prominence, with one finger of the other hand supporting the digit and 
serving as a control. Ask if the patient "feels the buzz," and determine when it 
can no longer be perceived. Compare sides, and if sensation is decreased at the 
toe, repeat at the ankle, knee, or hip to determine the extent of impairment. 
Compare leg and arm sensation as well. Abnormalities in the distallegs but not 
the arms are found in patients with polyneuropathies or lesions of the thora­
columbar spinal cord.
Joint Position Sense
Grasp the sides of the distal phalanx of a finger or toe and displace the tip 
up or down. Rehearse first with the patient watching, then test with the patient's 
eyes closed to determine the threshold for correctly perceiving the direction of 
movement.
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Romberg's Test
Instruct the patient to stand with the feet as close together as possible. (If 
the patient cannot stand with the feet together, a cerebellar lesion is present and 
Romberg's test is not applicable.) The patient is then observed with eyes closed. 
An abnormal result consists of swaying or other evidence of instability.
Finger-to-Finger Test
Instruct the patient to bring the extended forefingers together with eyes 
closed through two or three feet of space, or have the patient touch the tip of the 
nose with a finger. As in the Romberg test, the patient is demonstrating "pseu­
doataxia," a disorder of sensory input, if finger placement is clumsy with the 
eyes closed but not with eyes open.
2. SMALL-FIBER & SPINOTHALAMIC FUNCTION
Temperature Sensation
Using the cold flat disk of a tuning fork or other cold object, first establish 
the patient's ability to detect its temperature in a presumably normal area. Then 
have the patient compare the relative temperature of the stimulus from the dor­
sum of the feet upward, or from side to side, or between dermatomes.
Superficial Pain Sensation
Use a disposable instrument, such as a safety pin, for each patient. Prick 
the skin with enough force to be unpleasant but not harmful, and ask if the prick 
feels sharp or "hurts like a pin." As always, work from side to side, distal to 
proximal, or dermatome to dennatome -  and from area of deficit toward nonnal 
regions.
Light Touch Sensation
The sensation of light touch is served by both the large fiber -  posterior 
column system and the small fiber — spinothalamic system. Testing is done with 
a very light stimulus such as a wisp of cotton, the teased-out tip of a cotton 
swab, or a brush motion with the examiner's fingertips. Ask the patient to tell 
with closed eyes where the stimulus is perceived.
REFLEXES
1. DEEP TENDON REFLEXES
A deep tendon reflex is the reaction of a muscle to being passively 
stretched by percussion on the tendon. These reflexes are a measure of the integ­
rity both of the afferent and efferent peripheral nerves and of their central inhibi-
484
tory controls. Tendon reflexes are graded on a scale according to the force of the 
contraction or the minimum force needed to elicit the response: 4, very brisk, 
often with clonus (record the number of beats); 3, brisk but nonnal; 2, nonnal; 1, 
minimal; 0, absent.
In some cases, deep tendon reflexes are difficult to elicit without such re­
inforcement as having the patient clench the opposite fist or interlock the fingers 
and attempt to pull them apart. Hypoactivity or hyperactivity is generally of less 
significance than asymmetry; however, absent reflexes may be a clue to an un­
suspected neuropathy, and hyperactivity may be associated with spasticity.
The four most commonly tested tendon reflexes are described here.
Biceps Reflex (C5-6)
Support the patient's partly flexed elbow with one cupped hand, thumb 
positioned on the biceps tendon. Strike the thumb with a percussion hammer and 
assess the force of flexion at the elbow.
Triceps Reflex (C7-8)
Support the patient's partly flexed arm by holding the forearm against the 
patient's body, or suspend the abducted arm just above the elbow so that the 
forearm dangles freely. Strike the triceps tendon just above the elbow and assess 
the force of extension at the elbow.
Quadriceps (Patellar, Knee Jerk) Reflex (L3-4)
The patient's feet can remain on the floor, but it is easier to elicit this re­
flex if the patient crosses one leg and lets the foot dangle. If the patient is in bed, 
support the leg in partial flexion with one arm under the knee. Feel for the bot­
tom edge of the patella and strike just below it. Assess the force of extension at 
the knee.
Achilles (Ankle Jerk) Reflex (Sl-2)
The patient's foot is passively dorsiflexed, resting its weight on the ball of 
the foot, or by pressing on the sole. Strike the tendon or the sole directly. Assess 
the force of extension at the ankle.
2. BABIŃSKI SIGN
In patients over age 18 months, the nonnal response to stimulation of the 
lateral sole is plantar flexion of the toes. Extension upward of the great toe (Bab­
iński sign) is a sensitive but nonspecific sign of central nervous system disease 
and can be a consequence of pyramidal tract damage or diffuse cerebral dys­
function.
The foot should be held finnly and the patient told what to expect. Place 
the tip of a suitable instrument, such as the bare end of a swabstick, on the lat­
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eral aspect of the sole at the heel and sweep it finnly forward to the base of the 
toes. Apply the least pressure necessary to evoke a response. A void stroking 
across and under the toes, a maneuver that might evoke a conflicting (foot grasp) 
response manifested by flexion of the toes.
3. FRONTAL RELEASE SIGNS
Frontal release signs are primitive reflexes that can be thought of as adap­
tive for the infant, such as grasping or sucking, but which disappear as the brain 
matures. Diffuse neuronal dysfunction, especially frontal lobe damage, releases 
them from inhibition. The more important signs are grasp, or curling of the fin­
gers in response to stimulation of the palmar surface of the hand and fingertips 
(it can be seen in the foot as well); suck; snout, or pursing of the lips; and the 
glabellar sign, or persistent blink response.
Grasp Sign
The grasp response is elicited by lightly drawing one's fingertips along the 
central aspect of the patient's palm and then transversely across the fingertips, 
gently lifting. This test is performed while the patient is distracted. In a pro­
nounced grasp response, the patient's fingers will hook around the examiner's 
firmly. Even the touch of an inanimate object such as a chair arm may elicit a 
tenacious grasp.
Suck Sign
This sign is elicited by gently stroking the patient's lips with the fingers or 
with a tongue depressor. Sucking or swallowing movements constitute a positive 
response. The same responses may occur at the mere sight of an approaching 
finger.
Snout Sign
With an index finger positioned vertically over the lips, tapping the finger 
with the other hand or with a reflex hammer normally elicits protrusion of the 
lips. An abnormal response is exaggerated protrusion.
Glabellar Sign
This sign is elicited by repetitive tapping between the patient's eyebrows. 
The normal response is to blink a few times and then stop. The response is ab­
normal if the patient continues to blink with each tap as long as the stimulus 
continues. The glabellar sign may also be present in extrapyramidal disorders.
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4. PATHOLOGIC REFLEXES
Pathologic reflexes appear with upper motor neuron damage and conse­
quent loss of inhibition. If tendon reflexes are hyperactive (particularly if asym­
metric) or if spasticity is found, these pathologic reflexes need to be sought- 
though they are not in themselves diagnostic of disease and may in fact be pre­
sent in normal individuals. Pathologic reflexes include the crossed adductor, fin­
ger flexor, jaw jerk, and clonus reflexes.
Crossed Adduction Reflex
Place a hand on the patient's thigh adductor tendon just above and medial 
to the knee and strike briskly. Normally, only the struck leg will adduct. With 
upper motor neuron lesions, both legs may adduct and the patient's legs may 
make a scissoring motion.
Finger Flexor Reflex
Let the patient's arm and hand relax on the bed or table. With thumb and 
forefinger, pick up the patient's hand so that it dangles with the wrist dorsiflexed 
and the fingers partly flexed. With the other hand, "snap" the nail of the patient's 
middle finger with the thumbnail or strike sharply with a reflex hammer against 
the fingers holding the hand. An abnormal response consists of adduction and 
flex ion of the thumb and exaggerated flexion of the fingers.
Jaw Jerk Reflex
With an index finger on the patient’s relaxed chin, strike the finger down­
ward with a reflex hammer. Exaggerated contraction of the masseter suggests bi­
lateral pathology above the mid pons.
Clonus
Clonus is repetitive, rhythmic, involuntary contraction induced by sudden 
passive stretching of a muscle or of its tendon. It may occasionally occur spon­
taneously or be induced in response to a mild stimulus such as the weight of the 
bedclothes. It is most often seen at the ankle after strong and sustained dorsiflex- 
ion.
To elicit ankle clonus, grasp the foot firmly, push sharply upward against 
the sole, and maintain the pressure. A few beats of alternating flexion and ex­
tension of the foot are occasionally seen in normal individuals, but sustained 
clonus (five or more beats) is abnormal.
STANCE & GAIT
Watching the patient walk may be the most important part of the neu­
rologic examination. Seeing how the patient initiates a planned action, evaluat­
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ing the ability to maintain balance while "repetitively hurling oneself into 
space"-as the act of walking has been described-and analyzing an abnormal gait 
for clues to the nature of the deficit all provide valuable information.
The minimal screening examination should include evaluation of the fol­
lowing: (1) "Normal" gait across the room. (2) "Heel-walking" with ankles dor- 
siflexed. (3) "Toe-walking" on the balls of the feet with heels elevated. (4) 
"Tandem" gait, in which the patient puts one foot directly in front of the other, 
heel to toe, and walks an imaginary line.
Some characteristic stances and gaits are as follows.
Steppage Gait ("Foot Drop")
Steppage gait is inability to dorsiflex the foot. The patient compensates by exag­
gerated elevation of the flexed hip and knee to allow the foot to clear the ground 
while walking. This abnormality is usually the result of a peripheral nerve disor­
der such as a peroneal palsy or other neuropathy, but occasionally it results from 
a radiculopathy or central lesion.
Cerebellar Gait
This is a wide-based, irregular, staggering, or reeling gait, as if drunk.
Sensory-Ataxic Gait
A wide-based, short, uneven gait characterized by high steps and slapping 
down of the feet is seen with proprioceptive loss, as in tabes dorsalis. The eyes 
may remain "glued" to the ground.
Hemiplegic Gait
With the affected spastic leg extended and internally rotated and the foot 
in inversion and plantar flexion, the leg circumducts at the hip to allow the foot 
to clear the floor.
Paraplegic Gait
A slow, stiff shuffling gait with the toes scraping and the legs "scissoring" 
because of increased adductor tone associated with spasticity is seen in myelo­
pathy or other bilateral corticospinal tract disease.
Dystrophic Gait
Waddling and lordotic posture may result from pelvic muscle weakness.
Parkinsonian Gait
This consists of slow-starting, short shuffling steps with a tendency to ac­
celerate ("festinate") as if chasing the center of gravity. The posture is stooped, 
turns are "en bloc" with the feet moving only in tiny steps, and there is loss of
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normal associated movements, such as arm swinging, that help to maintain bal­
ance.
Apraxic Gait
Apraxia consists of inability to execute a learned motor program. Gait 
apraxia is loss of the ability to walk and results from diffuse cerebral damage- 
more specifically, damage to the frontal lobe-despite normal strength and coor­
dination. The gait is similar to a parkinsonian gait, but if severe the patient will 
simply stand, partially upright, unable to "remember” how to go about walking, 
the feet seeming to be "glued to the floor." Alternatively, the patient will lift and 
lower the feet without advancing, as if drawn to the floor by magnetic force.
Antalgic Gait
Antalgic gait is a response to pain-favoring one leg by putting as little 
weight as possible on it.
Choreic Gait
Choreic gait is described as lurching, "jerky twitching," and "dancing." 
Falls are surprisingly rare.
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LUMBAR PUNCTURE
Indications
Lumbar puncture is indicated for the following purposes:
1. Diagnosis of meningitis and other infective or inflammatory disorders, 
subarachnoid hemorrhage, hepatic encephalopathy, meningeal malignancies, 
paraneoplastic disorders, or suspected abnormalities of intracranial pressure.
2. Assessment of the response to therapy in meningitis and other infective 
or inflammatory disorders.
3. Administration of intrathecal medications or radiologic contrast media.
4. Rarely, to reduce cerebrospinal fluid (CSF) pressure.
Contraindications
1. Suspected intracranial mass lesion. In this situation, performing a lum­
bar puncture can hasten incipient transtentorial herniation.
2. Local infection overlying the site of puncture. Under this circumstance, 
cervical or cisternal puncture should be performed instead.
3. Coagulopathy. Clotting-factor deficiencies and thrombocytopenia (be­
low 20,000/mm3 or rapidly falling platelet counts) should be corrected before 
lumbar puncture is undertaken, to reduce the risk of hemorrhage.
4. Suspected spinal cord mass lesion. Lumbar puncture in this case should 
be performed only in association with myelography, which is used to determine 
the presence and level of structural spinal pathology.
Preparation
A. Personnel. With a cooperative patient, lumbar puncture can generally 
be performed by one person. An assistant can be helpful in positioning the pa­
tient and handling CSF samples, of course, especially if the patient is uncoopera­
tive or frightened.
B. Equipment and Supplies. The following items, which are usually in­
cluded in preassembled lumbar puncture trays, are required. All must be sterile.
1. Gloves.
2. Iodine-containing solution for sterilizing the skin.
3. Sponges.
4. Drapes.
5. Lidocaine (1 %).
6. Syringe (5 mL).
7. Needles (22- and 25-gauge).
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8. Spinal needles (preferably 22-gauge) with stylets.
9. Three-way stopcock.
10. Manometer.
11. Collection tubes.
12. Adhesive bandage.
C. Positioning. Lumbar puncture is usually performed with the patient in 
the lateral decubitus position, lying at the edge of the bed and facing away from 
the person performing the procedure. The patient's lumbar spine should be maxi­
mally flexed to open the intervertebral spaces. The spine should be parallel to 
the surface of the bed and the hips and shoulders aligned in the vertical plane.
Occasionally, it is desirable to perform lumbar puncture with the patient 
seated. In this case, the patient is seated on the side of the bed, bent over a pil­
low that rests on a bedside table, while the physician reaches over the bed from 
the opposite side to perform the procedure.
D. Site of Puncture. The usual practice is to enter the L3-4 or IA-5 inter­
space, since the spinal cord (conus medullaris) terminates at about the LI-2 level 
in adults. Thus, the procedure is performed without danger of puncturing the 
cord. The L3-4 interspace is located at the level of the posterior iliac crests.
Procedure
1. If a comparison between blood and CSF glucose levels is planned, ve­
nous blood is drawn for glucose determination. Ideally, blood and CSF glucose 
levels should be measured in samples obtained simultaneously after the patient 
has fasted for at least 4 hours.
2. The necessary equipment and supplies are placed within easy reach.
3. Sterile gloves are worn by the person performing the procedure.
4. A wide area surrounding the interspace to be entered is sterilized, using 
iodine-containing solution applied to sponges; the solution is then wiped off 
with clean sponges.
5. The area surrounding the sterile field may be draped.
6. The skin overlying the puncture site is anesthetized using lidocaine, a 
5-mL syringe, and a 25gauge needle. A 22-gauge needle is then substituted to 
anesthetize the underlying tissues.
7. With the stylet in place, the spinal needle is inserted at the midpoint of 
the chosen interspace. The needle should be parallel to the surface of the bed 
and angled slightly cephalad, or toward the umbilicus. The bevel of the needle 
should face upward, toward the face of the person performing the procedure.
8. The needle is advanced slowly until a pop, from penetration of the 
ligamentum flavum, is felt. The stylet is withdrawn to determine whether the 
CSF space has been entered, which is indicated by flow of CSF through the nee­
dle. If no CSF appears, the stylet is replaced and the needle advanced a short
491
distance; this is continued until CSF is obtained. If at some point the needle can­
not be advanced, it is likely that bone has been encountered. The needle is with­
drawn partway, maintained parallel to the surface of the bed, and advanced 
again at a slightly different angle.
9. When CSF is obtained, the stylet is reinserted. The patient is asked to 
straighten his or her legs, and the stopcock and manometer are attached to the 
needle. The stopcock is turned to allow CSF to enter the manometer to measure 
the opening pressure. The pressure should fluctuate with the phases of respira­
tion.
10. The stopcock is turned to allow the CSF to be collected, and the ap­
pearance (clarity and color) of the fluid is noted. The amount obtained and the 
number of tubes required varies, depending on the tests to be performed. Typi­
cally, 1-2 mL are collected in each of five tubes for cell count, glucose and pro­
tein determination, VDRL, Gram's stain, and cultures. Additional specimens 
may be collected for other tests, such as oligoclonal bands and glutamine, and 
for cytologic study. If the CSF appears to contain blood, additional fluid should 
be obtained so that the cell count can be repeated on the specimen in the last 
tube collected. Cytologic studies, if desired, require at least 10 mL of CSF.
11. The stopcock and manometer are replaced to record a closing pres­
sure.
12. The needle is withdrawn and an adhesive bandage is applied over the 
puncture site.
13. It has been customary to have the patient lie prone or supine for I or 2 
hours after the procedure to reduce the risk of post-lumbar-puncture headache. 
Current evidence suggests this is unnecessary.
Complications
A. Unsuccessful Tap. A variety of conditions, including marked obesity, 
degenerative disease of the spine, previous spinal surgery, recent lumbar punc­
ture, and dehydration, can make it difficult to perform lumbar puncture in the 
conventional manner. When puncture in the lateral decubitus position is impos­
sible, the procedure should be attempted with the patient in a sitting position. If 
the tap is again unsuccessful, alternative methods include lumbar puncture by an 
oblique approach or guided by fluoroscopy; lateral cervical puncture; or cister­
nal puncture. These procedures should be undertaken by a neurologist, neuro­
surgeon, or neuroradiologist experienced in performing them.
B. Arterial or Venous Puncture. If the needle enters a blood vessel 
rather than the spinal subarachnoid space, it should be withdrawn and a new 
needle used to attempt the tap at a different level. Patients who have coagulopa­
thy or are receiving aspirin or anticoagulants should be observed with particular 
care for signs of spinal cord compression from spinal subdural or epidural hema­
toma.
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C. Post-lumbar-Puncture Headache. A mild headache, worse in the up­
right position but relieved by recumbency, is not uncommon following lumbar 
puncture and will resolve spontaneously over a period of hours to days. Fre­
quency is directly related to the size of the spinal needle. Vigorous hydration or 
keeping the patient in bed for 1 or 2 hours after the procedure apparently does 
not reduce the likelihood of such headache. The headache usually responds to 
nonsteroidal anti-inflammatory drugs or caffeine. Severe and protracted head­
ache can be treated by an autologous blood clot patch, which should be applied 
by experienced personnel.
Analysis of Results
A. Appearance. The clarity and color of the CSF should be observed as it 
leaves the spinal needle, and any changes in the appearance of fluid during the 
course of the procedure should be noted. CSF is normally clear and colorless. It 
may appear cloudy or turbid with white blood cell counts that exceed about 
200/pL, but counts as low as about 50/pL can be detected by holding the tube up 
to direct sunlight and observing the light-scattering (Tyndall) effect of sus­
pended cells. Color can be imparted to the CSF by hemoglobin (pink), bilirubin 
(yellow), or, rarely, melanin (black).
B. Pressure. With the patient in the lateral decubitus position, CSF pres­
sure in the lumbar region does not normally exceed 180-200 mm water. When 
lumbar puncture is performed with patients in the sitting position, they should 
assume a lateral decubitus posture before CSF pressure is measured. Increased 
CSF pressure may result from obesity, agitation, or increased intra-abdominal 
pressure related to position; the latter factor may be eliminated by having the pa­
tient extend the legs and back once the CSF space has been entered and before 
the opening pressure is recorded. Pathologic conditions associated with in­
creased CSF pressure include intracranial mass lesions, meningoencephalitis, 
subarachnoid hemorrhage, and pseudotumor cerebri.
C. Microscopic Examination. This may be performed either by the per­
son who performed the lumbar puncture or by a technician at the clinical lab­
oratory; it always includes a cell count and differential. Gram's stain for bacteria, 
acid-fast stain for mycobacteria, an India ink preparation for Cryptococcus, and 
cytologic examination for tumor cells may also be indicated. The CSF normally 
contains up to five mononuclear leukocytes (lymphocytes or monocytes) per mi­
croliter, no polymorphonuclear cells, and no erythrocytes. Erythrocytes may be 
present, however, if the lumbar puncture is traumatic (see below). Normal CSF 
is sterile, so that in the absence of central nervous system infection, no organ­
isms should be observed with the various stains listed above.
D. Bloody CSF. If the lumbar puncture yields bloody CSF, it is crucial to 
distinguish between central nervous system hemorrhage and a traumatic tap. The 
fluid should be watched as it leaves the spinal needle to determine whether the
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blood clears, which suggests a traumatic tap. This can be established with 
greater accuracy by comparing cell counts in the first and last tubes of CSF ob­
tained; a marked decrease in the number of red cells supports a traumatic cause. 
The specimen should be centrifuged promptly and the supernatant examined. 
With a traumatic lumbar puncture, the supernatant is colorless. In contrast, fol­
lowing central nervous system hemorrhage, enzymatic degradation of hemoglo­
bin to bilirubin in situ renders the supernatant yellow (xanthochromic). The time 
course of changes in CSF color following subarachnoid hemorrhage is outlined 
for bilirubin (yellow): appearance -  8-12 hours, maximum -  2-4 days, disap­
pearance -  2-3 weeks.
Blood in the CSF following a traumatic lumbar puncture usually clears 
within 24 hours; blood is usually present after subarachnoid hemorrhage for at 
least 6 days. In addition, blood related to traumatic puncture does not clot, while 
clotting may occur with subarachnoid hemorrhage. Crenation (shriveling) of red 
blood cells, however, is of no diagnostic value.
In addition to breakdown of hemoglobin from red blood cells, other 
causes of CSF xanthochromia include jaundice with serum bilirubin levels 
above 4-6 mg/dL, CSF protein concentrations greater than 150 mg/dL, and, 
rarely, the presence of carotene pigments.
White blood cells seen in the CSF early after subarachnoid hemorrhage or 
with traumatic lumbar puncture result from leakage of circulating whole blood. 
If the hematocrit and peripheral white blood cell count are within normal limits, 
there is approximately one white blood cell for each 1000 red cells. If the pe­
ripheral white cell count is elevated, a proportionate increase in this ratio should 
be expected. In addition, every 1000 red cells present in CSF will increase the 
CSF protein concentration by about 1 mg/dL.
494
